Clustering O 0 3.180588237228221e-07
of O 0 2.2978847269428115e-08
missense O 0 9.212517966261657e-07
mutations O 0 8.657441430415247e-10
in O 0 2.5457943045315012e-11
the O 0 9.504141473826166e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 6.186834866639401e-07
in O 0 3.0250180138580163e-10
a O 0 1.6449583015165636e-11
sporadic B-Disease 0 1.2349488542895415e-06
T I-Disease 1 0.986178994178772
- I-Disease 0 2.403106918791309e-05
cell I-Disease 0 2.8504537112894468e-05
leukaemia I-Disease 1 0.9963143467903137
. O 0 6.180027156688084e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.5511315016046865e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.570284208993495e-13
is O 0 4.132553894491695e-15
a O 0 1.5310728691277607e-14
recessive B-Disease 0 1.0872548195095533e-08
multi I-Disease 0 1.3423749805951957e-05
- I-Disease 1 0.9999995231628418
system I-Disease 1 0.5802461504936218
disorder I-Disease 0 8.032502955757082e-05
caused O 0 1.4165790762632469e-09
by O 0 1.014260984227855e-11
mutations O 0 1.2457242702657023e-11
in O 0 1.0691638546722615e-12
the O 0 8.29016629649848e-12
ATM O 0 3.8924046208421714e-09
gene O 0 2.579498897467558e-12
at O 0 4.903439199815951e-12
11q22 O 0 8.68438743140132e-09
- O 0 1.4574575324388661e-08
q23 O 0 2.3780560809427698e-07
( O 0 3.2626835261284626e-12
ref O 0 1.1280588907425226e-08
. O 0 2.602966800435702e-11
3 O 0 7.526104045529891e-11
) O 0 2.8235080289443215e-13
. O 0 1.392450044157556e-10

The O 0 1.2788190950629996e-08
risk O 0 5.7065494551977736e-09
of O 0 9.548140056381271e-10
cancer B-Disease 0 4.204855486023007e-07
, O 0 2.1060899552116652e-11
especially O 0 2.656339148643383e-09
lymphoid B-Disease 0 3.700545221363427e-06
neoplasias I-Disease 0 3.939186626666924e-06
, O 0 6.551122491704753e-12
is O 0 4.4496056958356206e-14
substantially O 0 1.169542934720269e-10
elevated O 0 3.45589512562583e-08
in O 0 2.8020955000762626e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9993863105773926
and O 0 6.311362023281308e-12
has O 0 3.189192210014194e-14
long O 0 2.4735242472968474e-14
been O 0 3.381809873912074e-14
associated O 0 1.3881058628928411e-11
with O 0 3.406674942141308e-11
chromosomal O 1 1.0
instability O 1 1.0
. O 0 2.32614965511857e-07

By O 0 4.261699881880077e-09
analysing O 0 3.044237928406801e-07
tumour B-Disease 1 1.0
DNA O 0 1.7565888299486687e-07
from O 0 5.317067341970017e-10
patients O 0 4.549597143466144e-09
with O 0 3.72672514592845e-13
sporadic B-Disease 0 2.9695357284253987e-07
T I-Disease 0 0.00047153676860034466
- I-Disease 0 1.0189314707531594e-06
cell I-Disease 0 2.5590509267203743e-06
prolymphocytic I-Disease 0 4.910871575702913e-05
leukaemia I-Disease 1 0.9611281156539917
( O 0 2.205201299343429e-12
T B-Disease 0 1.2521078396332541e-08
- I-Disease 0 1.944839622680661e-09
PLL I-Disease 0 3.0983763110725704e-08
) O 0 2.131710471120138e-13
, O 0 3.030845160349044e-14
a O 0 3.635952622966718e-14
rare O 0 1.3855928557293673e-11
clonal B-Disease 0 1.8015056113540595e-08
malignancy I-Disease 0 8.340696666664371e-08
with O 0 1.6217762809772607e-12
similarities O 0 7.38845096215357e-11
to O 0 4.366802492522526e-12
a O 0 3.32763261390312e-11
mature B-Disease 0 1.4720639285314974e-07
T I-Disease 0 3.035482620816765e-07
- I-Disease 0 3.8437266702828765e-09
cell I-Disease 0 1.3642121210466485e-08
leukaemia I-Disease 0 1.7821859046307509e-06
seen O 0 1.6094264809751735e-11
in O 0 2.062086395734908e-12
A B-Disease 1 0.9999216794967651
- I-Disease 0 9.856101678451523e-05
T I-Disease 1 1.0
, O 0 1.613532007657681e-12
we O 0 1.8711676088786766e-14
demonstrate O 0 1.9228767680228888e-14
a O 0 1.2431582811913778e-15
high O 0 3.181150004874511e-13
frequency O 0 4.074129054953968e-12
of O 0 7.329384495158298e-12
ATM O 0 1.5128884456316882e-07
mutations O 0 3.6990290830374306e-09
in O 0 8.598892264899405e-09
T B-Disease 0 0.0005641841562464833
- I-Disease 0 4.06194294555462e-06
PLL I-Disease 0 4.436044400790706e-05
. O 0 1.2765186241381343e-08

In O 0 8.17608980518969e-10
marked O 0 3.898586342643284e-09
contrast O 0 1.8562885673034657e-09
to O 0 3.0351360313929376e-11
the O 0 1.6271133052025988e-10
ATM O 0 4.2328139215896954e-08
mutation O 0 1.7027625143217762e-10
pattern O 0 7.30398866388704e-11
in O 0 9.027375201531296e-12
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
, O 0 5.2063206176788945e-12
the O 0 2.6696667879827496e-13
most O 0 7.47983540204519e-15
frequent O 0 2.9045886315169807e-15
nucleotide O 0 2.675534219089698e-13
changes O 0 9.296288782170703e-13
in O 0 1.125029106333053e-12
this O 0 1.3444344248991769e-10
leukaemia B-Disease 0 0.001546450424939394
were O 0 4.2229091334888835e-09
missense O 0 1.0159624252992216e-06
mutations O 0 2.677169419484926e-08
. O 0 9.904875142296987e-09

These O 0 1.916683523006668e-08
clustered O 0 5.643746359140778e-09
in O 0 7.1263286070821774e-12
the O 0 1.2131406122717348e-11
region O 0 6.64294105834351e-11
corresponding O 0 3.72355479782982e-10
to O 0 2.5576124551562884e-10
the O 0 1.322718379270782e-09
kinase O 0 1.377420399961693e-09
domain O 0 2.937203813502265e-10
, O 0 7.59902449125327e-13
which O 0 1.183528237436518e-13
is O 0 1.6280919212623146e-13
highly O 0 3.232642625805582e-11
conserved O 0 5.467169772455094e-11
in O 0 4.847514317035673e-12
ATM O 0 4.0031856940458965e-08
- O 0 1.4669362391472873e-09
related O 0 1.5598702773900186e-08
proteins O 0 2.9793809086520184e-10
in O 0 6.511013950216693e-11
mouse O 0 1.845876673733926e-09
, O 0 2.446957783966419e-12
yeast O 0 2.5152747440415624e-08
and O 0 6.110028039074678e-10
Drosophila O 0 1.628338175407862e-08
. O 0 1.69395242277659e-09

The O 0 1.844501440473323e-08
resulting O 0 3.112158708518109e-08
amino O 0 2.1505753622363954e-08
- O 0 1.4162420569618916e-08
acid O 0 3.2330358834542494e-08
substitutions O 0 1.6876580133384778e-08
are O 0 1.31904431821539e-10
predicted O 0 6.039124311740807e-09
to O 0 6.461219753672864e-11
interfere O 0 2.314960889648887e-09
with O 0 4.197271002981395e-12
ATP O 0 5.493372867704238e-08
binding O 0 7.891174935714673e-10
or O 0 1.3382023267283216e-10
substrate O 0 9.332496553327019e-09
recognition O 0 6.687401188365527e-10
. O 0 3.0975473297445433e-09

Two O 0 3.910748169744238e-09
of O 0 3.0465594491602133e-09
seventeen O 0 4.200146364041757e-08
mutated O 0 2.0459808069972496e-08
T B-Disease 0 2.6695522592490306e-07
- I-Disease 0 6.963090992684329e-09
PLL I-Disease 0 8.392976980076128e-08
samples O 0 2.1815832473848218e-10
had O 0 1.3354727480124895e-12
a O 0 2.1175827069489297e-14
previously O 0 4.417653309135572e-12
reported O 0 4.2283211654225994e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999972581863403
T I-Disease 1 1.0
allele O 0 3.088753146585077e-07
. O 0 1.909264746302597e-09

In O 0 5.525536028727629e-09
contrast O 0 8.596826361895182e-09
, O 0 3.3093403017936396e-11
no O 0 3.0517848664812774e-11
mutations O 0 3.005359502927796e-11
were O 0 8.293771919243298e-12
detected O 0 6.667901231161011e-10
in O 0 4.0675001561352175e-11
the O 0 3.7989730805598754e-10
p53 O 0 3.1636315789285163e-10
gene O 0 5.956477672208749e-11
, O 0 1.9341236511677407e-12
suggesting O 0 2.650940925108536e-11
that O 0 2.620848687812788e-13
this O 0 1.1014136824805121e-10
tumour B-Disease 1 1.0
suppressor O 0 4.492927018873161e-06
is O 0 3.2747660919790755e-12
not O 0 2.3700347782408537e-13
frequently O 0 4.4590299876946793e-13
altered O 0 7.895115117229068e-11
in O 0 4.707970558542884e-12
this O 0 3.9510983373958197e-10
leukaemia B-Disease 0 0.0036881400737911463
. O 0 4.1371350789631833e-08

Occasional O 0 3.5943173770647263e-06
missense O 0 1.3875006516173016e-05
mutations O 0 3.946688309497404e-08
in O 0 1.2158521967009506e-09
ATM O 0 6.644693712587468e-06
were O 0 1.4213403787266543e-08
also O 0 2.5676506060223758e-11
found O 0 1.1069900204829786e-11
in O 0 2.6308179593148573e-11
tumour B-Disease 1 1.0
DNA O 0 2.532759957318831e-08
from O 0 1.6139584113616934e-10
patients O 0 7.238338817217027e-10
with O 0 2.8768911623615334e-13
B B-Disease 0 5.320989657775499e-07
- I-Disease 0 5.374584666206772e-10
cell I-Disease 0 1.3949028243587236e-07
non I-Disease 0 1.5418054317706265e-05
- I-Disease 0 9.31993272388354e-05
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.8978739380836487
( O 0 1.5185567647096887e-12
B B-Disease 0 8.881009705419274e-09
- I-Disease 0 5.9383466026463605e-12
NHL I-Disease 0 3.777788748493549e-09
) O 0 4.003845120574036e-14
and O 0 5.139129681704102e-13
a O 0 4.654985164692649e-12
B B-Disease 0 2.809031514061644e-07
- I-Disease 0 7.611831165377225e-10
NHL I-Disease 0 6.082749450797564e-07
cell O 0 1.744749908993981e-07
line O 0 8.029098808037816e-08
. O 0 3.122187175463864e-09

The O 0 2.9144184288121266e-10
evidence O 0 2.3282530070556362e-10
of O 0 2.437186910619893e-11
a O 0 4.110053226577537e-13
significant O 0 2.5181128016082965e-11
proportion O 0 8.90792883900815e-10
of O 0 1.8932969081397744e-10
loss O 0 4.678843076866279e-11
- O 0 3.9503897375503527e-10
of O 0 6.340703961882355e-09
- O 0 1.1385681286668614e-09
function O 0 4.445082843473891e-11
mutations O 0 9.744582528045664e-13
and O 0 1.8478059319736347e-14
a O 0 7.607980475536451e-15
complete O 0 9.187497117257859e-12
absence O 0 5.59472024264096e-10
of O 0 5.993195523190664e-11
the O 0 7.33814051190329e-12
normal O 0 4.9650283884261626e-11
copy O 0 4.59360015303556e-11
of O 0 1.2397936843822066e-11
ATM O 0 1.3880225857576534e-09
in O 0 1.2154330276611947e-12
the O 0 5.777354723096595e-12
majority O 0 7.094038464300345e-12
of O 0 2.1554887041919102e-10
mutated O 0 2.881072077798308e-06
tumours B-Disease 1 1.0
establishes O 0 5.637054378837547e-09
somatic O 0 7.358266884693876e-08
inactivation O 0 2.4284025812448817e-07
of O 0 5.6914990081979866e-11
this O 0 1.2230444521726946e-12
gene O 0 1.3021549984115754e-12
in O 0 6.374997101391e-13
the O 0 2.750801843254269e-11
pathogenesis O 0 2.0267668787710136e-07
of O 0 1.3579912749861478e-09
sporadic B-Disease 0 2.939239323040965e-07
T I-Disease 0 1.088657882064581e-05
- I-Disease 0 2.148294271364648e-07
PLL I-Disease 0 2.0365450836834498e-06
and O 0 1.486575099129972e-11
suggests O 0 1.0677297587746715e-11
that O 0 1.0076359844711676e-14
ATM O 0 4.818242471671397e-10
acts O 0 1.0151279990211481e-11
as O 0 2.4339859988620205e-11
a O 0 8.889627228780839e-11
tumour B-Disease 1 1.0
suppressor O 0 2.4295281036756933e-05
. O 0 3.08170839957711e-08

As O 0 2.2957074463647587e-08
constitutional O 0 2.7823610082577943e-08
DNA O 0 6.0747291641405354e-09
was O 0 1.167314300776212e-10
not O 0 2.1087165759207938e-13
available O 0 3.469017174212441e-12
, O 0 1.233315885399225e-13
a O 0 2.405830092436223e-12
putative O 0 1.3402902823145268e-06
hereditary O 1 0.9999654293060303
predisposition O 1 0.9999339580535889
to O 0 1.5623882063664496e-05
T B-Disease 1 0.9999797344207764
- I-Disease 0 4.198862825433025e-06
PLL I-Disease 0 2.861943812604295e-06
will O 0 2.8994896761336264e-12
require O 0 3.347235140969962e-13
further O 0 2.0641000302197565e-13
investigation O 0 2.205117165254844e-12
. O 0 3.284111264184597e-12
. O 0 1.3677410592993766e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.0004183043201919645
kinase O 0 1.2274198013528803e-07
is O 0 1.7995100852138957e-12
involved O 0 1.3059922609505448e-13
in O 0 1.305341553299805e-14
the O 0 9.130521181786519e-14
modulation O 0 2.6780730411068987e-12
of O 0 1.0601983700675444e-12
the O 0 1.4501015839496478e-11
Ca2 O 0 3.975818008150611e-10
+ O 0 4.903989214710691e-09
homeostasis O 0 7.409175051265038e-09
in O 0 2.1189767995810627e-10
skeletal O 0 2.4657128960825503e-07
muscle O 0 6.960430596336664e-07
cells O 0 0.0024456889368593693
. O 0 2.3540343363492866e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.9582373056437063e-07
DM B-Disease 1 1.0
) O 0 1.468654503566924e-10
, O 0 3.3850010468239322e-12
the O 0 1.89670050498858e-11
most O 0 5.858440121908615e-11
prevalent O 0 1.592297849128954e-05
muscular B-Disease 0 1.5292671378119849e-06
disorder I-Disease 0 3.713822297868319e-05
in O 0 5.106122746845188e-10
adults O 0 4.885743476457094e-10
, O 0 2.1948551510346873e-14
is O 0 2.692943685360101e-15
caused O 0 1.2464794821309688e-12
by O 0 9.001876501157913e-12
( O 0 2.437185652945373e-12
CTG O 0 1.4362635525344558e-08
) O 0 3.117520008962503e-14
n O 0 7.052523170493485e-13
- O 0 1.92004593647932e-12
repeat O 0 3.3480414621256394e-12
expansion O 0 9.412447904422194e-11
in O 0 3.2838713844539347e-13
a O 0 1.261003562853802e-13
gene O 0 4.125470852520824e-13
encoding O 0 1.0940248706958755e-10
a O 0 8.638847276420947e-11
protein O 0 1.5483898607726587e-08
kinase O 0 4.719037960398964e-08
( O 0 1.399743515539953e-10
DM B-Disease 1 1.0
protein O 0 6.942445907043293e-08
kinase O 0 1.921627745815613e-09
; O 0 1.8031255308303962e-11
DMPK O 0 2.5036208626261214e-06
) O 0 2.738642917044648e-13
and O 0 2.0497800234508395e-13
involves O 0 8.820472022046111e-13
changes O 0 2.4203108267562e-11
in O 0 1.0466232741590531e-10
cytoarchitecture O 0 1.5537925719399936e-05
and O 0 1.2370342972189974e-08
ion O 0 9.826942459767452e-07
homeostasis O 0 2.754153229034273e-06
. O 0 8.091429322121257e-07

To O 0 7.635299614783264e-10
obtain O 0 3.4559459738403575e-09
clues O 0 1.8374216592675907e-09
to O 0 4.649942540388419e-13
the O 0 2.8794069992926774e-12
normal O 0 1.765269264097924e-09
biological O 0 1.4961677730074285e-10
role O 0 9.525143174204942e-11
of O 0 3.043947316427875e-08
DMPK O 1 1.0
in O 0 7.130745871108957e-06
cellular O 0 1.536859457473838e-07
ion O 0 2.478693872376425e-08
homeostasis O 0 1.2875124077993405e-08
, O 0 5.096788963099286e-11
we O 0 9.345931147042297e-12
have O 0 1.8575254182029433e-12
compared O 0 1.4661885594513535e-10
the O 0 3.268415399437785e-11
resting O 0 2.9377824617426995e-09
[ O 0 9.685366224310155e-12
Ca2 O 0 9.709888058526128e-13
+ O 0 3.4906678242352385e-12
] O 0 8.53665055311481e-12
i O 0 6.513019832656008e-13
, O 0 8.906139782366602e-15
the O 0 5.367710128375419e-14
amplitude O 0 7.945416893861967e-12
and O 0 4.896184369398981e-13
shape O 0 7.440578014827892e-11
of O 0 1.311878661258703e-10
depolarization O 0 1.8622249298161364e-09
- O 0 1.3092297246330986e-09
induced O 0 3.6940233094640007e-09
Ca2 O 0 2.236940493949291e-11
+ O 0 6.665007955264368e-12
transients O 0 5.2514419895954845e-11
, O 0 1.6159880914965938e-14
and O 0 7.788190123196592e-15
the O 0 9.136322341035674e-14
content O 0 4.7766222401046665e-12
of O 0 9.68004756213281e-12
ATP O 0 9.854640126150116e-08
- O 0 2.2519529352393874e-08
driven O 0 4.169161726963466e-08
ion O 0 8.350976798965348e-09
pumps O 0 3.5459475355992254e-09
in O 0 5.30800611797666e-11
cultured O 0 5.296333682736076e-08
skeletal O 0 1.9681598573129122e-08
muscle O 0 5.730826369010344e-10
cells O 0 3.63366901012796e-08
of O 0 1.9649055993387066e-10
wild O 0 1.7416203201836566e-10
- O 0 1.910977669508651e-12
type O 0 2.187244309281855e-11
and O 0 7.474309799554435e-13
DMPK O 0 9.442883879273722e-07
[ O 0 1.1354884810188537e-09
- O 0 2.285449163252906e-08
/ O 0 8.192691325348278e-08
- O 0 1.138655193244631e-06
] O 0 4.493911376357573e-08
knockout O 0 1.9642975246370042e-07
mice O 0 3.742025356245904e-09
. O 0 1.7374596206209958e-10

In O 0 3.139194859613781e-08
vitro O 0 1.7987713363254443e-06
- O 0 1.2392515600367915e-06
differentiated O 0 4.310303211241262e-06
DMPK O 0 0.046261657029390335
[ O 0 1.3500840445601625e-08
- O 0 9.37688859892205e-09
/ O 0 5.100547539882427e-09
- O 0 9.29265553395453e-09
] O 0 7.694743731079257e-10
myotubes O 0 2.611881377845293e-09
exhibit O 0 2.6738264380377075e-12
a O 0 5.738001084476183e-14
higher O 0 7.584900069135259e-11
resting O 0 1.0096278257876179e-09
[ O 0 7.025969216145622e-12
Ca2 O 0 2.9575400288528453e-12
+ O 0 1.1455854494191176e-11
] O 0 5.069351882713846e-11
i O 0 7.856579969933719e-12
than O 0 3.071362825526891e-12
do O 0 7.820260823458713e-13
wild O 0 5.0973530951736734e-11
- O 0 7.136475872054904e-12
type O 0 1.5653647822411187e-10
myotubes O 0 6.535060492751654e-08
because O 0 6.433586996479335e-11
of O 0 6.0563017274806175e-12
an O 0 4.008481355410832e-15
altered O 0 4.8608676112005256e-11
open O 0 1.207507965145238e-11
probability O 0 6.3493472632347725e-12
of O 0 8.044227610415344e-12
voltage O 0 1.1769759389324008e-08
- O 0 8.40841507532275e-10
dependent O 0 1.0367136038524905e-09
l O 0 7.317845981957838e-12
- O 0 1.9905781883933216e-11
type O 0 1.5561860827739693e-11
Ca2 O 0 1.170874855405124e-11
+ O 0 1.9914745200133588e-11
and O 0 1.2610330531528935e-12
Na O 0 2.581504732201978e-10
+ O 0 9.238267789646315e-11
channels O 0 4.151998536650048e-11
. O 0 9.072570472667962e-11

The O 0 2.390842723798414e-07
mutant O 0 7.549476777057862e-07
myotubes O 0 3.999723048764281e-06
exhibit O 0 7.90755638746532e-09
smaller O 0 2.779854402223947e-10
and O 0 6.0176247665411076e-12
slower O 0 9.53182333063296e-09
Ca2 O 0 3.983068541657531e-09
+ O 0 1.7872124891127328e-09
responses O 0 9.313051718695675e-11
upon O 0 8.40594191475752e-11
triggering O 0 7.475314811600242e-11
by O 0 8.644590577221167e-13
acetylcholine O 0 2.078650168657603e-10
or O 0 1.5370860140251352e-10
high O 0 6.752667314202654e-10
external O 0 3.740717458011744e-10
K O 0 3.204384313448827e-08
+ O 0 1.2411908167919705e-09
. O 0 3.4521890901473284e-10

In O 0 4.83865347788992e-09
addition O 0 2.1777137870770957e-09
, O 0 8.796691153278857e-11
we O 0 1.0406093521597715e-11
observed O 0 2.1032840399892727e-11
that O 0 1.4965565136963732e-13
these O 0 4.912641474175139e-12
Ca2 O 0 2.2887927664250185e-10
+ O 0 1.6468593155849476e-09
transients O 0 2.124494891120321e-08
partially O 0 2.904295380579125e-11
result O 0 2.623030482054589e-12
from O 0 1.1584875853759558e-12
an O 0 1.377437948451481e-14
influx O 0 1.8435737311750522e-11
of O 0 7.564900095236027e-12
extracellular O 0 2.0978309367425396e-11
Ca2 O 0 1.7084613238016466e-11
+ O 0 1.3354733117976192e-11
through O 0 8.281769367513014e-13
the O 0 1.2622170019252477e-12
l O 0 7.881385431438015e-13
- O 0 1.7862019155434616e-11
type O 0 4.443023379763211e-11
Ca2 O 0 6.636646787683276e-11
+ O 0 3.8547814940059766e-10
channel O 0 5.743801961832773e-11
. O 0 8.53144638268688e-11

Neither O 0 3.0360697564901784e-06
the O 0 6.623628756585731e-09
content O 0 5.8658371493436334e-09
nor O 0 2.5084274657416472e-09
the O 0 9.839089612495577e-12
activity O 0 2.2719431891360387e-10
of O 0 2.199850371309431e-11
Na O 0 1.0690636154109256e-09
+ O 0 2.0681859003168768e-10
/ O 0 4.149997567814978e-10
K O 0 5.445587869523649e-10
+ O 0 2.015372244090763e-11
ATPase O 0 3.396184375392686e-11
and O 0 9.729502360028564e-13
sarcoplasmic O 0 3.480645494047252e-10
reticulum O 0 2.0536232714363223e-09
Ca2 O 0 2.8983976330110295e-10
+ O 0 1.772431090785176e-10
- O 0 1.767812285446979e-10
ATPase O 0 2.232611040486887e-10
are O 0 1.3995358691398785e-13
affected O 0 7.338098878539867e-12
by O 0 1.0808208494861304e-11
DMPK O 1 0.7095828056335449
absence O 0 3.711326644406654e-05
. O 0 4.0213919305642776e-07

In O 0 2.961377365551243e-09
conclusion O 0 4.256056485019144e-08
, O 0 9.19847878422253e-11
our O 0 3.559014541409944e-11
data O 0 2.0227739622180607e-11
suggest O 0 4.312046206211839e-11
that O 0 3.186390767125763e-13
DMPK O 0 0.013671409338712692
is O 0 2.074046013059161e-12
involved O 0 4.68632294428617e-13
in O 0 1.9624869763111563e-13
modulating O 0 8.600425926985622e-11
the O 0 2.8434680825195624e-12
initial O 0 1.185196558950441e-11
events O 0 4.851643785612654e-14
of O 0 2.0554647664917242e-13
excitation O 0 1.9599957212790287e-09
- O 0 2.93330870704267e-09
contraction O 0 1.3821522815149478e-09
coupling O 0 9.26638543674585e-10
in O 0 2.742848830006306e-11
skeletal O 0 4.708300860301051e-09
muscle O 0 3.6197285169237148e-09
. O 0 2.8824225228873956e-09
. O 0 8.324752442945282e-09

Constitutional O 0 0.00034106848761439323
RB1 O 0 0.015304838307201862
- O 0 0.0007265186286531389
gene O 0 4.896495653383681e-08
mutations O 0 1.3927117237244602e-08
in O 0 1.4944165349639604e-10
patients O 0 1.0078355217046919e-07
with O 0 1.992325575350673e-11
isolated O 0 2.1928875071353104e-07
unilateral B-Disease 0 1.2300825801503379e-05
retinoblastoma I-Disease 1 0.9999998807907104
. O 0 0.00050604302668944

In O 0 4.044435453209871e-09
most O 0 5.516382350911897e-10
patients O 0 2.737113424799986e-09
with O 0 4.412710214590776e-12
isolated O 0 1.2088997891623876e-07
unilateral B-Disease 0 2.202556424890645e-05
retinoblastoma I-Disease 1 1.0
, O 0 7.74525574342988e-07
tumor B-Disease 1 0.9999994039535522
development O 0 1.1344543082714154e-08
is O 0 7.154162245254225e-13
initiated O 0 1.5751755802484446e-11
by O 0 1.016609349870426e-13
somatic O 0 2.153168088270263e-09
inactivation O 0 5.327965979518012e-08
of O 0 1.9635074816060083e-11
both O 0 3.3828324256385267e-12
alleles O 0 3.1932492674385804e-12
of O 0 2.029529148905862e-11
the O 0 3.737565257289077e-10
RB1 O 0 7.111939794413047e-06
gene O 0 1.6348851161751554e-09
. O 0 7.378487598685979e-09

However O 0 7.813956699465052e-07
, O 0 3.1945682210654525e-10
some O 0 1.1265048789621535e-11
of O 0 4.5467903747598015e-11
these O 0 2.1170135089398912e-10
patients O 0 1.1215149919863165e-09
can O 0 1.7310219230237678e-11
transmit O 0 2.5489645949505757e-09
retinoblastoma B-Disease 0 6.861328074592166e-06
predisposition O 0 2.7441435577202355e-06
to O 0 7.580857719347023e-09
their O 0 1.0933921856803863e-07
offspring O 0 1.5175572798398207e-06
. O 0 7.63897478606168e-09

To O 0 2.684893418702927e-10
determine O 0 4.889787186268535e-11
the O 0 7.27623170049263e-12
frequency O 0 2.577239255341368e-10
and O 0 4.155537892958083e-12
nature O 0 7.143643315776771e-11
of O 0 2.1530437155359294e-10
constitutional O 0 1.119621742873278e-06
RB1 O 0 0.0001129197480622679
- O 0 1.355194513052993e-06
gene O 0 7.141167102098223e-10
mutations O 0 7.01890434662289e-10
in O 0 2.688853306676009e-11
patients O 0 7.092195719593519e-09
with O 0 2.321492824364224e-12
isolated O 0 1.3937002663055864e-08
unilateral B-Disease 0 3.607056555665622e-07
retinoblastoma I-Disease 1 0.9989951252937317
, O 0 6.928658979887814e-09
we O 0 1.0228893426722507e-10
analyzed O 0 1.3049906988360505e-10
DNA O 0 1.545965300220331e-10
from O 0 1.0429779435938702e-11
peripheral O 0 2.1069689992714302e-08
blood O 0 7.094877929603172e-08
and O 0 1.5952221488202412e-10
from O 0 2.5151378202359354e-10
tumor B-Disease 0 6.68700465666916e-07
tissue O 0 1.4861443276004138e-07
. O 0 1.3155132094766486e-08

The O 0 1.1859756510190778e-09
analysis O 0 2.1514756642915245e-10
of O 0 8.224360747988158e-09
tumors B-Disease 1 1.0
from O 0 9.68425766245673e-08
54 O 0 6.654985185150508e-08
( O 0 7.031006094178338e-13
71 O 0 3.6877978448757176e-10
% O 0 7.630323239568582e-13
) O 0 3.1036411623635045e-15
of O 0 1.2593360599125192e-12
76 O 0 1.2277605598853825e-09
informative O 0 5.06722719340047e-10
patients O 0 5.252766555052801e-10
showed O 0 1.745896656413226e-11
loss O 0 2.2132420895992766e-11
of O 0 5.13535547419508e-10
constitutional O 0 1.3838849554304034e-05
heterozygosity O 0 0.005112913902848959
( O 0 1.0441155717799688e-09
LOH O 0 0.0020311709959059954
) O 0 7.191405890921709e-12
at O 0 7.829283749094529e-11
intragenic O 0 2.160615792945464e-07
loci O 0 3.5842255385887256e-08
. O 0 1.6911767986016457e-08

Three O 0 5.80373793468425e-09
of O 0 5.590335971916716e-10
13 O 0 1.868231258583819e-08
uninformative O 0 0.0005519188707694411
patients O 0 8.134973177220672e-05
had O 0 5.366822541930105e-09
constitutional O 0 1.9398669337533647e-06
deletions O 0 6.336804744933033e-06
. O 0 1.3556804105974152e-06

For O 0 4.525530528098898e-08
39 O 0 3.0905052881280426e-06
randomly O 0 8.357943670489476e-08
selected O 0 1.619679437681043e-06
tumors B-Disease 1 1.0
, O 0 1.8526602474366882e-08
SSCP O 1 0.9999997615814209
, O 0 8.195017109358105e-09
hetero O 0 3.4843289142827416e-08
- O 0 1.6758905374558708e-10
duplex O 0 4.870047698446456e-10
analysis O 0 2.7785952792097612e-12
, O 0 1.1551111629704014e-13
sequencing O 0 7.717727845690803e-11
, O 0 3.849928188748297e-12
and O 0 9.571834644339638e-12
Southern O 0 2.8761493187090537e-10
blot O 0 5.067558817017925e-09
analysis O 0 4.0010629358266936e-12
were O 0 8.659542809381915e-13
used O 0 6.31880236068999e-13
to O 0 1.8395800507886584e-11
identify O 0 2.1074662015507784e-09
mutations O 0 3.364243639225606e-08
. O 0 8.684109786827321e-08

Mutations O 0 5.527156758944329e-07
were O 0 6.979442024324101e-10
detected O 0 7.781171817988763e-10
in O 0 1.4097501811749513e-11
21 O 0 1.6663738167110864e-09
( O 0 3.4052228810137197e-13
91 O 0 1.1807821387321837e-09
% O 0 1.6587035564508135e-12
) O 0 2.125238190726214e-14
of O 0 3.441418677807562e-11
23 O 0 3.963923063565744e-06
tumors B-Disease 1 1.0
with O 0 4.706346317107091e-06
LOH O 1 1.0
. O 0 0.00015918092685751617

In O 0 7.688909064995642e-09
6 O 0 2.6725418322826044e-08
( O 0 3.7653955474448164e-12
38 O 0 1.4813291704385279e-09
% O 0 5.9676755724547e-12
) O 0 1.6849907157490823e-13
of O 0 3.681501214991556e-10
16 O 0 6.3037923609954305e-06
tumors B-Disease 1 1.0
without O 1 0.9999996423721313
LOH O 1 1.0
, O 0 5.132401170726553e-09
one O 0 2.0252136773146745e-11
mutation O 0 3.484275368226264e-12
was O 0 1.3761946226695243e-12
detected O 0 3.416448374204961e-11
, O 0 2.7024294802814597e-13
and O 0 3.664094310081023e-13
in O 0 4.026487476771479e-12
9 O 0 8.131270101685573e-10
( O 0 1.6310788982475122e-13
56 O 0 1.0679299111693297e-10
% O 0 2.7750506970472544e-13
) O 0 7.86945107602438e-15
of O 0 1.366637445571195e-11
the O 0 1.2504902713317279e-07
tumors B-Disease 1 1.0
without O 1 0.9999911785125732
LOH O 1 1.0
, O 0 4.924704199993357e-09
both O 0 1.1954363887678454e-10
mutations O 0 8.296307391075786e-11
were O 0 2.9958934638640855e-11
found O 0 1.545728822716086e-11
. O 0 7.625068909611343e-10

Thus O 0 2.9152555924838452e-08
, O 0 1.7698389628839628e-11
a O 0 5.636978514175772e-13
total O 0 1.8360736108585796e-12
of O 0 2.9842361221055214e-11
45 O 0 7.267056956195006e-10
mutations O 0 1.0664216731903764e-10
were O 0 9.595602784573387e-11
identified O 0 4.395251107514042e-10
in O 0 9.905984921232402e-10
tumors B-Disease 1 1.0
of O 0 2.0932581890065194e-07
36 O 0 4.060526634930284e-07
patients O 0 9.77532153001448e-08
. O 0 7.457436446145493e-09

Thirty O 0 1.8811412019204e-06
- O 0 3.7327172464074465e-08
nine O 0 7.178229677329284e-10
of O 0 7.021993403411031e-11
the O 0 1.7681225927823618e-10
mutations O 0 7.421953329700415e-11
- O 0 1.3756561445532611e-09
including O 0 1.1246076292437124e-10
34 O 0 7.985994976422717e-09
small O 0 3.8941232183287156e-11
mutations O 0 2.978884847126828e-11
, O 0 2.778102617742584e-12
2 O 0 2.1992388465896795e-10
large O 0 1.0166102334951965e-11
structural O 0 8.133007045607599e-10
alterations O 0 3.186685353284702e-05
, O 0 2.3238454716079104e-08
and O 0 4.9188862760729535e-08
hypermethylation O 1 0.9996416568756104
in O 0 3.368859097463428e-06
3 O 0 5.091619095765054e-05
tumors O 1 1.0
- O 0 2.8702760168641817e-09
were O 0 5.021485310896523e-11
not O 0 2.8724499992124897e-13
detected O 0 3.558390040958592e-11
in O 0 1.14029581133393e-13
the O 0 1.1186611532931767e-12
corresponding O 0 9.746600748705703e-11
peripheral O 0 2.480391714243524e-08
blood O 0 2.3532390258651503e-08
DNA O 0 7.223697906511006e-08
. O 0 6.558771303843969e-09

In O 0 2.0114812926408376e-08
6 O 0 4.0489908315066714e-08
( O 0 2.32115607116945e-12
17 O 0 1.4965444161685326e-10
% O 0 5.494186377554e-13
) O 0 1.936394185663294e-15
of O 0 1.074758012621635e-12
the O 0 6.00253041715959e-11
36 O 0 1.3575206736504697e-08
patients O 0 1.1839888713893743e-07
, O 0 6.35539364191029e-12
a O 0 1.2797052480195692e-11
mutation O 0 6.630121451856041e-10
was O 0 4.0342942875248866e-10
detected O 0 8.252110994533268e-09
in O 0 5.763214905307734e-11
constitutional O 0 4.580865464731687e-09
DNA O 0 3.065935949564391e-09
, O 0 2.7761215635330183e-12
and O 0 1.2048938236031148e-12
1 O 0 1.583813635797071e-10
of O 0 2.323770863232877e-11
these O 0 9.394154898423324e-11
mutations O 0 7.776534624581721e-12
is O 0 1.1441061043438588e-13
known O 0 4.778296898780288e-13
to O 0 2.480797143232516e-13
be O 0 1.0692842011134074e-12
associated O 0 2.2161242285712035e-10
with O 0 6.501753128940191e-12
reduced O 0 1.795400237369904e-07
expressivity O 0 4.190510935586644e-06
. O 0 2.7313726391753335e-08

The O 0 2.7897476329030724e-08
presence O 0 1.0109265646818244e-09
of O 0 3.0060562927758383e-09
a O 0 1.430700089649628e-11
constitutional O 0 5.931405588910366e-09
mutation O 0 4.823297317102515e-11
was O 0 4.479559518461018e-12
not O 0 1.6486466326241095e-14
associated O 0 9.364180438009573e-13
with O 0 1.4089301463864512e-15
an O 0 4.201940133613248e-16
early O 0 1.3320644066949772e-11
age O 0 3.17545503780714e-11
at O 0 3.0627399488086793e-12
treatment O 0 7.5745267835714e-09
. O 0 5.488018484101076e-09

In O 0 3.077125887429588e-09
1 O 0 1.1028424751202692e-07
patient O 0 1.0784387995954603e-06
, O 0 2.4445345747636793e-10
somatic O 0 0.0001549275330035016
mosaicism O 0 0.2572288513183594
was O 0 1.67884761648196e-09
demonstrated O 0 6.339209712713512e-11
by O 0 3.9410366788582285e-13
molecular O 0 1.6017267807227897e-12
analysis O 0 3.4416580371211813e-13
of O 0 1.1103220122835045e-12
DNA O 0 2.2690849199591412e-10
and O 0 7.028006648868157e-12
RNA O 0 4.8102355432178e-10
from O 0 6.052552209423467e-11
peripheral O 0 2.3347575961452094e-07
blood O 0 5.132976070854056e-07
. O 0 3.47023529911894e-08

In O 0 3.326089270672128e-08
2 O 0 8.42495850861269e-08
patients O 0 3.4838620877053472e-09
without O 0 6.072858188543862e-11
a O 0 2.5280742776967458e-11
detectable O 0 1.8349661559113883e-06
mutation O 0 3.6932711111603567e-08
in O 0 3.0974511844306107e-10
peripheral O 0 2.7788928491645493e-06
blood O 0 1.8392463971395046e-05
, O 0 2.550076816376645e-10
mosaicism O 0 6.847196345916018e-06
was O 0 4.6189405078500556e-10
suggested O 0 1.2377954217157594e-10
because O 0 1.2800104726151673e-11
1 O 0 3.9304354215730086e-10
of O 0 6.551584795511101e-12
the O 0 1.5883938608851622e-10
patients O 0 3.495885181337144e-08
showed O 0 2.244547125940244e-08
multifocal O 1 0.9999984502792358
tumors B-Disease 1 1.0
and O 0 1.0618478540891374e-08
the O 0 5.907647149250295e-10
other O 0 4.4123839998411185e-11
later O 0 8.679597596206179e-10
developed O 0 2.007019217487027e-09
bilateral B-Disease 0 5.002741818316281e-05
retinoblastoma I-Disease 0 0.0009561973274685442
. O 0 3.0721898269803205e-07

In O 0 1.0226635094312542e-09
conclusion O 0 8.759330150098776e-09
, O 0 6.412100017616496e-11
our O 0 3.616412724838369e-11
results O 0 3.698883907499173e-11
emphasize O 0 6.458533707842662e-11
that O 0 1.0025219044675071e-13
the O 0 5.193129780367567e-12
manifestation O 0 1.9402165207793587e-08
and O 0 2.1111021264452745e-10
transmissibility O 0 6.81662470469746e-07
of O 0 1.7240184835287664e-09
retinoblastoma B-Disease 0 6.278799702386095e-08
depend O 0 5.417546855568389e-09
on O 0 2.0214019347264411e-10
the O 0 6.346756453723401e-12
nature O 0 2.0337412309778813e-11
of O 0 1.3583110330950277e-11
the O 0 1.0172504331940058e-11
first O 0 2.890479522399403e-11
mutation O 0 3.4921063436776922e-12
, O 0 9.010147635586316e-14
its O 0 7.420356917895582e-14
time O 0 2.0684797191056203e-12
in O 0 4.981379024548982e-12
development O 0 4.4060957660185807e-10
, O 0 2.4130866575766685e-12
and O 0 3.956440643854142e-12
the O 0 1.6157502419344993e-11
number O 0 9.39778810327141e-12
and O 0 6.513392256102257e-13
types O 0 3.6287944871205013e-11
of O 0 2.787837669049331e-12
cells O 0 1.5147912438284727e-11
that O 0 4.92849711779611e-14
are O 0 1.6947181776406223e-13
affected O 0 5.198186325827692e-11
. O 0 6.018224113502058e-11
. O 0 2.127705567289695e-09

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
of I-Disease 0 0.009296375326812267
the I-Disease 0 5.586823590419954e-07
fifth I-Disease 0 8.93935663270895e-08
component I-Disease 0 2.0061325045617195e-08
of I-Disease 0 2.2179604819427823e-09
complement I-Disease 0 1.0178497156232424e-08
in O 0 8.602174084160197e-09
man O 0 6.798667584462237e-08
. O 0 3.475494736449036e-08

I O 0 0.003754732199013233
. O 0 7.931348022793827e-07

Clinical O 0 2.761030373221729e-06
, O 0 3.8603881202803336e-10
immunochemical O 0 2.7334912374499254e-05
, O 0 4.899237127098388e-10
and O 0 2.8615723679514815e-10
family O 0 6.232582228093975e-10
studies O 0 3.523716873843341e-10
. O 0 5.731460306357405e-10

The O 0 3.707250506579385e-09
first O 0 4.33642871611184e-10
recognized O 0 1.2376873970154634e-09
human O 0 3.4428140338604862e-09
kindred O 0 0.09216216951608658
with O 0 1.3105637686194882e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999934434890747
of I-Disease 0 5.844979750690982e-05
the I-Disease 0 1.3617841077007142e-08
fifth I-Disease 0 3.829135675204043e-09
component I-Disease 0 2.693450129598318e-09
of I-Disease 0 5.878807218806514e-09
complement I-Disease 0 1.4933731051769428e-07
( O 0 5.339089725886481e-10
C5 O 0 0.01613149419426918
) O 0 2.7055510609663713e-12
is O 0 1.490958723669722e-12
described O 0 2.2800958343616173e-10
. O 0 5.944203351759825e-09

The O 0 6.706183341975702e-08
proband O 0 5.771320502390154e-05
, O 0 3.382874536050906e-10
a O 0 7.867691741159089e-12
20 O 0 2.801175090494379e-11
- O 0 2.5816352094282236e-12
year O 0 7.622167653986711e-12
- O 0 1.0859563248644122e-10
old O 0 8.366050907593348e-11
black O 0 5.462692472847641e-13
female O 0 7.397263242215051e-15
with O 0 1.7067651206736055e-14
systemic B-Disease 1 0.9999997615814209
lupus I-Disease 1 0.9999804496765137
erythematosus I-Disease 1 1.0
since O 0 7.364174234680831e-05
age O 0 0.12266521155834198
11 O 0 3.080014465695058e-09
, O 0 1.0598692930241516e-11
lacked O 0 7.76760789023001e-09
serum O 0 2.7397156543429446e-08
hemolytic O 0 7.801478204783052e-05
complement O 0 7.55648876804571e-09
activity O 0 3.5941038589726304e-08
, O 0 2.5552548358481753e-12
even O 0 2.102801439918256e-12
during O 0 6.69525962448958e-11
remission O 0 8.649180927022826e-08
. O 0 2.6715825107714863e-09

C5 O 1 0.9927840232849121
was O 0 4.83849873944564e-07
undetectable O 0 1.0794893796628457e-06
in O 0 5.413824943900636e-10
her O 0 1.2932105039609176e-11
serum O 0 2.262774967398684e-10
by O 0 4.991070057247526e-12
both O 0 1.201175409137889e-10
immunodiffusion O 0 2.005900205404032e-05
and O 0 6.223699777763159e-09
hemolytic O 0 0.3305603861808777
assays O 0 2.5113420633715577e-05
. O 0 6.355908226396423e-07

Other O 0 1.8018827541155247e-09
complement O 0 8.680855478893079e-10
components O 0 8.631819148341435e-10
were O 0 2.7090947540830967e-11
normal O 0 7.61789867298468e-11
during O 0 2.58328167884736e-11
remission O 0 2.7727086404638612e-08
of O 0 3.467651166211283e-10
lupus O 0 9.78580260380113e-07
, O 0 1.2134150351172934e-09
but O 0 1.1034522628960985e-08
C1 O 0 5.710423010896193e-06
, O 0 1.5177853418535392e-10
C4 O 0 7.668406851735199e-07
, O 0 2.0819186652420996e-11
C2 O 0 1.2689591599723826e-08
, O 0 1.6353762094523105e-11
and O 0 4.8182335898872e-10
C3 O 1 0.5263859629631042
levels O 0 2.5265583190048346e-06
fell O 0 1.3030528407398378e-06
during O 0 3.2063207644483782e-09
exacerbations O 0 9.606630919734016e-05
. O 0 2.0150415025455004e-07

A O 0 7.183966317825252e-06
younger O 0 5.548431090574013e-06
half O 0 2.348835614895961e-08
- O 0 2.2021642962499755e-06
sister O 0 6.05237573836348e-07
, O 0 1.0072935541227679e-11
who O 0 1.327412246961146e-12
had O 0 9.610800870418768e-12
no O 0 8.706287080162411e-11
underlying O 0 3.8304239069475443e-07
disease O 0 5.8395510649233984e-08
, O 0 4.929543643943102e-13
was O 0 2.734094547984789e-11
also O 0 1.1025349470200618e-12
found O 0 1.4680620000900868e-12
to O 0 7.469098256551732e-12
lack O 0 8.186146516209192e-08
immunochemically O 0 9.624236554373056e-05
detectable O 0 0.008477933704853058
C5 O 0 0.0015462059527635574
. O 0 5.897700816603901e-08

By O 0 3.636698764353241e-08
hemolytic O 1 0.8830104470252991
assay O 0 2.2663836716674268e-05
, O 0 3.0849769405705274e-09
she O 0 7.239601713254773e-12
exhibited O 0 2.0597681546496993e-11
1 O 0 5.6319119506875737e-11
- O 0 2.86288093925835e-11
2 O 0 1.0526734345317479e-10
% O 0 4.5086666605048675e-13
of O 0 6.232545675301931e-14
the O 0 1.0988274092710304e-12
normal O 0 3.5468064041310754e-09
serum O 0 2.794380726811596e-08
C5 O 0 3.2827574614202604e-06
level O 0 4.2634701324928415e-10
and O 0 2.3182700876166196e-13
normal O 0 2.638194350479406e-11
concentrations O 0 4.5790961300529176e-11
of O 0 1.2922629546302522e-12
other O 0 2.691258457407364e-12
complement O 0 3.06102615477144e-10
components O 0 8.36341040866273e-09
. O 0 2.5006849924125163e-08

C5 O 0 0.00015597371384501457
levels O 0 7.044661742838798e-08
of O 0 4.210748194566349e-09
other O 0 1.9504738102416042e-10
family O 0 8.778756888094819e-11
members O 0 9.29345250928748e-13
were O 0 1.1044676458127345e-11
either O 0 4.049863309291135e-12
normal O 0 8.314291477518054e-10
or O 0 2.0386455110849022e-12
approximately O 0 4.1657492342792035e-13
half O 0 9.302390671997451e-13
- O 0 1.916834052595462e-11
normal O 0 3.323906039298663e-09
, O 0 5.635441115495188e-13
consistent O 0 2.8441367316833777e-11
with O 0 1.3185746982127822e-13
autosomal O 0 5.78552361574225e-09
codominant O 0 8.361818970570312e-08
inheritance O 0 2.5386106550229215e-09
of O 0 2.881373742033566e-12
the O 0 3.731122615729943e-12
gene O 0 1.1422129908567058e-10
determining O 0 2.450331294312491e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 4.230269951221999e-06

Normal O 0 0.00013607395521830767
hemolytic O 1 0.992871105670929
titers O 0 0.00020422144734766334
were O 0 2.0131996070205105e-09
restored O 0 1.8924898981254046e-08
to O 0 9.631707931223588e-11
both O 0 1.1637379948581383e-09
homozygous O 0 0.015626924112439156
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 4.057462366091613e-09
C5D B-Disease 1 1.0
) O 0 1.1586455406220608e-10
sera O 0 4.4131776011369084e-10
by O 0 1.6092098628021217e-13
addition O 0 6.728951597312349e-12
of O 0 1.1265999244614022e-10
highly O 0 4.197639782432816e-07
purified O 0 0.0002298397885169834
human O 0 2.8898205073346617e-07
C5 O 0 0.005370316095650196
. O 0 4.231352690453605e-08

In O 0 1.3692747380389392e-08
specific O 0 5.6867552444828107e-08
C5 O 0 0.00021128497610334307
titrations O 0 7.082053343765438e-07
, O 0 2.956148173471895e-11
however O 0 2.405671772898188e-10
, O 0 2.1428648785959403e-12
it O 0 2.906254067697872e-13
was O 0 1.7500183246976775e-10
noted O 0 3.691124836335824e-11
that O 0 1.0650925670943612e-13
when O 0 1.4481797922308304e-12
limited O 0 4.261937157357121e-12
amounts O 0 1.8252163669352228e-10
of O 0 3.391389669094025e-10
C5 O 0 2.022165517701069e-06
were O 0 2.1634916080870426e-10
assayed O 0 1.419703243854542e-09
in O 0 1.2306377705079141e-12
the O 0 9.320221460926148e-13
presence O 0 1.466136673872187e-12
of O 0 2.0759706453876703e-11
low O 0 1.0468280464692725e-08
dilutions O 0 3.441411422500096e-07
of O 0 9.771342623920987e-10
either O 0 1.630414203646069e-08
C5D B-Disease 1 1.0
serum O 0 4.6467002334793506e-07
, O 0 1.5999047572878844e-11
curving O 0 2.2194913962270135e-10
rather O 0 5.042809485961142e-12
than O 0 2.623289226903053e-13
linear O 0 6.790295756231579e-12
dose O 0 1.5627127369910454e-10
- O 0 2.0666626396326215e-11
response O 0 3.67757629904375e-11
plots O 0 8.345718005564606e-10
were O 0 4.6021242372518145e-11
consistently O 0 1.6894140600354213e-11
obtained O 0 5.879471388914315e-12
, O 0 1.7345166644124055e-13
suggesting O 0 1.2590269105050567e-11
some O 0 1.8236486539618957e-12
inhibitory O 0 2.6951050280388245e-09
effect O 0 1.6807899072546206e-08
. O 0 6.015731202069219e-08

Further O 0 2.419128541930604e-08
studies O 0 4.906026140893971e-10
suggested O 0 5.7323538277254116e-11
that O 0 4.557908954774814e-13
low O 0 2.8648738492620396e-08
dilutions O 0 5.6695411331020296e-05
of O 0 1.7775354876903293e-07
C5D B-Disease 1 1.0
serum O 0 8.223837539844681e-07
contain O 0 2.526369391464556e-10
a O 0 3.369308141949051e-13
factor O 0 1.3478536863009705e-11
( O 0 2.7590682017721024e-14
or O 0 8.508654393037107e-13
factors O 0 3.3718573072549773e-11
) O 0 1.1041125967062998e-13
interfering O 0 6.437761435051925e-11
at O 0 4.9029086346408235e-11
some O 0 2.365961810149586e-12
step O 0 3.406728510402246e-10
in O 0 1.4989492286288097e-11
the O 0 4.32790137061545e-10
hemolytic O 0 0.00011103494034614414
assay O 0 5.943270025454694e-06
of O 0 1.0119118087459356e-05
C5 O 0 0.0003459701547399163
, O 0 1.910095996301986e-12
rather O 0 8.52206922651727e-13
than O 0 1.1834966600482444e-13
a O 0 7.760320706352852e-13
true O 0 9.85051595847608e-10
C5 O 0 4.755433110403828e-06
inhibitor O 0 1.9179378085709686e-08
or O 0 2.90835466820738e-10
inactivator O 0 1.011032281894586e-06
. O 0 5.5293345013751605e-08

Of O 0 1.4277996740474919e-07
clinical O 0 9.969802476916811e-07
interest O 0 1.7912510941187065e-07
are O 0 3.907143011905312e-11
( O 0 1.738564262172837e-13
a O 0 1.363854911168652e-13
) O 0 3.800035864453969e-15
the O 0 5.683289532347133e-14
documentation O 0 6.638849886497766e-11
of O 0 6.791801843153422e-11
membranous O 1 0.9995375871658325
glomerulonephritis B-Disease 1 1.0
, O 0 5.302094763237619e-08
vasculitis B-Disease 1 1.0
, O 0 1.651332071084255e-09
and O 0 8.195110368092173e-09
arthritis B-Disease 1 1.0
in O 0 1.0439069164647208e-08
an O 0 2.35300104053926e-12
individual O 0 7.113977740225153e-10
lacking O 0 5.7451425163890235e-06
C5 O 0 2.808457793435082e-05
( O 0 3.10603078630331e-13
and O 0 7.671373302223228e-13
its O 0 6.928155423489846e-13
biologic O 0 1.0730396127200947e-08
functions O 0 2.976248154179517e-12
) O 0 5.635489769067678e-15
, O 0 2.8572582938968943e-14
and O 0 2.721438796971648e-13
( O 0 1.492166985675794e-13
b O 0 1.0377874254396957e-10
) O 0 9.429823831237204e-15
a O 0 1.6540081478923219e-13
remarkable O 0 3.06934408444981e-11
propensity O 0 4.480839255194269e-09
to O 0 4.7711522233040426e-11
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.718822480178961e-11
the O 0 2.3744747487675077e-12
proband O 0 7.435956850265768e-10
, O 0 2.5282456250080854e-13
even O 0 2.1050517015272496e-13
during O 0 1.0380812962701436e-12
periods O 0 3.033152895515201e-10
of O 0 8.790379882328558e-12
low O 0 3.8620823206159116e-10
- O 0 4.532777798937904e-12
dose O 0 3.526803016296043e-10
or O 0 1.5505824705816518e-12
alternate O 0 1.8360896136826454e-10
- O 0 4.3328302751222125e-11
day O 0 1.5479127701834017e-10
corticosteroid O 0 7.321727224507413e-08
therapy O 0 1.620889023001837e-08
. O 0 2.11018827411813e-10

Other O 0 7.530820411716377e-09
observations O 0 4.833829336803319e-09
indicate O 0 6.00449967524952e-11
that O 0 2.006594082516397e-13
the O 0 2.3675442162307547e-10
C5D B-Disease 1 1.0
state O 0 1.1319017723110392e-08
is O 0 4.4992880948724334e-12
compatible O 0 3.6269282022161065e-10
with O 0 2.9521277458179063e-13
normal O 0 4.021103727769315e-10
coagulation O 0 3.5340705917263904e-09
function O 0 7.501996940328937e-11
and O 0 7.065529259754622e-13
the O 0 1.0517733602458113e-12
capacity O 0 2.2376574551619122e-11
to O 0 9.925039089198062e-12
mount O 0 2.0579413728682994e-08
a O 0 6.196430035743106e-10
neutrophilic O 0 0.001905009150505066
leukocytosis O 0 0.00011495179205667228
during O 0 2.175934383785716e-07
pyogenic B-Disease 0 1.9098624761682004e-05
infection I-Disease 0 8.574720027354488e-07
. O 0 1.2280462202696185e-09
. O 0 3.985257013283672e-09

Susceptibility O 0 0.00021826577722094953
to O 0 1.0219196155958343e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.0016913223080337048
twins O 0 0.00017497158842161298
: O 0 6.89185796105829e-13
the O 0 7.158038810121947e-13
role O 0 1.3353504500074331e-12
of O 0 3.055005554086776e-11
genes O 0 1.7425698037309978e-11
, O 0 6.805206571869338e-12
HLA O 0 2.3678144316363614e-06
, O 0 8.920999355899184e-11
and O 0 1.6571740507620447e-11
the O 0 4.5167453111005784e-11
environment O 0 3.3226257301066653e-09
. O 0 1.757103129662596e-09

OBJECTIVE O 0 1.0176748901358224e-06
To O 0 2.781019858844047e-11
determine O 0 1.773498709001231e-11
the O 0 5.236196459063036e-12
relative O 0 9.390648259000045e-10
effects O 0 1.92390170461465e-09
of O 0 1.3814196453409977e-09
genetic O 0 9.367004061289208e-09
and O 0 8.020263056116028e-13
environmental O 0 2.8716804975625898e-11
factors O 0 3.720931548989448e-12
in O 0 4.1486697974560394e-13
susceptibility O 0 3.6850578144509427e-09
to O 0 8.956962394002232e-10
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 2.675567145615787e-07
AS B-Disease 1 1.0
) O 0 4.987389667920894e-11
. O 0 7.934399248732404e-10

METHODS O 0 0.0003083174815401435
Twins O 0 0.002369517693296075
with O 0 2.4832564823884518e-11
AS B-Disease 1 1.0
were O 0 3.7919781897821636e-11
identified O 0 1.1898568610425875e-13
from O 0 8.006896571276494e-15
the O 0 1.6315448680124557e-14
Royal O 0 6.940436420022067e-11
National O 0 2.4603424766261872e-12
Hospital O 0 2.9396096667966276e-09
for O 0 1.712820336952081e-11
Rheumatic B-Disease 1 0.9999998807907104
Diseases I-Disease 0 0.01280382089316845
database O 0 1.550165684705007e-08
. O 0 2.418168776330276e-08

Clinical O 0 1.2414268439897569e-06
and O 0 4.819464827221509e-10
radiographic O 0 7.198342473202501e-07
examinations O 0 1.1848123193658466e-07
were O 0 7.87652443268172e-11
performed O 0 1.1112887519926229e-11
to O 0 2.1984177716108388e-13
establish O 0 4.0877527057725516e-11
diagnoses O 0 0.000163434146088548
, O 0 6.827623882932343e-11
and O 0 7.998059159408655e-11
disease O 0 2.3864705767095984e-08
severity O 0 2.0566390901421983e-07
was O 0 1.370302760150821e-10
assessed O 0 1.1733927718360349e-10
using O 0 3.3741442257394227e-13
a O 0 6.723210177602898e-14
combination O 0 4.814407119496655e-12
of O 0 2.3122271458619892e-11
validated O 0 5.029007610346525e-08
scoring O 0 9.803250655693319e-09
systems O 0 5.176585560207059e-08
. O 0 3.9358840631109615e-09

HLA O 0 0.00012740334204863757
typing O 0 1.0036803388402404e-07
for O 0 1.285106743242892e-10
HLA O 0 3.581116629902681e-07
- O 0 5.62602565423731e-07
B27 O 0 2.013032229797318e-07
, O 0 6.442646763304971e-12
HLA O 0 2.017697342537872e-09
- O 0 1.2488658995835067e-09
B60 O 0 1.038657693186451e-08
, O 0 1.3295964806578353e-12
and O 0 1.8219102441985324e-12
HLA O 0 3.583367913506663e-07
- O 0 8.723138307686895e-06
DR1 O 0 0.06602668762207031
was O 0 1.09927712765856e-10
performed O 0 3.015912606457727e-12
by O 0 7.072846404691455e-14
polymerase O 0 1.1991421744461661e-11
chain O 0 5.185745929892072e-12
reaction O 0 1.590882460489329e-11
with O 0 1.703351137439038e-13
sequence O 0 2.3892793668024714e-13
- O 0 1.17634959932722e-12
specific O 0 4.508772695477337e-12
primers O 0 1.9073892465470976e-10
, O 0 3.9084957059037917e-13
and O 0 6.618033486678609e-13
zygosity O 0 8.329945622165269e-09
was O 0 8.772529924705452e-11
assessed O 0 1.7931538476290143e-09
using O 0 2.3594703968399244e-10
microsatellite O 0 1.440868260260686e-07
markers O 0 7.126424605985449e-08
. O 0 2.732618042955437e-08

Genetic O 0 3.600434638428851e-06
and O 0 3.0556479568843997e-10
environmental O 0 2.772908125336926e-09
variance O 0 1.2381170533259933e-09
components O 0 1.3350169858483696e-08
were O 0 5.32928146057543e-10
assessed O 0 7.139128399558103e-09
with O 0 2.527976742869309e-12
the O 0 2.1098302271926883e-10
program O 0 5.348718690179055e-11
Mx O 0 1.9581265775503454e-10
, O 0 3.5023348696032464e-14
using O 0 1.6912298587946038e-14
data O 0 2.0154315499495978e-13
from O 0 7.707889366917811e-14
this O 0 1.0317405431522694e-13
and O 0 3.119847045637836e-13
previous O 0 2.1816654385831136e-11
studies O 0 1.0345510255763135e-12
of O 0 1.2384789374597638e-12
twins O 0 1.506822933095009e-08
with O 0 1.4932868309947e-12
AS B-Disease 1 1.0
. O 0 2.4065004211593077e-08

RESULTS O 0 3.3656444884400116e-06
Six O 0 2.026185441650341e-09
of O 0 8.488501568315598e-10
8 O 0 1.4508238166399678e-07
monozygotic O 0 6.524158834508853e-06
( O 0 8.358553432730176e-11
MZ O 0 1.5516927305725403e-05
) O 0 2.026125447973648e-11
twin O 0 1.215754830141691e-09
pairs O 0 9.012047184897565e-12
were O 0 2.1162967211996175e-12
disease O 0 1.361099705166069e-10
concordant O 0 2.601179573957779e-07
, O 0 6.109369520695962e-12
compared O 0 1.6372746214354805e-10
with O 0 2.690215400707324e-13
4 O 0 2.5010163384742157e-10
of O 0 5.709871811476752e-12
15 O 0 1.1198209894092148e-11
B27 O 0 1.858917575425778e-09
- O 0 1.8752979724645513e-10
positive O 0 1.2304395002882274e-10
dizygotic O 0 1.6078648457096278e-07
( O 0 7.118880138157202e-13
DZ O 0 2.814364208347797e-08
) O 0 5.274806741568938e-13
twin O 0 2.1748941536614552e-10
pairs O 0 3.0805622809604305e-12
( O 0 1.0607945186320855e-13
27 O 0 1.2320909847929329e-09
% O 0 5.329449555280252e-12
) O 0 1.6606961845185703e-14
and O 0 1.0724808627987636e-12
4 O 0 2.296515477784311e-10
of O 0 2.5945959269968455e-10
32 O 0 5.717269768723554e-09
DZ O 0 5.9542244343901984e-06
twin O 0 6.457604229126446e-09
pairs O 0 1.8105694027381602e-11
overall O 0 3.777924084680251e-10
( O 0 2.035730118548143e-13
12 O 0 1.9523375971441936e-11
. O 0 2.2614609837545707e-12
5 O 0 5.0992200045785196e-11
% O 0 1.1172304401063649e-12
) O 0 3.438972400577299e-14
. O 0 9.853085708444453e-11

Nonsignificant O 0 5.022062759962864e-05
increases O 0 1.1477540340365522e-07
in O 0 3.1447757592451e-11
similarity O 0 3.515203406134759e-11
with O 0 2.1248986999209546e-13
regard O 0 4.799806108124471e-10
to O 0 2.0550501404759114e-12
age O 0 7.446943062205946e-10
at O 0 2.135219301716007e-12
disease O 0 2.7111210845753853e-11
onset O 0 1.72736349668412e-08
and O 0 1.5933115937727393e-11
all O 0 1.6237138586797095e-12
of O 0 4.0956795246960276e-12
the O 0 8.896917057243936e-12
disease O 0 9.520529503648234e-11
severity O 0 5.825138704729227e-10
scores O 0 6.045337841431575e-12
assessed O 0 3.851017074674168e-11
were O 0 1.3026915700667385e-12
noted O 0 1.7278805339651648e-12
in O 0 1.7352622160363151e-12
disease O 0 7.158053261235864e-09
- O 0 9.079749929696845e-08
concordant O 0 0.0004084501997567713
MZ O 0 0.0008295442094095051
twins O 0 3.103587289388088e-07
compared O 0 2.8429125720208503e-10
with O 0 1.7121205711859155e-12
concordant O 0 4.6246623242041096e-05
DZ O 0 0.020899377763271332
twins O 0 5.097963730804622e-05
. O 0 1.7285829656543683e-08

HLA O 0 0.0002388869907008484
- O 0 3.1145726097747684e-05
B27 O 0 2.934230678874883e-06
and O 0 5.572597244762889e-11
B60 O 0 5.501559208198614e-09
were O 0 1.858100305562882e-11
associated O 0 7.692315534546523e-12
with O 0 3.3270498714984414e-14
the O 0 7.332740317722575e-12
disease O 0 1.19363252615301e-09
in O 0 8.738274860642381e-12
probands O 0 5.225038535172644e-07
, O 0 2.310995795770654e-12
and O 0 1.536406635596621e-13
the O 0 6.743234985152891e-13
rate O 0 9.176854415260394e-11
of O 0 2.681199717542021e-13
disease O 0 9.188168281770714e-11
concordance O 0 7.091218168220337e-10
was O 0 1.4213382207306502e-11
significantly O 0 5.860555374326282e-10
increased O 0 3.0021312102945785e-09
among O 0 2.6583552026338e-10
DZ O 0 4.433210563092871e-07
twin O 0 7.627410369970278e-10
pairs O 0 6.253041162120054e-13
in O 0 4.479845449678957e-14
which O 0 1.525540219322885e-14
the O 0 1.0434012594900954e-12
co O 0 4.574030824239239e-12
- O 0 1.1809954403307898e-10
twin O 0 5.090631804982593e-10
was O 0 1.755292612648507e-11
positive O 0 2.971511708568797e-12
for O 0 8.022129510155962e-13
both O 0 3.88376613855157e-12
B27 O 0 8.889674063539132e-08
and O 0 1.2509638880331408e-09
DR1 O 0 0.0003041918680537492
. O 0 3.086402600160909e-08

Additive O 0 1.2525718375400174e-05
genetic O 0 5.281031079107379e-08
effects O 0 8.963542130757673e-10
were O 0 2.994145209544996e-11
estimated O 0 1.9582365243242528e-12
to O 0 4.0932879373338504e-13
contribute O 0 6.878992167558273e-12
97 O 0 1.1820642242810209e-09
% O 0 2.1100039304753487e-13
of O 0 8.1907730245653e-15
the O 0 3.752629717385103e-14
population O 0 2.085034957730915e-14
variance O 0 8.01259544824795e-11
. O 0 2.4740871573669665e-09

CONCLUSION O 0 4.986571366316639e-05
Susceptibility O 0 5.299443728290498e-06
to O 0 2.890945705047443e-09
AS B-Disease 1 1.0
is O 0 1.390947634849482e-10
largely O 0 3.030492523592443e-10
genetically O 0 7.293324971735515e-11
determined O 0 2.0582885396080997e-10
, O 0 1.7056016972036292e-12
and O 0 1.7067798997044692e-12
the O 0 2.199724430385075e-11
environmental O 0 3.2077094314075794e-09
trigger O 0 5.63371675699198e-11
for O 0 3.27607651293485e-13
the O 0 2.458326771315189e-11
disease O 0 2.0041961423800103e-09
is O 0 1.6985697787533227e-12
probably O 0 3.223697697674055e-10
ubiquitous O 0 1.1481334105667429e-08
. O 0 5.975691941273453e-09

HLA O 0 2.5172357709379867e-05
- O 0 1.1931923609154182e-06
B27 O 0 2.2962248635849392e-07
accounts O 0 2.356456002550189e-11
for O 0 6.822836159979875e-14
a O 0 7.929904833909457e-14
minority O 0 3.662347389330606e-13
of O 0 2.493035075254446e-13
the O 0 9.953622127911732e-13
overall O 0 7.665242329757405e-10
genetic O 0 1.2378945091207072e-10
susceptibility O 0 1.2395449111579637e-08
to O 0 4.3984213493608593e-10
AS B-Disease 1 1.0
. O 0 4.7323644025709655e-07

Cell O 0 6.079194463382009e-07
cycle O 0 2.6830837995817092e-08
- O 0 8.901020365215118e-09
dependent O 0 7.818576008844502e-09
colocalization O 0 6.031535235706542e-07
of O 0 1.2577495489551893e-08
BARD1 O 1 0.9999988079071045
and O 0 8.451981869939118e-08
BRCA1 O 0 6.213783709796417e-09
proteins O 0 3.992357226062504e-12
in O 0 2.3338481754814344e-12
discrete O 0 2.844192381612487e-10
nuclear O 0 2.1478861356172274e-08
domains O 0 3.000948112230617e-08
. O 0 2.8799622242559053e-08

Germ O 0 0.00022680190159007907
- O 0 2.496625484127435e-06
line O 0 2.905530891439412e-07
mutations O 0 1.1060857785238909e-09
of O 0 1.6856716023028184e-10
the O 0 5.644066325416475e-10
BRCA1 O 0 1.493824730580684e-09
gene O 0 6.140936283788312e-12
predispose O 0 1.2617037414841548e-09
women O 0 1.5808634783176512e-12
to O 0 1.6464351312427822e-13
early O 0 5.449251005984479e-08
- O 0 1.692840305622667e-05
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 3.391567192020939e-12
compromising O 0 9.356124763826301e-10
the O 0 1.0254679050358817e-10
genes O 0 8.239599280646104e-11
presumptive O 0 3.539273407682231e-08
function O 0 2.675358198866995e-11
as O 0 2.6588238988961566e-12
a O 0 4.3885789099973316e-12
tumor B-Disease 0 9.563239444787541e-08
suppressor O 0 2.777700956357876e-06
. O 0 1.986689568411748e-08

Although O 0 3.6116691148890823e-07
the O 0 6.095016047424906e-09
biochemical O 0 2.815180550896912e-06
properties O 0 6.124693754827604e-06
of O 0 5.03047090205655e-07
BRCA1 O 0 1.295741327567157e-07
polypeptides O 0 3.336609877280239e-09
are O 0 3.0401852910144633e-13
not O 0 1.0410848073384715e-13
understood O 0 7.789687297976577e-12
, O 0 1.2246007972862433e-13
their O 0 2.1787855807725576e-13
expression O 0 1.9220024877197872e-12
pattern O 0 1.5011150308885668e-11
and O 0 4.85374707006464e-13
subcellular O 0 6.736936786211345e-09
localization O 0 7.617063424447679e-09
suggest O 0 8.450631860945634e-11
a O 0 2.6101730911214094e-13
role O 0 2.006690820455237e-12
in O 0 1.0930647879880961e-11
cell O 0 2.1813608697129894e-08
- O 0 1.5102115114018488e-09
cycle O 0 7.958897541016086e-09
regulation O 0 1.6882246711702464e-08
. O 0 9.540094270121813e-10

When O 0 2.388882478498999e-07
resting O 0 2.5110336991929216e-06
cells O 0 9.555395585891802e-09
are O 0 2.902123420051028e-12
induced O 0 4.5350653787856743e-10
to O 0 6.528868157912315e-12
proliferate O 0 2.3999076059766367e-09
, O 0 1.2820793688847476e-12
the O 0 6.166453198758193e-12
steady O 0 3.7481737158451267e-10
- O 0 7.286782939194825e-13
state O 0 8.079745097804014e-13
levels O 0 4.678414600167713e-11
of O 0 5.680499039900644e-12
BRCA1 O 0 1.919115907855762e-12
increase O 0 5.96654507484945e-13
in O 0 1.7277289625014514e-12
late O 0 1.8414011648815176e-08
G1 O 0 9.29265553395453e-09
and O 0 1.621680437505213e-12
reach O 0 5.443720561132404e-13
a O 0 1.3774689075057031e-15
maximum O 0 7.533262208481162e-13
during O 0 1.333504001665986e-10
S O 0 2.802499921017443e-07
phase O 0 2.7522605705598835e-07
. O 0 2.30717756011245e-08

Moreover O 0 7.46429748232913e-07
, O 0 3.7510200501245095e-10
in O 0 4.242767803752656e-10
S O 0 4.651036761060823e-06
phase O 0 2.9900493245804682e-06
cells O 0 2.2649582831490989e-07
, O 0 1.7547445441135068e-10
BRCA1 O 0 1.5754055837646774e-09
polypeptides O 0 1.4976189177673405e-09
are O 0 4.6691058137871e-12
hyperphosphorylated O 0 1.9581060328732747e-08
and O 0 2.6445928780205463e-11
accumulate O 0 5.993221474653865e-10
into O 0 4.3609782451881074e-11
discrete O 0 2.9525055733614636e-09
subnuclear O 0 2.367227352806367e-06
foci O 0 2.447607812428032e-06
termed O 0 6.347203793666267e-07
" O 0 1.471586728030161e-07
BRCA1 O 0 7.236799604015687e-08
nuclear O 0 5.965615201830587e-08
dots O 0 5.279137553770852e-07
. O 0 1.5031458744374504e-08

" O 0 1.6482530554640107e-05
BRCA1 O 0 7.944709977891762e-06
associates O 0 1.3769904327887161e-08
in O 0 1.2973566665408498e-10
vivo O 0 2.184865621757126e-09
with O 0 2.5433065484366246e-13
a O 0 4.654878479198876e-12
structurally O 0 1.1147171363745656e-07
related O 0 1.8398218060156069e-07
protein O 0 1.4443892268900527e-06
termed O 0 1.9448591501713963e-06
BARD1 O 1 0.9995701909065247
. O 0 7.371709784820268e-07

Here O 0 2.2325705728576395e-08
we O 0 4.468382955313821e-11
show O 0 1.4005139279196777e-12
that O 0 1.4835704144127923e-14
the O 0 1.8881667063208596e-12
steady O 0 3.5403027731639725e-10
- O 0 1.991116473087917e-12
state O 0 1.7817265674999194e-12
levels O 0 1.3799757170307458e-10
of O 0 6.958539647272666e-12
BARD1 O 0 2.3743634301354177e-05
, O 0 2.609248320878388e-12
unlike O 0 2.280668709442324e-11
those O 0 2.579759756510258e-12
of O 0 3.430788292346776e-11
BRCA1 O 0 3.03917530031228e-10
, O 0 2.9393122050885845e-13
remain O 0 1.2211638818204751e-11
relatively O 0 3.241890480024101e-12
constant O 0 2.2459516885176e-12
during O 0 2.331931696353262e-11
cell O 0 1.1436704028255917e-08
cycle O 0 2.247224450968588e-08
progression O 0 1.760123637950528e-07
. O 0 4.289009147839806e-09

However O 0 6.905177087901393e-07
, O 0 4.30371915882688e-09
immunostaining O 0 2.0478080841712654e-05
revealed O 0 9.784387344780043e-08
that O 0 4.0228603781500283e-10
BARD1 O 1 0.999951958656311
resides O 0 9.896343300397348e-08
within O 0 3.1158156055255404e-09
BRCA1 O 0 6.031273258599867e-09
nuclear O 0 3.942585813376809e-09
dots O 0 1.2728637033276868e-09
during O 0 2.593037728981784e-10
S O 0 5.758221455209878e-09
phase O 0 4.039377721198889e-09
of O 0 1.357249295591556e-11
the O 0 1.191947148621031e-12
cell O 0 8.117841468480158e-12
cycle O 0 3.1068320659188853e-12
, O 0 7.746943853830044e-15
but O 0 1.4359031270862882e-14
not O 0 3.6347810069940756e-14
during O 0 1.6223649160207465e-11
the O 0 3.746928115000436e-11
G1 O 0 3.627263467365083e-08
phase O 0 4.356022031970497e-08
. O 0 6.166415822406179e-09

Nevertheless O 0 2.260934707010165e-05
, O 0 4.353502891518701e-09
BARD1 O 0 0.00024475730606354773
polypeptides O 0 2.6251878892935565e-08
are O 0 5.076993513097872e-12
found O 0 4.673647536687642e-13
exclusively O 0 3.7731222226472516e-13
in O 0 9.440464089714024e-14
the O 0 4.4501427824868156e-13
nuclear O 0 2.2820330070061345e-09
fractions O 0 8.067737411465714e-08
of O 0 1.118831471913495e-09
both O 0 2.666219328650854e-11
G1 O 0 4.107608475578672e-09
- O 0 4.767961581109148e-10
and O 0 9.51068824389667e-12
S O 0 6.326123624944557e-09
- O 0 8.615530511235647e-11
phase O 0 4.623438076833963e-09
cells O 0 1.446202935184715e-09
. O 0 8.948351781778996e-11

Therefore O 0 3.356930022846427e-08
, O 0 6.22435852859482e-11
progression O 0 4.077477910868765e-09
to O 0 8.435183974919713e-12
S O 0 1.4878426490838592e-08
phase O 0 4.287774579836423e-09
is O 0 1.1954026906801224e-13
accompanied O 0 2.5733759741186635e-12
by O 0 8.293494065331544e-14
the O 0 5.58582216939052e-12
aggregation O 0 1.3349907845849884e-09
of O 0 5.975776817823686e-11
nuclear O 0 4.873802481597522e-07
BARD1 O 1 0.9421496987342834
polypeptides O 0 3.1248212053469615e-06
into O 0 5.781643253044422e-08
BRCA1 O 0 7.28477189682053e-08
nuclear O 0 5.456167073703e-08
dots O 0 5.394158506533131e-07
. O 0 1.0763439028949051e-08

This O 0 1.1395456800400439e-09
cell O 0 9.558750235783009e-09
cycle O 0 2.2146127154343276e-09
- O 0 8.971598464135866e-10
dependent O 0 3.841586604380609e-09
colocalization O 0 7.510855937198357e-08
of O 0 1.520866432791479e-09
BARD1 O 1 0.984740674495697
and O 0 5.330036856321385e-09
BRCA1 O 0 8.042272403585571e-10
indicates O 0 1.7930322157577727e-11
a O 0 1.4786606726373275e-14
role O 0 1.3471481688422798e-13
for O 0 2.4693125148800288e-12
BARD1 O 1 0.8301312923431396
in O 0 9.946895715984283e-07
BRCA1 O 0 4.743470526591409e-06
- O 0 7.869145406402822e-07
mediated O 0 1.1187145219082595e-06
tumor B-Disease 0 0.00036271658609621227
suppression O 0 1.5288036593119614e-05
. O 0 4.377585938186712e-08

Ethnic O 0 3.200157649985158e-08
differences O 0 9.340741513597095e-09
in O 0 1.1049148401776065e-10
the O 0 9.814883350500736e-10
HFE O 0 5.7276818552054465e-05
codon O 0 1.9770622827763873e-07
282 O 0 1.58498849600619e-07
( O 0 1.2606664323566719e-10
Cys O 0 1.2758482625940815e-05
/ O 0 1.3090161132822686e-07
Tyr O 0 3.1156693580669526e-07
) O 0 8.405953016987766e-12
polymorphism O 0 1.3455029090891912e-08
. O 0 4.489179694644463e-09

Recent O 0 7.650555744476151e-08
studies O 0 4.108726692209075e-10
have O 0 7.970304646311155e-13
shown O 0 1.1664902550834189e-11
that O 0 4.6158733085777115e-11
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 4.518248886142828e-09
HH B-Disease 0 0.0016388383228331804
) O 0 6.8907542432467e-13
is O 0 7.972854825346112e-14
likely O 0 4.98153081285313e-12
to O 0 1.33760827392658e-13
be O 0 9.084266542128128e-13
caused O 0 1.2751107114628013e-10
by O 0 9.331965755698945e-12
homozygosity O 0 1.216916984958516e-07
for O 0 1.1773467617492983e-11
a O 0 1.1034358322892235e-11
Cys282Tyr O 0 1.627072236942695e-07
mutation O 0 5.800060431937482e-10
in O 0 1.9061481559834448e-11
the O 0 1.53238477462736e-10
HFE O 0 4.220283517497592e-05
gene O 0 1.5506477879512204e-08
located O 0 1.5346729442811124e-09
4 O 0 3.4156588668565746e-08
. O 0 9.794373312388416e-09

5 O 0 1.3016432376389275e-06
Mb O 0 5.314163331604504e-07
telomeric O 0 4.712440841103671e-06
to O 0 1.2066072585525944e-08
HLA O 0 0.00033534562680870295
- O 0 0.00018436623213347048
A O 0 2.205091732321307e-06
. O 0 1.4160152161935002e-08

Population O 0 2.418973632511978e-10
studies O 0 6.407341237441022e-12
of O 0 4.3998745619111546e-13
this O 0 5.995063928794508e-13
polymorphism O 0 1.1637291130739413e-09
are O 0 9.105321612792525e-14
facilitated O 0 6.946813458676149e-13
by O 0 7.394741286317896e-14
the O 0 1.549476801206151e-12
fact O 0 8.519762044294221e-13
that O 0 1.5330337504006544e-14
the O 0 1.0535567210312458e-11
Cys282Tyr O 0 2.0346581095509464e-06
mutation O 0 1.2203019039702667e-08
creates O 0 3.3576502689314225e-10
a O 0 8.411679339181966e-12
Rsal O 0 7.600999651913298e-07
restriction O 0 4.0918433796832687e-07
site O 0 7.430575976741238e-08
. O 0 1.7376072136698895e-08

We O 0 2.6306197220549166e-09
have O 0 5.0803740554716814e-12
studied O 0 2.46440177292806e-11
the O 0 6.335846777782983e-12
codon O 0 3.3474334415473095e-09
282 O 0 1.806133020920697e-08
( O 0 1.0544860817862656e-10
Cys O 0 4.579069354804233e-06
/ O 0 3.876920828815855e-08
Tyr O 0 8.128439787924435e-08
) O 0 1.3829775269858652e-13
polymorphism O 0 2.269940832522188e-11
in O 0 6.167720414257394e-13
different O 0 4.507895359079361e-12
ethnic O 0 1.1795698098837626e-11
groups O 0 9.205406402423844e-12
. O 0 1.0098275687875358e-10

In O 0 1.3713911117818611e-09
agreement O 0 2.9712118987390568e-08
with O 0 4.858809535268627e-11
previous O 0 6.995441026447224e-08
observations O 0 3.373599355427359e-08
the O 0 1.135611937819192e-09
Tyr O 0 2.341045274079079e-06
allele O 0 1.932968451967554e-09
appeared O 0 4.341692561027344e-10
to O 0 1.6180368947894125e-13
be O 0 2.8643474853269624e-13
rare O 0 3.181286831188679e-11
or O 0 1.1632353066892698e-11
absent O 0 3.168597162428455e-09
in O 0 9.15999134182277e-12
Asiatic O 0 4.183897228671185e-09
( O 0 1.2439511463816551e-14
Indian O 0 1.2472737686425317e-12
, O 0 4.9289955119822745e-14
Chinese O 0 9.612083698429252e-12
) O 0 4.871127372990669e-13
populations O 0 1.1871784805217445e-11
. O 0 8.153909492047973e-11

The O 0 1.0239087355756737e-09
highest O 0 1.9434451825617316e-09
allele O 0 2.720200974193343e-11
frequency O 0 2.15700513006567e-11
( O 0 3.78388726601786e-14
7 O 0 1.4697156686116486e-11
. O 0 6.215856822311405e-13
5 O 0 1.780487736413594e-11
% O 0 2.886432954631035e-13
) O 0 2.3954644437349697e-15
was O 0 6.973101349810884e-12
found O 0 2.2853531133487648e-12
in O 0 6.785133566111767e-11
Swedes O 0 2.6819691356649855e-06
. O 0 1.442515440430725e-07

Saamis O 0 0.0016671756748110056
( O 0 5.25257670691559e-10
2 O 0 9.434097947291775e-09
% O 0 2.6321731252942904e-11
) O 0 4.133786073320066e-14
and O 0 1.7205468820502556e-12
Mordvinians O 0 1.1274909184066928e-06
( O 0 6.834144253113628e-13
1 O 0 4.452900548290728e-10
. O 0 5.273380690451468e-12
8 O 0 6.575411048981294e-11
% O 0 3.3109214155058186e-13
) O 0 2.335719610075098e-15
had O 0 6.738683504432796e-13
significantly O 0 1.6181812834137332e-10
lower O 0 6.146219089231408e-09
frequencies O 0 6.920823358846917e-10
of O 0 4.195960245922947e-11
the O 0 1.2703244012257642e-09
Tyr O 0 7.99813733465271e-06
allele O 0 9.479230556053153e-08
. O 0 1.775864078013001e-08

Comparisons O 0 1.8042243254967616e-07
with O 0 1.3954225275281118e-10
allele O 0 1.0537105632479893e-09
frequencies O 0 2.570847146277089e-10
based O 0 2.6346932448240157e-12
on O 0 2.138659258368869e-12
prevalence O 0 7.044168026659747e-11
estimates O 0 1.0717391384085229e-11
of O 0 6.721588563518566e-12
HH B-Disease 1 0.9999995231628418
showed O 0 5.567608241108246e-06
some O 0 2.6182245260741865e-10
disagreements O 0 6.10237993470264e-09
with O 0 1.8355510254114416e-13
the O 0 4.372252993684045e-12
RFLP O 0 3.403301196414077e-09
data O 0 3.9155585024319706e-11
, O 0 2.5811511673683174e-13
particularly O 0 1.3191670845957848e-11
in O 0 2.756032554951382e-11
Finns O 0 1.7145920594430208e-07
. O 0 4.660562158420589e-09

The O 0 3.738838358913199e-07
newly O 0 3.7666138723579934e-06
described O 0 1.9515164240146987e-07
HFE O 0 0.001745079061947763
marker O 0 4.3032412122556707e-07
provides O 0 1.6690248141881803e-11
a O 0 1.8261154849548433e-13
new O 0 5.391026600826132e-12
approach O 0 5.619143345070299e-11
to O 0 3.760398568052048e-13
the O 0 9.70598059389649e-13
screening O 0 6.391406293104751e-10
of O 0 8.500503079211796e-11
HH B-Disease 0 0.0008514260989613831
as O 0 1.1908303509944318e-10
well O 0 7.160141620235483e-13
as O 0 4.047781735987653e-14
studies O 0 4.4450930431058286e-14
of O 0 2.2008414716861123e-14
the O 0 4.1874170146963263e-13
relationship O 0 7.966828585725949e-12
between O 0 3.065243198152601e-11
the O 0 9.001421830134859e-10
HFE O 0 5.1360355428187177e-05
Tyr O 0 5.1904098654631525e-06
allele O 0 1.0253985216479578e-08
and O 0 1.0991109931912657e-11
different O 0 2.4406582310732006e-10
disorders O 0 1.713275992187846e-06
including O 0 7.117292977198986e-09
cancer B-Disease 1 0.999754011631012

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.998170018196106
associated O 0 4.177950074790715e-08
with O 0 1.8847099228502806e-11
a O 0 7.501367582651852e-11
missense O 0 5.6860503860889366e-08
mutation O 0 6.982131539601255e-10
encoding O 0 9.210913698431966e-10
Gly23 O 0 6.477331453424995e-07
- O 0 8.929285399972287e-08
- O 0 1.0510859738133149e-07
> O 0 3.9705554399915854e-08
Val O 0 9.987068949612876e-10
in O 0 1.1697720916914456e-11
neurophysin O 0 1.660731982155994e-06
II O 1 1.0
. O 0 1.4217166608432308e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.1964185198110044e-08
ADNDI B-Disease 1 1.0
) O 0 4.5207271953673356e-11
is O 0 1.8854748491670126e-12
an O 0 1.1277146751142997e-12
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.172871907328954e-05
by O 0 8.789048377977338e-10
progressive O 1 0.9989835619926453
degeneration O 1 0.9999997615814209
of O 0 2.1908551417482158e-08
the O 0 7.825077252832102e-10
magnocellular O 0 1.1177211689528121e-07
neurons O 0 4.1719735999201646e-10
of O 0 2.696289892745174e-11
the O 0 9.283965263229277e-11
hypothalamus O 0 4.9857971085032204e-09
leading O 0 2.2965165324961845e-09
to O 0 6.370263344601668e-11
decreased O 0 4.903467925032601e-07
ability O 0 2.3511415037091865e-10
to O 0 5.884320114502017e-11
produce O 0 2.3304800311763074e-09
the O 0 2.9043205618251022e-09
hormone O 0 3.325873620951825e-08
arginine O 0 3.4292565231908156e-08
vasopressin O 0 4.124214569856122e-08
( O 0 2.3454207326301102e-11
AVP O 0 1.8553838287971303e-07
) O 0 1.9037828605239504e-11
. O 0 1.938450955307758e-09

Affected O 0 6.011952109474805e-07
individuals O 0 1.890893275291461e-10
are O 0 5.637881654585453e-13
not O 0 5.475554363219837e-13
symptomatic O 0 3.4030676054896958e-09
at O 0 8.734141881960866e-12
birth O 0 1.4934665060195584e-08
, O 0 2.487436255235731e-12
but O 0 1.7819280773156976e-11
usually O 0 6.359113680076689e-09
develop O 0 1.5418935106481513e-07
diabetes B-Disease 1 0.9379469156265259
insipidus I-Disease 0 2.3605280148331076e-05
at O 0 5.30284816058213e-10
1 O 0 9.49640099889848e-09
- O 0 5.788018064833977e-09
6 O 0 1.9724025079881358e-08
yr O 0 4.799087705009697e-08
of O 0 6.131576496537505e-11
age O 0 2.6338682346249698e-09
. O 0 1.1348000317212836e-09

The O 0 1.437156282868557e-09
genetic O 0 6.002212615818792e-10
locus O 0 8.285096220195243e-11
of O 0 3.153016042700685e-11
the O 0 2.0038053161197666e-10
disease O 0 1.6780201406163542e-07
is O 0 5.4318997216862286e-12
the O 0 1.0296307556556528e-10
AVP O 0 2.9460322821250884e-06
- O 0 1.0461996424737663e-07
neurophysin O 0 1.4363822629093193e-05
II O 1 1.0
( O 0 2.1254532855952135e-10
NPII O 0 0.003539696801453829
) O 0 4.218364546559883e-11
gene O 0 7.462750556408437e-11
, O 0 1.679332714554782e-11
and O 0 1.1443783420883591e-10
mutations O 0 1.2949340211232396e-10
that O 0 2.7461138831647025e-12
cause O 0 3.322525543580923e-08
ADNDI B-Disease 1 0.99998939037323
have O 0 2.335734383684951e-10
been O 0 6.7198837640225495e-12
found O 0 2.3070616055574644e-13
in O 0 4.6156546466835646e-14
both O 0 3.412783158287733e-14
the O 0 1.9124389843017814e-13
signal O 0 2.3172734564536057e-11
peptide O 0 8.511936815114307e-12
of O 0 4.096416261756275e-11
the O 0 7.622538711338223e-10
prepro O 0 5.122055881656706e-05
- O 0 1.6818965377751738e-05
AVP O 0 5.727300958824344e-05
- O 0 2.2486786122044577e-07
NPII O 0 8.755716407904401e-05
precursor O 0 8.568935072617023e-08
and O 0 7.355015207988203e-11
within O 0 9.015511670540377e-10
NPII O 1 0.8174907565116882
itself O 0 1.6969510241438002e-08
. O 0 7.977225990885017e-09

An O 0 2.8754035263922617e-10
affected O 0 1.0348219348088605e-07
girl O 0 2.2265029997470265e-07
who O 0 2.3753591107955607e-11
presented O 0 1.4021672711805877e-10
at O 0 2.2032767971191802e-11
9 O 0 3.60502148966102e-11
months O 0 3.904339958976655e-12
of O 0 2.5457539722106848e-12
age O 0 2.5254059954349373e-10
and O 0 8.788435257311988e-12
her O 0 1.8741306249958622e-12
similarly O 0 4.100621925351433e-11
affected O 0 7.089839271223752e-10
younger O 0 1.9222886393777117e-08
brother O 0 5.197557051417334e-09
and O 0 2.2764054530277633e-11
father O 0 7.973783300307957e-10
were O 0 2.2522857190399037e-10
all O 0 1.820888925752051e-12
found O 0 1.0606063417925235e-13
to O 0 5.603519357506512e-14
have O 0 8.597952265518988e-14
a O 0 5.84384808339361e-13
novel O 0 1.2763329282350355e-09
missense O 0 2.988615221966029e-08
mutation O 0 2.2998730697665337e-10
( O 0 7.217506757181691e-14
G1758 O 0 1.583683878481068e-10
- O 0 1.2489820289118825e-10
- O 0 3.7773836836230146e-10
> O 0 5.710945605308382e-10
T O 0 5.137371084096287e-11
) O 0 4.852184827907713e-16
encoding O 0 2.2025770421950364e-13
the O 0 4.4654132279851877e-13
amino O 0 3.4574836483419746e-12
acid O 0 4.0362292501316954e-12
substitution O 0 5.71530434090306e-10
Gly23 O 0 1.4509676304896857e-07
- O 0 1.3001523413436189e-08
- O 0 2.5768096989509104e-08
> O 0 4.9808001278961456e-08
Val O 0 5.573017602955588e-09
within O 0 1.0123544225137948e-09
NPII O 0 0.004712232854217291
. O 0 8.6585231429126e-08

The O 0 1.2427933882008801e-07
mutation O 0 3.694180250590762e-08
was O 0 6.50385523215391e-10
confirmed O 0 2.1949646267227507e-10
by O 0 2.551003462289425e-12
restriction O 0 4.528429631278641e-09
endonuclease O 0 1.3150371103165526e-07
analysis O 0 8.680590690701706e-10
. O 0 3.508454859968424e-09

A O 0 5.786309316135885e-07
T1 O 0 0.0001757338468451053
- O 0 1.3090834727336187e-07
weighted O 0 5.5643852192588383e-08
magnetic O 0 2.057681358635932e-09
resonance O 0 3.300581363774313e-09
imaging O 0 1.4226726818833413e-07
of O 0 4.352871840751504e-09
the O 0 7.040000014058023e-07
fathers O 0 0.00014617809210903943
pituitary O 0 0.00013322601444087923
gland O 0 3.295269607406226e-06
demonstrates O 0 3.717538943348586e-09
an O 0 7.185454922037371e-12
attenuated O 0 2.6151833480980713e-06
posterior O 0 7.644077868462773e-07
pituitary O 0 0.00039887227467261255
bright O 1 0.9994033575057983
spot O 0 2.3334014258580282e-05
. O 0 5.012277881633054e-08

This O 0 6.116925277410701e-08
mutation O 0 7.508893418162188e-08
may O 0 2.091967488127011e-09
be O 0 4.411879195309609e-11
valuable O 0 3.704887785449529e-10
for O 0 8.226447409560855e-13
developing O 0 1.1248650622075473e-10
models O 0 8.6692064638072e-10
of O 0 4.949356480210554e-09
dominantly B-Disease 0 0.0012264233082532883
inherited I-Disease 0 0.08467026054859161
neurodegeneration I-Disease 1 1.0
, O 0 7.851355676713467e-11
as O 0 3.5509149873963475e-13
the O 0 1.0190068596869703e-13
early O 0 1.3445158181246697e-11
age O 0 2.9101622153748785e-11
of O 0 1.0116695892473104e-12
onset O 0 2.2041508884740324e-07
of O 0 1.3250472719050777e-08
symptoms O 0 0.014974251389503479
suggests O 0 2.780184527040319e-09
that O 0 5.850360885843731e-13
this O 0 3.744047172987708e-12
mutation O 0 6.531637036788496e-11
may O 0 1.8851269503739054e-11
be O 0 8.307545623642554e-12
particularly O 0 2.070759397287958e-10
deleterious O 0 5.5134083964958336e-09
to O 0 9.989769428342399e-11
the O 0 3.2828511020710494e-09
magnocellular O 0 5.122226411913289e-06
neuron O 0 3.850068708288745e-07
. O 0 2.172407809197807e-09
. O 0 7.741117968862454e-09

Frequent O 0 2.6878010928044205e-08
inactivation O 0 7.078316411934793e-05
of O 0 1.3970025065646041e-06
PTEN O 1 0.9999996423721313
/ O 1 0.5128342509269714
MMAC1 O 1 1.0
in O 0 1.681221760918561e-06
primary O 1 0.9999998807907104
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3315851649385877e-06

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 2.959944289671057e-08
the O 0 1.1133307609156873e-09
most O 0 9.743997969602347e-11
common O 0 3.3911567998146097e-10
male B-Disease 0 4.579497892009954e-11
cancer I-Disease 0 2.0641739706395157e-10
in O 0 4.434078429947641e-13
the O 0 5.291577072352727e-12
Western O 0 2.78370659856364e-10
world O 0 2.6291197951361367e-13
, O 0 2.7044957324529918e-14
yet O 0 5.267568065764339e-13
many O 0 1.2310637094957704e-14
of O 0 2.0411140971301166e-14
the O 0 6.71395786731345e-14
major O 0 1.2169269498346624e-12
genetic O 0 3.907526700212133e-13
events O 0 5.095702099210467e-14
involved O 0 8.24449083764063e-14
in O 0 1.059963274378968e-13
the O 0 1.4917210262171965e-12
progression O 0 2.0768944897220365e-10
of O 0 1.291592809267439e-12
this O 0 7.340506674724523e-12
often O 0 7.631135723329407e-10
fatal O 0 7.322634587580978e-08
cancer B-Disease 0 0.0001748783397488296
remain O 0 1.791978476717304e-08
to O 0 2.0806679296159203e-11
be O 0 3.608449095082733e-10
elucidated O 0 1.0497397852304857e-05
. O 0 4.712031298481634e-08

Numerous O 0 5.8825115445415577e-08
cytogenetic O 0 3.120143446722068e-05
and O 0 1.3880331328763873e-09
allelotype O 0 2.416281495243311e-05
studies O 0 1.606753508021086e-09
have O 0 1.8311214090155348e-12
reported O 0 2.4554295229017864e-12
frequent O 0 4.02853054734531e-12
loss O 0 2.835567718129095e-11
of O 0 7.293495252191917e-10
heterozygosity O 0 9.457625310460571e-06
on O 0 2.481485523730953e-07
chromosomal O 0 2.4540469212297467e-07
arm O 0 1.6609332931238896e-07
10q O 0 1.1926838396902895e-06
in O 0 1.232420743235707e-08
sporadic B-Disease 1 0.997102677822113
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1576526048884261e-06

Deletion O 0 8.038474561544717e-07
mapping O 0 2.6011441889295384e-08
studies O 0 1.190374465664945e-09
have O 0 7.479504862684117e-12
unambiguously O 0 4.818683785323685e-10
identified O 0 3.469984716231167e-11
a O 0 6.058355314815522e-13
region O 0 6.905405414148191e-11
of O 0 4.4992673475796607e-10
chromosome O 0 3.92946841731856e-10
10q23 O 0 3.5619858174129604e-09
to O 0 1.1384143410939074e-12
be O 0 1.6949896347595583e-13
the O 0 9.316861518393615e-13
minimal O 0 8.206665902399379e-10
area O 0 2.767000240044837e-10
of O 0 1.5348330939524146e-10
loss O 0 1.3082817496012922e-08
. O 0 1.4222548827547143e-07

A O 0 4.1788825910771266e-07
new O 0 1.4877240062105557e-07
tumor B-Disease 0 5.099646296002902e-05
suppressor O 0 1.9568125935620628e-05
gene O 0 6.629695015192283e-09
, O 0 8.423954311886916e-10
PTEN O 0 0.0003836088872049004
/ O 0 1.1584344292714377e-06
MMAC1 O 1 0.9999884366989136
, O 0 2.1103291336643792e-10
was O 0 2.762603479311565e-09
isolated O 0 7.854984440669455e-10
recently O 0 4.03890393352313e-11
at O 0 4.364845724441624e-12
this O 0 7.001110845575309e-13
region O 0 9.652415672301018e-11
of O 0 2.0030485603506065e-10
chromosome O 0 1.1482943068630291e-10
10q23 O 0 6.071972258325786e-09
and O 0 1.609984389729091e-12
found O 0 1.9235784839977121e-13
to O 0 2.5091624809262143e-14
be O 0 1.372780605553639e-13
inactivated O 0 5.377271405926365e-10
by O 0 7.543661008357905e-12
mutation O 0 3.1824067825425573e-09
in O 0 6.428095833399539e-10
three O 0 1.8134857171503427e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.2637035474181175e-06
lines O 0 4.887992233193472e-09
. O 0 1.2520953163175363e-09

We O 0 2.203796839239658e-06
screened O 0 2.7945387046202086e-05
80 O 0 8.38042251416482e-06
prostate B-Disease 1 0.9997091889381409
tumors I-Disease 1 1.0
by O 0 4.6535869602237767e-10
microsatellite O 0 8.283334906877826e-09
analysis O 0 1.801496105069411e-11
and O 0 5.091092478148873e-12
found O 0 1.2128260201693664e-11
chromosome O 0 9.364814479440042e-11
10q23 O 0 1.04714352744395e-08
to O 0 1.9994441866066914e-11
be O 0 6.475320973864385e-11
deleted O 0 8.337492363175159e-10
in O 0 2.0831260327813794e-11
23 O 0 4.865480240923148e-10
cases O 0 2.1711889230946468e-10
. O 0 3.2144586992188806e-09

We O 0 3.1562801261486584e-09
then O 0 1.830151655224377e-11
proceeded O 0 7.783364230906642e-11
with O 0 1.7382838730914721e-15
sequence O 0 5.369714123625328e-15
analysis O 0 9.01153439792756e-15
of O 0 1.106663792180794e-13
the O 0 2.23054994613614e-11
entire O 0 5.738883146477747e-08
PTEN O 0 0.0013570641167461872
/ O 0 5.970082838757662e-06
MMAC1 O 0 0.19945232570171356
coding O 0 9.497019703985643e-08
region O 0 6.761937232369064e-09
and O 0 6.242679984058697e-11
tested O 0 5.697823879380337e-10
for O 0 6.219326442735706e-11
homozygous O 0 1.5352642490640278e-09
deletion O 0 1.7162943288795418e-10
with O 0 3.379528915829072e-13
new O 0 1.5256537699848138e-10
intragenic O 0 7.729008899559631e-08
markers O 0 2.2067783156387577e-09
in O 0 7.406281317401398e-12
these O 0 3.746712141927677e-12
23 O 0 1.028633081490149e-11
cases O 0 1.1553496874483482e-12
with O 0 1.4746168695844997e-13
10q23 O 0 6.333103641509297e-08
loss O 0 4.588840862851384e-09
of O 0 1.3405998977589206e-08
heterozygosity O 0 0.00010136619675904512
. O 0 5.103820512886159e-07

The O 0 7.28095500557302e-11
identification O 0 1.6961176907415165e-10
of O 0 2.8073258995231498e-11
the O 0 2.0224960595172092e-11
second O 0 8.771225412651518e-11
mutational O 0 3.0406379636360725e-09
event O 0 1.1221129928018492e-11
in O 0 1.4135620842251062e-12
10 O 0 1.1158935754596033e-11
( O 0 2.6039966623953026e-13
43 O 0 1.6119503509770539e-09
% O 0 4.1801620498382874e-10
) O 0 5.934502889104465e-10
tumors B-Disease 1 1.0
establishes O 0 4.831964906770736e-05
PTEN O 1 0.9999948740005493
/ O 0 3.60044687113259e-05
MMAC1 O 1 0.9999128580093384
as O 0 2.942265528438348e-11
a O 0 1.5075721432940975e-13
main O 0 6.3526423704773904e-12
inactivation O 0 2.108045071835818e-09
target O 0 7.0305809785065065e-12
of O 0 3.915349294780768e-11
10q O 0 1.2463094662962249e-06
loss O 0 1.6421653015186166e-07
in O 0 7.573677862637851e-08
sporadic B-Disease 1 0.9999973773956299
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.6201940617198716e-09
. O 0 1.1236047647855685e-09

Risk O 0 1.0195759614362032e-06
reversals O 0 6.533839069788883e-08
in O 0 5.870778863048542e-11
predictive O 0 2.0535957379053116e-09
testing O 0 3.820148197775097e-09
for O 0 1.0445782017143301e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 9.295350764659815e-07

The O 0 1.0633004476900965e-09
first O 0 3.4793626313422976e-11
predictive O 0 2.628912920688009e-10
testing O 0 2.067926496707173e-09
for O 0 9.398823053174965e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.1638611081832284e-11
HD B-Disease 0 7.266260126925772e-08
) O 0 7.98562401643256e-14
was O 0 6.227786949336567e-12
based O 0 1.7347062371622646e-12
on O 0 1.2620973710575356e-11
analysis O 0 4.739242418644318e-12
of O 0 4.902177188487178e-12
linked O 0 4.3642425784362615e-10
polymorphic O 0 1.3600812032166232e-08
DNA O 0 3.2025375684696655e-09
markers O 0 3.042121554663879e-10
to O 0 3.9877357058820673e-13
estimate O 0 2.631400132513395e-11
the O 0 4.064262218873155e-13
likelihood O 0 5.0195701761790446e-11
of O 0 5.459521376649512e-11
inheriting O 0 8.479153379425952e-09
the O 0 7.176395033781091e-10
mutation O 0 2.900742424039038e-10
for O 0 5.805392624957939e-11
HD B-Disease 0 3.4392339784972137e-06
. O 0 3.6516848211931574e-08

Limits O 0 1.0297446806362132e-06
to O 0 5.431635696773185e-10
accuracy O 0 1.1790610265904888e-08
included O 0 8.806700924068878e-10
recombination O 0 7.731169038294183e-10
between O 0 3.277604923579425e-11
the O 0 1.9999554096150618e-11
DNA O 0 3.51858570057928e-10
markers O 0 4.631856009851276e-10
and O 0 1.1096028609824948e-11
the O 0 4.6535490738630614e-11
mutation O 0 1.293309764838213e-10
, O 0 1.0407258822092702e-12
pedigree O 0 3.9010986108145573e-10
structure O 0 2.1099187674789022e-10
, O 0 6.601772947756324e-12
and O 0 1.1884964583666613e-12
whether O 0 1.9613540392510176e-12
DNA O 0 1.2269071175685653e-11
samples O 0 4.301315813942663e-12
were O 0 1.6897603921563892e-13
available O 0 4.085971198972832e-13
from O 0 2.361291284030953e-12
family O 0 4.882117626836546e-11
members O 0 9.518309751488374e-12
. O 0 8.276571095144902e-10

With O 0 1.4611133136721577e-10
direct O 0 2.7371327426806147e-10
tests O 0 1.7051741962870182e-10
for O 0 1.5953278628688672e-11
the O 0 8.39966318721963e-10
HD B-Disease 0 4.251433892932255e-06
mutation O 0 2.1551609385994652e-09
, O 0 6.6833903862584254e-12
we O 0 2.418330076123243e-12
have O 0 1.1012901474007769e-13
assessed O 0 2.942467450250952e-11
the O 0 7.816801134326312e-13
accuracy O 0 2.017118069796986e-11
of O 0 3.1889339259516536e-12
results O 0 8.314552171762024e-12
obtained O 0 4.829702610065212e-12
by O 0 1.937866777853084e-13
linkage O 0 1.890726464282011e-11
approaches O 0 1.4851050944564292e-10
when O 0 1.1543408373268504e-12
requested O 0 1.851492847926295e-10
to O 0 4.8351152942549547e-11
do O 0 1.428398892222571e-11
so O 0 1.0688377266587779e-12
by O 0 7.685780451741758e-14
the O 0 1.3019016203638656e-12
test O 0 1.7865767892866202e-11
individuals O 0 5.37611708623098e-12
. O 0 1.2568136531498908e-09

For O 0 5.089398902313746e-10
six O 0 1.192061380161924e-11
such O 0 8.533357939537189e-13
individuals O 0 5.658241887182558e-13
, O 0 1.991134443738926e-13
there O 0 7.205018103407373e-14
was O 0 3.1944249762744237e-12
significant O 0 1.2988020381410337e-11
disparity O 0 8.429965614453749e-10
between O 0 2.3162041729030136e-11
the O 0 1.7144391462053932e-10
tests O 0 9.490547236978841e-10
. O 0 2.6376387740612017e-09

Three O 0 6.227728022167867e-08
went O 0 2.4504938522795783e-08
from O 0 2.3185555905747002e-11
a O 0 2.763621796686433e-12
decreased O 0 1.6949252312770113e-07
risk O 0 2.2909329988607396e-10
to O 0 6.222512197347208e-13
an O 0 4.79929969057118e-15
increased O 0 7.465565492192905e-12
risk O 0 1.0927312873998396e-11
, O 0 5.805506222240561e-14
while O 0 6.360907894159551e-13
in O 0 3.183407855898712e-13
another O 0 4.4731706945293215e-13
three O 0 5.660484694901616e-14
the O 0 2.754181431530167e-12
risk O 0 3.2446507286509885e-11
was O 0 8.992699640497648e-11
decreased O 0 7.531211565492413e-08
. O 0 1.6567277327794727e-08

Knowledge O 0 7.582739840472641e-07
of O 0 1.5088849281141847e-08
the O 0 5.56806378781971e-10
potential O 0 3.3216862593832275e-10
reasons O 0 6.96942503708442e-10
for O 0 1.6945184404953961e-12
these O 0 2.3468785508712342e-12
changes O 0 3.068869811051478e-11
in O 0 1.2003046126474182e-11
results O 0 1.062014851060944e-10
and O 0 8.792124146783653e-12
impact O 0 1.881740319120695e-10
of O 0 6.004798047687387e-11
these O 0 3.242733165320644e-11
risk O 0 4.9344025393471824e-11
reversals O 0 2.042165603288737e-10
on O 0 1.8642924703993202e-10
both O 0 1.6289103746403022e-11
patients O 0 4.5720232044743625e-09
and O 0 6.961592760590385e-12
the O 0 8.753213709411511e-10
counseling O 0 1.1564714741396642e-09
team O 0 1.0093258694110485e-12
can O 0 1.2687672635604275e-13
assist O 0 2.7059033833043422e-11
in O 0 4.81831154836021e-12
the O 0 2.9011064384132368e-11
development O 0 5.024515248308603e-10
of O 0 5.002690969813095e-11
strategies O 0 6.262011048585592e-11
for O 0 3.724292738354479e-14
the O 0 5.107683481893333e-13
prevention O 0 2.6097025582205724e-11
and O 0 2.2762282510246923e-14
, O 0 1.6532242951326033e-15
where O 0 6.6227744317283455e-15
necessary O 0 2.4286983014987218e-12
, O 0 4.583583404320357e-13
management O 0 3.3872292991288244e-12
of O 0 1.642270846223537e-12
a O 0 1.3258282275871447e-12
risk O 0 4.909880488290774e-11
reversal O 0 1.0443360759504472e-10
in O 0 2.6854592768271734e-12
any O 0 1.0146769709173942e-11
predictive O 0 7.611130475870809e-11
testing O 0 8.078982621784192e-11
program O 0 3.2737312860575685e-11
. O 0 4.387247943410388e-12
. O 0 4.367356754020335e-10

A O 0 3.1016874402212125e-08
novel O 0 6.467884894334475e-09
common O 0 4.594042479766358e-09
missense O 0 1.820405088892585e-07
mutation O 0 1.3241091556537299e-09
G301C O 0 2.7668221047605357e-09
in O 0 2.9819246030737823e-12
the O 0 1.1623747103728377e-11
N O 0 2.1097588120966293e-09
- O 0 9.246734489209985e-10
acetylgalactosamine O 0 6.182847300806316e-08
- O 0 4.187905133790082e-09
6 O 0 1.4607907106167772e-09
- O 0 1.4676772297494978e-10
sulfate O 0 8.679762464325336e-10
sulfatase O 0 5.941803138398427e-08
gene O 0 2.804234067177447e-10
in O 0 1.6404380631662718e-10
mucopolysaccharidosis B-Disease 0 0.005628975108265877
IVA I-Disease 1 1.0
. O 0 1.6746207620599307e-05

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 0 0.0656985193490982
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.7344201075353283e-10
is O 0 5.1126078197405445e-12
an O 0 2.5130028266651117e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.010454866445798e-06
by O 0 1.778014541153894e-10
a O 0 3.930932468421133e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.4257871550071854e-09
N O 0 3.865461195573516e-08
- O 0 4.859611824059584e-09
acetylgalactosamine O 0 1.7957565034976142e-07
- O 0 3.9861792089368464e-08
6 O 0 9.850202431493926e-09
- O 0 2.2174022618060008e-09
sulfate O 0 8.214750657487002e-09
sulfatase O 0 5.632005581901467e-07
( O 0 3.5217731508829786e-11
GALNS O 0 0.12874861061573029
) O 0 2.0605865624911957e-10
. O 0 8.764126313565157e-09

In O 0 3.105103019152011e-08
previous O 0 4.0012889712670585e-07
studies O 0 5.711056960677752e-09
, O 0 1.2506785537769183e-11
we O 0 7.693239274797481e-12
have O 0 1.343722984444018e-12
found O 0 1.1085361144649863e-12
two O 0 7.810403392831747e-14
common O 0 2.353747405314799e-11
mutations O 0 1.2444655549115335e-11
in O 0 3.712821283058387e-12
Caucasians O 0 8.413484908764701e-10
and O 0 1.0465983548563207e-12
Japanese O 0 1.4285692628845936e-09
, O 0 2.3838455081443e-12
respectively O 0 2.6457142032754177e-10
. O 0 2.896354489578812e-09

To O 0 1.1154420498371564e-08
characterize O 0 3.195229965058388e-07
the O 0 5.313349760172059e-09
mutational O 0 3.828893113677623e-06
spectrum O 0 2.2176195102474594e-07
in O 0 1.5540235764888166e-11
various O 0 1.6481649378619068e-11
ethnic O 0 6.119539337073876e-12
groups O 0 6.854940877085158e-13
, O 0 1.0176860303903398e-13
mutations O 0 5.606162777928303e-13
in O 0 8.626802614278284e-13
the O 0 2.36143771203956e-10
GALNS O 1 0.556897759437561
gene O 0 2.829336098741919e-09
in O 0 1.3587504454903865e-09
Colombian O 0 5.644426437356742e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.00131873635109514
were O 0 2.1373076919406486e-10
investigated O 0 2.425400158490021e-10
, O 0 6.282680539010377e-12
and O 0 1.3801172010774465e-11
genetic O 0 9.855327665064806e-10
backgrounds O 0 8.682747854038553e-09
were O 0 5.889058685148996e-11
extensively O 0 1.9406799084409343e-11
analyzed O 0 9.653943616738658e-11
to O 0 2.6330656405226804e-12
identify O 0 6.845880112793523e-11
racial O 0 1.027872058301238e-11
origin O 0 9.091659369797611e-11
, O 0 6.193286714636231e-14
based O 0 3.739939469769339e-14
on O 0 3.4662770158518097e-13
mitochondrial O 0 3.74964295724034e-12
DNA O 0 4.576878459561229e-11
( O 0 1.7823953033999085e-13
mtDNA O 0 2.291616766139648e-12
) O 0 4.3029384851241137e-13
lineages O 0 1.5809072106964805e-10
. O 0 2.4966029243955745e-10

Three O 0 5.211790607972944e-07
novel O 0 5.888281066290801e-06
missense O 0 0.000162057694979012
mutations O 0 6.761835606994282e-07
never O 0 9.42453297625434e-08
identified O 0 5.5016324829182395e-09
previously O 0 8.251634375788797e-10
in O 0 1.9253716676548294e-11
other O 0 1.6166750230195426e-11
populations O 0 5.347033579794491e-12
and O 0 3.5927172153081555e-13
found O 0 7.286421357770301e-13
in O 0 3.834582391198937e-12
16 O 0 2.9335925355589154e-10
out O 0 3.4364123959601534e-12
of O 0 3.550369720439761e-11
19 O 0 7.880840979801462e-10
Colombian O 0 7.770585952471265e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 7.928975520599124e-08
alleles O 0 4.778292345131163e-11
account O 0 1.2310093049083815e-11
for O 0 7.701960597072954e-12
84 O 0 3.510043100618532e-08
. O 0 9.26013576929563e-09

2 O 0 3.014952199009713e-08
% O 0 5.0192256600967156e-11
of O 0 3.0839133330351487e-12
the O 0 1.4303946048455085e-11
alleles O 0 8.228428355350204e-12
in O 0 2.6439206726736053e-12
this O 0 3.2315250735742707e-12
study O 0 1.6449928225137356e-11
. O 0 1.7762044612901207e-10

The O 0 5.441129147243373e-08
G301C O 0 2.8241186100785853e-06
and O 0 2.0250845444991228e-09
S162F O 0 3.8569555727008265e-07
mutations O 0 7.314253092083334e-10
account O 0 3.230004458343316e-11
for O 0 2.182264612071716e-11
68 O 0 3.763787503885396e-08
. O 0 7.374407751115086e-09

4 O 0 8.038098826546047e-07
% O 0 2.5250603830073715e-09
and O 0 1.0234787323204486e-10
10 O 0 3.1443334047587257e-10
. O 0 1.972405350159079e-09

5 O 0 1.4472804821252794e-07
% O 0 6.429444754374458e-10
of O 0 1.0141241318928351e-10
mutations O 0 4.473627371326394e-11
, O 0 1.0218436340136972e-11
respectively O 0 9.461663674770193e-10
, O 0 1.6216904555332867e-11
whereas O 0 1.9311772181396236e-09
the O 0 2.359791251294041e-09
remaining O 0 7.206934924397501e-07
F69V O 0 0.006988467648625374
is O 0 7.445443567233312e-12
limited O 0 8.035854967558542e-12
to O 0 2.2501697228595463e-13
a O 0 9.627032244302614e-13
single O 0 2.3700652551639223e-10
allele O 0 1.047039699386687e-08
. O 0 6.586966527777349e-09

The O 0 1.5054554936000386e-08
skewed O 0 2.5908551748443642e-08
prevalence O 0 1.1020641288439492e-08
of O 0 4.188987351438911e-11
G301C O 0 1.4072941034726227e-08
in O 0 2.1675218911387795e-11
only O 0 3.2327148770383562e-12
Colombian O 0 1.4163351047535855e-10
patients O 0 6.94246604648896e-10
and O 0 7.322170213902579e-13
haplotype O 0 5.616590092322182e-12
analysis O 0 5.13277910300404e-14
by O 0 5.48304204977027e-15
restriction O 0 4.0453258798311964e-11
fragment O 0 2.649227365258966e-11
length O 0 2.5123845712182735e-11
polymorphisms O 0 3.420923544439347e-10
in O 0 1.035696702011979e-11
the O 0 3.0008073803600155e-10
GALNS O 0 0.00021005005692131817
gene O 0 2.2957094558684332e-10
suggest O 0 1.1789698384223612e-10
that O 0 6.352865689019868e-14
G301C O 0 1.717074482598946e-09
originated O 0 3.790546002080397e-11
from O 0 1.480281012784107e-13
a O 0 8.442466831962842e-14
common O 0 2.2247374081851845e-11
ancestor O 0 7.637837917684465e-09
. O 0 5.111718603956206e-09

Investigation O 0 3.989115668900922e-07
of O 0 1.2578551533692917e-08
the O 0 3.0143068041610377e-09
genetic O 0 1.5112373574766025e-09
background O 0 2.330074466705412e-10
by O 0 9.849299110673004e-13
means O 0 8.825529890232886e-11
of O 0 9.901181957649996e-11
mtDNA O 0 3.598083289646503e-11
lineages O 0 9.423005778441684e-12
indicate O 0 1.0280754112607093e-12
that O 0 6.750048331833356e-15
all O 0 1.7951691023455896e-13
our O 0 2.3109515603220165e-12
patients O 0 1.0682675230522243e-11
are O 0 3.5345319048294506e-15
probably O 0 1.1377001771228912e-12
of O 0 3.1827056181515934e-12
native O 0 1.2811077199081922e-10
American O 0 6.23120333109739e-10
descent O 0 1.7538971519570623e-07

Low O 0 4.0213114971265895e-07
frequency O 0 1.1382863540632115e-08
of O 0 2.7230226962160486e-09
BRCA1 O 0 9.506008780135744e-08
germline O 0 2.0645428833176993e-07
mutations O 0 2.422672340518517e-10
in O 0 1.2414754554240792e-12
45 O 0 3.960189676188719e-10
German O 0 0.0009846471948549151
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.580524848307732e-09
. O 0 5.684429038588235e-10

In O 0 8.099904774683253e-11
this O 0 3.6079898292108725e-13
study O 0 2.345861406603117e-13
we O 0 2.0784594409613798e-14
investigated O 0 7.901740026183823e-12
45 O 0 1.4758938515768705e-10
German O 0 0.0001267529878532514
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.299643528524413e-11
for O 0 5.3191214453851554e-12
germline O 0 9.642434406487155e-09
mutations O 0 1.917914022042666e-10
in O 0 1.9689864322325334e-11
the O 0 1.7500859650354528e-09
BRCA1 O 0 1.59504107699604e-08
gene O 0 9.206803097683292e-10
. O 0 8.076495028319641e-09

We O 0 4.706345890781449e-08
identified O 0 2.4603568959946642e-08
four O 0 2.2789914400078715e-10
germline O 0 1.1061815996527002e-07
mutations O 0 8.00502275577486e-10
in O 0 6.498322019377056e-11
three O 0 1.426940093862683e-10
breast B-Disease 0 5.760531621490372e-06
cancer I-Disease 0 8.99589795153588e-05
families O 0 1.0080922763222588e-09
and O 0 2.7096233590206964e-10
in O 0 2.459306003288475e-08
one O 0 0.00025691898190416396
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.0053463617154534e-09
. O 0 1.930401151428729e-12
among O 0 1.4885426333384466e-13
these O 0 1.1836629834377672e-14
were O 0 3.311976344219647e-13
one O 0 4.001991880248079e-13
frameshift O 0 3.405377368981277e-10
mutation O 0 8.643672583241724e-12
, O 0 5.32346248246357e-13
one O 0 8.173301987469961e-13
nonsense O 0 2.585571534652331e-09
mutation O 0 2.1830900975849943e-10
, O 0 1.0734550184507419e-12
one O 0 4.179294172020065e-13
novel O 0 6.642902894427039e-11
splice O 0 1.5592576119161095e-08
site O 0 1.4480026067076324e-09
mutation O 0 1.1052632142849461e-09
, O 0 1.9363456151000324e-12
and O 0 3.5334315768437152e-12
one O 0 3.0307225479253574e-11
missense O 0 4.885404223387013e-07
mutation O 0 5.763465438235471e-08
. O 0 1.866421861507206e-08

The O 0 3.510619706048601e-07
missense O 0 1.5978090232238173e-05
mutation O 0 2.4786134034116003e-08
was O 0 8.4110457487796e-10
also O 0 3.930147006447893e-12
found O 0 8.929217608366624e-12
in O 0 3.9781750810208294e-11
2 O 0 3.786902524893776e-08
. O 0 8.998679135174825e-09

8 O 0 2.9178366389714938e-08
% O 0 9.462670230719894e-11
of O 0 1.0645676180864871e-11
the O 0 1.2266520264814229e-11
general O 0 7.946610480757954e-09
population O 0 9.266906686455911e-12
, O 0 5.714270744951178e-13
suggesting O 0 1.3822247166284107e-11
that O 0 4.637902136449788e-14
it O 0 6.723569319572534e-14
is O 0 5.699192745338422e-14
not O 0 1.3217026214804029e-12
disease O 0 1.297822627144285e-09
associated O 0 1.0627941193774859e-08
. O 0 1.2415944183885586e-07

The O 0 1.0611204137589425e-09
average O 0 1.2081264877394915e-09
age O 0 8.652819571963732e-10
of O 0 1.5810151798856253e-11
disease O 0 7.07557701318251e-09
onset O 0 8.357415595128259e-07
in O 0 1.0980345105382483e-10
those O 0 8.624573277771219e-11
families O 0 7.630400651603697e-12
harbouring O 0 1.649147707283305e-09
causative O 0 2.771433083026409e-09
mutations O 0 9.224943586794154e-10
was O 0 1.0461029820163503e-09
between O 0 7.284958747355574e-10
32 O 0 3.339642162814016e-08
. O 0 1.1214257966685182e-08

3 O 0 3.318448989375611e-06
and O 0 5.476244790969531e-09
37 O 0 2.2981637926022813e-07
. O 0 2.860451076003301e-08

4 O 0 1.0240621151069718e-07
years O 0 1.829196377700626e-10
, O 0 4.468721399863984e-12
whereas O 0 4.059999558769789e-10
the O 0 1.236952762440069e-10
family O 0 1.5938475539378771e-10
harbouring O 0 1.1528491938861407e-08
the O 0 5.550483406224771e-10
missense O 0 4.988444146647453e-08
mutation O 0 2.576757696104437e-10
had O 0 1.6701003644273293e-12
an O 0 5.032978716543223e-16
average O 0 8.401813316252782e-13
age O 0 6.911502186540686e-12
of O 0 1.1799382000979297e-12
onset O 0 9.05178936250195e-08
of O 0 7.068633323115137e-08
51 O 0 1.6648185408030258e-07
. O 0 2.0683376789065733e-08

2 O 0 1.7783116845748737e-06
years O 0 1.6660758106468165e-08
. O 0 3.176647211944328e-08

These O 0 7.656803546751689e-08
findings O 0 2.2776029950932752e-08
show O 0 4.900919670092208e-10
that O 0 1.313873836117363e-11
BRCA1 O 0 7.796373324708838e-09
is O 0 3.15410891849055e-12
implicated O 0 4.270336861900148e-11
in O 0 9.975135951620362e-13
a O 0 1.0101727803855584e-13
small O 0 6.364253877589113e-14
fraction O 0 3.1061049565739296e-11
of O 0 3.462671216425406e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.920331065667472e-12
suggesting O 0 1.3549923715602125e-13
the O 0 8.290927894314543e-15
involvement O 0 1.0182743455941848e-13
of O 0 4.2736081058529496e-13
another O 0 1.4076913463015317e-12
susceptibility O 0 5.073126363441816e-10
gene O 0 5.1895480968067176e-11
( O 0 7.190431843689948e-12
s O 0 6.991852785631636e-08
) O 0 6.041839806236737e-10

Paternal O 0 0.0017276288708671927
transmission O 0 0.00012198089098092169
of O 0 1.3913483599026222e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.6268507242202759

We O 0 3.931322378747382e-09
report O 0 1.556738071784025e-11
a O 0 6.015885489416006e-14
rare O 0 1.309944665760232e-12
case O 0 1.2306664368133546e-11
of O 0 2.1639290359587449e-10
paternally O 1 0.9999997615814209
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.668008646291355e-09
DM B-Disease 1 1.0
) O 0 2.683163136119049e-10
. O 0 3.0264566408533256e-09

The O 0 1.0030849040276735e-08
proband O 0 1.244970690095215e-06
is O 0 5.034775114182155e-12
a O 0 2.6702983357482224e-13
23 O 0 7.852449246392723e-11
year O 0 1.9271131565523625e-11
old O 0 6.820696540899007e-08
, O 0 1.1037821767700962e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.00012779452663380653
who O 0 2.9757021291487717e-09
suffers O 0 3.7361297700044815e-07
severe O 0 0.0028645845595747232
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999535083770752

He O 0 4.398605646382947e-10
presented O 0 1.0278260464957611e-09
with O 0 1.4305472605113945e-11
respiratory O 1 0.9999998807907104
and O 0 1.4536928105712832e-08
feeding O 0 9.380323717778083e-07
difficulties O 0 4.819954657619974e-09
at O 0 4.281308085829494e-10
birth O 0 1.3469442592395353e-06
. O 0 4.2017646251224505e-08

His O 0 6.030062422723859e-07
two O 0 8.015033969854812e-09
sibs O 1 0.9999035596847534
suffer O 0 2.1075281608773366e-07
from O 0 1.6220014220635903e-09
childhood O 0 5.088817260912037e-07
onset O 1 0.9999886751174927
DM B-Disease 1 1.0
. O 0 5.882612822460942e-05

Their O 0 1.7505975336007396e-08
late O 0 1.3982680684421211e-05
father O 0 2.9167237514116096e-08
had O 0 4.3074755567973355e-11
the O 0 5.410802556872485e-13
adult O 0 3.0160027036582604e-13
type O 0 5.595181436224284e-13
of O 0 1.1614527915815298e-11
DM B-Disease 1 1.0
, O 0 5.0037023135995895e-11
with O 0 1.9217742360574247e-13
onset O 0 6.830264709378753e-08
around O 0 2.4041936844132472e-11
30 O 0 1.1669425148408408e-10
years O 0 7.899901219299288e-12
. O 0 2.1615201295510644e-10

Only O 0 4.190317870467197e-09
six O 0 4.931652308748369e-12
other O 0 1.0423062288484122e-14
cases O 0 1.3293802636395874e-13
of O 0 1.4307649032554992e-12
paternal O 0 1.5705946054822562e-07
transmission O 0 2.681741477772448e-07
of O 0 2.494107320671901e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.7342058811209426e-07
been O 0 8.704726522923423e-11
reported O 0 6.472947611940727e-12
recently O 0 4.975560588538208e-11
. O 0 2.3072675714441715e-10

We O 0 2.7655453482822168e-09
review O 0 8.4599899308202e-10
the O 0 1.629497752009268e-11
sex O 0 7.95506108902666e-12
related O 0 2.0525480620703362e-11
effects O 0 2.7117105436125222e-11
on O 0 9.354281932383302e-11
transmission O 0 1.9507734094759144e-08
of O 0 3.575060913973971e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0011837385827675462

Decreased O 0 1.1157408152939752e-06
fertility O 0 1.2249687131316023e-07
of O 0 1.0065853706109351e-10
males O 0 6.305430136355206e-12
with O 0 4.7056403776812514e-14
adult O 0 6.71969563326158e-11
onset O 0 2.6067272074215e-07
DM B-Disease 1 1.0
and O 0 4.5413667271176905e-10
contraction O 0 1.3051107972117393e-09
of O 0 1.688760797868838e-10
the O 0 7.359193116007745e-12
repeat O 0 2.538751977740339e-12
upon O 0 7.250213884119061e-12
male O 0 4.44681645022163e-13
transmission O 0 6.272640149266803e-14
contribute O 0 1.0948430238853866e-14
to O 0 1.3075019108317772e-14
the O 0 8.218135373605495e-13
almost O 0 1.620088286614918e-12
absent O 0 1.6845618650007665e-11
occurrence O 0 6.908098767501036e-13
of O 0 9.754884617088622e-13
paternal O 0 1.313818120962651e-08
transmission O 0 3.020575789491886e-08
of O 0 4.727810143378974e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00011260811879765242

Also O 0 8.928852102130236e-10
the O 0 1.3324767678124516e-10
fathers O 0 1.046812059257718e-08
of O 0 2.2971012245132094e-11
the O 0 1.5898208097220312e-11
reported O 0 2.8525753981156754e-10
congenitally O 0 1.153136690845713e-05
affected O 0 4.279636645065921e-09
children O 0 2.027969632500959e-11
showed O 0 8.37081879506707e-12
, O 0 4.158007488666571e-14
on O 0 7.2498821182542805e-12
average O 0 9.889744578828186e-11
, O 0 1.481771302880297e-11
shorter O 0 3.820631775397487e-07
CTG O 0 2.8385424229782075e-05
repeat O 0 3.3751824446426326e-08
lengths O 0 2.217213506128246e-07
and O 0 1.0548677382982152e-11
hence O 0 4.735181136084066e-10
less O 0 2.1141323414131108e-10
severe O 0 1.3278903532309982e-09
clinical O 0 1.216214018384676e-09
symptoms O 0 2.4295174760879945e-09
than O 0 1.5631730935702914e-12
the O 0 6.599720769884243e-12
mothers O 0 2.6121278751123356e-11
of O 0 4.1389241751781103e-13
children O 0 4.917485689481804e-13
with O 0 1.2653336494902745e-12
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.00010800897143781185

We O 0 1.8078243346764111e-09
conclude O 0 4.085153104682604e-09
that O 0 1.7463553389843178e-12
paternal O 0 1.371655571347219e-06
transmission O 0 4.4832190724264365e-06
of O 0 4.193310587652377e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 1.7364012450116206e-08
rare O 0 6.11268591299563e-10
and O 0 8.468921093920945e-13
preferentially O 0 6.167088541231269e-12
occurs O 0 2.1826621456402795e-13
with O 0 3.596798090875502e-16
onset O 0 2.8478838731693656e-10
of O 0 8.082562397149218e-10
DM B-Disease 1 1.0
past O 0 1.0120228211007998e-08
30 O 0 2.0902982469928055e-11
years O 0 1.9389463721663364e-13
in O 0 1.8174103240680035e-14
the O 0 7.163310743185658e-13
father O 0 4.816145746100453e-11
. O 0 2.2521340695136338e-11
. O 0 4.5887335597960544e-10

The O 0 7.409968816318724e-07
RB1 O 0 0.00026348792016506195
gene O 0 9.101003506373218e-09
mutation O 0 6.4892873297139886e-09
in O 0 1.773065895493975e-11
a O 0 1.402967048091952e-10
child O 0 1.2576684582654707e-07
with O 0 4.555692711960546e-09
ectopic B-Disease 1 0.9779466390609741
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.00010500715870875865

The O 0 1.4616299495173735e-06
RB1 O 0 0.0003702185058500618
gene O 0 1.4857498342735198e-08
mutation O 0 1.2768546220343069e-08
was O 0 1.5972131950370283e-10
investigated O 0 6.12190353965758e-10
in O 0 1.3047865565773975e-10
a O 0 5.194868424318599e-10
child O 0 1.8793754463786172e-07
with O 0 4.618317284155182e-09
ectopic B-Disease 0 0.0004066946275997907
intracranial I-Disease 1 0.9997836947441101
retinoblastoma I-Disease 0 1.6934667655732483e-05
using O 0 1.484150857766764e-10
DNA O 0 1.5715903578517043e-10
obtained O 0 1.8368626064635407e-11
from O 0 4.320787217598765e-12
both O 0 4.765574653647908e-12
the O 0 1.0920130771863157e-10
pineal B-Disease 0 3.694820770760998e-05
and I-Disease 0 1.605148347572083e-09
retinal I-Disease 0 0.08712822198867798
tumours I-Disease 1 1.0
of O 0 6.602692081969508e-08
the O 0 9.537951761728891e-09
patient O 0 1.3562623735197121e-06
. O 0 6.102798710827528e-09

A O 0 1.4351550703395333e-07
nonsense O 0 1.6040129935390723e-07
mutation O 0 2.9641460397300534e-09
in O 0 2.4648072471933347e-10
exon O 0 2.6441025369194904e-08
17 O 0 2.914531060937975e-09
( O 0 3.102864536488892e-12
codon O 0 2.580811786501158e-09
556 O 0 3.755854738329845e-09
) O 0 1.1323032355486928e-12
of O 0 1.2869316723396196e-10
the O 0 7.138202029466356e-09
RB1 O 0 3.174510129611008e-05
gene O 0 4.727600533271925e-10
was O 0 8.580669508262417e-10
found O 0 6.00882755011356e-12
to O 0 1.6979924682015285e-13
be O 0 1.1668056928634818e-12
present O 0 2.0492828267659746e-10
homozygously O 0 2.896770638471935e-06
in O 0 2.4724916558582777e-10
both O 0 2.4565174547297453e-11
the O 0 6.179101674774756e-11
retinal B-Disease 0 1.2306036296649836e-06
and I-Disease 0 1.6176637807063798e-09
the I-Disease 0 1.5643834672118828e-07
pineal I-Disease 1 0.9999418258666992
tumours I-Disease 1 1.0
. O 0 8.482641078444431e-07

The O 0 1.632728729994426e-09
same O 0 1.379523162370333e-10
mutation O 0 8.710340088091684e-11
was O 0 6.880779973572615e-11
present O 0 6.844143307649375e-11
heterozygously O 0 3.3320395687042037e-07
in O 0 1.939940569295473e-10
the O 0 2.553390138215761e-11
DNA O 0 2.2001450661335298e-10
from O 0 1.261380149636393e-11
the O 0 1.779720294747822e-11
constitutional O 0 1.1150563805628622e-09
cells O 0 4.10182082744015e-10
of O 0 1.0995366075960966e-11
the O 0 6.555384273604359e-12
patient O 0 5.824142057520021e-09
, O 0 3.909972118212174e-13
proving O 0 3.518436583749285e-11
it O 0 1.9964725808977943e-14
to O 0 1.3716656391445092e-13
be O 0 2.366259748906585e-12
of O 0 2.253127823204082e-10
germline O 0 4.576728329652724e-08
origin O 0 3.129974279758585e-09
. O 0 2.775045748748539e-09

The O 0 8.619583269364739e-09
initial O 0 4.4695315892795406e-08
mutation O 0 9.155983193842587e-10
was O 0 1.3215525895837743e-10
shown O 0 3.5814161965935787e-12
to O 0 1.4943808994069552e-12
have O 0 1.0370185613006733e-12
occurred O 0 4.829762145774907e-10
in O 0 4.885813541938289e-12
the O 0 6.865088358898319e-11
paternally O 0 3.2496112112312403e-07
derived O 0 1.8117680156137794e-07
RB1 O 0 0.00014697600272484124
allele O 0 4.706018330580264e-07
. O 0 3.8171858562918715e-08

The O 0 6.449099032579397e-09
mutation O 0 1.2704498564275468e-10
is O 0 4.313004218093469e-13
in O 0 2.1753805083245953e-13
an O 0 9.66062845090274e-15
area O 0 6.047809475440147e-11
of O 0 8.875260248952799e-11
the O 0 8.4110457487796e-10
gene O 0 1.2286868571187437e-11
that O 0 2.4913059896297662e-12
encodes O 0 1.0256077671161323e-12
the O 0 4.400061044684822e-12
protein O 0 3.6508764761356005e-12
- O 0 8.748280745651815e-12
binding O 0 7.530813472822473e-11
region O 0 1.0059217903091167e-09
known O 0 7.937785845291145e-11
as O 0 1.1745027693466081e-11
the O 0 4.038402945383268e-11
pocket O 0 2.2803416044325786e-08
region O 0 9.473528628234362e-10
and O 0 2.57126875347069e-10
has O 0 1.0127898519840528e-11
been O 0 8.996847537801056e-12
detected O 0 9.125263877862722e-10
in O 0 3.1753807482742813e-12
other O 0 2.1280757104419346e-12
cases O 0 3.724355546186331e-11
of O 0 1.7247081540716636e-10
retinoblastoma B-Disease 0 4.5408086180032114e-07
. O 0 6.3333915889529635e-09
. O 0 1.3585411906547051e-08

Low O 0 3.4326769764447818e-06
levels O 0 1.755332057484793e-08
of O 0 2.3141120963909856e-10
beta O 0 2.341034255337604e-09
hexosaminidase O 0 1.0403314831819443e-07
A O 0 4.089470428958464e-10
in O 0 1.1593413729027446e-11
healthy O 0 3.9208664093237644e-10
individuals O 0 1.020502516583914e-13
with O 0 7.72734944066121e-14
apparent O 0 1.38622723966364e-07
deficiency O 0 3.067957368330099e-05
of O 0 3.6854320484280834e-08
this O 0 2.4989719182855197e-09
enzyme O 0 1.424311193432004e-07
. O 0 1.558145790170329e-08

Appreciable O 0 3.905516678059939e-06
beta O 0 1.1454009296585355e-07
hexosaminidase O 0 1.7261258108192123e-05
A O 0 1.397087885379733e-06
( O 0 1.974387875414152e-10
hex O 0 3.5930966646446905e-07
A O 0 1.282390105217246e-08
) O 0 6.935536780300344e-12
activity O 0 2.858907599545546e-08
has O 0 4.663498320151005e-12
been O 0 2.970108187172471e-11
detected O 0 7.073636254517623e-08
in O 0 9.549364854422038e-09
cultured O 0 0.0007255395757965744
skin O 0 0.0005148891941644251
fibroblasts O 0 4.844122486247215e-06
and O 0 8.698954889752031e-10
melanoma B-Disease 0 4.581199846143136e-07
tissue O 0 2.8936488760678003e-09
from O 0 1.8001572454906523e-10
healthy O 0 1.1588826565045451e-09
individuals O 0 5.809881655632898e-14
previously O 0 2.880219934081607e-12
reported O 0 2.5201678851421994e-12
as O 0 2.882650541879972e-11
having O 0 4.724511448728208e-09
deficiency B-Disease 0 0.0008788375416770577
of I-Disease 0 6.968913112359587e-06
hex I-Disease 0 2.1282501165842405e-06
A I-Disease 0 1.6151971982125701e-09
activity O 0 2.0059237604286295e-10
indistinguishable O 0 2.6929234883676934e-11
from O 0 2.8549141725670154e-15
that O 0 2.282350294147536e-17
of O 0 7.424091316753437e-15
patients O 0 1.4048220919882226e-11
with O 0 3.2441019315321284e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9999992847442627
( O 0 2.835140455736962e-11
TSD B-Disease 0 2.3288621378014795e-05
) O 0 2.024796476318702e-11
. O 0 2.992184500172357e-09

Identification O 0 1.034823412737751e-06
and O 0 9.402153500204236e-10
quantitation O 0 9.14369520614855e-05
of O 0 7.4432532528589945e-06
hex O 0 9.48492088355124e-05
A O 0 4.563121791534286e-08
, O 0 2.1008010869100202e-12
amounting O 0 6.342790181967928e-11
to O 0 3.958541133775029e-11
3 O 0 8.89713369645051e-09
. O 0 2.660867526316224e-09

5 O 0 2.8638964977290016e-07
% O 0 6.587745460251426e-09
- O 0 2.8139242047586777e-08
6 O 0 4.1817930451770735e-08
. O 0 5.9697113918844025e-09

9 O 0 3.2523143289608925e-08
% O 0 7.745098312694765e-11
of O 0 8.74135833162093e-12
total O 0 1.002668260918771e-11
beta O 0 1.3841255919189166e-09
hexosaminidase O 0 4.672046145515196e-07
activity O 0 3.0396688543987693e-07
, O 0 8.235885931573428e-12
has O 0 1.0517646730759042e-13
been O 0 6.883802203391451e-14
obtained O 0 1.1386988357439676e-12
by O 0 1.0197058475380771e-11
cellulose O 0 1.9053153721415583e-07
acetate O 0 1.2677307381636638e-07
gel O 0 1.5186851953785663e-07
electrophoresis O 0 6.353621184729263e-09
, O 0 2.3012508565400935e-10
DEAE O 0 1.7209436919074506e-05
- O 0 1.0093433644442484e-08
cellulose O 0 4.4704353996394275e-08
ion O 0 1.4785690893859282e-08
- O 0 9.052563143541192e-09
exchange O 0 3.835070927493689e-09
chromatography O 0 4.453785784619413e-09
, O 0 5.17292328763852e-12
radial O 0 1.0159755259309122e-09
immunodiffusion O 0 1.0813945436893846e-06
, O 0 8.899738584977612e-11
and O 0 6.46979067542297e-11
radioimmunoassay O 0 9.702876923256554e-06
. O 0 1.4947751481031446e-07

Previous O 0 0.0054053352214396
family O 0 1.8689337366595282e-07
studies O 0 7.254634115660963e-10
suggested O 0 1.0945738065926136e-10
that O 0 2.4946188235779043e-13
these O 0 2.3835180790882093e-12
individuals O 0 1.3046627580365344e-13
may O 0 4.962961899085405e-12
be O 0 1.306010421336934e-12
compound O 0 1.949317235405701e-10
heterozygotes O 0 1.251419745607052e-09
for O 0 5.153106674010699e-13
the O 0 1.5399874084276455e-11
common O 0 7.64698859789803e-10
mutant O 0 2.17810125491269e-08
TSD B-Disease 0 2.3688262444920838e-06
gene O 0 1.1532856614149267e-10
and O 0 1.3389872977748185e-12
a O 0 3.864847081692241e-13
rare O 0 1.1367686653107612e-10
( O 0 9.634679339065588e-12
allelic O 0 2.846290136915286e-08
) O 0 7.100729726428057e-11
mutant O 0 2.9683457469786845e-08
gene O 0 1.5022192378921773e-09
. O 0 7.364006293641978e-09

Thus O 0 2.1795440829919244e-07
, O 0 4.4550413358379615e-10
the O 0 7.229977172507063e-10
postulated O 0 4.0448853155794495e-07
rate O 0 2.100661475878951e-07
mutant O 0 9.923804000777636e-09
gene O 0 7.564384535418966e-11
appears O 0 2.015150268874777e-10
to O 0 2.0305107692897978e-13
code O 0 8.060934190111391e-13
for O 0 1.5848718279594387e-13
the O 0 1.8221292530373745e-12
expression O 0 8.611041567296862e-12
of O 0 3.5855444047855345e-12
low O 0 1.3851603197778672e-10
amounts O 0 5.0954865327135224e-11
of O 0 1.5454700019734702e-10
hex O 0 4.7566805960741476e-07
A O 0 1.04163802916446e-07
. O 0 3.27668487898336e-08

Heterozygotes O 0 3.7381763831945136e-05
for O 0 7.398442747330591e-09
the O 0 5.148735660043258e-09
rare O 0 9.972835002258762e-09
mutant O 0 1.44517793287946e-08
may O 0 7.114354244608379e-11
be O 0 4.446140504377194e-12
indistinguishable O 0 3.4060790299328403e-10
from O 0 6.170543676714546e-13
heterozygotes O 0 4.848545454017028e-10
for O 0 1.6744445456920443e-12
the O 0 3.839692799822991e-11
common O 0 1.7583982270252818e-08
TSD B-Disease 0 0.00042106478940695524
mutant O 0 1.8269321344632772e-06
. O 0 3.8235178578815976e-08

However O 0 3.245485302727502e-08
, O 0 1.2698943459288348e-11
direct O 0 1.9805497519786996e-11
visualization O 0 6.427105958550783e-09
and O 0 5.843876771383094e-11
quantitation O 0 0.001429912867024541
of O 0 0.0012440746650099754
hex O 0 2.121397847076878e-05
A O 0 2.7734952112723477e-09
by O 0 1.1936557428246508e-12
the O 0 1.195754432969931e-12
methods O 0 6.9983539796592e-11
described O 0 1.6737878444361698e-11
may O 0 1.2207865794644501e-11
prevent O 0 8.344213341116014e-12
false O 0 1.3826578770803621e-10
- O 0 4.867556704923892e-11
positive O 0 9.65224514898333e-12
prenatal O 0 1.916346192842866e-09
diagnosis O 0 2.049885816646224e-09
of O 0 2.367967627536771e-11
TSD B-Disease 0 2.094353112624958e-05
in O 0 1.2321755837874093e-09
fetuses O 0 3.7257180451888416e-08
having O 0 3.065856943318401e-11
the O 0 3.02151192954625e-10
incomplete O 0 0.0008315242012031376
hex B-Disease 0 1.2110605894122273e-05
A I-Disease 0 1.0105014069949902e-07
deficiency I-Disease 0 1.3827985867465031e-06
of O 0 6.6733121251161265e-09
the O 0 5.3004892142105575e-11
type O 0 3.8368394572607656e-10
described O 0 1.8062579210109675e-11
in O 0 2.31784686929859e-12
the O 0 6.854320583338236e-11
four O 0 2.1905843458625007e-11
healthy O 0 4.398121422610757e-09
individuals O 0 7.443644312044029e-11

The O 0 1.0731837392086163e-06
tumor B-Disease 0 0.0002093302900902927
suppressor O 0 5.579130811383948e-05
gene O 0 3.119379243798903e-08
Smad4 O 0 4.446264210855588e-05
/ O 0 1.6126298874041822e-07
Dpc4 O 0 1.294682988373097e-06
is O 0 2.3845274713107933e-12
required O 0 1.2083096675996607e-11
for O 0 3.1485430582178786e-12
gastrulation O 0 2.4285648692057293e-07
and O 0 1.711203921617166e-11
later O 0 4.508983464379668e-10
for O 0 1.0518460234754112e-11
anterior O 0 7.435574378433785e-10
development O 0 1.1490441931272244e-09
of O 0 1.7319176648378232e-10
the O 0 2.1385472559476426e-10
mouse O 0 3.624357258757982e-09
embryo O 0 4.562442867950267e-08
. O 0 4.8965866916717005e-09

Mutations O 0 2.6777726702675864e-07
in O 0 4.762653604828415e-10
the O 0 6.214695869033449e-09
SMAD4 O 1 0.9999977350234985
/ O 0 0.00019987199630122632
DPC4 O 1 0.5462799072265625
tumor B-Disease 0 0.0001659825793467462
suppressor O 0 6.525949061142455e-07
gene O 0 6.22822973750381e-11
, O 0 5.471190991576669e-13
a O 0 5.001655014637285e-13
key O 0 8.876149593106675e-09
signal O 0 3.545091260548361e-07
transducer O 0 4.0053282646113075e-07
in O 0 3.0068934009364057e-09
most O 0 2.6558781840435586e-09
TGFbeta O 0 1.4613561688747723e-05
- O 0 1.5821790100289945e-08
related O 0 7.17458163990159e-08
pathways O 0 1.196436172357096e-09
, O 0 2.7473157890355385e-14
are O 0 1.5546244190558416e-16
involved O 0 5.242501315771639e-16
in O 0 4.6250492585081515e-14
50 O 0 2.76166294693736e-11
% O 0 6.473814539997846e-11
of O 0 8.782847782384806e-10
pancreatic B-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999943971633911
. O 0 5.798218626296148e-05

Homozygous O 0 0.0026391339488327503
Smad4 O 0 0.05402332544326782
mutant O 0 3.9978811400942504e-05
mice O 0 3.6376604839460924e-07
die O 0 2.806589849413399e-09
before O 0 1.7032172894282382e-10
day O 0 4.667403352698329e-09
7 O 0 2.4106119766997836e-08
. O 0 3.3310905145356173e-09

5 O 0 9.609890412320965e-07
of O 0 1.0938924432934982e-08
embryogenesis O 0 1.965025694516953e-05
. O 0 2.991518783801439e-07

Mutant O 0 7.685695891268551e-06
embryos O 0 5.703325314243557e-07
have O 0 2.2347826714175234e-11
reduced O 0 4.130500108612267e-10
size O 0 2.837138024514019e-10
, O 0 2.3130343126953612e-11
fail O 0 1.7644209426848079e-09
to O 0 3.113525409714768e-11
gastrulate O 0 1.4531074157275725e-06
or O 0 1.7780925343213738e-10
express O 0 3.2080468923695316e-12
a O 0 6.16132104645957e-14
mesodermal O 0 9.306917014839655e-09
marker O 0 1.7879695501932247e-09
, O 0 3.0505784530399094e-12
and O 0 3.4856711701031218e-12
show O 0 4.6083432209131914e-11
abnormal O 0 5.90035309500081e-09
visceral O 0 1.3141193733190448e-07
endoderm O 0 9.274620242649689e-05
development O 0 4.261962374130235e-07
. O 0 5.579891748652699e-08

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 2.810620117088547e-06
the O 0 9.392877586833492e-08
Smad4 O 1 0.5257373452186584
- O 0 7.932232256280258e-05
deficient O 0 8.190814924091683e-07
embryos O 0 2.215813665884525e-08
results O 0 1.3448037128327428e-10
from O 0 4.029767838864551e-12
reduced O 0 1.0808858252886466e-09
cell O 0 9.964958858077466e-10
proliferation O 0 1.0061732558241943e-09
rather O 0 8.905065920772337e-12
than O 0 1.055398607049951e-12
increased O 0 6.985115263979935e-10
apoptosis O 0 8.842763321581515e-08
. O 0 1.1376612540914266e-08

Aggregation O 0 2.9821580938005354e-06
of O 0 7.722510986241105e-08
mutant O 0 2.8746717362082563e-06
Smad4 O 0 0.00013107479026075453
ES O 0 9.270950727113814e-07
cells O 0 1.3412821964209343e-09
with O 0 1.9464460696439617e-13
wild O 0 1.6447584960666006e-10
- O 0 6.529133483867966e-11
type O 0 1.0066627531557515e-09
tetraploid O 0 5.033651632402325e-06
morulae O 0 1.9423127014306374e-05
rescues O 0 5.05176387832762e-07
the O 0 7.283986191986003e-10
gastrulation B-Disease 0 2.5475026632193476e-05
defect I-Disease 0 2.635903456393862e-06
. O 0 2.3601620569024817e-07

These O 0 4.546881982037121e-09
results O 0 1.4682042248637117e-09
indicate O 0 2.8043423139223478e-09
that O 0 4.175982042803339e-12
Smad4 O 0 3.7622987747454317e-07
is O 0 1.0773769029692737e-12
initially O 0 2.3316279462726186e-12
required O 0 1.105078160056061e-12
for O 0 7.714066608795547e-14
the O 0 4.428798040106985e-12
differentiation O 0 1.6774831523846956e-10
of O 0 3.046184485211434e-11
the O 0 2.101916210528465e-11
visceral O 0 2.6152211507479706e-09
endoderm O 0 2.1519134918435157e-07
and O 0 6.925332269452911e-12
that O 0 5.6147205212010026e-14
the O 0 9.66569359273084e-12
gastrulation B-Disease 0 5.4569891716482744e-08
defect I-Disease 0 1.2984590069820001e-09
in O 0 2.6135132252802507e-11
the O 0 4.854141047450078e-11
epiblast O 0 2.1906843983288127e-07
is O 0 3.2238849177052e-12
secondary O 0 1.4256892333364135e-09
and O 0 1.4872152988287812e-12
non O 0 1.6942731662084043e-08
- O 0 6.25514431362717e-08
cell O 0 4.0755858208285645e-06
autonomous O 0 2.2088512352524958e-08
. O 0 5.574761097193459e-09

Rescued O 0 4.2920994019368663e-05
embryos O 0 3.0960541153035592e-06
show O 0 3.9014351749244724e-09
severe O 0 6.881931824409548e-08
anterior O 0 2.7403489184507634e-06
truncations O 1 0.9997881054878235
, O 0 4.0450216509668735e-09
indicating O 0 1.9052823319043455e-08
a O 0 5.333873100143993e-12
second O 0 6.1052489452873e-11
important O 0 5.925169382914319e-11
role O 0 8.58996207497853e-12
for O 0 1.7775558802668456e-11
Smad4 O 0 2.7920902994083008e-06
in O 0 1.4091869893206876e-09
anterior O 0 1.1580679526446147e-08
patterning O 0 2.040789240709273e-06
during O 0 1.9084252755874331e-07
embryogenesis O 0 1.3923094229539856e-05
. O 0 1.2643332070183533e-07

Prevalence O 0 6.180434411362512e-06
of O 0 7.34498506460568e-09
p16 O 0 2.8568723564603715e-07
and O 0 1.2151108563784874e-08
CDK4 O 1 0.9999903440475464
germline O 0 0.0009348192252218723
mutations O 0 1.0817385032169113e-07
in O 0 7.065108498238715e-10
48 O 0 2.6509905381999488e-08
melanoma B-Disease 0 0.001787467859685421
- O 0 9.933396540873218e-07
prone O 0 2.679438182440208e-07
families O 0 1.8648969868362286e-10
in O 0 3.770744827491512e-11
France O 0 2.769335205599077e-09
. O 0 1.2997010578885693e-08

The O 0 1.1956944945268333e-07
French O 0 8.077689017227385e-06
Familial B-Disease 1 0.9430109858512878
Melanoma I-Disease 1 1.0
Study O 0 3.1290986157728184e-07
Group O 0 1.9487372826532123e-10
. O 0 2.437086088491469e-10

Germline O 0 0.0003122393100056797
mutations O 0 1.9021710784272727e-07
in O 0 6.399079044427936e-10
the O 0 2.378036212391521e-09
p16 O 0 7.021655790140358e-08
and O 0 3.2086331369640675e-09
CDK4 O 0 0.48889926075935364
genes O 0 1.3725326653002412e-08
have O 0 1.1245362280254412e-11
been O 0 3.2108382792828127e-12
reported O 0 3.027058204790878e-12
in O 0 1.5280664103847763e-12
a O 0 3.962860421757863e-12
subset O 0 5.367191135974281e-09
of O 0 3.597234454755238e-10
melanoma B-Disease 0 8.817086381895933e-06
pedigrees O 0 8.178780319667567e-08
, O 0 2.995177456749376e-12
but O 0 2.5535058009035216e-12
their O 0 3.3920329652742387e-12
prevalence O 0 2.325886185039483e-11
is O 0 3.5367843771944366e-15
not O 0 7.006289943828001e-14
well O 0 2.579892679696605e-12
known O 0 6.293310317317946e-11
. O 0 5.510822020937667e-09

We O 0 8.874423862437197e-09
searched O 0 3.2711394482021205e-08
for O 0 6.635507421304254e-11
such O 0 1.3394600095750775e-08
germline O 0 0.0001928770652739331
mutations O 0 3.375215555934119e-07
in O 0 6.115814521479024e-09
48 O 0 2.5044587914635486e-07
French O 0 5.882393452338874e-07
melanoma B-Disease 1 0.9998781681060791
- O 0 9.129620593739673e-06
prone O 0 9.500105875304143e-07
families O 0 1.801538224155408e-10
selected O 0 3.780293439392679e-11
according O 0 9.085792014584815e-13
to O 0 2.8831643561315345e-13
two O 0 1.7340594021461597e-14
major O 0 2.644016516145653e-12
criteria O 0 3.0731239775150243e-10
families O 0 2.0923434426028953e-12
with O 0 7.097289488560256e-15
at O 0 5.617990881529034e-13
least O 0 1.5778502636398795e-13
three O 0 7.612091295836065e-14
affected O 0 1.6550268100434806e-10
members O 0 9.32454721075393e-12
( O 0 1.4230837916493627e-13
n O 0 1.0066040882772409e-11
= O 0 9.036535625686626e-13
20 O 0 2.4240425205296345e-12
) O 0 4.428039644075463e-15
or O 0 1.0194098169769017e-12
families O 0 7.596391397857172e-12
with O 0 9.494275076413553e-14
two O 0 1.3354012990893227e-12
affected O 0 2.59278643000016e-09
members O 0 1.3850987197472353e-11
, O 0 2.2314168741932594e-12
one O 0 9.689537583748575e-13
of O 0 1.0009752575423914e-11
them O 0 3.5074308908644714e-13
affected O 0 3.482435043458687e-12
before O 0 1.6353326678930635e-11
the O 0 4.840935378253031e-12
age O 0 5.914205236656755e-11
of O 0 1.7446983094360213e-11
50 O 0 2.5088075714108093e-11
( O 0 1.814130612496235e-14
n O 0 2.7006118695493964e-12
= O 0 1.3065385362151516e-12
28 O 0 1.2081075029257704e-10
) O 0 3.495861166193971e-14
, O 0 1.7213928036902831e-13
and O 0 9.189381162478041e-14
one O 0 7.378834685194818e-14
additional O 0 1.7853836898479303e-12
minor O 0 2.0814083789844062e-09
criterion O 0 1.3243620742287021e-05
. O 0 9.09746347588225e-07

Sixteen O 0 7.200410618679598e-05
different O 0 1.0803219652189e-07
p16 O 0 2.971676394736278e-06
germline O 0 3.444035655775224e-06
mutations O 0 2.1601032074158866e-09
were O 0 3.152222233238078e-11
found O 0 3.9314718472925614e-13
in O 0 5.684658473115167e-13
21 O 0 3.9432906939751433e-10
families O 0 2.924691391847922e-11
, O 0 7.335226176463649e-13
while O 0 5.4831451878900594e-12
one O 0 3.75121678511392e-12
germline O 0 8.609395862890779e-09
mutation O 0 5.568573380188013e-10
, O 0 4.6760928462674656e-12
Arg24His O 0 3.3538904631313926e-07
, O 0 8.936748910337577e-12
was O 0 3.6942868902878345e-11
detected O 0 6.437199107089953e-10
in O 0 2.142342900302019e-11
the O 0 1.1969815139067919e-09
CDK4 O 0 0.01719764992594719
gene O 0 4.963899513654724e-08
. O 0 7.248320343933301e-08

The O 0 4.265172215411894e-09
frequency O 0 4.524889352097716e-09
of O 0 5.372104427969759e-10
p16 O 0 2.879510185849199e-09
gene O 0 4.818553195340414e-11
mutation O 0 2.951022065600384e-11
in O 0 3.785674464878985e-12
our O 0 1.8178014649095076e-11
sample O 0 4.649503351772388e-11
( O 0 9.640367931024185e-14
44 O 0 6.435060123655134e-11
% O 0 4.687950331747071e-13
) O 0 2.1255451131146517e-15
is O 0 1.1468299251330034e-14
among O 0 5.252014914549491e-14
the O 0 8.438522368934068e-14
highest O 0 6.938384589094682e-11
rates O 0 4.4835447854385535e-11
yet O 0 5.0816334647152406e-12
reported O 0 5.42334883599227e-12
and O 0 2.6485794894087755e-12
the O 0 5.773237790607233e-11
CDK4 O 0 6.142725760582834e-05
mutation O 0 1.0251984816633808e-09
is O 0 3.3257383934455487e-13
the O 0 9.080629043839439e-13
second O 0 1.4238562585922043e-11
mutation O 0 1.9988724217490095e-11
detected O 0 3.448575869313686e-10
in O 0 3.3015272373621007e-12
this O 0 6.21022330782317e-11
gene O 0 2.84829659857877e-10
worldwide O 0 8.79175968138135e-11
. O 0 1.4078122667626758e-08

In O 0 7.153968528683663e-10
summary O 0 1.1109380082530151e-09
, O 0 2.6795765259435278e-11
our O 0 3.742542734053167e-11
results O 0 9.497749808851097e-11
show O 0 1.77965905900912e-11
frequent O 0 8.164514528861966e-13
involvement O 0 2.765530643031311e-12
of O 0 1.7636959601108337e-11
the O 0 2.898961626307539e-10
p16 O 0 3.3977105573512745e-09
gene O 0 1.6007266345763327e-10
in O 0 8.175758681172596e-11
familial B-Disease 0 1.892728107577568e-08
melanoma I-Disease 0 2.9246452868392225e-06
and O 0 8.712429215573803e-12
confirm O 0 2.5424556557296363e-11
the O 0 6.899753338118764e-12
role O 0 1.6781150037267767e-12
of O 0 4.680467471929184e-11
the O 0 9.647579402027873e-10
CDK4 O 1 0.8182398676872253
gene O 0 5.723966300941186e-10
as O 0 2.3967581391781678e-11
a O 0 1.260548002784967e-11
melanoma B-Disease 0 5.107236574986018e-06
- O 0 1.7651329642376368e-07
predisposing O 0 5.973118959445856e-07
gene O 0 1.355729417618079e-09
. O 0 6.514048189742994e-10
. O 0 5.059233476600866e-09

Progression O 0 4.4362092012306675e-05
of O 0 1.9690314445597323e-07
somatic O 0 0.0002782951050903648
CTG O 0 2.6477258870727383e-05
repeat O 0 6.1011808938360446e-09
length O 0 3.019127170489355e-10
heterogeneity O 0 2.7596542828689508e-09
in O 0 3.147078084242416e-12
the O 0 9.726241513574596e-12
blood O 0 2.0784994558820102e-10
cells O 0 4.697590316737887e-09
of O 0 1.1293865842532114e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999500513076782
. O 0 8.559362640880863e-08

The O 0 4.959295751838511e-10
genetic O 0 8.422251229767141e-10
basis O 0 2.655462738587744e-09
of O 0 3.308348084374302e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.163764664281814e-10
DM B-Disease 1 1.0
) O 0 4.2859994524822864e-13
is O 0 1.6905978028093627e-14
the O 0 3.040729018403965e-14
expansion O 0 8.303954052157891e-11
of O 0 4.830248354070754e-11
an O 0 1.1931595034903042e-12
unstable O 0 4.425843158628595e-08
CTG O 0 3.6073214459975134e-07
repeat O 0 3.810627646760878e-10
in O 0 9.899137932978253e-12
the O 0 2.1536054189974507e-11
34 O 0 8.520230077024848e-10
UTR O 0 4.880970209342195e-06
of O 0 1.1147411466128077e-10
the O 0 3.186609864869183e-09
DM B-Disease 1 1.0
protein O 0 6.695166234749195e-07
kinase O 0 2.8992189982091077e-08
gene O 0 1.9657041272491682e-10
on O 0 7.604749052703141e-10
chromosome O 0 3.8354364129133955e-09
19 O 0 1.1401550814582606e-08
. O 0 1.1511945174902394e-08

One O 0 8.973103926557258e-10
of O 0 2.1019815055201008e-10
the O 0 1.0332230210297055e-10
principal O 0 6.632929760996831e-10
features O 0 2.6961753142595857e-12
of O 0 1.023704645358725e-11
the O 0 7.35732030854308e-10
DM B-Disease 1 1.0
mutation O 0 2.303255719482422e-08
is O 0 9.142811291038e-13
an O 0 9.182963702056464e-15
extraordinarily O 0 7.582585254128915e-11
high O 0 1.569394614264752e-10
level O 0 2.4841342871617655e-10
of O 0 5.924539192569966e-10
somatic O 0 7.864203325880226e-06
mosaicism O 0 1.9918341422453523e-05
, O 0 7.454779848981019e-12
due O 0 1.6985790551871105e-09
to O 0 7.740989273197219e-12
an O 0 7.626623670705518e-14
extremely O 0 5.858764862143317e-11
high O 0 2.1539135058867842e-11
degree O 0 1.8665018142183243e-10
of O 0 5.830783078586421e-11
somatic O 0 2.5559727419022238e-06
instability O 0 3.309128970840902e-09
both O 0 1.7040351768526918e-11
within O 0 2.4274351625996893e-11
and O 0 1.4337971998915067e-12
between O 0 9.042678064674625e-12
different O 0 1.296268370420961e-10
tissues O 0 1.5883446735642792e-07
. O 0 1.6167854610671384e-08

This O 0 6.538513730447448e-08
instability O 0 7.252469202967404e-08
appears O 0 4.10720124577324e-09
to O 0 3.185997472787694e-12
be O 0 2.65387885278745e-12
biased O 0 5.3815986389427195e-11
towards O 0 6.887082570905534e-11
further O 0 1.2668726311060308e-11
expansion O 0 1.0941945127740382e-09
and O 0 7.260537657205468e-12
continuous O 0 4.7929420848857873e-11
throughout O 0 6.13578458874553e-12
the O 0 2.2016805045765864e-11
life O 0 1.1715500791709132e-10
of O 0 9.036424386543729e-11
an O 0 1.7474273438823629e-13
individual O 0 3.682424157269715e-12
, O 0 6.274007463731579e-13
features O 0 5.283737856964787e-13
that O 0 6.1891380319638745e-15
could O 0 1.0758258975514245e-13
be O 0 1.661958331372615e-13
associated O 0 8.812540107372424e-12
with O 0 1.3258679907018206e-13
the O 0 4.305553483185953e-11
progressive O 0 2.0733943983941572e-07
nature O 0 1.95691671200926e-10
of O 0 8.631612785636733e-12
the O 0 4.312769932846017e-11
disease O 0 5.046146167586585e-09
. O 0 3.789075275761888e-09

Although O 0 2.538863697054694e-08
increasing O 0 1.0486619350658088e-09
measured O 0 1.231257096279137e-09
allele O 0 2.0510513287774756e-09
size O 0 2.682252198127344e-10
between O 0 2.7461377616333493e-10
patients O 0 5.900034807382326e-07
clearly O 0 3.4948752225538726e-10
correlates O 0 4.823262900188752e-10
with O 0 1.1607954655541534e-14
an O 0 5.790669804894692e-16
increased O 0 1.0875222163780895e-12
severity O 0 8.595280598377997e-10
of O 0 1.0914050913024553e-10
symptoms O 0 4.576850471949001e-07
and O 0 6.1800881252793705e-12
an O 0 3.405056777852763e-15
earlier O 0 1.0889654629420153e-11
age O 0 6.620855252936764e-11
of O 0 2.4152093085899606e-12
onset O 0 6.466289725892693e-10
, O 0 3.138756073627069e-13
this O 0 1.9337167229873525e-13
correlation O 0 2.402733502611387e-13
is O 0 4.4815009755743655e-15
not O 0 1.7789775593390553e-14
precise O 0 1.2290674034076687e-10
and O 0 2.5588994465031156e-11
measured O 0 1.0134517669513343e-09
allele O 0 2.2569041080444663e-10
length O 0 3.87908941079651e-11
cannot O 0 8.072232118849776e-12
be O 0 1.0644833132360601e-13
used O 0 4.0806128007858655e-13
as O 0 6.507279795304327e-14
an O 0 7.915329662700344e-16
accurate O 0 2.542048342657477e-11
predictor O 0 8.363713277503848e-09
of O 0 2.697534730311535e-11
age O 0 1.2915601921292819e-09
of O 0 8.485924463119687e-11
onset O 0 1.7437797623642837e-06
. O 0 7.028609871895242e-08

In O 0 4.01194133470284e-10
order O 0 2.294435613725554e-10
to O 0 4.193509688804609e-12
further O 0 3.4486927202870277e-11
characterize O 0 3.177748508775835e-09
the O 0 2.458843961772317e-10
dynamics O 0 1.4255921776396008e-08
of O 0 1.5046006751617824e-07
DM B-Disease 1 1.0
CTG O 0 0.003247554413974285
repeat O 0 8.956115493674588e-08
somatic O 0 1.1499917036417173e-06
instability O 0 3.8848371741728727e-10
, O 0 3.882801469668601e-13
we O 0 1.0050567691467782e-13
have O 0 5.198773472803696e-14
studied O 0 1.2705260021145248e-12
repeat O 0 2.5144721916593726e-13
length O 0 1.7619288189898996e-13
changes O 0 1.102993456118806e-12
over O 0 1.1441480358628797e-12
time O 0 1.3659806792631901e-11
in O 0 7.067288421147566e-11
111 O 0 2.7836941285386274e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 7.23917310097022e-07
with O 0 1.7861933991353968e-13
varying O 0 5.716543904910054e-11
clinical O 0 7.848406646804307e-11
severity O 0 4.460502189829185e-09
and O 0 1.4981552109993856e-10
CTG O 0 3.6369904421462707e-08
repeat O 0 2.302031135159588e-11
size O 0 4.668606647106888e-12
over O 0 1.6382781361980875e-13
time O 0 1.5488790263383512e-13
intervals O 0 3.0701855988080062e-12
of O 0 1.2113273708744265e-12
1 O 0 1.272050104139666e-10
- O 0 1.0317106197144099e-10
7 O 0 3.2071326150351354e-10
years O 0 1.743770058904026e-11
. O 0 2.1239740521927786e-10

We O 0 1.23187309242212e-08
have O 0 8.748597332686181e-12
found O 0 4.996696958102509e-13
a O 0 1.109364048513346e-14
direct O 0 6.096422195192575e-13
progression O 0 4.806420261793676e-10
of O 0 9.246813384433672e-12
the O 0 1.0234762690131127e-11
size O 0 9.559451841223421e-11
heterogeneity O 0 7.335013707532312e-10
over O 0 6.082812639002233e-12
time O 0 1.499120792780584e-11
related O 0 2.6621873594478984e-09
to O 0 1.1238227709542414e-10
initial O 0 2.069205962129672e-08
CTG O 0 8.002298557130416e-08
repeat O 0 2.50740591484222e-11
size O 0 1.2691558741451114e-11
and O 0 6.507978292553951e-13
the O 0 3.8341855732038077e-13
time O 0 8.226258758382843e-13
interval O 0 1.577906034999632e-11
and O 0 1.1677385404126883e-12
always O 0 5.241212845674692e-12
biased O 0 1.0429043913184888e-11
towards O 0 3.8945617564234425e-11
further O 0 1.2061045218114685e-10
expansion O 0 1.1480583594902782e-07
. O 0 2.5693301708429317e-08

Attempts O 0 6.274291877161886e-07
to O 0 2.5368182554608154e-10
mathematically O 0 1.6280463199791484e-08
model O 0 1.3182955838075827e-09
the O 0 3.3164206936220353e-09
dynamics O 0 5.726373615289049e-07
have O 0 2.433162338277839e-09
proved O 0 2.3107585889192706e-07
only O 0 1.2365494739263738e-10
partially O 0 1.9216608304617466e-09
successful O 0 3.518329030893774e-11
suggesting O 0 2.0589000990223205e-11
that O 0 2.063831181962298e-14
individual O 0 7.827987119190388e-14
specific O 0 1.8999693311705368e-12
genetic O 0 2.7644032896123605e-11
and O 0 4.966986457549671e-12
/ O 0 4.5348254040789016e-09
or O 0 3.813126897567187e-11
environmental O 0 2.5304069950493613e-09
factors O 0 1.3685945432495572e-10
also O 0 6.98046980461553e-13
play O 0 2.312115559774397e-12
a O 0 3.9390978543232813e-13
role O 0 1.7775694111099583e-11
in O 0 3.453493324645507e-10
somatic O 0 2.8032749469275586e-05
mosaicism O 0 3.3622847695369273e-05
. O 0 3.5465901326858784e-09
. O 0 6.597351998038903e-09

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 3.831022610256696e-08
Palestinian O 0 1.8523216738230985e-07
Arabs O 0 6.399670837708982e-08
. O 0 3.376069424021466e-09

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9999008178710938
AGU B-Disease 1 1.0
) O 0 1.139297406416162e-10
is O 0 3.497624011163797e-13
a O 0 1.5326922944789573e-13
rare O 0 7.912158039857786e-09
disorder B-Disease 1 0.9999960660934448
of I-Disease 0 0.05183941870927811
glycoprotein I-Disease 0 0.0016101548681035638
metabolism I-Disease 1 0.9966501593589783
caused O 0 5.893770471665505e-10
by O 0 1.4503774700344585e-12
the O 0 4.122275576445844e-10
deficiency B-Disease 0 2.859115397768619e-07
of I-Disease 0 6.60641485961122e-10
the I-Disease 0 6.713369860023022e-10
lysosomal I-Disease 0 8.330941341228026e-07
enzyme I-Disease 0 3.302938367255592e-08
aspartylglucosaminidase I-Disease 0 5.77046694161254e-06
( O 0 4.753829274672938e-11
AGA O 0 6.743297126377001e-05
) O 0 4.380736398634788e-11
. O 0 9.44014089121481e-10

AGU B-Disease 1 1.0
is O 0 6.475546570072765e-07
inherited O 0 0.0008166898624040186
as O 0 8.673048057517008e-09
an O 0 2.8088806280912593e-10
autosomal O 0 0.05549371615052223
recessive O 0 2.803782990667969e-05
trait O 0 1.3015397826166009e-07
and O 0 6.889394610354316e-11
occurs O 0 5.377327055855474e-12
with O 0 4.361351893105185e-15
a O 0 1.236763902417613e-14
high O 0 5.06575337233528e-12
frequency O 0 1.136924148575913e-11
in O 0 7.205475365673619e-13
Finland O 0 1.227448420682009e-10
because O 0 1.7200687055241026e-11
of O 0 7.18507475738761e-11
a O 0 1.8959771252990976e-11
founder O 0 1.829071671899385e-09
effect O 0 9.382112864386727e-09
. O 0 4.435643852218618e-09

While O 0 4.339825920851581e-07
very O 0 4.5726422648328935e-09
few O 0 6.29326857293222e-09
patients O 0 9.919001087155266e-08
with O 0 2.42550202145253e-10
AGU B-Disease 1 1.0
have O 0 3.7664498186984474e-09
been O 0 6.262464852246907e-11
reported O 0 7.0816013643393294e-12
from O 0 1.2883407014829817e-11
non O 0 1.062821941566483e-09
- O 0 2.2491421919346166e-11
Finnish O 0 4.20273843504404e-10
origin O 0 1.6875332728427672e-11
, O 0 9.572779851793611e-13
we O 0 1.1144812503416368e-11
diagnosed O 0 2.927944024122553e-06
the O 0 3.5643783480310276e-09
disorder O 0 3.762722144529107e-06
in O 0 4.4378105634734766e-09
8 O 0 2.8775955840387724e-08
patients O 0 2.584023217622189e-09
originating O 0 1.167681784597363e-10
from O 0 4.827611834595791e-12
3 O 0 5.343019082726386e-11
unrelated O 0 1.6260368052023466e-10
families O 0 2.3377109709815658e-12
, O 0 2.1380207649332288e-14
all O 0 1.9155336699965518e-14
Palestinian O 0 7.726373707495071e-11
Arabs O 0 6.625917696456707e-12
from O 0 2.0203272648594561e-13
the O 0 9.15282186522183e-14
region O 0 6.967487025701102e-13
of O 0 3.262907522297298e-12
Jerusalem O 0 3.0846496201775153e-07
. O 0 2.4641140683456797e-08

The O 0 1.555965845057017e-08
clinical O 0 3.1113310683394957e-07
diagnosis O 1 0.9999992847442627
of O 1 0.9999502897262573
AGU B-Disease 1 1.0
is O 0 1.823116768662203e-08
often O 0 2.6213113277218092e-11
difficult O 0 1.0432843824959015e-11
, O 0 4.808171005440953e-14
in O 0 8.222787143026544e-14
particular O 0 2.5853110884738184e-12
early O 0 1.0886820334121694e-09
in O 0 6.699876656073023e-13
the O 0 1.9893398994080824e-12
course O 0 1.4246386188798699e-11
of O 0 5.981951587720469e-13
the O 0 1.5395197052944787e-12
disease O 0 1.3908282858743348e-10
, O 0 4.955278808810304e-13
and O 0 6.775646666998258e-13
most O 0 1.3934158731368496e-12
of O 0 1.5936026370039214e-12
the O 0 5.956054226208263e-12
patients O 0 1.71446537522435e-10
are O 0 2.6782234809345946e-14
diagnosed O 0 1.1437951280557357e-11
after O 0 2.187089051530755e-12
the O 0 2.7458309063976838e-12
age O 0 8.904357112760053e-11
of O 0 1.457624819456438e-11
5 O 0 7.247451944136785e-11
years O 0 1.4030895369165908e-11
. O 0 6.541190367137517e-10

However O 0 4.125709835989255e-07
, O 0 1.9897136716018338e-10
since O 0 8.505908755118696e-10
these O 0 3.7060893243179294e-10
patients O 0 1.2649277181253638e-09
excrete O 0 2.0427821656454626e-09
early O 0 1.3037020074602168e-10
large O 0 3.445868536258029e-13
amounts O 0 4.302694485425196e-12
of O 0 3.019338598586607e-11
aspartylglucosamine O 0 1.5620681779182632e-06
in O 0 2.6836814992492464e-09
urine O 0 9.182571147903218e-09
, O 0 5.016368180219e-13
biochemical O 0 1.7174919472728867e-11
screening O 0 3.7648413275803705e-09
is O 0 6.060438609289953e-12
easy O 0 9.37796992839246e-11
by O 0 3.972486836006928e-12
urine O 0 1.8439869631237116e-09
chromatography O 0 5.843815209516379e-09
. O 0 3.731567554954296e-10
. O 0 2.217825256778383e-09

Detection O 0 1.94761383909281e-07
of O 0 5.907759836887294e-10
heterozygous O 0 1.3493353136218023e-11
carriers O 0 1.361391685147928e-12
of O 0 4.109616293102025e-12
the O 0 3.577259022335966e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.5219508703600013e-09
ATM O 0 7.492840268241707e-07
) O 0 2.1198234140262784e-12
gene O 0 1.9032770151583556e-12
by O 0 1.3057512970177099e-12
G2 O 0 7.402185246974113e-07
phase O 0 6.752544123855841e-08
chromosomal O 0 4.75859032178505e-08
radiosensitivity O 0 4.1635385059635155e-06
of O 0 3.117333235991282e-08
peripheral O 0 5.924824654357508e-05
blood O 0 0.0004942735540680587
lymphocytes O 0 1.643148971197661e-05
. O 0 1.4326849040458e-08

In O 0 1.2346565199550241e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.334031367150601e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.473999824448292e-11
patients O 0 9.126035038775626e-09
, O 0 2.3395296659158016e-13
mutations O 0 1.7505063425269501e-13
in O 0 8.32044529846046e-14
a O 0 1.3250792336213374e-13
single O 0 3.8033920631008744e-12
gene O 0 1.4071168275703316e-12
, O 0 6.616215821736438e-13
ATM O 0 9.244142673558997e-10
, O 0 1.5717399373649764e-14
result O 0 1.5408827642657275e-12
in O 0 9.749086954391473e-12
an O 0 4.353577942595166e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.0237823921954714e-08
embraces O 0 1.4040332230180752e-09
a O 0 1.9128658889071976e-13
variety O 0 2.503705576195614e-12
of O 0 9.300084573976575e-13
clinical O 0 3.719428931514557e-11
features O 0 7.133849067031406e-12
and O 0 6.8975298563034304e-12
manifests O 0 8.104498738781274e-10
extreme O 0 1.416981643131976e-09
radiosensitivity O 0 7.350426045604763e-08
and O 0 1.743640301588023e-11
a O 0 4.0333053737129365e-12
strong O 0 4.369420797400991e-11
pre O 0 1.1302302027615951e-07
- O 0 1.4947715953894658e-08
disposition O 0 2.530261190258898e-05
to O 0 2.318761183062179e-09
malignancy B-Disease 0 4.974483817932196e-05
. O 0 3.441514184743255e-09

Heterozygotes O 0 4.683516181103187e-06
for O 0 9.65398538887996e-10
the O 0 6.196527735369273e-09
ATM O 0 4.980572612112155e-07
gene O 0 1.3155669609243859e-10
have O 0 2.2315870939343396e-12
no O 0 1.4034902797235849e-12
clinical O 0 7.20527240302693e-12
expression O 0 4.1049550911220756e-12
of O 0 8.48558778798747e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 5.824402765641779e-11
may O 0 5.114314787640906e-12
be O 0 1.837324346484759e-12
cancer B-Disease 0 1.0924677829038387e-09
prone O 0 9.649207648176894e-12
with O 0 6.7331521421180006e-15
a O 0 2.337486757972296e-13
moderate O 0 8.819694419237578e-10
increase O 0 5.470956326858456e-11
in O 0 1.916801266321766e-11
in O 0 1.0286550777838244e-10
vitro O 0 8.10313025567666e-08
radiosensitivity O 0 1.0626876019159681e-06
. O 0 3.196168307795233e-08

We O 0 1.4662124847575342e-08
performed O 0 4.116298413237018e-09
a O 0 3.963663425254893e-11
blind O 0 1.6339436470502733e-09
chromosomal O 0 7.69920682763825e-10
analysis O 0 1.2370447721732347e-10
on O 0 8.211065161134457e-10
G2 O 0 1.373096267798246e-07
- O 0 5.219569776393485e-10
phase O 0 5.2556785590240906e-08
lymphocytes O 0 1.462661547435573e-09
from O 0 1.7159651520895491e-12
7 O 0 6.262153989800012e-11
unrelated O 0 3.11680836695416e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.0015011858195066452
, O 0 9.678234776100414e-13
13 O 0 1.4476697618448497e-11
obligate O 0 1.3444652335881102e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999837875366211
T I-Disease 1 1.0
heterozygotes O 0 5.000924119258343e-08
( O 0 5.2057689485084796e-14
parents O 0 1.160220601233511e-13
of O 0 9.833634083346483e-15
the O 0 4.6277933064440765e-14
patients O 0 1.8044870068664731e-12
) O 0 1.8106900493677826e-15
, O 0 1.2981963052292878e-13
and O 0 2.7160264055164918e-12
14 O 0 3.030774589629637e-11
normal O 0 8.629382763913895e-10
controls O 0 4.1029221686805784e-11
following O 0 5.779738146416413e-11
X O 0 7.101890986405124e-08
- O 0 1.6468436614403004e-09
irradiation O 0 6.444668656513386e-07
with O 0 1.5165017679119597e-12
1 O 0 1.8802980006338288e-10
Gy O 0 1.5011945464493692e-08
in O 0 1.5286982292007922e-13
order O 0 3.234355274925327e-12
to O 0 7.456326138119418e-13
evaluate O 0 5.20584651775291e-11
this O 0 3.379878625239807e-12
cytogenetic O 0 1.307705872477527e-07
method O 0 2.1302687613911075e-08
as O 0 2.7917232761631716e-11
a O 0 6.234213449293757e-13
tool O 0 1.412597816496941e-11
for O 0 2.6072817949779337e-13
detection O 0 9.16538756001728e-09
of O 0 2.9136695278708657e-09
ATM O 0 9.27657492866274e-06
carriers O 0 9.061739802973534e-08
. O 0 1.6040138106632185e-08

Both O 0 3.0584445198655885e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 7.594951966893859e-06
and O 0 3.2010928630032964e-11
heterozygotes O 0 4.9868811302644644e-09
showed O 0 4.727120778147409e-11
significantly O 0 1.4700976547210587e-10
increased O 0 3.2666331445385666e-11
levels O 0 5.107788081382125e-10
of O 0 2.2593409781945795e-11
radiation O 0 2.4896946342778392e-05
- O 0 4.3224858359280915e-08
induced O 0 1.823946490731032e-06
chromatid O 0 1.7323958445558674e-07
damage O 0 4.494560279511006e-09
relative O 0 1.2498715395992122e-09
to O 0 3.245613413443982e-13
that O 0 3.8019297454207346e-14
of O 0 8.023358019637605e-12
normal O 0 1.7628778437028814e-08
controls O 0 1.0511496562060074e-08
. O 0 1.1673221500529962e-08

These O 0 2.378643948475201e-09
results O 0 1.5679053610995197e-09
show O 0 2.1058861598977074e-10
that O 0 6.597489481813268e-13
the O 0 1.0518947518578514e-10
G2 O 0 9.651270374888554e-06
- O 0 7.929459400202177e-08
phase O 0 2.1555479179369286e-06
chromosomal O 0 4.74063526212376e-08
radiosensitivity O 0 2.2734761273568438e-07
assay O 0 2.2173938241110136e-09
can O 0 5.986060713954189e-13
be O 0 1.9410175032476447e-14
used O 0 6.688404238547503e-15
for O 0 3.1403577112863734e-15
the O 0 1.3268083327985444e-14
detection O 0 1.4604668863160697e-10
of O 0 7.58522133992301e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 4.330872343416559e-06
. O 0 1.041637531784545e-08

In O 0 2.5400357372973303e-08
combination O 0 5.655937229676056e-08
with O 0 1.4978837614698648e-10
molecular O 0 2.3520776437635504e-07
genetic O 0 4.465526970420797e-08
analyses O 0 5.949270520666516e-10
, O 0 4.642135200544351e-13
this O 0 1.0338364414769555e-13
test O 0 3.955625757501302e-12
may O 0 3.1961373651856473e-12
be O 0 1.681677258384695e-13
of O 0 3.931839391829034e-13
value O 0 1.3254792229078216e-12
in O 0 3.050715198038914e-14
studies O 0 1.7460481031936897e-13
of O 0 5.148371421022369e-13
familial B-Disease 0 1.549576689185983e-09
and I-Disease 0 1.3694777534212221e-09
sporadic I-Disease 0 1.3781393590761581e-06
cancers I-Disease 0 3.0637224313068145e-07
aimed O 0 7.029220538967706e-10
at O 0 3.499335543555304e-11
determination O 0 1.9522715388742284e-10
of O 0 1.1099124397340177e-10
the O 0 1.341969157325762e-11
potential O 0 4.710146508934976e-11
involvement O 0 4.4530681225785074e-11
of O 0 1.848507596990956e-10
ATM O 0 7.105589361344755e-07
mutations O 0 2.577835722661348e-09
in O 0 4.19092122116993e-11
tumor B-Disease 0 4.870062184636481e-06
risk O 0 6.663175344812089e-09
or O 0 5.5851216013147464e-11
development O 0 3.8129979729184527e-10
. O 0 1.7358497972352893e-10
. O 0 2.394220155466087e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.9986532429072668e-09
identification O 0 7.0757657510966965e-09
and O 0 6.718457712905079e-13
detection O 0 1.8253842881676974e-09
of O 0 3.484897093120054e-10
founder O 0 5.569489314183329e-09
- O 0 6.939225638546986e-09
effect O 0 3.780053958735152e-08
mutations O 0 1.4259768366109427e-10
in O 0 2.8430829739078955e-12
the O 0 5.411011916311992e-12
ATM O 0 3.36850525251009e-09
gene O 0 6.213797705545421e-12
in O 0 2.2949452668091785e-12
ethnic O 0 8.17328010827012e-11
populations O 0 1.1626725276991934e-10
. O 0 2.1649694537106967e-10

To O 0 1.7349306435932021e-09
facilitate O 0 2.546709731987562e-09
the O 0 1.2507007929318803e-10
evaluation O 0 2.269710464020136e-08
of O 0 1.253218950836299e-08
ATM O 0 7.391269264189759e-06
heterozygotes O 0 4.2925637444568565e-07
for O 0 2.223440320747727e-10
susceptibility O 0 6.08991754802446e-08
to O 0 7.104739713215125e-11
other O 0 1.0489575180683275e-10
diseases O 0 5.177050184101972e-07
, O 0 9.332393365035774e-12
such O 0 6.854085354834893e-11
as O 0 1.900397172960311e-08
breast B-Disease 0 2.9149025522201555e-06
cancer I-Disease 0 6.917873207612502e-08
, O 0 9.121635738407186e-12
we O 0 4.122861340521977e-12
have O 0 1.7802149728310401e-12
attempted O 0 2.2525852710897354e-11
to O 0 2.7706836391167e-12
define O 0 1.735286220272414e-11
the O 0 8.578631728595187e-12
most O 0 1.8118120935842197e-12
common O 0 1.026488356120625e-12
mutations O 0 8.565771112160545e-14
and O 0 3.0553677806115925e-14
their O 0 6.943339132814419e-14
frequencies O 0 8.934225755041769e-12
in O 0 1.1494864088357204e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 7.565073190107796e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.422329693941739e-12
homozygotes O 0 2.4340025550628752e-09
from O 0 2.332508752117546e-12
10 O 0 3.078664927158581e-12
ethnic O 0 1.7399186475267059e-12
populations O 0 1.300827588007758e-11
. O 0 1.187650255918271e-10

Both O 0 2.87654273734006e-07
genomic O 0 2.756316348495602e-07
mutations O 0 1.6044422679328818e-08
and O 0 1.6056191098900996e-10
their O 0 2.2825312820384802e-11
effects O 0 6.391171619712921e-11
on O 0 2.7991789441905723e-10
cDNA O 0 1.3957879296810916e-09
were O 0 7.742439328550788e-11
characterized O 0 4.2854503279343703e-10
. O 0 2.600339277236685e-09

Protein O 0 5.84973989248283e-08
- O 0 1.3670976573010307e-09
truncation O 0 5.235385458490782e-09
testing O 0 7.099975052327068e-10
of O 0 4.18943657543025e-10
the O 0 2.3560570161507144e-10
entire O 0 2.7450917094995475e-09
ATM O 0 2.5804787640026916e-08
cDNA O 0 6.860864099067499e-10
detected O 0 1.1637824037791233e-09
92 O 0 2.6055719803963484e-09
( O 0 4.0409185329479125e-13
66 O 0 2.2661955645375542e-10
% O 0 4.903907141473596e-12
) O 0 4.662091025731119e-13
truncating O 0 1.8594858985920837e-08
mutations O 0 1.432727825267932e-09
in O 0 1.269645499846206e-10
140 O 0 3.4234184376202847e-09
mutant O 0 4.95043295245523e-09
alleles O 0 2.6562416155506696e-10
screened O 0 2.990632408383931e-09
. O 0 2.454590308786919e-09

The O 0 5.877475928173226e-08
haplotyping O 0 0.00034355290699750185
of O 0 1.8372302292846143e-06
patients O 0 0.0003279023803770542
with O 0 2.429224321698342e-10
identical O 0 1.6609000113021466e-06
mutations O 0 6.802154395302296e-09
indicates O 0 3.0606832623902847e-09
that O 0 3.1938077941877363e-13
almost O 0 5.843134678364115e-13
all O 0 9.801917442856314e-14
of O 0 1.6347757566051446e-13
these O 0 7.835336654667124e-14
represent O 0 2.9717300533338084e-14
common O 0 1.269687696994759e-12
ancestry O 0 2.5579612213111336e-12
and O 0 1.3516419157966891e-13
that O 0 3.881770393402567e-14
very O 0 9.253270892572996e-12
few O 0 2.4748036953070596e-10
spontaneously O 0 4.303499423485846e-08
recurring O 0 1.3617087013528817e-08
ATM O 0 3.6843400721409125e-06
mutations O 0 5.369968647528367e-08
exist O 0 1.0111140369417626e-08
. O 0 2.021319112088804e-08

Assays O 0 1.3910174629927496e-06
requiring O 0 3.413737559299079e-08
minimal O 0 3.0518071980623063e-07
amounts O 0 1.7115494799213593e-08
of O 0 2.3972817064787932e-09
genomic O 0 1.736970234311741e-09
DNA O 0 4.235105155458996e-09
were O 0 6.437564370465054e-11
designed O 0 2.095503631727169e-11
to O 0 2.6607518271992703e-12
allow O 0 8.253042346750838e-12
rapid O 0 2.9704481929737625e-11
screening O 0 2.6761864946323044e-10
for O 0 5.445800928260969e-12
common O 0 3.920090918541064e-09
ethnic O 0 1.0710821118919966e-09
mutations O 0 5.355707433096768e-09
. O 0 6.609506719712499e-09

These O 0 1.1135568911413429e-07
rapid O 0 1.3067435133962135e-07
assays O 0 1.6164192118139908e-07
detected O 0 4.232079504618014e-07
mutations O 0 2.8291364806420916e-09
in O 0 7.841657878593367e-11
76 O 0 2.1552645890210442e-08
% O 0 5.1765876307729997e-11
of O 0 3.11371518846304e-11
Costa O 0 2.833516088429633e-09
Rican O 0 2.712031061946618e-07
patients O 0 1.8690263914322713e-07
( O 0 2.2017160501448113e-13
3 O 0 3.6751709314719605e-11
) O 0 1.3234090201746235e-14
, O 0 1.2479536989299517e-13
50 O 0 1.4607886298159678e-12
% O 0 5.253808252705418e-14
of O 0 1.113719373343515e-13
Norwegian O 0 1.5395286823149945e-08
patients O 0 2.172864732585822e-08
( O 0 8.075888590676483e-14
1 O 0 6.22668583361019e-11
) O 0 7.328785710627225e-15
, O 0 3.757442558591402e-14
25 O 0 1.8469902256929016e-12
% O 0 1.0278239983294371e-13
of O 0 1.4328013601960787e-13
Polish O 0 1.0624820134808033e-08
patients O 0 7.06554544649407e-07
( O 0 3.94629478834424e-13
4 O 0 1.6751491860311774e-10
) O 0 1.8794695482013055e-14
, O 0 1.7422688454709484e-13
and O 0 6.802944709297098e-13
14 O 0 1.4824865293694423e-11
% O 0 4.688182351011982e-13
of O 0 7.993811775713899e-13
Italian O 0 5.255395230108206e-09
patients O 0 6.333635269584192e-07
( O 0 7.305370501239916e-14
1 O 0 2.642148722031834e-10
) O 0 6.665878244348222e-14
, O 0 9.072665036781447e-13
as O 0 4.472012603978781e-12
well O 0 3.1572689341424764e-12
as O 0 6.874345385467218e-13
in O 0 1.2468265352463814e-12
patients O 0 1.1280169159855191e-10
of O 0 3.8259635043447204e-11
Amish O 0 1.5574741496493516e-08
/ O 0 4.085979554702135e-09
Mennonite O 0 1.4691349470297155e-08
and O 0 6.962518669245688e-13
Irish O 0 1.0769177910541217e-10
English O 0 1.351669748350659e-10
backgrounds O 0 1.1697042223701715e-09
. O 0 6.091236404159872e-10

Additional O 0 6.219264037099492e-08
mutations O 0 6.984932632292384e-09
were O 0 2.102683305249542e-10
observed O 0 1.4156625871564188e-10
in O 0 8.369972250010793e-12
Japanese O 0 1.4202021780818086e-08
, O 0 6.01218640844392e-12
Utah O 0 1.996870002685114e-09
Mormon O 0 1.888742273692401e-09
, O 0 1.255876641830661e-13
and O 0 7.074303301360732e-14
African O 0 5.339285328968824e-13
American O 0 8.798313640145938e-12
patients O 0 4.3665404625414794e-10
. O 0 7.964907067226079e-10

These O 0 5.784619006021785e-09
assays O 0 2.0356645258345907e-09
should O 0 8.088352904112028e-12
facilitate O 0 1.0690095510190734e-11
screening O 0 7.283986191986003e-10
for O 0 3.343805787814347e-11
A B-Disease 1 1.0
- I-Disease 1 0.9999474287033081
T I-Disease 1 1.0
heterozygotes O 0 1.7822944897716297e-08
in O 0 1.2676647925813356e-12
the O 0 3.076069130317216e-13
populations O 0 8.32728796942156e-14
studied O 0 1.0247512473998688e-12
. O 0 1.6804821423299643e-12
. O 0 3.505256085389874e-10

The O 0 1.0143727422473603e-06
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999992847442627
tumor I-Disease 1 0.9999285936355591
suppressor O 0 4.116330728720641e-06
gene O 0 2.8346483146868273e-11
is O 0 1.9331919352545517e-14
required O 0 1.8883675276682582e-13
for O 0 5.732586172250975e-14
cell O 0 7.473946461722392e-11
cycle O 0 9.869732114919927e-11
exit O 0 7.424077325124401e-11
upon O 0 1.8457164616125787e-11
serum O 0 4.831771094337967e-10
withdrawal O 0 8.160203179841119e-09
. O 0 8.938466855568095e-09

The O 0 1.6332697694299014e-10
inactivation O 0 1.0324064305677894e-06
of O 0 1.4315041374501902e-09
the O 0 1.6872975905357634e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 3.8724124351574574e-08
VHL I-Disease 1 0.9999961853027344
) I-Disease 0 1.741236665964152e-08
tumor I-Disease 0 0.002070728223770857
suppressor O 0 6.50462752673775e-05
gene O 0 2.9569182657951387e-09
predisposes O 0 5.909701172868154e-09
affected O 0 3.219771116391712e-10
individuals O 0 1.0168076233427192e-12
to O 0 1.1315432098257805e-12
the O 0 2.318671782353121e-10
human O 0 5.11996495333733e-06
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.5325035037798704e-12
is O 0 1.0614457006212757e-14
associated O 0 7.368122496680118e-13
with O 0 3.7437381753685495e-13
sporadic B-Disease 0 1.653754043218214e-05
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 2.9874724916112427e-10
RCC B-Disease 0 0.0027178479358553886
) O 0 2.1965979035698524e-10
and O 0 1.2610933630696763e-08
brain B-Disease 0 1.6971158402157016e-05
hemangioblastomas I-Disease 0 0.00023104425054043531
. O 0 1.3367033488975721e-06

VHL O 0 0.40894272923469543
- O 0 0.0007053464069031179
negative O 0 4.214312411932042e-06
786 O 0 1.062180490407627e-05
- O 0 4.045543846586952e-06
0 O 0 2.3265224058377498e-07
RCC B-Disease 0 6.925708476046566e-06
cells O 0 9.677869172719511e-08
are O 0 3.127667569380321e-11
tumorigenic O 0 1.967472599062603e-06
in O 0 1.3955836486445605e-08
nude O 0 1.2015163974865573e-07
mice O 0 9.297526637475073e-10
which O 0 7.566941051615622e-14
is O 0 2.3559399805919527e-14
suppressed O 0 4.529185360091503e-11
by O 0 9.200890917215876e-13
the O 0 3.7015165238463155e-11
reintroduction O 0 1.1516188891391721e-07
of O 0 4.2337464090103083e-10
VHL B-Disease 0 0.0005650849780067801
. O 0 5.068412178843573e-07

Remarkably O 0 1.9906738089048304e-05
, O 0 1.0247791330797451e-11
this O 0 6.046926197614266e-13
occurs O 0 1.038022445776221e-11
without O 0 1.1832269539158169e-11
affecting O 0 6.485852827031735e-11
the O 0 2.0764775315873507e-11
growth O 0 1.0777690961916164e-09
rate O 0 1.3739411830471226e-09
and O 0 2.296792313630225e-13
cell O 0 3.20721678381819e-11
cycle O 0 2.8248845970746395e-11
profile O 0 4.015833672543767e-12
of O 0 2.5573757521379914e-12
these O 0 4.321479805946549e-12
cells O 0 6.586281520171156e-11
in O 0 1.1582047170291543e-12
culture O 0 8.62835775050641e-11
. O 0 2.485816552599829e-10

The O 0 2.0044615212100325e-07
786 O 0 6.973951940381085e-07
- O 0 4.0303373083361294e-08
0 O 0 3.0090450131581292e-09
cell O 0 1.2800581705718628e-09
line O 0 4.0317731375694166e-09
, O 0 9.052428077971353e-12
like O 0 2.661768201683845e-11
many O 0 9.845252391116333e-11
cancer B-Disease 0 3.996447173193474e-09
cells O 0 3.7698910659855756e-10
, O 0 1.4080027291654695e-12
fails O 0 7.653710998312135e-11
to O 0 3.1756108159752827e-12
exit O 0 6.523348528020279e-10
the O 0 3.3779773683101366e-12
cell O 0 3.8218646997156824e-11
cycle O 0 5.372262964348229e-12
upon O 0 3.410508854495564e-12
serum O 0 2.0729250260753673e-10
withdrawal O 0 3.0530395989103454e-09
. O 0 6.7261392011630505e-09

Here O 0 4.229948658007743e-08
, O 0 1.5165228448021928e-11
it O 0 7.403166892450824e-14
is O 0 8.704742452563842e-15
shown O 0 1.4931542533977958e-14
that O 0 1.6150998715722792e-15
reintroduction O 0 6.147540809742225e-10
of O 0 6.547599268325044e-12
the O 0 2.1790619655903676e-11
wild O 0 9.289638502885111e-10
- O 0 2.1856357002025817e-10
type O 0 2.954133604404774e-09
VHL B-Disease 0 2.579289321147371e-05
gene O 0 1.0450000864636877e-09
restores O 0 1.7402406626843003e-08
the O 0 8.187259203928932e-11
ability O 0 2.91415606923362e-11
of O 0 7.688464864763489e-10
VHL O 1 1.0
- O 1 1.0
negative O 1 0.5499967932701111
RCC B-Disease 1 0.9987078905105591
cancer I-Disease 0 4.6028776523598935e-07
cells O 0 8.726403627479229e-11
to O 0 4.2387171246896505e-13
exit O 0 7.09256750552889e-11
the O 0 5.083483005201284e-13
cell O 0 8.926016176191709e-12
cycle O 0 3.2672933802935233e-11
and O 0 1.3280402168594496e-12
enter O 0 3.122270442190711e-09
G0 O 0 8.011182944756001e-05
/ O 0 3.64714622946849e-08
quiescence O 0 1.8891977049406705e-07
in O 0 2.8894102388488108e-11
low O 0 1.5155787735920967e-09
serum O 0 3.9486969249935555e-09
. O 0 1.770107505016938e-09

Both O 0 3.3829627454906586e-07
VHL O 1 0.9527158737182617
- O 0 0.00027411733753979206
positive O 0 2.1834425467659457e-07
and O 0 3.2837903507498822e-09
VHL O 1 0.999930739402771
- O 0 9.357004455523565e-05
negative O 0 5.259504973764706e-07
RCC B-Disease 0 2.058379141089972e-05
cells O 0 2.882418570493428e-08
exit O 0 2.722607028715629e-09
the O 0 9.71381503879487e-13
cell O 0 3.132001602512702e-11
cycle O 0 9.054137647956928e-12
by O 0 1.8276695532438297e-13
contact O 0 7.627173892466033e-11
inhibition O 0 4.7184979479197864e-08
. O 0 3.363325973282372e-08

The O 0 9.725765721668722e-07
cyclin O 0 1.6300542483804747e-05
- O 0 6.484167442977196e-07
dependent O 0 1.39025999601472e-07
kinase O 0 2.735985447088751e-07
inhibitor O 0 1.9591901434523606e-07
, O 0 1.7619415648706394e-10
p27 O 0 1.2840084195886448e-07
, O 0 2.852187583335386e-11
accumulates O 0 5.525164770148194e-10
upon O 0 1.6270195260514875e-11
serum O 0 2.286937132722766e-11
withdrawal O 0 1.1055895088318834e-10
, O 0 7.020848204024321e-13
only O 0 8.101529972055765e-14
in O 0 1.368453961259064e-13
the O 0 5.407078322409997e-13
presence O 0 6.189053176203219e-12
of O 0 5.448860807000244e-10
VHL B-Disease 0 0.11500153690576553
, O 0 1.147851952376655e-10
as O 0 2.1618353808483537e-12
a O 0 1.5412752115708493e-14
result O 0 1.797259037558327e-13
of O 0 1.3693209164212378e-13
the O 0 1.9267217216210192e-13
stabilization O 0 3.6521127788624597e-10
of O 0 5.7549874588058714e-11
the O 0 4.0847775162333733e-10
protein O 0 7.006561997258132e-09
. O 0 1.2564596474362588e-08

We O 0 2.605928528520707e-10
propose O 0 2.5422047800205405e-10
that O 0 5.322810267094184e-14
the O 0 8.4924766871608e-12
loss O 0 1.0890802148999512e-10
of O 0 2.5922661239796696e-10
wild O 0 4.227277194956969e-09
- O 0 4.0017841818063005e-10
type O 0 2.3703288221099683e-09
VHL B-Disease 0 1.8774798036247375e-06
gene O 0 2.0062939157239335e-11
results O 0 1.4857134619794543e-11
in O 0 4.862457550318389e-13
a O 0 1.2976021624387657e-13
specific O 0 2.291562356537824e-10
cellular O 0 6.6324652436833276e-09
defect O 0 3.3593430259770685e-09
in O 0 1.7584827691208282e-11
serum O 0 3.2413636219530417e-09
- O 0 2.4538380216654332e-08
dependent O 0 1.6061170171610684e-08
growth O 0 2.0386398125182836e-10
control O 0 5.26974332226704e-11
, O 0 2.43309712655293e-13
which O 0 5.727648715557476e-13
may O 0 2.398853893303965e-10
initiate O 0 1.305743957402683e-08
tumor B-Disease 0 1.1949209692829754e-06
formation O 0 8.988116917407751e-08
. O 0 1.9803829687248253e-08

This O 0 4.6079762228146137e-10
is O 0 8.557125494301765e-12
corrected O 0 4.202818648657569e-10
by O 0 2.2550002230087296e-12
the O 0 1.4244321867862286e-11
reintroduction O 0 6.58705401335169e-09
of O 0 1.2176843734723608e-11
wild O 0 1.2132738147485611e-09
- O 0 6.698941401594993e-10
type O 0 2.958093148208718e-08
VHL B-Disease 1 0.9818558096885681
, O 0 4.608716963616644e-09
implicating O 0 2.5129286314040655e-06
VHL B-Disease 1 0.9999996423721313
as O 0 1.1986620052084618e-07
the O 0 2.6597055668986513e-09
first O 0 3.3086350326172465e-10
tumor B-Disease 0 7.066732621296978e-08
suppressor O 0 2.982533686690658e-08
involved O 0 9.398343214783722e-12
in O 0 2.4260639070600165e-12
the O 0 1.658596870957041e-11
regulation O 0 1.347978506593961e-09
of O 0 2.41010822410459e-10
cell O 0 6.522949957954438e-10
cycle O 0 1.285866690903248e-10
exit O 0 1.4256723579464392e-10
, O 0 1.873953500242196e-14
which O 0 5.880134907091349e-15
is O 0 1.1545334356783971e-14
consistent O 0 7.8685322146832e-12
with O 0 3.95182848846997e-14
its O 0 1.3092676899237321e-12
gatekeeper O 0 5.7121189722675325e-11
function O 0 2.1568228973645187e-12
in O 0 1.7067667808581821e-12
the O 0 2.5873794426423125e-11
kidney O 0 1.1890594464603055e-07
. O 0 6.839279698134249e-10
. O 0 2.308783164650663e-09

Piebaldism B-Disease 1 1.0
with O 0 0.01276289951056242
deafness B-Disease 1 1.0
: O 0 3.854649377466046e-10
molecular O 0 3.179576393841366e-11
evidence O 0 2.6484530714354637e-12
for O 0 6.139349011807793e-14
an O 0 1.1056721537687844e-13
expanded O 0 8.687595141054771e-07
syndrome O 1 0.999997615814209
. O 0 5.318662260833662e-06

In O 0 2.0937668265830212e-10
a O 0 5.391232599238904e-12
South O 0 4.6746415766074634e-11
African O 0 1.1504026030395575e-11
girl O 0 3.3808154192849216e-11
of O 0 2.4286798700617895e-12
Xhosa O 0 3.1567981562119485e-09
stock O 0 1.779069530583044e-10
with O 0 4.174350735273958e-15
severe O 0 1.8214742214528457e-10
piebaldism B-Disease 0 2.034002864093054e-05
and O 0 2.3390001047118858e-08
profound O 1 0.9990444779396057
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 6.065688751277776e-08
identified O 0 2.1985427367532395e-10
a O 0 2.1615497477860124e-13
novel O 0 2.0063168140738163e-11
missense O 0 3.995105579690517e-09
substitution O 0 1.6041024508695045e-08
at O 0 3.668519377164614e-10
a O 0 1.525327086859818e-11
highly O 0 3.1566413927208714e-09
conserved O 0 4.631151462319849e-09
residue O 0 1.9279397633908957e-08
in O 0 6.442207878265549e-11
the O 0 7.7377736162898e-11
intracellular O 0 1.3028741974174807e-10
kinase O 0 4.947051657211432e-10
domain O 0 2.179616070963064e-10
of O 0 1.5811182918490374e-10
the O 0 9.48477407725079e-10
KIT O 0 0.005908964667469263
proto O 0 2.417453288217075e-06
- O 0 2.1728269530285615e-06
oncogene O 0 8.933295134738728e-07
, O 0 5.3224324253475785e-11
R796G O 0 2.6136325459447107e-07
. O 0 1.1773756192212659e-08

Though O 0 5.941003109910525e-06
auditory B-Disease 0 0.0010112507734447718
anomalies I-Disease 0 3.1909912650007755e-05
have O 0 2.2973389857128268e-10
been O 0 6.995751894445235e-11
observed O 0 5.044950568411366e-10
in O 0 6.545992220496899e-11
mice O 0 2.8622490488849905e-10
with O 0 1.157557665172615e-12
dominant O 0 5.1494943420493655e-08
white O 0 5.618830556386456e-08
spotting O 0 9.57882662078191e-07
( O 0 1.9180143584485165e-12
W O 0 8.41607317170201e-09
) O 0 3.8373826143599243e-13
due O 0 1.306018475588644e-07
to O 0 1.1372012664878639e-08
KIT O 1 1.0
mutations O 0 0.00013748620403930545
, O 0 4.890503646493016e-08
deafness B-Disease 1 1.0
is O 0 1.3966760040173831e-11
not O 0 5.432383601115809e-13
typical O 0 5.326352553458591e-11
in O 0 8.837345460456503e-13
human O 0 6.814353942230511e-11
piebaldism B-Disease 0 2.5484030174993677e-06
. O 0 5.875581976511057e-08

Thus O 0 1.082462008916707e-09
, O 0 4.0405103308299717e-13
the O 0 2.310386311519391e-13
occurrence O 0 1.7542491070887678e-10
of O 0 1.3502622664418595e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 1.16013484330324e-06
this O 0 2.297848356036525e-09
patient O 0 1.034962124890626e-07
extends O 0 1.7305078203744273e-10
considerably O 0 8.252673544539846e-10
the O 0 1.0905970571073453e-11
phenotypic O 0 1.0903396935324494e-10
range O 0 1.8100084764327562e-09
of O 0 2.361527917660311e-10
piebaldism B-Disease 0 1.268611526938912e-06
due O 0 4.74893431601231e-06
to O 0 2.0989709526020306e-08
KIT O 0 0.28193947672843933
gene O 0 2.7259236645704732e-08
mutation O 0 2.5650212620575985e-08
in O 0 1.0247909291993818e-11
humans O 0 3.263432232780694e-11
and O 0 1.5386859538238373e-12
tightens O 0 6.095385307602896e-10
the O 0 3.354908711949989e-11
clinical O 0 2.3127708081993603e-10
similarity O 0 1.755701972694368e-10
between O 0 3.983368496163209e-11
piebaldism B-Disease 0 2.4250931573988055e-07
and O 0 5.204692146015821e-12
the O 0 6.777909396932236e-13
various O 0 1.9321462561405073e-13
forms O 0 4.048923002430982e-11
of O 0 5.548980164249429e-10
Waardenburg B-Disease 1 0.9999996423721313
syndrome I-Disease 0 0.001992657547816634
. O 0 2.548546484959502e-09
. O 0 6.3572578312687256e-09

Cycloheximide O 0 2.187232530559413e-05
facilitates O 0 2.165243095930691e-09
the O 0 2.708598796641315e-11
identification O 0 2.5730559904957317e-09
of O 0 4.228244865345232e-09
aberrant O 0 2.89537922526506e-07
transcripts O 0 1.3743088445039575e-08
resulting O 0 3.0512348203615147e-09
from O 0 1.280885397747511e-10
a O 0 1.2883283849463023e-11
novel O 0 1.3145544652815033e-09
splice O 0 1.806870564280416e-08
- O 0 1.3471972426515322e-09
site O 0 3.605779841375778e-10
mutation O 0 5.897860672066102e-11
in O 0 5.627331825346082e-13
COL17A1 O 0 2.0250492525519803e-05
in O 0 6.552322052988391e-12
a O 0 1.4606660065502597e-12
patient O 0 4.426541799773531e-09
with O 0 6.744061906149845e-12
generalized O 0 0.16746996343135834
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999631643295288
bullosa I-Disease 0 0.023363973945379257
. O 0 6.99860379427264e-07

Patients O 0 3.054545959457755e-05
with O 0 6.87383150399512e-10
generalized O 1 0.9069972634315491
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.7458527684211731
often O 0 3.1393969646131836e-09
show O 0 7.68218752500438e-11
decreased O 0 1.6208757669389229e-09
expression O 0 9.281574814279381e-11
of O 0 6.068214680743367e-11
type O 0 2.3309353025524615e-07
XVII O 1 0.9999912977218628
collagen O 0 2.6520531264395686e-06
, O 0 4.3230008461847547e-10
a O 0 2.0605617906399587e-11
transmembrane O 0 1.9017802610488133e-10
hemidesmosomal O 0 1.2700100526785718e-08
protein O 0 8.45427949869304e-10
encoded O 0 7.567140664077598e-11
by O 0 1.6548587153386585e-11
COL17A1 O 0 0.0004286674957256764
. O 0 1.322192417774204e-07

This O 0 9.821026214495987e-10
report O 0 7.992843886750478e-11
documents O 0 1.3208375504447645e-09
a O 0 1.6575974967625307e-11
novel O 0 8.284309904738052e-10
splice O 0 4.480234849779663e-08
- O 0 2.2113961772873836e-09
site O 0 5.020128202026797e-10
mutation O 0 9.398563177720476e-11
in O 0 6.754279752684e-13
COL17A1 O 0 0.0006567007512785494
in O 0 2.216774160068713e-11
a O 0 1.134900593641186e-11
patient O 0 1.068330774955939e-07
with O 0 4.3858694454002034e-11
generalized O 1 0.9999622106552124
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9998441934585571
bullosa I-Disease 0 0.00042512445361353457
, O 0 1.293512102984451e-10
and O 0 2.5110228566577186e-12
applies O 0 3.3229897999920155e-11
a O 0 1.3258629762667729e-13
new O 0 7.419459144286655e-12
methodology O 0 1.353800960224305e-10
to O 0 1.0242901362159107e-12
define O 0 5.351770068773298e-11
and O 0 6.892913757133856e-12
characterize O 0 1.1011201950239524e-09
the O 0 9.225643166077546e-11
resulting O 0 1.4273109361084835e-09
mRNA O 0 1.4663802616610155e-08
splice O 0 3.292377925845358e-08
variants O 0 6.264525787003095e-09
. O 0 9.031969838702025e-09

Mutational O 0 4.50050856670714e-06
analysis O 0 1.2907672708450946e-09
of O 0 8.95192808769707e-09
COL17A1 O 1 0.9999997615814209
identified O 0 2.149616165070256e-07
a O 0 7.57796270178801e-10
maternally O 0 6.66039454699785e-07
inherited O 0 7.224585942822159e-07
G O 0 5.180605739951716e-07
- O 0 2.12659490017586e-08
to O 0 1.8837233994872804e-09
- O 0 4.691208630447363e-07
T O 0 9.779430456546834e-07
transversion O 0 5.8499378674525815e-09
at O 0 9.80562419455877e-13
the O 0 8.966276749929405e-14
- O 0 3.585255464906567e-13
1 O 0 1.4496315606238319e-11
position O 0 4.158447891589034e-12
of O 0 1.2891470009546158e-11
exon O 0 1.123561910176818e-09
32 O 0 2.2189083903612072e-09
. O 0 2.5720108265403496e-09

This O 0 6.898527526999487e-09
acceptor O 0 5.3253650378337625e-08
splice O 0 2.0412532819591434e-07
- O 0 6.0397229439956845e-09
site O 0 4.3226071611002226e-09
mutation O 0 7.349647557219896e-10
led O 0 4.4824931960674164e-11
to O 0 8.820994065392163e-13
the O 0 7.82435314455876e-12
formation O 0 1.469179111701635e-09
of O 0 3.7097244720563083e-10
aberrant O 0 1.0743051781503254e-08
transcripts O 0 5.705740879768939e-10
present O 0 1.7191404549921074e-11
at O 0 6.039371086563605e-11
extremely O 0 2.5631223810052006e-09
low O 0 8.510700588715281e-09
levels O 0 5.237382971756688e-09
. O 0 3.4523883751802487e-09

Based O 0 9.581384574630647e-09
on O 0 2.8052518086241207e-09
our O 0 1.0105752346056818e-10
recent O 0 2.221989259254542e-11
finding O 0 4.8827789034255886e-11
that O 0 6.180391485047232e-13
cycloheximide O 0 2.0474542452575406e-06
stabilized O 0 0.0002302765060449019
mutant O 0 2.8049646516592475e-06
COL17A1 O 0 0.00018755618657451123
transcripts O 0 2.1147556594769412e-08
in O 0 3.2730443355610817e-11
keratinocytes O 0 5.809854641825041e-08
homozygous O 0 5.761613408594712e-10
for O 0 1.7521107177967399e-12
a O 0 8.715288039862212e-12
frameshift O 0 4.86890137096907e-08
mutation O 0 5.113734435902018e-10
, O 0 1.1835107546764867e-12
the O 0 3.94047511634299e-12
effects O 0 2.2765118679046736e-09
of O 0 2.9649392274677666e-08
the O 0 8.617741187322281e-09
splice O 0 1.9026094477681e-08
- O 0 6.523397932944874e-10
site O 0 1.9032171671984344e-10
mutation O 0 7.691743075799451e-12
on O 0 4.218875140730993e-13
splicing O 0 7.527768686177438e-11
of O 0 9.029377939784311e-11
COL17A1 O 0 0.0005360287614166737
transcripts O 0 1.2745139166270292e-08
were O 0 5.6331120323882544e-12
determined O 0 1.9004368391473125e-12
using O 0 2.921571404940204e-13
reverse O 0 2.5070997361487102e-11
transcriptase O 0 3.2269239363946767e-12
polymerase O 0 3.500081518018061e-12
chain O 0 1.826172242938573e-12
reaction O 0 2.0609628587076045e-11
of O 0 3.98562571835015e-11
total O 0 9.863892688755094e-12
RNA O 0 6.4900320360938846e-12
from O 0 1.027542200632281e-12
keratinocytes O 0 2.713224089845312e-09
incubated O 0 3.3157629975022473e-09
for O 0 1.991811663520915e-12
2 O 0 6.899207871668978e-10
. O 0 4.910482576114816e-10

5 O 0 1.259747648418852e-07
h O 0 1.0682095208380815e-09
in O 0 3.691143744821712e-12
the O 0 5.552383205986722e-12
presence O 0 1.1177041930876541e-11
or O 0 1.893152301590817e-10
absence O 0 1.338209330015161e-07
of O 0 3.1023070778957162e-09
10 O 0 1.6959041115871543e-10
microg O 0 1.8400177381749927e-08
cycloheximide O 0 4.040358092538554e-08
per O 0 8.341934254474381e-09
ml O 0 2.02241494662303e-07
. O 0 1.1328110005592862e-08

Using O 0 1.1915498969450322e-11
this O 0 1.926553751599447e-12
approach O 0 2.6447568579612835e-09
, O 0 3.2727136972665605e-11
an O 0 2.696339896149369e-12
abnormally O 0 1.7807076702069935e-08
spliced O 0 1.3588747904691445e-09
transcript O 0 1.1999882865154632e-08
was O 0 2.908576435256549e-10
identified O 0 2.222612371927113e-11
that O 0 3.1558330032327095e-14
contains O 0 8.76799988950433e-14
an O 0 3.0412089049202317e-15
extra O 0 5.6266050846298654e-12
264 O 0 9.32371610473659e-11
bases O 0 3.194761469260676e-11
upstream O 0 1.3280803123905116e-09
from O 0 6.123398454960238e-10
exon O 0 4.66506255847321e-09
32 O 0 2.9337379747751413e-10
, O 0 6.647152039950324e-14
resulting O 0 2.8273466467360064e-12
in O 0 1.3094375844041606e-12
a O 0 6.7715681152658025e-12
premature O 0 1.4959759653265792e-07
termination O 0 1.258082647837e-06
codon O 0 1.619923892803854e-07
27 O 0 2.1658850357653137e-07
bp O 0 1.6222962528900098e-08
downstream O 0 4.4870569482213796e-09
from O 0 4.6868637443298056e-11
the O 0 2.5643825951604526e-10
cryptic O 0 9.944346857082564e-08
splice O 0 7.311093952466763e-08
site O 0 2.6092237703778665e-08
. O 0 8.036694865154459e-09

Three O 0 3.6310847661980006e-08
other O 0 4.335196646110262e-10
splice O 0 2.4663897590926354e-08
variants O 0 7.283430525362178e-10
, O 0 1.1358121908278118e-11
including O 0 1.7776634114383127e-12
one O 0 3.338003430521791e-13
derived O 0 8.438869394944426e-12
from O 0 4.787494619490351e-12
the O 0 1.1915567491027623e-11
skipping O 0 2.333126358777804e-09
of O 0 2.740946636325958e-10
exon O 0 6.763211102267519e-10
32 O 0 3.33921224004996e-10
, O 0 1.3026244579522617e-12
were O 0 2.0550432883181813e-11
also O 0 5.46740690915426e-12
identified O 0 3.800204873005697e-10
. O 0 4.572441536510041e-09

These O 0 1.0148677453969412e-09
results O 0 1.5272462461357605e-10
indicate O 0 2.9550334401662326e-10
the O 0 1.2116006115059363e-11
usefulness O 0 1.1549350364958855e-09
of O 0 2.2183305539713594e-11
cycloheximide O 0 3.417242311343216e-08
treatment O 0 4.100862582845366e-08
in O 0 6.723986818724104e-12
evaluating O 0 3.240853418962075e-11
the O 0 3.009315886759456e-12
abnormal O 0 2.354502703916239e-10
processing O 0 1.6383760126359448e-08
of O 0 5.2751589763033735e-09
mRNA O 0 7.691856929170626e-09
due O 0 5.124373387843661e-07
to O 0 2.4633597939249796e-10
splice O 0 1.839709007356305e-08
- O 0 1.6052402740385219e-09
site O 0 6.526733042910848e-10
mutations O 0 2.605927279519804e-11
, O 0 1.6459201352108516e-13
because O 0 4.894674509453578e-12
( O 0 1.0740856988544767e-12
i O 0 5.574765996052555e-11
) O 0 5.987271225679769e-13
aberrant O 0 8.998538025828395e-10
splicing O 0 2.3608431876098734e-10
often O 0 2.1624416667032076e-12
generates O 0 4.907843879561891e-13
a O 0 3.940929207317881e-14
premature O 0 1.622051049032791e-09
termination O 0 9.072236650808918e-08
codon O 0 5.38931788085506e-09
, O 0 3.396968123459132e-11
( O 0 4.5427461163420613e-13
ii O 0 1.5498144989578577e-07
) O 0 3.396979312425552e-12
transcripts O 0 7.089731024478851e-10
with O 0 8.720271683568259e-13
premature O 0 6.492521009704433e-08
termination O 0 7.275620816926676e-08
codons O 0 8.283235763961727e-10
can O 0 5.6224855500552895e-12
occur O 0 3.380525026575043e-11
at O 0 1.777982969186631e-11
low O 0 1.6092071009055076e-09
or O 0 3.715073821491943e-12
undetectable O 0 4.232277028837217e-10
levels O 0 4.5596978970330326e-10
due O 0 1.4347459886820957e-09
to O 0 3.862116876307553e-11
nonsense O 0 2.9283224733944735e-09
- O 0 1.8501723764163813e-10
mediated O 0 9.186735816513192e-10
mRNA O 0 1.6843056116488953e-10
decay O 0 6.91697277233061e-09
, O 0 3.0807016551497035e-13
and O 0 6.149639445677396e-14
( O 0 7.897208345705904e-15
iii O 0 9.623539742875664e-10
) O 0 2.47240297896259e-13
the O 0 1.0780557870015972e-11
levels O 0 6.688421483325158e-10
of O 0 2.2051940135048298e-11
these O 0 4.581286305177512e-12
transcripts O 0 2.303744174592115e-11
can O 0 6.32974033430711e-14
be O 0 6.780853818982163e-14
increased O 0 2.371981604187834e-11
by O 0 2.218779153462247e-11
cycloheximide O 0 9.309162123827264e-06
. O 0 1.8016264391462755e-07

A O 0 2.0515949472610373e-07
deletion O 0 2.4159790612543475e-08
mutation O 0 3.0892810531923942e-09
in O 0 3.6547799509012435e-11
COL17A1 O 0 0.030739888548851013
in O 0 6.435109389801852e-11
five O 0 2.854744001953846e-12
Austrian O 0 1.2902626744804024e-09
families O 0 1.1459308328631845e-11
with O 0 1.2400082046240546e-12
generalized O 0 4.346767673268914e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9966412782669067
bullosa I-Disease 0 5.240186510491185e-05
represents O 0 5.550609971649578e-10
propagation O 0 7.0998158463453365e-09
of O 0 2.4335452056267748e-11
an O 0 3.4129670660812406e-13
ancestral O 0 1.132315645691051e-07
allele O 0 1.6790701806712605e-07
. O 0 1.546179362321709e-08

Patients O 0 5.118833723827265e-05
with O 0 1.4157335304076923e-09
generalized O 1 0.9989610910415649
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999996423721313
bullosa I-Disease 1 0.9581266045570374
, O 0 5.66332591933616e-10
a O 0 4.162740898511208e-12
usually O 0 7.323881778820152e-11
nonlethal O 0 4.3723954235019846e-08
form O 0 2.616967753610311e-09
of O 0 1.7754399550540256e-07
junctional B-Disease 1 0.9997367262840271
epidermolysis I-Disease 0 0.2179933488368988
bullosa I-Disease 0 0.0003435353864915669
, O 0 5.793225621442133e-11
have O 0 2.3157920893412953e-12
generalized O 0 3.0625344482615446e-09
blistering B-Disease 0 1.270424974109119e-07
, O 0 3.1097521779877013e-10
nail B-Disease 0 0.0007744351751171052
dystrophy I-Disease 1 0.9999984502792358
, O 0 2.02258860326765e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 0.9999905824661255
, O 0 3.4285938532718774e-09
and O 0 1.551101007635225e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9825950860977173

Skin B-Disease 1 0.9999983310699463
fragility I-Disease 0 0.00021494038810487837
in O 0 1.086595036170479e-09
most O 0 2.5222563621030147e-11
cases O 0 2.470567153634029e-11
is O 0 9.724895720522944e-14
due O 0 5.054273666260656e-10
to O 0 2.3408620528075907e-11
mutations O 0 5.031130026478259e-11
in O 0 5.160073323490222e-12
the O 0 1.4564715752896085e-11
gene O 0 1.5414470914965062e-12
encoding O 0 1.6480157238873971e-09
type O 0 3.222723989892984e-07
XVII O 1 0.9998058676719666
collagen O 0 7.2663742685108446e-06
( O 0 6.760708104458502e-10
COL17A1 O 0 0.09809932857751846
) O 0 1.3730550030288668e-10
. O 0 2.8212527869442283e-09

Recently O 0 2.729379104948748e-07
, O 0 1.2596113041496437e-10
we O 0 5.330435745576345e-12
reported O 0 2.7409853900484116e-12
five O 0 8.095474702922434e-14
Austrian O 0 1.2864874443518914e-10
families O 0 6.32214506440798e-12
with O 0 1.8874177394601066e-12
generalized O 0 0.00014087045565247536
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999923706054688
bullosa I-Disease 1 0.7799450755119324
who O 0 1.0636133751518173e-08
share O 0 1.1723236270633208e-10
the O 0 2.0888952026454355e-11
same O 0 1.0602606570486728e-09
COL17A1 O 0 0.25976553559303284
mutation O 0 9.123790505327634e-07
. O 0 2.2398898735787043e-08

Affected O 0 8.804977369436529e-07
individuals O 0 5.333766206483403e-10
in O 0 1.3573328572213939e-10
three O 0 1.1893723853018123e-11
families O 0 1.2023737040733895e-11
are O 0 1.6220880162069046e-13
homozygous O 0 2.1511943702062775e-12
for O 0 1.2804615224029647e-12
4003delTC O 0 8.87577744634882e-09
, O 0 1.623980138733272e-12
whereas O 0 5.830115556992865e-11
those O 0 9.345931147042297e-12
in O 0 5.316970821955813e-12
two O 0 2.488716426950893e-13
others O 0 1.5147037270291097e-12
are O 0 7.25967205729601e-14
compound O 0 9.035131670609431e-11
heterozygotes O 0 1.986011355370465e-08
. O 0 1.1990593407062988e-08

To O 0 3.054175135019932e-09
determine O 0 1.6641917843784881e-09
if O 0 2.5721896834696167e-11
the O 0 8.727697384247612e-12
occurrence O 0 9.473541395799145e-11
of O 0 3.7742919900551897e-11
4003delTC O 0 1.785080705474229e-08
in O 0 7.212160989950034e-12
these O 0 2.239287314603766e-12
unrelated O 0 9.123031496915956e-11
families O 0 2.7186372185579455e-13
signifies O 0 7.493069532904517e-12
propagation O 0 3.456036845594923e-10
of O 0 8.451606927327437e-13
an O 0 3.277118634510516e-14
ancestral O 0 1.2161682327871404e-08
allele O 0 2.866878290319619e-09
or O 0 1.2262854620637142e-10
a O 0 4.275732198855131e-11
mutational O 0 1.7354614101350307e-06
hot O 0 7.419497251248686e-06
spot O 0 2.5982087592524294e-08
, O 0 1.3177211058423843e-11
haplotypes O 0 5.734850372363098e-10
were O 0 1.1477944462934264e-11
determined O 0 4.432696223966026e-11
for O 0 3.938641947309751e-12
polymorphisms O 0 8.704751586208204e-09
both O 0 2.7611588016007715e-10
within O 0 1.3812035959404056e-09
and O 0 7.091028875194638e-10
flanking O 0 6.539150376738689e-07
COL17A1 O 1 0.9966177344322205
. O 0 5.658957888954319e-07

Five O 0 7.201960983138633e-08
intragenic O 0 4.826162694371305e-06
polymorphisms O 0 1.6058389462614286e-07
were O 0 4.937945052851944e-10
chosen O 0 1.8778679999886805e-10
based O 0 1.996091139599976e-11
on O 0 2.2991274162276198e-10
their O 0 7.501625015615687e-11
informativeness O 0 1.3927191275797668e-06
. O 0 2.6454342716419887e-08

One O 0 1.2564685958338373e-09
of O 0 1.0727642385521818e-10
these O 0 8.737258312685459e-12
, O 0 4.816691750314517e-13
not O 0 5.857216296180356e-13
previously O 0 1.8097199086519744e-11
reported O 0 5.55679070465831e-12
, O 0 2.466176676936549e-13
was O 0 5.647638259831389e-11
2988 O 0 6.658133600012661e-08
A O 0 4.143397447364805e-08
or O 0 5.348173459651662e-09
C O 0 6.465509159170324e-06
that O 0 9.391672552497288e-13
introduces O 0 1.0333800655459857e-11
a O 0 5.1995669732686836e-14
new O 0 1.1069008123282265e-12
restriction O 0 2.7986021833292796e-10
site O 0 1.2000923865773672e-10
for O 0 2.6410830987477762e-12
Eco0109 O 0 2.1917794867931661e-07
I O 0 1.8525703353589051e-06
. O 0 1.62249733648423e-08

All O 0 1.9917498761401475e-09
the O 0 2.69751054826628e-10
4003delTC O 0 4.872896042229513e-08
alleles O 0 2.3158430728642543e-10
showed O 0 4.91851281925193e-11
the O 0 6.261718032106456e-13
same O 0 1.59998034786335e-12
haplotype O 0 1.6412862735570855e-10
for O 0 2.375267517396029e-12
these O 0 1.3811679230868457e-11
five O 0 3.447007436430116e-12
polymorphic O 0 3.318243013694655e-09
markers O 0 1.1935079591296471e-08
. O 0 1.2865330134559372e-08

Fourteen O 0 4.437196366779972e-06
microsatellite O 0 1.2951634289493086e-06
polymorphisms O 0 3.378313522262033e-07
were O 0 1.2299825602468673e-09
selected O 0 1.2683674943669843e-10
based O 0 5.5237576665478905e-12
on O 0 1.8380130750728085e-10
their O 0 3.2407545397239446e-11
high O 0 1.0783858250817957e-09
heterozygosity O 0 6.120881579363413e-08
and O 0 1.0460000920975432e-11
their O 0 4.186221681801161e-12
location O 0 1.156076137598383e-10
within O 0 1.1394798993258348e-10
10q23 O 0 4.433675471204879e-08
- O 0 1.215736844528692e-08
q25 O 0 2.065657724870107e-07
near O 0 1.0270270855983199e-08
COL17A1 O 0 0.0005047095473855734
. O 0 6.803778518360559e-08

Three O 0 8.161603837208986e-09
families O 0 8.272278417820189e-10
shared O 0 4.3350148470899796e-10
microsatellite O 0 8.769163883926012e-08
polymorphisms O 0 4.601314884666863e-08
covering O 0 2.829880996202405e-09
at O 0 6.899233961910056e-10
most O 0 2.0080213880557807e-10
19 O 0 7.129082324475178e-10
cM O 0 3.7944106190401783e-10
, O 0 1.30842884270288e-12
whereas O 0 4.809297751706687e-11
the O 0 9.644980647482981e-11
others O 0 1.0902107688837148e-10
shared O 0 4.920079621495432e-11
smaller O 0 7.840701005124018e-11
regions O 0 1.7702012078402163e-10
consistent O 0 1.5208309611658422e-10
with O 0 7.632008089744624e-14
cross O 0 1.5972246095175002e-11
- O 0 2.408397786757277e-11
over O 0 1.4712238588857063e-12
events O 0 5.316975565340318e-14
during O 0 1.3176947326245386e-13
passage O 0 6.4931029303272325e-12
of O 0 1.463230578369057e-13
this O 0 4.3087533324256966e-13
mutation O 0 7.03704716026321e-12
through O 0 2.128717124447177e-12
several O 0 2.9260231390604297e-12
generations O 0 2.2403491561906463e-10
. O 0 2.7305901983964986e-09

These O 0 1.5912064554868266e-08
results O 0 3.464036835154616e-09
indicate O 0 1.5043926104851835e-09
that O 0 1.983686869280743e-12
4003delTC O 0 5.516238132940998e-09
occurs O 0 1.418191519081402e-11
on O 0 1.425937276242073e-12
a O 0 4.63290701375324e-14
single O 0 2.895864104068835e-12
ancestral O 0 5.686079607158945e-09
allele O 0 1.5214061122037492e-09
. O 0 1.2225115364472572e-10
. O 0 7.430087656246087e-10

The O 0 1.8744029262052209e-07
haptoglobin O 0 1.624319156690035e-05
- O 0 3.5094817008030077e-07
gene O 0 1.4260156389056533e-09
deletion O 0 1.0433470754023233e-09
responsible O 0 6.563582316543304e-11
for O 0 3.758580946477963e-11
anhaptoglobinemia B-Disease 0 7.571990136057138e-05
. O 0 6.70005249503447e-07

We O 0 1.4933410952266968e-08
have O 0 1.987865427821589e-11
found O 0 1.6178155820209539e-12
an O 0 3.364772653211001e-14
allelic O 0 1.0711822540088178e-09
deletion O 0 3.059310305086882e-10
of O 0 4.623629812350316e-10
the O 0 3.630106437668701e-09
haptoglobin O 0 1.5133433407754637e-05
( O 0 1.8426210210420457e-11
Hp O 0 4.5129411319067003e-10
) O 0 1.0805523142920492e-12
gene O 0 1.2744943989062563e-12
from O 0 2.6551955079057166e-12
an O 0 4.505312003457926e-14
individual O 0 4.989953762690735e-13
with O 0 2.1188493667945174e-12
anhaptoglobinemia B-Disease 0 1.53647724800976e-05
. O 0 4.030529794363247e-07

The O 0 3.9577625443598663e-07
Hp O 0 2.1274880168675736e-07
gene O 0 6.445984301883811e-10
cluster O 0 3.5246396912214095e-09
consists O 0 5.759456800369378e-11
of O 0 3.5425707506364645e-11
coding O 0 2.532034137914252e-09
regions O 0 2.0048150872753467e-07
of O 0 0.009428274817764759
the O 0 0.0002661117759998888
alpha O 0 7.24000187801721e-07
chain O 0 7.390198175638574e-11
and O 0 1.028567747467235e-12
beta O 0 1.8244288024771294e-11
chain O 0 7.692266962289196e-13
of O 0 2.0225260268652567e-12
the O 0 4.199595185494509e-11
haptoglobin O 0 4.610125969861656e-08
gene O 0 3.4101464707614326e-11
( O 0 1.0693225141076776e-13
Hp O 0 1.3481622936073467e-11
) O 0 3.410999984527173e-14
and O 0 8.004246679522986e-13
of O 0 3.512549279216515e-11
the O 0 3.668519377164614e-10
alpha O 0 1.6716422690521426e-09
chain O 0 3.8048231232323815e-11
and O 0 3.996928656102572e-12
beta O 0 1.5348126936043371e-10
chain O 0 9.475469887887389e-12
of O 0 7.880953702132931e-12
the O 0 4.0665072004175684e-11
haptoglobin O 0 7.589135719854312e-08
- O 0 1.940541283218522e-09
related O 0 9.803179779055426e-08
gene O 0 1.9416213081768774e-10
( O 0 1.0206393022405003e-12
Hpr O 0 1.1144147826769313e-08
) O 0 3.244523790260634e-13
, O 0 7.210603099848389e-13
in O 0 3.4571011418155217e-12
tandem O 0 2.0644023990268323e-10
from O 0 8.124351191796109e-11
the O 0 1.1449488024339871e-09
5 O 0 3.881328591859301e-09
side O 0 2.3156410122737725e-09
. O 0 7.74761765853782e-09

Southern O 0 3.1065360417414922e-06
blot O 0 7.3509545472916216e-06
and O 0 1.260943571779194e-09
PCR O 0 4.317929125363662e-08
analyses O 0 1.1801628563290478e-09
have O 0 1.4082767070544566e-12
indicated O 0 8.523732067389211e-12
that O 0 1.2105869421057819e-14
the O 0 7.922108607137657e-13
individual O 0 1.8425559201225988e-13
with O 0 8.334279040555018e-14
anhaptoglobinemia B-Disease 0 2.375942820265209e-08
was O 0 6.096059768090356e-10
homozygous O 0 1.209048000605506e-10
for O 0 7.009384826034415e-12
the O 0 1.020309461918778e-10
gene O 0 4.841480515105356e-12
deletion O 0 6.184242007378771e-11
and O 0 2.4707636110676834e-12
that O 0 1.0606388000950623e-13
the O 0 1.4574218568097486e-11
gene O 0 2.8292114744726815e-13
deletion O 0 2.068720411987912e-12
was O 0 1.7280529437946335e-11
included O 0 4.318785346707488e-12
at O 0 1.6245565006081653e-12
least O 0 2.7270294854740695e-13
from O 0 8.861516121588808e-13
the O 0 2.418635777767797e-11
promoter O 0 2.170411628199531e-09
region O 0 1.585758191424702e-09
of O 0 4.286858867885712e-09
Hp O 0 1.0511818082648006e-08
to O 0 1.4716760254884775e-08
Hpr O 0 2.0953962120984215e-06
alpha O 0 1.8460490913696503e-09
but O 0 1.6254738440663052e-12
not O 0 1.8103681531309035e-12
to O 0 5.1729752426066256e-11
Hpr O 0 8.627043257547484e-07
beta O 0 3.412246485368087e-08
( O 0 1.0281720787264081e-11
Hpdel O 0 5.75118235701666e-07
) O 0 5.2695223184962003e-11
. O 0 4.543760923070295e-09

In O 0 4.224907090843999e-09
addition O 0 1.2289929074427164e-09
, O 0 6.378701039588819e-11
we O 0 2.7774787678125357e-11
found O 0 1.6860084509073836e-11
seven O 0 2.494463186356044e-12
individuals O 0 1.0827096326698066e-13
with O 0 1.6822932207439384e-13
hypohaptoglobinemia B-Disease 0 8.796703809821338e-08
in O 0 3.615724664118858e-10
three O 0 3.493651765454353e-12
families O 0 1.298556097720227e-12
, O 0 4.4589765907376844e-14
and O 0 1.2185567767504513e-13
the O 0 4.2384689508123685e-12
genotypes O 0 6.580784805976236e-10
of O 0 3.0610730616942305e-10
six O 0 9.110994077243806e-12
of O 0 2.255465779421595e-11
the O 0 1.8003624632778603e-11
seven O 0 6.037798299524111e-13
individuals O 0 1.3773461300799986e-14
were O 0 1.3531491465518242e-12
found O 0 6.450607870122152e-14
to O 0 2.2925994327786803e-13
be O 0 4.7907032507676917e-11
Hp2 O 0 3.511766772135161e-05
/ O 0 7.959292815939989e-07
Hpdel O 0 2.6459510991116986e-05
. O 0 8.272096607697677e-08

The O 0 3.640245722635882e-07
phenotypes O 0 1.0588878467387985e-06
and O 0 2.1899642099754146e-09
genotypes O 0 1.9843417575771127e-08
in O 0 3.5463767339427577e-11
one O 0 6.260213159491046e-13
of O 0 1.2899285589326737e-12
these O 0 1.1230631225336851e-12
three O 0 4.0195081150214834e-14
families O 0 3.401853451712178e-13
showed O 0 2.5405346229523396e-12
the O 0 2.2853617869661447e-12
father O 0 9.967956321466076e-11
to O 0 2.943386636852785e-12
be O 0 3.001099369015492e-10
hypohaptoglobinemic B-Disease 0 9.27409746509511e-06
( O 0 1.0201396151432451e-11
Hp2 O 0 2.2350553763317293e-07
) O 0 1.1184372655445585e-12
and O 0 1.3968970945243964e-11
Hp2 O 0 4.143611818108184e-07
/ O 0 3.3275595612280995e-09
Hpdel O 0 8.774071034167719e-07
, O 0 2.7918086245581897e-11
the O 0 2.967980305967899e-10
mother O 0 1.071525534968032e-09
to O 0 1.526648599203817e-11
be O 0 2.1820992235355163e-10
Hp2 O 0 9.238892744178884e-06
- O 0 1.8442412041963507e-08
1 O 0 8.53386339372264e-09
and O 0 8.775672029337489e-12
Hp1 O 0 1.59489275119995e-07
/ O 0 7.968493087595618e-10
Hp2 O 0 1.631612605024202e-07
, O 0 1.0178476984867846e-12
one O 0 7.561660987035618e-14
of O 0 1.2090791692495606e-12
the O 0 6.0337147604616614e-12
two O 0 3.263441220816704e-13
children O 0 2.800974242041926e-13
to O 0 1.2608401193762997e-13
be O 0 1.6875011804584616e-11
hypohaptoglobinemic B-Disease 0 3.2330042358807987e-06
( O 0 1.506671176709773e-11
Hp2 O 0 1.4796165714869858e-06
) O 0 3.975275837675429e-12
and O 0 8.348292890314468e-11
Hp2 O 0 5.266614152787952e-06
/ O 0 2.0206329054417438e-08
Hpdel O 0 1.140278618549928e-05
, O 0 4.279158971609576e-11
and O 0 9.627074311346906e-12
the O 0 4.4010874805655575e-11
other O 0 1.1870878412201247e-11
child O 0 4.19252861594277e-11
to O 0 8.214498959518979e-13
be O 0 5.2866870603462957e-11
Hp1 O 0 4.064508630108321e-06
and O 0 6.823214770967923e-10
Hp1 O 0 1.3782320820610039e-05
/ O 0 7.236371146746023e-08
Hpdel O 0 1.1801035952885286e-06
, O 0 3.985639075720915e-12
showing O 0 1.107792677035313e-11
an O 0 3.191005538147676e-14
anomalous O 0 1.4216691113233537e-07
inheritance O 0 3.474021468719002e-06
of O 0 1.2704188634415914e-07
Hp O 0 3.773023848907542e-08
phenotypes O 0 7.705693150228399e-08
in O 0 2.348411048957999e-11
the O 0 1.876270319667306e-11
child O 0 4.8728049373281124e-11
with O 0 2.1310112962441563e-13
Hp1 O 0 7.3438213803456165e-06
. O 0 8.617647040409793e-08

The O 0 1.1565573743155255e-07
Hp2 O 0 0.00041071910527534783
/ O 0 2.2453646124631632e-06
Hpdel O 0 2.2740690837963484e-05
individuals O 0 1.7932452744950922e-10
had O 0 1.5613242643208736e-10
an O 0 9.616823803222305e-14
extremely O 0 3.4413547012057677e-10
low O 0 1.1076289885281199e-09
level O 0 2.7279442593730607e-10
of O 0 1.8379289756786932e-10
Hp O 0 1.7220630477154941e-09
( O 0 3.4851060839308223e-12
mean O 0 1.3315932800850305e-09
+ O 0 5.5438778567840075e-11
/ O 0 2.632926168755212e-11
- O 0 1.4576784224118455e-10
SD O 0 3.415344229651396e-09
= O 0 1.7342141611642603e-11
0 O 0 2.444533291068307e-11
. O 0 5.583124565965158e-13
049 O 0 3.939787662776695e-10
+ O 0 6.748475476353599e-12
/ O 0 2.55517308700437e-11
- O 0 1.8035253845916088e-10
0 O 0 5.891867549401297e-11
. O 0 1.5936878552946787e-12
043 O 0 1.5747027015677872e-09
mg O 0 2.505456675461204e-10
/ O 0 3.202980242145159e-11
ml O 0 8.986526800480732e-11
; O 0 2.0016410404166685e-12
n O 0 4.2319659061818005e-12
= O 0 1.0324340124143183e-12
6 O 0 9.578299958734604e-12
) O 0 2.8953072679974417e-15
, O 0 3.6248182054684705e-14
compared O 0 1.0640419101370924e-11
with O 0 9.884260564977515e-14
the O 0 7.035332733051902e-11
level O 0 4.224939065267108e-09
( O 0 9.896013316527258e-14
1 O 0 4.661971156338929e-11
. O 0 2.0786478007600584e-12
64 O 0 3.696436559619265e-11
+ O 0 3.5600719421047256e-12
/ O 0 6.795478676296929e-12
- O 0 2.739032438359157e-11
1 O 0 2.700510301489878e-11
. O 0 6.0870113203354e-13
07 O 0 4.9360026482814234e-11
mg O 0 1.8446931482341e-10
/ O 0 3.202131268476016e-11
ml O 0 3.392248287825694e-11
) O 0 7.414580830821665e-15
obtained O 0 4.437583547151069e-12
from O 0 2.06178060735418e-11
52 O 0 9.806804257550539e-09
healthy O 0 7.172731297799828e-09
volunteers O 0 1.9781497273552162e-10
having O 0 1.4056931833816844e-11
phenotype O 0 6.012955111600604e-08
Hp2 O 0 5.191603122511879e-06
, O 0 4.768950512268333e-11
whereas O 0 3.0124144845267153e-10
the O 0 1.4653129404296195e-11
serum O 0 2.148457384221203e-10
Hp O 0 7.472293617194481e-11
level O 0 4.524867980304492e-11
of O 0 1.8587657454882667e-12
an O 0 2.537179832074192e-15
individual O 0 3.7389836777916574e-14
with O 0 5.3432661127703757e-14
Hp1 O 0 5.068905011285096e-07
/ O 0 1.3070596160957848e-08
Hpdel O 0 4.296011866244953e-07
was O 0 4.799131314570104e-09
0 O 0 7.562660719884207e-09
. O 0 6.501809091119526e-10

50 O 0 9.801833300571161e-08
mg O 0 5.4472764077218017e-08
/ O 0 2.621528771840076e-09
ml O 0 6.978420952208353e-09
, O 0 1.8101955481450438e-12
which O 0 3.456919673476902e-14
was O 0 3.4821826411929324e-12
approximately O 0 2.1746338996035675e-13
half O 0 1.0280244537586025e-12
the O 0 1.3334314121621338e-12
level O 0 4.3704567742608447e-10
of O 0 1.6040886674506538e-10
Hp O 0 7.307559557467869e-10
in O 0 2.705502211153288e-10
control O 0 6.288924936370677e-09
sera O 0 1.6822966353302604e-09
from O 0 7.658965475720869e-12
the O 0 3.780625118521286e-11
Hp1 O 0 8.203431889342028e-07
phenotype O 0 1.879675970428707e-08
( O 0 1.123754680889405e-13
1 O 0 2.433795699696706e-11
. O 0 1.296863116027891e-12
26 O 0 9.292398100990695e-11
+ O 0 1.1279561486221557e-11
/ O 0 2.758130702995576e-11
- O 0 1.5705804712329297e-10
0 O 0 5.366223437830442e-11
. O 0 3.716560208460312e-13
33 O 0 7.755353650940044e-12
mg O 0 9.854735083525412e-12
/ O 0 3.5587409755177823e-12
ml O 0 1.6511918568551387e-11
; O 0 3.510710331385697e-13
n O 0 1.6000687103404077e-12
= O 0 6.528516334307344e-13
9 O 0 1.543978660201173e-11
) O 0 1.8457908405921167e-14
, O 0 1.5417021500575834e-13
showing O 0 5.055734043218907e-12
a O 0 2.5489948693446784e-12
gene O 0 2.039762803107692e-11
- O 0 1.4704238937568448e-09
dosage O 0 1.261901388716069e-06
effect O 0 7.39531344606803e-07
. O 0 6.756963699672269e-08

The O 0 3.446291430009296e-08
other O 0 1.6735658414646082e-09
allele O 0 2.072926053031665e-09
( O 0 2.0206982788428807e-12
Hp2 O 0 8.608036239365902e-08
) O 0 3.7245505074209873e-13
of O 0 9.49510088610328e-12
individuals O 0 6.92466754510096e-13
with O 0 3.4363076620302913e-12
Hp2 O 0 0.0017873572651296854
/ O 0 2.442431252802635e-07
Hpdel O 0 5.179384061193559e-06
was O 0 5.125179169951366e-10
found O 0 6.431446087501458e-13
to O 0 1.1456936473749207e-13
have O 0 3.0459719490595616e-13
, O 0 8.161708613639573e-14
in O 0 1.3349531983314344e-12
all O 0 1.9910757070862317e-11
exons O 0 7.094827503273393e-11
, O 0 1.7309210434326289e-13
no O 0 1.930073505532204e-12
mutation O 0 2.1427954896569013e-12
, O 0 3.663030233411364e-14
by O 0 3.3251800293267186e-13
DNA O 0 5.511650025269432e-10
sequencing O 0 1.305868568834967e-08
. O 0 9.487258090246087e-09

On O 0 1.2235485513656386e-08
the O 0 3.3693374479337734e-11
basis O 0 1.040304301036521e-10
of O 0 3.2818819276775324e-12
the O 0 1.3775155061762634e-12
present O 0 1.3943895517398719e-11
study O 0 5.480739993790618e-12
, O 0 9.664941542670159e-15
the O 0 9.648222298137485e-14
mechanism O 0 2.193849962806027e-11
of O 0 4.4487726003072936e-11
anhaptoglobinemia B-Disease 0 6.687189397780458e-07
and O 0 2.8572894050782338e-11
the O 0 8.147111457690315e-12
mechanism O 0 3.898760828069392e-11
of O 0 1.760600346067953e-11
anomalous O 0 3.487220823217285e-08
inheritance O 0 7.574544724775478e-08
of O 0 1.8492701814309953e-09
Hp O 0 1.1369887253920297e-08
phenotypes O 0 1.372193025872548e-07
were O 0 2.1343022904574127e-09
well O 0 3.4077293764589456e-10
explained O 0 9.575300552455701e-09
. O 0 3.5811897891591116e-09

However O 0 2.326204651126318e-08
, O 0 8.285439175026443e-12
the O 0 2.877276758864178e-12
mechanism O 0 5.326375451808474e-10
of O 0 4.003349318715266e-10
hypohaptoglobinemia B-Disease 0 0.00015663188241887838
remains O 0 4.178200015303446e-06
unknown O 0 1.6350735450032516e-06

ATM O 0 0.0004405626095831394
mutations O 0 4.414550289766339e-07
and O 0 9.094023312172794e-10
phenotypes O 0 3.019625182787422e-06
in O 0 2.933216194378474e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 7.546172469119483e-07
in O 0 1.6152634785271403e-11
the O 0 4.308015749687755e-12
British O 0 2.5411273779640808e-11
Isles O 0 8.721449118453961e-10
: O 0 1.7575922813505007e-13
expression O 0 2.024409286038864e-12
of O 0 1.643800221808045e-12
mutant O 0 7.678550503764647e-12
ATM O 0 2.280161059964314e-10
and O 0 1.8663200393215403e-14
the O 0 4.846103851324432e-14
risk O 0 1.221559312036824e-12
of O 0 2.1221861074005588e-12
leukemia B-Disease 0 0.0030713987071067095
, O 0 5.368972821884199e-09
lymphoma B-Disease 1 1.0
, O 0 2.468710533776175e-07
and O 0 5.08886103034456e-07
breast B-Disease 1 0.9837694764137268
cancer I-Disease 0 0.00022107906988821924
. O 0 6.813862682975014e-07

We O 0 8.019265251846264e-10
report O 0 1.2041041774768502e-11
the O 0 5.816040791334354e-12
spectrum O 0 8.979340826442694e-09
of O 0 5.469370789601413e-11
59 O 0 1.9178307830713948e-09
ATM O 0 6.331108526325124e-09
mutations O 0 2.3269332641295826e-11
observed O 0 5.321620227816126e-11
in O 0 1.2425747542010868e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 6.852878868812695e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.4383715572774403e-12
patients O 0 1.2235705504348715e-10
in O 0 2.6012056549527818e-14
the O 0 3.101283064989996e-13
British O 0 5.470100761240104e-11
Isles O 0 2.3294102646786996e-08
. O 0 6.4466636473525796e-09

Of O 0 4.196893496555276e-05
51 O 0 7.5758534876513295e-06
ATM O 0 3.971449041273445e-05
mutations O 0 2.1000081673605564e-08
identified O 0 7.297725757027251e-10
in O 0 3.806949894213929e-11
families O 0 9.979637255463913e-11
native O 0 7.117688816810075e-12
to O 0 1.8973138218945224e-13
the O 0 3.44431948240409e-12
British O 0 5.6792237579372795e-11
Isles O 0 7.528005774304347e-09
, O 0 9.957804546212312e-12
11 O 0 2.9310800314652496e-11
were O 0 2.0470170003505928e-10
founder O 0 2.1342736467033774e-09
mutations O 0 3.1381123394291777e-11
, O 0 3.0357773586620063e-12
and O 0 3.350085400061209e-12
2 O 0 2.384534514288106e-10
of O 0 1.7394748835775076e-11
these O 0 1.1019530773981323e-11
11 O 0 3.6299138608114623e-12
conferred O 0 1.1094510032894078e-10
a O 0 4.837610347030452e-13
milder O 0 3.2622207868371333e-07
clinical O 0 2.224909367853911e-09
phenotype O 0 1.9841970289036226e-09
with O 0 1.0663650816316803e-13
respect O 0 2.2849052511153545e-11
to O 0 2.090900369511317e-11
both O 0 3.525547187521738e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 1.319497073382081e-06
cellular O 0 5.3753691275915116e-08
features O 0 2.6286423038257567e-10
. O 0 6.927558526825806e-10

We O 0 5.554931514772932e-10
report O 0 1.8722022196437926e-11
, O 0 3.0248576538514926e-13
in O 0 2.604374506852414e-13
two O 0 5.175111641303465e-13
A B-Disease 1 1.0
- I-Disease 1 0.9999980926513672
T I-Disease 1 1.0
families O 0 6.899404936255848e-10
, O 0 4.1886771964339334e-14
an O 0 4.698131769417021e-15
ATM O 0 2.8992839240515877e-09
mutation O 0 7.796648049396282e-11
( O 0 1.0673723732125551e-13
7271T O 0 1.7355759052151143e-09
- O 0 1.0475424971900793e-09
- O 0 7.2352781543827405e-09
> O 0 4.997136038298322e-09
G O 0 7.727984918659558e-10
) O 0 2.1693453985754084e-15
that O 0 1.0241087847678377e-15
may O 0 7.859439011062563e-13
be O 0 4.4937025021202226e-13
associated O 0 9.751044416361765e-11
with O 0 9.755829363756671e-14
an O 0 1.4148094656008144e-14
increased O 0 6.582136918842352e-11
risk O 0 7.523294209832443e-10
of O 0 2.113456076813236e-09
breast B-Disease 0 6.01210058448487e-06
cancer I-Disease 0 1.738484911584237e-07
in O 0 1.8422845193821757e-10
both O 0 8.33234148345241e-10
homozygotes O 0 5.426039706435404e-08
and O 0 2.056149001061769e-11
heterozygotes O 0 7.780177058158699e-10
( O 0 1.3528335895095223e-13
relative O 0 3.485987332130236e-10
risk O 0 2.2689973164236044e-11
12 O 0 1.1692941536897705e-12
. O 0 2.0816224991556526e-13
7 O 0 1.789834079557462e-11
; O 0 1.6680119742026878e-12
P O 0 2.8903393012313927e-09
= O 0 1.0511114548195089e-12
. O 0 5.339224071546078e-13
0025 O 0 1.1948436684505737e-10
) O 0 1.2722119347986739e-15
, O 0 3.74069358320228e-15
although O 0 1.874379828865208e-13
there O 0 7.754960681862627e-14
is O 0 1.7770207438243084e-14
a O 0 2.1928856300257316e-13
less O 0 1.4559202732300491e-09
severe O 0 0.00017455847410019487
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 2.249933794828962e-09
in O 0 6.254406579231028e-15
terms O 0 1.567703994777899e-14
of O 0 5.36690557413047e-16
the O 0 2.2537238561655664e-15
degree O 0 3.3103992637395496e-12
of O 0 6.064258123439359e-11
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
. O 0 3.192211806890555e-05

This O 0 5.40569722318196e-09
mutation O 0 2.1192769761313457e-09
( O 0 1.293081635690696e-12
7271T O 0 1.5739939351888665e-09
- O 0 5.899798427577707e-10
- O 0 2.286110634130978e-09
> O 0 2.4867286008145584e-09
G O 0 1.0401083327948868e-09
) O 0 1.0972931513886144e-14
also O 0 8.003781184096493e-15
allows O 0 1.0191015918517912e-14
expression O 0 3.514394992468889e-13
of O 0 1.0065210383908285e-12
full O 0 1.834547487880589e-12
- O 0 1.0201766514894572e-11
length O 0 2.715416606846599e-11
ATM O 0 1.4616993171401305e-09
protein O 0 7.308068213085495e-12
at O 0 4.867152687826337e-13
a O 0 1.9898652156894424e-14
level O 0 1.9611445713912934e-12
comparable O 0 1.9636233611342035e-11
with O 0 7.436449527453877e-15
that O 0 4.761735304019757e-14
in O 0 8.733376001546223e-12
unaffected O 0 6.883901448873075e-08
individuals O 0 4.747867377030701e-11
. O 0 3.738615195203465e-09

In O 0 9.192906436084058e-10
addition O 0 1.1558357743135517e-10
, O 0 3.6287995178185817e-12
we O 0 6.549994379344282e-13
have O 0 3.169896528425198e-13
studied O 0 5.980611839095928e-11
18 O 0 3.78811954027114e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 3.464046187673375e-07
, O 0 3.75247030578443e-15
in O 0 1.9461767809293706e-15
15 O 0 2.4799693548738233e-13
families O 0 8.837544004979339e-14
, O 0 4.9840919558825567e-14
who O 0 7.040440279382221e-13
developed O 0 1.2260481518922006e-08
leukemia B-Disease 1 1.0
, O 0 2.274748112540692e-05
lymphoma B-Disease 1 1.0
, O 0 1.0418565921099798e-07
preleukemic O 0 0.00023588267504237592
T O 0 0.00014480052050203085
- O 0 3.622133704084263e-08
cell O 0 4.205635395493346e-09
proliferation O 0 3.871620801731979e-09
, O 0 5.899417781542182e-13
or O 0 2.6365674088424385e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.8607241020495167e-08
mostly O 0 6.618595255192261e-11
in O 0 2.4355034048545443e-12
childhood O 0 5.001646208313559e-09
. O 0 5.4922284498104545e-09

A O 0 2.38903612626018e-06
wide O 0 1.536833167392615e-07
variety O 0 1.1281600542645265e-08
of O 0 6.370585836634746e-09
ATM O 0 3.295034048278467e-06
mutation O 0 8.769326598212501e-09
types O 0 8.017098096502195e-09
, O 0 2.4533286860362047e-11
including O 0 4.626008950903149e-11
missense O 0 3.5245008689344104e-07
mutations O 0 2.3761861367432857e-09
and O 0 2.4305205417740616e-11
in O 0 1.883297684468488e-11
- O 0 6.40254627093384e-10
frame O 0 2.790533581986665e-09
deletions O 0 1.6021691751078038e-09
, O 0 1.9012198499562816e-12
were O 0 5.66785854361207e-12
seen O 0 9.473971086804145e-12
in O 0 6.380665852449841e-13
these O 0 8.613373903010313e-12
patients O 0 6.610044733790232e-10
. O 0 5.661403013057509e-10

We O 0 6.213404013521995e-09
also O 0 1.3908672824580748e-11
show O 0 1.454504512709079e-13
that O 0 7.805049678736979e-16
25 O 0 5.070100697786295e-13
% O 0 1.2609362067938362e-13
of O 0 4.423553266307695e-13
all O 0 1.3757282639470514e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.00957570318132639
carried O 0 5.095114434527925e-12
in O 0 9.222145752130553e-14
- O 0 4.493456388227068e-12
frame O 0 5.951075188193045e-10
deletions O 0 2.5959696614563654e-08
or O 0 9.796839783859923e-09
missense O 0 5.741203494835645e-07
mutations O 0 2.115230435251192e-09
, O 0 2.5976980982944653e-12
many O 0 3.1500431603437296e-13
of O 0 5.782577108121023e-13
which O 0 1.2249324276257523e-13
were O 0 3.5629656777030894e-12
also O 0 5.307846244234811e-14
associated O 0 2.654648636329915e-12
with O 0 2.6243200321185434e-13
expression O 0 1.956140666115047e-10
of O 0 1.0587909715642496e-10
mutant O 0 2.4658053376924727e-09
ATM O 0 1.0594611410397192e-07
protein O 0 8.783437976944697e-09
. O 0 2.4439950063737115e-09

The O 0 5.0345160929055055e-08
DMPK O 1 0.9999653100967407
gene O 0 9.973255146178417e-07
of O 0 2.855279035429703e-07
severely O 1 0.9999998807907104
affected O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999958276748657
is O 0 1.3368291716664427e-11
hypermethylated O 0 1.1847959946464925e-08
proximal O 0 1.5334278202772111e-07
to O 0 1.5090360905301026e-10
the O 0 1.619043565881384e-09
largely O 0 1.7099049287594426e-08
expanded O 0 1.676419714158328e-08
CTG O 0 2.2950278435018845e-05
repeat O 0 1.1697989066306036e-07
. O 0 2.711745850092484e-08

Using O 0 4.6611422277464953e-08
methylation O 0 1.496145728197007e-06
- O 0 8.795611279310833e-07
sensitive O 0 4.374324362288462e-06
restriction O 0 3.5508568885234126e-07
enzymes O 0 1.3070446946983338e-08
, O 0 2.1731682425807364e-11
we O 0 1.8426059289478047e-12
characterized O 0 9.13047762396424e-12
the O 0 5.070606261259325e-12
methylation O 0 1.9112057769721247e-10
pattern O 0 4.607932646560897e-10
on O 0 5.421531279470315e-11
the O 0 1.0178675610705845e-11
5 O 0 4.0649639904133394e-11
side O 0 1.9560389766248854e-11
of O 0 6.383155115585737e-11
the O 0 9.368321673974833e-10
CTG O 0 6.479438070527976e-07
repeat O 0 3.994356789771558e-10
in O 0 1.951377254227893e-11
the O 0 8.031476872449872e-11
DMPK O 0 5.263641469355207e-06
gene O 0 3.424068320545537e-11
of O 0 1.1905162619618714e-11
normal O 0 2.0753827545405557e-09
individuals O 0 3.456822501857193e-13
and O 0 5.842733523560295e-13
of O 0 1.4292273094185237e-11
patients O 0 5.235844646733767e-09
affected O 0 2.102567897566132e-09
with O 0 7.78755615549187e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 6.611706321324462e-11
showing O 0 3.6915661499881125e-12
expansions O 0 2.316972828875219e-11
of O 0 6.388377240401644e-12
the O 0 3.20741246062628e-11
repetitive O 0 2.76966805046186e-09
sequence O 0 1.4661549752048586e-10
. O 0 4.209220472173314e-10

The O 0 2.2557056666983044e-08
gene O 0 2.691030176471543e-10
segment O 0 4.4326986525788925e-10
analyzed O 0 2.2311381908668437e-10
corresponds O 0 1.299605423277228e-10
to O 0 1.167694500120442e-11
the O 0 1.3098534756839086e-10
genomic O 0 3.669311965381894e-09
SacI O 0 4.88306568513508e-07
- O 0 1.2999780141242923e-09
HindIII O 0 3.378080748461798e-08
fragment O 0 3.986030672198382e-10
carrying O 0 5.540220712751953e-11
exons O 0 6.133064611724137e-10
11 O 0 9.180670806907543e-11
- O 0 5.780557144063891e-10
15 O 0 9.066692951975597e-10
. O 0 1.0624874313691635e-09

There O 0 9.05615493707046e-09
is O 0 8.18715026329464e-11
constitutive O 0 3.364789620263764e-07
methylation O 0 1.0663575267244596e-06
in O 0 5.538887037914719e-08
intron O 0 1.518941530775919e-06
12 O 0 4.507867412684163e-09
at O 0 2.924986988728229e-11
restriction O 0 1.8416038694013537e-09
sites O 0 3.664155645566325e-10
of O 0 1.7527976292619485e-10
SacII O 0 7.633276254637167e-06
and O 0 1.770492530361878e-09
HhaI O 0 9.985597898776177e-06
, O 0 2.963860407101393e-11
localized O 0 1.2611504063286816e-09
1 O 0 1.5740689862653312e-09
, O 0 1.055398607049951e-12
159 O 0 1.358316931154846e-10
- O 0 9.088747116026141e-11
1 O 0 1.6010205383665266e-09
, O 0 3.915840308260643e-12
232 O 0 3.9412381691583676e-10
bp O 0 9.53505496781304e-10
upstream O 0 1.940259952704082e-09
of O 0 4.901200001405925e-10
the O 0 5.3328230720239844e-09
CTG O 0 1.4831223779765423e-05
repeat O 0 1.7688327247356028e-08
, O 0 5.6243763119079304e-11
whereas O 0 6.272007357921439e-10
most O 0 2.9080593835772994e-11
, O 0 2.0799715302975003e-13
if O 0 1.9099346128086114e-13
not O 0 1.176533696856108e-12
all O 0 3.3455454118841432e-12
, O 0 2.3907381608255507e-13
of O 0 2.3173960580352704e-12
the O 0 2.610861396870612e-12
other O 0 5.248292577440805e-13
sites O 0 1.3181207861312494e-11
of O 0 1.9332613634959195e-11
SacII O 0 2.7873389285559824e-07
, O 0 5.3741306543786393e-11
HhaI O 0 1.6997583998090704e-06
, O 0 7.142635094492533e-11
and O 0 3.643441798262259e-11
HpaII O 0 6.793624152123812e-07
in O 0 1.1360208607147371e-10
this O 0 6.906972910281084e-11
region O 0 1.7594440349100182e-09
are O 0 2.7654897469253648e-11
unmethylated O 0 2.4806141141198168e-08
, O 0 2.997696492076929e-13
in O 0 2.76426342753211e-13
normal O 0 5.987097484450032e-10
individuals O 0 9.357306596236015e-13
and O 0 1.4947885594238097e-12
most O 0 9.720228094645122e-13
of O 0 2.0482881883665538e-12
the O 0 6.281797304552583e-11
patients O 0 3.1865430294431007e-09
. O 0 6.190735701849803e-10

In O 0 6.792919560183464e-10
a O 0 7.479704355883854e-12
number O 0 2.733562855239402e-11
of O 0 1.5141449205557933e-10
young O 0 1.0265995831204577e-09
and O 0 7.650909072953738e-11
severely O 0 1.857476519262491e-07
affected O 0 1.7915756700404017e-07
patients O 0 2.7726775897463085e-06
, O 0 6.790542086965168e-12
however O 0 3.7618244630444053e-10
, O 0 4.968824830753338e-12
complete O 0 1.4885848109713606e-10
methylation O 0 3.49592377268948e-09
of O 0 9.455850685791134e-11
these O 0 1.938396491929506e-12
restriction O 0 5.19380614905085e-11
sites O 0 1.194029684153941e-11
was O 0 5.508302147738675e-12
found O 0 4.808027348653099e-13
in O 0 6.315789904953739e-13
the O 0 3.1514405668398027e-11
mutated O 0 7.460295492478508e-09
allele O 0 2.6761634686067737e-08
. O 0 9.41737798854092e-09

In O 0 3.977830065338139e-09
most O 0 5.484863258020667e-11
of O 0 6.926045240801537e-12
these O 0 5.7565215615118515e-12
patients O 0 4.979994541742805e-11
, O 0 3.502493518874267e-15
the O 0 1.4062085236478047e-14
onset O 0 2.3855137865069764e-09
of O 0 7.023386733306936e-11
the O 0 5.901487076798162e-10
disease O 0 3.7558386338787386e-06
was O 0 6.079089587274211e-08
congenital O 1 0.9999991655349731
. O 0 1.6951787529251305e-06

Preliminary O 0 2.107487034663791e-06
in O 0 3.4063681653151434e-08
vivo O 0 2.4043270059337374e-06
footprinting O 0 0.00016403257905039936
data O 0 2.1978069142392087e-08
gave O 0 1.2876492094804348e-09
evidence O 0 3.12244757827429e-10
for O 0 2.2405532290603603e-11
protein O 0 8.275434781879198e-10
- O 0 1.5990735402482414e-09
DNA O 0 4.124629082724596e-09
contact O 0 8.884575714018794e-11
in O 0 3.331582579257919e-11
normal O 0 5.514662575478724e-07
genes O 0 7.052950445896045e-10
at O 0 1.6594765492317087e-11
an O 0 1.6711191621037597e-13
Sp1 O 0 4.760739802378566e-09
consensus O 0 4.1907495251791715e-09
binding O 0 4.758912153235428e-10
site O 0 2.6551285614573317e-09
upstream O 0 4.783455853640817e-10
of O 0 5.7728304775350736e-11
the O 0 2.3510385305236525e-10
CTG O 0 3.947193363273982e-07
repeat O 0 1.439113966883454e-10
and O 0 9.122953044046755e-13
for O 0 1.3834121565317603e-14
a O 0 2.6773743727566196e-15
significant O 0 5.517792169354441e-14
reduction O 0 3.815135013462978e-11
of O 0 2.037931108589408e-11
this O 0 1.217572375387943e-12
interaction O 0 2.0480861798177763e-11
in O 0 3.126699637048813e-12
cells O 0 1.0834234551171384e-11
with O 0 7.668206212152126e-15
a O 0 9.99505708233761e-13
hypermethylated O 0 2.5419899429834913e-07
DMPK O 0 0.0002877580118365586
gene O 0 5.944022163362206e-09
. O 0 1.6153759441195348e-09
. O 0 8.59707238731744e-09

The O 0 2.4170312826754525e-06
hemochromatosis B-Disease 1 1.0
gene O 0 1.0072108835856852e-07
product O 0 2.1566711083664813e-08
complexes O 0 5.7964144595246125e-09
with O 0 3.3667532737396977e-12
the O 0 8.23760296086995e-11
transferrin O 0 1.5668695141357603e-07
receptor O 0 1.0768408387207273e-08
and O 0 4.8749435044292966e-11
lowers O 0 5.072652298210301e-10
its O 0 2.0795429993888254e-13
affinity O 0 6.369794557266328e-13
for O 0 1.0426725536574408e-13
ligand O 0 4.168346501298714e-10
binding O 0 3.944135240629976e-09
. O 0 1.326959342407008e-08

We O 0 4.864807578996988e-08
recently O 0 1.9911079451873093e-09
reported O 0 3.034737044993463e-11
the O 0 5.755423481551558e-12
positional O 0 1.7262066220880001e-09
cloning O 0 3.457475861168291e-09
of O 0 8.957124104924663e-12
a O 0 1.9002627162784114e-12
candidate O 0 1.5085187543562029e-09
gene O 0 1.1147624490170926e-10
for O 0 4.3706233077145384e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9987640380859375
HFE O 1 0.9997702240943909
. O 0 5.048584625910735e-07

The O 0 2.0859600269318435e-08
gene O 0 2.7144635497688974e-11
product O 0 1.3411459443002371e-10
, O 0 1.9801673321884206e-12
a O 0 3.4086991042292514e-13
member O 0 8.798024158165885e-13
of O 0 2.5061817204852233e-11
the O 0 1.5559344090920746e-10
major O 0 3.5643170637200683e-09
histocompatibility O 0 9.098820186181911e-08
complex O 0 6.391702278563116e-09
class O 0 5.2449152659894693e-11
I O 0 5.501955002706893e-10
- O 0 2.989044081691539e-11
like O 0 2.3514666776247584e-12
family O 0 8.944383319935134e-13
, O 0 1.915307173386456e-14
was O 0 1.1745784466582476e-12
found O 0 2.3303508103235393e-13
to O 0 6.8544703333423e-13
have O 0 4.020555156164507e-12
a O 0 1.198760188336756e-11
mutation O 0 2.822478362141112e-10
, O 0 1.2029126826573755e-11
Cys O 0 3.4076418131689934e-08
- O 0 2.098025309038576e-09
282 O 0 1.5124714813907758e-09
- O 0 1.678175265418247e-09
- O 0 3.152730299049722e-09
> O 0 1.0086889545846134e-08
Tyr O 0 4.448083501529254e-08
( O 0 4.3661570263116636e-14
C282Y O 0 1.0431595864890397e-10
) O 0 3.7869538641001e-15
, O 0 4.997072989909113e-15
in O 0 2.5080142430629164e-14
85 O 0 3.991765251676327e-11
% O 0 7.856560996395701e-13
of O 0 1.8027497897254996e-12
patient O 0 1.0025168251104333e-08
chromosomes O 0 2.2162618407151058e-08
. O 0 2.8521538908421462e-08

This O 0 1.2177326702556002e-08
mutation O 0 7.740409202483534e-09
eliminates O 0 6.951598852111829e-09
the O 0 1.0555485652208318e-10
ability O 0 3.3589679648837745e-11
of O 0 1.1860661341955847e-09
HFE O 0 0.0004682890430558473
to O 0 1.458168474854915e-09
associate O 0 1.6327340868205198e-10
with O 0 1.3946009874265392e-13
beta2 O 0 5.075077069705003e-07
- O 0 2.5232304778910475e-07
microglobulin O 0 1.520683872513473e-05
( O 0 1.3990809379083036e-11
beta2m O 0 5.305063837113266e-07
) O 0 4.595595605449976e-12
and O 0 5.305827392027007e-12
prevents O 0 6.572151156625239e-11
cell O 0 1.000873606216146e-08
- O 0 8.994300304543401e-10
surface O 0 3.849664551580645e-07
expression O 0 2.586253522451898e-08
. O 0 9.42158262517978e-09

A O 0 1.2579134818224702e-06
second O 0 6.063017110591318e-08
mutation O 0 9.198448669422987e-10
that O 0 1.4025937529471566e-12
has O 0 1.6896766375385647e-13
no O 0 1.7882727633769524e-13
effect O 0 4.670978534515591e-11
on O 0 3.5881617121980014e-10
beta2m O 0 1.8125626866094535e-06
association O 0 1.039959562909587e-09
, O 0 2.1515402306993003e-11
H63D O 0 0.0006527365767396986
, O 0 1.5261099675645262e-11
was O 0 7.680707458934677e-11
found O 0 1.503145589769328e-12
in O 0 2.824759306671587e-12
eight O 0 3.553721769980478e-12
out O 0 8.895452733789777e-13
of O 0 2.0236768857873066e-11
nine O 0 4.6052852503697395e-11
patients O 0 2.360402151513341e-10
heterozygous O 0 8.837430028225957e-13
for O 0 1.7908396120203118e-13
the O 0 3.833428713351239e-11
C282Y O 0 2.0040467063608958e-07
mutant O 0 1.1630778118387752e-07
. O 0 1.2039452101930692e-08

In O 0 1.305346802871199e-10
this O 0 2.653585250839141e-12
report O 0 1.092900162730226e-11
, O 0 8.698510119663216e-13
we O 0 9.15815275177867e-13
demonstrate O 0 2.691896532069915e-11
in O 0 2.2241264385769455e-11
cultured O 0 5.334911179488699e-07
293 O 0 7.96988359752504e-08
cells O 0 5.7932339814215084e-08
overexpressing O 0 3.3653799391686334e-07
wild O 0 5.579484430029424e-09
- O 0 5.209345177448199e-10
type O 0 3.6317131524299384e-09
or O 0 1.2956238304440149e-09
mutant O 0 3.795058844957566e-08
HFE O 0 1.4419421177080949e-06
proteins O 0 1.3323515034302513e-11
that O 0 2.978131792823885e-13
both O 0 6.587732204361985e-13
the O 0 4.830494511331995e-12
wild O 0 9.804218548126187e-10
- O 0 3.577228235851493e-10
type O 0 5.039778816495755e-09
and O 0 3.318893215809027e-10
H63D O 0 0.0009930382948368788
HFE O 0 3.940784517908469e-05
proteins O 0 4.836067657443266e-10
form O 0 7.588604050701164e-11
stable O 0 2.0710359815989676e-10
complexes O 0 3.2402706819784077e-12
with O 0 6.674844935127856e-15
the O 0 7.642397999163553e-13
transferrin O 0 6.614513381464349e-09
receptor O 0 2.2933823728976677e-09
( O 0 6.1166566603376715e-12
TfR O 0 1.355976309014295e-07
) O 0 3.092507153135138e-12
. O 0 2.6664903618467406e-10

The O 0 1.1565937541035964e-07
C282Y O 0 1.2907125892525073e-05
mutation O 0 1.0024999141933222e-07
nearly O 0 1.4807691184337557e-10
completely O 0 6.80946826703277e-11
prevents O 0 9.845698041577311e-12
the O 0 1.6646978934220513e-11
association O 0 7.7165510092847e-11
of O 0 9.048031768266185e-11
the O 0 5.640052314070942e-10
mutant O 0 3.116358016086451e-08
HFE O 0 3.367114913999103e-06
protein O 0 1.2107471691891192e-09
with O 0 2.357492185408455e-13
the O 0 2.973475285439342e-11
TfR O 0 2.401810661467607e-06
. O 0 3.092995637388185e-09

Studies O 0 4.5062968467846076e-08
on O 0 4.361363215021896e-10
cell O 0 1.534572607875262e-10
- O 0 3.439502502255998e-11
associated O 0 1.0502428787750873e-10
transferrin O 0 1.0539687167465672e-07
at O 0 4.823778043672178e-10
37 O 0 1.3348526450851494e-10
degrees O 0 1.2232819202040446e-09
C O 0 2.463313997225214e-09
suggest O 0 3.213399381654658e-12
that O 0 4.8792706122203e-14
the O 0 7.063164636500474e-11
overexpressed O 0 1.5379093554201972e-07
wild O 0 5.686784820824187e-09
- O 0 4.63570959396975e-10
type O 0 4.676920628554626e-09
HFE O 0 1.6977980976662366e-06
protein O 0 1.0639800152034695e-09
decreases O 0 3.584262608935518e-10
the O 0 2.926681900300432e-12
affinity O 0 1.1266380189889347e-11
of O 0 6.115338704176798e-12
the O 0 1.8389343867108998e-11
TfR O 0 1.0530143157438943e-07
for O 0 4.1884256479773896e-12
transferrin O 0 1.3073417903797235e-07
. O 0 3.6554755666884375e-08

The O 0 0.0002891647454816848
overexpressed O 0 0.02915690280497074
H63D O 1 0.9998176693916321
protein O 0 1.7674642549536657e-07
does O 0 1.1620960443936568e-10
not O 0 4.535441466835266e-12
have O 0 3.0716014042149464e-13
this O 0 5.689038514366737e-14
effect O 0 7.68177743637466e-11
, O 0 8.35267998430117e-13
providing O 0 2.074156818521189e-12
the O 0 3.5691263312875865e-13
first O 0 1.4912538163960182e-13
direct O 0 8.485247416810046e-14
evidence O 0 4.737333030198354e-13
for O 0 3.4214123911411806e-14
a O 0 1.7198240986719682e-13
functional O 0 3.6854214124915075e-10
consequence O 0 3.1605214001473314e-09
of O 0 4.861648861265166e-10
the O 0 2.17268114610647e-09
H63D O 0 0.0020276736468076706
mutation O 0 4.062986533881485e-07
. O 0 8.664020612059176e-09

Addition O 0 1.5695459154585478e-08
of O 0 2.3645410962558344e-08
soluble O 1 0.9779111742973328
wild O 0 7.699882189626805e-06
- O 0 1.8499068232813443e-07
type O 0 1.6793132999737281e-06
HFE O 1 0.999996542930603
/ O 0 0.001230228110216558
beta2m O 0 0.00031421889434568584
heterodimers O 0 8.227514626923949e-06
to O 0 8.980260979285504e-10
cultured O 0 1.674895884207217e-07
cells O 0 1.1386468656837678e-08
also O 0 3.1468003116458254e-13
decreased O 0 3.5138558729386205e-11
the O 0 8.264348407005517e-13
apparent O 0 6.055796836212934e-11
affinity O 0 3.1787517063008863e-11
of O 0 1.796572092482851e-11
the O 0 5.544954252700851e-12
TfR O 0 2.1527493121453745e-09
for O 0 2.4166214209332508e-14
its O 0 7.126264368103458e-15
ligand O 0 1.2157181728325583e-12
under O 0 1.642829448866845e-11
steady O 0 2.1581544884519133e-10
- O 0 4.242211237241028e-13
state O 0 1.9699537411477924e-13
conditions O 0 1.841322871953821e-09
, O 0 8.503883903478171e-13
both O 0 1.0802164284590132e-12
in O 0 1.0937175644321062e-11
293 O 0 2.4488466809913234e-10
cells O 0 4.3169859353930917e-10
and O 0 6.239153291232036e-12
in O 0 1.2459626386185363e-10
HeLa O 0 1.6401070297433762e-06
cells O 0 5.0255746231187004e-08
. O 0 4.02702360347007e-09

Furthermore O 0 2.5343641851804932e-08
, O 0 1.197649444895088e-11
at O 0 6.772187845227595e-12
4 O 0 4.629910690945316e-11
degrees O 0 1.1149803746945963e-08
C O 0 9.055450078676586e-08
, O 0 1.8402378958778248e-13
the O 0 2.044568290712756e-12
added O 0 7.401906865212027e-11
soluble O 0 2.7573310035222676e-07
complex O 0 1.332841570444998e-08
of O 0 1.3239551677202144e-09
HFE O 0 7.550042937509716e-05
/ O 0 9.110993204330953e-08
beta2m O 0 8.733459821996803e-08
inhibited O 0 2.1182908760408736e-09
binding O 0 3.510193524736138e-10
of O 0 1.1942695443689644e-10
transferrin O 0 5.3865360172267174e-08
to O 0 2.6601876257359436e-09
HeLa O 0 2.9263053420436336e-06
cell O 0 2.812990196332521e-08
TfR O 0 1.4645584656136634e-07
in O 0 3.9506928544569275e-13
a O 0 7.202998099234761e-14
concentration O 0 1.7417864373037162e-10
- O 0 7.868960483214948e-10
dependent O 0 9.739306250367008e-09
manner O 0 4.091494787417105e-08
. O 0 1.6054523044317648e-08

Scatchard O 0 0.0002075962838716805
plots O 0 2.5634372491367685e-07
of O 0 4.052728819203821e-09
these O 0 9.367619180356002e-11
data O 0 8.549788654832469e-11
indicate O 0 3.2610444899994206e-10
that O 0 1.0363759546730411e-12
the O 0 1.7176041144928433e-10
added O 0 4.3678063943453083e-10
heterodimer O 0 2.7654398770948774e-09
substantially O 0 2.0834538538849756e-09
reduced O 0 1.1553471512826263e-09
the O 0 2.47044433521193e-11
affinity O 0 8.423339803442786e-11
of O 0 5.458438215311112e-11
TfR O 0 8.639585047376386e-08
for O 0 2.0482257383214186e-12
transferrin O 0 1.1032969382540614e-07
. O 0 3.981505969363752e-08

These O 0 2.208571991957342e-09
results O 0 6.13031680973819e-10
establish O 0 2.5752150412117203e-10
a O 0 2.2996645820255734e-12
molecular O 0 4.2636387476147064e-11
link O 0 2.2055399173659396e-10
between O 0 7.868570239821793e-10
HFE O 1 0.9999997615814209
and O 0 3.175702190105767e-08
a O 0 5.586829332493437e-10
key O 0 1.4800427550198947e-07
protein O 0 1.2327538989609366e-09
involved O 0 3.6068925624022086e-11
in O 0 5.535908103454501e-12
iron O 0 2.1353701029624972e-08
transport O 0 9.282986468406307e-08
, O 0 5.036561445681542e-12
the O 0 3.092644543234435e-11
TfR O 0 1.0750947154747337e-07
, O 0 1.3920025071847975e-12
and O 0 1.5630628302093497e-12
raise O 0 2.216452889280962e-11
the O 0 1.3762051394305974e-12
possibility O 0 1.4864902711519967e-11
that O 0 9.922190022729205e-14
alterations O 0 7.537057200579511e-09
in O 0 1.556093968957395e-11
this O 0 8.584389167391737e-13
regulatory O 0 4.125461361415006e-10
mechanism O 0 5.010629133828104e-10
may O 0 1.8433952975183132e-10
play O 0 4.282324495008538e-12
a O 0 5.679778411374174e-14
role O 0 3.5329177734341743e-13
in O 0 7.625202552707933e-13
the O 0 8.065787621136522e-11
pathogenesis O 0 1.1239910236326978e-05
of O 0 7.075566088587948e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 6.694576586596668e-05
. O 0 4.1847929566074527e-08

Genomic O 0 9.360737607266856e-08
organization O 0 6.578851907690364e-10
of O 0 5.906757305496058e-10
the O 0 2.0758390562036766e-08
UBE3A O 1 0.6459974646568298
/ O 0 5.175725164008327e-06
E6 O 0 4.104758409084752e-05
- O 0 1.4781905122163153e-07
AP O 0 9.884134897220065e-07
gene O 0 4.069548517615651e-11
and O 0 7.181355119942334e-13
related O 0 1.293236406851861e-09
pseudogenes O 0 1.680215063970536e-06
. O 0 4.172550660541674e-08

The O 0 4.1232831904380873e-07
UBE3A O 0 0.0001373643463011831
gene O 0 1.23778642890926e-09
encodes O 0 4.9814003616477365e-11
the O 0 3.0077812462891984e-10
E6 O 0 3.4816100651369197e-06
- O 0 6.23230249630069e-08
AP O 0 3.5743951798394846e-07
ubiquitin O 0 5.1888306984437804e-09
- O 0 1.3370044626981326e-08
protein O 0 1.860452486512898e-10
ligase O 0 1.9651455462899037e-10
and O 0 9.690841185072685e-11
has O 0 7.311814456852084e-13
recently O 0 9.169916345350138e-13
been O 0 2.1246017301696472e-14
shown O 0 2.00752720789241e-14
to O 0 2.2759548287893186e-14
be O 0 9.734922286688819e-13
mutated O 0 1.275934806699297e-07
in O 0 5.797179980504552e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999427795410156
who O 0 9.362796649092786e-11
lack O 0 4.793475061326546e-10
15q11 O 0 4.435527856117005e-08
- O 0 1.0070222877800461e-08
q13 O 0 1.9878311263710202e-07
deletions O 0 1.9699736952816238e-08
or O 0 5.539420588895894e-10
chromosome O 0 4.89691354133015e-09
15 O 0 3.1880933448746873e-09
paternal O 0 6.468512765422929e-06
uniparental B-Disease 0 0.0068795569241046906
disomy I-Disease 0 0.0013087914558127522
. O 0 4.583080226439051e-06

Previous O 0 1.6359785149688832e-05
UBE3A O 0 7.946919504320249e-05
cDNA O 0 2.658281772482951e-08
analysis O 0 1.139840791197777e-10
has O 0 2.635632055485171e-13
shown O 0 1.268975294852273e-13
a O 0 5.937763301877563e-14
coding O 0 1.255006931710767e-10
region O 0 2.067618021239781e-10
of O 0 3.5703709433398956e-10
approximately O 0 1.5545226217383856e-10
2 O 0 6.944985475598742e-09
. O 0 9.582147297848564e-10

6 O 0 1.748494105413556e-05
kb O 0 5.780099172625341e-07
and O 0 5.4537685478806e-10
a O 0 1.21727392055071e-10
3 O 0 2.8069338853242698e-08
- O 0 9.409966139628523e-08
untranslated O 0 0.3800428509712219
region O 0 5.4399951210371e-09
( O 0 9.361054683146297e-13
UTR O 0 1.357512473987299e-06
) O 0 1.339313588418628e-13
of O 0 3.268826875846287e-11
< O 0 2.120392972315699e-09
50 O 0 1.5018029875246697e-10
bp O 0 1.251192344176033e-10
, O 0 2.6988497157584557e-13
whereas O 0 2.2137319755088924e-11
Northern O 0 6.773159810791185e-11
analysis O 0 3.89400230810244e-12
has O 0 1.7242221647846556e-13
indicated O 0 2.076607115431006e-12
mRNA O 0 4.4102781322774565e-12
sizes O 0 4.121903859899412e-11
of O 0 1.3958104637390445e-11
5 O 0 1.5790878604704517e-09
- O 0 8.383246097309893e-09
8 O 0 1.0535864625182967e-08
kb O 0 3.08491934220001e-08
. O 0 1.0471954858815025e-08

We O 0 1.5032294697903126e-07
have O 0 3.0580968313209667e-10
analyzed O 0 2.5304106032741913e-10
additional O 0 1.8752550901002252e-10
cDNA O 0 9.872829664914207e-09
clones O 0 2.3459433506900496e-08
and O 0 7.51071253801694e-12
provide O 0 4.970329703368748e-13
evidence O 0 4.550394891618403e-13
for O 0 2.1939888057362356e-14
an O 0 8.551826747563076e-15
additional O 0 1.5879781864458486e-11
0 O 0 4.365451555798927e-09
. O 0 6.100944749398707e-10

5 O 0 1.2334387520240853e-06
kb O 0 1.8101565046890755e-07
of O 0 1.2918564884500938e-08
5 O 0 9.454817018195172e-08
- O 0 8.670025408719084e-08
UTR O 0 0.012760929763317108
and O 0 2.356731199082418e-10
> O 0 6.912937333680702e-09
2 O 0 4.3866668630876404e-10
kb O 0 3.699789363764694e-10
of O 0 2.0504829778555944e-10
3 O 0 5.3988475912092326e-08
- O 0 4.94756136504293e-07
UTR O 0 0.2415449470281601
. O 0 8.274921015072323e-08

We O 0 3.1902345209999794e-09
have O 0 1.820097241325702e-12
established O 0 1.6638748755529176e-12
the O 0 6.320984317562117e-13
genomic O 0 2.7267826885335467e-11
organization O 0 7.67620775971034e-12
of O 0 4.6690193378218225e-11
UBE3A O 0 4.462165634322446e-06
and O 0 1.3971049143968184e-11
the O 0 1.0825683231796557e-11
sequence O 0 3.5280845085694512e-12
of O 0 2.323637983414617e-11
intron O 0 3.848186658217401e-09
- O 0 2.8446185851294103e-08
exon O 0 4.513806217687488e-08
borders O 0 4.742549908343108e-09
. O 0 2.792547881824703e-08

We O 0 2.383673489703142e-07
have O 0 6.544160213728389e-10
also O 0 7.433060417172399e-11
mapped O 0 2.041761648641227e-09
two O 0 1.6494951238232858e-11
highly O 0 2.7579387662513e-09
homologous O 0 9.700370506848799e-10
processed O 0 1.045234228058689e-07
pseudogenes O 0 1.3257268847155501e-06
, O 0 2.8640731453144497e-10
UBE3AP1 O 0 0.0010585675481706858
and O 0 8.786952832018358e-10
UBE3AP2 O 1 0.9477431178092957
, O 0 2.654762520926113e-10
to O 0 7.500881166189188e-11
chromosomes O 0 2.9038427218353036e-10
2 O 0 1.798695220545099e-10
and O 0 8.563652174539693e-13
21 O 0 7.064659968136766e-11
, O 0 4.3791863581568724e-13
respectively O 0 2.7182976355955013e-11
, O 0 9.968175373673005e-13
and O 0 5.175822335827529e-13
determined O 0 5.687071993887294e-11
their O 0 2.3727644848925422e-11
genomic O 0 6.121728679531202e-10
organization O 0 2.7833774174368386e-10
. O 0 4.0825982594583365e-09

These O 0 7.964728432341417e-09
results O 0 2.6767071892308536e-10
will O 0 2.489164039817804e-12
form O 0 1.896446541471697e-12
the O 0 1.3592123303610149e-12
basis O 0 1.1420115070617798e-12
for O 0 1.3751219909670983e-15
studies O 0 3.513495375716269e-14
of O 0 6.204222926424821e-14
mutation O 0 1.1362212169394037e-12
and O 0 2.2675943154443212e-12
imprinting O 0 4.490698302106466e-08
of O 0 2.034632906600109e-08
UBE3A O 0 0.012756545096635818
. O 0 4.3530985749384854e-07

Mutation O 0 4.124618044443196e-06
spectrum O 0 2.398953711235663e-06
and O 0 4.740250414414504e-10
genotype O 0 4.39668525586967e-07
- O 0 1.161246814262995e-07
phenotype O 0 1.8931396894572572e-08
analyses O 0 2.1485547715971443e-11
in O 0 4.888849741702117e-13
Cowden B-Disease 0 3.61216370947659e-05
disease I-Disease 0 3.821833871597846e-08
and O 0 1.1861966964232806e-10
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.6941938130177192e-10
two O 0 2.966032280893316e-11
hamartoma B-Disease 0 0.016215700656175613
syndromes I-Disease 0 0.12231690436601639
with O 0 2.8389379735926923e-08
germline O 1 0.9879642724990845
PTEN O 1 0.9695264101028442
mutation O 0 8.46959028422134e-06
. O 0 4.2427561908198186e-08

The O 0 3.4505119401728734e-05
tumour B-Disease 1 1.0
suppressor O 1 0.9987020492553711
gene O 0 2.1866505903744837e-06
PTEN O 0 0.0007237385725602508
, O 0 3.019079430899296e-11
which O 0 3.646733793844642e-13
maps O 0 2.499823958945768e-10
to O 0 3.9806422047483636e-11
10q23 O 0 2.408862201264128e-06
. O 0 9.33497403821093e-08

3 O 0 1.827169455737021e-07
and O 0 4.2548728429459004e-11
encodes O 0 1.0538662824355338e-11
a O 0 2.0879461354317286e-12
403 O 0 1.383673592370016e-10
amino O 0 3.326750333543238e-11
acid O 0 1.3860747272165241e-10
dual O 0 4.833080047284e-10
specificity O 0 4.052867819126504e-09
phosphatase O 0 9.453548955207225e-06
( O 0 2.0164266090194616e-10
protein O 0 2.8023319220693566e-09
tyrosine O 0 6.778311245625446e-09
phosphatase O 0 5.1373984177871534e-08
; O 0 1.3293137424152945e-10
PTPase O 0 9.818730006827536e-08
) O 0 4.626851744619909e-13
, O 0 5.107322984670981e-13
was O 0 2.0634879221992364e-11
shown O 0 3.719256673473392e-12
recently O 0 2.4140084028956288e-11
to O 0 2.69428489935164e-11
play O 0 2.689408973299834e-10
a O 0 1.199958882258656e-11
broad O 0 3.343145760226207e-09
role O 0 1.9152407090827772e-11
in O 0 2.983331290340452e-11
human O 0 1.2511905955747693e-09
malignancy B-Disease 0 3.489476512186229e-05
. O 0 1.9491853464614906e-08

Somatic O 0 0.21225394308567047
PTEN O 0 0.009831767529249191
deletions O 0 1.2763064205500996e-06
and O 0 9.044378024292143e-10
mutations O 0 4.889416649334066e-10
were O 0 4.797595480610095e-12
observed O 0 1.9507668050366966e-11
in O 0 2.85075175271432e-11
sporadic B-Disease 0 0.00040412539965473115
breast I-Disease 1 1.0
, I-Disease 0 3.105075847997796e-06
brain I-Disease 1 1.0
, I-Disease 0 4.622104825102724e-05
prostate I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cell O 0 4.275005096587847e-07
lines O 0 8.528419637165996e-11
and O 0 3.616767529999315e-13
in O 0 7.347002238360101e-13
several O 0 4.9689957010157215e-12
primary O 0 3.6235917377780424e-08
tumours B-Disease 1 1.0
such O 0 2.3563628825939986e-10
as O 0 9.453518856616938e-08
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 1.64441553351935e-05
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.578395426273346
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.01726934127509594

In O 0 2.3780000191209183e-09
addition O 0 2.78221112814947e-09
, O 0 1.562975748825579e-09
PTEN O 1 0.9420658946037292
was O 0 2.8372706850632312e-08
identified O 0 5.98560145892435e-10
as O 0 4.43292234517112e-12
the O 0 8.74212594675905e-12
susceptibility O 0 4.884047610786979e-10
gene O 0 5.7058875853333024e-12
for O 0 1.4137292682001035e-12
two O 0 1.4139249493450023e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.8169549107551575
( O 0 9.932442888993531e-12
CD B-Disease 0 2.104199438690557e-06
; O 0 5.125315727383395e-10
MIM O 0 1.1620082887020544e-06
158350 O 0 8.680495433566193e-09
) O 0 2.2448370744741764e-13
and O 0 2.0596844542419834e-12
Bannayan B-Disease 0 6.336804744933033e-06
- I-Disease 0 3.243330866098404e-05
Zonana I-Disease 0 0.014085369184613228
( I-Disease 0 4.49647645506257e-11
BZS I-Disease 0 8.481981240038294e-06
) I-Disease 0 1.7471616601399953e-12
or I-Disease 0 2.7070803931827925e-11
Ruvalcaba I-Disease 0 6.080481398385018e-07
- I-Disease 0 7.175142400228651e-07
Riley I-Disease 0 3.130270488327369e-05
- I-Disease 1 1.0
Smith I-Disease 1 0.9999982118606567
syndrome I-Disease 1 1.0
( O 0 1.991772746734455e-09
MIM O 0 0.0005211097304709256
153480 O 0 1.3807875802740455e-06
) O 0 2.1234181080131975e-11
. O 0 2.5697208805297578e-09

Constitutive O 0 6.177087016112637e-06
DNA O 0 3.351604505041905e-07
from O 0 1.0129841410133622e-09
37 O 0 8.628498804341689e-09
CD B-Disease 0 5.6630288014503094e-08
families O 0 1.8392501063835276e-11
and O 0 3.763435743597832e-12
seven O 0 1.659312097446186e-11
BZS B-Disease 0 0.0018969931406900287
families O 0 1.2922568570772341e-10
was O 0 3.136676682280459e-11
screened O 0 6.118950346412078e-10
for O 0 1.67955455099289e-10
germline O 0 2.57329193118494e-05
PTEN O 0 0.0009813412325456738
mutations O 0 7.217286110972054e-07
. O 0 7.9638205363608e-08

PTEN O 0 0.0391639806330204
mutations O 0 8.033669018914225e-07
were O 0 4.659931107653392e-09
identified O 0 2.355859396452331e-10
in O 0 6.653487656660406e-12
30 O 0 2.3969332074713634e-10
of O 0 1.596138221593435e-10
37 O 0 6.122653939399925e-09
( O 0 1.3013380520746076e-12
81 O 0 9.052890881378062e-09
% O 0 2.269242736427368e-12
) O 0 8.724421569027401e-15
CD B-Disease 0 6.764182103324856e-09
families O 0 9.599039445251645e-12
, O 0 3.055293648288049e-13
including O 0 2.9148491346303596e-12
missense O 0 1.0275466877374129e-07
and O 0 1.3054917147314882e-09
nonsense O 0 2.5462722419433703e-07
point O 0 3.943533499750629e-09
mutations O 0 3.4158360168179414e-11
, O 0 2.9732410110339114e-12
deletions O 0 5.710792949642496e-10
, O 0 1.3786754723965622e-11
insertions O 0 9.29678167782555e-10
, O 0 2.1018232727182395e-12
a O 0 2.9515270436042407e-12
deletion O 0 1.2373309044022562e-09
/ O 0 7.969347848302277e-09
insertion O 0 1.6069902741833175e-08
and O 0 5.780447231984454e-10
splice O 0 1.009942366181349e-06
site O 0 2.2341600924846716e-07
mutations O 0 6.63164527736626e-08
. O 0 2.580439328880857e-08

These O 0 4.578212653427727e-08
mutations O 0 7.089329123743937e-09
were O 0 9.902981767950791e-10
scattered O 0 2.2695523238525084e-10
over O 0 5.196260956241705e-12
the O 0 3.497026973553474e-11
entire O 0 2.2183656300800436e-10
length O 0 1.2452118502981335e-10
of O 0 1.4784697910386058e-09
PTEN O 0 2.402974587312201e-06
, O 0 2.1006729342132324e-12
with O 0 2.8410730189341697e-15
the O 0 1.2269761487208874e-13
exception O 0 2.3851905693594855e-13
of O 0 8.392215416520854e-14
the O 0 1.194600381072483e-13
first O 0 1.087764969244509e-12
, O 0 3.445868536258029e-13
fourth O 0 1.286676459821834e-10
and O 0 9.877711495964725e-12
last O 0 1.6109021894195052e-09
exons O 0 1.2593723397458234e-08
. O 0 1.1581938963445282e-08

A O 0 2.7796245376521256e-06
hot O 0 0.000127279112348333
spot O 0 1.5361487726295309e-07
for O 0 7.49760920015774e-10
PTEN O 0 2.958125878649298e-05
mutation O 0 1.365946289411113e-08
in O 0 2.9988908578637563e-10
CD B-Disease 0 4.421312667091115e-07
was O 0 2.1751815904025307e-09
identified O 0 5.018557791558464e-10
in O 0 1.8095001885765072e-10
exon O 0 3.7081979709086e-09
5 O 0 2.619972849782215e-10
that O 0 1.6321338269613406e-13
contains O 0 6.271235267196751e-12
the O 0 6.696063842293043e-11
PTPase O 0 1.0247815225739032e-05
core O 0 9.184096256831253e-07
motif O 0 2.9585867089565454e-10
, O 0 2.0957131971650889e-13
with O 0 5.966584783754017e-15
13 O 0 1.0624458778030199e-11
of O 0 1.6906131009020164e-11
30 O 0 2.4598381664908686e-10
( O 0 2.1436404897250821e-13
43 O 0 3.5911332241234106e-10
% O 0 1.3796480234293251e-12
) O 0 3.591283154647136e-14
CD B-Disease 0 1.2649937097819475e-08
mutations O 0 1.107421376822515e-10
identified O 0 4.3567215807227555e-11
in O 0 2.2508286900979613e-11
this O 0 6.184268652731362e-10
exon O 0 1.4586927932214167e-07
. O 0 2.1964533303275857e-08

Seven O 0 3.603363296633688e-08
of O 0 3.2044682463094887e-09
30 O 0 9.60418145012909e-09
( O 0 1.4150565484996602e-12
23 O 0 9.695209080007317e-10
% O 0 1.3915301202982455e-12
) O 0 3.671394006139143e-15
were O 0 4.64866773547401e-12
within O 0 3.2547790851378267e-11
the O 0 2.805989052223623e-10
core O 0 5.253714263631082e-08
motif O 0 4.273204706750633e-11
, O 0 1.7561982684072275e-13
the O 0 5.920782961132964e-12
majority O 0 2.7674091317153593e-12
( O 0 8.28091189911985e-14
five O 0 3.669684348062141e-12
of O 0 3.6438241313163644e-11
seven O 0 4.750536769515534e-12
) O 0 2.500243393398216e-14
of O 0 6.50842834487575e-12
which O 0 5.081798697126327e-12
were O 0 6.4156298051898375e-09
missense O 0 7.740721912341542e-07
mutations O 0 3.938482429077794e-09
, O 0 1.1297884502936562e-11
possibly O 0 4.796868458001313e-10
pointing O 0 8.468707957121069e-10
to O 0 9.067856058045387e-13
the O 0 6.403101573265735e-12
functional O 0 2.9013513813680447e-10
significance O 0 8.77571459945159e-10
of O 0 8.736595474845288e-11
this O 0 3.5288941907518634e-11
region O 0 4.373585493766541e-09
. O 0 5.826786608764678e-09

Germline O 0 0.07568895816802979
PTEN O 0 0.004867842886596918
mutations O 0 3.7678464082091523e-07
were O 0 8.868496492731026e-10
identified O 0 3.1438639885861264e-11
in O 0 1.23633113295607e-12
four O 0 2.2466359014036014e-13
of O 0 5.4915915564945905e-12
seven O 0 9.956246764530885e-12
( O 0 2.5754170931285847e-13
57 O 0 8.82452444450621e-10
% O 0 3.5506322274697633e-12
) O 0 1.948883085077166e-13
BZS B-Disease 0 1.654047446209006e-05
families O 0 1.228856322255112e-10
studied O 0 1.7317567380104038e-09
. O 0 4.424760557952823e-09

Interestingly O 0 1.7154227407445433e-06
, O 0 4.868738745500423e-10
none O 0 2.1501638247656274e-09
of O 0 1.6543892644715896e-10
these O 0 7.427193582376646e-11
mutations O 0 5.406269182328671e-11
was O 0 3.463465278463751e-11
observed O 0 7.018110398382404e-11
in O 0 6.2670740992587515e-12
the O 0 3.2383956627413113e-10
PTPase O 0 2.0490388124017045e-05
core O 0 1.1670208550640382e-05
motif O 0 4.198151870582478e-08
. O 0 2.2646715613916513e-09

It O 0 4.92994589595952e-10
is O 0 5.386524993405972e-12
also O 0 5.296966749772369e-13
worthy O 0 3.9159633868912636e-10
of O 0 7.0166754351230765e-12
note O 0 1.0131724452466795e-11
that O 0 1.8395478266060262e-15
a O 0 3.91135725425016e-14
single O 0 4.420949283739928e-12
nonsense O 0 1.5429555411117235e-09
point O 0 1.9409732154862525e-10
mutation O 0 6.756872839019934e-12
, O 0 5.766024051452601e-13
R233X O 0 8.911060334071408e-09
, O 0 4.7870925973247935e-12
was O 0 1.4816534110728696e-10
observed O 0 3.8124597923072656e-10
in O 0 6.157077625523755e-11
the O 0 6.369124672112036e-10
germline O 0 2.182659386562591e-08
DNA O 0 2.2729671478316504e-09
from O 0 3.9688231867618384e-11
two O 0 6.283540311333158e-13
unrelated O 0 6.700577315221778e-10
CD B-Disease 0 1.911288478595452e-07
families O 0 8.470835838325641e-11
and O 0 1.4748714402545993e-11
one O 0 5.6064684145207266e-11
BZS B-Disease 1 0.9539860486984253
family O 0 9.508653420198243e-09
. O 0 1.8177901850435774e-08

Genotype O 0 5.8149020333075896e-05
- O 0 1.8362929949944373e-06
phenotype O 0 1.0042318621117374e-07
studies O 0 3.951849611438796e-11
were O 0 4.726665022922183e-13
not O 0 5.897998154322584e-14
performed O 0 6.300934166786343e-12
on O 0 3.700970953313121e-12
this O 0 5.576483285557599e-13
small O 0 5.128302730389445e-12
group O 0 9.975339646103518e-14
of O 0 1.0537416425537849e-11
BZS B-Disease 1 0.9997718930244446
families O 0 1.8773256726944965e-08
. O 0 1.913224600968988e-08

However O 0 1.4925444702384993e-07
, O 0 9.102179010511691e-10
genotype O 0 9.782110765854668e-08
- O 0 2.724499381656642e-08
phenotype O 0 9.595652983307446e-08
analysis O 0 1.1778414354957079e-10
inthe O 0 5.264768674351217e-07
group O 0 7.443641189541772e-12
of O 0 8.40359726250739e-12
CD B-Disease 0 1.4493936760118231e-05
families O 0 1.5813958476051937e-10
revealed O 0 1.2201401000666579e-10
two O 0 3.1238890190994975e-14
possible O 0 2.059130643772278e-12
associations O 0 1.1480610299235972e-12
worthy O 0 2.4692303757234413e-10
of O 0 3.3101212743025243e-12
follow O 0 6.31590179461794e-12
- O 0 1.0658700484722505e-11
up O 0 1.744544287675398e-12
in O 0 1.9487120521844564e-13
independent O 0 5.983685769095359e-13
analyses O 0 1.2619961499427124e-11
. O 0 1.3406292742601522e-10

The O 0 5.422808868615903e-09
first O 0 2.7238108990523813e-10
was O 0 2.9890812047739246e-09
an O 0 6.019699170557724e-13
association O 0 1.11618735088026e-11
noted O 0 2.4296863132544644e-11
in O 0 2.444723460129361e-12
the O 0 1.1629024999904036e-11
group O 0 4.944437939050257e-14
of O 0 2.3328146597605126e-13
CD B-Disease 0 2.513743538656854e-06
families O 0 6.13426670570405e-11
with O 0 1.954934825132426e-11
breast B-Disease 0 0.00011634769180091098
disease I-Disease 0 5.585299618360295e-07
. O 0 3.374822767909791e-07

A O 0 1.7214038194879322e-08
correlation O 0 1.2728047782406549e-10
was O 0 3.4239049095941e-11
observed O 0 9.426636554676904e-12
between O 0 1.0297082197324725e-12
the O 0 1.1933945151532122e-11
presence O 0 2.7472377150949967e-10
/ O 0 1.0890900625781796e-07
absence O 0 2.6230063099319523e-07
of O 0 1.3712080360051004e-09
a O 0 9.582983018230351e-11
PTEN O 0 1.7193386838698643e-06
mutation O 0 1.8956961000959893e-10
and O 0 1.613817450984642e-13
the O 0 1.0570216983597433e-13
type O 0 5.0613041535640946e-11
of O 0 2.8426574982809427e-10
breast O 0 2.82308548094079e-07
involvement O 0 3.910099355408647e-09
( O 0 5.245055431646328e-11
unaffected O 0 1.3031053640588652e-05
versus O 0 4.148174048168585e-05
benign O 0 0.00640618521720171
versus O 0 3.226012995583005e-05
malignant O 0 5.774623787146993e-05
) O 0 8.677821655700413e-11
. O 0 2.6932807095647604e-09

Specifically O 0 1.4705030970674215e-08
and O 0 8.724673067339594e-11
more O 0 1.0656051778815123e-12
directly O 0 2.641264377351016e-12
, O 0 3.4847786548747317e-13
an O 0 2.0857269836488217e-14
association O 0 1.9312481301658746e-12
was O 0 1.7598088264403344e-10
also O 0 6.375216110229842e-13
observed O 0 3.846346418451274e-12
between O 0 3.5404394260057925e-13
the O 0 2.2325990069269747e-13
presence O 0 6.180768787403257e-13
of O 0 2.6513910858505518e-11
a O 0 1.2202571175734533e-09
PTEN O 1 0.9999973773956299
mutation O 0 0.02828928269445896
and O 0 1.734892407512234e-07
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999994039535522
disease I-Disease 0 0.00019425425853114575
. O 0 4.04119134600478e-07

Secondly O 0 7.75627268012613e-05
, O 0 1.7036404509340741e-09
there O 0 4.934044839366436e-11
appeared O 0 7.102806121039862e-10
to O 0 7.725570400421433e-13
be O 0 5.46336240137002e-12
an O 0 1.748141670483705e-12
interdependent O 0 1.994073528521767e-08
association O 0 3.42870487557434e-09
between O 0 5.530323310409813e-09
mutations O 0 5.920667511816191e-09
upstream O 0 5.803716174312967e-09
and O 0 7.725441814043776e-12
within O 0 5.890136989261663e-11
the O 0 2.767105711232176e-10
PTPase O 0 5.469933239510283e-05
core O 0 1.6071571735665202e-05
motif O 0 5.398443470028269e-09
, O 0 1.8189624069117616e-12
the O 0 7.743203647714303e-12
core O 0 2.0438188919058575e-09
motif O 0 3.322001007610709e-11
containing O 0 7.086367625509793e-13
the O 0 5.191228523437896e-12
majority O 0 1.5429128460975328e-11
of O 0 2.4241895157928184e-09
missense O 0 1.9283116614587925e-07
mutations O 0 3.0460117761421657e-10
, O 0 2.1398098137143107e-12
and O 0 3.522354120617105e-13
the O 0 3.48962747804063e-13
involvement O 0 2.099926542332639e-13
of O 0 5.297795080232148e-13
all O 0 3.1333351305272775e-14
major O 0 3.089977709466729e-12
organ O 0 4.3730770116212625e-09
systems O 0 9.308691005571745e-06
( O 0 8.535026851941296e-11
central O 0 1.4199754332366865e-06
nervous O 0 5.149228400114225e-06
system O 0 8.555020940548275e-06
, O 0 2.760158213099828e-10
thyroid O 1 0.9968037605285645
, O 0 9.14405177354638e-07
breast O 1 1.0
, O 0 1.2307573342695832e-06
skin O 1 1.0
and O 1 0.9999991655349731
gastrointestinal O 1 1.0
tract O 1 0.9998512268066406
) O 0 3.0620422863947283e-10
. O 0 8.268563078672742e-08

However O 0 1.5354662536992691e-06
, O 0 7.592082518215193e-10
these O 0 2.7878815575532734e-11
observations O 0 8.967009079707822e-11
would O 0 1.0755171926668528e-11
need O 0 2.1343204981150166e-11
to O 0 4.485184793012742e-12
be O 0 4.782940536685043e-12
confirmed O 0 7.486301856207689e-11
by O 0 1.5436126769158287e-12
studying O 0 1.3304089600818525e-11
a O 0 1.0378742983584936e-14
larger O 0 6.30187959108075e-13
number O 0 7.088557171797127e-13
of O 0 3.391858191884034e-12
CD B-Disease 0 1.7086941852539894e-06
families O 0 1.4012588867018394e-09
. O 0 2.1201744804244527e-09

Molecular O 0 0.0014959139516577125
defects O 1 0.999446451663971
leading O 0 1.1378592290611778e-07
to O 0 2.3360717874010284e-11
human O 0 8.513666993614777e-10
complement B-Disease 0 3.23707026836928e-05
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.0738937517018599e-11
an O 0 4.694243888189124e-15
African O 0 7.48129450100013e-14
- O 0 2.6459941009082666e-12
American O 0 1.0732870755342239e-12
family O 0 5.973403195691507e-12
. O 0 8.978885690513749e-11

Complement B-Disease 0 8.767297913436778e-06
component I-Disease 1 0.9999923706054688
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 7.176733513025724e-11
C6D B-Disease 0 5.1016795623581856e-05
) O 0 1.9378270689485166e-12
was O 0 6.256903883894438e-10
diagnosed O 0 6.132942189651658e-07
in O 0 1.4574060014371781e-10
a O 0 7.433766276154774e-12
16 O 0 5.18534312710095e-11
- O 0 2.2313572430737727e-12
year O 0 1.6704517977195188e-11
- O 0 2.6413968234884067e-11
old O 0 1.3114433150551719e-10
African O 0 4.000907949126137e-13
- O 0 2.5674620307385154e-13
American O 0 2.052725055364489e-14
male O 0 4.792816330986306e-14
with O 0 1.4043939249649019e-14
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.8626560677480484e-08

The O 0 1.5490366322978844e-08
patients O 0 6.438900186367391e-07
father O 0 8.43486276380645e-08
and O 0 1.428796103652985e-08
two O 0 1.5612208192905541e-09
brothers O 0 3.755698685381503e-08
also O 0 7.080888653199224e-11
had O 0 9.639889997359319e-10
C6D B-Disease 1 0.9998179078102112
, O 0 7.271167175304516e-12
but O 0 2.4180533877288246e-12
gave O 0 1.0574658553322291e-12
no O 0 7.575967034701564e-14
history O 0 8.141003062650531e-13
of O 0 4.569374826429717e-12
meningitis B-Disease 1 0.9999278783798218
or O 0 3.845541593494595e-11
other O 0 8.507717100258994e-12
neisserial B-Disease 0 1.559451590082972e-07
infection I-Disease 0 1.0129123211299884e-06
. O 0 3.647341273449456e-08

By O 0 6.680530018066122e-10
using O 0 1.547174749427782e-10
exon O 0 1.1093711504983617e-09
- O 0 5.389507937159088e-11
specific O 0 3.6590275948045203e-11
polymerase O 0 7.484774605659439e-11
chain O 0 7.39247812270305e-12
reaction O 0 3.494999775699448e-11
( O 0 9.901243236756785e-14
PCR O 0 1.5782980478107334e-10
) O 0 8.493975244298554e-14
/ O 0 4.0852876637131885e-12
single O 0 5.364120063931777e-13
- O 0 8.22814559542362e-12
strand O 0 4.442802722937067e-11
conformation O 0 7.914168452527459e-12
polymorphism O 0 6.545776507632661e-12
as O 0 2.160674661107545e-14
a O 0 2.0481131727249262e-15
screening O 0 2.3441493971626537e-12
step O 0 3.29263005749425e-11
and O 0 9.206122192698118e-13
nucleotide O 0 2.267353318985421e-11
sequencing O 0 1.252777881433076e-10
of O 0 5.480670084434536e-11
target O 0 2.813556054803712e-10
exons O 0 3.3197861126765815e-10
, O 0 7.855841628254256e-13
we O 0 1.0765300190998181e-13
determined O 0 4.12636981875214e-12
that O 0 2.0419668899014122e-14
the O 0 4.137261280096061e-12
proband O 0 1.5072684433903305e-08
was O 0 8.814292351555508e-11
a O 0 1.3688593444513564e-12
compound O 0 1.5607861669764134e-09
heterozygote O 0 5.798164437464948e-08
for O 0 2.547009547715362e-10
two O 0 9.824828728355328e-10
C6 O 0 0.00019477284513413906
gene O 0 2.1628997259881544e-08
mutations O 0 9.632326936070967e-08
. O 0 5.23315186740092e-08

The O 0 1.0234368019723661e-08
first O 0 6.759213189155844e-10
, O 0 1.6169402622390194e-11
1195delC O 0 1.0741699085770051e-08
located O 0 1.699799884180564e-10
in O 0 8.31176585891491e-11
exon O 0 6.42095487890515e-09
7 O 0 1.7553722031493635e-08
, O 0 2.8165709781841075e-12
is O 0 1.3973007863612996e-13
a O 0 1.1988847414823312e-13
novel O 0 2.126457690487804e-11
mutation O 0 8.767473726190023e-12
, O 0 2.392918762444962e-13
while O 0 9.805457227424208e-13
the O 0 2.3376305231803673e-12
second O 0 4.383210461256226e-11
, O 0 1.6623839891455328e-12
1936delG O 0 1.6686064752136076e-09
in O 0 1.1601715421694081e-10
exon O 0 4.70002592400931e-10
12 O 0 1.7353400660891083e-10
, O 0 2.541988754906077e-12
has O 0 3.7182334034630005e-13
been O 0 2.2036875362702046e-12
described O 0 3.536189136649215e-12
before O 0 9.531831574038918e-11
to O 0 3.027359959939524e-11
cause O 0 8.359857162076878e-08
C6D B-Disease 1 0.9998302459716797
in O 0 2.3296922724291846e-10
an O 0 2.6446355413760336e-13
unrelated O 0 3.0620889157617626e-10
African O 0 1.3541560451094115e-12
- O 0 3.249684592601665e-12
American O 0 5.182776950662937e-13
individual O 0 4.673721045594936e-12
. O 0 1.8670823220823252e-10

Both O 0 4.4123066089696295e-08
mutations O 0 6.873415170360886e-09
result O 0 4.5616899146949663e-10
in O 0 6.056423140776701e-10
premature O 0 1.7527077034174e-06
termination O 0 6.295663752098335e-06
codons O 0 3.4890879874183156e-07
and O 0 6.834353971640894e-09
C6 O 0 8.449580491287634e-05
null O 0 3.252142505516531e-06
alleles O 0 1.607827293526043e-08
. O 0 2.1777980308002043e-08

Allele O 0 2.9889747565903235e-08
- O 0 2.0106822873344754e-09
specific O 0 8.892883651689942e-11
PCR O 0 3.3696943013694636e-09
indicated O 0 2.2246961217664563e-10
that O 0 2.4830823364802544e-14
the O 0 4.274547295984865e-12
probands O 0 3.7942445487715304e-06
two O 0 3.1543648248977263e-10
brothers O 0 2.589638281591533e-09
also O 0 3.799519726621625e-12
inherited O 0 7.657613987355205e-10
the O 0 3.81339820831883e-10
1195delC O 0 1.42566562999491e-08
mutation O 0 5.6977554618864446e-11
from O 0 3.6463184902024715e-12
their O 0 4.6350177168585915e-11
heterozygous O 0 1.9527473388292194e-11
mother O 0 1.4136975444445365e-11
and O 0 1.3237303505934939e-13
the O 0 1.6626566659919129e-12
1936delG O 0 2.4203918869147856e-09
mutation O 0 3.648017651847191e-11
from O 0 5.234868528242176e-12
their O 0 6.432605836881322e-11
homozygous O 0 5.300633820759515e-10
father O 0 6.275250319376369e-10
. O 0 8.898075332108846e-11
. O 0 1.387080339476654e-09

PAX6 O 0 0.09385576844215393
mutations O 0 2.5524903321638703e-05
reviewed O 0 5.304272235662211e-06
. O 0 7.427345281030284e-07

Mutations O 0 2.015087920881342e-05
in O 0 3.344920784797978e-08
PAX6 O 0 0.15313227474689484
are O 0 2.807166443741238e-10
responsible O 0 7.380872996121113e-11
for O 0 3.904356699058198e-11
human O 0 6.380362460589595e-09
aniridia B-Disease 1 1.0
and O 0 1.8254124370287172e-05
have O 0 4.926054564258209e-10
also O 0 2.3040506134941463e-12
been O 0 2.0245434560577091e-13
found O 0 2.2577348112806997e-14
in O 0 4.064043074509041e-14
patients O 0 3.871356360485301e-12
with O 0 5.660441665627895e-14
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.233454393651968e-10
with O 0 1.2226286649763551e-09
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 5.7836729183691205e-08
with O 0 1.6537465841182097e-09
autosomal B-Disease 1 0.9999001026153564
dominant I-Disease 0 0.03644520044326782
keratitis I-Disease 1 0.9999117851257324
, O 0 2.5422919325279736e-10
and O 0 2.0070708983688235e-11
with O 0 3.774616036400502e-11
isolated B-Disease 1 0.8911208510398865
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9984190464019775

No O 0 1.4378972679196522e-08
locus O 0 3.917128843511364e-10
other O 0 3.670083334461616e-12
than O 0 6.5586984628052125e-12
chromosome O 0 6.25070162296737e-10
11p13 O 0 1.0338040112856106e-07
has O 0 1.595708287727149e-11
been O 0 2.7816512981893027e-11
implicated O 0 3.086575994792895e-10
in O 0 5.372073896836582e-10
aniridia B-Disease 1 1.0
, O 0 1.7149730524579354e-09
and O 0 2.5466889708170015e-10
PAX6 O 0 2.7284751922707073e-05
is O 0 1.2290103830470134e-11
clearly O 0 2.30503637010937e-11
the O 0 3.139476092289817e-12
major O 0 1.0916757081647077e-10
, O 0 6.440775647195696e-13
if O 0 1.4685940180961254e-12
not O 0 1.8507211822088587e-12
only O 0 6.278152910738077e-12
, O 0 1.970221511979342e-12
gene O 0 7.291290834987585e-12
responsible O 0 3.5081321181351655e-10
. O 0 5.7679304887869876e-08

Twenty O 0 3.606454583859886e-07
- O 0 5.450124263006728e-08
eight O 0 6.401423280344432e-10
percent O 0 2.1949059236803237e-10
of O 0 1.9670647055658463e-11
identified O 0 2.150516875687458e-09
PAX6 O 0 0.0011388957500457764
mutations O 0 3.37521477433711e-08
are O 0 2.562392797944568e-10
C O 0 2.4496674200236157e-07
- O 0 8.422126995810686e-09
T O 0 6.766519788925507e-08
changes O 0 5.211561182605351e-10
at O 0 4.1952258333921577e-10
CpG O 0 6.344554037696071e-08
dinucleotides O 0 1.1254353182721388e-07
, O 0 1.6728941149013465e-11
20 O 0 7.020614645192325e-11
% O 0 3.002435973453732e-12
are O 0 2.880612347505411e-14
splicing O 0 8.943625007251654e-11
errors O 0 7.328374795889658e-09
, O 0 2.0285152030341536e-11
and O 0 1.9870239134633927e-11
more O 0 7.447101746035911e-13
than O 0 6.298995613301939e-13
30 O 0 2.4260373224227472e-11
% O 0 9.01030606462877e-13
are O 0 4.865402565291379e-15
deletion O 0 3.2977681457997676e-13
or O 0 4.744223677105586e-13
insertion O 0 1.1245046560581784e-10
events O 0 1.6689048754070512e-10
. O 0 1.253615788954221e-08

There O 0 5.7098374917075034e-09
is O 0 2.50130124945791e-11
a O 0 1.925401157953921e-11
noticeably O 0 1.4287642216004315e-06
elevated O 0 2.2146277842693962e-06
level O 0 1.0322706245347035e-08
of O 0 4.168457801156933e-10
mutation O 0 2.8021794953869694e-11
in O 0 8.219769483119865e-12
the O 0 2.340745999807048e-11
paired O 0 7.481930006103532e-12
domain O 0 2.1601331834375515e-12
compared O 0 1.3720908957626232e-11
with O 0 4.293784498419183e-15
the O 0 1.0469057261722203e-12
rest O 0 3.842813914300969e-11
of O 0 5.2977977907375795e-12
the O 0 9.649231413888515e-11
gene O 0 7.72933661519204e-11
. O 0 5.556131554840249e-09

Increased O 0 4.949000640408485e-07
mutation O 0 2.085570116605595e-08
in O 0 1.9069261794624204e-11
the O 0 8.339604007367996e-11
homeodomain O 0 9.241664855608178e-08
is O 0 1.5383396596499455e-12
accounted O 0 3.978190693532113e-11
for O 0 2.847910777104175e-14
by O 0 6.051010387198019e-13
the O 0 6.796285062504737e-11
hypermutable O 0 7.110659794307139e-07
CpG O 0 2.9188728944973263e-07
dinucleotide O 0 6.943531616343535e-08
in O 0 7.914025546007508e-10
codon O 0 1.8575502025441892e-08
240 O 0 4.38946434755394e-09
. O 0 2.919159802772242e-09

Very O 0 4.829324780075694e-07
nearly O 0 2.1311130637968745e-09
all O 0 3.60489943451725e-10
mutations O 0 4.375394213607109e-10
appear O 0 1.4753626098595873e-09
to O 0 2.702571326451686e-11
cause O 0 2.170826718383978e-08
loss O 0 4.927334984472509e-09
of O 0 2.8727518142090958e-09
function O 0 5.568007860334845e-11
of O 0 1.193613680117167e-10
the O 0 3.095276465692187e-11
mutant O 0 1.8242139743218644e-10
allele O 0 8.468085607726827e-12
, O 0 1.0120898531144201e-13
and O 0 1.3618552527274331e-14
more O 0 2.820501765018915e-15
than O 0 1.742620364144059e-14
80 O 0 1.8677891264889945e-12
% O 0 1.2622550032113933e-13
of O 0 2.8684259828493097e-13
exonic O 0 4.909941786479521e-09
substitutions O 0 6.062028656828033e-10
result O 0 8.147477692510563e-10
in O 0 6.386178807993304e-10
nonsense O 0 1.5560614485821134e-07
codons O 0 5.369231104168648e-08
. O 0 1.3327221992653904e-08

In O 0 1.880099098627852e-08
a O 0 2.3589977193871903e-10
gene O 0 7.897539566759093e-11
with O 0 1.0577765876748635e-12
such O 0 4.297368016992209e-10
extraordinarily O 0 1.1738421079598993e-07
high O 0 2.292561340766497e-08
sequence O 0 1.9125841188571968e-10
conservation O 0 4.574515211075436e-10
throughout O 0 1.5101350725466034e-11
evolution O 0 6.741287389422368e-11
, O 0 1.1832850237841752e-12
there O 0 7.388193355717387e-12
are O 0 3.04931219163862e-11
presumed O 0 3.711321312493965e-07
undiscovered O 0 2.4879429474822246e-05
missense O 0 1.9930582766392035e-06
mutations O 0 7.216066411075417e-09
, O 0 3.837298534481448e-11
these O 0 4.872860795424039e-11
are O 0 3.763650849308853e-12
hypothesized O 0 1.1014555933996917e-10
to O 0 1.2704733966251158e-11
exist O 0 1.5659559760017316e-10
in O 0 2.0956396340476857e-11
as O 0 2.031904644539395e-10
- O 0 2.75023781526329e-09
yet O 0 5.325674345968423e-10
unidentified O 0 1.6651718892646272e-10
phenotypes O 0 6.846772038215931e-10
. O 0 2.4941266066336176e-11
. O 0 2.897646012023358e-10

Genetic O 0 8.286488082376309e-07
heterogeneity O 0 2.48201558861183e-07
and O 0 2.829896039724389e-10
penetrance O 0 1.8883366692534764e-07
analysis O 0 1.0998266186668104e-10
of O 0 6.460323387358358e-10
the O 0 1.0557513974163157e-07
BRCA1 O 0 2.7413707357482053e-06
and O 0 1.0348772150337027e-07
BRCA2 O 0 4.7587539597770956e-07
genes O 0 1.8359572750981101e-09
in O 0 3.6650646406677367e-10
breast B-Disease 0 0.00012253732711542398
cancer I-Disease 0 2.3239390429807827e-05
families O 0 6.7586749530335055e-09
. O 0 6.044473366273451e-08

The O 0 4.8844831326277927e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 2.938369107141625e-05
Consortium O 0 6.895320581179476e-08
. O 0 1.961046436349534e-09

The O 0 6.127370832942347e-10
contribution O 0 3.4827856154606707e-09
of O 0 3.114421076588769e-08
BRCA1 O 0 1.1564299029487302e-06
and O 0 1.72392802255672e-07
BRCA2 O 0 0.00011826862464658916
to O 0 1.40436177389347e-05
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 2.220302945943331e-07
assessed O 0 8.283761232519282e-09
by O 0 2.6511483980362627e-11
linkage O 0 1.1771233987545315e-09
and O 0 3.487034445914805e-12
mutation O 0 5.341811520030715e-13
analysis O 0 2.8401046908688686e-14
in O 0 1.58703701357921e-14
237 O 0 7.935178555906752e-12
families O 0 3.3233729353557284e-13
, O 0 8.846983001330362e-15
each O 0 1.9664752902356095e-15
with O 0 3.493713175343029e-15
at O 0 2.2543551227161007e-12
least O 0 5.334216141711368e-13
four O 0 2.4313005019091678e-14
cases O 0 5.4237521592004345e-12
of O 0 6.848326350450407e-10
breast B-Disease 0 1.8609867993291118e-06
cancer I-Disease 0 6.294745169554972e-09
, O 0 9.091507521862344e-14
collected O 0 9.442450077043474e-13
by O 0 2.698201091808766e-13
the O 0 6.8707151079649975e-09
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.5975896161535275e-08
Consortium O 0 1.3225764927682349e-10
. O 0 4.06215061588e-11

Families O 0 2.080778394031313e-08
were O 0 7.29541219102181e-11
included O 0 3.4942717122565803e-12
without O 0 6.256850072772213e-12
regard O 0 3.824185412781844e-10
to O 0 9.489012223543036e-13
the O 0 1.7568123605177233e-12
occurrence O 0 2.202056537115027e-09
of O 0 9.596055150495886e-08
ovarian B-Disease 1 0.9985021352767944
or I-Disease 0 5.82560574002855e-07
other I-Disease 0 1.0115929427456649e-07
cancers I-Disease 0 7.814134733052924e-05
. O 0 1.3686877764484962e-07

Overall O 0 0.00039352194289676845
, O 0 1.3559938061291632e-08
disease O 0 0.011556214652955532
was O 0 1.3158567071513971e-06
linked O 0 5.5690206863800995e-06
to O 0 3.8953249514861454e-08
BRCA1 O 0 2.2805467381203925e-07
in O 0 4.770460415581823e-11
an O 0 1.6494455540999597e-14
estimated O 0 2.5193977221289743e-13
52 O 0 6.506740025252755e-12
% O 0 1.8109060258286735e-13
of O 0 3.7491759913646505e-13
families O 0 2.071184153004668e-12
, O 0 2.7136702173552463e-12
to O 0 2.071675886394786e-10
BRCA2 O 0 1.5268255992850754e-08
in O 0 6.295255289279211e-11
32 O 0 5.879541298270397e-11
% O 0 1.597034136879838e-13
of O 0 1.4811169326590934e-13
families O 0 2.0978610016687826e-13
, O 0 1.000699360615559e-13
and O 0 5.089905818871088e-13
to O 0 5.679611295161813e-12
neither O 0 3.400755788085519e-10
gene O 0 1.8689045536840476e-12
in O 0 9.750202381586526e-12
16 O 0 1.2535714133399267e-10
% O 0 7.990061520399272e-13
( O 0 1.2289984314121276e-15
95 O 0 6.168644761661568e-11
% O 0 5.184045033523876e-12
confidence O 0 1.6829312943222874e-10
interval O 0 3.708988394190982e-10
[ O 0 1.7478575253804252e-09
CI O 0 3.3987378174060723e-06
] O 0 3.5576588897079375e-10
6 O 0 1.5133422293089893e-10
% O 0 7.669617436804888e-13
- O 0 5.5091638716253666e-12
28 O 0 1.576667268965437e-10
% O 0 9.715074881719299e-13
) O 0 6.363717028107143e-15
, O 0 9.728736506718974e-14
suggesting O 0 1.146692185649556e-10
other O 0 8.075166091359165e-10
predisposition O 0 3.6945213651051745e-05
genes O 0 3.4688071082200622e-06
. O 0 9.076578635358601e-07

The O 0 1.6655420154165768e-08
majority O 0 4.993941371544963e-10
( O 0 2.8191507288333195e-12
81 O 0 7.305361648946018e-09
% O 0 3.1976741133449282e-12
) O 0 1.7182495321856582e-14
of O 0 1.551358347340326e-11
the O 0 5.016032105231716e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3723017167066587e-09
were O 0 7.51800791759516e-12
due O 0 4.823851873503315e-10
to O 0 8.104880655501745e-11
BRCA1 O 0 2.1268158068021847e-10
, O 0 2.462172176212474e-13
with O 0 3.2768356831544857e-15
most O 0 1.9804203849754787e-12
others O 0 8.139822908585781e-13
( O 0 7.397037084418134e-15
14 O 0 6.677707432151125e-12
% O 0 1.5808806087119764e-13
) O 0 2.968176453658545e-15
due O 0 1.0020269058941267e-09
to O 0 2.3106037971842852e-08
BRCA2 O 0 8.259290552814491e-06
. O 0 3.30417719851539e-07

Conversely O 0 9.080924883164698e-07
, O 0 3.3242259639409966e-11
the O 0 4.713522974708617e-12
majority O 0 1.1322773231167704e-12
of O 0 2.8972026167028986e-11
families O 0 1.472313763961619e-11
with O 0 8.564845339030513e-13
male B-Disease 0 1.3056156156210363e-10
and I-Disease 0 1.4421467492420348e-11
female I-Disease 0 4.39810861341261e-11
breast I-Disease 0 3.7010050579766585e-09
cancer I-Disease 0 5.66578894911629e-10
were O 0 4.6690633997981124e-11
due O 0 1.635366970731411e-07
to O 0 3.818467675387183e-08
BRCA2 O 0 1.0271880768186747e-07
( O 0 1.3039270184422858e-12
76 O 0 4.739656223051725e-09
% O 0 7.659446861485453e-12
) O 0 1.1818025941537358e-13
. O 0 1.519931958071652e-10

The O 0 2.3338529331340396e-08
largest O 0 2.9447051463904472e-09
proportion O 0 1.0123428761943387e-09
( O 0 5.394644691895933e-13
67 O 0 2.77267431236794e-10
% O 0 7.649282140857749e-13
) O 0 2.4294404175569974e-15
of O 0 6.963107174184913e-12
families O 0 2.5406425227525453e-11
due O 0 1.313632310484536e-06
to O 0 6.6875318616155255e-09
other O 0 1.306795471833766e-08
genes O 0 2.1921446602402028e-10
was O 0 1.1109586861568488e-10
found O 0 1.8343339000526093e-12
in O 0 3.164908005809375e-12
families O 0 1.5920115919998423e-11
with O 0 2.2464045597650473e-13
four O 0 2.5630585436149655e-13
or O 0 5.406965023282972e-13
five O 0 5.951142356686034e-14
cases O 0 1.0743255243750305e-12
of O 0 4.628374419834991e-11
female O 0 3.2428539853412985e-09
breast B-Disease 0 3.590236872241803e-07
cancer I-Disease 0 8.987256272519062e-09
only O 0 5.4677852523443704e-11
. O 0 7.087949782658143e-09

These O 0 4.702485068008855e-09
estimates O 0 1.957074502456635e-09
were O 0 2.216106291530462e-11
not O 0 1.084663500509897e-12
substantially O 0 1.3965467671184228e-09
affected O 0 2.1345210321488395e-10
either O 0 8.463241392420162e-12
by O 0 8.09334858246219e-13
changing O 0 6.431958854413722e-10
the O 0 2.9677468815769714e-11
assumed O 0 2.7456975582040855e-10
penetrance O 0 6.450476597308352e-09
model O 0 5.162576269257535e-11
for O 0 3.173148202528786e-11
BRCA1 O 0 7.68740904266707e-10
or O 0 1.273279441951769e-12
by O 0 1.352446529333945e-13
including O 0 7.556416430076762e-13
or O 0 3.263757319960092e-10
excluding O 0 4.3349700717953965e-07
BRCA1 O 0 3.673816806326613e-08
mutation O 0 2.5584185880944688e-09
data O 0 5.770048328024302e-10
. O 0 1.2884600053553186e-09

Among O 0 7.1173200666407865e-09
those O 0 8.826068348399829e-11
families O 0 1.5098759048592925e-11
with O 0 3.1222520771069517e-13
disease O 0 5.052871543398396e-08
due O 0 0.09885971993207932
to O 0 5.0297174425395497e-08
BRCA1 O 0 1.3159096923232028e-08
that O 0 3.1629950394962414e-12
were O 0 6.3510672415612035e-12
tested O 0 9.747854650202226e-13
by O 0 1.089373613560353e-13
one O 0 1.1562507949789552e-13
of O 0 9.304053160503686e-14
the O 0 7.01106246626601e-14
standard O 0 9.587068552224798e-13
screening O 0 9.371314488304527e-12
methods O 0 1.2464712595416927e-10
, O 0 2.0195347130713692e-12
mutations O 0 1.7269524352214738e-11
were O 0 2.7940460708975046e-11
detected O 0 1.4914901536045022e-09
in O 0 3.0290003144584077e-11
the O 0 1.7019216591585007e-10
coding O 0 8.308758681074835e-10
sequence O 0 3.128669892604741e-11
or O 0 1.3446184270182737e-11
splice O 0 2.238009777499883e-09
sites O 0 4.0862091488236274e-11
in O 0 3.485596143312786e-13
an O 0 6.694122557974417e-15
estimated O 0 1.3376141557233656e-12
63 O 0 1.0773080344472774e-10
% O 0 1.7941363455661885e-12
( O 0 3.232335663776002e-14
95 O 0 5.967146776697518e-10
% O 0 4.767995720467155e-11
CI O 0 2.0537501654871448e-07
51 O 0 2.49959997145055e-10
% O 0 3.299053088004489e-12
- O 0 9.658842475834817e-11
77 O 0 2.7807137148450067e-10
% O 0 4.927844157037731e-12
) O 0 1.2841539897417986e-13
. O 0 2.2380898523355341e-10

The O 0 2.054974856946501e-09
estimated O 0 1.2786025710420645e-11
sensitivity O 0 2.8570565357988187e-10
was O 0 1.1929125742771163e-10
identical O 0 1.92600345394478e-11
for O 0 8.211894976951212e-14
direct O 0 1.6738762069132274e-12
sequencing O 0 4.111133655726462e-10
and O 0 3.4814655498760505e-12
other O 0 1.1601017455703522e-12
techniques O 0 7.816156610829239e-10
. O 0 1.6310292005883298e-09

The O 0 1.2020205986118526e-07
penetrance O 0 0.0007437584572471678
of O 0 4.77214734928566e-06
BRCA2 O 0 5.359774149837904e-06
was O 0 4.962947830478015e-10
estimated O 0 2.5346395989001014e-12
by O 0 4.626869091854668e-13
maximizing O 0 1.1807774757954803e-09
the O 0 7.509302069053092e-10
LOD O 0 0.0005305922240950167
score O 0 1.1392160104151117e-08
in O 0 5.39727762483011e-10
BRCA2 O 0 9.915479104449787e-09
- O 0 1.5580853274244078e-09
mutation O 0 2.0812367107492236e-10
families O 0 2.2652598113265254e-12
, O 0 2.4015774381636566e-14
over O 0 3.5999106934346894e-14
all O 0 1.958863166074895e-13
possible O 0 1.268038590795939e-10
penetrance O 0 4.818381285076612e-07
functions O 0 6.913039030109758e-10
. O 0 1.322950526905231e-09

The O 0 1.6681546144425852e-09
estimated O 0 5.232355521078702e-11
cumulative O 0 1.6706126482191053e-09
risk O 0 7.801143619978745e-10
of O 0 6.64696242491658e-10
breast B-Disease 0 7.100522338987503e-07
cancer I-Disease 0 1.863907215238214e-07
reached O 0 1.790202119877904e-08
28 O 0 3.341617471619429e-08
% O 0 2.2983327047088054e-11
( O 0 1.430264259349827e-14
95 O 0 4.0533143508270086e-10
% O 0 7.882351889254569e-12
CI O 0 4.388662944165844e-08
9 O 0 7.312045413598867e-11
% O 0 9.58470932829747e-13
- O 0 9.173000033169121e-12
44 O 0 2.231545503939003e-11
% O 0 1.0683072942984165e-13
) O 0 1.2746642804694323e-16
by O 0 1.330379000187695e-14
age O 0 5.1502822839832874e-11
50 O 0 7.330726303766966e-12
years O 0 8.305370822504765e-13
and O 0 8.43876834730195e-13
84 O 0 5.185246676475685e-10
% O 0 2.4092511839712838e-12
( O 0 9.530503014380798e-15
95 O 0 2.246073882439248e-10
% O 0 1.4584507213033504e-11
CI O 0 8.228240488961092e-08
43 O 0 1.2344615607506881e-10
% O 0 2.9997212396340456e-13
- O 0 1.949649859958602e-12
95 O 0 4.130907768629122e-11
% O 0 8.514299291648153e-14
) O 0 1.1353632271974602e-16
by O 0 5.839277087034411e-14
age O 0 4.687581434126287e-10
70 O 0 1.0951627799071773e-10
years O 0 3.1037301201353173e-11
. O 0 3.3653460018712167e-09

The O 0 1.5591659519031964e-07
corresponding O 1 0.9999940395355225
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 2.690930784865486e-07
were O 0 5.038084949227084e-10
0 O 0 7.206327978792615e-09
. O 0 6.083561432390638e-10

4 O 0 7.607207521687087e-07
% O 0 2.4941861909155705e-09
( O 0 2.950868499204673e-12
95 O 0 1.6054983120739053e-08
% O 0 3.648673030376415e-10
CI O 0 1.2460895959520712e-06
0 O 0 2.0744200801559032e-10
% O 0 8.808602718762826e-13
- O 0 2.223400066489467e-12
1 O 0 1.4185215502227067e-11
% O 0 7.13030505407504e-14
) O 0 7.169884420834906e-17
by O 0 8.556394796247618e-15
age O 0 4.0295010383939456e-11
50 O 0 2.5256537312945415e-12
years O 0 7.73177637365674e-13
and O 0 1.5042870378165207e-12
27 O 0 9.132263278921471e-10
% O 0 4.077176096739521e-12
( O 0 1.2738975727153573e-14
95 O 0 1.346942141156049e-10
% O 0 3.4633444116055623e-12
CI O 0 7.867823725860035e-09
0 O 0 9.44870570673828e-12
% O 0 1.3270672538298611e-13
- O 0 1.950445881193641e-12
47 O 0 1.5093058747250865e-11
% O 0 3.85534703120638e-14
) O 0 1.0338743202609611e-16
by O 0 4.869508726909784e-14
age O 0 7.834141668716654e-10
70 O 0 2.4712468182919167e-10
years O 0 8.447585686521819e-11
. O 0 3.918535718128169e-09

The O 0 2.243977803573216e-08
lifetime O 0 2.6768023531076324e-07
risk O 0 3.863022186578746e-07
of O 0 5.440692802949343e-07
breast B-Disease 1 0.9999986886978149
cancer I-Disease 1 0.8748970031738281
appears O 0 2.5928176938805336e-08
similar O 0 3.7577013722867036e-10
to O 0 3.6116287044363204e-11
the O 0 1.3499520390425346e-09
risk O 0 3.3159588408437912e-09
in O 0 1.3073224447435194e-10
BRCA1 O 0 1.1451710413279415e-10
carriers O 0 9.784070255369759e-12
, O 0 1.6851191937065219e-13
but O 0 2.815581155810737e-13
there O 0 1.0081824562474181e-13
was O 0 3.6198060607978144e-12
some O 0 1.3086129131267138e-13
suggestion O 0 6.63029561809303e-11
of O 0 1.0240327683042061e-11
a O 0 7.62272016341381e-12
lower O 0 3.896960265592497e-08
risk O 0 6.848626665778568e-10
in O 0 1.3356930839147907e-10
BRCA2 O 0 3.6223926636047565e-10
carriers O 0 2.973304935594001e-11
< O 0 3.524752156813804e-10
50 O 0 4.321504525756081e-12
years O 0 7.812802190138371e-14
of O 0 7.047708770746564e-13
age O 0 1.0518832471717587e-09
. O 0 4.494594474380165e-09

Eye B-Disease 1 0.9999643564224243
movement I-Disease 0 2.0050125385751016e-05
abnormalities I-Disease 0 2.6361874461144907e-06
correlate O 0 1.6382696088612647e-08
with O 0 3.4072840035537233e-12
genotype O 0 7.165431838984659e-07
in O 0 8.117323480050231e-10
autosomal O 1 0.9999790191650391
dominant O 1 0.9999831914901733
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 3.1198308079183334e-06

We O 0 1.1577387937222738e-08
compared O 0 5.314061723993291e-08
horizontal O 0 1.6222567467139015e-07
eye O 0 4.570799137582071e-05
movements O 0 4.1662451621959917e-07
( O 0 5.310567957605983e-11
visually O 0 2.733085979755856e-09
guided O 0 1.1218830309189798e-09
saccades O 0 1.8693111059064904e-08
, O 0 7.032324375599863e-12
antisaccades O 0 1.2736100174493004e-08
, O 0 1.1327747767575502e-11
and O 0 3.3437783791834264e-12
smooth O 0 6.959100656844797e-11
pursuit O 0 1.4502793410642312e-10
) O 0 3.015138797814697e-14
in O 0 1.3828015338682165e-12
control O 0 1.1814819955713318e-10
subjects O 0 5.005063030694146e-09
( O 0 1.7911231308884168e-13
n O 0 2.8720036765461643e-11
= O 0 7.0187636085072835e-12
14 O 0 1.1146598401234886e-11
) O 0 4.355510160977856e-14
and O 0 1.5576551550336437e-12
patients O 0 5.1229673281305566e-11
with O 0 3.5691108814066286e-14
three O 0 2.5321449581214295e-13
forms O 0 1.467397980903229e-09
of O 0 2.509529792860121e-07
autosomal O 1 0.9867321848869324
dominant O 0 0.16556531190872192
cerebellar B-Disease 1 0.9999986886978149
ataxias I-Disease 0 0.0001483646483393386
type I-Disease 0 9.228374983649701e-05
I I-Disease 0 0.0008806510595604777
spinocerebellar B-Disease 0 0.0018527673091739416
ataxias I-Disease 0 3.2918600481934845e-05
1 I-Disease 0 2.231673050800964e-07
and I-Disease 0 1.2389575476667858e-10
2 I-Disease 0 4.900267747132148e-09
( O 0 1.661769029673299e-12
SCA1 B-Disease 0 4.99393318023067e-05
, O 0 4.075965259753289e-11
n O 0 2.8203137741877882e-11
= O 0 4.216978762711099e-12
11 O 0 2.2019857725402714e-12
; O 0 4.502410813969626e-13
SCA2 B-Disease 0 2.0134864371357253e-06
, O 0 2.0436452877192757e-11
n O 0 2.1375920131183612e-11
= O 0 5.795985219547717e-12
10 O 0 3.788751864325368e-12
) O 0 6.412958272056235e-14
and O 0 4.951825754995198e-11
SCA3 B-Disease 1 1.0
/ O 1 0.5019323825836182
Machado B-Disease 0 6.27732049451879e-07
- I-Disease 0 1.825525117737925e-07
Joseph I-Disease 0 8.944453497861105e-07
disease I-Disease 0 4.147019581068889e-07
( O 0 7.951223013336062e-12
MJD B-Disease 1 1.0
) O 0 1.579176719945785e-11
( O 0 3.712068629910248e-13
n O 0 6.518891676465799e-11
= O 0 2.8479583275009546e-11
16 O 0 9.392147476416923e-11
) O 0 1.6349169197280022e-12
. O 0 1.6427496030146926e-09

In O 0 1.482183442647056e-08
SCA1 B-Disease 0 0.0002550484787207097
, O 0 9.63609955717537e-11
saccade O 0 3.756506217200695e-09
amplitude O 0 8.537440754352588e-10
was O 0 2.5395912803261034e-11
significantly O 0 1.7008019992381662e-10
increased O 0 2.1787471826684168e-10
, O 0 5.320254870336272e-13
resulting O 0 8.279930213683784e-11
in O 0 1.1923280418546511e-10
hypermetria B-Disease 0 5.111807695357129e-06
. O 0 1.0866395427910902e-07

The O 0 9.39652888831688e-09
smooth O 0 4.0657223365769823e-08
pursuit O 0 7.276022984115116e-08
gain O 0 1.6274098513235913e-08
was O 0 3.469234233222096e-09
decreased O 0 2.3159220745583298e-06
. O 0 3.0287967689446305e-08

In O 0 2.2326473114731016e-08
SCA2 B-Disease 0 0.0003332590567879379
, O 0 1.103821686831985e-10
saccade O 0 4.1243777282318206e-09
velocity O 0 3.378027413347695e-09
was O 0 1.6284616988215816e-09
markedly O 0 5.367104222386843e-06
decreased O 0 5.451815013657324e-06
. O 0 3.050864094689132e-08

The O 0 5.485287335460498e-09
percentage O 0 9.578609905247504e-08
of O 0 2.065569271181289e-09
errors O 0 1.3763807373834425e-06
in O 0 3.464607090108984e-08
antisaccades O 1 0.9757132530212402
was O 0 1.2876331823008513e-07
greatly O 0 8.248054683690498e-08
increased O 0 1.2188666964618733e-08
and O 0 4.159899421457558e-12
was O 0 1.3387351990856722e-11
significantly O 0 1.373982455588063e-10
correlated O 0 2.2583251935159865e-10
with O 0 4.036764209036127e-14
age O 0 2.9089095021639366e-10
at O 0 1.8845770430320208e-11
disease O 0 1.2160099593927498e-09
onset O 0 4.6166638867362053e-07
. O 0 4.661409036543773e-08

In O 0 8.390984018724623e-10
addition O 0 2.1739611499871359e-10
, O 0 1.7580457489091428e-12
a O 0 2.7445100771010533e-13
correlation O 0 1.2595764275341592e-12
between O 0 2.0864573090084715e-12
smooth O 0 1.8370772958409276e-10
pursuit O 0 1.6881458730910737e-10
gain O 0 1.0096350144817023e-10
and O 0 1.7397915790320906e-13
the O 0 1.0651946989390093e-12
number O 0 9.182574839394775e-12
of O 0 5.076298756345743e-11
trinucleotide O 0 7.809801161329233e-08
repeats O 0 6.443755945495511e-11
was O 0 1.1589151860391667e-10
found O 0 4.2424418145170506e-11
. O 0 2.4387609709464186e-09

In O 0 3.505226970901276e-07
SCA3 B-Disease 1 1.0
, O 0 2.413363517916878e-07
gaze B-Disease 0 5.90787640248891e-05
- I-Disease 0 7.169969194364967e-06
evoked I-Disease 0 2.2345980141835753e-06
nystagmus I-Disease 0 1.398079461978341e-06
was O 0 6.196311241879471e-10
often O 0 1.7913665342761398e-12
present O 0 8.484895728730346e-13
as O 0 4.36458540750001e-13
was O 0 8.431002423980871e-12
saccade O 0 8.714765020734205e-10
hypometria O 0 3.369991219415169e-08
and O 0 2.936446225065836e-11
smooth O 0 1.4231625877769716e-09
pursuit O 0 3.444357687953925e-09
gain O 0 2.415512456721558e-09
was O 0 2.0122552513157643e-09
markedly O 0 1.0549121725489385e-05
decreased O 0 2.509520527382847e-06
. O 0 1.6499759780685963e-08

Three O 0 1.2520809944405187e-09
major O 0 4.833752842436922e-10
criteria O 0 1.24244685650865e-08
, O 0 2.7423780260549258e-11
saccade O 0 2.231790308115933e-09
amplitude O 0 6.582818179445837e-10
, O 0 1.1067234368528078e-12
saccade O 0 2.5545263127035867e-10
velocity O 0 1.8951755442753182e-10
, O 0 6.041084733149349e-12
and O 0 3.5026994325837446e-12
presence O 0 1.5985177070909629e-10
of O 0 1.5398495634144638e-07
gaze B-Disease 0 0.00022346941113937646
- I-Disease 0 2.296922048117267e-06
evoked I-Disease 0 1.0734837587733637e-06
nystagmus I-Disease 0 2.2473273020295892e-08
, O 0 1.8579354634645773e-13
permitted O 0 1.962057469620526e-12
the O 0 3.6177750248680973e-13
correct O 0 1.3904721124502473e-11
assignment O 0 1.3548593670587028e-11
of O 0 8.938419449044943e-12
90 O 0 8.353549102446678e-11
% O 0 1.6222990832648332e-12
of O 0 1.9387330282838455e-12
the O 0 4.341342563218831e-11
SCA1 B-Disease 0 0.0016643241979181767
, O 0 1.4189391328578438e-10
90 O 0 8.124680928034422e-10
% O 0 1.4773174003557266e-12
of O 0 1.0355855712892992e-12
the O 0 1.2789489085840433e-11
SCA2 B-Disease 0 0.00015881177387200296
, O 0 3.47557572999424e-11
and O 0 1.021142198576186e-11
93 O 0 1.3874605631070125e-10
% O 0 2.166097975899589e-13
of O 0 8.251082109222985e-14
the O 0 2.8682251886069654e-12
patients O 0 9.983450732775623e-10
with O 0 1.1775399232083483e-11
SCA3 B-Disease 1 1.0
to O 0 7.633859240741003e-06
their O 0 5.077236551187525e-07
genetically O 0 1.7979702988668578e-06
confirmed O 0 4.651714675674157e-07
patient O 1 0.9874688386917114
group O 0 4.811533983739569e-12
and O 0 2.8554017332017845e-13
, O 0 6.620732065885926e-14
therefore O 0 1.8864326767342732e-11
, O 0 6.379205974224589e-13
may O 0 5.958477461431855e-11
help O 0 7.000971330439754e-11
orient O 0 2.1931887772552727e-07
diagnoses O 0 1.4165710808811127e-06
of O 0 2.15639017753233e-09
SCA1 B-Disease 0 0.24394449591636658
, O 0 6.90526108515499e-11
SCA2 B-Disease 0 0.0009884197497740388
, O 0 3.046951579932511e-11
and O 0 1.0071308370607213e-10
SCA3 B-Disease 1 1.0
at O 0 4.335504844021898e-09
early O 0 3.786372992919951e-09
clinical O 0 3.1444877951480876e-11
stages O 0 1.376621316939719e-10
of O 0 7.551925230997458e-12
the O 0 7.711283694922244e-11
diseases O 0 2.4304501522465216e-08
. O 0 6.961613507883158e-10
. O 0 3.752009369861753e-09

Genetic O 0 7.331285445388858e-08
basis O 0 3.573436546666642e-10
and O 0 4.533960284037325e-13
molecular O 0 8.630723739855295e-12
mechanism O 0 2.1815832473848218e-10
for O 0 2.050549591237072e-10
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 2.0672590835602023e-05

Ventricular B-Disease 1 0.9999088048934937
fibrillation I-Disease 1 0.9098774790763855
causes O 0 2.3893276193120982e-06
more O 0 2.7483895367885758e-11
than O 0 1.2579869871492955e-12
300 O 0 2.9391847029131e-12
, O 0 4.6774883906463074e-14
000 O 0 7.306395939654653e-12
sudden O 0 8.547823364922491e-13
deaths O 0 9.8452799732196e-13
each O 0 1.3464539067573923e-14
year O 0 1.2434946735501162e-12
in O 0 5.407112257937996e-12
the O 0 3.0710731180327855e-10
USA O 0 5.350183851504653e-09
alone O 0 3.4327407583134573e-10
. O 0 3.8678910074807504e-10

In O 0 1.7611101910119942e-08
approximately O 0 1.7505558114194741e-10
5 O 0 6.851043621303177e-10
- O 0 4.811520071257291e-10
12 O 0 1.329737292499189e-10
% O 0 2.2397658814427013e-12
of O 0 1.4881452732422307e-13
these O 0 5.184959381873515e-14
cases O 0 6.139785945283305e-13
, O 0 4.430905918865677e-14
there O 0 6.66652673277264e-14
are O 0 6.318293192244737e-14
no O 0 7.2139768117485126e-12
demonstrable O 0 1.329543835026925e-07
cardiac O 0 0.0005322440410964191
or O 0 6.210039593668171e-09
non O 0 9.882637641567271e-06
- O 0 1.9060694285144564e-06
cardiac O 0 0.00031448894878849387
causes O 0 8.235360726693841e-10
to O 0 2.5244964538956305e-13
account O 0 2.775686039520331e-13
for O 0 1.538201125717356e-13
the O 0 1.1161112312141341e-10
episode O 0 6.09191030953582e-10
, O 0 6.152466502842152e-14
which O 0 2.1335874791905945e-15
is O 0 1.985720302313701e-15
therefore O 0 6.469710292673903e-13
classified O 0 1.2554874674608474e-11
as O 0 5.0384089261834575e-11
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999996423721313
fibrillation I-Disease 1 1.0
( O 0 7.766763232552876e-09
IVF B-Disease 1 1.0
) O 0 1.3187526071156697e-10
. O 0 2.4716912960798254e-09

A O 0 6.307324724730279e-07
distinct O 0 3.400856485313852e-08
group O 0 1.0942440009653609e-10
of O 0 1.7024127663134436e-09
IVF B-Disease 1 1.0
patients O 1 0.9999356269836426
has O 0 4.2297201440118226e-13
been O 0 9.631142048162691e-14
found O 0 1.6377024587258156e-14
to O 0 1.7187411501082446e-14
present O 0 1.7683096740356286e-12
with O 0 6.771225426064134e-14
a O 0 1.89819796166113e-12
characteristic O 0 2.2936272880969e-09
electrocardiographic O 0 1.6973093863725808e-07
pattern O 0 6.439993427420632e-08
. O 0 9.345946239136538e-09

Because O 0 5.473668096556139e-08
of O 0 6.829845133893286e-09
the O 0 2.858244751990924e-10
small O 0 4.182422637388772e-12
size O 0 6.3254861418227115e-12
of O 0 5.7348254617339833e-11
most O 0 5.8131489205637266e-11
pedigrees O 0 1.3275940347057258e-09
and O 0 2.7970716563220643e-13
the O 0 2.376757102760807e-13
high O 0 9.180175716827499e-12
incidence O 0 1.0622452570330232e-11
of O 0 1.1509946641619084e-12
sudden B-Disease 0 3.088671332585058e-11
death I-Disease 0 1.8102604970593461e-09
, O 0 5.176229670583732e-12
however O 0 1.8591504724607688e-10
, O 0 7.24544122615578e-13
molecular O 0 4.09029320830312e-12
genetic O 0 2.4550361743536087e-12
studies O 0 1.8512533899502776e-13
of O 0 1.0833237518853567e-12
IVF B-Disease 1 1.0
have O 0 4.84716537740848e-11
not O 0 4.77163187434515e-12
yet O 0 4.085616914228929e-11
been O 0 3.2321968452403427e-12
done O 0 5.548585549353113e-11
. O 0 5.578672523931516e-10

Because O 0 1.4973362567616277e-06
IVF B-Disease 1 1.0
causes O 1 0.9788445830345154
cardiac O 1 1.0
rhythm O 1 0.9066210389137268
disturbance O 0 0.01086683850735426
, O 0 3.988424521206291e-11
we O 0 6.359019213975081e-12
investigated O 0 4.962512623052362e-10
whether O 0 6.497519744463887e-10
malfunction O 0 5.8428173360880464e-05
of O 0 1.2339542720951613e-08
ion O 0 8.831375453155488e-07
channels O 0 3.8400629343016135e-09
could O 0 1.474545138768768e-11
cause O 0 7.838555582395657e-09
the O 0 2.210880645225899e-10
disorder O 0 1.0393830685018202e-08
by O 0 1.33079979328099e-11
studying O 0 2.1460001831119513e-10
mutations O 0 1.2566111345924114e-11
in O 0 7.169981297051875e-13
the O 0 1.2789049333439273e-11
cardiac O 0 3.339151533054974e-08
sodium O 0 3.548598783709167e-07
channel O 0 2.760456041528414e-08
gene O 0 8.81224648807688e-10
SCN5A O 0 0.00020194817625451833
. O 0 2.0587447124853497e-07

We O 0 2.462798320834736e-08
have O 0 1.7946309716077025e-10
now O 0 2.457539033384748e-11
identified O 0 2.7309206979131417e-11
a O 0 9.759225545746819e-12
missense O 0 1.0965207764002116e-07
mutation O 0 1.8025014814071483e-09
, O 0 2.158337527799481e-12
a O 0 8.724813948569887e-13
splice O 0 5.8729008323155085e-09
- O 0 3.3871248028560785e-09
donor O 0 4.958049082404159e-09
mutation O 0 1.0804405148334695e-09
, O 0 2.429832322761033e-13
and O 0 1.008926896564101e-13
a O 0 3.0581152844419424e-13
frameshift O 0 1.2094200085854823e-09
mutation O 0 9.43854716606296e-12
in O 0 4.565521680328921e-13
the O 0 4.7536731495601e-12
coding O 0 1.2312799391178686e-10
region O 0 5.056681809390007e-11
of O 0 1.7760723447501903e-10
SCN5A O 0 0.0023380815982818604
in O 0 1.2816357697342795e-10
three O 0 4.270532191763543e-11
IVF B-Disease 1 1.0
families O 0 7.955159864181383e-10
. O 0 4.1530778815968006e-10

We O 0 8.752917501908541e-09
show O 0 4.977373721515299e-11
that O 0 9.24599345654073e-14
sodium O 0 3.8193304074951584e-10
channels O 0 1.2604950937189496e-11
with O 0 3.4027410744782646e-14
the O 0 3.279668550626447e-11
missense O 0 7.319982131548386e-08
mutation O 0 1.582718289760976e-09
recover O 0 9.517321375440702e-10
from O 0 5.839082255904016e-12
inactivation O 0 1.4084428130445303e-06
more O 0 4.5853689768782235e-12
rapidly O 0 2.0212091722537906e-10
than O 0 3.6846356044409334e-13
normal O 0 2.6982771572647835e-10
and O 0 5.111055350649762e-13
that O 0 3.114589952591361e-14
the O 0 4.3151315853862116e-11
frameshift O 0 2.4363121298165424e-08
mutation O 0 9.257123539940793e-11
causes O 0 3.982441806882342e-11
the O 0 1.9693508976348362e-11
sodium O 0 8.395034667429968e-10
channel O 0 2.2804947166776834e-11
to O 0 3.8049714746156427e-13
be O 0 7.046919471564994e-12
non O 0 3.6409744552656775e-08
- O 0 1.958501982812777e-08
functional O 0 9.53271737103023e-08
. O 0 6.14837647461286e-09

Our O 0 2.774258689441922e-08
results O 0 1.026090545863667e-09
indicate O 0 3.4303861973228322e-09
that O 0 1.8136315366179545e-11
mutations O 0 9.837860526218378e-10
in O 0 1.646437569613468e-10
cardiac O 0 1.648548533239591e-07
ion O 0 7.755486564064995e-08
- O 0 1.4731637065779069e-06
channel O 0 1.6005077263514522e-09
genes O 0 5.625338736492402e-12
contribute O 0 8.663937080786999e-13
to O 0 8.092788592040101e-14
the O 0 9.090020945158594e-13
risk O 0 5.663536046390805e-12
of O 0 3.63379335302505e-12
developing O 0 4.5566750372927345e-09
IVF B-Disease 1 1.0
. O 0 3.1649491916141415e-09
. O 0 1.2328243981230003e-09

Molecular O 0 2.2480396921764623e-07
heterogeneity O 0 4.583590111906233e-07
in O 0 5.975578254435732e-09
mucopolysaccharidosis B-Disease 0 0.002038422506302595
IVA I-Disease 1 0.9999996423721313
in O 0 3.561736150459183e-08
Australia O 0 4.156406330224627e-10
and O 0 2.7665342239302504e-11
Northern O 0 5.963972093958603e-10
Ireland O 0 6.849305567158126e-10
: O 0 3.0833838086941068e-12
nine O 0 4.5737779882926155e-12
novel O 0 5.5185158526205313e-11
mutations O 0 8.759919005452144e-12
including O 0 6.286933322031951e-13
T312S O 0 7.578486282966423e-09
, O 0 7.683996668117477e-13
a O 0 1.4930125278450612e-13
common O 0 1.9709215162699856e-11
allele O 0 2.1184625234593746e-11
that O 0 1.2953809540598629e-14
confers O 0 2.5440467441018022e-11
a O 0 1.650756462946712e-12
mild O 0 6.608159708321182e-08
phenotype O 0 2.517659140721662e-06
. O 0 4.453338320331568e-08

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 1 0.9311997890472412
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.2420333645190027e-10
is O 0 3.0837016967710795e-12
an O 0 8.974669098160692e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 7.890608344496286e-07
by O 0 7.00039679002451e-11
a O 0 3.539710524691486e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 4.524785879311821e-09
N O 0 2.187685765875358e-08
- O 0 2.3120927394870705e-09
acetylgalactosamine O 0 1.3012765975872753e-07
- O 0 1.3068402360261189e-08
6 O 0 2.1661188398525155e-09
- O 0 9.162062220013922e-10
sulfate O 0 4.173519752015409e-09
sulfatase O 0 8.204668802136439e-07
( O 0 4.0415008145666675e-11
GALNS O 1 0.5756015181541443
) O 0 1.208716043921143e-10
. O 0 8.614093438552572e-09

Previous O 0 5.0867157597167534e-08
studies O 0 3.588886965388838e-10
of O 0 1.8747500080129598e-11
patients O 0 2.6587759771601327e-10
from O 0 6.207942688553347e-13
a O 0 4.2609734913611613e-14
British O 0 7.429272474990256e-12
- O 0 1.3232828721676526e-10
Irish O 0 3.0163183062370535e-10
population O 0 4.396552566454659e-13
showed O 0 1.616876798464853e-13
that O 0 1.4434757498655074e-15
the O 0 8.453234856889424e-13
I113F O 0 6.711453170993309e-09
mutation O 0 3.616108801285378e-11
is O 0 2.5576120878828025e-14
the O 0 2.2304186763581063e-14
most O 0 3.9095893270826507e-14
common O 0 4.5024449663380595e-13
single O 0 1.7997239115663533e-11
mutation O 0 8.568861176172504e-10
among O 0 2.4437515899755624e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 1 0.9918348789215088
and O 0 1.3656368570702515e-11
produces O 0 4.173911650334761e-12
a O 0 2.9770698167959353e-13
severe O 0 6.415580955376754e-09
clinical O 0 1.2805037385987816e-07
phenotype O 0 8.532792890036944e-06
. O 0 1.8986870742310202e-08

We O 0 4.587390378674172e-08
studied O 0 1.63875721881368e-08
mutations O 0 4.155019384111114e-10
in O 0 4.5747749338742594e-11
the O 0 8.215342295336825e-10
GALNS O 0 0.1825811117887497
gene O 0 1.4125615122040358e-09
from O 0 2.5725835350876025e-10
23 O 0 2.0113728460557923e-09
additional O 0 2.751381567023259e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.1086554005742073
( O 0 1.9281039438656666e-13
15 O 0 9.076061950608061e-12
from O 0 6.925618932507316e-13
Australia O 0 5.542846455257322e-13
, O 0 4.625295914502392e-14
8 O 0 3.3927962436036685e-12
from O 0 1.4641023853359525e-12
Northern O 0 9.398311989761154e-11
Ireland O 0 2.542397542493191e-11
) O 0 7.590662039896889e-14
, O 0 1.279416026248037e-13
with O 0 3.214119373212351e-14
various O 0 1.1554191631235611e-10
clinical O 0 8.491975478364111e-08
phenotypes O 0 3.755015541173634e-06
( O 0 2.5972732645151986e-11
severe O 0 2.8604955559785594e-07
, O 0 7.548328628814716e-11
16 O 0 4.258161184766962e-11
cases O 0 1.2743613456156488e-11
; O 0 7.668681228228946e-13
intermediate O 0 2.1203495847998965e-08
, O 0 5.289838662589363e-13
4 O 0 7.16653949725532e-12
cases O 0 6.365304984490283e-12
; O 0 8.291003300575639e-12
mild O 0 1.385841272849575e-07
, O 0 5.2728703348048356e-11
3 O 0 6.234341931588006e-10
cases O 0 6.876949010248268e-11
) O 0 2.4153567600854187e-12
. O 0 1.891132139775209e-09

We O 0 3.335498490741884e-07
found O 0 2.3896122858246827e-09
two O 0 1.565172817741267e-11
common O 0 1.7817590458601984e-10
mutations O 0 8.147581914697e-11
that O 0 1.2870677830803534e-12
together O 0 5.368872447314432e-12
accounted O 0 1.45279885344074e-10
for O 0 1.3861843530665885e-12
32 O 0 7.103371363337274e-11
% O 0 6.963049928310205e-13
of O 0 3.097056573871104e-13
the O 0 5.620105509446249e-12
44 O 0 1.20538232173395e-10
unrelated O 0 4.1082018342741833e-10
alleles O 0 6.484612326274064e-12
in O 0 4.5106561714913784e-12
these O 0 9.347041196594574e-11
patients O 0 4.179031787288068e-09
. O 0 1.0522965832038267e-09

One O 0 1.2306395902328404e-09
is O 0 3.530817782246287e-12
the O 0 7.118127615113323e-11
T312S O 0 4.0481694441041327e-07
mutation O 0 7.460139173076641e-09
, O 0 2.914676963325369e-12
a O 0 7.188083678624779e-13
novel O 0 5.775267486463065e-10
mutation O 0 4.014735210944309e-10
found O 0 1.0646279864634511e-12
exclusively O 0 2.3190453463800553e-12
in O 0 1.1625516087993004e-12
milder O 0 0.03972277417778969
patients O 1 0.7776835560798645
. O 0 1.9462899558675417e-07

The O 0 1.924787262908012e-08
other O 0 4.7504215838767294e-11
is O 0 4.2525157657388735e-13
the O 0 1.210435939848209e-12
previously O 0 9.700452247018987e-12
described O 0 2.091933570813609e-11
I113F O 0 5.477100994966122e-09
that O 0 1.7644916018751122e-13
produces O 0 6.6950516311448105e-12
a O 0 8.475611163426267e-13
severe O 0 3.162965356295899e-08
phenotype O 0 9.723206312628463e-05
. O 0 2.24944642468472e-07

The O 0 1.485161078562669e-07
I113F O 0 5.092033916298533e-06
and O 0 6.418077624914531e-09
T312S O 0 8.707775691618735e-07
mutations O 0 9.944944867612548e-10
accounted O 0 2.274793020617949e-09
for O 0 6.903084007192639e-12
8 O 0 4.288410182518021e-10
( O 0 9.001661720707543e-14
18 O 0 4.548906737400493e-11
% O 0 3.9561973488866364e-13
) O 0 2.5780883470530227e-15
and O 0 5.877057738037927e-13
6 O 0 2.3148803707240262e-10
( O 0 8.699966203180864e-14
14 O 0 2.3621753858504846e-11
% O 0 2.2024678088261584e-13
) O 0 1.1936152182273553e-15
of O 0 8.859116782181098e-13
44 O 0 3.6259301117169684e-11
unrelated O 0 5.172878791981361e-10
alleles O 0 2.8581997879584264e-11
, O 0 6.589017092356597e-12
respectively O 0 4.4795983589196453e-10
. O 0 4.995115876482714e-09

The O 0 3.895027944622598e-08
relatively O 0 2.0968141001276308e-08
high O 0 5.9293920884329054e-09
residual O 0 9.73694000094838e-07
GALNS O 0 0.0029373581055551767
activity O 0 9.887494201166191e-08
seen O 0 3.7687047926837636e-10
when O 0 1.6517525194825744e-11
the O 0 4.281722545962374e-11
T312S O 0 2.15957722815574e-08
mutant O 0 1.7233543481154356e-09
cDNA O 0 1.1105064423588829e-08
is O 0 2.2514171083010126e-11
overexpressed O 0 3.997516273557267e-08
in O 0 1.349325078753294e-11
mutant O 0 7.586176686835699e-10
cells O 0 1.5826087662595967e-10
provides O 0 2.8467161218353673e-14
an O 0 8.643485506274444e-17
explanation O 0 2.2920801541481683e-12
for O 0 7.871090931810265e-14
the O 0 3.064144077358222e-11
mild O 0 4.342065551554697e-07
phenotype O 0 3.8283423009488615e-07
in O 0 4.943908130106145e-11
patients O 0 1.483856371109482e-10
with O 0 6.799928408031267e-15
this O 0 1.683555530228309e-12
mutation O 0 4.653853413749687e-10
. O 0 1.3942738075201078e-09

The O 0 1.980665187417685e-09
distribution O 0 1.748843708737624e-10
and O 0 2.9780368709236837e-12
relative O 0 1.32625452287094e-10
frequencies O 0 4.42940024936167e-11
of O 0 7.0018617639999725e-12
the O 0 2.079822945810772e-11
I113F O 0 3.2964244667255116e-08
and O 0 6.14138739862824e-10
T312S O 0 1.2573231344958913e-07
mutations O 0 2.997426751250032e-10
in O 0 1.8368872395368996e-11
Australia O 0 1.583018612028031e-11
corresponded O 0 3.09456210656478e-11
to O 0 7.657138811900666e-12
those O 0 1.948565440945682e-11
observed O 0 2.1846396913716148e-10
in O 0 4.7774263711719556e-11
Northern O 0 6.587717038541996e-10
Ireland O 0 1.179178976684625e-10
and O 0 1.2272441743399476e-11
are O 0 4.728179653357145e-13
unique O 0 1.0337265982443555e-12
to O 0 1.6662154512028793e-12
these O 0 4.13226328155325e-11
two O 0 3.755977733693738e-12
populations O 0 4.6129753662749184e-12
, O 0 2.0879130401604135e-13
suggesting O 0 1.0510919391804041e-11
that O 0 1.6740613886442879e-12
both O 0 3.503135628801779e-11
mutations O 0 3.798869552262829e-11
were O 0 1.172748426148118e-10
probably O 0 5.863214080914503e-11
introduced O 0 6.037182559426313e-11
to O 0 2.5720656073729975e-12
Australia O 0 2.801343141831114e-13
by O 0 9.177715824728455e-14
Irish O 0 2.9683526470147825e-11
migrants O 0 5.818034855969989e-13
during O 0 3.414490641184126e-13
the O 0 3.453329744558531e-13
19th O 0 2.8606570445788293e-09
century O 0 5.146980797121614e-08
. O 0 5.507872202770159e-08

Haplotype O 0 4.639044846044271e-07
analysis O 0 1.229900403743045e-09
using O 0 3.716835172973276e-10
6 O 0 2.7800057367244335e-08
RFLPs O 0 2.3059646991896443e-06
provides O 0 8.010390961654679e-12
additional O 0 3.322772612612823e-12
data O 0 3.6222370589089614e-12
that O 0 4.5132592053822446e-14
the O 0 7.082644887246303e-11
I113F O 0 1.459767133837886e-07
mutation O 0 4.952357413046116e-10
originated O 0 6.60195231816374e-11
from O 0 1.5956883709332403e-13
a O 0 8.426973582918024e-14
common O 0 4.185226123998298e-11
ancestor O 0 1.5914736195554724e-08
. O 0 1.0814142470394472e-08

The O 0 1.8886713633037289e-06
other O 0 3.9683371255705424e-08
9 O 0 2.9751200258942845e-07
novel O 0 3.4654924263577414e-08
mutations O 0 2.2606103655675724e-09
identified O 0 1.6543230674237464e-10
in O 0 9.59958935259353e-12
these O 0 6.8338515402111e-11
23 O 0 5.552875936842838e-10
patients O 0 9.963152525216401e-10
were O 0 7.671465893088758e-12
each O 0 5.594620429362658e-15
limited O 0 1.685273421465558e-13
to O 0 1.2922894362683152e-13
a O 0 1.6109918303877646e-12
single O 0 1.1042454728382722e-09
family O 0 6.769082516733249e-10
. O 0 5.705058203631097e-09

These O 0 4.489745020208602e-09
data O 0 6.958543463664313e-11
provide O 0 1.2681629834795927e-12
further O 0 1.0601032855370174e-12
evidence O 0 1.39287435751978e-11
for O 0 3.860730745514074e-12
extensive O 0 5.842767603070342e-09
allelic O 0 1.770467150663535e-07
heterogeneity O 0 3.192622841652337e-07
in O 0 7.51600026660526e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 1.4105308587808452e-10
British O 0 1.1432155916368814e-10
- O 0 4.811501752577385e-10
Irish O 0 7.006598079506432e-10
patients O 0 4.5451797880957656e-10
and O 0 4.1899795942936316e-14
provide O 0 3.053344557713781e-15
evidence O 0 7.25038654331503e-14
for O 0 6.961107851168741e-14
their O 0 1.1093890563140807e-11
transmission O 0 5.151363016708821e-11
to O 0 1.2618510836920338e-12
Australia O 0 2.2089171854491885e-13
by O 0 3.346244315709582e-14
British O 0 1.4514048816971492e-11
- O 0 9.23500928506904e-11
Irish O 0 9.76900851878959e-11
migrants O 0 5.701927211637647e-12
. O 0 1.7944058240161598e-13
. O 0 6.828532097408191e-12

Identification O 0 2.693485612326185e-07
of O 0 2.3162961326761433e-08
constitutional O 0 0.00018980678578373045
WT1 O 1 0.9993745684623718
mutations O 0 7.521169322899368e-07
, O 0 2.924116851432679e-11
in O 0 1.4012254898054799e-11
patients O 0 4.9968980064818425e-09
with O 0 7.794621718903993e-12
isolated O 0 1.2348850759735797e-05
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.2521926551212204e-10
and O 0 2.974742576832695e-13
analysis O 0 3.093054241551374e-13
of O 0 1.0992471689841299e-11
genotype O 0 8.558938446867614e-08
/ O 0 6.865867874239484e-09
phenotype O 0 1.1618993545070566e-09
correlations O 0 1.1249759804266013e-11
by O 0 2.8139891404457135e-15
use O 0 3.857531698583938e-14
of O 0 1.063850613505779e-12
a O 0 2.8344848169992165e-12
computerized O 0 3.2206525446554224e-08
mutation O 0 1.4191562369703092e-09
database O 0 2.90386464874004e-10
. O 0 1.306979191539881e-09

Constitutional O 0 3.897231181326788e-06
mutations O 0 2.2248256570378544e-08
of O 0 3.3676958999251383e-09
the O 0 1.5019335108945597e-08
WT1 O 0 1.6889460312086158e-05
gene O 0 1.4916095025796494e-09
, O 0 2.719189456934501e-11
encoding O 0 1.6463443941461264e-09
a O 0 2.86787787961984e-10
zinc O 0 2.6561840513750212e-06
- O 0 1.3643848433275707e-06
finger O 0 5.898600079490279e-07
transcription O 0 8.873425940691959e-07
factor O 0 6.757542792001914e-08
involved O 0 2.0116711074713578e-10
in O 0 5.530141344856077e-10
renal O 1 1.0
and O 0 8.433913478711474e-08
gonadal O 0 2.6835994503926486e-05
development O 0 8.690489039508975e-08
, O 0 4.662519936110554e-12
are O 0 3.178856036365439e-14
found O 0 2.7089770449637354e-14
in O 0 1.5774372503747983e-14
most O 0 3.881720520102633e-13
patients O 0 1.8548213312485906e-11
with O 0 1.5148770909564901e-12
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.957453750431e-10
DDS B-Disease 1 1.0
) O 0 1.1953035783385246e-11
, O 0 4.705815598304852e-12
or O 0 3.508200618895785e-09
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.2289507189677806e-09
DMS B-Disease 0 4.272015758033376e-06
) O 0 3.5417765183350103e-13
associated O 0 1.1134274058299809e-11
with O 0 1.6563356589061051e-12
pseudohermaphroditism B-Disease 1 1.0
and O 0 5.94659297803446e-07
/ O 0 2.763982229225803e-05
or O 0 2.5599380393259707e-08
Wilms B-Disease 1 0.9999016523361206
tumor I-Disease 1 0.888982355594635
( O 0 6.87197937443429e-11
WT B-Disease 1 1.0
) O 0 2.720330731509346e-11
. O 0 7.702659066133322e-10

Most O 0 1.5800414132627338e-07
mutations O 0 3.4405708504436916e-08
in O 0 3.971886375353506e-09
DDS B-Disease 1 1.0
patients O 1 0.9999817609786987
lie O 0 4.1623046342920134e-08
in O 0 1.5084834770195954e-10
exon O 0 1.2087495449009111e-08
8 O 0 1.0554570550880271e-08
or O 0 4.91670537616784e-10
exon O 0 2.7840703964443492e-08
9 O 0 1.9184025035201557e-08
, O 0 6.119075385280226e-11
encoding O 0 1.407027667710281e-07
zinc O 0 0.0009901681914925575
finger O 0 0.009161867201328278
2 O 0 0.0002994235837832093
or O 0 1.7193767121170822e-07
zinc O 0 3.8600868720095605e-05
finger O 0 2.627495405249647e-06
3 O 0 1.48526581256192e-07
, O 0 2.7174356515002884e-12
respectively O 0 7.974540472410752e-11
, O 0 9.903476693232105e-13
with O 0 8.517255097820892e-14
a O 0 3.348130800384652e-12
hot O 0 1.7734222410581424e-06
spot O 0 4.5349293209540065e-09
( O 0 1.2411646959763906e-13
R394W O 0 1.2551176764574734e-09
) O 0 2.370848743021847e-13
in O 0 3.203560680620221e-11
exon O 0 7.228946774517908e-09
9 O 0 2.088603423544555e-08
. O 0 7.1906760545914494e-09

We O 0 5.017374071769609e-09
analyzed O 0 1.7812638031244887e-09
a O 0 1.8342254798353608e-12
series O 0 4.062681181055128e-13
of O 0 1.1911290096616733e-12
24 O 0 3.7033190403157334e-10
patients O 0 1.3132869014498283e-08
, O 0 2.9740010367568237e-12
10 O 0 1.979900271509294e-11
with O 0 1.080218488443141e-12
isolated B-Disease 0 4.040174133024266e-07
DMS I-Disease 1 0.9999997615814209
( O 0 5.355561549791332e-10
IDMS B-Disease 0 0.0032233758829534054
) O 0 7.2656633313961105e-12
, O 0 2.011799364251554e-12
10 O 0 3.3808327231515944e-12
with O 0 2.589366438279783e-13
DDS B-Disease 1 1.0
, O 0 7.330477891365206e-11
and O 0 8.844331517154913e-12
4 O 0 2.910052476767788e-10
with O 0 5.69069043190179e-13
urogenital B-Disease 0 1.1423054502301966e-06
abnormalities I-Disease 0 2.3625993890163954e-06
and O 0 6.587129952606574e-09
/ O 0 3.4794948078342713e-07
or O 0 1.8330162276924966e-07
WT B-Disease 1 1.0
. O 0 2.1596884280938866e-08

We O 0 5.717506041946763e-07
report O 0 1.5185953827767662e-07
WT1 O 0 0.003768370021134615
heterozygous O 0 4.387281933304621e-07
mutations O 0 2.30830332625942e-09
in O 0 3.525341824017758e-11
16 O 0 1.722473719212303e-09
patients O 0 3.661027925261351e-09
, O 0 2.710524946852866e-12
4 O 0 6.92901180876504e-10
of O 0 1.7170408150857241e-10
whom O 0 1.7036990707097743e-09
presented O 0 1.1214899231504205e-08
with O 0 7.087513909098675e-10
IDMS B-Disease 0 0.02563796378672123
. O 0 5.101523470329994e-07

One O 0 5.540839342899062e-09
male O 0 5.044988871105716e-10
and O 0 2.5632946286380243e-12
two O 0 7.377150106069319e-13
female O 0 3.832171385775851e-11
IDMS B-Disease 0 0.0009171273559331894
patients O 0 8.282828275696374e-06
with O 0 3.663793934904902e-09
WT1 O 1 0.9999957084655762
mutations O 0 3.456638296484016e-05
underwent O 0 1.4131184798316099e-05
normal O 0 0.0002906104491557926
puberty O 0 0.00019582158711273223
. O 0 3.409052595770845e-08

Two O 0 2.7836782123813464e-07
mutations O 0 3.837640960568933e-08
associated O 0 9.655721555645869e-09
with O 0 1.8474713425753464e-10
IDMS B-Disease 0 0.028853369876742363
are O 0 6.835833288310056e-11
different O 0 1.7163939540487672e-12
from O 0 1.8227932184478046e-12
those O 0 5.757660515894047e-13
described O 0 9.927764339778822e-12
in O 0 6.684260783762497e-11
DDS B-Disease 1 1.0
patients O 0 0.0018581501208245754
. O 0 1.7798518214817705e-08

No O 0 4.943198291584849e-06
WT1 O 0 0.0009411832434125245
mutations O 0 8.570732745738496e-08
were O 0 4.822637289514375e-10
detected O 0 1.8826711301045407e-09
in O 0 1.8834845141868506e-11
the O 0 1.1328227939033653e-10
six O 0 4.842618667177945e-11
other O 0 2.2037023594823069e-10
IDMS B-Disease 1 0.9999996423721313
patients O 0 0.02306952513754368
, O 0 1.1292239712745733e-11
suggesting O 0 2.7366525712224643e-10
genetic O 0 4.308069456726571e-10
heterogeneity O 0 3.329870823520764e-09
of O 0 2.052505040928132e-11
this O 0 7.711077609773298e-11
disease O 0 4.059326386141038e-07
. O 0 1.4583667606871131e-08

We O 0 5.964773919231448e-08
analyzed O 0 1.375287439486783e-07
genotype O 0 5.2976242841396015e-06
/ O 0 4.207968515856919e-07
phenotype O 0 4.3886796419201346e-08
correlations O 0 7.382326971949738e-10
, O 0 1.58694387383633e-13
on O 0 3.333778565706158e-13
the O 0 4.2238331295031337e-14
basis O 0 1.6869242547984387e-12
of O 0 2.971028642290846e-13
the O 0 1.3301291491851774e-12
constitution O 0 1.9216590124715438e-11
of O 0 2.9568716919392557e-10
a O 0 1.297470603178752e-10
WT1 O 0 1.1784620255639311e-05
mutation O 0 4.534764563857152e-09
database O 0 2.068939464194841e-10
of O 0 1.183430714535305e-10
84 O 0 1.135844307498246e-08
germ O 0 1.6908865291043185e-05
- O 0 3.149503982058377e-06
line O 0 9.34252529987134e-05
mutations O 0 3.016503713482166e-09
, O 0 1.5860037892376222e-12
to O 0 1.2243071140227713e-12
compare O 0 3.939710363498605e-11
the O 0 1.549122158675531e-12
distribution O 0 1.2697029191932607e-11
and O 0 3.295441718988157e-13
type O 0 3.174306095754531e-10
of O 0 1.0693511631743036e-09
mutations O 0 1.783369805996582e-11
, O 0 8.236805199490424e-14
according O 0 5.639172397271797e-13
to O 0 1.1512465243265768e-13
the O 0 2.662752180207506e-12
different O 0 4.577384651871519e-11
symptoms O 0 2.438693229578348e-07
. O 0 2.563876577710289e-08

This O 0 2.2173853864160264e-09
demonstrated O 0 3.008507221125001e-08
( O 0 2.98749219806993e-12
1 O 0 4.643727624653593e-10
) O 0 1.7146032586356358e-13
the O 0 1.2233925678062363e-11
association O 0 1.9127435746391086e-11
between O 0 6.21072013262669e-11
mutations O 0 4.956439703107662e-10
in O 0 6.434351385031789e-10
exons O 0 2.9145255098228517e-09
8 O 0 1.2244864011634604e-09
and O 0 1.1384213884080285e-11
9 O 0 1.092132273505797e-09
and O 0 2.7510327349489216e-11
DMS B-Disease 0 5.548992248805007e-06
; O 0 4.308989831613985e-10
( O 0 2.6060056890209182e-12
2 O 0 1.198066534868758e-09
) O 0 3.8588072624398673e-13
among O 0 1.194182339819827e-11
patients O 0 9.236488657249353e-11
with O 0 3.002417108335931e-13
DMS B-Disease 0 1.2230263735091285e-07
, O 0 1.159349634523299e-12
a O 0 1.2100335924219996e-13
higher O 0 3.183338315171369e-11
frequency O 0 1.5770636532796978e-11
of O 0 1.3129844433912297e-11
exon O 0 4.826173682914714e-09
8 O 0 7.488509368158702e-09
mutations O 0 1.2865543075335495e-09
among O 0 1.983601616295516e-10
46 O 0 1.8397853240870177e-09
, O 0 5.328974067575487e-11
XY O 0 1.5003522548795445e-06
patients O 0 9.600555905819874e-09
with O 0 5.201672426125015e-13
female O 0 1.0183646460826257e-11
phenotype O 0 8.652192295954819e-10
than O 0 1.0897528539277612e-11
among O 0 1.8151336336758028e-11
46 O 0 4.1997252897552073e-10
, O 0 2.6453899834577577e-11
XY O 0 5.3975368246028665e-06
patients O 0 1.7062990309568704e-07
with O 0 8.910582775106812e-13
sexual O 0 3.5062303754829216e-11
ambiguity O 0 2.988304326212443e-10
or O 0 3.971049183926212e-11
male O 0 1.6677489250715993e-11
phenotype O 0 6.615819003741308e-11
; O 0 6.385779491996368e-13
and O 0 1.0994604749195447e-12
( O 0 7.06974423122543e-14
3 O 0 4.2982836040428296e-11
) O 0 7.743077148425828e-14
statistically O 0 5.291678119995202e-12
significant O 0 7.758218980441489e-13
evidence O 0 1.3573218070328519e-11
that O 0 8.866356433767653e-12
mutations O 0 1.782534897465382e-09
in O 0 1.5884470627725022e-08
exons O 0 1.9968905462519615e-07
8 O 0 1.2975213792287832e-08
and O 0 3.384886468338344e-11
9 O 0 4.1049591503750094e-10
preferentially O 0 2.6331986591188183e-10
affect O 0 3.4453612185458837e-10
amino O 0 1.096964810654022e-10
acids O 0 3.285904881522583e-11
with O 0 2.436821903116504e-13
different O 0 1.5939736509873459e-12
functions O 0 4.1713013251842845e-12
. O 0 2.0017489402168742e-11
. O 0 8.675756779652488e-10

The O 0 5.4197066674532834e-06
185delAG O 0 0.00037099228939041495
BRCA1 O 0 5.0871367420768365e-06
mutation O 0 6.109273975596352e-09
originated O 0 1.2144794891977284e-10
before O 0 4.075620917143308e-12
the O 0 1.6220290627137757e-13
dispersion O 0 1.09641254408821e-10
of O 0 3.137083301463228e-11
Jews O 0 7.926968109694954e-11
in O 0 1.2277423001860743e-12
the O 0 3.1820923934028356e-12
diaspora O 0 2.116229240456402e-11
and O 0 3.400828609608636e-13
is O 0 1.656536236308015e-14
not O 0 9.911162331382312e-14
limited O 0 2.939937529533587e-11
to O 0 1.8570914250837234e-10
Ashkenazim O 0 2.2591328161070123e-05
. O 0 6.918215689211138e-08

The O 0 1.687810140538204e-07
185delAG O 0 5.271609097690089e-06
mutation O 0 1.5872211633904953e-07
in O 0 3.059953845863106e-09
BRCA1 O 0 3.889198740836264e-09
is O 0 9.178665856882096e-13
detected O 0 6.025701465572908e-11
in O 0 1.034965624487072e-12
Ashkenazi O 0 1.1834019320033917e-09
Jews O 0 4.5723258512708753e-10
both O 0 2.8966481990799764e-12
in O 0 1.0313445930609788e-10
familial B-Disease 1 0.9636702537536621
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.4294290577587798e-11
in O 0 3.2534909553787184e-13
the O 0 1.048328524683173e-12
general O 0 9.079010460100179e-11
population O 0 1.1466647943658703e-12
. O 0 7.312882244203678e-11

All O 0 3.85452061379965e-08
tested O 0 1.4057408570522512e-08
Ashkenazi O 0 7.532576518087808e-08
mutation O 0 1.6656301893291925e-09
carriers O 0 8.829553754807762e-11
share O 0 4.299306570476613e-12
the O 0 1.437471290003517e-13
same O 0 3.381568029064974e-12
allelic O 0 3.3596443405059517e-09
pattern O 0 1.2629702839106471e-09
at O 0 4.759790478425785e-11
the O 0 2.5698862482492757e-10
BRCA1 O 0 6.051207979140827e-09
locus O 0 3.206673815370209e-10
. O 0 1.1299360336280984e-09

Our O 0 1.6143901859777543e-07
previous O 0 4.59863898072399e-08
study O 0 1.3956406863524506e-10
showed O 0 9.691390051580484e-12
that O 0 2.235470042042352e-14
this O 0 1.6572751851406942e-11
Ashkenazi O 0 6.839364630195632e-08
mutation O 0 6.022740639544111e-10
also O 0 3.965474595826052e-13
occurs O 0 4.599434440082095e-13
in O 0 1.2274483187670049e-14
Iraqi O 0 1.397392705021483e-11
Jews O 0 3.5638103579316294e-11
with O 0 1.5596959758879675e-14
a O 0 9.704440213659932e-14
similar O 0 1.9189996813828714e-11
allelic O 0 1.8072151775072598e-08
pattern O 0 4.137506337542618e-08
. O 0 6.72602329387928e-09

We O 0 7.276214741835929e-09
extended O 0 1.6471933150796758e-08
our O 0 1.8868653861581208e-10
analysis O 0 6.301066439451386e-12
to O 0 2.2983490111094795e-12
other O 0 4.920020987841944e-12
non O 0 7.662234402516788e-09
- O 0 2.2971384794345795e-09
Ashkenazi O 0 1.839599361730393e-09
subsets O 0 1.1276861666686955e-09
354 O 0 5.7239411127563145e-11
of O 0 7.368765157517859e-14
Moroccan O 0 1.73650469004194e-11
origin O 0 4.737317309266853e-12
, O 0 3.207715126504751e-13
200 O 0 1.300484568124427e-12
Yemenites O 0 2.3012356464846562e-08
and O 0 8.038579567617998e-13
150 O 0 1.7600521734495445e-12
Iranian O 0 2.454795255957265e-10
Jews O 0 4.0510133025861705e-09
. O 0 3.143507454339556e-09

Heteroduplex O 0 1.4587539226340596e-05
analysis O 0 1.1776534192264876e-09
complemented O 0 2.5348074750297656e-09
by O 0 6.989399944229424e-12
direct O 0 3.624159999882082e-11
DNA O 0 1.112220759935667e-09
sequencing O 0 5.6312301488503635e-09
of O 0 3.2323049792282177e-10
abnormally O 0 3.3476761363004925e-09
migrating O 0 1.1060077298452597e-09
bands O 0 1.5056435265226042e-10
were O 0 8.990551358944998e-12
employed O 0 1.1791587151144256e-10
. O 0 8.875231105598402e-10

Four O 0 7.40747951866183e-09
of O 0 9.990688276673154e-10
Moroccan O 0 5.65521425244242e-08
origin O 0 6.536974850313015e-10
( O 0 1.2370146411106592e-13
1 O 0 1.1166004752760639e-11
. O 0 1.117379030014104e-13
1 O 0 4.324019441115379e-12
% O 0 4.443829608761704e-14
) O 0 3.2683324782156774e-16
and O 0 4.2089067149066184e-14
none O 0 1.0029245663123465e-11
of O 0 2.2144076503027854e-11
the O 0 6.292569243449009e-10
Yemenites O 0 1.7900709963214467e-06
or O 0 3.228477207795066e-11
Iranians O 0 8.515254473762113e-11
was O 0 4.262758115242127e-12
a O 0 3.5274351663358225e-14
carrier O 0 4.803957253697588e-13
of O 0 1.0975245235203546e-12
the O 0 7.601569373960615e-11
185delAG O 0 3.2991485454658687e-07
mutation O 0 2.9187939176722466e-08
. O 0 1.0380794002173843e-08

BRCA1 O 0 0.0001696838007774204
allelic O 0 4.736789833259536e-06
patterns O 0 6.492173554306646e-08
were O 0 6.194929014213812e-10
determined O 0 1.634659768656732e-10
for O 0 3.209246670493604e-12
four O 0 6.367948703067672e-13
of O 0 1.9982158289133523e-12
these O 0 6.187562940317137e-13
individuals O 0 2.133372925745055e-14
and O 0 1.0005638353439983e-13
for O 0 8.079155427347454e-14
12 O 0 4.566079502346665e-13
additional O 0 2.34854751748545e-13
non O 0 3.078051702409823e-10
- O 0 4.605067716045852e-10
Ashkenazi O 0 1.7707627586460717e-09
185delAG O 0 3.430857375974483e-09
mutation O 0 1.4081706634083702e-10
carriers O 0 2.677849608723193e-11
who O 0 1.5901604685786275e-11
had O 0 3.02691987030812e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.120538162373123e-07

Six O 0 2.1195654653638485e-07
non O 0 1.8312354086447158e-06
- O 0 3.0838083375783754e-07
Ashkenazi O 0 7.488397812949188e-08
individuals O 0 2.6434229805083476e-11
shared O 0 7.346487133907953e-12
the O 0 1.8099815266361952e-12
common O 0 3.3563360424260225e-11
Ashkenazi O 0 1.6618104226040487e-08
haplotype O 0 3.1540055012158064e-09
, O 0 5.411592701731749e-11
four O 0 4.326246392377664e-12
had O 0 1.59684696021678e-11
a O 0 5.392731075061497e-13
closely O 0 3.025113146093439e-12
related O 0 1.208112082595747e-10
pattern O 0 3.796662151334118e-10
, O 0 2.0044521055993803e-13
and O 0 2.8774180846173614e-13
the O 0 2.7725405304934725e-11
rest O 0 1.1410464795247321e-09
( O 0 5.82312789567524e-14
n O 0 1.0007156561742114e-11
= O 0 3.217747899728063e-12
6 O 0 1.0779981941821948e-11
) O 0 6.594539011948097e-15
displayed O 0 4.091221719043636e-12
a O 0 1.2043613502321637e-11
distinct O 0 9.957003221927607e-09
BRCA1 O 0 9.579816406812824e-08
allelic O 0 5.408854804045404e-07
pattern O 0 2.947387827134662e-07
. O 0 4.555382204785019e-08

We O 0 1.019450657224752e-08
conclude O 0 2.1033873309761475e-08
that O 0 5.544161050391461e-12
the O 0 2.5339944031976813e-10
185delAG O 0 2.632582209116663e-06
BRCA1 O 0 1.8133582102564105e-07
mutation O 0 8.51824777381438e-10
occurs O 0 5.694822044488568e-11
in O 0 9.290511068793528e-13
some O 0 1.0952033550892804e-12
non O 0 5.687707194113045e-09
- O 0 1.1882359984838331e-08
Ashkenazi O 0 3.0122048855218964e-08
populations O 0 3.6061906932838284e-11
at O 0 3.314756780690986e-13
rates O 0 6.818532826032009e-13
comparable O 0 8.762587552259282e-13
with O 0 5.620930225616442e-16
that O 0 6.274818040380784e-14
of O 0 3.437366502545558e-10
Ashkenazim O 0 3.885551905113971e-06
. O 0 1.2054571563169247e-08

The O 0 1.6359901877649463e-08
majority O 0 2.1857733678576352e-10
of O 0 7.648549571470653e-10
Jewish O 0 8.648570570812808e-08
185delAG O 0 2.05420647603205e-07
mutation O 0 1.2489278500282808e-09
carriers O 0 4.741188344703495e-11
have O 0 3.6245572515580804e-13
a O 0 1.9693601404583566e-13
common O 0 5.6644678531059256e-11
allelic O 0 4.253806196174992e-09
pattern O 0 9.077144036417906e-10
, O 0 1.9455266390966397e-12
supporting O 0 5.685604331090444e-12
the O 0 4.793015637161169e-11
founder O 0 9.114201060533844e-10
effect O 0 5.098845790030282e-09
notion O 0 1.0613315559737657e-08
, O 0 1.306396505730556e-12
but O 0 9.581182418630374e-13
dating O 0 3.1320133986323384e-11
the O 0 2.12133609289733e-12
mutations O 0 4.2572144269038825e-13
origin O 0 9.372220881320725e-13
to O 0 2.0407453667475178e-13
an O 0 2.3843147372920245e-15
earlier O 0 6.70719382811491e-12
date O 0 6.269163854710769e-09
than O 0 1.1619270649798619e-11
currently O 0 2.0699913137744996e-12
estimated O 0 4.886521309116487e-12
. O 0 4.336495051937561e-10

However O 0 2.294284939807767e-08
, O 0 1.6843304528890712e-11
the O 0 1.3903474725684983e-11
different O 0 2.373058693994068e-11
allelic O 0 1.2188015929837093e-08
pattern O 0 2.643354868325787e-09
at O 0 7.656295736291341e-11
the O 0 2.6920260465246315e-10
BRCA1 O 0 2.928104425592437e-09
locus O 0 7.072898516868875e-11
even O 0 3.7495447718916e-11
in O 0 2.1853417513095774e-12
some O 0 1.0075294548314573e-12
Jewish O 0 8.250894412142884e-10
mutation O 0 1.1626147961019129e-10
carriers O 0 2.1876908271045714e-11
, O 0 1.3749510427776834e-12
might O 0 2.3274437932485625e-11
suggest O 0 2.01773372315861e-11
that O 0 1.7041374550646332e-13
the O 0 1.5083330417997587e-11
mutation O 0 5.883131481976278e-11
arose O 0 9.229942365962529e-10
independently O 0 6.988816469988279e-11
. O 0 5.27195509469891e-11
. O 0 1.3466731063616066e-09

Crystal O 0 1.44040700433834e-06
structure O 0 1.473884623237609e-07
of O 0 1.3204459037297056e-07
the O 0 7.576002758469258e-07
hemochromatosis B-Disease 1 1.0
protein O 0 7.194033969426528e-05
HFE O 0 0.0010437165619805455
and O 0 6.471247149253401e-11
characterization O 0 3.018351346639747e-09
of O 0 5.512165168752858e-10
its O 0 8.341098645114897e-11
interaction O 0 1.8329927853333317e-10
with O 0 3.065498809656786e-12
transferrin O 0 1.2769744728302612e-07
receptor O 0 3.187949104699328e-08
. O 0 5.401616043343438e-09

HFE O 1 0.9989451766014099
is O 0 1.9971289066944564e-09
an O 0 2.062358790688723e-11
MHC O 0 2.352962155782734e-06
- O 0 2.0451554973988095e-06
related O 0 2.9706195618928177e-06
protein O 0 6.069494240534823e-09
that O 0 3.657829112302044e-14
is O 0 1.1163388566142168e-14
mutated O 0 1.1965627273735624e-11
in O 0 2.0851513061765498e-13
the O 0 4.8633805316278256e-11
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 5.098984911455773e-05

HFE O 0 0.0003156947495881468
binds O 0 1.662967719084918e-08
to O 0 5.413205439452895e-10
transferrin O 0 1.292283400289307e-07
receptor O 0 8.0147133374453e-09
( O 0 5.107754063454761e-12
TfR O 0 6.172042077423612e-08
) O 0 1.3905211346514762e-13
and O 0 1.8751521873878324e-13
reduces O 0 4.1540028361541914e-11
its O 0 4.125937005244884e-12
affinity O 0 1.642441738169964e-10
for O 0 1.9265214423747068e-11
iron O 0 1.922193888503898e-07
- O 0 1.4350588273259746e-08
loaded O 0 2.0015984425469924e-09
transferrin O 0 2.2695113344184392e-08
, O 0 5.346299358083284e-12
implicating O 0 2.6211388615138276e-09
HFE O 0 0.00020693465194199234
in O 0 1.1976604596952711e-08
iron O 0 0.0008700804901309311
metabolism O 0 0.0036335703916847706
. O 0 3.513865465265553e-07

The O 0 2.3179407548923336e-07
2 O 0 4.509994369072956e-07
. O 0 2.2343812133840402e-08

6 O 0 7.122746410459513e-06
A O 0 3.3268694465959925e-08
crystal O 0 2.5019545546456357e-07
structure O 0 7.113698643479438e-07
of O 0 2.70303985416831e-06
HFE O 1 0.9999679327011108
reveals O 0 1.3546960886401394e-08
the O 0 1.5463776092961012e-11
locations O 0 1.389791337569335e-10
of O 0 4.185924495914151e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 6.771103926439537e-06
and O 0 3.1584241888538145e-09
a O 0 1.0094386437842218e-10
patch O 0 0.00014160957653075457
of O 0 7.284031016752124e-05
histidines O 1 0.7375561594963074
that O 0 9.802264035185804e-12
could O 0 1.873515882364063e-12
be O 0 3.368042064862131e-13
involved O 0 2.8024758620508183e-13
in O 0 6.907993057789219e-13
pH O 0 6.745631253579631e-08
- O 0 5.3150248646716136e-08
dependent O 0 1.2403395643900694e-08
interactions O 0 7.084350883701518e-10
. O 0 2.3088757572509166e-09

We O 0 6.79765648214925e-08
also O 0 1.7494443393939463e-10
demonstrate O 0 2.2488344519899783e-10
that O 0 1.0432943571558884e-11
soluble O 0 5.506505840457976e-05
TfR O 0 4.171754699200392e-05
and O 0 1.4111335711053385e-10
HFE O 0 6.169424295876524e-07
bind O 0 7.749294261838457e-11
tightly O 0 6.189106449561166e-10
at O 0 1.3598094004974026e-11
the O 0 1.149349886098161e-11
basic O 0 5.219950693913233e-09
pH O 0 3.327370734496071e-08
of O 0 1.0371334013825617e-08
the O 0 5.577246997567897e-10
cell O 0 8.476755963826577e-10
surface O 0 1.0075963396971588e-09
, O 0 7.576419418058034e-13
but O 0 3.733955852847082e-12
not O 0 2.369023597084685e-12
at O 0 9.047405186146662e-12
the O 0 2.2787077780250797e-11
acidic O 0 4.869839287380273e-08
pH O 0 1.680207333265571e-07
of O 0 3.3395897158783328e-09
intracellular O 0 1.5932890562453395e-09
vesicles O 0 2.0843459935804276e-07
. O 0 1.6870981056626988e-08

TfR O 0 0.0037895883433520794
HFE O 0 0.0030316603370010853
stoichiometry O 0 4.473464741749922e-06
( O 0 4.2163234015291096e-10
2 O 0 3.3253773068508963e-09
1 O 0 5.217738463514365e-10
) O 0 1.5646757164661934e-13
differs O 0 3.2981256614661447e-10
from O 0 3.613916804701134e-11
TfR O 0 2.1312203557499743e-07
transferrin O 0 9.87015624787091e-09
stoichiometry O 0 1.4077532917156077e-08
( O 0 2.4418292908501282e-12
2 O 0 1.2590492537434272e-10
2 O 0 1.9933213066258837e-11
) O 0 2.3537392195883966e-14
, O 0 1.218261602708992e-13
implying O 0 1.3677404694933948e-11
a O 0 1.2449517328497195e-12
different O 0 4.8049676217021275e-12
mode O 0 9.056979055621639e-10
of O 0 5.932448976508908e-12
binding O 0 1.1177729575262418e-10
for O 0 1.2100308255380554e-10
HFE O 0 2.7252295694779605e-05
and O 0 2.463063641933161e-10
transferrin O 0 4.0750073537765275e-08
to O 0 3.797944181371804e-10
TfR O 0 1.6575231711613014e-06
, O 0 4.498636272526335e-12
consistent O 0 1.5528570096456917e-10
with O 0 1.4052065175525208e-13
our O 0 1.9527175015854326e-11
demonstration O 0 5.556192173017394e-10
that O 0 9.99170256081594e-13
HFE O 0 4.4317748688627034e-06
, O 0 1.1957230344750158e-11
transferrin O 0 2.1853418630257693e-08
, O 0 8.760586873990395e-12
and O 0 1.6071617777932423e-12
TfR O 0 1.2316053066285804e-08
form O 0 1.2747787851360992e-12
a O 0 8.086589666118915e-13
ternary O 0 8.974977561138076e-08
complex O 0 3.050006398552796e-07
. O 0 4.0265721423793366e-08

Identification O 0 8.143824175022019e-07
of O 0 4.569427503042789e-08
three O 0 1.5465020930527373e-10
novel O 0 8.963969566622154e-10
mutations O 0 7.232483362207276e-11
and O 0 1.0053237539317528e-12
a O 0 9.16683382304849e-14
high O 0 8.872920627400749e-12
frequency O 0 7.737150330144882e-12
of O 0 1.2096279923892728e-12
the O 0 1.2779296718057331e-11
Arg778Leu O 0 3.175272524913453e-07
mutation O 0 1.7392701168184033e-10
in O 0 8.645613521970907e-13
Korean O 0 2.2840056512762885e-09
patients O 0 2.966984158359054e-10
with O 0 5.989007033357918e-13
Wilson B-Disease 0 1.0578190767773776e-08
disease I-Disease 0 1.1223329821063999e-08
. O 0 8.987873556520753e-09

Four O 0 9.482699070417766e-09
mutations O 0 1.0164170199944422e-10
- O 0 3.2501898394876605e-10
- O 0 1.4001688697362624e-09
R778L O 0 1.3994379877146912e-08
, O 0 1.1184670811043018e-12
A874V O 0 4.992131708014824e-10
, O 0 2.0799993129781702e-13
L1083F O 0 1.5809795139709593e-10
, O 0 1.5279638177542049e-13
and O 0 7.300843279543431e-14
2304delC O 0 3.320733965583855e-11
- O 0 1.2871813857839864e-11
- O 0 1.706377955601468e-10
in O 0 1.3215041040626208e-11
the O 0 1.0762292966537412e-11
copper O 0 1.497569568353896e-10
- O 0 3.834918927553277e-12
transporting O 0 8.656429739684057e-11
enzyme O 0 9.493945907212975e-11
, O 0 6.697682772976998e-12
P O 0 4.3550748785037285e-08
- O 0 1.604181232295332e-09
type O 0 4.442163081819217e-09
ATPase O 0 1.9449433175111608e-09
( O 0 4.871963834966742e-13
ATP7B O 0 1.926712002386921e-06
) O 0 1.4566840301263179e-13
, O 0 7.742516073801567e-14
were O 0 5.984850202228609e-13
identified O 0 3.3411373169013603e-13
in O 0 2.000205150164483e-13
Korean O 0 6.7261392011630505e-09
Patients O 0 4.575424927821814e-09
with O 0 4.026584838126568e-13
Wilson B-Disease 0 1.3197101189632576e-08
disease I-Disease 0 2.8097836946017196e-08
. O 0 3.315056318342613e-08

Arg778Leu O 0 0.00035461137304082513
, O 0 3.2982403475045885e-09
the O 0 2.2215975725714543e-09
most O 0 3.03846836580135e-10
frequently O 0 3.328330666629853e-11
reported O 0 8.359824985038067e-12
mutation O 0 2.5389133503916916e-11
of O 0 2.4460258471470375e-11
this O 0 6.728951597312349e-12
enzyme O 0 2.6635421646048485e-10
, O 0 8.2448926158607e-12
was O 0 1.1203107885826569e-10
found O 0 4.649501270104217e-12
in O 0 1.5488562038826204e-12
six O 0 1.7335716195887585e-12
of O 0 9.417256904842297e-12
eight O 0 4.900690096787397e-12
unrelated O 0 3.628014277889946e-10
patients O 0 1.2967828200149967e-10
studied O 0 1.7537789796795433e-12
, O 0 6.216609851542173e-15
an O 0 1.3982057563621461e-15
allele O 0 1.7390029303718246e-12
frequency O 0 8.526387235141542e-11
of O 0 4.2753245388382766e-11
37 O 0 1.044255526494453e-08
. O 0 8.093118175622749e-09

5 O 0 4.074063895131985e-07
% O 0 2.064911353016896e-09
, O 0 2.4721164785385108e-12
which O 0 1.6948958512716383e-13
is O 0 1.1024985584846478e-13
considerably O 0 1.0264057381803582e-09
higher O 0 4.4020215250739625e-10
than O 0 8.394749196997953e-13
those O 0 8.723266249968664e-13
in O 0 8.556974573359355e-13
other O 0 2.5540609124158342e-12
Asian O 0 4.2781958531357134e-11
populations O 0 2.5122216806838793e-11
. O 0 7.441288557563652e-11

The O 0 2.079904248830644e-09
novel O 0 8.489440816994431e-10
single O 0 5.024493668348562e-11
nucleotide O 0 2.703533175107964e-09
deletion O 0 6.556203913099523e-10
, O 0 4.833332952619562e-12
2304delC O 0 1.0290741592200447e-08
, O 0 2.2781808991373387e-12
was O 0 6.980477307294564e-11
found O 0 6.82096957041467e-12
in O 0 3.7008443184993745e-12
one O 0 1.0214227033622514e-11
patient O 0 6.318902734392395e-08
. O 0 1.1873071414925107e-08

Since O 0 4.088161809079338e-09
a O 0 1.5365634112307625e-11
mutation O 0 5.626597451846571e-11
at O 0 5.7145819326587244e-11
cDNA O 0 4.647185303241486e-09
nucleotide O 0 3.889222810471438e-08
2302 O 0 3.948393441532971e-06
( O 0 3.3306786148545875e-12
2302insC O 0 3.757918420888018e-09
) O 0 8.335253060681724e-13
had O 0 3.87493370723746e-11
been O 0 6.954466082870203e-12
previously O 0 2.282766337069475e-11
described O 0 1.1540728442338555e-11
, O 0 1.179777846596619e-13
this O 0 3.916361050564088e-13
region O 0 7.144296959582519e-11
of O 0 1.168809354856748e-10
the O 0 9.603408068770136e-10
ATP7B O 0 0.05482527241110802
gene O 0 3.758969802092338e-10
may O 0 3.6267067127226937e-10
be O 0 2.368301908750592e-11
susceptible O 0 1.0166257879973273e-07
to O 0 7.061363160865142e-10
gene O 0 2.179647395905704e-08
rearrangements O 0 0.0009018832352012396
causing O 0 0.0003817400138359517
Wilson B-Disease 0 0.00010242420830763876
disease I-Disease 0 7.554383500973927e-06
. O 0 6.277135611298945e-08

Disruption O 0 5.5457335292885546e-06
of O 0 1.3652663888308325e-08
splicing O 0 2.1154654916699656e-08
regulated O 0 1.4180713270306455e-09
by O 0 2.6185416682200646e-12
a O 0 1.955407407175369e-12
CUG O 0 9.295198651670944e-06
- O 0 6.6374385987444384e-09
binding O 0 8.995745481854556e-09
protein O 0 2.752234138370113e-07
in O 0 5.439567130061107e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.6955773389781825e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.5770666550452006e-07
DM B-Disease 1 1.0
) O 0 4.892308225201702e-10
is O 0 6.437070061010575e-12
caused O 0 7.504658700030475e-11
by O 0 6.421128819628086e-12
a O 0 1.588674851393801e-11
CTG O 0 3.661149037270661e-07
expansion O 0 2.9995785855163604e-09
in O 0 4.330522919426816e-12
the O 0 1.12291807796705e-11
3 O 0 1.3669455845022327e-10
untranslated O 0 8.349897484549729e-08
region O 0 8.927275585435268e-12
of O 0 5.071960212932325e-12
the O 0 2.663802511904123e-09
DM B-Disease 1 1.0
gene O 0 1.2298382046083134e-07
. O 0 6.607945834957718e-08

One O 0 9.943612599982998e-11
model O 0 3.66278618546545e-10
of O 0 5.130756708382478e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.9827648997306824
suggests O 0 2.1860913079763122e-09
that O 0 7.14186129398102e-14
RNAs O 0 2.362716272630294e-11
from O 0 1.6728420948811107e-12
the O 0 1.510503874757596e-11
expanded O 0 1.6012465797743403e-09
allele O 0 2.660170694834818e-10
create O 0 4.5302455363438465e-12
a O 0 1.160340703729168e-12
gain O 0 1.0612858508673995e-10
- O 0 4.4184395725510583e-11
of O 0 9.947938306442694e-11
- O 0 1.6714532535822002e-10
function O 0 4.832005455479571e-12
mutation O 0 6.839034547012623e-13
by O 0 5.829125312458274e-15
the O 0 3.9125583469693664e-14
inappropriate O 0 3.9738503286590454e-12
binding O 0 1.799003133962085e-11
of O 0 9.582379334460711e-11
proteins O 0 1.6871879327667871e-12
to O 0 4.04777860535388e-12
the O 0 2.403378884796581e-10
CUG O 0 0.007363865617662668
repeats O 0 4.9892623366076805e-08
. O 0 7.823902414827444e-09

Data O 0 3.192389241846172e-09
presented O 0 1.0003234907074443e-09
here O 0 3.925683736416552e-11
indicate O 0 8.203891732616597e-11
that O 0 6.955626531560469e-14
the O 0 2.229631063110915e-11
conserved O 0 7.329925999499665e-09
heterogeneous O 0 3.03583540528507e-08
nuclear O 0 4.028900661978696e-07
ribonucleoprotein O 0 3.5592717040344724e-07
, O 0 2.6012346790449392e-11
CUG O 0 1.1400026096453075e-06
- O 0 1.0012779494417146e-09
binding O 0 1.3712865287729414e-09
protein O 0 3.4635730394860786e-10
( O 0 2.148278164517889e-13
CUG O 0 6.981237675063312e-06
- O 0 1.423755247031977e-08
BP O 0 9.155223068546547e-08
) O 0 2.488782834333958e-13
, O 0 6.443380442915092e-13
may O 0 4.82149459246628e-11
mediate O 0 7.135200069674497e-11
the O 0 3.472010873251108e-11
trans O 0 1.566864277213753e-10
- O 0 3.6335698894163215e-09
dominant O 0 2.3042476815504642e-09
effect O 0 3.1146212275956486e-09
of O 0 2.264596982159972e-10
the O 0 1.7896233106551307e-10
RNA O 0 1.6265991886754705e-09
. O 0 8.291138331451009e-10

CUG O 1 0.9999994039535522
- O 1 0.898262619972229
BP O 0 0.00045915908413007855
was O 0 5.103486522273215e-09
found O 0 2.7722379513511752e-12
to O 0 1.3047797163458913e-13
bind O 0 4.898052449742174e-13
to O 0 2.691693439318965e-13
the O 0 3.6357830808519953e-12
human O 0 8.052920830170507e-11
cardiac O 0 5.764900379290339e-06
troponin O 0 2.88073206320405e-05
T O 0 1.0916831342910882e-05
( O 0 8.250111206177524e-13
cTNT O 0 1.4521263080879976e-09
) O 0 1.2664219987360698e-13
pre O 0 1.5806367326121062e-09
- O 0 4.097668593328052e-10
messenger O 0 2.1727879218058632e-10
RNA O 0 1.174398217562711e-10
and O 0 6.193182902278216e-13
regulate O 0 2.664052572293185e-12
its O 0 1.43748023467144e-12
alternative O 0 2.7409061686967107e-09
splicing O 0 1.5963072641511644e-08
. O 0 5.588228102482162e-09

Splicing O 0 7.866491813501852e-08
of O 0 1.5381639073552833e-08
cTNT O 0 1.2445750144252088e-05
was O 0 3.271800963489113e-08
disrupted O 0 7.305577128136065e-06
in O 0 1.5223765359451136e-08
DM B-Disease 1 1.0
striated O 0 6.6029774643538985e-06
muscle O 0 9.664428262112779e-07
and O 0 1.8312928062869105e-08
in O 0 2.1564932062290154e-09
normal O 0 1.7172969819512218e-06
cells O 0 4.074759019090379e-08
expressing O 0 9.153080376966827e-11
transcripts O 0 4.6828874111781715e-11
that O 0 1.114650093145958e-13
contain O 0 3.553074501283504e-10
CUG O 0 0.00019083372899331152
repeats O 0 2.965708389979227e-08
. O 0 7.904932708413526e-09

Altered O 0 6.624977686442435e-06
expression O 0 4.345338311395608e-07
of O 0 1.768501221022234e-07
genes O 0 5.777366141046514e-08
regulated O 0 6.029066668133964e-08
posttranscriptionally O 0 4.520871641489066e-07
by O 0 5.489397270075358e-10
CUG O 1 1.0
- O 0 0.001640393165871501
BP O 0 9.708689503895584e-06
therefore O 0 1.7574240673834396e-10
may O 0 8.116510068212346e-12
contribute O 0 9.345521752301966e-12
to O 0 5.6520999686116014e-11
DM B-Disease 1 1.0
pathogenesis O 0 0.00023331353440880775
. O 0 2.9256927991383463e-09
. O 0 1.876565569602917e-09

Identification O 0 3.1700317038030335e-08
of O 0 8.300664045002293e-10
a O 0 1.3594359145330248e-11
novel O 0 4.4262524201421627e-10
nonsense O 0 2.920507613524137e-09
mutation O 0 1.2063529342132284e-10
and O 0 2.938616960445478e-13
a O 0 1.196956352393294e-13
missense O 0 1.5115364515594365e-10
substitution O 0 3.011006999287247e-10
in O 0 9.716988498553736e-12
the O 0 2.23764895501688e-11
vasopressin O 0 4.416832177778218e-10
- O 0 5.107067546639144e-10
neurophysin O 0 4.055158697724437e-08
II O 1 0.9981009364128113
gene O 0 1.335917210187887e-10
in O 0 5.965638573413035e-12
two O 0 2.7068400147191307e-13
Spanish O 0 3.0635362302522395e-11
kindreds O 0 5.641378475473857e-09
with O 0 3.6032528957091747e-12
familial B-Disease 0 4.196925146970898e-05
neurohypophyseal I-Disease 1 0.9999966621398926
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999936819076538
. O 0 6.125090749264928e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 8.471232604279066e-09
FNDI B-Disease 1 1.0
) O 0 1.2248799197145388e-11
is O 0 6.609303490785756e-13
an O 0 2.010349352266072e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 3.5305882192915305e-05
by O 0 5.354940935120567e-09
deficiency O 0 0.31606969237327576
in O 0 1.4299104122983408e-09
the O 0 3.674992088420481e-09
antidiuretic O 0 1.7272489571951155e-07
hormone O 0 6.666136975752579e-09
arginine O 0 5.344369835569296e-09
vasopressin O 0 4.164947053908463e-09
( O 0 2.0887666596358656e-12
AVP O 0 1.1554909029598548e-08
) O 0 6.368917302183516e-14
encoded O 0 6.788867428289547e-13
by O 0 8.57411309920092e-13
the O 0 1.3749576477373182e-10
AVP O 0 4.411484042066149e-06
- O 0 5.679871151187399e-07
neurophysin O 0 0.00010484146332601085
II O 1 1.0
( O 0 2.996170644919971e-09
AVP O 0 8.280072506750003e-06
- O 0 1.5200878067389567e-07
NPII O 0 3.461820597294718e-05
) O 0 1.3199246383377439e-11
gene O 0 1.4517648368184144e-11
on O 0 1.336251109762543e-10
chromosome O 0 1.7042905975372946e-09
20p13 O 0 4.6372576889552874e-07
. O 0 4.43346408474099e-08

In O 0 8.230068848646965e-10
this O 0 1.3373264301508314e-11
study O 0 1.1199533488104318e-11
, O 0 3.144244576074734e-13
we O 0 2.3975282479812843e-13
analyzed O 0 6.755548898063068e-11
two O 0 4.2699741312213213e-13
families O 0 1.6734260461712114e-12
with O 0 1.6301582750778004e-13
FNDI B-Disease 1 1.0
using O 0 6.398319374323336e-11
direct O 0 8.186838013068964e-11
automated O 0 9.472534978627323e-10
fluorescent O 0 4.739385328633716e-09
, O 0 2.5130914601927123e-13
solid O 0 4.8432629434769225e-12
phase O 0 9.112075677331077e-11
, O 0 6.773719091060851e-14
single O 0 4.0478997107365466e-13
- O 0 4.0148310023746525e-12
stranded O 0 6.775499605815583e-11
DNA O 0 2.0977020034201876e-12
sequencing O 0 9.86541664332874e-12
of O 0 2.880933989632406e-12
PCR O 0 3.480011656620263e-08
- O 0 6.272371706472768e-07
amplified O 0 3.331840616738191e-06
AVP O 0 1.6115678590722382e-05
- O 0 1.3243857210909482e-07
NPII O 0 3.0361707104020752e-05
DNA O 0 1.1596311111361501e-07
. O 0 3.1385707366382576e-09

In O 0 1.4557564043116145e-09
one O 0 2.2559595250909448e-12
of O 0 1.3532858644457746e-12
the O 0 2.6957023852719475e-12
families O 0 1.5833529149258951e-12
, O 0 5.79340449311655e-14
affected O 0 6.3596740720872624e-12
individuals O 0 1.3337028421760155e-13
presented O 0 1.5502765737807067e-10
a O 0 2.7783675967535393e-12
novel O 0 3.775366963498783e-10
nonsense O 0 2.592751791041792e-09
mutation O 0 5.048798532025778e-11
in O 0 1.0960858089215098e-11
exon O 0 1.8020845926614015e-10
3 O 0 7.825312620113323e-11
of O 0 1.569980603854937e-11
the O 0 5.979083200768898e-11
gene O 0 3.563591045516179e-12
, O 0 2.0057458298416986e-12
consisting O 0 1.6633862256337784e-12
in O 0 8.057091235511016e-13
a O 0 2.7892206773405537e-12
G O 0 2.044560609704149e-08
to O 0 9.39748764916537e-11
T O 0 3.0077384138849084e-08
transition O 0 6.600583413174377e-10
at O 0 4.6278449822301226e-11
nucleotide O 0 1.1963995349972834e-09
2101 O 0 4.558833097689785e-07
, O 0 7.459925147230984e-13
which O 0 1.3974706164672241e-14
produces O 0 2.779445951010557e-14
a O 0 1.1097577494272298e-14
stop O 0 1.4762105383578361e-12
signal O 0 1.5398413100164987e-10
in O 0 5.1904983783268577e-11
codon O 0 1.6282388770605394e-08
82 O 0 1.2292072426589584e-07
( O 0 1.0021520072123202e-11
Glu O 0 1.7614905800655833e-07
) O 0 1.086887741266751e-12
of O 0 1.1258093762789301e-10
NPII O 0 0.06214407458901405
. O 0 2.632870916841057e-07

The O 0 3.0967814268478833e-07
premature O 0 8.536847417417448e-06
termination O 0 7.909277428552741e-07
eliminates O 0 2.3765275969367394e-08
part O 0 4.5378345525648456e-10
of O 0 1.5767342986805488e-09
the O 0 6.609695457626685e-09
C O 0 3.956509715408174e-07
- O 0 3.882518750941699e-10
terminal O 0 4.661620423007662e-09
domain O 0 1.1919393250181542e-10
of O 0 6.5065661192242885e-12
NPII O 0 9.44675412029028e-06
, O 0 2.762483384405323e-12
including O 0 6.421052383374926e-13
a O 0 9.452631819645285e-13
cysteine O 0 7.15941125828401e-11
residue O 0 1.9625021607794224e-09
in O 0 3.646069904328364e-11
position O 0 1.0150089657656736e-09
85 O 0 1.1968789292993165e-09
, O 0 5.469052402791441e-13
which O 0 5.5922121452870246e-14
could O 0 3.1318787081964505e-13
be O 0 3.277139031063886e-13
involved O 0 5.560286389302838e-13
in O 0 2.8869064799298683e-13
the O 0 3.5786438916385332e-12
correct O 0 3.8295866477966456e-10
folding O 0 7.737984697442357e-10
of O 0 3.076488716557968e-11
the O 0 8.668379902765366e-10
prohormone O 0 0.00010523852688493207
. O 0 8.255672412360582e-08

In O 0 1.9030503561889844e-10
the O 0 7.713784472285212e-11
second O 0 1.4678738224915833e-09
family O 0 1.5312095341668552e-11
, O 0 2.1318160453066837e-13
a O 0 4.72067995587952e-14
G279A O 0 8.19325857159825e-11
substitution O 0 2.0954486756874502e-10
at O 0 2.3403621055018142e-11
position O 0 1.3201865815826164e-11
- O 0 6.249407675379404e-12
1 O 0 1.2121884052085363e-10
of O 0 1.6296926915598808e-12
the O 0 7.546823951355697e-13
signal O 0 4.42629231878211e-11
peptide O 0 7.032914181581695e-12
was O 0 2.932951624623481e-12
observed O 0 1.5300271466456294e-11
in O 0 2.97765046126941e-12
all O 0 9.579761463263115e-12
affected O 0 5.442960526735874e-10
individuals O 0 2.862520810664737e-11
. O 0 6.616229342171209e-09

This O 0 3.066633524895224e-08
missense O 0 1.1360152711858973e-05
mutation O 0 4.677806231256909e-08
, O 0 5.188835472402786e-11
which O 0 3.090486200285625e-11
replaces O 0 4.2969051605723507e-07
Ala O 0 8.341315833604313e-07
with O 0 1.259933268826785e-10
Thr O 0 4.0153818190447055e-06
, O 0 3.6003627162939367e-11
is O 0 8.83850880938758e-13
frequent O 0 1.3695390307932875e-11
among O 0 2.4511163931872915e-11
FNDI B-Disease 1 1.0
patients O 1 1.0
and O 0 4.873448866682395e-10
is O 0 3.835928536616295e-12
thought O 0 1.5055364940841365e-11
to O 0 3.7516010805739575e-13
reduce O 0 1.1193042152857213e-11
the O 0 2.053404538418513e-12
efficiency O 0 8.908302429055936e-10
of O 0 2.093849746365173e-11
cleavage O 0 4.634929245961317e-11
by O 0 4.965357552205729e-12
signal O 0 7.087273878880751e-09
peptidases O 0 3.5045708557390753e-08
. O 0 1.0530389060736667e-10
. O 0 3.7694666832344126e-10

Genetic O 0 6.943272410353529e-07
heterogeneity O 0 2.2550783285169018e-07
of O 0 4.396135722117833e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.283930320538644e-11
due O 0 2.359598916257255e-08
to O 0 1.0729893362704246e-10
TWIST O 0 0.00038627232424914837
and O 0 2.9863005401864484e-09
FGFR O 1 0.9986791014671326
mutations O 0 7.258674941112986e-07
. O 0 2.7070122143868502e-08

Thirty O 0 2.8980196020711446e-06
- O 0 2.3493603862334567e-07
two O 0 1.9801871947722205e-11
unrelated O 0 1.4513988233488817e-08
patients O 0 2.621513894851546e-09
with O 0 6.609902072028922e-15
features O 0 2.392399646444776e-12
of O 0 5.744703601706647e-10
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.39843105913451e-12
a O 0 7.178971501466125e-13
common O 0 1.1045134584719563e-08
autosomal B-Disease 0 0.45525288581848145
dominant I-Disease 0 0.0012688047718256712
condition I-Disease 1 0.9998511075973511
of O 1 0.7213853597640991
craniosynostosis B-Disease 1 1.0
and O 0 0.00010717803525039926
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9932025671005249
, O 0 2.7000068847371494e-10
were O 0 9.825629893045473e-11
screened O 0 2.809426857819375e-10
for O 0 1.1640870559159744e-12
mutations O 0 7.66665290280466e-12
in O 0 1.4251821944810672e-11
TWIST O 0 3.1139632028498454e-06
, O 0 1.7558828002695037e-10
FGFR2 O 1 0.9642338752746582
, O 0 1.7861416512499062e-10
and O 0 1.831745033431531e-10
FGFR3 O 0 0.43051809072494507
. O 0 2.0461472161059646e-07

Nine O 0 3.757404272164422e-07
novel O 0 4.61420768260723e-08
and O 0 1.2953593753195491e-09
three O 0 1.777597513630269e-10
recurrent O 0 4.0241999954560015e-08
TWIST O 0 7.894033842603676e-06
mutations O 0 1.1004839262085397e-09
were O 0 1.6058265828178264e-11
found O 0 2.8334994940648617e-13
in O 0 9.3669494903581e-13
12 O 0 1.5022443011769582e-10
families O 0 8.353231301105879e-11
. O 0 8.875248314055284e-10

Seven O 0 8.963070996514944e-08
families O 0 5.331559083110449e-10
were O 0 1.1401343064099123e-10
found O 0 4.9636054814949926e-12
to O 0 2.5617208007644443e-12
have O 0 7.163915727997905e-12
the O 0 2.988053693364634e-10
FGFR3 O 0 0.0013920161873102188
P250R O 0 2.3705025853359984e-07
mutation O 0 3.2425551133030694e-10
, O 0 6.317043242665132e-13
and O 0 3.067696379040197e-13
one O 0 3.4206165189839405e-14
individual O 0 1.4436058753020294e-14
was O 0 2.5140419260272218e-12
found O 0 4.555735671520067e-13
to O 0 8.675810720878974e-13
have O 0 5.668421027699155e-12
an O 0 5.348376906286201e-13
FGFR2 O 0 2.9343926144065335e-05
VV269 O 0 5.391175363911316e-07
- O 0 1.6277109438078696e-08
270 O 0 1.1417866652152497e-09
deletion O 0 1.0149954210447731e-09
. O 0 5.955435034010748e-10

To O 0 5.250282986146715e-10
date O 0 6.514836741189356e-07
, O 0 6.540874786242767e-11
our O 0 6.920683644218162e-12
detection O 0 1.8398089995930178e-10
rate O 0 2.8425855419511592e-11
for O 0 5.844870892618079e-14
TWIST O 0 4.995394675688658e-08
or O 0 1.1024503532297558e-09
FGFR O 0 0.00023132817295845598
mutations O 0 5.533950520053565e-10
is O 0 1.9928717964051712e-12
68 O 0 2.5319687319003137e-11
% O 0 3.978284986595054e-13
in O 0 2.7364604180714347e-13
our O 0 2.663445575201706e-10
Saethre B-Disease 1 0.9808405041694641
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.9852383047691546e-05
, O 0 5.435752759366808e-13
including O 0 2.421393706202035e-13
our O 0 4.9988183731253244e-11
five O 0 1.7766329856935825e-12
patients O 0 4.245380436085355e-11
elsewhere O 0 1.9353930350712867e-12
reported O 0 2.3985162272109617e-13
with O 0 6.130353928483767e-13
TWIST O 0 1.3119986761012115e-05
mutations O 0 3.060264575083238e-08
. O 0 1.229577328842879e-08

More O 0 7.150070313599599e-09
than O 0 1.817005018667217e-10
35 O 0 1.5892220872615326e-09
different O 0 4.497582861695548e-11
TWIST O 0 7.833004929125309e-07
mutations O 0 4.2122241805664373e-10
are O 0 9.103658582185203e-13
now O 0 2.9008710039114816e-13
known O 0 5.843989978352934e-14
in O 0 9.139179891386531e-14
the O 0 8.228188638249867e-13
literature O 0 3.4402636989172564e-11
. O 0 1.4178569429645904e-10

The O 0 1.4054867847335117e-07
most O 0 8.591412581360203e-10
common O 0 1.872931670865441e-10
phenotypic O 0 4.5917779994963936e-11
features O 0 1.993640669217811e-11
, O 0 3.7521307133352166e-13
present O 0 8.745845193891544e-12
in O 0 2.9995398526105888e-12
more O 0 1.596029352516487e-13
than O 0 5.862041944524818e-14
a O 0 4.326341395593028e-14
third O 0 1.5098240366273608e-11
of O 0 2.27806870589653e-11
our O 0 4.137186426778072e-10
patients O 0 4.393172770011944e-10
with O 0 4.743933653024446e-13
TWIST O 0 3.879621317537385e-07
mutations O 0 6.953956299682318e-10
, O 0 2.5356355470157466e-12
are O 0 1.7959098834799403e-12
coronal B-Disease 0 9.314020417150459e-07
synostosis I-Disease 0 2.3227657948154956e-06
, O 0 3.7946135122979285e-10
brachycephaly B-Disease 0 3.847062907880172e-05
, O 0 1.9331830358737534e-08
low B-Disease 0 0.0021042018197476864
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 0 5.680179810951813e-07
facial B-Disease 1 0.9844996929168701
asymmetry I-Disease 1 0.9999784231185913
, O 0 3.463417641569322e-08
ptosis B-Disease 1 0.9816619753837585
, O 0 8.190730871326934e-10
hypertelorism B-Disease 0 2.7147013952344423e-06
, O 0 4.305917011837579e-10
broad B-Disease 0 2.2073618310969323e-06
great I-Disease 0 0.0001413416612194851
toes I-Disease 0 0.0007888298714533448
, O 0 3.3650360276027413e-10
and O 0 3.311867724509199e-10
clinodactyly B-Disease 0 6.07638867222704e-05
. O 0 5.759915211456246e-07

Significant O 0 2.4092435069178464e-06
intra O 0 4.439612166606821e-05
- O 0 4.809163874597289e-05
and O 0 4.901482775210297e-09
interfamilial O 0 3.7237048218230484e-06
phenotypic O 0 3.1506520059565446e-08
variability O 0 6.467751489935836e-08
is O 0 5.746820662573537e-13
present O 0 1.7885328634781317e-12
for O 0 1.3987519909691715e-12
either O 0 1.4272075743448909e-09
TWIST O 0 4.8718480684328824e-05
mutations O 0 1.8606392870879063e-07
or O 0 1.9091382696956316e-08
FGFR O 0 0.04711592197418213
mutations O 0 5.302059662426473e-07
. O 0 3.0252632399196955e-08

The O 0 6.53607017397917e-08
overlap O 0 5.528677959887318e-09
in O 0 8.018909841700506e-11
clinical O 0 1.036743246807248e-09
features O 0 3.774990389726618e-11
and O 0 5.46148673161162e-12
the O 0 1.360800534755402e-11
presence O 0 1.246356490236522e-11
, O 0 1.1502968716436968e-12
in O 0 1.1117248614744835e-12
the O 0 8.264478511266216e-12
same O 0 8.022469841217905e-12
genes O 0 3.110603354755659e-12
, O 0 1.9806989978287531e-13
of O 0 5.661246645083384e-12
mutations O 0 8.976411194211442e-13
for O 0 3.4147316051169607e-13
more O 0 3.96485443218339e-13
than O 0 2.399460187832436e-12
one O 0 5.545522266219016e-13
craniosynostotic B-Disease 0 4.377433082680682e-09
condition I-Disease 0 1.7209968561360256e-08
- O 0 6.019088560904606e-10
such O 0 4.2310155379254866e-11
as O 0 1.8376581506496237e-11
Saethre B-Disease 0 1.0100755076791756e-07
- I-Disease 0 2.3774284763078413e-09
Chotzen I-Disease 0 3.234898997561686e-07
, I-Disease 0 1.2404653693121048e-11
Crouzon I-Disease 0 4.567110863717971e-06
, I-Disease 0 2.0266445466265992e-10
and I-Disease 0 1.1687898426870902e-09
Pfeiffer I-Disease 0 0.007024609018117189
syndromes I-Disease 1 0.9999948740005493
- O 0 0.002354367170482874
support O 0 1.6999475604961845e-08
the O 0 8.226490599838598e-10
hypothesis O 0 2.074848515221106e-09
that O 0 1.198823077483771e-13
TWIST O 0 1.0844261311149239e-07
and O 0 1.7937540341961267e-11
FGFRs O 0 1.1653672515876679e-07
are O 0 4.674298600092219e-13
components O 0 1.947435789018126e-11
of O 0 5.629181148991691e-12
the O 0 3.95411741543894e-12
same O 0 5.9862123938381195e-12
molecular O 0 1.1500823730858922e-11
pathway O 0 8.903639978075084e-12
involved O 0 1.585959757076892e-14
in O 0 2.6459901079949532e-15
the O 0 3.060436425767962e-14
modulation O 0 2.9091576370099403e-11
of O 0 4.632472183629943e-11
craniofacial O 1 0.9999746084213257
and O 0 7.718563921343957e-08
limb O 1 0.999997615814209
development O 0 4.200474847948499e-07
in O 0 9.440550424733019e-11
humans O 0 9.646212995040315e-11
. O 0 2.419807756948167e-11
. O 0 2.438815538408079e-10

Mutation O 0 1.8973112858589047e-08
analysis O 0 1.2941438198854627e-10
of O 0 5.679768322330858e-10
UBE3A O 1 1.0
in O 0 0.00027337035862728953
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999556541442871
. O 0 3.9645769334129e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.158844373909233e-07
AS B-Disease 1 1.0
) O 0 1.6026749372066718e-11
is O 0 4.2281233852622946e-13
caused O 0 6.752376435770202e-12
by O 0 9.473572967766408e-12
chromosome O 0 3.931830139247694e-10
15q11 O 0 4.375140250090226e-08
- O 0 2.517577479821398e-09
q13 O 0 1.982072106443411e-08
deletions O 0 2.215473360323017e-10
of O 0 5.026868244578653e-12
maternal O 0 1.8540513568865435e-10
origin O 0 7.444677686818668e-12
, O 0 4.686105765038494e-14
by O 0 4.077407628113455e-13
paternal O 0 2.239316927443724e-06
uniparental B-Disease 1 0.999405026435852
disomy I-Disease 1 0.9998204112052917
( O 0 2.389457298690445e-09
UPD B-Disease 1 1.0
) O 0 8.879019741669936e-11
15 O 0 7.195666285042535e-10
, O 0 6.651847584034087e-13
by O 0 7.425887162126887e-12
imprinting O 0 2.9513741537812166e-05
defects O 1 0.8509953022003174
, O 0 4.09976358417552e-10
and O 0 4.724557984420175e-12
by O 0 8.871228404649933e-12
mutations O 0 1.1243674047367591e-10
in O 0 2.2029364443731936e-11
the O 0 2.9814628543789468e-09
UBE3A O 0 8.92087773536332e-05
gene O 0 5.6068159004496465e-09
. O 0 1.774509783558642e-08

UBE3A O 0 0.0035851553548127413
encodes O 0 2.4392461384081798e-08
a O 0 1.7813377162223532e-10
ubiquitin O 0 5.388118395899255e-08
- O 0 1.491753209847957e-07
protein O 0 8.820927988040239e-09
ligase O 0 1.557925699557927e-08
and O 0 1.5626091531828479e-09
shows O 0 1.033893748392245e-09
brain O 0 6.555732401380965e-09
- O 0 1.6358333576604878e-09
specific O 0 4.2899830354770074e-09
imprinting O 0 1.6706125052223797e-06
. O 0 3.3418913858440646e-08

Here O 0 6.253652173882074e-08
we O 0 7.804418222789877e-10
describe O 0 2.7373026512123033e-08
UBE3A O 0 0.00043425694457255304
coding O 0 3.121497229585657e-06
- O 0 5.67832876186003e-06
region O 0 1.3378188157275872e-07
mutations O 0 8.33492030949401e-09
detected O 0 9.652259436165878e-09
by O 0 1.61225303940693e-11
SSCP O 0 7.076318433973938e-05
analysis O 0 6.058546719867053e-11
in O 0 4.173369982929387e-12
13 O 0 1.0355866164601935e-10
AS B-Disease 1 1.0
individuals O 0 3.1373211320517846e-12
or O 0 2.7016128917312088e-11
families O 0 4.093221941947611e-11
. O 0 3.487131139401356e-10

Two O 0 2.197643489409984e-08
identical O 0 1.5265059971625305e-07
de O 0 4.204899539672624e-08
novo O 0 1.9609165846645737e-08
5 O 0 7.624145581530684e-08
- O 0 2.3294189688272127e-08
bp O 0 2.2336100968800565e-08
duplications O 0 9.188054761466447e-09
in O 0 4.427932742689933e-10
exon O 0 7.687032343994815e-09
16 O 0 8.454182909289898e-10
were O 0 9.560709168798809e-11
found O 0 9.070909995356757e-11
. O 0 3.5950278309826444e-09

Among O 0 1.7548674691170163e-07
the O 0 8.462524014873907e-10
other O 0 1.2094908408144533e-10
11 O 0 1.3206152837952345e-10
unique O 0 4.474864923054156e-11
mutations O 0 5.881313491773454e-11
, O 0 5.811017465828794e-12
8 O 0 1.2055531017907128e-09
were O 0 1.510104125079792e-10
small O 0 4.234317410589661e-11
deletions O 0 9.423015701059967e-10
or O 0 2.2546680078505688e-09
insertions O 0 4.0361300079894136e-08
predicted O 0 2.6701624022962278e-08
to O 0 1.672298410859696e-10
cause O 0 2.848840949809528e-07
frameshifts O 0 0.00017923378618434072
, O 0 1.0651470677691677e-10
1 O 0 6.126646412418779e-10
was O 0 1.408567620181378e-11
a O 0 6.278089484910987e-13
mutation O 0 4.439734170580412e-12
to O 0 8.541972467898673e-13
a O 0 1.4875727602850497e-12
stop O 0 1.5985542056728974e-10
codon O 0 6.299509802687453e-10
, O 0 9.886985327667297e-12
1 O 0 2.2169020785778315e-10
was O 0 4.686068547088418e-11
a O 0 7.152473925631231e-12
missense O 0 1.2031738272355597e-08
mutation O 0 2.7845242778212764e-10
, O 0 5.532604322594503e-12
and O 0 6.499272908050413e-12
1 O 0 1.10630304916981e-09
was O 0 4.0662145872616406e-10
predicted O 0 1.7406381891404976e-09
to O 0 5.061909225112515e-12
cause O 0 1.64199071006621e-10
insertion O 0 1.488085876744094e-09
of O 0 4.460925517868475e-10
an O 0 8.910260767061584e-13
isoleucine O 0 1.8390835521131521e-09
in O 0 1.2278669400678233e-11
the O 0 8.844571602883988e-11
hect O 0 2.1616671119772946e-07
domain O 0 5.717793349901967e-09
of O 0 1.3113439223388923e-09
the O 0 7.481641972617581e-09
UBE3A O 0 5.702623457182199e-05
protein O 0 1.7634496529694843e-08
, O 0 2.935134340437129e-12
which O 0 9.323737528571518e-14
functions O 0 2.4003802417960074e-12
in O 0 4.607936428258075e-12
E2 O 0 3.0143311846586585e-08
binding O 0 8.858488387275543e-10
and O 0 5.248377774047519e-11
ubiquitin O 0 4.164184552735151e-09
transfer O 0 1.8357940234636771e-06
. O 0 7.621324726869716e-08

Eight O 0 9.142725687638631e-09
of O 0 1.4814810489482966e-10
the O 0 1.924531020658371e-11
cases O 0 1.4599321751518346e-10
were O 0 1.1051488196800463e-10
familial O 0 1.4599160769179775e-09
, O 0 4.3576524333399647e-11
and O 0 5.4692663592481594e-11
five O 0 3.834430689630963e-11
were O 0 1.0386804610851286e-10
sporadic O 0 1.5489716176375623e-08
. O 0 4.510172679772495e-09

In O 0 2.1323176113696718e-08
two O 0 6.712150280030471e-11
familial O 0 6.193419999078742e-09
cases O 0 9.301131420613729e-09
and O 0 7.58244411702691e-10
one O 0 1.9319858213240337e-11
sporadic O 0 8.265910622640149e-09
case O 0 2.069733717746658e-09
, O 0 9.313939897115375e-11
mosaicism O 0 9.658570888859686e-06
for O 0 7.422442660498518e-09
UBE3A O 0 0.000272225181106478
mutations O 0 3.824420780063065e-09
was O 0 6.196296947758029e-11
detected O 0 5.898906363377421e-11
in O 0 8.56068037638491e-13
the O 0 1.0557212222483958e-11
mother O 0 1.530926913018149e-10
of O 0 3.1687710788652623e-10
three O 0 5.155245674792752e-11
AS B-Disease 1 1.0
sons O 0 2.3393214476641333e-08
, O 0 1.249926133732246e-13
in O 0 6.310104077710682e-14
the O 0 1.2126866351380716e-12
maternal O 0 8.027958298129079e-10
grandfather O 0 4.80568962402117e-09
of O 0 6.4910943287088685e-09
two O 0 4.273425016632082e-11
AS B-Disease 1 1.0
first O 0 6.975263144859412e-10
cousins O 0 1.8356763331617287e-10
, O 0 1.1048078413494061e-13
and O 0 4.026659783601741e-14
in O 0 3.997587918786079e-14
the O 0 1.126388262176481e-12
mother O 0 2.8866119564097126e-11
of O 0 8.202901899401205e-12
an O 0 3.3129239369183994e-13
AS B-Disease 1 1.0
daughter O 0 2.589003315733862e-06
. O 0 5.617084042341958e-08

The O 0 6.723075784975663e-08
frequencies O 0 1.9091408454130487e-09
with O 0 1.1657266948614242e-12
which O 0 2.789747382755947e-12
we O 0 3.093751817229151e-12
detected O 0 4.861769320463338e-10
mutations O 0 1.2838131946413256e-10
were O 0 1.853125014550372e-10
5 O 0 1.298871982191585e-10
( O 0 7.991780251893205e-14
14 O 0 1.9603154169378634e-11
% O 0 4.551991921418475e-13
) O 0 5.640629564991617e-15
of O 0 5.836065138098423e-12
35 O 0 8.314555988153671e-11
in O 0 4.786654579647109e-12
sporadic O 0 4.126486263800189e-09
cases O 0 2.3145723115902683e-09
and O 0 1.0846320508406393e-09
8 O 0 3.522529379296202e-09
( O 0 1.6718972126877896e-13
80 O 0 2.501220237871582e-11
% O 0 4.288319780656677e-14
) O 0 1.941533981587233e-16
of O 0 8.614104845009948e-14
10 O 0 4.997364284539674e-13
in O 0 4.949932065796692e-13
familial O 0 2.771690654768122e-10
cases O 0 1.3399039655581646e-09
. O 0 2.803133725137741e-09
. O 0 1.4221213540110966e-08

The O 0 3.2259817999147344e-06
hemochromatosis B-Disease 1 1.0
845 O 0 2.1914042918069754e-06
G O 0 3.891448940862574e-08
- O 0 1.044183295384471e-09
- O 0 1.0602829725314677e-09
> O 0 1.5871469694062057e-09
A O 0 1.0072114670078847e-10
and O 0 2.8932620730649783e-13
187 O 0 6.674727610900266e-12
C O 0 4.9510891914072985e-11
- O 0 7.0070993278548155e-12
- O 0 2.2591867265830956e-10
> O 0 7.773432564306404e-09
G O 0 2.2208825001257537e-08
mutations O 0 4.50133333385061e-11
: O 0 4.4000146272793125e-14
prevalence O 0 2.9348447283528145e-11
in O 0 5.85216879296635e-13
non O 0 5.5435451784546785e-09
- O 0 3.5006959109296076e-08
Caucasian O 0 1.7081315917266693e-08
populations O 0 1.2957300787874715e-09
. O 0 4.586860891109268e-10

Hemochromatosis B-Disease 1 0.9999984502792358
, O 0 2.8842828569963785e-08
the O 0 0.00017755523731466383
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 2.055590364591353e-09
leads O 0 9.83636061491211e-10
, O 0 6.824934497759449e-13
if O 0 7.613134428430257e-11
untreated O 1 0.9999102354049683
, O 0 6.533103918959782e-12
to O 0 2.9585174587953844e-11
progressive O 1 0.9743503332138062
iron B-Disease 1 1.0
overload I-Disease 1 0.9999806880950928
and O 0 9.701503600467731e-09
premature B-Disease 0 1.2106620488339104e-06
death I-Disease 0 5.150211990212483e-08
. O 0 7.381753430735216e-09

The O 0 6.324199148366461e-06
hemochromatosis B-Disease 1 1.0
gene O 0 5.043502824264579e-07
, O 0 2.8600350976404343e-09
HFE O 1 0.9563372731208801
, O 0 3.552900418313243e-09
recently O 0 1.7983119438014228e-09
has O 0 7.412382881967494e-13
been O 0 7.699238924359364e-13
identified O 0 4.25391319391899e-12
, O 0 2.0701086786596712e-13
and O 0 4.772376612817431e-13
characterization O 0 9.735513506470284e-10
of O 0 6.437739785702945e-10
this O 0 1.9577379994917266e-10
gene O 0 2.0977270268063286e-11
has O 0 5.851722643772372e-13
shown O 0 3.411274897540534e-13
that O 0 4.188786717794013e-15
it O 0 1.5771814464247275e-14
contains O 0 5.547383841349174e-13
two O 0 2.8668382365303405e-14
mutations O 0 2.3236401409769403e-13
that O 0 1.301704139714411e-14
result O 0 1.273423467368362e-11
in O 0 2.841544707865573e-11
amino O 0 1.6667352220611775e-10
acid O 0 2.850166214152239e-10
substitutions O 0 2.1239537906225792e-10
- O 0 8.43996816879411e-11
cDNA O 0 1.9807283591077862e-10
nucleotides O 0 1.0280916742932966e-11
845 O 0 7.997815604232628e-11
G O 0 3.324130901094513e-11
- O 0 1.0161605064340495e-11
- O 0 1.8199315318656595e-11
> O 0 1.0372312730932975e-10
A O 0 5.018804122292053e-11
( O 0 1.488241123490542e-14
C282Y O 0 1.2502762714028393e-10
) O 0 7.62678037180076e-15
and O 0 1.2579046419942952e-13
187 O 0 6.4202467127405516e-12
C O 0 3.9086785891262465e-11
- O 0 7.966326383279654e-12
- O 0 1.3052645075894986e-10
> O 0 3.851792218512173e-09
G O 0 4.650361873359543e-08
( O 0 1.093003834141959e-12
H63D O 0 1.9258821339462884e-05
) O 0 2.1838053934630786e-11
. O 0 2.1970345542854375e-09

Although O 0 3.754753925022669e-05
hemochromatosis B-Disease 1 1.0
is O 0 1.0402035899303996e-09
common O 0 5.5750559724288e-10
in O 0 3.42156095123336e-11
Caucasians O 0 8.874491363997095e-09
, O 0 2.9286362831365542e-12
affecting O 0 8.43600883593254e-11
> O 0 2.823932476747615e-10
= O 0 2.114267311573159e-12
1 O 0 6.06566576480394e-12
/ O 0 2.329867635625371e-12
300 O 0 1.8586725854165959e-13
individuals O 0 4.738358211115075e-15
of O 0 1.2281803178637585e-12
northern O 0 3.374669294009536e-11
European O 0 1.4522169577979582e-10
origin O 0 2.945388932751314e-10
, O 0 1.1672418673974727e-12
it O 0 3.107836728309492e-14
has O 0 4.3455754809461e-15
not O 0 1.1444394287492624e-14
been O 0 5.424339363097053e-13
recognized O 0 5.236785831363999e-12
in O 0 2.659544242819556e-12
other O 0 2.258341257055374e-11
populations O 0 1.315805381318924e-10
. O 0 5.25878174340022e-10

The O 0 5.988996409911351e-09
present O 0 9.972601633378986e-10
study O 0 1.4864533215419584e-11
used O 0 1.128172858952392e-12
PCR O 0 7.139890456642206e-09
and O 0 1.9231696096744244e-11
restriction O 0 3.7876590752716766e-09
- O 0 2.059074022398022e-10
enzyme O 0 9.11763928246323e-11
digestion O 0 3.12923376100116e-09
to O 0 9.569055617331124e-13
analyze O 0 4.770401738560248e-13
the O 0 7.307545004222107e-14
frequency O 0 9.597277399880921e-13
of O 0 4.867449759221598e-13
the O 0 7.341976852870413e-12
845 O 0 2.1083618184647435e-10
G O 0 6.071410041386116e-11
- O 0 1.2755309829193262e-11
- O 0 3.5434762762909244e-11
> O 0 6.708988919967851e-11
A O 0 1.4834708114697115e-11
and O 0 3.852068674887327e-14
187 O 0 4.468386652443229e-13
C O 0 3.4598981665801e-12
- O 0 7.490722452041521e-13
- O 0 5.196719443656406e-11
> O 0 2.6074962189426287e-09
G O 0 1.0724134469342061e-08
mutations O 0 3.881554105911178e-11
in O 0 5.089849982459205e-12
HLA O 0 6.748202885376031e-09
- O 0 1.566474416847541e-08
typed O 0 3.3092284468239086e-10
samples O 0 1.750284465973362e-11
from O 0 4.683124005776251e-13
non O 0 1.682520373025298e-10
- O 0 2.9024252445886134e-10
Caucasian O 0 1.357345763564055e-10
populations O 0 6.518366575669621e-12
, O 0 5.524173376765876e-14
comprising O 0 4.8576160455171546e-14
Australian O 0 6.572771840684943e-13
Aboriginal O 0 8.244766848408691e-12
, O 0 8.551434571308497e-15
Chinese O 0 6.356254498435243e-12
, O 0 4.0569275911762903e-13
and O 0 1.6774110312561819e-12
Pacific O 0 8.017242425495397e-11
Islanders O 0 1.3492241990320508e-08
. O 0 6.691127096836169e-10

Results O 0 1.4717973328970402e-07
showed O 0 5.774069222752587e-09
that O 0 8.372793560904035e-13
the O 0 5.152031232191767e-11
845 O 0 2.829756873268252e-09
G O 0 2.4035540224787155e-09
- O 0 4.5454834340930006e-10
- O 0 1.3255420094893111e-09
> O 0 2.226352657785924e-09
A O 0 8.110339483335949e-11
mutation O 0 1.8916706309018982e-12
was O 0 2.2693756867187692e-13
present O 0 4.4103772283560216e-13
in O 0 2.3396725095520265e-13
these O 0 1.3764151493914079e-12
populations O 0 4.818345700728643e-13
( O 0 2.7809609964916633e-15
allele O 0 7.14009417996514e-13
frequency O 0 6.412708038194825e-12
0 O 0 3.3837615869003468e-12
. O 0 1.750202494868111e-13
32 O 0 4.309215744652262e-12
% O 0 6.111857710471708e-14
) O 0 1.1803889046350978e-15
, O 0 2.2298614980854024e-14
and O 0 3.217697104856282e-13
, O 0 3.475797395128405e-13
furthermore O 0 1.0175710968285401e-10
, O 0 4.987422692719068e-13
it O 0 2.2176852639433503e-13
was O 0 3.190671060693262e-10
always O 0 6.094637988729446e-11
seen O 0 2.4430697048716254e-11
in O 0 6.902264133509806e-13
conjunction O 0 1.6197522489935778e-11
with O 0 2.511856174447491e-12
HLA O 0 3.31137897546796e-07
haplotypes O 0 4.79709916234583e-09
common O 0 9.228565134300482e-11
in O 0 2.3940337559591462e-12
Caucasians O 0 2.68178673712427e-10
, O 0 3.0472158000019456e-13
suggesting O 0 7.288510073255594e-12
that O 0 4.1882637765930375e-13
845 O 0 9.903869946370492e-10
G O 0 2.6846849188189026e-09
- O 0 1.5384946649987796e-09
- O 0 1.0953726814477704e-08
> O 0 3.547376792312207e-08
A O 0 2.174928681597521e-09
may O 0 3.3816213718118604e-11
have O 0 6.107047918584019e-13
been O 0 2.5562334909391693e-13
introduced O 0 2.5679237382336684e-12
into O 0 7.259066394857405e-13
these O 0 9.06989259630113e-14
populations O 0 7.081742283516698e-14
by O 0 6.169906572412939e-14
Caucasian O 0 2.5864679842335647e-10
admixture O 0 9.648210230750465e-09
. O 0 1.110642067203571e-08

187 O 0 2.9360145958889916e-07
C O 0 1.2138693605834305e-08
- O 0 1.604339439076341e-10
- O 0 4.03004879467872e-10
> O 0 1.4297305561683515e-09
G O 0 9.892163754798844e-10
was O 0 5.279637946449534e-13
present O 0 1.4806255180244143e-13
at O 0 3.628484502877366e-14
an O 0 2.660462195294385e-16
allele O 0 8.466525955796653e-14
frequency O 0 5.327609881033979e-12
of O 0 5.075463053311191e-12
2 O 0 3.3288420908661465e-09
. O 0 3.2232259083997405e-09

68 O 0 8.434571441284788e-07
% O 0 3.8245059896802047e-10
in O 0 2.7068622950737753e-12
the O 0 2.0965470678979692e-11
two O 0 1.089619280220111e-12
populations O 0 1.6365767248338603e-12
analyzed O 0 3.0837974535069534e-11
( O 0 1.508250989379345e-13
Australian O 0 2.161771595066142e-10
Aboriginal O 0 7.114737687885508e-10
and O 0 2.437639933655644e-13
Chinese O 0 4.005837328513451e-11
) O 0 3.3188688884806805e-13
. O 0 1.6861506635379442e-10

In O 0 2.4769770679000658e-09
the O 0 2.2329177395974398e-10
Australian O 0 1.0280495343906182e-09
Aboriginal O 0 8.062084888571519e-10
samples O 0 4.091887245705195e-11
, O 0 2.650781612441311e-13
187 O 0 1.0716981989344898e-11
C O 0 1.732869264747805e-10
- O 0 9.200386980046105e-12
- O 0 1.9668555673035826e-10
> O 0 6.1499596526459754e-09
G O 0 1.3438461898829246e-08
was O 0 1.95709507627706e-11
found O 0 1.7566705739786165e-13
to O 0 6.162919567037628e-14
be O 0 8.163487247303536e-13
associated O 0 3.096730649687629e-10
with O 0 5.79866397953932e-11
HLA O 0 1.1121448551421054e-05
haplotypes O 0 1.2420297679227588e-08
common O 0 1.74102579575397e-10
in O 0 6.808811869353504e-13
Caucasians O 0 5.914453649058515e-11
, O 0 2.4746286088534776e-14
suggesting O 0 2.739964830543451e-13
that O 0 1.5342876344482986e-15
it O 0 8.124800169402504e-15
was O 0 7.416879610477878e-13
introduced O 0 2.7834913193802713e-12
by O 0 7.636613238472256e-13
recent O 0 1.1074297728841387e-10
admixture O 0 9.600702455259125e-09
. O 0 4.8326582735569446e-09

In O 0 4.025871191970509e-09
the O 0 4.010280996169513e-10
Chinese O 0 1.8379194832718326e-09
samples O 0 1.3184658920195602e-10
analyzed O 0 6.033084448686665e-11
, O 0 4.0960057611297285e-13
187 O 0 2.8995021661426534e-11
C O 0 6.522921786045188e-11
- O 0 1.7087537981796963e-12
- O 0 1.601153237773545e-11
> O 0 1.6880942477204286e-10
G O 0 1.8719245598042278e-10
was O 0 6.64465769732725e-13
present O 0 7.110398966662934e-13
in O 0 2.8193012160948605e-12
association O 0 6.798511840294674e-12
with O 0 2.1391804885632915e-13
a O 0 5.065444157875687e-12
wide O 0 1.7399137686169297e-10
variety O 0 8.97453708570417e-11
of O 0 1.460556120491674e-10
HLA O 0 1.3064119741557079e-07
haplotypes O 0 3.1492806140676066e-09
, O 0 2.4274803087781516e-12
showing O 0 1.3949102289911863e-12
this O 0 7.024890109723347e-14
mutation O 0 1.579295369610531e-13
to O 0 9.751308918323764e-14
be O 0 1.0483844695152733e-12
widespread O 0 2.9299801473925413e-10
and O 0 4.53752660445339e-12
likely O 0 4.696513178359396e-10
to O 0 9.152499071130027e-12
predate O 0 4.554843613391313e-08
the O 0 3.764638323300318e-10
more O 0 5.8595884221135375e-12
genetically O 0 2.217952044247795e-09
restricted O 0 1.928181392329975e-09
845 O 0 4.1795420457901855e-09
G O 0 2.2673209976176167e-09
- O 0 5.671032532461595e-10
- O 0 1.4583910745713524e-09
> O 0 1.0925725213439819e-08
A O 0 1.0478702350269486e-09
mutation O 0 7.573829896578843e-10
. O 0 1.2853028363846164e-10

Genotype O 0 6.313183257589117e-05
- O 0 8.535821507393848e-06
phenotype O 0 1.9481819890643237e-06
correlations O 0 6.245952022254642e-08
in O 0 1.3768636231148434e-09
attenuated B-Disease 1 0.9999985694885254
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 7.007395470282063e-05

Germ O 0 0.0008862573886290193
- O 0 1.0534906323300675e-05
line O 0 8.303148320010223e-07
mutations O 0 6.577411948427425e-09
of O 0 7.184047107200442e-11
the O 0 1.845298497338277e-10
tumor B-Disease 0 9.984465805246145e-07
suppressor O 0 1.6471906292281346e-06
APC O 0 3.470193687959977e-09
are O 0 2.37790445970984e-13
implicated O 0 1.7985708408718715e-11
in O 0 6.435713628683004e-10
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.8446991134624113e-07
AAPC B-Disease 1 1.0
) O 0 6.451574083993217e-12
, O 0 6.737947873258765e-14
a O 0 2.0016543896559172e-14
variant O 0 1.3388469888298005e-08
of O 0 0.007229459937661886
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.034742318026474e-09
FAP B-Disease 0 1.3727351415582234e-06
) O 0 8.937980217060826e-11
. O 0 4.147870935611309e-09

AAPC B-Disease 1 1.0
is O 0 1.8947643454225727e-09
recognized O 0 8.866428424791906e-11
by O 0 4.2150709463582847e-13
the O 0 1.375097843751838e-12
occurrence O 0 6.170691735363221e-11
of O 0 1.046719100283866e-10
< O 0 2.9989283234499453e-07
100 O 0 2.14759410255283e-09
colonic B-Disease 0 3.1313127237808658e-06
adenomas I-Disease 0 1.5890294946530048e-07
and O 0 7.051580998805596e-13
a O 0 8.038575095284037e-14
later O 0 5.281395459855176e-11
onset O 0 4.576454102789285e-06
of O 0 4.160403841524385e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.2848360533369036e-13
age O 0 2.110839454616542e-11
> O 0 3.971942913461035e-11
40 O 0 3.0023043513099923e-12
years O 0 2.461815473697726e-13
) O 0 2.4137208074273553e-13
. O 0 4.0743819429422956e-10

The O 0 2.9422349001606563e-09
aim O 0 5.967374372417567e-10
of O 0 1.9841191190028695e-11
this O 0 1.843790745081897e-12
study O 0 2.4308625858754374e-12
was O 0 1.8188269900604181e-12
to O 0 7.201944119197834e-13
assess O 0 1.1732462112945541e-08
genotype O 0 4.161930519330781e-06
- O 0 3.758045750146266e-06
phenotype O 0 5.917762337048771e-06
correlations O 0 2.4250724095509213e-07
in O 0 5.217598575413263e-10
AAPC B-Disease 1 1.0
families O 0 3.462704256662619e-08
. O 0 1.1107140096555668e-08

By O 0 1.0580848419650124e-09
protein O 0 4.30596847067477e-09
- O 0 2.2825163981110563e-09
truncation O 0 4.084344951138519e-08
test O 0 3.403913240163092e-08
( O 0 1.3924467481829517e-11
PTT O 0 8.869938561417712e-09
) O 0 8.695681741127063e-15
assay O 0 2.662428437438802e-11
, O 0 2.0815670693195842e-13
the O 0 9.243934827665723e-13
entire O 0 8.37996061431312e-11
coding O 0 3.9599779011467717e-10
region O 0 1.3475569549115107e-09
of O 0 6.694183696254186e-08
the O 0 1.2157181572547415e-06
APC B-Disease 0 8.772542514634551e-08
gene O 0 4.6308994833266226e-11
was O 0 4.7625691584896046e-11
screened O 0 6.64931720795181e-11
in O 0 9.125877137305949e-13
affected O 0 6.64617250123456e-11
individuals O 0 2.5718598258006597e-12
from O 0 8.765878023453411e-10
11 O 0 4.134579256742654e-08
AAPC B-Disease 1 1.0
kindreds O 0 1.490637532697292e-05
, O 0 1.1672231237103148e-10
and O 0 9.816708210208525e-12
their O 0 3.230103337581447e-11
phenotypic O 0 9.757542551724896e-10
differences O 0 7.470662310993248e-09
were O 0 1.8894303899230636e-09
examined O 0 9.510124954204002e-08
. O 0 1.5483248461123367e-08

Five O 0 2.6385405860196443e-08
novel O 0 1.2562439088981137e-08
germ O 0 2.155996480723843e-05
- O 0 6.252613275137264e-06
line O 0 1.9101284124189988e-05
APC B-Disease 0 1.964188811598433e-07
mutations O 0 1.251536652091545e-09
were O 0 3.616177843279722e-11
identified O 0 1.960457490790546e-11
in O 0 1.3208135973830082e-11
seven O 0 8.995530709210442e-11
kindreds O 0 1.3397484508459456e-06
. O 0 1.0883648648984945e-08

Mutations O 0 3.20345606041883e-07
were O 0 1.6779576617054204e-09
located O 0 4.1431861413920856e-11
in O 0 4.420856476033963e-12
three O 0 1.3073163428536927e-12
different O 0 2.7977776345666783e-12
regions O 0 2.682329081071799e-10
of O 0 5.886751530681522e-09
the O 0 1.2964655127234437e-07
APC B-Disease 0 1.5983973256084028e-08
gene O 0 9.64937331426885e-12
( O 0 1.98496394424345e-14
1 O 0 3.2258671428531116e-11
) O 0 2.7617731591375117e-15
at O 0 5.697249855045328e-13
the O 0 2.398814870699373e-12
5 O 0 1.1959450096910018e-10
end O 0 6.033248900472188e-10
spanning O 0 1.0410193818088942e-09
exons O 0 7.768388710083229e-10
4 O 0 3.8439887384278393e-10
and O 0 1.555049665424857e-11
5 O 0 3.887831723226043e-10
, O 0 3.776659106974334e-12
( O 0 6.820805991411896e-14
2 O 0 4.2771515496031753e-11
) O 0 2.8952758430750986e-14
within O 0 1.9699557957109093e-11
exon O 0 1.1135638938730708e-10
9 O 0 2.375845076230121e-10
, O 0 2.6164047057380957e-12
and O 0 7.284757866377056e-12
( O 0 1.5422167395136993e-13
3 O 0 8.679328089566951e-11
) O 0 6.764277214797807e-15
at O 0 1.22623287392154e-12
the O 0 3.5276339141465662e-12
3 O 0 8.065956236258387e-11
distal O 0 6.875746083601086e-10
end O 0 2.7364139842944724e-09
of O 0 2.053517356159773e-09
the O 0 7.440075222575615e-09
gene O 0 9.041480342197872e-10
. O 0 2.8478105207341287e-08

Variability O 0 4.240792350174161e-06
in O 0 6.689531706349783e-10
the O 0 3.140820936664568e-10
number O 0 2.5485706878214387e-09
of O 0 1.201857116939209e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 2.5537843839629204e-07
most O 0 1.6886473122590395e-11
apparent O 0 1.0080224849273733e-10
in O 0 3.884633066608689e-12
individuals O 0 5.143680078222024e-13
with O 0 9.16995212402183e-13
mutations O 0 4.1623305496729657e-11
in O 0 3.3383126124553186e-11
region O 0 4.7971728811546654e-09
1 O 0 2.12364255958164e-07
, O 0 1.9838353182421997e-11
and O 0 1.195376991836028e-10
upper O 0 0.0001322123280260712
- O 0 6.213197139004478e-06
gastrointestinal O 0 0.007211497984826565
manifestations O 0 7.946308642203803e-07
were O 0 2.707876978202961e-10
more O 0 3.1465121849184874e-13
severe O 0 4.860033209208581e-11
in O 0 1.7389307008230936e-11
them O 0 1.7596537074671126e-11
. O 0 7.04981684140904e-10

In O 0 5.813398651355328e-09
individuals O 0 4.5213652266618e-11
with O 0 1.512816261151073e-11
mutations O 0 1.9626658631644034e-10
in O 0 1.1351674461534955e-10
either O 0 6.804135588289739e-10
region O 0 2.775760510331793e-09
2 O 0 2.036161461660413e-09
or O 0 1.2881342693893405e-11
region O 0 6.242299038783372e-11
3 O 0 1.94182114832131e-10
, O 0 1.5086135194807698e-13
the O 0 1.535513686687362e-12
average O 0 3.495773115425038e-11
number O 0 5.8069209163402746e-11
of O 0 4.192234337452305e-10
adenomas B-Disease 0 1.234041178577172e-06
tended O 0 2.3379658387057134e-07
to O 0 2.5546662008046894e-11
be O 0 3.150443100841116e-11
lower O 0 7.987548400478772e-09
than O 0 3.929517301826113e-12
those O 0 1.6240297951927718e-12
in O 0 1.0366290074600992e-12
individuals O 0 1.7304654074696418e-13
with O 0 5.068611546102386e-13
mutations O 0 1.0108310022349798e-11
in O 0 3.701521728016743e-12
region O 0 2.242536711882792e-11
1 O 0 9.386238314368356e-11
, O 0 1.2581248027979455e-14
although O 0 3.6658837857667104e-13
age O 0 2.368256632467869e-11
at O 0 1.9338653942102546e-12
diagnosis O 0 2.9040436722027607e-09
was O 0 5.674697864388456e-11
similar O 0 6.568908750281821e-10
. O 0 1.2509024038820371e-08

In O 0 2.745244742641262e-08
all O 0 3.59515297532198e-08
AAPC B-Disease 1 1.0
kindreds O 0 1.776130375219509e-06
, O 0 1.2149787469509232e-12
a O 0 1.0497305065124141e-13
predominance O 0 1.902935142794604e-09
of O 0 3.6163353200890924e-08
right O 1 1.0
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 1.5834180885576643e-05
rectal B-Disease 1 0.9999945163726807
polyp I-Disease 0 0.0001886101672425866
sparing O 0 1.5889658300238807e-07
was O 0 4.07624911602511e-09
observed O 0 1.597093124416915e-08
. O 0 2.11160777752184e-08

No O 0 8.260374306701124e-05
desmoid B-Disease 1 0.9999953508377075
tumors I-Disease 1 1.0
were O 0 3.9185451328194176e-08
found O 0 6.582965422774478e-11
in O 0 8.91262758040412e-12
these O 0 2.389551889692143e-10
kindreds O 0 1.2535484756881488e-06
. O 0 1.7688934761395103e-08

Our O 0 5.418964406089799e-07
data O 0 1.6780377087854959e-09
suggest O 0 2.611192650991967e-10
that O 0 3.879751337906856e-13
, O 0 2.7815276124054655e-12
in O 0 1.749477646084685e-10
AAPC B-Disease 1 1.0
families O 0 2.0848374138182635e-09
, O 0 4.4308974485362043e-14
the O 0 1.858965929866889e-14
location O 0 8.605590198773605e-12
of O 0 7.042474936547194e-11
the O 0 1.2402353810614386e-08
APC B-Disease 0 3.723239387909416e-07
mutation O 0 1.4030220540917071e-08
may O 0 1.0341225653576203e-09
partially O 0 2.79074119369227e-09
predict O 0 1.7071405400415074e-09
specific O 0 2.694491851862324e-10
phenotypic O 0 1.2400012572300056e-08
expression O 0 5.034122807501262e-08
. O 0 4.7752021004043854e-08

This O 0 3.657215363883637e-10
should O 0 7.709548277556877e-11
help O 0 6.1525663036521294e-12
in O 0 5.942207446582581e-13
the O 0 2.1546356279017465e-12
design O 0 4.922673380036713e-10
of O 0 5.2894605362396874e-11
tailored O 0 2.2176994463052324e-08
clinical O 0 2.778445917783756e-09
- O 0 6.317050355031384e-11
management O 0 2.4006458713282663e-12
protocols O 0 1.162900886697571e-10
in O 0 3.7914387341492217e-13
this O 0 2.2533865507053108e-13
subset O 0 1.0037996128753335e-10
of O 0 7.988663550118069e-12
FAP B-Disease 0 1.094333228479627e-07
patients O 0 2.9420455405215762e-08
. O 0 1.3303182166968242e-10
. O 0 9.636619280328773e-10

Wilms B-Disease 1 0.9999994039535522
' I-Disease 0 0.19876570999622345
tumor I-Disease 0 0.0001915149186970666
1 O 0 2.086382409061116e-07
and O 0 1.586241277218292e-10
Dax O 0 1.9397561118239537e-05
- O 0 4.3464030596851444e-08
1 O 0 7.275912139448337e-08
modulate O 0 8.922285132939578e-09
the O 0 7.200114393590695e-10
orphan O 0 6.418178344347325e-08
nuclear O 0 5.013126802566603e-09
receptor O 0 1.0160957630844791e-09
SF O 0 5.9802428040711675e-06
- O 0 1.768737378782248e-09
1 O 0 2.969571533117943e-10
in O 0 3.347222401594435e-13
sex O 0 2.15880983337087e-13
- O 0 5.550347507987663e-13
specific O 0 2.3515562327242057e-12
gene O 0 2.831205105427448e-12
expression O 0 8.513759836015211e-11
. O 0 4.60779164823677e-10

Products O 0 9.800562139616886e-08
of O 0 2.4428219447258925e-08
steroidogenic O 1 0.5700103044509888
factor O 0 1.5647579232336284e-07
1 O 0 1.6418859161149157e-08
( O 0 6.761342787736657e-13
SF O 0 6.160523480502889e-05
- O 0 9.973258130457907e-08
1 O 0 2.6957387433412805e-08
) O 0 3.152677554782435e-12
and O 0 4.2969086622157704e-10
Wilms B-Disease 1 0.9986253976821899
tumor I-Disease 1 0.9911688566207886
1 O 0 6.369002676365199e-07
( O 0 1.0591459133346692e-11
WT1 O 0 8.168411795850261e-07
) O 0 5.634337180843163e-12
genes O 0 7.963075511485673e-12
are O 0 2.0213861915687956e-14
essential O 0 3.05255733884513e-12
for O 0 5.835271502108164e-13
mammalian O 0 1.1639383679096227e-08
gonadogenesis O 0 2.1108671433012205e-07
prior O 0 4.151838339794267e-08
to O 0 1.1862063553635949e-09
sexual O 0 2.9996014561106676e-09
differentiation O 0 6.25540579335393e-08
. O 0 1.8751997288291022e-08

In O 0 1.5333999625610772e-09
males O 0 2.1701951347097292e-10
, O 0 1.5390858726371803e-11
SF O 0 0.00021489981736522168
- O 0 8.923426548790303e-07
1 O 0 1.8045496119611926e-07
participates O 0 4.578720735892716e-11
in O 0 2.945519262526064e-13
sexual O 0 2.0772280922252973e-13
development O 0 1.5531509184232156e-13
by O 0 2.6986884745666163e-14
regulating O 0 1.1639526842355252e-10
expression O 0 1.4096164513421883e-10
of O 0 9.595963780528738e-12
the O 0 1.3698166212439133e-10
polypeptide O 0 8.429105236018586e-08
hormone O 0 4.3203653987688995e-09
Mullerian O 0 6.094077775742335e-07
inhibiting O 0 2.060234827183649e-08
substance O 0 3.6159013916403637e-07
( O 0 3.077822718910994e-10
MIS O 0 1.1450974852778018e-05
) O 0 1.0580540610316547e-10
. O 0 5.258202762092878e-09

Here O 0 5.67150344465972e-08
, O 0 1.3779348495557286e-10
we O 0 6.7272832270093286e-12
show O 0 5.6022959708801334e-12
that O 0 1.7943142631426934e-12
WT1 O 0 1.4446067325479817e-05
- O 0 3.468036538833985e-06
KTS O 0 0.002473112428560853
isoforms O 0 9.669695799630063e-08
associate O 0 2.263242260269749e-09
and O 0 1.0564786025180073e-11
synergize O 0 1.2609899791016232e-08
with O 0 6.732854291452428e-12
SF O 0 0.0034478106535971165
- O 0 5.25381437910255e-07
1 O 0 7.204997132248536e-08
to O 0 4.5517360713898114e-11
promote O 0 5.446910034123675e-09
MIS O 0 2.2306538085103966e-05
expression O 0 1.260448900808342e-08
. O 0 1.0985398146701186e-09

In O 0 1.6187076568030534e-08
contrast O 0 1.634175816889183e-07
, O 0 9.758012176064312e-09
WT1 O 0 0.0015490914229303598
missense O 0 2.6321720724808984e-05
mutations O 0 8.623019631670559e-09
, O 0 2.110472170288591e-12
associated O 0 2.6535666025617743e-11
with O 0 3.13976362270596e-12
male B-Disease 0 1.3337030368987257e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 3.2540764749455775e-08
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.605721111630487e-09
fail O 0 1.1188363124858824e-08
to O 0 4.8811028136031e-11
synergize O 0 8.420201424996776e-07
with O 0 1.530486154477373e-10
SF O 1 0.9999997615814209
- O 0 3.5935900086769834e-05
1 O 0 8.730942226975458e-07
. O 0 3.0478612966788887e-09

Additionally O 0 3.244519675149604e-08
, O 0 3.0350843366333535e-11
the O 0 2.0911597106709756e-11
X O 0 8.487836566928308e-07
- O 0 6.548660991256838e-08
linked O 0 3.709579914357164e-07
, O 0 9.924053766263707e-12
candidate O 0 2.6154332172234618e-11
dosage O 0 8.31527458000636e-10
- O 0 1.1570307212327435e-11
sensitive O 0 6.880599978664748e-10
sex O 0 3.4345712038308385e-12
- O 0 1.124051633022427e-11
reversal O 0 4.0941294798813033e-10
gene O 0 1.3564340622940207e-11
, O 0 5.822889045936641e-12
Dax O 0 3.4333545499976026e-06
- O 0 6.057489621014156e-09
1 O 0 2.393737297268217e-08
, O 0 9.985915740140516e-12
antagonizes O 0 2.499110030029783e-09
synergy O 0 5.2048934606752084e-11
between O 0 4.45709580354503e-11
SF O 0 1.8709768482949585e-05
- O 0 1.9594660116695195e-08
1 O 0 6.127374163611421e-09
and O 0 9.241594468856196e-12
WT1 O 0 1.160874774086551e-07
, O 0 1.78931077853689e-12
most O 0 1.0464465665521727e-12
likely O 0 4.001772871409237e-12
through O 0 3.591242158252489e-14
a O 0 7.495488570910449e-15
direct O 0 1.0757048734839209e-13
interaction O 0 3.212878530930996e-12
with O 0 1.4120638252429485e-12
SF O 0 0.08637399971485138
- O 0 5.950535637566645e-07
1 O 0 1.392869108940431e-07
. O 0 1.3196842507667839e-09

We O 0 2.6009457698705774e-08
propose O 0 3.558877281761852e-08
that O 0 7.122867573539082e-11
WT1 O 0 0.0002959243720397353
and O 0 3.418572092073191e-08
Dax O 0 0.000174295375472866
- O 0 2.6063984748248004e-08
1 O 0 8.316007438224915e-09
functionally O 0 1.340302036023644e-10
oppose O 0 1.7015409914389323e-11
each O 0 6.78307914394119e-14
other O 0 1.403725090809091e-13
in O 0 1.0669352771067175e-12
testis O 0 2.283234712407989e-09
development O 0 7.800362786247739e-12
by O 0 1.8564769947021498e-12
modulating O 0 1.6019164661429386e-08
SF O 0 0.0004589170857798308
- O 0 2.405280383754871e-07
1 O 0 5.4891099665610454e-08
- O 0 1.0559638718987685e-09
mediated O 0 1.6869943220143568e-09
transactivation O 0 4.764202898854819e-08
. O 0 9.807055861843494e-11
. O 0 2.0189974692108592e-10

A O 0 1.5586241630671793e-08
mouse O 0 1.2646093061619013e-09
model O 0 3.915648014163331e-11
for O 0 1.007657846052723e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9829164147377014
centre O 0 1.1416999541324913e-06
mutations O 0 2.2569667024185947e-08
. O 0 3.007369464569365e-09

Imprinting O 0 3.127674744973774e-06
in O 0 6.942227348538665e-10
the O 0 5.202077102417491e-10
15q11 O 0 3.395092278424272e-07
- O 0 6.746892466935606e-08
q13 O 0 1.9882425306150253e-07
region O 0 1.6561257920599814e-10
involves O 0 3.506471155101387e-11
an O 0 8.430462681034354e-14
imprinting O 0 2.2855450865222338e-08
centre O 0 4.193339897540227e-09
( O 0 9.476694602661428e-13
IC O 0 6.658476792154033e-08
) O 0 2.8000716437333317e-13
, O 0 1.2966027990862772e-13
mapping O 0 1.5720173643721247e-12
in O 0 3.533982459967555e-13
part O 0 5.364430254173325e-12
to O 0 1.1628936529006761e-11
the O 0 4.0709793869275757e-10
promoter O 0 1.6103070876738457e-08
and O 0 4.7942316783178285e-11
first O 0 1.5652631968343655e-10
exon O 0 3.936860171194212e-09
of O 0 4.967455891069505e-10
SNRPN O 0 0.015786264091730118
. O 0 1.8196101336798165e-07

Deletion O 0 5.281474102503125e-08
of O 0 8.780218219150981e-10
this O 0 1.9910234572151353e-10
IC O 0 1.2794500435120426e-05
abolishes O 0 6.195413675413874e-07
local O 0 5.053100160523627e-09
paternally O 0 3.519482305591737e-08
derived O 0 1.2102617519271774e-10
gene O 0 1.874724117265081e-12
expression O 0 2.362822123288394e-13
and O 0 3.909639810246307e-15
results O 0 5.116488287736087e-13
in O 0 1.2898117296433753e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.2999909106147243e-06
PWS B-Disease 1 1.0
) O 0 1.0343907952403697e-09
. O 0 9.788453603221114e-09

We O 0 6.117975459574154e-08
have O 0 3.5612504611926e-10
created O 0 1.3660758080291657e-09
two O 0 5.358072319161522e-11
deletion O 0 4.8092658744280925e-09
mutations O 0 5.988425311187484e-09
in O 0 3.8201755647726543e-10
mice O 0 6.706500244035851e-09
to O 0 9.791169958139889e-11
understand O 0 8.037219600964818e-08
PWS B-Disease 1 1.0
and O 0 2.5698862482492757e-10
the O 0 8.054253444744752e-12
mechanism O 0 1.942149913114477e-11
of O 0 1.4838577415410281e-12
this O 0 6.502050634016321e-12
IC O 0 5.222062554821605e-06
. O 0 2.19023270631169e-08

Mice O 0 0.0006872525555081666
harbouring O 0 1.7290734831476584e-05
an O 0 1.6525790458299383e-10
intragenic O 0 2.847300038411049e-06
deletion O 0 2.348799732487805e-08
in O 0 1.7683089437170452e-09
Snrpn O 0 0.00048098122351802886
are O 0 1.5167991307407647e-09
phenotypically O 0 1.5065467778185848e-05
normal O 0 7.826829460100271e-07
, O 0 2.0322677568573866e-11
suggesting O 0 8.905715748186438e-11
that O 0 6.4651945906255e-13
mutations O 0 2.0989847360208813e-10
of O 0 5.466244679119825e-10
SNRPN O 1 0.9999823570251465
are O 0 1.9063479961278773e-11
not O 0 1.3739496736511758e-12
sufficient O 0 2.0217950924550365e-10
to O 0 7.007931734914763e-11
induce O 0 1.6681019587849732e-06
PWS B-Disease 1 1.0
. O 0 8.32950809126487e-06

Mice O 0 2.6917471132037463e-06
with O 0 4.921241365807294e-12
a O 0 8.721474063777546e-12
larger O 0 4.959200827769905e-10
deletion O 0 5.843009964756618e-10
involving O 0 1.9978291243560875e-10
both O 0 9.7609996474457e-11
Snrpn O 0 2.531758582335897e-06
and O 0 4.714865303734328e-11
the O 0 2.1967948293788453e-10
putative O 0 2.6347746029387054e-07
PWS O 1 1.0
- O 0 1.2576172139233677e-06
IC O 0 6.347716407617554e-06
lack O 0 2.085267958307213e-08
expression O 0 1.9093474024067802e-10
of O 0 1.4181428600879009e-11
the O 0 4.11762915430991e-11
imprinted O 0 1.9397427664102906e-08
genes O 0 1.9543477947081556e-09
Zfp127 O 0 1.918583620863501e-06
( O 0 4.6061286729237594e-11
mouse O 0 6.5387233405544976e-09
homologue O 0 5.87016018016584e-08
of O 0 6.8216170490131844e-09
ZNF127 O 1 0.9999977350234985
) O 0 1.4015422156177237e-09
, O 0 2.322913417174277e-09
Ndn O 0 1.7602278035155905e-07
and O 0 6.660284129766936e-11
Ipw O 0 6.455931611526466e-08
, O 0 4.5971587647741785e-11
and O 0 1.0944145763247537e-11
manifest O 0 3.423699324045515e-09
several O 0 2.2317160272566916e-11
phenotypes O 0 1.7745977132221924e-08
common O 0 1.112413716697347e-09
to O 0 5.129073610277146e-09
PWS B-Disease 1 1.0
infants O 1 0.9999872446060181
. O 0 2.2777058461542765e-07

These O 0 1.206913413653865e-08
data O 0 4.120710994648391e-10
demonstrate O 0 1.2587178521705766e-10
that O 0 2.1998270989097984e-13
both O 0 8.411482231227008e-13
the O 0 4.437515892935506e-12
position O 0 1.9584878857559218e-11
of O 0 1.0121409786678637e-11
the O 0 6.450442176925142e-12
IC O 0 1.8158537784529472e-07
and O 0 1.1959694519447783e-11
its O 0 8.687401926305016e-13
role O 0 3.8167177209523506e-13
in O 0 7.362137700687998e-13
the O 0 2.938786800715798e-12
coordinate O 0 5.2002298300823924e-11
expression O 0 1.0461688182417106e-09
of O 0 5.435587535629338e-09
genes O 0 1.2275965799446453e-09
is O 0 4.751977891043202e-12
conserved O 0 1.0649154474906553e-10
between O 0 3.771169140853736e-11
mouse O 0 4.964086031122861e-09
and O 0 9.783398917384556e-12
human O 0 8.560097075616113e-12
, O 0 3.1791260162589152e-12
and O 0 1.7968555246147822e-12
indicate O 0 1.127448481796911e-11
that O 0 2.1908370300208202e-13
the O 0 3.8462087681434554e-11
mouse O 0 2.6164873045964043e-10
is O 0 1.9227778345746495e-14
a O 0 2.945257859688212e-15
suitable O 0 8.401769731325448e-12
model O 0 5.9865883951515375e-12
system O 0 2.843877910940762e-10
in O 0 1.2283846682892285e-11
which O 0 1.6410121959214985e-12
to O 0 3.052528499067342e-12
investigate O 0 8.161782361071346e-11
the O 0 2.2187581633081876e-11
molecular O 0 6.877342445532619e-11
mechanisms O 0 7.685503344845301e-10
of O 0 2.7236549127174214e-10
imprinting O 0 4.9243658040154514e-09
in O 0 2.4937732000934743e-12
this O 0 6.251144892520377e-13
region O 0 5.361731891806443e-11
of O 0 1.0685488084638539e-11
the O 0 2.4674588761097738e-11
genome O 0 1.0277230455546515e-11
. O 0 1.0939178382574077e-11
. O 0 5.778947875789697e-10

Mutations O 0 3.3116756981144135e-07
of O 0 7.843879323843339e-09
the O 0 1.1037237790390009e-08
ATM O 0 2.718525138334371e-06
gene O 0 3.021765615507377e-10
detected O 0 7.46153361319557e-09
in O 0 8.81015815856756e-11
Japanese O 1 0.9987983703613281
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999997615814209
: O 0 6.152047187651943e-13
possible O 0 2.4172599685789997e-12
preponderance O 0 3.668787051935851e-09
of O 0 1.0709238183748138e-11
the O 0 2.5438331996419095e-11
two O 0 7.0229551341061125e-12
founder O 0 2.3424366890623105e-09
mutations O 0 4.0449885108095884e-10
4612del165 O 0 4.4381511798974316e-08
and O 0 1.2605222421413487e-10
7883del5 O 0 3.4307225860175095e-07
. O 0 2.0221056828972905e-08

The O 0 3.017897753920806e-08
ATM O 0 4.661934326577466e-06
( O 0 4.3669737270768394e-10
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 1.2918403846651216e-10
mutated O 0 3.2741448441342413e-10
) O 0 1.6933804076850467e-13
gene O 0 2.517697151021431e-13
on O 0 2.105293587031931e-12
human O 0 5.2334009521814995e-12
chromosome O 0 9.21087872640669e-10
11q22 O 0 5.445156716632482e-07
. O 0 4.1384137006161836e-08

3 O 0 1.6433024939033203e-05
has O 0 1.7107121275117265e-10
recently O 0 1.0443718806429914e-10
been O 0 7.436828930451611e-12
identified O 0 1.1956546863700623e-11
as O 0 3.1312756207380055e-13
the O 0 4.460833558008609e-13
gene O 0 3.1397363279162677e-14
responsible O 0 1.0210082630160607e-14
for O 0 2.0009510134965172e-15
the O 0 1.1501014984122149e-12
human O 0 2.5424289340492123e-09
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 6.427598719938032e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.370089277088262e-11
. O 0 7.827644643576548e-10

In O 0 1.5866898905869675e-09
order O 0 5.740629083206272e-10
to O 0 1.5585593579614532e-11
define O 0 1.0663952360046025e-10
the O 0 8.638201265398493e-12
types O 0 3.9921480010640664e-10
of O 0 3.099382209215129e-11
disease O 0 3.140536364298896e-08
- O 0 7.503564880551039e-09
causing O 0 1.2321057951680814e-08
ATM O 0 4.832730269299645e-07
mutations O 0 1.5959851495939148e-11
in O 0 2.1986819103651106e-13
Japanese O 0 9.251555077582907e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
patients O 0 2.719484882618417e-06
as O 0 1.1633812403016863e-12
well O 0 6.46240534501151e-14
as O 0 1.83086798353398e-14
to O 0 5.884211168446715e-14
look O 0 2.194112513204116e-12
for O 0 2.446742081944203e-13
possible O 0 2.762791939669995e-10
mutational O 0 3.333069003019773e-07
hotspots O 0 3.459271624706162e-08
, O 0 1.3109924604237655e-11
reverse O 0 1.6155538018480797e-10
- O 0 1.428053647556382e-10
transcribed O 0 9.663486677524702e-11
RNA O 0 1.5675389805624995e-11
derived O 0 1.0313853937571338e-11
from O 0 1.216708699937341e-12
ten O 0 2.611530089402514e-11
patients O 0 4.952345131203906e-11
belonging O 0 9.558184322147611e-13
to O 0 6.476970110420865e-13
eight O 0 1.3563014643683258e-12
unrelated O 0 2.405763643853476e-10
Japanese O 0 2.5252188606827985e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 8.901673842487412e-11
was O 0 4.560963585975575e-12
analyzed O 0 1.7277035704865717e-11
for O 0 2.4173881212757875e-13
mutations O 0 3.664850974777201e-12
by O 0 5.949953529003904e-13
the O 0 9.413341633957018e-12
restriction O 0 9.143313328685565e-10
endonuclease O 0 2.6954491971764583e-09
fingerprinting O 0 2.549470412560595e-09
method O 0 2.668216314560823e-09
. O 0 6.2495364439030254e-09

As O 0 9.160917358030929e-08
has O 0 3.45814488156293e-11
been O 0 4.8881437092473945e-12
reported O 0 1.6708970361836717e-12
by O 0 2.9793890878732077e-12
others O 0 1.2822395922817975e-10
, O 0 6.233003696509698e-12
mutations O 0 4.818072156520525e-12
that O 0 3.588566889391881e-13
lead O 0 6.920093664763982e-11
to O 0 2.363005624506087e-10
exon O 0 1.4745059218057577e-07
skipping O 0 4.7078901843633503e-07
or O 0 1.6948832337604358e-09
premature O 0 9.490953090107723e-08
protein O 0 6.226391624508665e-10
truncation O 0 1.250387260398611e-08
were O 0 1.9561330333317528e-10
also O 0 5.600180909282049e-12
predominant O 0 1.707978469767113e-08
in O 0 9.437418208024795e-11
our O 0 2.069173277163827e-09
mutants O 0 1.3013337252232304e-07
. O 0 3.403535009383063e-09

Six O 0 1.1025060331348868e-07
different O 0 6.927399764933284e-10
mutations O 0 1.6492609500318167e-09
were O 0 1.0085687146554889e-10
identified O 0 1.13931850065363e-11
on O 0 1.868185640907516e-11
12 O 0 8.1527232881351e-12
of O 0 1.501747077387039e-12
the O 0 4.881065343576019e-11
16 O 0 8.809959983757665e-10
alleles O 0 1.200756299946093e-10
examined O 0 3.038621798623353e-08
. O 0 1.7735962032361385e-08

Four O 0 3.4007707760963513e-09
were O 0 6.643983141429999e-10
deletions O 0 2.0926300692281075e-09
involving O 0 8.244456506378839e-11
a O 0 1.3100076579064535e-11
loss O 0 3.3578936853295716e-10
of O 0 4.068823500347207e-09
a O 0 6.9410983905005e-11
single O 0 8.888851876776016e-10
exon O 0 4.700817068936658e-09
exon O 0 4.9611901253854285e-09
7 O 0 6.331531299252902e-09
, O 0 3.267742326729106e-11
exon O 0 3.764037082021332e-09
16 O 0 4.735120295862316e-09
, O 0 3.5737979242611573e-10
exon O 0 5.157151505841284e-08
33 O 0 1.5311978529553016e-07
or O 0 1.1756700502019157e-08
exon O 0 1.0731848760769935e-06
35 O 0 4.143489320540539e-07
. O 0 9.934186095961195e-08

The O 0 4.783342077985253e-08
others O 0 2.6418629506252955e-09
were O 0 1.597462995217569e-10
minute O 0 1.8439728632912988e-09
deletions O 0 2.071590010643831e-09
, O 0 3.248527141730406e-11
4649delA O 0 1.66514180222066e-08
in O 0 8.497120229655764e-10
exon O 0 2.4789821750914598e-08
33 O 0 4.146368137725176e-09
and O 0 1.5965728739075757e-11
7883del5 O 0 3.379743418463477e-08
in O 0 2.447755109713512e-09
exon O 0 1.329799914628893e-07
55 O 0 3.8728263263010376e-08
. O 0 9.16829012709286e-09

The O 0 4.811860435438575e-06
mutations O 0 6.863742214591184e-07
4612del165 O 0 2.635895725688897e-06
and O 0 1.1864417226448154e-09
7883del5 O 0 1.8706705873228202e-07
were O 0 9.46180911398642e-10
found O 0 5.209806978184739e-12
in O 0 3.298950739319406e-13
more O 0 5.131399455739552e-14
than O 0 8.041366238251829e-14
two O 0 7.2534124838158e-15
unrelated O 0 1.0526447768999248e-11
families O 0 1.8614043683154446e-13
; O 0 1.1064737857500659e-13
44 O 0 2.7208601691142142e-11
% O 0 3.571823013141101e-13
( O 0 1.4638544096643802e-15
7 O 0 2.0227507169234826e-11
of O 0 1.2251440313637563e-11
16 O 0 5.8368358757388e-11
) O 0 6.560581206982788e-14
of O 0 2.998328668679662e-11
the O 0 5.488976287382208e-11
mutant O 0 3.289279959517444e-10
alleles O 0 8.77286004258293e-12
had O 0 2.4829723346830868e-11
one O 0 5.473852707910121e-13
of O 0 2.16365445525335e-12
the O 0 2.347833212568151e-11
two O 0 1.6847995221169754e-11
mutations O 0 1.000445615240153e-09
. O 0 6.576947875203132e-09

The O 0 3.589028096939728e-07
4612del165 O 0 3.9485289562435355e-06
mutations O 0 4.094576677715622e-09
in O 0 2.052951385278501e-11
three O 0 3.4062946148612216e-13
different O 0 2.773928818849275e-13
families O 0 5.178271006434088e-13
were O 0 2.087340933779047e-12
all O 0 1.5610688468888773e-13
ascribed O 0 3.159903241845008e-11
to O 0 1.7490455698349061e-12
the O 0 1.8892916744950305e-11
same O 0 9.827353514291204e-11
T O 0 8.108163029874049e-10
- O 0 1.1296547898498321e-11
- O 0 1.0550145826404567e-11
> O 0 1.7429951579273073e-11
A O 0 6.073071733003754e-13
substitution O 0 4.30461569167484e-12
at O 0 1.2901443422700526e-13
the O 0 1.8989863392708528e-13
splice O 0 2.1060990451626793e-10
donor O 0 2.560199274803665e-10
site O 0 4.940922115892477e-10
in O 0 2.0225088270819924e-10
intron O 0 3.1684425039202324e-07
33 O 0 1.7787769479582494e-07
. O 0 2.827924028281359e-08

Microsatellite O 0 5.650946332025342e-05
genotyping O 0 1.68529059010325e-05
around O 0 1.6664754021178396e-09
the O 0 7.813250602062283e-10
ATM O 0 8.546448384549876e-07
locus O 0 1.7671626384441197e-09
also O 0 4.775511149718303e-12
indicated O 0 8.58354186339394e-12
that O 0 1.0341278716327878e-14
a O 0 7.809375433646959e-14
common O 0 1.9068717091452747e-11
haplotype O 0 1.283216422010014e-09
was O 0 2.3372362378815126e-10
shared O 0 2.737923819953747e-12
by O 0 1.5255875176426598e-13
the O 0 7.844914821919513e-12
mutant O 0 3.248863678084746e-10
alleles O 0 5.0738791640414505e-11
in O 0 2.6544573830666884e-11
both O 0 1.02313130190268e-10
mutations O 0 1.5937146047306783e-09
. O 0 4.424515864798195e-09

This O 0 3.920584301653207e-09
suggests O 0 2.7556357196090175e-09
that O 0 2.66392550379857e-12
these O 0 1.151957834677475e-10
two O 0 1.2669958832089989e-11
founder O 0 4.554346233476281e-09
mutations O 0 4.2097503261118163e-10
may O 0 3.9761899328638606e-10
be O 0 9.078247875660139e-11
predominant O 0 4.0904578213485365e-07
among O 0 4.321514673888416e-11
Japanese O 0 2.057634063135083e-09
ATM O 0 2.35131722092774e-07
mutant O 0 5.9519553730069674e-08
alleles O 0 6.8385528351200264e-09
. O 0 9.1727327955482e-09

W474C O 0 2.383339960942976e-06
amino O 0 5.259968016702032e-09
acid O 0 4.173899559312133e-10
substitution O 0 1.2396293991301377e-09
affects O 0 5.173251410584001e-11
early O 0 1.2013107175690152e-10
processing O 0 9.809362211399275e-10
of O 0 7.475233765319445e-10
the O 0 3.8315667305610646e-10
alpha O 0 4.328842839740332e-10
- O 0 4.535625694468415e-11
subunit O 0 5.69770923150581e-12
of O 0 2.4757450863693853e-12
beta O 0 1.4409370398260624e-11
- O 0 1.9757731908875975e-11
hexosaminidase O 0 3.3139673227822186e-09
A O 0 3.1154620550033485e-11
and O 0 4.576452267818741e-14
is O 0 8.647413886265132e-16
associated O 0 3.8762602069114527e-13
with O 0 1.9735500126488725e-12
subacute O 0 8.076967787928879e-05
G B-Disease 0 0.0001354541163891554
( I-Disease 0 5.174307510236176e-11
M2 I-Disease 0 2.463241116856807e-06
) I-Disease 0 2.7121036319521785e-11
gangliosidosis I-Disease 0 7.211802994788741e-07
. O 0 3.534901793500467e-08

Mutations O 0 1.736335804025657e-07
in O 0 5.424823368294085e-10
the O 0 3.504776469043236e-09
HEXA O 0 1.3976974514662288e-05
gene O 0 3.4784689018074744e-10
, O 0 3.5129761512958657e-12
encoding O 0 2.3628604281511478e-11
the O 0 7.497390902555523e-11
alpha O 0 1.7711864960801016e-11
- O 0 2.1067396958895923e-12
subunit O 0 6.917143724124997e-13
of O 0 8.460558100463478e-13
beta O 0 5.4343040484239324e-12
- O 0 2.1926200438615595e-11
hexosaminidase O 0 1.1494656781962931e-08
A O 0 2.1306740816129377e-09
( O 0 5.759659784700111e-13
Hex O 0 2.1628572266507717e-09
A O 0 7.833346471475267e-11
) O 0 3.707085433437597e-14
, O 0 2.70738072667134e-14
that O 0 1.2656003767772331e-14
abolish O 0 1.486168410558264e-09
Hex O 0 4.218459181970502e-08
A O 0 1.199369215054702e-10
enzyme O 0 4.477378912071117e-09
activity O 0 3.1848560411162907e-07
cause O 1 0.9999992847442627
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 5.841113009941168e-11
TSD B-Disease 0 0.0001037247566273436
) O 0 2.6611933143239064e-12
, O 0 1.2451013527495225e-12
the O 0 1.5382289192400478e-11
fatal O 0 1.6438905792171e-09
infantile B-Disease 0 2.4030601508684413e-08
form I-Disease 0 7.071417895687659e-10
of I-Disease 0 3.8030663063182146e-07
G I-Disease 0 3.943554020224838e-06
( I-Disease 0 2.9616495887674343e-12
M2 I-Disease 0 8.153874375693704e-08
) I-Disease 0 3.5550078505974803e-13
gangliosidosis I-Disease 0 6.700171528706278e-09
, I-Disease 0 2.447200645253056e-12
Type I-Disease 0 1.1766206897689813e-09
1 I-Disease 0 2.1641996639232275e-08
. O 0 1.714907660321785e-09

Less O 0 9.906919729019137e-08
severe O 0 2.7137382403452648e-06
, O 0 5.5090043638017505e-09
subacute O 0 0.24694015085697174
( O 0 3.099778420057042e-11
juvenile O 0 9.333851630799472e-05
- O 0 3.456580799365838e-08
onset O 1 0.9967503547668457
) O 0 1.682552569493012e-10
and O 0 6.807475916303929e-09
chronic O 0 0.045505765825510025
( O 0 4.496354243793688e-12
adult O 0 4.809376008552135e-09
- O 0 1.773130947624324e-10
onset O 0 1.5103051964615588e-07
) O 0 1.048994550077731e-12
variants O 0 1.4043725904411275e-10
are O 0 9.360643770522925e-13
characterized O 0 6.433445898408607e-13
by O 0 2.0605872151809035e-13
a O 0 3.769189387686778e-12
broad O 0 1.7378184447025546e-09
spectrum O 0 2.6759899185435643e-08
of O 0 7.15785113472589e-12
clinical O 0 8.150080436919449e-12
manifestations O 0 1.1496574525704517e-10
and O 0 3.6870048572383574e-13
are O 0 1.599368458038517e-14
associated O 0 5.096006082394577e-13
with O 0 3.5083254254194077e-14
residual O 0 4.0336900042348134e-08
levels O 0 9.149375301831242e-08
of O 0 2.2478920946866765e-09
Hex O 0 9.347907052870141e-07
A O 0 8.030182740981218e-09
enzyme O 0 6.279515574192374e-09
activity O 0 5.172361738914333e-08
. O 0 3.7096978822148685e-09

We O 0 6.503400040713814e-09
identified O 0 1.0774031666827e-09
a O 0 1.119554015466262e-11
1422 O 0 1.6187361495667574e-07
G O 0 3.184800689837175e-08
- O 0 1.1128218346811991e-08
- O 0 3.85869185492993e-08
> O 0 7.007486857446565e-08
C O 0 2.281507605061961e-08
( O 0 2.292549898291925e-14
amino O 0 1.137376868035056e-12
acid O 0 1.035858139715462e-12
W474C O 0 1.0614958564914012e-11
) O 0 2.3709172171653033e-16
substitution O 0 6.522828609710485e-13
in O 0 9.550087771374033e-14
the O 0 2.704115685710218e-13
first O 0 1.0725299771571772e-12
position O 0 3.091983960534783e-11
of O 0 1.2631913570704256e-10
exon O 0 1.0981292541956122e-09
13 O 0 1.8020399061846604e-10
of O 0 1.5950486764726435e-10
HEXA O 0 3.8936195778660476e-05
of O 0 5.9392846196715254e-09
a O 0 8.396567469093341e-11
non O 0 3.2156015095097246e-07
- O 0 2.5836305539428395e-08
Jewish O 0 1.1882749362257528e-07
proband O 0 5.2700448577525094e-05
who O 0 5.400168159863661e-11
manifested O 0 6.046612655019601e-10
a O 0 2.449713175367574e-12
subacute O 0 3.616976584908116e-08
variant O 0 1.1169642100128385e-08
of O 0 2.1858918444195297e-06
G B-Disease 0 0.000496349239256233
( I-Disease 0 4.949814516597151e-11
M2 I-Disease 0 2.0147197119513294e-06
) I-Disease 0 2.477144357693195e-11
gangliosidosis I-Disease 0 1.3468416000250727e-06
. O 0 5.710090889010644e-08

On O 0 4.884071458377548e-08
the O 0 6.943207120357897e-10
second O 0 6.078669567699535e-09
maternally O 0 9.205949140778102e-07
inherited O 0 8.100609534267278e-07
allele O 0 1.8898280274015633e-08
, O 0 2.4615346653350523e-12
we O 0 1.1078633263593776e-13
identified O 0 5.982796181212835e-13
the O 0 9.720302904595024e-13
common O 0 2.0959463498115838e-08
infantile O 0 0.000115010334411636
disease O 0 3.106719532297575e-06
- O 0 1.0844133591092486e-08
causing O 0 5.699098526434909e-09
4 O 0 1.4384623270302654e-08
- O 0 3.2659869253492957e-10
bp O 0 4.5559078731827185e-10
insertion O 0 8.284179592310537e-11
, O 0 2.6614420303022746e-12
+ O 0 1.0285197693526982e-10
TATC O 0 1.9718493149412097e-06
1278 O 0 6.66289793116448e-07
, O 0 2.1652573831132393e-11
in O 0 1.3388559705340697e-10
exon O 0 4.391518260149496e-08
11 O 0 4.3871541954843e-09
. O 0 7.825887493595474e-09

Pulse O 0 1.4908907360222656e-05
- O 0 1.4217856403320184e-07
chase O 0 8.717707666860974e-10
analysis O 0 6.541782740510094e-12
using O 0 1.44492213333125e-11
proband O 0 4.646461206903041e-07
fibroblasts O 0 3.656193570122923e-08
revealed O 0 1.2003675831095961e-09
that O 0 3.438502195647619e-13
the O 0 3.3698625487299516e-12
W474C O 0 6.549054631932449e-10
- O 0 1.08681362520624e-11
containing O 0 6.838385760432608e-12
alpha O 0 1.3164976921109517e-11
- O 0 1.2618078240253516e-12
subunit O 0 5.510348579339241e-13
precursor O 0 2.2518807998861412e-11
was O 0 1.7672989807704376e-11
normally O 0 1.3343574292376537e-12
synthesized O 0 9.072812640065209e-11
, O 0 2.421384490483569e-13
but O 0 3.0085108666463856e-13
not O 0 8.685032402457049e-13
phosphorylated O 0 1.3658595365839687e-09
or O 0 1.7024532825149485e-11
secreted O 0 4.6038273887605285e-11
, O 0 1.3958577132697214e-12
and O 0 2.0105794199670735e-12
the O 0 1.0449756338015703e-10
mature O 0 2.7574774463801077e-08
lysosomal O 0 1.4719853425049223e-07
alpha O 0 4.124330210686367e-09
- O 0 2.649612751426389e-10
subunit O 0 6.715799444334536e-11
was O 0 5.775748976311057e-11
not O 0 1.730685039724733e-11
detected O 0 1.524241710626484e-08
. O 0 7.494682208175618e-09

When O 0 3.3810056976335545e-09
the O 0 3.3820618527968804e-10
W474C O 0 4.7461878871501995e-09
- O 0 9.412053775248452e-11
containing O 0 2.2209047101373613e-11
alpha O 0 1.568125143625032e-11
- O 0 1.9021702615806824e-12
subunit O 0 9.330039995800177e-13
was O 0 1.0839030194220722e-11
transiently O 0 1.9986303723129595e-09
co O 0 1.5149038273820636e-11
- O 0 3.481148355688468e-11
expressed O 0 1.4830012218247646e-11
with O 0 4.245244428343828e-14
the O 0 1.1695572895570328e-12
beta O 0 2.3618227599359054e-12
- O 0 1.8144750025400613e-12
subunit O 0 2.20174545912874e-13
to O 0 1.0946264375607737e-13
produce O 0 1.8631256260004392e-11
Hex O 0 1.564214180405088e-08
A O 0 6.479252689928217e-10
( O 0 2.600750561090881e-13
alphabeta O 0 8.076710855675628e-09
) O 0 5.267105653537774e-13
in O 0 2.259698678175326e-11
COS O 0 9.401319545077058e-08
- O 0 4.704350686779435e-09
7 O 0 1.2403530424975884e-09
cells O 0 8.73791247690825e-11
, O 0 2.775400081197338e-13
the O 0 2.7751156407573863e-12
mature O 0 6.75089914525806e-11
alpha O 0 2.5501133323058145e-12
- O 0 3.64192373090641e-13
subunit O 0 6.609930701742539e-14
was O 0 3.0048749946609554e-13
present O 0 2.0987253818507967e-13
, O 0 7.621868766552811e-14
but O 0 8.314178609903494e-14
its O 0 3.5223119722576496e-14
level O 0 2.697389403852335e-12
was O 0 1.3973067494732483e-12
much O 0 1.2136492982470215e-12
lower O 0 1.0777478909318461e-10
than O 0 2.9975593405021095e-13
that O 0 7.197792573554115e-14
from O 0 1.2831637662136242e-11
normal O 0 2.6653679263688446e-09
alpha O 0 2.9142072088816917e-10
- O 0 2.0470470804556662e-11
subunit O 0 4.482260049232245e-12
transfections O 0 1.335000998636815e-09
, O 0 2.277223819669577e-13
although O 0 1.1271748508526191e-12
higher O 0 3.1594272337232e-11
than O 0 2.710373700649804e-13
in O 0 9.44308108270786e-13
those O 0 1.0323754004448737e-11
cells O 0 1.2078862909881138e-10
transfected O 0 4.187202140570889e-09
with O 0 4.965627315258771e-14
an O 0 1.3785287574809551e-14
alpha O 0 2.0031164227329867e-11
- O 0 2.128283833890965e-11
subunit O 0 1.0380818600552733e-11
associated O 0 5.093397578703751e-11
with O 0 1.2334394790258774e-11
infantile O 0 2.7157630029250868e-06
TSD B-Disease 0 0.0001875063026091084
. O 0 7.621077457997671e-08

Furthermore O 0 2.6811960651684785e-08
, O 0 1.7598146898056832e-11
the O 0 3.425176808846686e-12
precursor O 0 2.927204034719466e-10
level O 0 3.0992610700053547e-09
of O 0 2.2399218591040437e-10
the O 0 1.6552541282077726e-10
W474C O 0 6.22887785795001e-09
alpha O 0 1.0464955985112212e-10
- O 0 2.6557018303202673e-12
subunit O 0 5.363844134478879e-13
was O 0 1.216087018411638e-12
found O 0 5.2436770610298986e-14
to O 0 2.884714019849195e-14
accumulate O 0 4.919589475377295e-12
in O 0 1.8925789754820066e-13
comparison O 0 1.801454818650683e-11
to O 0 2.0983902549592814e-12
the O 0 1.973720492598474e-11
normal O 0 3.362806566542531e-08
alpha O 0 1.9734702760842993e-09
- O 0 9.822181262775231e-11
subunit O 0 3.553994598615162e-11
precursor O 0 1.0053157195599738e-09
levels O 0 1.0202287015204092e-08
. O 0 9.333898098873306e-10

We O 0 6.719932610366186e-09
conclude O 0 1.1796818633058592e-08
that O 0 2.5326195134123264e-12
the O 0 2.8852467290341188e-11
1422 O 0 1.4453438268446916e-07
G O 0 1.0403390149349434e-08
- O 0 2.3984707553381668e-09
- O 0 6.0393885448206674e-09
> O 0 1.4796694536300947e-08
C O 0 6.678991137931689e-09
mutation O 0 2.477072366668942e-12
is O 0 2.8565029416782685e-16
the O 0 3.557351184186718e-15
cause O 0 1.965766958933468e-11
of O 0 9.039997084236973e-10
Hex B-Disease 0 0.038240186870098114
A I-Disease 0 0.005571356508880854
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.063327369545732e-10
the O 0 1.9125695471799986e-10
proband O 0 3.5826673183692037e-07
. O 0 7.420248415712649e-09

The O 0 5.1814526003113315e-09
resulting O 0 9.412924661944544e-09
W474C O 0 3.19363664402772e-07
substitution O 0 6.53224446978129e-07
clearly O 0 2.555420763883376e-08
interferes O 0 2.9942852641795525e-09
with O 0 4.2866391859741615e-12
alpha O 0 6.941946323335557e-11
- O 0 6.117053478332801e-12
subunit O 0 2.568619362347535e-12
processing O 0 9.984359172765522e-11
, O 0 3.174034657067032e-13
but O 0 1.3980257110388777e-13
because O 0 3.2195312361189485e-14
the O 0 6.606855633330827e-14
base O 0 6.500595959961497e-13
substitution O 0 8.820923436125838e-10
falls O 0 1.4111881663225745e-09
at O 0 1.5427825033123566e-12
the O 0 7.629814748749686e-13
first O 0 4.829342654943947e-12
position O 0 4.0400999212764077e-10
of O 0 1.7477042035807244e-09
exon O 0 1.0877153400201678e-08
13 O 0 1.054597187355455e-09
, O 0 5.7792499084940996e-12
aberrant O 0 1.4525557423539226e-09
splicing O 0 1.272793426210228e-09
may O 0 1.6403637337347732e-09
also O 0 1.512896925792706e-11
contribute O 0 2.7619065368078566e-10
to O 0 2.3512010116633064e-09
Hex B-Disease 0 0.060643672943115234
A I-Disease 0 5.41587269253796e-06
deficiency I-Disease 0 3.34978449245682e-06
in O 0 7.574172539159818e-11
this O 0 4.8929780366302467e-11
proband O 0 2.7382225198380183e-07
. O 0 4.362261663004574e-10
. O 0 1.6238959066328107e-09

Two O 0 2.7857052220525702e-09
frequent O 0 1.284196482487232e-08
missense O 0 7.29951125322259e-06
mutations O 0 2.1150728457541845e-07
in O 0 7.058461193309995e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00017418671632185578

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.390274562140803e-09
an O 0 2.1897803570425367e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.79277742265549e-07
by O 0 1.8223873798906e-11
early O 0 0.020596081390976906
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9995717406272888
goiter B-Disease 1 1.0
. O 1 0.861112117767334

A O 0 1.888706080421798e-09
century O 0 5.650765966258575e-10
after O 0 2.2121617038184382e-11
its O 0 3.1319863152620697e-13
recognition O 0 7.28983106518255e-12
as O 0 1.7605154530378475e-12
a O 0 2.394545282544125e-12
syndrome O 0 6.033548105577324e-10
by O 0 3.3069029285737184e-12
Vaughan O 0 2.555197227138706e-07
Pendred O 0 6.695728416161728e-07
, O 0 1.1404441844012347e-12
the O 0 4.308722649504215e-12
disease O 0 1.0606389100331626e-09
gene O 0 6.221272108586362e-11
( O 0 5.630319561272801e-12
PDS O 0 6.088981535867788e-06
) O 0 1.3246933931732041e-12
was O 0 1.3930424869190716e-10
mapped O 0 2.541312715820254e-10
to O 0 2.5150312388255713e-11
chromosome O 0 3.64596908219994e-09
7q22 O 0 1.6506328393006697e-06
- O 0 2.725045931128989e-07
q31 O 0 1.7574310504642199e-06
. O 0 2.196549786503965e-08

1 O 0 1.1000458925991552e-06
and O 0 6.58009424725492e-10
, O 0 5.868830421640325e-11
recently O 0 3.820933569542717e-10
, O 0 2.560167355891707e-12
found O 0 9.80046339221774e-13
to O 0 2.123595136543921e-12
encode O 0 1.6051660001181745e-10
a O 0 3.8705531835159235e-11
putative O 0 1.1092706131421437e-07
sulfate O 0 2.2206013738923502e-07
transporter O 0 1.1396787158446386e-06
. O 0 9.412479329284906e-08

We O 0 6.576947875203132e-09
performed O 0 3.021604078057294e-10
mutation O 0 1.1381564961332469e-11
analysis O 0 1.8400422244907455e-12
of O 0 2.1561412377746336e-11
the O 0 7.620866715463137e-10
PDS B-Disease 0 0.00022631522733718157
gene O 0 4.556585386783496e-10
in O 0 4.0332764905670615e-11
patients O 0 4.993353730498029e-09
from O 0 1.3364874311416752e-11
14 O 0 5.773237790607233e-11
Pendred B-Disease 0 7.347453845341079e-08
families O 0 7.72393954351358e-12
originating O 0 8.664205637665123e-12
from O 0 5.831733208318257e-13
seven O 0 2.2602866843815517e-13
countries O 0 5.975163533443809e-14
and O 0 1.0670492267550458e-12
identified O 0 1.250114040063366e-10
all O 0 1.8577822613607964e-10
mutations O 0 6.497792304216432e-10
. O 0 1.8816048719116907e-09

The O 0 2.400472851604718e-07
mutations O 0 8.618990854358799e-09
include O 0 8.895970765587791e-11
three O 0 5.538274266275733e-12
single O 0 2.6636574890215314e-11
base O 0 1.9178929555607738e-09
deletions O 0 3.383316737881614e-08
, O 0 2.3192688047846133e-10
one O 0 5.836123945224259e-11
splice O 0 4.9324810902362515e-08
site O 0 9.310947568508254e-09
mutation O 0 3.523732194921081e-09
and O 0 5.49139518579711e-11
10 O 0 1.9509622806168636e-09
missense O 0 1.0300333315171883e-06
mutations O 0 4.595631253323518e-08
. O 0 6.010031228242951e-08

One O 0 9.065318096190822e-08
missense O 0 1.7208512872457504e-06
mutation O 0 1.2547257455253202e-08
( O 0 6.033288885848309e-12
L236P O 0 1.2614782107789324e-08
) O 0 2.0166706846125315e-12
was O 0 5.291945770480311e-10
found O 0 2.2831278534418686e-11
in O 0 4.130827190723663e-12
a O 0 2.315469647615198e-12
homozygous O 0 3.313729846077251e-11
state O 0 1.0310333316276843e-11
in O 0 6.671214362180544e-12
two O 0 1.3029300945446853e-12
consanguineous O 0 1.762172701091913e-07
families O 0 3.04747442558817e-11
and O 0 2.379738550314925e-12
in O 0 1.4817902764183155e-12
a O 0 1.3740911620346852e-12
heterozygous O 0 1.8745560659283456e-12
state O 0 9.50016757969574e-13
in O 0 4.2590095946509754e-13
five O 0 1.5822170234148364e-13
additional O 0 2.651521146743163e-12
non O 0 1.6082934095607015e-08
- O 0 4.6111722440400627e-08
consanguineous O 0 1.280005290027475e-05
families O 0 1.0651902693226134e-09
. O 0 1.0899036118061645e-09

Another O 0 2.064180790739556e-07
missense O 0 6.162824320199434e-06
mutation O 0 9.640484854855913e-09
( O 0 4.086495464933337e-12
T416P O 0 1.0959118945663704e-08
) O 0 9.051888470550107e-13
was O 0 1.9946611029553196e-10
found O 0 6.533826864968395e-12
in O 0 2.2570311505182294e-12
a O 0 6.501848755571804e-13
homozygous O 0 4.539387962743113e-12
state O 0 6.676841371455744e-12
in O 0 7.964138896976447e-12
one O 0 6.975841345541189e-12
family O 0 3.6172315143190303e-12
and O 0 5.04831202882694e-13
in O 0 1.0600992739889792e-12
a O 0 5.293230046984898e-13
heterozygous O 0 7.639774772007224e-13
state O 0 4.2240280826062737e-13
in O 0 1.5065869558850142e-12
four O 0 1.3223455533686868e-12
families O 0 1.4023858463385608e-11
. O 0 5.375692113673836e-10

Pendred B-Disease 1 0.6241884231567383
patients O 1 0.5590357184410095
in O 0 3.0141917850556865e-09
three O 0 1.5896031713147352e-10
non O 0 3.5674548826136743e-07
- O 0 4.591986737523257e-07
consanguineous O 0 0.005503304768353701
families O 0 1.2723709863493582e-09
were O 0 8.643276198927463e-12
shown O 0 1.6149660276611189e-13
to O 0 3.641921833552608e-14
be O 0 1.3124673873751713e-13
compound O 0 1.1674233801883815e-10
heterozygotes O 0 1.264464755124095e-09
for O 0 5.814432268991254e-12
L236P O 0 2.449970359919007e-08
and O 0 6.795818768834394e-11
T416P O 0 1.4200537634678767e-07
. O 0 9.292513425407378e-09

In O 0 1.1503999530759756e-08
total O 0 8.322160738316597e-10
, O 0 8.309293531016948e-11
one O 0 1.1252077394829918e-11
or O 0 1.9802211953523496e-11
both O 0 1.2708416784190657e-11
of O 0 8.475765228554977e-11
these O 0 5.2188999649649404e-11
mutations O 0 5.387891521824173e-12
were O 0 1.1192914650681729e-11
found O 0 6.799169517332504e-13
in O 0 3.370259258304864e-13
nine O 0 1.781118330081155e-12
of O 0 8.935959611156008e-13
the O 0 1.7144121192136375e-11
14 O 0 1.1938777744191498e-10
families O 0 7.56091890485866e-12
analyzed O 0 3.9161351939043243e-10
. O 0 7.641098309640881e-10

The O 0 5.828362237281226e-10
identification O 0 2.200726534340447e-08
of O 0 3.712826712742867e-09
two O 0 4.384682200653245e-11
frequent O 0 3.9942274487891893e-10
PDS B-Disease 0 2.4231698262155987e-05
mutations O 0 2.2411397737620575e-10
will O 0 2.96768143913384e-13
facilitate O 0 2.6416525217287656e-12
the O 0 4.363603120331738e-13
molecular O 0 8.369497456195418e-11
diagnosis O 0 2.0852864679454797e-07
of O 0 5.8187264784237414e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 7.59799422667129e-06

Insertional O 0 7.51850166125223e-05
mutation O 0 2.5027366845620236e-08
by O 0 4.218879759432248e-11
transposable O 0 8.300424951812602e-07
element O 0 2.388802400332679e-08
, O 0 4.927614427607807e-10
L1 O 0 9.026015135304988e-08
, O 0 2.6857407357111507e-12
in O 0 5.539647299906969e-12
the O 0 3.1671409939093564e-09
DMD B-Disease 1 1.0
gene O 0 1.7554215858694988e-09
results O 0 3.41625017163949e-09
in O 0 2.012845445875655e-10
X B-Disease 1 0.9999892711639404
- I-Disease 1 0.6506361961364746
linked I-Disease 0 0.00020549616601783782
dilated I-Disease 0 0.02448049560189247
cardiomyopathy I-Disease 1 1.0
. O 0 4.787258149008267e-06

X B-Disease 1 0.9999996423721313
- I-Disease 1 1.0
linked I-Disease 1 0.999994158744812
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 0 1.314602648960772e-08
XLDCM B-Disease 1 0.9999938011169434
) O 0 1.3568189540652531e-12
is O 0 2.7726366531475796e-14
a O 0 7.632546802699078e-14
clinical O 0 5.566598293427205e-10
phenotype O 0 1.265370599412563e-07
of O 0 7.210947838842685e-09
dystrophinopathy B-Disease 0 0.0001393621787428856
which O 0 4.784877008501276e-11
is O 0 5.09469419776587e-13
characterized O 0 8.221976159801525e-13
by O 0 3.3750969683984944e-13
preferential O 0 1.4834674821884164e-08
myocardial B-Disease 0 2.807090027090453e-07
involvement I-Disease 0 3.044001994911838e-10
without O 0 2.1687788717694723e-11
any O 0 2.1910315575746075e-11
overt O 0 3.251182101315919e-10
clinical O 0 5.085915022462473e-10
signs O 0 6.316694722841021e-09
of O 0 3.0726582167517336e-08
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9997722506523132

To O 0 1.8024763626112161e-10
date O 0 3.9667369833296107e-07
, O 0 5.1014185931119727e-11
several O 0 5.313037336474036e-12
mutations O 0 8.272053181324068e-11
in O 0 3.884509033880157e-11
the O 0 3.417044354137033e-07
Duchenne B-Disease 1 0.9999880790710449
muscular I-Disease 1 0.9999796152114868
dystrophy I-Disease 1 1.0
gene O 0 0.0004636014346033335
, O 0 3.7040855715986254e-08
DMD O 1 1.0
, O 0 2.315295455357358e-10
have O 0 1.1101039792266176e-12
been O 0 3.148673541949337e-13
identified O 0 1.2428283228949066e-12
in O 0 8.861077019708952e-13
patients O 0 1.9859222599727389e-10
with O 0 4.18799218394883e-13
XLDCM B-Disease 1 0.9999998807907104
, O 0 4.9322008283114727e-11
but O 0 6.2266112405007235e-12
a O 0 8.250689085935459e-14
pathogenic O 0 1.898272233846754e-10
correlation O 0 3.671625503631759e-11
of O 0 3.0922300310598505e-12
these O 0 1.131479198529517e-11
cardiospecific O 0 2.1088666812829615e-08
mutations O 0 3.120554370461548e-10
in O 0 7.101637333750688e-11
DMD O 1 1.0
with O 0 2.323602595055707e-11
the O 0 3.14786330335437e-09
XLDCM B-Disease 1 0.9999998807907104
phenotype O 0 0.00016841139586176723
has O 0 5.784149201271127e-11
remained O 0 1.498430379776039e-09
to O 0 3.7058501883499573e-13
be O 0 1.039464781610322e-11
elucidated O 0 1.5047627357489546e-06
. O 0 3.917192614721898e-08

We O 0 3.90899534963296e-09
report O 0 3.0594020372642916e-11
here O 0 2.5673753487748252e-12
the O 0 8.101870140487383e-14
identification O 0 5.7434265676725715e-12
of O 0 2.5439676407112977e-12
a O 0 1.0308440299283683e-12
unique O 0 5.90595419791562e-11
de O 0 1.1645728825726565e-09
novo O 0 3.1891027596486765e-09
L1 O 0 2.4851177116147483e-08
insertion O 0 9.690328539591064e-10
in O 0 2.1014602558100393e-10
the O 0 7.378118116463384e-10
muscle O 0 1.1309090552913403e-08
exon O 0 9.866301553529411e-08
1 O 0 3.5541898313340425e-08
in O 0 6.009315267618831e-10
DMD O 1 1.0
in O 0 7.993127049132909e-09
three O 0 7.916497318793958e-11
XLDCM B-Disease 1 0.9904870390892029
patients O 0 2.0617267182387877e-06
from O 0 2.7806699651189426e-11
two O 0 2.351873578700092e-13
unrelated O 0 3.872379361613554e-10
Japanese O 0 6.5792944425879796e-09
families O 0 1.3532536202731649e-10
. O 0 8.518474814422916e-10

The O 0 1.8697640769005375e-08
insertion O 0 6.711363020883709e-09
was O 0 2.492730910574892e-09
a O 0 4.1152012353329326e-12
5 O 0 4.093416924866311e-11
- O 0 5.457155560772975e-12
truncated O 0 1.5900276928437762e-10
form O 0 2.3826147652061813e-11
of O 0 1.398395982343814e-10
human O 0 6.567827531833714e-11
L1 O 0 1.9150381280752526e-09
inversely O 0 7.707027016579104e-09
integrated O 0 2.6813863629460144e-11
in O 0 6.381200906221962e-13
the O 0 3.605246526663941e-12
5 O 0 6.34407248956137e-11
- O 0 1.2524577208683496e-10
untranslated O 0 9.509950018582458e-07
region O 0 7.757029046873143e-11
in O 0 1.9099147610668332e-11
the O 0 2.1193648225281692e-10
muscle O 0 1.5251482299305508e-09
exon O 0 1.9204444701159673e-09
1 O 0 9.805696254971963e-10
, O 0 7.165656821161645e-14
which O 0 1.7627111386199837e-14
affected O 0 5.143898328119345e-12
the O 0 3.4119794663223235e-12
transcription O 0 1.0579122647347283e-11
or O 0 1.1646022687883395e-12
the O 0 7.98202302865203e-12
stability O 0 8.037116111525577e-11
of O 0 1.1219702250597763e-10
the O 0 5.2254939958418234e-11
muscle O 0 1.0550654794272418e-10
form O 0 3.257664138445193e-09
of O 0 1.820566097876508e-08
dystrophin O 0 5.1757926833317924e-09
transcripts O 0 4.340847681305604e-10
but O 0 2.3657261588073963e-13
not O 0 2.4380295010487454e-14
that O 0 2.7251772277063317e-14
of O 0 4.836175904188167e-11
the O 0 9.141783330335329e-09
brain O 0 1.15596685645869e-06
or O 0 1.0175197573403238e-08
Purkinje O 0 1.3809964002575725e-05
cell O 0 2.2215831450012047e-06
form O 0 7.586596351139008e-10
, O 0 5.252871922156732e-12
probably O 0 1.898750184858855e-10
due O 0 1.1944347733106042e-08
to O 0 3.144505836272238e-11
its O 0 4.296519303531587e-12
unique O 0 1.2741564530890925e-12
site O 0 2.5667400496698356e-11
of O 0 1.369387502697661e-11
integration O 0 1.213197431404467e-09
. O 0 8.887873548246716e-09

We O 0 2.703565371575678e-08
speculate O 0 7.762971598879176e-09
that O 0 8.354715573880012e-14
this O 0 3.854599202757908e-13
insertion O 0 3.753796995464853e-10
of O 0 5.772910482981786e-10
an O 0 5.8070844140278854e-12
L1 O 0 5.575252970402289e-08
sequence O 0 4.214038146210797e-11
in O 0 4.310960616260573e-11
DMD O 1 1.0
is O 0 5.2359470925633644e-12
responsible O 0 5.754717991197922e-13
for O 0 1.2442222816280712e-13
some O 0 6.078411428703245e-14
of O 0 2.66058280008058e-13
the O 0 1.0630224863339074e-13
population O 0 1.244624495223075e-15
of O 0 5.711606267290318e-15
Japanese O 0 5.600846175735086e-11
patients O 0 2.9482086910670446e-11
with O 0 2.492925570835025e-13
XLDCM B-Disease 0 1.4531360648106784e-05
. O 0 2.7477211617110697e-09
. O 0 7.521619771466703e-09

Severe O 0 2.9254821129143238e-05
early O 1 0.9999047517776489
- O 1 0.9999991655349731
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 2.573783675074992e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 7.362141474231976e-08
red O 1 0.9987204074859619
hair O 0 0.00014535551599692553
pigmentation O 1 0.9997112154960632
caused O 0 1.7921260564435215e-07
by O 0 1.3507536422707744e-08
POMC O 1 0.9995324611663818
mutations O 0 3.609548002714291e-07
in O 0 3.3577784996907667e-10
humans O 0 2.0855253080043212e-09
. O 0 3.1491365071190103e-09

Sequential O 0 1.0691991292333114e-07
cleavage O 0 7.01794675705969e-08
of O 0 6.8662604491009915e-09
the O 0 2.2484528128252634e-10
precursor O 0 3.419229122059164e-09
protein O 0 6.879418701366546e-10
pre O 0 4.0929865008365596e-07
- O 0 1.2387654635404033e-07
pro O 0 2.2329673754484247e-07
- O 0 2.685222000309295e-07
opiomelanocortin O 0 2.6054026420752052e-06
( O 0 2.775381834074775e-11
POMC O 0 1.319405214417202e-06
) O 0 1.2884973036447755e-12
generates O 0 8.61447458505582e-12
the O 0 1.848258959075144e-12
melanocortin O 0 2.438297883600171e-07
peptides O 0 2.5680158000085385e-09
adrenocorticotrophin O 0 8.790050856077869e-07
( O 0 2.334548526716773e-11
ACTH O 0 1.7931209583821328e-07
) O 0 4.8402709791617315e-12
, O 0 1.4477525081546538e-11
melanocyte O 0 5.227625479164999e-07
- O 0 1.2310162844642036e-07
stimulating O 0 2.1721520582218545e-08
hormones O 0 3.217636157515358e-09
( O 0 2.0825131983454037e-12
MSH O 0 8.592983249400277e-07
) O 0 2.461530111685928e-12
alpha O 0 7.139230179253886e-11
, O 0 2.957871035776105e-13
beta O 0 9.845886259074454e-12
and O 0 8.800239725305359e-13
gamma O 0 4.021208713234081e-11
as O 0 1.020795514089512e-11
well O 0 1.3467506190106837e-12
as O 0 4.121239482492156e-13
the O 0 9.878424033632482e-13
opioid O 0 3.463044295770601e-10
- O 0 2.6398921937342834e-10
receptor O 0 7.527855422351237e-11
ligand O 0 4.5046357755040844e-09
beta O 0 2.700689449852689e-08
- O 0 1.8734553464128112e-08
endorphin O 0 3.3146757232316304e-06
. O 0 7.792894329838873e-09

While O 0 6.8547714171529606e-09
a O 0 5.371074678767185e-12
few O 0 8.576700981366425e-12
cases O 0 1.4539186521389524e-10
of O 0 2.733337645111078e-08
isolated O 1 0.9998651742935181
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 2.9178017779685206e-09
been O 0 1.7268610152942898e-10
reported O 0 1.6287994564212482e-10
( O 0 6.40577695054656e-12
OMIM O 0 1.4220000821296708e-06
201400 O 0 5.813301839907581e-08
) O 0 9.057207566408321e-13
, O 0 1.3939262070994385e-12
an O 0 1.936744601499507e-12
inherited O 0 0.2617265582084656
POMC O 1 1.0
defect O 1 0.9999990463256836
has O 0 3.481756438716843e-09
not O 0 2.471566180883844e-11
been O 0 2.1802094851697262e-11
described O 0 4.651649898601562e-11
so O 0 1.484705067222869e-11
far O 0 3.6090411215106144e-10
. O 0 6.328739199368272e-10

Recent O 0 7.09057630388088e-08
studies O 0 1.7031913379650376e-10
in O 0 7.980953137948221e-13
animal O 0 1.2122848731810354e-11
models O 0 3.9387616432295935e-12
elucidated O 0 2.787639674650677e-09
a O 0 1.966440899003885e-12
central O 0 3.6451171941953575e-11
role O 0 2.7571051344765785e-11
of O 0 2.6480178050292125e-09
alpha O 0 6.618197989638475e-09
- O 0 2.132275911392867e-09
MSH O 0 5.230789611232467e-06
in O 0 2.2829657001649517e-12
the O 0 2.8584258441113897e-13
regulation O 0 6.819837663346595e-12
of O 0 1.592836106067974e-13
food O 0 2.7295392508730476e-12
intake O 0 8.501029741259103e-13
by O 0 5.061457658295807e-15
activation O 0 1.5174060619127516e-10
of O 0 3.10973002903836e-09
the O 0 5.975181238682126e-08
brain O 0 9.209110203300952e-07
melanocortin O 0 1.9370495465409476e-06
- O 0 8.480709823288635e-08
4 O 0 1.592266052341529e-08
- O 0 4.5070916443457065e-10
receptor O 0 6.016456777224732e-11
( O 0 4.378184555349496e-13
MC4 O 0 1.0203959845966892e-06
- O 0 7.652361411203401e-09
R O 0 5.8245195333483935e-09
; O 0 3.619136240695653e-12
refs O 0 1.337158855863052e-10
3 O 0 5.7038446882318183e-11
- O 0 9.36434523673979e-12
5 O 0 5.036714968709166e-12
) O 0 1.865995159834621e-15
and O 0 2.172547352522619e-14
the O 0 5.584327488275531e-13
linkage O 0 2.3473731292078526e-10
of O 0 2.714515418000829e-11
human O 0 1.3278700361496476e-09
obesity B-Disease 1 1.0
to O 0 1.6954190829032711e-10
chromosome O 0 1.3315240576794451e-10
2 O 0 6.561733933985181e-10
in O 0 7.645114576126932e-12
close O 0 5.797569369025979e-11
proximity O 0 1.0593206312137227e-09
to O 0 5.276482029081819e-11
the O 0 5.747336384587243e-09
POMC O 0 9.645124009693973e-06
locus O 0 3.174717710940911e-10
, O 0 4.756929225524509e-12
led O 0 6.856030066587637e-12
to O 0 8.138421983853658e-14
the O 0 4.771138453936452e-13
proposal O 0 7.720672712263621e-11
of O 0 2.008433133346421e-12
an O 0 1.241950285153651e-14
association O 0 2.7988076266305395e-12
of O 0 3.234850581845805e-11
POMC O 0 0.00027043302543461323
with O 0 3.7709460554147256e-11
human O 0 5.950502313112338e-08
obesity B-Disease 1 1.0
. O 0 3.112402069405107e-08

The O 0 7.558129122564594e-10
dual O 0 3.741916221322583e-10
role O 0 8.375250493131148e-10
of O 0 6.356969350918007e-08
alpha O 0 7.695145995967323e-07
- O 0 2.750119563188491e-07
MSH O 0 0.00018940707377623767
in O 0 1.0095420159561552e-11
regulating O 0 3.139682958064327e-10
food O 0 5.559531723875466e-10
intake O 0 1.8604427998170081e-09
and O 0 2.3547845964810854e-11
influencing O 0 1.3988287150823453e-07
hair O 0 7.059638392092893e-06
pigmentation O 0 0.0005747341783717275
predicts O 0 1.6940946423460446e-09
that O 0 7.832796233451719e-14
the O 0 3.393624790903882e-12
phenotype O 0 8.629958969663676e-10
associated O 0 7.567352994231058e-12
with O 0 2.4101356896561246e-14
a O 0 5.498337787672447e-13
defect O 0 5.3979083425304e-09
in O 0 5.007275150070711e-10
POMC O 0 1.476686702517327e-05
function O 0 5.498500960099406e-11
would O 0 2.8275517777870407e-12
include O 0 2.5312685975054094e-11
obesity B-Disease 1 1.0
, O 0 9.56423850707877e-13
alteration O 0 2.6237168526677124e-07
in O 0 4.787604979128446e-08
pigmentation O 1 1.0
and O 0 1.829945540521294e-05
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999874830245972
. O 0 2.1913185719313333e-06

The O 0 2.290899026036186e-09
observation O 0 2.9166347559339556e-08
of O 0 3.4877695176405155e-10
these O 0 9.069840989361921e-10
symptoms O 0 0.0001974538608919829
in O 0 4.3126919813119e-09
two O 0 5.231068009314832e-11
probands O 0 1.2659997992159333e-06
prompted O 0 8.12107536773965e-09
us O 0 1.0152770985039083e-11
to O 0 3.714804505672298e-12
search O 0 4.10873279843571e-11
for O 0 2.1175565641240457e-12
mutations O 0 1.3443651747380159e-10
within O 0 1.479606659415822e-09
their O 0 2.9721810790306336e-08
POMC O 0 0.0021273973397910595
genes O 0 2.1911732517310156e-07
. O 0 3.6721772289638466e-08

Patient O 1 0.9800986051559448
1 O 0 3.5512530871528725e-07
was O 0 2.6775357486741314e-09
found O 0 1.430116268463788e-11
to O 0 1.322736516672085e-12
be O 0 2.6836824863069042e-12
a O 0 1.3769560578552609e-12
compound O 0 6.650208717040584e-10
heterozygote O 0 1.734676757791931e-08
for O 0 1.223245636727821e-11
two O 0 3.47758302189638e-12
mutations O 0 1.1671000103852247e-11
in O 0 1.2727101317278056e-10
exon O 0 5.246921563895057e-09
3 O 0 1.6940492342243374e-09
( O 0 7.504379062606148e-13
G7013T O 0 1.2758272660562398e-08
, O 0 9.922426595643241e-12
C7133delta O 0 3.827173600257083e-08
) O 0 1.1328772934939696e-13
which O 0 2.5935269624727426e-14
interfere O 0 4.394565494923036e-13
with O 0 2.6466562994079687e-15
appropriate O 0 6.740435466723316e-12
synthesis O 0 3.5997463343484526e-10
of O 0 3.021604078057294e-10
ACTH O 0 2.825325509547838e-06
and O 0 2.994182679572077e-09
alpha O 0 1.0029685881818295e-07
- O 0 1.1101489150178168e-07
MSH O 0 0.00012083086039638147
. O 0 1.3006582477714801e-08

Patient O 1 0.838399350643158
2 O 0 9.295423808453052e-08
was O 0 6.787299056121299e-10
homozygous O 0 5.714646811316726e-11
for O 0 4.1449046343615403e-13
a O 0 9.629254858756209e-13
mutation O 0 4.9749912522933926e-11
in O 0 3.9684821401264614e-11
exon O 0 3.752453014982393e-09
2 O 0 2.3370814172807286e-09
( O 0 3.8874995887325237e-13
C3804A O 0 5.291584947997308e-09
) O 0 2.7985551159445676e-13
which O 0 6.259452157986178e-12
abolishes O 0 2.23471005256215e-07
POMC O 0 0.0001788552908692509
translation O 0 8.647927529636945e-08
. O 0 3.370724499518474e-08

These O 0 1.1613615846783887e-08
findings O 0 1.54413615227611e-09
represent O 0 9.099289030589652e-12
the O 0 1.152317065551689e-12
first O 0 7.456183565533736e-13
examples O 0 3.582058477960559e-12
of O 0 1.6502150123817727e-12
a O 0 4.39479633240758e-11
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 8.84417694635431e-09
the O 0 3.9870495793792315e-10
POMC O 0 1.8248861124448013e-06
gene O 0 1.7442191788119565e-11
and O 0 1.6049307878778646e-13
define O 0 2.2687795652592824e-12
a O 0 2.0647693895359948e-13
new O 0 1.0623239177220967e-08
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 2.5798723072512075e-05
resulting O 0 1.6796195545509818e-09
in O 0 1.1684609009521285e-11
early O 0 2.6881814847001806e-05
- O 0 0.0003523121413309127
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 5.840962824521512e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.8566672461447524e-08
red O 0 4.328860450186767e-05
hair O 0 3.6294304095463303e-07
pigmentation O 0 6.900010248500621e-06
. O 0 3.3777634023124392e-09
. O 0 9.041260184972089e-09

A O 0 2.2526402077005514e-08
European O 0 7.2670882644843005e-09
multicenter O 0 2.6141758553421823e-06
study O 0 5.15805120837598e-10
of O 0 9.546727852693948e-08
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 3.07917913389133e-10
classification O 0 4.75263099986023e-08
of O 0 1.8316062000423017e-09
105 O 0 4.5601375120440935e-08
mutations O 0 4.980887577388238e-11
and O 0 1.0309030105265515e-12
a O 0 2.242320776757109e-13
general O 0 1.0009948425704351e-10
system O 0 5.0810453067207106e-11
for O 0 1.4627152570764745e-12
genotype O 0 6.037876865150338e-10
- O 0 3.539598822377421e-11
based O 0 1.51086608501938e-12
prediction O 0 6.7844934115157685e-09
of O 0 1.5452571514029678e-11
metabolic O 0 1.4090625882090535e-05
phenotype O 0 1.1721199371095281e-06
. O 0 4.258928765210612e-09

Phenylketonuria B-Disease 0 0.008555041626095772
( O 0 4.823228927364198e-09
PKU B-Disease 0 0.0010889911791309714
) O 0 1.3427123302101052e-10
and O 0 8.228934894605189e-11
mild B-Disease 1 0.9993925094604492
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.593653678355622e-06
MHP B-Disease 1 1.0
) O 0 4.2334558081336127e-10
are O 0 2.0023381563927245e-10
allelic B-Disease 0 6.902869063196704e-05
disorders I-Disease 0 1.5704644056313555e-06
caused O 0 3.761812195079983e-09
by O 0 4.213186396984092e-11
mutations O 0 1.8248960675926185e-10
in O 0 8.266496862030515e-12
the O 0 5.655820256578181e-11
gene O 0 3.461352038325316e-11
encoding O 0 2.017513622831757e-08
phenylalanine O 0 1.2301998140173964e-05
hydroxylase O 0 0.0009358537499792874
( O 0 1.6680655745560102e-09
PAH O 1 0.9999969005584717
) O 0 1.1443113123732473e-09
. O 0 1.3100846629754415e-08

Previous O 0 2.311473508598283e-06
studies O 0 2.1815385053969294e-09
have O 0 6.858001037716999e-13
suggested O 0 4.806562266257419e-12
that O 0 2.4427293057082333e-15
the O 0 2.6447114355281076e-13
highly O 0 2.680089206119618e-10
variable O 0 1.4680705540115468e-08
metabolic O 0 0.00017271412070840597
phenotypes O 0 6.6677116592472885e-06
of O 0 7.74781199197605e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
correlate O 0 1.3350062545214314e-05
with O 0 1.2411488725661002e-08
PAH O 1 1.0
genotypes O 0 0.004168454557657242
. O 0 1.9441510801243567e-07

We O 0 5.4125816717487396e-08
identified O 0 2.9156987935152756e-09
both O 0 3.475999696411769e-11
causative O 0 7.276328517491493e-08
mutations O 0 7.3717356663394185e-09
in O 0 1.3785947383659902e-10
686 O 0 1.050871460961389e-07
patients O 0 1.389499146853268e-07
from O 0 5.0624140296440245e-11
seven O 0 3.3158861073578905e-11
European O 0 6.200425728408732e-10
centers O 0 4.836992584245081e-09
. O 0 1.8906056720169317e-09

On O 0 9.423235525218843e-09
the O 0 1.898296624058826e-11
basis O 0 6.689311604635151e-11
of O 0 2.265056848679836e-12
the O 0 4.296035749362659e-12
phenotypic O 0 3.4352951039373636e-10
characteristics O 0 1.8633841136761475e-08
of O 0 1.921988079800485e-08
297 O 0 1.3025679379552457e-07
functionally O 0 1.4109359014469192e-08
hemizygous O 0 2.562185841270548e-07
patients O 0 1.428423388460942e-07
, O 0 3.5729422892538665e-12
105 O 0 1.3516756602882651e-09
of O 0 3.588734864834464e-11
the O 0 6.535400692841975e-11
mutations O 0 1.5405603875917606e-11
were O 0 2.2759667414606888e-11
assigned O 0 5.716388733895128e-12
to O 0 1.7009333394893411e-12
one O 0 8.226243037451342e-13
of O 0 5.312490464898234e-12
four O 0 4.722700095577403e-13
arbitrary O 0 1.5311429901743168e-10
phenotype O 0 1.9320847144399522e-08
categories O 0 2.1795381055511598e-09
. O 0 1.7905767979442544e-09

We O 0 3.153549954504342e-08
proposed O 0 3.621208222170935e-08
and O 0 2.2895350892948585e-10
tested O 0 2.6254756702037696e-10
a O 0 4.621127699250271e-13
simple O 0 1.4455002949817497e-12
model O 0 6.037464365254985e-13
for O 0 6.047338872066169e-14
correlation O 0 1.3299870102803646e-12
between O 0 5.305766243024479e-12
genotype O 0 3.611425603011753e-09
and O 0 2.4778900719474306e-12
phenotypic O 0 1.0006512979332527e-10
outcome O 0 3.717704259997845e-07
. O 0 8.809094964590258e-08

The O 0 2.992962322423409e-08
observed O 0 6.64857822130216e-08
phenotype O 0 9.77677359514928e-07
matched O 0 7.575773253165607e-08
the O 0 5.703956196256854e-10
predicted O 0 1.1409599487421929e-08
phenotype O 0 4.6752372639957684e-08
in O 0 5.451332094064121e-11
79 O 0 1.2038618990573013e-09
% O 0 4.2692086844875465e-13
of O 0 4.063353250876797e-14
the O 0 7.386804926415302e-14
cases O 0 5.407112257937996e-12
, O 0 1.3704686257359766e-12
and O 0 3.3278974194417277e-12
in O 0 5.2973532678468604e-12
only O 0 3.149209842553957e-12
5 O 0 1.4668424461183882e-11
of O 0 7.55128761169982e-13
184 O 0 2.7069976468729884e-11
patients O 0 8.826540193185295e-11
was O 0 2.622165071880511e-12
the O 0 6.074012820489472e-12
observed O 0 3.651846533503367e-11
phenotype O 0 2.406929378029332e-10
more O 0 2.674855508529722e-13
than O 0 1.9671452509452403e-13
one O 0 3.6990968963054524e-14
category O 0 1.5700158187414992e-12
away O 0 9.039707459142232e-13
from O 0 1.1668940011304307e-13
that O 0 4.6923399275302854e-14
expected O 0 4.83738027412528e-09
. O 0 9.55368317789862e-09

Among O 0 4.2324467131038546e-07
the O 0 4.2398556887590644e-10
seven O 0 2.4681885008037696e-11
contributing O 0 1.2318500386410136e-11
centers O 0 1.0828579005695005e-10
, O 0 8.540273387569117e-14
the O 0 5.320762276952995e-13
proportion O 0 1.013207139716199e-11
of O 0 7.492383449769768e-12
patients O 0 4.862223956791922e-10
for O 0 2.0874881684340707e-12
whom O 0 1.0166534974986874e-10
the O 0 2.2369578411840507e-11
observed O 0 1.388773818167266e-10
phenotype O 0 4.5990555808117506e-10
did O 0 9.0685167708493e-12
not O 0 1.6358683071343583e-12
match O 0 3.8096591853387096e-11
the O 0 9.360381393597184e-12
predicted O 0 2.4144886090482487e-10
phenotype O 0 6.225667203985097e-10
was O 0 2.1954280407521232e-11
4 O 0 7.360723142113557e-12
% O 0 1.5452377333420586e-13
- O 0 1.4887763331167259e-12
23 O 0 1.1701381183448767e-11
% O 0 5.933656886149274e-13
( O 0 2.0222925168223577e-14
P O 0 5.41372457973921e-09
< O 0 2.623088135589313e-10
. O 0 1.758119583077089e-12
0001 O 0 1.5252065166393436e-09
) O 0 4.090329962756767e-13
, O 0 5.101763738031562e-13
suggesting O 0 6.651575124028142e-11
that O 0 9.12573835942787e-13
differences O 0 2.573903867819638e-10
in O 0 3.222937975527751e-12
methods O 0 5.679592213203577e-11
used O 0 7.836375645609017e-12
for O 0 1.7118405651328494e-11
mutation O 0 3.057981645682162e-09
detection O 0 5.391972308643744e-07
or O 0 1.072249289357785e-09
phenotype O 0 9.126003419623885e-08
classification O 0 1.3166973067413323e-09
may O 0 6.628597844227091e-12
account O 0 2.6146974667871914e-13
for O 0 1.2239602370902117e-14
a O 0 8.026437621369651e-15
considerable O 0 3.305969647343643e-12
proportion O 0 5.4743175270655087e-11
of O 0 9.19707573987516e-11
genotype O 0 1.9531917132553644e-06
- O 0 8.750458619033452e-06
phenotype O 0 1.6865913494257256e-05
inconsistencies O 0 1.3819875732679066e-07
. O 0 9.021191793578964e-09

Our O 0 3.5562382549869653e-07
data O 0 2.906465068619468e-09
indicate O 0 4.316080270960754e-10
that O 0 5.128936012878393e-13
the O 0 1.1490304541172947e-10
PAH O 1 1.0
- O 0 1.9552271623979323e-05
mutation O 0 1.00875823250135e-08
genotype O 0 2.433212242802796e-10
is O 0 2.849755000764408e-16
the O 0 3.765747017837049e-16
main O 0 3.094157417261878e-13
determinant O 0 1.1660482301945052e-10
of O 0 5.718005235966217e-11
metabolic O 1 0.9814075827598572
phenotype O 0 8.972425007414131e-07
in O 0 8.830240358359553e-12
most O 0 1.3776160767697831e-11
patients O 0 2.0915367215934566e-09
with O 0 4.343382042915067e-10
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0605432353913784

In O 0 4.4283549049950466e-10
the O 0 3.027331163529823e-11
present O 0 5.768174826670247e-11
study O 0 8.336370656281122e-12
, O 0 2.8408468611372528e-14
the O 0 2.63423478993538e-13
classification O 0 1.736999988288801e-09
of O 0 1.373595348574952e-09
105 O 0 1.147191937889147e-06
PAH O 1 1.0
mutations O 0 6.501118310353604e-09
may O 0 9.34500948845951e-11
allow O 0 4.799938658345271e-12
the O 0 2.7099102042210665e-12
prediction O 0 2.430448953205655e-09
of O 0 4.858659048007086e-12
the O 0 6.037917128082215e-12
biochemical O 0 1.4793273273028262e-09
phenotype O 0 1.0051206977834681e-08
in O 0 1.843099110832025e-11
> O 0 5.4995235032606615e-09
10 O 0 2.960306999533202e-11
, O 0 6.670422135653109e-13
000 O 0 3.3497951634764433e-10
genotypes O 0 4.846180789996879e-09
, O 0 1.3144296848871528e-12
which O 0 1.6824344380769046e-13
may O 0 1.913647625778614e-12
be O 0 1.8496369800363732e-13
useful O 0 7.290035545712281e-13
for O 0 2.037539448686114e-14
the O 0 2.8048839292860173e-12
management O 0 1.0257843185978999e-11
of O 0 2.2216504677596838e-11
hyperphenylalaninemia B-Disease 1 1.0
in O 0 4.453261581716106e-08
newborns O 0 3.866925453621661e-06
. O 0 4.321486279934561e-09

Somatic O 0 0.0003431410004850477
instability O 0 1.9634734371720697e-07
of O 0 5.141819414689053e-08
the O 0 4.6373679651878774e-07
CTG O 1 0.9993354678153992
repeat O 0 9.572278258929146e-07
in O 0 4.095654482227928e-09
mice O 0 5.891986454287235e-09
transgenic O 0 6.255988616032937e-09
for O 0 3.836557373876337e-12
the O 0 3.2789351678275125e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 3.2458171972393757e-07
is O 0 2.5932426778868534e-12
age O 0 5.6348561233710015e-11
dependent O 0 5.6462677415491935e-12
but O 0 4.1427293859903555e-14
not O 0 6.361985184543187e-14
correlated O 0 2.6045459192158837e-11
to O 0 2.2330547784152333e-13
the O 0 2.6189812037807902e-12
relative O 0 4.99480146132214e-09
intertissue O 0 5.971940026938682e-07
transcription O 0 1.2224643342051422e-07
levels O 0 4.79682739751297e-07
and O 0 8.91649587497767e-10
proliferative O 1 0.5308731198310852
capacities O 0 4.65238963442971e-06
. O 0 4.483825364332006e-07

A O 0 5.808319656352978e-06
( O 0 1.2650049896478777e-09
CTG O 0 6.536614364449633e-06
) O 0 9.185009523793308e-12
nexpansion O 0 3.032294060290042e-08
in O 0 9.79165012959804e-12
the O 0 3.328673794933401e-11
3 O 0 8.706490528531674e-10
- O 0 3.520923996802594e-09
untranslated O 0 0.00010247129102936015
region O 0 1.7705802379808233e-09
( O 0 1.5912154406605428e-12
UTR O 0 1.2948710718774237e-05
) O 0 1.7586083143113912e-13
of O 0 7.019191651524981e-12
the O 0 1.947798144996682e-09
DM O 1 1.0
protein O 0 3.1709923860034905e-06
kinase O 0 1.0501881320124085e-07
gene O 0 1.0174919795602477e-09
( O 0 9.466667900970283e-13
DMPK O 0 0.00012057947606081143
) O 0 3.776059597383058e-13
is O 0 1.61505144246352e-14
responsible O 0 2.075667518723276e-13
for O 0 9.566390648391154e-13
causing O 0 4.41432320030799e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.1145240809755705e-09
DM B-Disease 1 1.0
) O 0 1.6694684523699266e-10
. O 0 2.0414734347440344e-09

Major O 0 2.8569767891895026e-05
instability O 0 2.1898331397096626e-06
, O 0 7.412662150763083e-10
with O 0 1.2123032612498807e-11
very O 0 7.836215704104532e-11
large O 0 6.751887243749977e-12
expansions O 0 1.7487035430807651e-10
between O 0 1.1834848379077556e-10
generations O 0 7.912954180788745e-10
and O 0 2.4800365754085174e-12
high O 0 5.128070537652185e-11
levels O 0 4.820418716966479e-11
of O 0 1.140305471575287e-11
somatic O 0 3.036513476217806e-07
mosaicism O 0 1.268738515136647e-06
, O 0 6.610211510105213e-13
is O 0 1.2623890207643079e-14
observed O 0 2.226060481780312e-12
in O 0 7.75331188140882e-12
patients O 0 1.768218815811906e-08
. O 0 6.541892361155988e-09

There O 0 4.281988097432077e-09
is O 0 5.740754226157829e-12
a O 0 1.153293281187795e-12
good O 0 2.5923143839867713e-11
correlation O 0 5.254986116393079e-12
between O 0 1.404531981170909e-12
repeat O 0 2.1048570872372885e-11
size O 0 8.61724025469357e-11
( O 0 1.935096505777112e-13
at O 0 8.509535090461817e-12
least O 0 2.1053098500645184e-12
in O 0 1.5040976276969875e-12
leucocytes O 0 1.7264939700112336e-08
) O 0 1.9274237425277035e-13
, O 0 5.918192097411484e-14
clinical O 0 6.513888820697256e-13
severity O 0 4.204935288854017e-10
and O 0 5.6666910747127375e-12
age O 0 9.259529809568789e-10
of O 0 2.1574711461802565e-10
onset O 0 7.902658580860589e-06
. O 0 2.1016033713294746e-07

The O 0 3.2902923976507736e-06
trinucleotide O 0 0.004623586777597666
repeat O 0 2.4562547196183004e-07
instability O 0 1.805399385546025e-08
mechanisms O 0 1.014862416326423e-08
involved O 0 1.1215550710375055e-10
in O 0 6.775670580161375e-10
DM B-Disease 1 1.0
and O 0 4.132622244412687e-09
other O 0 3.2908724356683905e-11
human O 0 1.484927403261338e-09
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 8.422864727734847e-13
unknown O 0 2.7072263875105307e-10
. O 0 1.4808988757497588e-10

We O 0 1.162773433094344e-08
studied O 0 1.1216888751164333e-08
somatic O 0 2.467863623678568e-06
instability O 0 9.526710531559957e-10
by O 0 6.549972803721049e-12
measuring O 0 8.502166082280382e-09
the O 0 1.3320072822509132e-09
CTG O 0 9.964071523427265e-07
repeat O 0 2.571455270938827e-10
length O 0 5.72413783039849e-11
at O 0 3.404769955556164e-12
several O 0 1.620668524512578e-13
ages O 0 8.184589811444098e-11
in O 0 1.4267208291521283e-12
various O 0 5.0394088207950105e-11
tissues O 0 5.521451740264638e-08
of O 0 4.344179682647109e-09
transgenic O 0 7.520459917031985e-07
mice O 0 3.828958539120464e-10
carrying O 0 2.9092726491763976e-12
a O 0 1.4057326266567194e-12
( O 0 1.3841869274042184e-12
CTG O 0 6.57479347410117e-07
) O 0 6.53592024252303e-12
55expansion O 0 9.128684297365908e-08
surrounded O 0 7.879383256970129e-10
by O 0 5.68403223794034e-12
45 O 0 1.157495432835276e-09
kb O 0 1.755160461414107e-09
of O 0 2.2326707149744607e-10
the O 0 1.5689345378433472e-09
human O 0 2.7697698357087575e-08
DM B-Disease 1 1.0
region O 0 2.0033760961268854e-07
, O 0 2.6327943731391246e-12
using O 0 2.5330688067926044e-12
small O 0 1.0356414510692691e-11
- O 0 1.1323951498720675e-10
pool O 0 2.649845343150048e-10
PCR O 0 8.599581491353092e-09
. O 0 4.815507548272535e-09

These O 0 2.8297342851146823e-06
mice O 0 1.7348808967199147e-07
have O 0 1.2848707341139853e-11
been O 0 1.7889287056913061e-12
shown O 0 1.8187853566969947e-12
to O 0 5.149412797209041e-13
reproduce O 0 9.722295885028487e-11
the O 0 1.6082234502445836e-11
intergenerational O 0 1.519080528034067e-09
and O 0 9.27258183430757e-12
somatic O 0 1.5428894073465926e-07
instability O 0 7.769737631058149e-10
of O 0 3.2997110599453094e-10
the O 0 1.5178062140464021e-09
55 O 0 6.099901028733257e-09
CTG O 0 1.0414755706733558e-06
repeat O 0 1.4422747440789863e-09
suggesting O 0 1.373138824867226e-10
that O 0 4.040880043770789e-13
surrounding O 0 7.897950626833961e-10
sequences O 0 1.5002934658503442e-11
and O 0 1.1804267415968517e-12
the O 0 4.236213810293599e-12
chromatin O 0 1.661075010872537e-08
environment O 0 1.1227912821709651e-08
are O 0 8.221694267236679e-13
involved O 0 6.970517912874286e-13
in O 0 2.436869499591876e-12
instability O 0 3.6802250136247494e-09
mechanisms O 0 4.544352094626447e-08
. O 0 3.558456640462282e-08

As O 0 8.944708085323327e-09
observed O 0 1.1520550069477054e-09
in O 0 1.585756526090165e-11
some O 0 7.094725197956397e-13
of O 0 2.8250823989189877e-12
the O 0 3.980541590786757e-12
tissues O 0 1.7699590681985455e-09
of O 0 5.073806264022096e-09
DM B-Disease 1 1.0
patients O 0 0.0012744548730552197
, O 0 2.8251779713404923e-13
there O 0 3.6261321229762514e-14
is O 0 3.604835427693321e-15
a O 0 1.487270593139578e-14
tendency O 0 5.675084534251251e-12
for O 0 1.2205206463555829e-12
repeat O 0 3.922861688265833e-11
length O 0 1.76471295909586e-10
and O 0 5.7333818248572754e-11
somatic O 0 5.214828391331139e-08
mosaicism O 0 2.7041739514288565e-08
to O 0 7.873152542241246e-13
increase O 0 6.468007011060928e-13
with O 0 1.3685237737145767e-14
the O 0 1.9937081499610265e-12
age O 0 1.717781195065271e-10
of O 0 8.58072640719243e-12
the O 0 1.1155748547153621e-10
mouse O 0 1.138412297763125e-08
. O 0 1.9778112481105836e-09

Furthermore O 0 1.1486786206660327e-06
, O 0 2.888838612769007e-10
we O 0 5.734932060491582e-12
observed O 0 1.8774372681495954e-11
no O 0 3.419365485202164e-13
correlation O 0 2.171152390902445e-13
between O 0 3.0034996842051576e-13
the O 0 3.0380942987046078e-12
somatic O 0 5.94575965351396e-07
mutation O 0 1.8397720680241036e-08
rate O 0 1.5706360656508878e-08
and O 0 4.1374187062515055e-12
tissue O 0 1.6124392931970988e-09
proliferation O 0 9.671300205127409e-08
capacity O 0 2.1115472037536165e-08
. O 0 1.2936565596533e-08

The O 0 4.4986367697674723e-07
somatic O 0 6.560944893863052e-05
mutation O 0 9.748286089461544e-08
rates O 0 5.112528178585762e-09
in O 0 2.3334255534745996e-12
different O 0 2.7909339336135153e-12
tissues O 0 4.4058184878181805e-10
were O 0 9.53194051467321e-11
also O 0 3.759759972972454e-13
not O 0 1.811648704316826e-13
correlated O 0 1.2690691553185474e-10
to O 0 4.467613345243704e-12
the O 0 1.4025630656888666e-10
relative O 0 6.601231206104785e-08
inter O 0 2.0056999616713256e-08
- O 0 5.20239717971549e-09
tissue O 0 1.6219836140862753e-08
difference O 0 2.523523057185173e-10
in O 0 1.3328788485249266e-13
transcriptional O 0 1.8706244886423917e-11
levels O 0 1.0919921911156649e-10
of O 0 7.803606719147815e-12
the O 0 9.791108028511797e-12
three O 0 4.317813467880072e-12
genes O 0 1.967665093360882e-11
( O 0 4.255274518166763e-13
DMAHP O 0 0.0026878498028963804
, O 0 4.5599765630122135e-10
DMPK O 0 0.4145635664463043
and O 0 9.74177294388312e-10
59 O 0 1.071852717693389e-09
) O 0 6.063820777967022e-14
surrounding O 0 1.050753789533232e-10
the O 0 4.295661396036543e-11
repeat O 0 4.3882403266692904e-10
. O 0 3.357266131764902e-10
. O 0 3.61547813909624e-09

A O 0 2.046931797394791e-07
novel O 0 1.4880163234920474e-07
missense O 0 3.1763797778694425e-06
mutation O 0 1.1799001775614215e-08
in O 0 3.306021775784096e-11
patients O 0 2.3494706180571256e-09
from O 0 8.276878314672498e-12
a O 0 2.218457535729801e-11
retinoblastoma B-Disease 0 1.4416354133572895e-05
pedigree O 0 6.121664455349674e-07
showing O 0 1.1067251559637725e-09
only O 0 2.932353145024269e-12
mild O 0 4.529293384791799e-09
expression O 0 4.530543717962132e-10
of O 0 1.4515245949642264e-10
the O 0 4.0500219844474827e-10
tumor B-Disease 0 4.0169075532503484e-07
phenotype O 0 2.486863479589374e-07
. O 0 2.6933422159203246e-09

We O 0 1.569480012619806e-08
have O 0 2.7552320234353056e-12
used O 0 5.478365157352005e-13
single O 0 2.925476267484628e-12
strand O 0 4.499170480620762e-11
conformation O 0 4.461771663938352e-12
polymorphism O 0 1.8882352278981607e-12
analysis O 0 7.510704840181515e-14
to O 0 3.727960052202911e-14
study O 0 3.785744504339328e-13
the O 0 1.282270188467105e-12
27 O 0 3.0447468990502102e-09
exons O 0 2.519090491759357e-09
of O 0 3.2041549968830907e-10
the O 0 1.8806936008530784e-09
RB1 O 0 6.695370302622905e-07
gene O 0 8.148681382436074e-12
in O 0 6.080002495391368e-13
individuals O 0 1.3902770536373954e-13
from O 0 2.055449994237124e-12
a O 0 1.964926268568923e-12
family O 0 1.5676467068903577e-11
showing O 0 1.0054878457621541e-10
mild O 0 4.072676773603234e-08
expression O 0 4.539100206812918e-09
of O 0 9.074409001996742e-10
the O 0 2.7186997098027632e-09
retinoblastoma B-Disease 0 7.428885510307737e-06
phenotype O 0 2.6210434498352697e-06
. O 0 7.4133166272360995e-09

In O 0 1.2411695005098977e-09
this O 0 1.6177430228747625e-10
family O 0 1.499711244079549e-09
affected O 0 8.689275077244929e-09
individuals O 0 1.3954225275281118e-10
developed O 0 3.27552925227792e-07
unilateral B-Disease 1 0.9843294620513916
tumors I-Disease 1 1.0
and O 0 5.631974531183914e-08
, O 0 3.129282857144977e-12
as O 0 1.2029781467845502e-13
a O 0 5.2955068376658e-15
result O 0 2.955237508699138e-13
of O 0 1.8024231196109297e-12
linkage O 0 4.805593076251391e-11
analysis O 0 4.762576184119682e-12
, O 0 5.98437098486837e-13
unaffected O 0 4.811476994603936e-09
mutation O 0 4.661935767980019e-11
carriers O 0 1.757302289795426e-11
were O 0 1.2464515530830056e-11
also O 0 6.333933486209198e-13
identified O 0 9.558552734045822e-12
within O 0 2.677287731789324e-11
the O 0 1.4951180571376455e-10
pedigree O 0 7.19572739171781e-08
. O 0 8.014071184447857e-09

A O 0 1.56413673124689e-08
single O 0 2.968637280442721e-10
band O 0 1.2000882509966004e-09
shift O 0 7.806885693462107e-11
using O 0 4.881900873138223e-12
SSCP O 0 0.0002116430550813675
was O 0 2.3756423495058243e-09
identified O 0 4.275538534326273e-10
in O 0 1.0365706903936456e-10
exon O 0 1.892882517395833e-09
21 O 0 1.9039070320303608e-10
which O 0 4.6964944547299783e-14
resulted O 0 9.571109876871375e-11
in O 0 1.8435140566874786e-11
a O 0 6.105376620935132e-11
missense O 0 2.912049694714369e-07
mutation O 0 6.59146559556234e-09
converting O 0 7.226092613166202e-09
a O 0 3.1713996012650014e-11
cys O 0 3.812638382783007e-08
- O 0 1.5593281110781732e-09
- O 0 2.3106732083277848e-09
> O 0 3.267533577044901e-09
arg O 0 2.8609611901764254e-10
at O 0 6.039157889048408e-13
nucleotide O 0 2.0220332352938186e-11
position O 0 4.192791946966423e-11
28 O 0 4.962910082895178e-10
in O 0 8.914344956645337e-12
the O 0 5.6959331695694e-10
exon O 0 4.9121265277563e-08
. O 0 1.8130394963122853e-08

The O 0 1.5543912468274357e-07
mutation O 0 1.5438166656167596e-07
destroyed O 0 4.5361254308318166e-08
an O 0 6.870678505299654e-12
NdeI O 0 2.2652743609796744e-06
restriction O 0 5.582626272371272e-07
enzyme O 0 2.8024331300002814e-07
site O 0 4.881352211327794e-08
. O 0 1.4335923559372077e-08

Analysis O 0 2.367611939835257e-10
of O 0 2.7321478413000477e-09
all O 0 1.3528000941676055e-09
family O 0 3.3056196668823645e-10
members O 0 9.882267530333944e-13
demonstrated O 0 8.118352344543833e-12
that O 0 4.03557870172315e-14
the O 0 1.1048664066981573e-10
missense O 0 2.14865693237698e-07
mutation O 0 6.137081953738743e-09
co O 0 4.396676633877661e-10
- O 0 1.8621262753981682e-08
segregated O 0 3.874752962929051e-09
with O 0 3.952290697408628e-13
patients O 0 1.3851932934016986e-08
with O 0 4.4962707168583194e-11
tumors B-Disease 1 1.0
or O 0 1.1078999705205206e-05
who O 0 2.0600254835301257e-09
, O 0 4.54285019975062e-13
as O 0 1.242737602278124e-13
a O 0 3.350962500984025e-15
result O 0 1.4990991033161233e-13
of O 0 1.4668137581289042e-12
linkage O 0 2.2335883143043134e-12
analysis O 0 3.0720703216545464e-13
had O 0 7.21083674541656e-13
been O 0 6.22375848774448e-13
predicted O 0 5.1193337763377755e-11
to O 0 1.5971415813151313e-12
carry O 0 1.1016756083781498e-11
the O 0 3.9504406690316074e-11
predisposing O 0 2.4737778403505217e-07
mutation O 0 1.330084131723197e-07
. O 0 2.7292273330203898e-08

These O 0 5.3367710250995515e-09
observations O 0 4.606520054295515e-09
point O 0 4.683041732178594e-10
to O 0 1.6329255655977981e-12
another O 0 1.0736316349846398e-11
region O 0 1.0530514238382693e-09
of O 0 4.918508711426739e-09
the O 0 1.2917215030938678e-07
RB1 O 0 2.2697251552017406e-05
gene O 0 8.241630711225412e-10
where O 0 9.438447801102257e-10
mutations O 0 1.780450266386513e-11
only O 0 2.7292582256699394e-12
modify O 0 4.751574689265681e-10
the O 0 1.0430242780579135e-10
function O 0 1.8540867452454535e-10
of O 0 7.27543303380429e-10
the O 0 8.014142682810643e-10
gene O 0 1.1378770842229713e-10
and O 0 1.4451213836697008e-10
raise O 0 6.433971133645855e-10
important O 0 3.336084533622774e-11
questions O 0 2.4451489444299312e-11
for O 0 1.5989665917270218e-13
genetic O 0 5.742049544177341e-11
counseling O 0 5.751848997093134e-11
in O 0 1.807931110592645e-13
families O 0 9.198609755844966e-13
with O 0 1.7348037747002068e-14
these O 0 3.942068893536543e-12
distinctive O 0 3.231041267870438e-10
phenotypes O 0 7.622396935857978e-09
. O 0 5.679031689354019e-10
. O 0 1.9228010295080367e-09

Maternal B-Disease 0 0.0008512045606039464
disomy I-Disease 0 0.040399760007858276
and O 0 2.4477843908243813e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.05519874021410942
with O 0 5.0438896115334586e-11
gamete O 0 4.0891396224651544e-07
complementation O 0 9.096533176489174e-05
in O 0 1.0971944706950065e-11
a O 0 1.4286971128721349e-13
case O 0 9.252710403417908e-11
of O 0 7.560291837016564e-10
familial O 0 1.807122629315927e-07
translocation O 0 9.624436643207446e-07
( O 0 9.563763626527222e-13
3 O 0 1.646534991683879e-10
; O 0 8.440185399541389e-13
15 O 0 1.7641534066914488e-11
) O 0 2.08967314074349e-14
( O 0 2.6495165179126097e-14
p25 O 0 1.2241547775460049e-09
; O 0 1.1607435932564636e-12
q11 O 0 1.419540707203737e-09
. O 0 2.0235764452980476e-11
2 O 0 1.6891506249283594e-10
) O 0 7.983632743617519e-13
. O 0 3.7225181270805763e-10

Maternal B-Disease 1 0.9999967813491821
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 0 4.8193049906331e-07
UPD I-Disease 1 1.0
) I-Disease 0 6.687758680179456e-10
for I-Disease 0 2.05086239657426e-10
chromosome I-Disease 0 1.3147575250727073e-09
15 I-Disease 0 4.544737919331965e-10
is O 0 7.81697636850244e-14
responsible O 0 2.845598919259257e-13
for O 0 1.3270267317736645e-13
an O 0 4.57526328767068e-15
estimated O 0 1.0253059387838395e-13
30 O 0 2.947879841706108e-13
% O 0 1.7155568144463368e-15
of O 0 1.1049157676405673e-16
cases O 0 1.6972791986973046e-14
of O 0 2.924140651838769e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.3595214315719204e-06
PWS B-Disease 1 1.0
) O 0 3.9770242654668664e-10
. O 0 4.130210840003201e-09

We O 0 4.213286608489852e-09
report O 0 8.699315573457156e-11
on O 0 1.6985902268062958e-11
an O 0 2.9153453146724e-15
unusual O 0 1.7700237976703281e-12
case O 0 6.524900758586583e-11
of O 0 5.175099793142124e-10
maternal B-Disease 0 3.612248292483855e-06
disomy I-Disease 0 0.00011720544716808945
15 I-Disease 0 1.1879077987941855e-07
in O 0 1.7396624141241546e-09
PWS B-Disease 1 1.0
that O 0 7.181937683453654e-11
is O 0 3.2044267413156025e-12
most O 0 1.401304961824723e-12
consistent O 0 1.588896028636988e-11
with O 0 4.083912095759375e-14
adjacent O 0 6.355020676362955e-11
- O 0 9.030445835556122e-11
1 O 0 6.441301381165943e-10
segregation O 0 6.55137541438755e-11
of O 0 1.5980283502720072e-12
a O 0 1.322191705080411e-12
paternal O 0 5.223698096301632e-08
t O 0 1.3083060190766105e-09
( O 0 6.328641901981111e-14
3 O 0 2.1666867952574442e-11
; O 0 2.273921068801643e-13
15 O 0 7.931879111855444e-12
) O 0 1.2048925937112754e-14
( O 0 2.6336153378003942e-14
p25 O 0 1.2913853320029034e-09
; O 0 6.628075909301256e-13
q11 O 0 8.537098250549491e-10
. O 0 4.782146467013915e-12
2 O 0 1.0987525125849551e-11
) O 0 4.934260414672523e-15
with O 0 1.3262264211637807e-14
simultaneous O 0 2.667606803855027e-12
maternal O 0 1.727455689604085e-08
meiotic O 0 8.374409503630886e-07
nondisjunction O 0 4.185242687526625e-06
for O 0 7.570280402546814e-09
chromosome O 0 9.883531326693173e-09
15 O 0 6.959611997814363e-09
. O 0 5.426978866296395e-09

The O 0 9.555508739822471e-08
patient O 0 4.849817287322367e-06
( O 0 9.829298833197164e-12
J O 0 8.071754820093702e-08
. O 0 2.2900755944355033e-11
B O 0 1.5169205891396587e-09
. O 0 2.4292239159356792e-14
) O 0 9.105555478589262e-16
, O 0 1.3743072299751344e-14
a O 0 4.881812049875242e-14
17 O 0 3.516099954595231e-12
- O 0 1.0797982516810856e-12
year O 0 3.823906122302212e-11
- O 0 2.945748367455536e-10
old O 0 3.1611844253376375e-09
white O 0 3.7438582789484087e-10
male O 0 4.5335389088629885e-12
with O 0 1.5468324253311953e-14
PWS B-Disease 1 1.0
, O 0 1.7222223647195278e-11
was O 0 2.449547509275618e-10
found O 0 1.538193877825833e-11
to O 0 3.326534880887522e-11
have O 0 2.1343581069199757e-10
47 O 0 4.06765954252819e-09
chromosomes O 0 8.133436979473885e-11
with O 0 1.5494700520476273e-13
a O 0 2.69625749678426e-12
supernumerary O 0 9.1525583911789e-07
, O 0 6.685484804647146e-11
paternal O 0 1.2340582600245398e-07
der O 0 1.2335306998068063e-08
( O 0 5.500855305116958e-13
15 O 0 2.709198143602265e-11
) O 0 4.692793767783424e-15
consisting O 0 2.5184466057731614e-13
of O 0 1.6888622661817565e-12
the O 0 7.49704812119667e-11
short O 0 1.0407851247506983e-09
arm O 0 4.4821793498961426e-10
and O 0 3.4749921690169217e-11
the O 0 1.5545945641903813e-09
proximal O 0 4.253676706866827e-06
long O 0 4.85617661638571e-08
arm O 0 1.636541790972501e-09
of O 0 4.586860891109268e-10
chromosome O 0 1.6157510052128288e-10
15 O 0 1.1414028749934246e-10
, O 0 4.884469022824189e-13
and O 0 9.509563275722499e-12
distal O 0 1.0506024636924849e-06
chromosome O 0 1.0798961511682137e-06
arm O 0 4.451301720109768e-06
3p O 0 0.0003064461052417755
. O 0 4.4160239554003056e-07

The O 0 1.3747816183240502e-06
t O 0 3.175690110879259e-08
( O 0 9.873469229704224e-13
3 O 0 3.9434240595159764e-11
; O 0 1.0066337412066584e-13
15 O 0 1.1388964858000117e-12
) O 0 8.642006110292505e-16
was O 0 2.1505709539570983e-12
present O 0 3.4986998107694456e-12
in O 0 2.4437069121724386e-12
the O 0 3.763061910688759e-12
balanced O 0 3.2444886621102453e-12
state O 0 2.808576125574308e-13
in O 0 9.544333368343566e-14
the O 0 3.240468440454669e-12
patients O 0 1.7311226896410403e-09
father O 0 4.189228963724645e-10
and O 0 3.868398310014065e-11
a O 0 3.2787694781433174e-10
sister O 0 2.524720343899389e-07
. O 0 1.0792284399485652e-07

Fluorescent O 0 5.61379456485156e-05
in O 0 3.6993252905404006e-09
situ O 0 1.3468566351093614e-07
hybridization O 0 1.599206878033499e-10
analysis O 0 1.62167740173913e-12
demonstrated O 0 4.140829606286145e-12
that O 0 1.1263789922479062e-13
the O 0 2.933234488633474e-10
PWS B-Disease 1 1.0
critical O 0 6.9567472564813215e-06
region O 0 7.594317175119158e-09
resided O 0 2.570898871567806e-08
on O 0 4.62514665455771e-10
the O 0 3.9847212335297755e-11
derivative O 0 1.4760888067399947e-09
chromosome O 0 2.3411834970676892e-11
3 O 0 2.5257899938235795e-11
and O 0 4.064918906576502e-14
that O 0 6.427760342216093e-15
there O 0 1.0597307807756057e-13
was O 0 7.2265639652902e-12
no O 0 1.3021152081918452e-12
deletion O 0 1.585100280199203e-11
of O 0 2.0532176653320633e-11
the O 0 4.3844167185724814e-10
PWS B-Disease 1 1.0
region O 0 8.37407299059123e-09
on O 0 3.823426852900269e-10
the O 0 6.5256441743322124e-12
normal O 0 3.574786577864586e-10
pair O 0 2.4124251207791048e-11
of O 0 2.9016804150433506e-12
15s O 0 8.794783235011039e-10
present O 0 1.4502848921793543e-10
in O 0 8.755350333622403e-10
J O 0 2.276349550811574e-05
. O 0 4.103397799326558e-08

B O 0 0.01147785596549511
. O 0 4.589849709191185e-07

Methylation O 0 2.974954682599673e-08
analysis O 0 7.632766640952582e-10
at O 0 1.3807083254491204e-09
exon O 0 1.7955674280756284e-08
alpha O 0 2.8922362282912673e-09
of O 0 2.5066851372379517e-10
the O 0 1.3316084901404679e-09
small O 0 5.266950070526022e-11
nuclear O 0 3.9308517330027826e-08
ribonucleoprotein O 0 1.6549644499264105e-07
- O 0 8.566201969983922e-09
associated O 0 1.9137063489438333e-08
polypeptide O 0 1.389324353340271e-07
N O 0 5.241872713668272e-08
( O 0 2.6276973218858357e-12
SNRPN O 0 3.1217116429616e-06
) O 0 1.0970165748025451e-11
gene O 0 2.1192667412628374e-11
showed O 0 4.444667550673742e-11
a O 0 2.2265392654596816e-13
pattern O 0 1.3505822848980387e-10
characteristic O 0 5.339249875557783e-11
of O 0 1.746782753164755e-11
only O 0 1.5225242941396822e-12
the O 0 2.005517106551391e-11
maternal O 0 7.122467060582949e-09
chromosome O 0 1.089616244454028e-10
15 O 0 2.1697317553748263e-10
in O 0 1.5133998221283917e-10
J O 0 1.2661962500715163e-05
. O 0 4.3325311338549e-08

B O 0 0.01127721183001995
. O 0 2.89327601876721e-07

Maternal B-Disease 0 0.04256509616971016
disomy I-Disease 0 0.00029385124798864126
was O 0 1.8830634829214432e-08
confirmed O 0 6.134410202029983e-10
by O 0 8.532316563350517e-13
polymerase O 0 9.227116466725693e-12
chain O 0 6.186830561749623e-13
reaction O 0 1.3692536687814894e-12
analysis O 0 5.374781565994913e-13
of O 0 3.2547775238866983e-12
microsatellite O 0 1.7098582549834873e-09
repeats O 0 3.324333863741202e-11
at O 0 1.0750532408732028e-12
the O 0 1.24143523152348e-12
gamma O 0 3.546723470471136e-10
- O 0 3.1632396702008236e-10
aminobutyric O 0 1.654757042501842e-08
acid O 0 1.637837754309146e-09
receptor O 0 1.1027468937996332e-09
beta3 O 0 8.335607759590857e-08
subunit O 0 3.3543345878683795e-10
( O 0 3.6221956423859725e-12
GABRB3 O 0 2.7506414426170522e-06
) O 0 3.628475991890312e-11
locus O 0 6.709068856025624e-10
. O 0 3.448558105745292e-09

A O 0 1.0004710020439234e-05
niece O 0 0.00019930832786485553
( O 0 3.4480565624939175e-10
B O 0 9.91287038232258e-07
. O 0 1.4052186497748309e-11
B O 0 1.3279257693454838e-09
. O 0 4.5882165390165666e-14
) O 0 2.9099232450187883e-15
with O 0 2.4500937913164884e-14
45 O 0 1.7800937807121997e-11
chromosomes O 0 2.9634294150537865e-12
and O 0 4.307052219217067e-13
the O 0 1.956578996042957e-12
derivative O 0 2.4166021614369093e-11
3 O 0 4.831323709153512e-12
but O 0 8.146481671753372e-14
without O 0 4.401202926412884e-12
the O 0 6.402690183593407e-11
der O 0 2.894929629349008e-09
( O 0 7.788940391099952e-13
15 O 0 4.9730747297971334e-11
) O 0 1.1516924024700115e-13
demonstrated O 0 1.078994393832744e-10
a O 0 1.1871987767864134e-11
phenotype O 0 2.428976486612555e-08
consistent O 0 1.9706114517958895e-09
with O 0 5.856945516687778e-14
that O 0 1.381500487873102e-14
reported O 0 3.5611157035361773e-13
for O 0 1.9205393297829637e-13
haploinsufficiency O 0 8.75495800300996e-08
of O 0 1.3205159632434516e-08
distal O 0 1.0116677003679797e-05
3 O 0 5.85638781558373e-06
p O 0 1.4962641614602035e-07
. O 0 2.977002200310608e-09

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.911526851472445e-06
with O 0 4.4517203812155515e-10
unbalanced O 0 2.5331787583127152e-06
segregation O 0 2.9892544262111187e-07
of O 0 2.8787868089352742e-08
non O 0 1.233856164617464e-05
- O 0 1.4271028021539678e-06
Robertsonian O 0 0.0004059423808939755
translocations O 0 5.739292987527733e-07
has O 0 9.363099878756387e-11
been O 0 2.0485899435152e-11
reported O 0 7.558727081746763e-12
previously O 0 5.563198859914742e-11
but O 0 2.6412947350118454e-12
has O 0 7.900676776218321e-14
not O 0 9.985943820976784e-14
, O 0 1.3444785920430774e-13
to O 0 7.643506595884919e-13
our O 0 4.865505220941202e-11
knowledge O 0 5.872648894955645e-11
, O 0 9.183388912595986e-14
been O 0 1.3873315473852954e-13
observed O 0 3.0888111079291347e-12
in O 0 2.1932119748796497e-13
a O 0 1.9768945324055015e-13
case O 0 4.301402567463697e-10
of O 0 4.6632209205199615e-09
PWS B-Disease 1 1.0
. O 0 5.197820428293198e-06

Furthermore O 0 4.027627255709376e-06
, O 0 1.761633394714579e-09
our O 0 7.709111127240931e-10
findings O 0 4.160070621317402e-10
are O 0 5.007802983056364e-13
best O 0 5.011911567188998e-13
interpreted O 0 7.2597626694925754e-12
as O 0 1.531162024427657e-12
true O 0 3.154941238814324e-11
gamete O 0 3.1915995180042955e-08
complementation O 0 5.559134024224477e-07
resulting O 0 2.305883040065737e-09
in O 0 4.87987594777195e-10
maternal B-Disease 0 5.598082498181611e-05
UPD I-Disease 1 1.0
15 I-Disease 0 4.840192195842974e-05
and O 0 3.8479177533190523e-07
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999860525131226
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 2.4876628231140785e-05
2 I-Disease 0 2.3708506091679737e-07
and O 0 2.7628009255376007e-11
Stuve B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 2.5353647133130597e-12
a O 0 3.28591253056891e-14
case O 0 7.950688176404375e-13
for O 0 1.0973502244686004e-13
" O 0 1.1703389993233948e-11
lumping O 0 4.5866510589576137e-10
" O 0 2.2581830849688345e-10
. O 0 3.087359257136768e-10

Recent O 0 4.8101398419930774e-08
studies O 0 2.1064765209910519e-10
demonstrated O 0 9.308186166290255e-11
the O 0 7.41242917740026e-12
existence O 0 3.601804965391864e-11
of O 0 3.729253364448404e-11
a O 0 1.0129076397080716e-11
genetically O 0 9.217423979634987e-08
distinct O 0 6.205773672718351e-10
, O 0 1.50497507251518e-13
usually O 0 3.073727389149919e-14
lethal O 0 8.807292460437377e-13
form O 0 7.511865614132432e-14
of O 0 3.00327064649622e-13
the O 0 8.85251680987631e-12
Schwartz B-Disease 0 2.0936044165864587e-05
- I-Disease 1 0.9996188879013062
Jampel I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.999945878982544
( O 0 1.5544031339853603e-11
SJS B-Disease 0 1.399132361257216e-05
) O 0 2.1751088777333116e-11
of O 0 7.093778897626635e-09
myotonia B-Disease 1 1.0
and O 0 1.612859523447696e-05
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.0112741755108345e-08
which O 0 3.265187772938383e-11
we O 0 1.9139224927133824e-11
called O 0 9.309748111308025e-11
SJS B-Disease 0 7.176201052061515e-06
type I-Disease 0 5.041132453698083e-07
2 I-Disease 0 6.304011179736335e-08
. O 0 1.3423187006367243e-09

This O 0 2.7199096308549997e-08
disorder O 0 0.00016989005962386727
is O 0 1.6939507088697958e-11
reminiscent O 0 1.1616140938031094e-08
of O 0 2.3387033976085547e-10
another O 0 6.224767337865977e-13
rare O 0 6.656572428681562e-12
condition O 0 1.0623760759997936e-09
, O 0 3.36789434231613e-13
the O 0 1.588184098122447e-11
Stuve B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.0613079243503307e-08
SWS B-Disease 0 0.13304679095745087
) O 0 1.4207683423847484e-12
, O 0 4.0113610133216127e-13
which O 0 5.642594139328161e-13
comprises O 0 3.260406701566243e-12
campomelia B-Disease 0 2.667362863917333e-08
at O 0 7.076869090738569e-10
birth O 0 1.7753374777385034e-05
with O 0 3.3607511218392006e-10
skeletal B-Disease 0 0.0017015166813507676
dysplasia I-Disease 1 0.999998927116394
, O 0 4.93535834422687e-09
contractures B-Disease 0 9.18218502192758e-05
, O 0 5.981844186653262e-11
and O 0 4.170378452295065e-12
early B-Disease 0 6.63781829501886e-09
death I-Disease 0 2.285043976257839e-08
. O 0 9.881551576995662e-09

To O 0 2.6997197810629814e-09
test O 0 1.1069151151232859e-09
for O 0 1.3111175339863834e-11
possible O 0 4.8093578008945315e-09
nosologic O 0 0.0004999086959287524
identity O 0 7.901797438591984e-09
between O 0 1.6800062729860343e-10
these O 0 3.4859207187487584e-10
disorders O 0 2.3934711990136748e-09
, O 0 9.25501320546418e-13
we O 0 3.3887592710245273e-13
reviewed O 0 4.56265580872639e-10
the O 0 6.5877980154338545e-12
literature O 0 7.685085207098652e-12
and O 0 1.0422823425192997e-14
obtained O 0 7.746327044437853e-14
a O 0 2.922684812808711e-14
follow O 0 4.438159041664225e-12
- O 0 7.441695697163464e-12
up O 0 2.8728460582660986e-12
of O 0 1.2348582443047484e-12
the O 0 7.309639547294078e-13
only O 0 1.693212491873583e-13
two O 0 1.7914946734204004e-14
surviving O 0 6.07813105402144e-11
patients O 0 1.5156771393520785e-09
, O 0 2.685873875737932e-12
one O 0 3.7836461394546994e-12
with O 0 1.147163635785431e-12
SJS B-Disease 0 2.681869375464885e-07
type I-Disease 0 8.097089931879964e-08
2 I-Disease 0 1.943704752704889e-09
at O 0 4.4921024365540685e-12
age O 0 2.742503446562239e-11
10 O 0 2.1649579373152206e-13
years O 0 8.155546279541709e-14
and O 0 5.0837711319286216e-14
another O 0 2.332071710221817e-13
with O 0 1.4952354133491996e-13
SWS B-Disease 0 2.0488633367676812e-07
at O 0 1.4459422374712982e-11
age O 0 2.3334500998117846e-10
7 O 0 2.537457188811487e-10
years O 0 2.0503100953139786e-11
. O 0 8.085985214734137e-10

Patients O 0 0.0017892859177663922
reported O 0 2.838166368590578e-10
as O 0 1.3811310602129812e-11
having O 0 3.263208106507598e-11
either O 0 5.707790240450095e-09
neonatal O 1 0.9999998807907104
SJS B-Disease 1 1.0
or O 0 8.947627975430805e-06
SWS B-Disease 0 3.109052704530768e-05
presented O 0 7.334964233218777e-12
a O 0 6.7300193907625806e-15
combination O 0 5.701924392711999e-13
of O 0 2.373260008653455e-13
a O 0 1.0126072886012388e-13
severe O 0 3.0548510387973238e-09
, O 0 5.296952113043041e-11
prenatal O 1 0.9998316764831543
- O 1 0.9496411681175232
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.5687856347312845e-08
with O 0 1.3951131450085086e-07
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 0 0.0002168938663089648
respiratory O 1 1.0
and O 0 1.341765710094478e-05
feeding O 0 0.1337779462337494
difficulties O 0 3.070456102705066e-07
, O 0 2.136663623808488e-10
tendency O 0 1.6424206439324962e-09
to O 0 2.1210956602235598e-10
hyperthermia B-Disease 0 0.46513956785202026
, O 0 2.99031563399943e-11
and O 0 5.966113020283714e-13
frequent O 0 1.2636810001187548e-13
death O 0 2.5610234419271016e-11
in O 0 1.8156599487784142e-11
infancy O 0 3.44778392502576e-08
) O 0 1.1026430961867673e-14
with O 0 3.961221575635252e-15
a O 0 3.1735383635225767e-13
distinct O 0 2.4100624274048243e-10
campomelic B-Disease 0 2.2263011487666517e-05
- I-Disease 0 0.003762454492971301
metaphyseal I-Disease 0 0.0018207982648164034
skeletal I-Disease 1 0.6270533204078674
dysplasia I-Disease 1 1.0
. O 0 4.24200770794414e-05

The O 0 5.233299127382907e-09
similarity O 0 1.275530436828376e-08
of O 0 4.823541566167933e-09
the O 0 2.1212502865353144e-09
clinical O 0 1.872733612628963e-08
and O 0 1.9083572222466927e-10
radiographic O 0 0.0025523179210722446
findings O 0 4.469171472010203e-06
is O 0 1.1341545758103422e-10
so O 0 5.238054781586676e-12
extensive O 0 1.5272135986399427e-11
that O 0 2.274458833079196e-13
these O 0 8.353872038568966e-10
disorders O 0 1.5770689643090918e-08
appear O 0 1.8794672485000774e-09
to O 0 1.1440346283156377e-12
be O 0 8.566919959887564e-13
a O 0 7.04945650464861e-13
single O 0 2.2993367626567007e-11
entity O 0 1.8681018953969897e-09
. O 0 1.3488381966908491e-08

The O 0 3.424608863156209e-08
follow O 0 7.9391870855261e-09
- O 0 1.2776578683926232e-09
up O 0 1.3430650688817103e-11
observation O 0 1.0756162627245658e-10
of O 0 3.429339060986858e-13
an O 0 4.647135727311102e-15
identical O 0 2.5412436044369713e-11
and O 0 1.0579662146348312e-12
unique O 0 5.327243854380548e-12
pattern O 0 7.600751139591466e-09
of O 0 3.840577278424462e-08
progressive O 1 0.999993085861206
bone B-Disease 1 0.998955488204956
dysplasia I-Disease 1 0.9944127202033997
in O 0 6.381993600257374e-09
the O 0 1.6213209663717976e-09
two O 0 4.009397414767024e-12
patients O 0 2.457343495354536e-10
( O 0 1.4992042709268544e-14
one O 0 3.49556971909748e-13
with O 0 1.419667741654404e-13
SJS B-Disease 0 8.065091350317743e-08
type I-Disease 0 3.0163899822355233e-08
2 I-Disease 0 6.501242211243152e-09
, O 0 9.044294718534018e-13
one O 0 5.392937073474269e-13
with O 0 1.2327332080466769e-12
SWS B-Disease 0 2.4260739905912487e-07
) O 0 8.965152296751266e-13
surviving O 0 5.184348950137974e-09
beyond O 0 6.696469512235126e-08
infancy O 0 8.295005926584054e-08
adds O 0 2.6283501416979327e-11
to O 0 9.45054039365456e-13
the O 0 1.0763869179655772e-12
evidence O 0 3.4060623245457666e-12
in O 0 2.514276764217782e-12
favor O 0 1.2733396559383436e-09
of O 0 4.456483793102706e-11
identity O 0 6.962024845513781e-10
. O 0 2.5794044677951433e-09

The O 0 3.640294323759008e-07
hypothesis O 0 8.396342309424654e-06
that O 0 1.8511899790851771e-09
SWS B-Disease 1 0.5589088201522827
and O 0 3.540993498418743e-09
SJS B-Disease 0 0.002517339074984193
type I-Disease 0 1.8946422642329708e-05
2 I-Disease 0 1.8954888503230904e-07
are O 0 4.493162569438325e-13
the O 0 1.8107860046481794e-12
same O 0 2.0273481504684554e-10
disorder O 0 5.695265770100377e-08
should O 0 9.52180140290082e-11
be O 0 2.5350275698055036e-11
testable O 0 4.531885533509694e-09
by O 0 9.310266994204744e-14
molecular O 0 7.891283113070635e-13
methods O 0 1.5442789408348645e-11
. O 0 3.928994282698106e-11
. O 0 1.7446866173997932e-09

A O 0 5.880870901364688e-09
mouse O 0 1.1678227274103392e-09
model O 0 1.2325105346044918e-11
of O 0 2.5103105358303957e-11
severe O 1 0.9999986886978149
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 2.0161151041975245e-06
defects O 0 1.9224215066060424e-05
in O 0 1.5239444151049497e-09
hemostasis O 0 4.6972585550975055e-05
and O 0 1.943378569180254e-09
thrombosis B-Disease 0 0.0003851412911899388
. O 0 2.9530261258514656e-07

von B-Disease 0 0.05117534101009369
Willebrand I-Disease 1 0.9999377727508545
factor I-Disease 0 0.06278831511735916
( I-Disease 0 3.230096012885042e-07
vWf I-Disease 1 0.9999974966049194
) I-Disease 0 2.162794089599629e-06
deficiency I-Disease 1 1.0
causes O 1 0.9999996423721313
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 1.3316011973074637e-05
humans O 0 5.8984880979551235e-08
. O 0 2.3849950903098716e-09

We O 0 4.707456646713126e-09
generated O 0 3.292757733142082e-10
a O 0 1.6002060787556616e-12
mouse O 0 4.7850501339041784e-11
model O 0 7.08469144895113e-13
for O 0 8.197419522695815e-14
this O 0 1.354398797975831e-12
disease O 0 1.9168788778500812e-10
by O 0 3.508878083924305e-12
using O 0 5.722107163097512e-11
gene O 0 1.035560942552749e-10
targeting O 0 1.1248741937919249e-09
. O 0 4.933409680774048e-09

vWf B-Disease 1 0.999924898147583
- I-Disease 1 1.0
deficient I-Disease 1 0.9999998807907104
mice O 0 2.3658963982597925e-05
appeared O 0 3.3078606520575704e-09
normal O 0 6.278326747377605e-10
at O 0 9.907864459424154e-12
birth O 0 8.917006577568998e-10
; O 0 1.9300771918195903e-12
they O 0 1.567137587234202e-12
were O 0 1.796225841677046e-11
viable O 0 7.181821803925459e-09
and O 0 8.724439920504423e-11
fertile O 0 4.0718384752835846e-07
. O 0 2.8951561148460314e-09

Neither O 0 1.920590875670314e-05
vWf O 0 0.00019120438082609326
nor O 0 1.8163895219913684e-05
vWf O 0 0.0002649669477250427
propolypeptide O 0 0.00038772571133449674
( O 0 2.80258860563265e-09
von B-Disease 0 0.0018159913597628474
Willebrand I-Disease 0 0.0010218510869890451
antigen O 0 1.852740388130769e-05
II O 1 1.0
) O 0 4.0836165005053715e-10
were O 0 6.657036033530517e-10
detectable O 0 2.3922128278286436e-08
in O 0 1.1131725749513599e-11
plasma O 0 1.3801080278597055e-09
, O 0 2.2713428360354726e-12
platelets O 0 7.351656616805258e-09
, O 0 3.4579583120530888e-12
or O 0 3.2200993173997494e-12
endothelial O 0 7.862659412438688e-10
cells O 0 1.607967647920816e-09
of O 0 2.8964731654812503e-11
the O 0 1.7345658243073103e-10
homozygous O 0 1.1892336004848403e-08
mutant O 0 8.555331731940896e-08
mice O 0 2.7852603778910634e-08
. O 0 1.4014619464930433e-09

The O 0 1.1793093790402054e-06
mutant O 0 4.6657220082124695e-05
mice O 0 7.26567691344826e-07
exhibited O 0 2.3234155932527756e-08
defects O 0 1.2156717730249511e-06
in O 0 3.1408224909768023e-09
hemostasis O 0 1.713788151391782e-05
with O 0 4.7470881392452924e-11
a O 0 1.7372939198345705e-10
highly O 0 1.4110698884906014e-06
prolonged O 0 0.00026290019741281867
bleeding O 0 0.00022766334586776793
time O 0 2.8178339661621976e-08
and O 0 1.3871385151631443e-09
spontaneous O 0 1.2734525967061927e-07
bleeding O 0 3.3449252256900763e-09
events O 0 1.3226735245258636e-12
in O 0 1.254145984112831e-13
approximately O 0 4.923254661478964e-14
10 O 0 2.525373031352085e-13
% O 0 1.163715797987061e-13
of O 0 2.0236168697760487e-13
neonates O 0 7.040897642696109e-09
. O 0 6.623426251906039e-09

As O 0 1.1349905459923093e-09
in O 0 1.5680144682672648e-11
the O 0 1.0518039564311188e-11
human O 0 7.046489260142952e-12
disease O 0 6.744982350426199e-10
, O 0 6.191517567741278e-13
the O 0 8.651292356109952e-12
factor O 0 4.4855660852327617e-10
VIII O 0 0.3427395522594452
level O 0 9.250973107555183e-07
in O 0 5.668869818009625e-10
these O 0 1.5909923378742974e-10
mice O 0 1.4738711640038815e-10
was O 0 1.2039594148027799e-11
reduced O 0 1.145151862225191e-09
strongly O 0 1.6930858104391433e-10
as O 0 2.3230918057282057e-12
a O 0 9.181602011890458e-14
result O 0 8.41713591187565e-12
of O 0 2.921418315593449e-11
the O 0 1.765533552688936e-11
lack O 0 7.328356810276659e-10
of O 0 5.1452917447514235e-12
protection O 0 3.772372414445613e-10
provided O 0 2.5299509015530575e-11
by O 0 2.805120719040488e-11
vWf O 0 1.6823764781292994e-06
. O 0 5.974896311045086e-08

Defective O 1 1.0
thrombosis B-Disease 1 1.0
in O 0 3.5176428355043754e-05
mutant O 0 1.3458769899443723e-05
mice O 0 5.3346976613966035e-08
was O 0 8.481215035827105e-11
also O 0 5.509760399660668e-13
evident O 0 3.026859041188601e-10
in O 0 2.9412751531218695e-13
an O 0 1.9620544135256525e-15
in O 0 4.3313280479601035e-14
vivo O 0 3.8066719915130776e-12
model O 0 3.810464097031563e-12
of O 0 2.9073340956919935e-10
vascular B-Disease 1 0.9999996423721313
injury I-Disease 1 1.0
. O 0 0.000617214769590646

In O 0 7.481092134664635e-11
this O 0 5.838522482322361e-13
model O 0 2.9269347362470555e-11
, O 0 1.0776502303369573e-12
the O 0 1.4136489721872092e-11
exteriorized O 0 1.27126270399458e-06
mesentery O 0 1.6665846487740055e-05
was O 0 7.572735327698865e-09
superfused O 0 2.1059217942820396e-06
with O 0 9.807729628441564e-11
ferric O 0 5.222393042458862e-07
chloride O 0 8.576783727676229e-08
and O 0 2.9345997853980066e-10
the O 0 4.2399200816944926e-10
accumulation O 0 2.664724206624669e-06
of O 0 2.075482719021693e-08
fluorescently O 0 8.418085599259939e-06
labeled O 0 2.305936952495813e-08
platelets O 0 4.314487611623008e-08
was O 0 6.424893256307129e-11
observed O 0 2.1624426208011194e-11
by O 0 4.374956126540486e-12
intravital O 0 2.3408907168231963e-07
microscopy O 0 2.6992302082362585e-07
. O 0 4.16558485483165e-08

We O 0 1.284069117701847e-08
conclude O 0 3.7389522589137414e-08
that O 0 5.54226846707917e-12
these O 0 1.7298015797528876e-10
mice O 0 5.725738105866185e-09
very O 0 2.3843239882470613e-11
closely O 0 8.723478606142976e-10
mimic O 0 9.173259627459629e-07
severe O 1 0.695950448513031
human O 1 0.9999992847442627
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 1.2666407656070078e-07
will O 0 1.1658608106701607e-11
be O 0 1.4177364794296099e-12
very O 0 2.855494161436989e-13
useful O 0 9.295698705138328e-14
for O 0 5.012037415109136e-16
investigating O 0 3.461427650584825e-13
the O 0 8.536906533247735e-13
role O 0 2.402982110169538e-12
of O 0 6.329822777040306e-11
vWf O 0 8.860051536885294e-08
in O 0 1.4738936460201302e-10
normal O 0 4.031152798233961e-07
physiology O 0 1.5842413603195382e-08
and O 0 7.563164504398312e-13
in O 0 1.1756318574890345e-12
disease O 0 5.625835214351227e-11
models O 0 1.895464618595355e-10
. O 0 3.572250828476342e-10
. O 0 5.4556856809995224e-09

Oral O 0 4.883439760305919e-05
contraceptives O 0 4.6543382268282585e-06
and O 0 2.3193074197291885e-11
the O 0 7.119268369271126e-11
risk O 0 1.0392783877932743e-07
of O 0 4.578424704959616e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0264844831908704e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 5.505573881237069e-06
Study O 0 8.890755687218643e-09
Group O 0 1.7895107617960093e-10
. O 0 5.563827731869253e-10

BACKGROUND O 0 0.00032738447771407664
Women O 0 1.3544344534821562e-09
with O 0 2.2096896794970844e-12
mutations O 0 2.004568906699422e-11
in O 0 9.426565431014389e-12
either O 0 3.2171190711416386e-10
the O 0 1.1178998171601506e-08
BRCA1 O 0 1.0229879165990496e-08
or O 0 2.9266736256694514e-10
the O 0 3.465034925653754e-09
BRCA2 O 0 2.0934363131885902e-09
gene O 0 1.5656795521526434e-12
have O 0 1.1607291428743834e-14
a O 0 5.859557088670753e-15
high O 0 8.716252546114855e-12
lifetime O 0 1.795849996488741e-10
risk O 0 6.887246772890876e-09
of O 0 1.7176032542920439e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.860006607212199e-08

Oral O 1 0.9981579184532166
contraceptives O 1 0.9999822378158569
protect O 0 3.432336961850524e-05
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 6.258841001027804e-09
general O 0 1.6897580223940167e-08
, O 0 1.3584069633032492e-11
but O 0 5.645912556917487e-12
it O 0 1.4088940246664156e-13
is O 0 1.916319377758425e-14
not O 0 1.338532149702809e-13
known O 0 5.916617456386275e-12
whether O 0 3.763710176851731e-11
they O 0 1.7966439100347564e-11
also O 0 1.0003371828798402e-12
protect O 0 5.075918418223635e-12
against O 0 3.9144007479841036e-11
hereditary B-Disease 0 0.00026771065313369036
forms I-Disease 1 0.9999531507492065
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0735677236084484e-08

METHODS O 0 6.300122663560614e-07
We O 0 4.867737768421421e-09
enrolled O 0 8.94081964020188e-09
207 O 0 3.9029365850318243e-10
women O 0 1.3728389085254644e-12
with O 0 5.0520898228767486e-12
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.900692698872611e-11
161 O 0 6.299062660364285e-11
of O 0 4.3947546990441566e-11
their O 0 1.180761821650833e-09
sisters O 0 2.9481725949409565e-09
as O 0 7.55865509072251e-12
controls O 0 1.3989181341100831e-11
in O 0 1.4874536064662935e-12
a O 0 4.116266518177508e-13
case O 0 1.0673963796170582e-10
- O 0 1.5257758945175226e-10
control O 0 2.5016747007278184e-10
study O 0 5.650310774818479e-11
. O 0 6.597697388421864e-11

All O 0 1.3659357200879185e-08
the O 0 8.679911234210635e-10
patients O 0 1.8646988397819086e-09
carried O 0 2.24500951682971e-12
a O 0 1.0971702469079678e-13
pathogenic O 0 4.589418622913399e-09
mutation O 0 6.906557992181206e-09
in O 0 1.4789738878029368e-10
either O 0 1.8241175236966e-09
BRCA1 O 0 5.051346452233929e-09
( O 0 2.4337655371922673e-13
179 O 0 3.642415258298115e-10
women O 0 4.478138779934193e-13
) O 0 7.603021944663224e-14
or O 0 1.6877627073697e-10
BRCA2 O 0 1.5991719948260652e-08
( O 0 7.558347936247045e-13
28 O 0 7.669370027940658e-09
women O 0 1.0583098633554222e-11
) O 0 5.960175929187184e-13
. O 0 3.044756946568583e-10

The O 0 4.8963649135203013e-08
control O 0 1.0125866367616254e-08
women O 0 1.2162034400409194e-11
were O 0 2.1836636665550913e-11
enrolled O 0 4.324821403778323e-11
regardless O 0 1.801104231036188e-11
of O 0 4.200337994086922e-12
whether O 0 4.599542101357823e-12
or O 0 1.2611780543514417e-11
not O 0 1.5396114938504013e-11
they O 0 3.8190443862884393e-11
had O 0 7.831314763340202e-11
either O 0 1.1270883115699348e-09
mutation O 0 3.378059831860014e-09
. O 0 3.300682172024949e-09

Lifetime O 0 4.662601895688567e-06
histories O 0 1.170825044027879e-06
of O 0 1.474932886935676e-08
oral O 0 1.6769735111665796e-06
- O 0 4.1123588978564385e-09
contraceptive O 0 5.636237698780633e-09
use O 0 1.1884307557150087e-12
were O 0 5.40126483036113e-13
obtained O 0 1.2552066590981736e-12
by O 0 6.215098422891752e-13
interview O 0 5.291496407711094e-12
or O 0 3.510301858217213e-13
by O 0 2.847455615479638e-13
written O 0 2.2154372520538645e-12
questionnaire O 0 1.0024497508129282e-12
and O 0 3.9740736065439417e-14
were O 0 7.604418397061385e-13
compared O 0 1.0583502824124125e-11
between O 0 1.9275312682781598e-12
patients O 0 7.570453597338656e-09
and O 0 3.599118182304184e-12
control O 0 3.090511180303679e-10
women O 0 9.754475872869595e-13
, O 0 9.023298838531976e-15
after O 0 9.063684183610934e-14
adjustment O 0 5.516482236289644e-12
for O 0 2.039452387894193e-14
year O 0 2.0282965574030393e-13
of O 0 1.1071794522865552e-12
birth O 0 1.5955576859738585e-09
and O 0 2.035161622560011e-11
parity O 0 1.2292654893997224e-08
. O 0 4.0426226810552635e-09

RESULTS O 0 5.551938784265076e-07
The O 0 4.30831015307831e-09
adjusted O 0 2.583402078926156e-07
odds O 0 5.00867542996275e-07
ratio O 0 1.6295319937853492e-07
for O 0 8.763812786583003e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.0847561737747924e-09
with O 0 5.039345676860485e-13
any O 0 1.0628857169403538e-11
past O 0 7.769685068936827e-12
use O 0 1.0172692766277636e-12
of O 0 4.653795578068998e-12
oral O 0 1.2236085478178893e-09
contraceptives O 0 1.8398483847548164e-09
was O 0 2.3726513809219085e-11
0 O 0 3.2253641424340174e-10
. O 0 7.260859968827305e-11

5 O 0 2.748562053511705e-07
( O 0 6.848257377845002e-11
95 O 0 1.3882461757930287e-07
percent O 0 5.147360759849562e-09
confidence O 0 2.4018447231100026e-09
interval O 0 4.358618743705023e-10
, O 0 1.7714355373191215e-12
0 O 0 1.3530672242356712e-11
. O 0 2.19157686247827e-13
3 O 0 1.4445026121426285e-12
to O 0 2.733330597450012e-13
0 O 0 2.2911764499533582e-11
. O 0 9.311958756169636e-13
8 O 0 5.8205044950465634e-11
) O 0 5.432684467218674e-13
. O 0 4.5851553109876875e-10

The O 0 6.628812343478785e-08
risk O 0 1.666921178866687e-08
decreased O 0 4.49979253858146e-09
with O 0 6.059742009394131e-13
increasing O 0 9.391552639737011e-12
duration O 0 7.437744309335415e-10
of O 0 8.845106938548675e-12
use O 0 2.042741323315944e-11
( O 0 1.3512379149621667e-12
P O 0 4.759008120913677e-08
for O 0 7.803249366111764e-12
trend O 0 8.416261576549289e-10
, O 0 1.0384194318226875e-13
< O 0 8.716717452006417e-12
0 O 0 2.2299020269178627e-12
. O 0 8.441468688337797e-14
001 O 0 5.9681873158801135e-12
) O 0 2.186500542144607e-16
; O 0 7.092928433552199e-16
use O 0 2.6098130343561905e-14
for O 0 1.910462890317155e-13
six O 0 6.156437122248337e-13
or O 0 9.065676269577605e-13
more O 0 1.166429013923706e-13
years O 0 5.730686650044781e-13
was O 0 8.77225321462699e-13
associated O 0 4.38447889106186e-12
with O 0 7.710036087219332e-14
a O 0 1.1249647047240074e-12
60 O 0 3.171762505416176e-11
percent O 0 1.6755339520349577e-12
reduction O 0 4.438516915117319e-11
in O 0 1.0551353193943847e-11
risk O 0 1.893413204001604e-09
. O 0 4.606405923368584e-09

Oral O 0 0.042125996202230453
- O 0 9.125185169978067e-05
contraceptive O 0 4.3351188651286066e-05
use O 0 7.963421921886038e-09
protected O 0 7.548199937446043e-05
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.708610584769346e-11
for O 0 2.0099343738845532e-13
carriers O 0 1.7089167537662209e-12
of O 0 7.496829546038697e-12
the O 0 2.940898080616705e-10
BRCA1 O 0 5.714933526412835e-10
mutation O 0 1.5489162036308457e-11
( O 0 1.7523661558285775e-14
odds O 0 2.038690327665904e-10
ratio O 0 2.111801879201014e-11
, O 0 9.378581895466698e-14
0 O 0 7.704160118020276e-13
. O 0 5.87223683307797e-14
5 O 0 1.0268016905484734e-12
; O 0 2.5430691081608503e-13
95 O 0 2.2245445485680193e-09
percent O 0 3.9066380685959246e-10
confidence O 0 2.4292706735096203e-10
interval O 0 6.117231721169958e-11
, O 0 7.84295100652449e-13
0 O 0 7.077644893771495e-12
. O 0 3.78166681996861e-13
3 O 0 2.807110230026999e-12
to O 0 6.161488420169947e-13
0 O 0 3.5286384925115044e-11
. O 0 1.5279935519987853e-12
9 O 0 2.7864568291624536e-11
) O 0 1.0758069748353829e-14
and O 0 7.656635064466275e-14
for O 0 1.0938959563470615e-13
carriers O 0 1.9552592184224338e-11
of O 0 1.5888756976778495e-10
the O 0 2.870168103186188e-08
BRCA2 O 0 7.933165591111901e-08
mutation O 0 5.66103608434787e-10
( O 0 3.4640562987520163e-13
odds O 0 9.126203681653067e-10
ratio O 0 1.3763036543767981e-10
, O 0 2.5045162341599814e-13
0 O 0 4.022887058197089e-12
. O 0 1.9101095759341963e-13
4 O 0 8.775922696879768e-12
; O 0 9.072405370361136e-13
95 O 0 8.200427004112498e-09
percent O 0 6.116721573690143e-10
confidence O 0 4.344749282569893e-10
interval O 0 1.5111846496385084e-10
, O 0 9.19134885389583e-13
0 O 0 5.1206790543933955e-12
. O 0 9.517428891433338e-14
2 O 0 1.344728039857912e-12
to O 0 1.2984836188049964e-13
1 O 0 2.4173949300654307e-11
. O 0 1.5852838789950918e-12
1 O 0 1.6316693829399043e-10
) O 0 7.943290664981506e-13
. O 0 8.259413153410833e-10

CONCLUSIONS O 0 0.001179293030872941
Oral O 0 0.00028665614081546664
- O 0 2.6688951493269997e-07
contraceptive O 0 1.734501253736198e-08
use O 0 8.610363940939059e-13
may O 0 1.9221490718535073e-12
reduce O 0 1.1495077459344749e-11
the O 0 1.3840133032683166e-11
risk O 0 3.373670054429567e-08
of O 0 1.0557797395449597e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.3858698750852696e-11
women O 0 4.5192717840550345e-14
with O 0 3.2829413083965316e-15
pathogenic O 0 2.9027238945822376e-10
mutations O 0 4.065485448290218e-10
in O 0 1.9182166272058154e-11
the O 0 3.312159879698129e-09
BRCA1 O 0 1.8991728722994594e-07
or O 0 1.0652176740677533e-07
BRCA2 O 0 2.9735419957432896e-06
gene O 0 8.086655611805327e-08

A O 0 4.001160736066822e-09
Japanese O 0 8.59347011328282e-08
family O 0 2.766731010961365e-10
with O 0 1.2814051902898527e-11
adrenoleukodystrophy B-Disease 1 1.0
with O 0 2.997996989551055e-11
a O 0 4.2396107458042565e-11
codon O 0 7.929229717262842e-09
291 O 0 8.508472260082556e-10
deletion O 0 1.6807298608423338e-11
: O 0 1.2682294823422157e-14
a O 0 1.0864181800821111e-14
clinical O 0 5.495667289301398e-12
, O 0 1.1089013821768967e-13
biochemical O 0 1.8085556385827317e-09
, O 0 6.527785256782437e-12
pathological O 0 2.2447393348556943e-06
, O 0 3.42491729421468e-11
and O 0 1.941783366044003e-11
genetic O 0 1.8771957321916943e-09
report O 0 1.8488108266545566e-10
. O 0 3.942036919113434e-09

We O 0 3.5004055209952867e-10
report O 0 4.419962659762966e-12
a O 0 1.0740319495317757e-13
Japanese O 0 4.171400724839458e-10
family O 0 2.6679080819547174e-11
with O 0 2.7298009339093987e-11
adrenoleukodystrophy B-Disease 1 1.0
( O 0 1.0101675940177302e-08
ALD B-Disease 1 1.0
) O 0 1.6182599964914557e-12
with O 0 9.756704179384595e-14
a O 0 2.0060163382837337e-13
three O 0 8.054060890438919e-14
base O 0 4.442582413055618e-11
pair O 0 1.6568429961338893e-10
deletion O 0 8.053135935881528e-11
( O 0 2.2024257959919746e-13
delGAG O 0 2.7587926609839997e-08
291 O 0 1.6462681218243347e-10
) O 0 2.1417268728906452e-14
in O 0 1.8425215780187854e-12
the O 0 2.8838853527446418e-09
ALD B-Disease 1 1.0
gene O 0 8.493091172567802e-07
. O 0 3.0819620633337763e-07

A O 0 7.836121795889994e-08
variety O 0 2.3016646366613713e-09
of O 0 3.765672496047756e-10
phenotypes O 0 1.7445909605839915e-08
were O 0 2.8306502974917436e-11
observed O 0 6.689690468242304e-12
within O 0 5.503209433294076e-12
this O 0 1.0227893185166259e-11
family O 0 3.354436728386645e-10
. O 0 5.0174500110244935e-09

While O 0 8.386828120876544e-09
the O 0 1.1628549234643515e-09
proband O 0 0.00022682744020130485
( O 0 1.970963947606208e-10
patient O 0 3.2288135116687045e-05
1 O 0 1.0507888781319252e-08
) O 0 2.337183723465086e-13
was O 0 4.4172679403153836e-11
classified O 0 5.850392392758863e-10
as O 0 5.5396603970692126e-11
having O 0 3.933101240527481e-12
a O 0 3.238322966985646e-13
rare O 0 1.337010103324987e-11
intermediate O 0 2.284999078838723e-09
type O 0 3.069410003941897e-10
of O 0 5.293853688748129e-10
adult O 0 3.326875841480614e-08
cerebral O 0 1.9264184913936333e-07
and O 0 5.500423450044423e-10
cerebello O 0 3.4081538160535274e-06
- O 0 2.69652616680105e-07
brain O 0 1.0198653654924783e-07
stem O 0 3.028668205118379e-09
forms O 0 1.3034508195008954e-10
, O 0 4.905850573867776e-13
his O 0 1.6767337518430736e-11
younger O 0 2.7917916867181702e-08
brother O 0 6.655706652480831e-09
( O 0 9.354129883870632e-13
patient O 0 1.322825049498988e-08
2 O 0 3.1854522491991943e-11
) O 0 1.2194489396131353e-14
and O 0 4.155022680085718e-12
nephew O 0 3.410386568702961e-07
( O 0 1.9542301804564843e-11
patient O 0 2.9360106054809876e-05
3 O 0 4.698683664372538e-09
) O 0 2.1369170810029564e-13
had O 0 2.6364138303036633e-11
a O 0 5.848827672183532e-11
childhood O 0 2.6426212116348324e-06
ALD B-Disease 1 1.0
type O 0 0.00899901706725359
. O 0 2.1535117866733344e-06

Another O 0 8.555377917218721e-07
nephew O 0 0.003086264245212078
( O 0 9.950029689065332e-10
patient O 0 2.5855419153231196e-05
4 O 0 5.926226176455884e-09
) O 0 3.6841084111345623e-13
of O 0 2.4034338408363e-10
patient O 0 1.0868175195355434e-05
1 O 0 2.289231737506725e-08
was O 0 1.1375841935112874e-10
classified O 0 3.036637608033743e-10
as O 0 1.3290342784633147e-11
having O 0 1.8318558475671765e-11
an O 0 2.78042291881192e-13
adolescent O 0 3.545986282382785e-10
form O 0 4.455413121773333e-11
. O 0 2.2046915404416723e-09

The O 0 3.489676103640704e-08
tau O 0 4.011231347078592e-09
level O 0 6.839175337169934e-10
in O 0 6.983869212107141e-12
the O 0 1.4607956511092368e-10
cerebrospinal O 0 1.967529250634925e-08
fluid O 0 2.878232976399886e-07
( O 0 4.011351806276764e-10
CSF O 0 8.313191756315064e-06
) O 0 6.280739817121628e-12
in O 0 1.1406983135842097e-09
patient O 0 0.440321683883667
1 O 0 1.4936379955088341e-07
was O 0 8.250265470799434e-10
as O 0 1.4452308273738002e-11
high O 0 3.092256728454146e-10
as O 0 1.0303147495328152e-13
that O 0 1.7703654577269656e-15
of O 0 6.935824527556922e-13
patients O 0 2.3064096466018924e-10
with O 0 1.5734212977652762e-12
Alzheimers B-Disease 1 0.9746837615966797
disease I-Disease 0 9.155764502111197e-08
( O 0 9.3531302494676e-13
AD B-Disease 0 6.636605576204602e-08
) O 0 6.9722504679459174e-12
. O 0 1.7026271503794987e-09

His O 0 1.3585912483904394e-06
brain O 0 1.9105412718545267e-07
magnetic O 0 1.1082681083962598e-07
resonance O 0 2.0818310986214783e-07
image O 0 2.2955680378800025e-07
( O 0 2.1575123632100457e-10
MRI O 0 0.000530590710695833
) O 0 9.394118122285633e-11
showed O 0 5.172405281861359e-10
abnormalities B-Disease 0 8.868399348216371e-09
in I-Disease 0 1.429974454819627e-11
the I-Disease 0 4.0703893033899874e-10
bilateral I-Disease 1 0.8044938445091248
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9997178912162781
and O 0 2.7292747972751386e-07
brain O 0 1.3099663931370742e-07
stem O 0 6.530560092699034e-09
, O 0 9.767633614909607e-14
but O 0 7.304534987940745e-14
not O 0 9.680536266262058e-14
in O 0 3.8515054318587205e-13
the O 0 1.0007823562918627e-11
cerebral O 0 1.9722172783787073e-09
white O 0 7.238983718016456e-11
matter O 0 2.906180851525164e-10
, O 0 1.8569637133861693e-14
where O 0 6.3513727934503324e-15
marked O 0 1.675804812842699e-13
reductions O 0 1.2358043754989723e-10
of O 0 5.791269894195317e-11
the O 0 4.2029868474458e-10
cerebral O 0 1.656883199530057e-07
blood O 0 3.6927326618751977e-07
flow O 0 1.2080285216597986e-07
and O 0 1.0860640164978008e-10
oxygen O 0 1.3449590774428088e-08
metabolism O 0 4.961665567293494e-08
were O 0 1.225397006088258e-10
clearly O 0 5.399899971614275e-11
demonstrated O 0 1.430773815397357e-11
by O 0 1.5613405750583564e-12
positron O 0 3.4802241088982555e-08
emission O 0 8.01465560584802e-08
tomography O 0 5.355327061806747e-07
( O 0 7.41850053609383e-11
PET O 0 3.844275397568708e-06
) O 0 1.0093033180058608e-11
. O 0 6.547430930758935e-10

In O 0 4.1361804647976896e-08
patients O 0 4.071639068570221e-06
2 O 0 3.538436743610873e-08
and O 0 1.2956652417628334e-10
3 O 0 3.1957156920725538e-09
, O 0 7.516053751599472e-13
the O 0 6.053945539319372e-12
autopsy O 0 2.0393962074649608e-08
findings O 0 5.1640784981543675e-09
showed O 0 8.646682259083605e-10
massive O 0 1.9196679801325445e-09
demyelination B-Disease 1 1.0
of I-Disease 0 2.6634997993824072e-06
the I-Disease 0 4.343138115814327e-08
cerebral I-Disease 0 5.0394447725921054e-08
white I-Disease 0 2.8274679819695336e-10
matter I-Disease 0 8.868560052999186e-11
with O 0 3.571383131990933e-15
sparing O 0 7.334306773021382e-12
of O 0 8.085919434019928e-11
the O 0 1.4180902008220642e-09
U O 0 1.9831022655125707e-06
- O 0 9.314680227134886e-08
fibers O 0 5.5952916966361954e-08
, O 0 1.6246936088148978e-11
compatible O 0 2.18750823011149e-10
with O 0 1.8899158361332033e-14
the O 0 2.6614710327103885e-13
findings O 0 1.4845040127720033e-11
of O 0 3.518087210441223e-11
childhood O 0 5.675463512488932e-07
ALD B-Disease 1 1.0
. O 0 2.9004527277720626e-06

Oleic O 0 0.052216917276382446
and O 0 1.2395825024213991e-06
erucic O 1 0.8166552186012268
acids O 0 4.6812301661702804e-06
( O 0 2.918891239822585e-10
Lorenzos O 0 1.704424175841268e-05
Oil O 0 3.882263968080224e-07
) O 0 5.687022575952272e-13
were O 0 8.480143670608342e-12
administered O 0 7.674183012153224e-13
to O 0 1.8240799495861104e-12
patients O 0 7.850341487980472e-10
1 O 0 9.8076591292795e-10
and O 0 1.3026921555359117e-11
4 O 0 5.050958540309125e-10
, O 0 3.5960354160570474e-13
but O 0 7.253530458564694e-13
sufficient O 0 2.759161996102044e-11
effectiveness O 0 5.907486305689602e-11
was O 0 1.8192756329193926e-11
not O 0 1.0274952546782123e-12
obtained O 0 4.708657352914258e-10
. O 0 3.013553850905737e-09

The O 0 2.925080444526884e-08
findings O 0 6.283936482276431e-09
in O 0 1.9194940775735247e-11
this O 0 1.9152113922560332e-11
family O 0 1.1486749051936584e-11
suggest O 0 3.844036200462142e-12
that O 0 9.976991021537485e-15
delGAG291 O 0 7.174136840149004e-10
is O 0 5.2323173327676817e-14
part O 0 2.219310211949363e-13
of O 0 1.6094777420538886e-12
the O 0 3.428628041202142e-12
cause O 0 2.963240208764262e-10
of O 0 1.2960063577871495e-10
Japanese O 0 1.6574410892644664e-06
ALD B-Disease 1 1.0
with O 0 8.083406166647933e-11
phenotypic O 0 4.125368935348206e-09
variations O 0 1.8056513795272622e-07
. O 0 2.3296145457152306e-08

Moreover O 0 2.595356534129678e-07
, O 0 2.3174812763260277e-11
although O 0 9.17453960025405e-12
the O 0 1.2270656496102261e-12
scale O 0 8.182357569275212e-11
of O 0 1.635594611137936e-11
the O 0 7.413362458630335e-12
study O 0 1.582441209319052e-12
is O 0 3.685341250648632e-15
limited O 0 4.955694600343452e-13
, O 0 1.165103712293114e-13
there O 0 8.354895009339558e-13
is O 0 2.337450979300604e-13
a O 0 7.103526209091549e-13
possibility O 0 1.3422649658423325e-09
that O 0 9.591796801267094e-11
PET O 1 0.9982695579528809
can O 0 3.5271212617260517e-09
detect O 0 2.600410766717687e-07
an O 0 2.3691692704885803e-11
insidious B-Disease 0 6.198130449774908e-06
lesion I-Disease 0 0.0010989907896146178
which O 0 1.439948577042216e-10
is O 0 3.0228172395729835e-12
undetectable O 0 1.923625425614972e-10
by O 0 6.029734003765164e-12
computed O 0 6.824170384334138e-08
tomogram O 0 6.063376349629834e-05
( O 0 6.946170721944256e-11
CT O 0 1.587808583281003e-06
) O 0 2.827724165932466e-12
or O 0 6.2375230848454866e-12
MRI O 0 3.0373470849553996e-08
analysis O 0 3.972463850920871e-12
, O 0 8.657919487679161e-14
and O 0 1.0200661082688297e-14
that O 0 1.0338353699802772e-15
the O 0 1.3522042101483944e-13
higher O 0 5.328344016009012e-11
level O 0 6.92092173501524e-12
of O 0 5.742043667801566e-13
tau O 0 9.556620252093584e-12
reflects O 0 7.103110200717966e-12
the O 0 3.1449869157497076e-14
process O 0 2.1140264885866067e-11
of O 0 2.6086985349671465e-10
neuronal B-Disease 0 4.239023110130802e-05
degeneration I-Disease 1 0.9999969005584717
in O 0 5.64843332995224e-07
ALD B-Disease 1 1.0
. O 0 4.1591806620999705e-06

Lorenzos O 0 4.241611168254167e-05
Oil O 0 5.999162766556765e-08
should O 0 3.827129585465272e-12
be O 0 6.257082525717994e-14
given O 0 2.548628896901356e-13
in O 0 7.515447547059781e-14
the O 0 3.789746836659058e-13
early O 0 2.811373078781543e-10
stage O 0 5.3861574922375866e-11
. O 0 1.4448339226424967e-11
. O 0 5.115393109100808e-10

Nonsense O 0 5.622294338536449e-06
mutation O 0 7.919724964722263e-08
in O 0 9.931070410473808e-10
exon O 0 9.464127259661836e-08
4 O 0 7.54194662277996e-09
of O 0 1.1185449788619906e-10
human O 0 3.026050798826674e-10
complement O 0 1.0349442902679584e-07
C9 O 1 0.999934196472168
gene O 0 6.698239185531918e-10
is O 0 1.247439651574922e-13
the O 0 1.3826215020974753e-13
major O 0 4.264002345655271e-12
cause O 0 4.921881999186972e-11
of O 0 2.1860306967380616e-11
Japanese O 0 1.2758192724504624e-07
complement B-Disease 0 1.9809172044915613e-06
C9 I-Disease 1 0.9999998807907104
deficiency I-Disease 0 0.00020531284098979086
. O 0 1.3097103135351063e-07

Deficiency B-Disease 1 0.517143726348877
of I-Disease 0 6.342847314044775e-07
the I-Disease 0 2.7705314664672187e-07
ninth I-Disease 0 8.994477866508532e-06
component I-Disease 0 5.465988692776591e-07
of I-Disease 0 2.9453468997076016e-08
human I-Disease 0 4.025272559715631e-09
complement I-Disease 0 4.2871755567830405e-07
( O 0 4.7392176988347856e-11
C9 O 0 0.015431606210768223
) O 0 6.934038304477752e-13
is O 0 6.118226042982344e-14
the O 0 3.3047951311301893e-13
most O 0 2.5839209244482575e-12
common O 0 8.986605237737422e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.83343079501941e-10
Japan O 0 6.218570658411693e-10
but O 0 1.012109558488905e-12
is O 0 1.3204690535179985e-14
rare O 0 7.111660435890621e-13
in O 0 6.476253452784853e-13
other O 0 5.947982124193674e-12
countries O 0 1.0431510689967727e-11
. O 0 3.1423683655162904e-09

We O 0 2.854877723112992e-10
studied O 0 2.5450223525846916e-11
the O 0 1.1708914545403848e-13
molecular O 0 2.2008438908122097e-12
basis O 0 5.05462789679445e-11
of O 0 1.2501981672130569e-09
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999873638153076
in O 0 4.094717453995145e-09
four O 0 1.6951660561370652e-11
Japanese O 0 1.1535288280128952e-08
C9 B-Disease 1 0.9999840259552002
- I-Disease 0 6.177501927595586e-05
deficient I-Disease 0 8.603753485658672e-06
patients O 0 1.703792077023536e-05
who O 0 5.167600722333354e-11
had O 0 9.365815067940986e-11
suffered O 0 1.0575769593401674e-08
from O 0 1.1744154448933841e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.1946971767429204e-07

Direct O 0 7.627705578272526e-09
sequencing O 0 1.7390727080623947e-08
of O 0 2.7791298151669253e-09
amplified O 0 3.484818194010586e-07
C9 O 0 8.369045826839283e-05
cDNA O 0 1.8731551421069526e-08
and O 0 6.459901363831122e-11
DNA O 0 1.022936624295312e-09
revealed O 0 4.281765220159883e-10
a O 0 4.396990584132343e-12
nonsense O 0 1.884604028390413e-09
substitution O 0 5.475869091497998e-09
( O 0 1.2219275070946e-12
CGA O 0 3.142716087367603e-09
- O 0 2.2671164945364808e-10
- O 0 3.1908778397315984e-10
> O 0 3.08713526964155e-10
TGA O 0 1.8292531933639111e-09
) O 0 3.767230871329873e-14
at O 0 7.533449233355916e-13
codon O 0 2.3701094906125597e-11
95 O 0 3.8950168090856607e-10
in O 0 1.982311016723859e-11
exon O 0 5.276645786977952e-10
4 O 0 4.01475824807207e-10
in O 0 5.4858335755969545e-12
the O 0 1.5412135456749354e-10
four O 0 1.8304388560430596e-10
C9 B-Disease 1 0.9999399185180664
- I-Disease 0 4.078296115039848e-05
deficient I-Disease 0 2.920681708928896e-06
individuals O 0 2.968433276961946e-10
. O 0 4.592833668937146e-09

An O 0 2.2454912929070758e-10
allele O 0 3.630985734304204e-09
- O 0 1.2256640147256803e-09
specific O 0 8.965320152931611e-10
polymerase O 0 4.806111064681318e-09
chain O 0 3.281359628459768e-10
reaction O 0 2.9581126437250305e-10
system O 0 1.407567284950062e-09
designed O 0 5.274130021604151e-10
to O 0 5.758676868694579e-11
detect O 0 3.2608576949755275e-10
exclusively O 0 1.5180306664475118e-11
only O 0 8.629204664191426e-13
one O 0 1.1065118005887387e-13
of O 0 1.1524225584230718e-12
the O 0 1.0980318217168605e-11
normal O 0 5.835138594534328e-09
and O 0 3.099293738317854e-11
mutant O 0 4.4818970756921317e-10
alleles O 0 6.457162929351945e-12
indicated O 0 5.894621596391758e-11
that O 0 8.880326622705617e-14
all O 0 3.8891161341716995e-13
the O 0 2.4996116287923087e-12
four O 0 3.373693739736755e-13
patients O 0 2.5885543708525915e-11
were O 0 8.589733091479701e-12
homozygous O 0 8.533769177421213e-12
for O 0 3.2110345198760326e-12
the O 0 1.6297782567953334e-10
mutation O 0 2.058500453427925e-10
in O 0 3.3680538913394287e-10
exon O 0 2.636346030371328e-09
4 O 0 9.745247941950197e-10
and O 0 8.689837586485505e-13
that O 0 2.3682802341939112e-14
the O 0 8.413444420318772e-12
parents O 0 1.7014112341229293e-11
of O 0 7.255830918734274e-12
patient O 0 2.37524044877091e-08
2 O 0 2.3904829227205937e-09
were O 0 1.6684401082933675e-10
heterozygous O 0 2.2951447686825333e-10
. O 0 7.172919480602502e-10

The O 0 1.5695997390707817e-08
common O 0 1.9382561333713966e-08
mutation O 0 5.466320729397012e-09
at O 0 4.2793732446533284e-10
codon O 0 3.9956389308315465e-09
95 O 0 3.8922358669424284e-08
in O 0 7.396632750733545e-10
exon O 0 1.618578160389461e-08
4 O 0 8.003831486469437e-10
might O 0 8.193942052647785e-12
be O 0 1.5428759344345705e-13
responsible O 0 1.3430413465381763e-12
for O 0 3.5329177734341743e-13
most O 0 1.4370588052869948e-11
Japanese O 0 3.351297550580057e-07
C9 B-Disease 1 1.0
deficiency I-Disease 0 8.734292350709438e-06
. O 0 4.195812142171462e-09
. O 0 4.5533994352808804e-09

BRCA1 O 0 1.758311896082887e-07
required O 0 2.2775747954284498e-10
for O 0 1.3873540337383528e-11
transcription O 0 2.2337169980346516e-07
- O 0 9.670558256402728e-07
coupled O 0 4.255551175447181e-06
repair O 0 4.175081357971067e-06
of O 0 7.668433887886295e-09
oxidative O 0 4.067323516210308e-06
DNA O 0 3.647240873760893e-06
damage O 0 2.518251676519867e-05
. O 0 7.389913037059159e-08

The O 0 6.830747679487104e-06
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.5502020716667175
gene O 0 7.735010854048596e-08
BRCA1 O 0 7.56716573846461e-08
encodes O 0 7.138031138387291e-11
a O 0 1.497965987362626e-11
zinc O 0 5.651504864090384e-08
finger O 0 1.2037063790160119e-08
protein O 0 4.38964020688104e-09
of O 0 7.847706373631524e-10
unknown O 0 2.4881909865825946e-08
function O 0 6.401483787499274e-10
. O 0 1.0354883617225141e-09

Association O 0 3.653356728250401e-08
of O 0 1.8961825887231498e-08
the O 0 3.4696000739131705e-08
BRCA1 O 0 4.157843402907702e-09
protein O 0 1.905345742292397e-10
with O 0 4.580297187535554e-13
the O 0 3.3720245345980615e-11
DNA O 0 2.620824002264044e-09
repair O 0 2.8769707682840817e-07
protein O 0 3.7261802532384536e-08
Rad51 O 0 8.386480487843073e-08
and O 0 2.7548013783323944e-12
changes O 0 4.469471667767344e-12
in O 0 9.256337016316785e-13
the O 0 1.6536936750521924e-12
phosphorylation O 0 5.676624448280876e-11
and O 0 9.375747574147386e-12
cellular O 0 4.304617426398316e-11
localization O 0 2.850863323189401e-09
of O 0 6.356572906929259e-11
the O 0 8.212267671448004e-11
protein O 0 2.42658448890154e-10
after O 0 4.204406267582783e-10
exposure O 0 1.690195761128166e-09
to O 0 2.1127929267228396e-11
DNA O 0 2.0140444867422502e-09
- O 0 4.108499651600539e-10
damaging O 0 1.0398663041755185e-09
agents O 0 5.6054418051676436e-11
are O 0 7.450497467240136e-13
consistent O 0 9.016259960858974e-12
with O 0 3.437659287750818e-15
a O 0 4.572377700529269e-14
role O 0 1.746009044810426e-12
for O 0 2.4249177318913517e-11
BRCA1 O 0 1.7466045276748332e-09
in O 0 6.822221260138761e-11
DNA O 0 4.310079404490352e-08
repair O 0 1.1180501132912468e-05
. O 0 1.6999678109641536e-07

Here O 0 3.746826493511435e-08
, O 0 2.5801005429371138e-11
it O 0 3.2586146237953417e-13
is O 0 1.434042636158303e-13
shown O 0 3.4583408185795417e-12
that O 0 4.202606145031762e-12
mouse O 0 1.0999371369280198e-07
embryonic O 0 2.376674092374742e-05
stem O 0 5.018179308535764e-06
cells O 0 2.2901938336872263e-06
deficient B-Disease 0 3.3846760061351233e-07
in I-Disease 0 3.298792350392432e-10
BRCA1 I-Disease 0 1.2349048450488453e-09
are O 0 2.7811655973000726e-13
defective O 0 7.239802091163483e-10
in O 0 5.529030705497817e-11
the O 0 1.0128058808289708e-10
ability O 0 2.5993499019882904e-11
to O 0 7.478905515723167e-12
carry O 0 2.7599988267068554e-11
out O 0 5.370480535976663e-12
transcription O 0 4.707231937572942e-09
- O 0 1.3390743625052437e-08
coupled O 0 4.614797717295005e-07
repair O 0 7.896554734543315e-07
of O 0 7.817066438597919e-10
oxidative O 0 6.847744060678451e-08
DNA O 0 1.6185138917990116e-07
damage O 0 4.876912953477586e-06
, O 0 8.380200006152805e-11
and O 0 5.876379938207776e-11
are O 0 1.5099104258564644e-11
hypersensitive O 0 2.164129853099439e-07
to O 0 6.810303432303044e-10
ionizing O 0 6.201145879458636e-05
radiation O 0 5.442024485091679e-05
and O 0 8.642522114632456e-11
hydrogen O 0 7.846153948776191e-09
peroxide O 0 3.363653888754925e-07
. O 0 2.1963403540326e-08

These O 0 2.112828312306192e-08
results O 0 8.23261636639927e-09
suggest O 0 1.3159549006047655e-08
that O 0 6.073611058532435e-11
BRCA1 O 0 4.701516509442172e-09
participates O 0 9.884722380892885e-12
, O 0 6.409437325501088e-14
directly O 0 6.879565818927735e-13
or O 0 2.164157958742252e-12
indirectly O 0 1.2187439425714874e-11
, O 0 7.903334020217812e-13
in O 0 1.0697295479977775e-11
transcription O 0 1.3547405330882611e-07
- O 0 4.724468567474105e-07
coupled O 0 1.3182959719415521e-06
repair O 0 6.594711976504186e-07
of O 0 5.430413896334585e-10
oxidative O 0 7.901845577862332e-08
DNA O 0 8.638876636268833e-08
damage O 0 2.3492729894769582e-07
. O 0 1.0373742975744449e-09
. O 0 2.612882799013505e-09

Truncation O 0 1.2595096450240817e-05
mutations O 0 9.284721613767033e-08
in O 0 1.1880625649940413e-10
the O 0 1.772255259213651e-10
transactivation O 0 7.474505423488154e-07
region O 0 7.341707242147777e-09
of O 0 3.68742014700274e-09
PAX6 O 0 9.978614980354905e-05
result O 0 2.1283762308144105e-08
in O 0 1.1087535334297627e-09
dominant O 0 2.0581538251462916e-07
- O 0 5.9020102582962863e-08
negative O 0 1.3777416540960985e-08
mutants O 0 5.491078525210469e-08
. O 0 8.011041274791353e-10

PAX6 O 0 0.0593089759349823
is O 0 9.109230592052597e-10
a O 0 3.5656325114707954e-11
transcription O 0 2.411481148101302e-08
factor O 0 1.349934652949969e-08
with O 0 4.332572061532813e-12
two O 0 1.701929612865638e-12
DNA O 0 1.0115143445066366e-10
- O 0 1.9624561697906273e-10
binding O 0 1.2700555052092e-09
domains O 0 7.154528081088074e-10
( O 0 4.555032024310124e-13
paired O 0 3.90869350774814e-11
box O 0 1.604284483036622e-10
and O 0 3.890335102674225e-12
homeobox O 0 1.1413968659113038e-09
) O 0 1.2011851474418023e-13
and O 0 1.8884837270360944e-12
a O 0 4.773234325156084e-12
proline O 0 5.751635168138591e-09
- O 0 8.38538838365821e-09
serine O 0 1.298011937933552e-07
- O 0 1.5274845566182194e-07
threonine O 0 3.744811749584187e-08
( O 0 1.7798178295752587e-12
PST O 0 4.30015205665768e-07
) O 0 3.490095365488166e-12
- O 0 2.38862796209105e-09
rich O 0 2.919059660655421e-09
transactivation O 0 8.966864584181167e-07
domain O 0 1.5129193897678306e-08
. O 0 2.6915090156620636e-09

PAX6 O 1 0.999997615814209
regulates O 0 0.0005692249396815896
eye O 1 0.999922513961792
development O 0 3.378017083832674e-07
in O 0 9.953688567820862e-11
animals O 0 6.340879210586792e-11
ranging O 0 3.2961006146692284e-10
from O 0 1.43076566219702e-11
jellyfish O 0 3.125099068412851e-10
to O 0 1.7806573923695446e-11
Drosophila O 0 1.1101711772099065e-09
to O 0 1.744811413406655e-11
humans O 0 4.591289848310254e-10
. O 0 5.59640955799523e-09

Heterozygous O 0 5.709230208594818e-06
mutations O 0 7.936812806974558e-08
in O 0 1.2373209401506102e-10
the O 0 5.76714342948037e-10
human O 0 3.6658072133377573e-09
PAX6 O 0 0.006461976561695337
gene O 0 3.4402802828736867e-09
result O 0 1.4311383189635762e-09
in O 0 1.5493120675280636e-11
various O 0 5.932938168529134e-11
phenotypes O 0 8.47462633402074e-09
, O 0 2.3793288303139426e-13
including O 0 1.2965533323621575e-13
aniridia B-Disease 1 1.0
, O 0 4.471351899848486e-10
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.9610567336680873e-10
autosomal B-Disease 0 4.363474545243662e-06
dominant I-Disease 0 8.099443220999092e-06
keratitis I-Disease 1 0.9995576739311218
, O 0 3.1102402875404778e-09
and O 0 5.782721412828096e-09
familial B-Disease 1 0.9972034692764282
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9996095299720764

It O 0 2.945079735638956e-10
is O 0 4.344073711859409e-12
believed O 0 8.608429941103779e-12
that O 0 1.3128721844206642e-14
the O 0 2.7153218909448107e-12
mutated O 0 7.62197593928704e-09
allele O 0 3.6130533231926165e-08
of O 0 4.20843582205066e-09
PAX6 O 0 0.0010112370364367962
produces O 0 3.1163430169733886e-10
an O 0 1.68991502649124e-13
inactive O 0 6.0261906575931334e-09
protein O 0 3.782632540527686e-10
and O 0 6.631218490982249e-11
aniridia B-Disease 1 1.0
is O 0 7.511934130288722e-11
caused O 0 1.1639467167867679e-09
due O 0 1.8897942766216147e-07
to O 0 1.3237936302701314e-09
genetic O 0 9.740424644633094e-08
haploinsufficiency O 0 2.2089787307777442e-05
. O 0 1.096819843837693e-07

However O 0 9.134811080002692e-06
, O 0 4.4915267061185205e-09
several O 0 5.304527372906875e-10
truncation O 0 3.693180019581632e-07
mutations O 0 6.088300530393553e-09
have O 0 1.923253917235357e-11
been O 0 3.1891102172248997e-12
found O 0 5.375847878831552e-13
to O 0 1.1237010806445027e-13
occur O 0 1.4546994251546375e-12
in O 0 6.706934812215903e-13
the O 0 2.364862299042425e-11
C O 0 7.764719534009146e-09
- O 0 3.530226805326109e-11
terminal O 0 4.919399554381698e-09
half O 0 1.0362499920646417e-11
of O 0 6.215255740626979e-12
PAX6 O 0 5.858375971001806e-07
in O 0 2.4266899253944096e-11
patients O 0 8.855345901004341e-10
with O 0 1.0465584562163732e-12
Aniridia B-Disease 1 1.0
resulting O 0 5.487934231496183e-06
in O 0 3.05064129513255e-09
mutant O 0 4.16812584447257e-09
proteins O 0 2.7489869755537022e-11
that O 0 1.3348716663280635e-12
retain O 0 3.20481939597439e-11
the O 0 1.0103163965158313e-11
DNA O 0 5.416631726484766e-11
- O 0 7.294827242265711e-11
binding O 0 3.43280626147191e-10
domains O 0 7.137691132585999e-11
but O 0 1.2932548261457288e-11
have O 0 1.2121779274787414e-12
lost O 0 1.8318770111935834e-11
most O 0 6.497147248376092e-14
of O 0 4.782673280849525e-13
the O 0 1.5194037000787475e-11
transactivation O 0 1.0188289678580986e-07
domain O 0 8.810872031972394e-09
. O 0 6.570202604194719e-09

It O 0 2.3445720365167233e-10
is O 0 1.567295989171602e-12
not O 0 4.32680529859758e-13
clear O 0 1.6906002639482942e-11
whether O 0 3.696625471005799e-12
such O 0 5.046141629549972e-11
mutants O 0 2.1818721052113688e-06
really O 0 8.914387561453907e-10
behave O 0 3.037180576481724e-11
as O 0 1.5893226405078176e-12
loss O 0 3.5412176663252026e-12
- O 0 1.3811916020622927e-11
of O 0 4.1565390018760695e-11
- O 0 4.3547715433689405e-10
function O 0 4.838316552957522e-11
mutants O 0 6.490311066364995e-10
as O 0 3.6123550982078423e-13
predicted O 0 1.9957941549408886e-11
by O 0 3.98322217223801e-12
haploinsufficiency O 0 1.1730626283679157e-06
. O 0 4.123144492496067e-08

Contrary O 0 2.8062041224075074e-07
to O 0 2.076152791352648e-11
this O 0 7.140479180156589e-12
theory O 0 5.302557504194283e-09
, O 0 2.8425027089051813e-12
our O 0 1.0216642636062812e-11
data O 0 9.517620198906673e-12
showed O 0 1.3016863628645403e-11
that O 0 1.0662430411246399e-13
these O 0 1.188605897733952e-11
mutants O 0 4.986329571465831e-09
are O 0 7.844974669879434e-12
dominant O 0 6.968162713505421e-10
- O 0 3.9316502831177047e-10
negative O 0 4.4464673609745375e-10
in O 0 1.2962133970340073e-11
transient O 0 1.373176239383156e-09
transfection O 0 1.3980232527188718e-09
assays O 0 2.956341560444997e-10
when O 0 3.825423311454301e-11
they O 0 7.618562898603631e-12
are O 0 9.006560688223919e-13
coexpressed O 0 2.5504734324499623e-08
with O 0 1.1903527642742606e-11
wild O 0 7.947432578703229e-08
- O 0 1.9283222130184186e-08
type O 0 2.973520167870447e-07
PAX6 O 0 0.005144777242094278
. O 0 2.0362485031455435e-07

We O 0 2.706071366986862e-09
found O 0 2.5416363458319324e-11
that O 0 1.492232444381958e-13
the O 0 3.972443207711507e-11
dominant O 0 2.9019464165003228e-08
- O 0 9.081928986631738e-09
negative O 0 4.140701559407489e-09
effects O 0 1.4780495716237851e-09
result O 0 3.1150534929302864e-10
from O 0 9.797666150612727e-12
the O 0 2.3719489913864855e-12
enhanced O 0 2.8786670963620864e-11
DNA O 0 2.2122051412942767e-10
binding O 0 6.362471105525458e-10
ability O 0 2.4911042673103623e-10
of O 0 1.7889306702656427e-10
these O 0 3.725735830961696e-10
mutants O 0 5.469681241265789e-08
. O 0 1.7002516061737083e-09

Kinetic O 0 1.1223758065170841e-06
studies O 0 1.7404190311154366e-09
of O 0 5.229033178677511e-11
binding O 0 2.835008006130124e-09
and O 0 8.018577468682508e-10
dissociation O 0 2.6105379191676548e-08
revealed O 0 9.51476231136894e-10
that O 0 3.8020552418222e-13
various O 0 6.087838132912138e-12
truncation O 0 9.77990577410992e-09
mutants O 0 8.771451120992424e-09
have O 0 4.336292176027046e-12
3 O 0 1.0643727219039611e-11
- O 0 3.411380769882677e-12
5 O 0 2.6185827811664453e-11
- O 0 1.3067834141178292e-11
fold O 0 1.396277121701317e-10
higher O 0 4.0914677201797645e-10
affinity O 0 5.52430540548543e-12
to O 0 4.4780878224320864e-13
various O 0 7.339200319526895e-13
DNA O 0 3.6457204442841284e-12
- O 0 4.955042452736702e-13
binding O 0 2.9055295495961087e-12
sites O 0 3.2028318799198763e-12
when O 0 3.620701828632722e-13
compared O 0 7.89571359682828e-12
with O 0 7.9174778441337e-15
the O 0 2.699829075580862e-12
wild O 0 1.64845903594113e-09
- O 0 6.611961533842248e-10
type O 0 4.3741639643712915e-08
PAX6 O 0 0.0006356463418342173
. O 0 1.1103946206958426e-07

These O 0 1.1935870070090004e-09
results O 0 8.652947108833686e-11
provide O 0 5.6203193141146635e-12
a O 0 2.2839575283123414e-13
new O 0 2.6110318768202134e-11
insight O 0 7.217899888889434e-12
into O 0 3.7406118784041875e-13
the O 0 5.427640216611185e-13
role O 0 1.5936088169563045e-12
of O 0 2.7454554255013086e-11
mutant O 0 3.306360696342381e-08
PAX6 O 0 0.00016722692816983908
in O 0 5.838386440970567e-10
causing O 0 3.014066862760956e-08
aniridia B-Disease 1 1.0
. O 0 2.1337783095987106e-08
. O 0 1.594214005251615e-08

Reversal O 0 1.8121927496395074e-06
of O 0 2.0287039603772428e-08
severe O 0 0.00016530595894437283
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
and O 0 5.660967872245237e-05
excellent O 0 2.8377577621085948e-08
neuropsychologic O 0 9.77897656184723e-08
outcome O 0 2.134329406544566e-06
in O 0 2.0994453397982227e-10
very B-Disease 0 1.713323580232462e-11
- I-Disease 0 9.788255622700248e-11
long I-Disease 0 4.1137981909855625e-11
- I-Disease 0 1.421688738956206e-10
chain I-Disease 0 5.4603228188954134e-11
acyl I-Disease 0 1.1931050813984712e-08
- I-Disease 0 5.3341051575728216e-09
coenzyme I-Disease 0 4.488340810127056e-09
A I-Disease 0 4.278804421886662e-09
dehydrogenase I-Disease 0 3.6371397982293274e-07
deficiency I-Disease 0 6.373474025167525e-05
. O 0 4.9657746359343946e-08

Very B-Disease 0 1.8458740314031274e-08
- I-Disease 0 3.062838427325687e-09
long I-Disease 0 1.7391439677272302e-10
- I-Disease 0 1.309094083135065e-10
chain I-Disease 0 1.3255709897797008e-11
acyl I-Disease 0 4.845938095243696e-10
- I-Disease 0 8.018405384113692e-11
coenzyme I-Disease 0 5.536143071749322e-11
A I-Disease 0 1.0715899521895889e-11
dehydrogenase I-Disease 0 5.6074304921605034e-11
( I-Disease 0 2.335108235246297e-12
VLCAD I-Disease 1 0.9978541731834412
) I-Disease 0 3.825337824281405e-10
deficiency I-Disease 0 3.4515455809014384e-06
is O 0 3.5985346646949523e-12
a O 0 1.168661608458299e-11
disorder O 0 0.33504948019981384
of O 0 0.0382210910320282
fatty O 1 0.995299220085144
acid O 0 3.1180547921394464e-06
beta O 0 2.1602568622824947e-08
oxidation O 0 1.4104408307957783e-08
that O 0 9.585061910843962e-12
reportedly O 0 5.825227522571197e-10
has O 0 4.022861958916796e-13
high O 0 1.9685020974380407e-11
rates O 0 9.696161408501158e-12
of O 0 1.6931284662052154e-13
morbidity O 0 5.3520716747357255e-09
and O 0 2.71667011803034e-11
mortality O 0 1.0715138998307339e-08
. O 0 2.527392295448294e-09

We O 0 7.995374501357233e-11
describe O 0 5.052456283211049e-12
the O 0 1.2255547054626503e-12
outcome O 0 1.9794490491165107e-09
of O 0 1.0057083638104203e-10
a O 0 3.5632355898339296e-13
5 O 0 3.311573671532786e-12
- O 0 2.471007610766601e-13
year O 0 7.137864518197423e-12
- O 0 6.684621189911866e-10
old O 0 4.867564129540369e-08
girl O 0 8.444549948194435e-09
with O 0 1.071385515027945e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.4990421126626075e-09
was O 0 3.337892115484742e-11
first O 0 7.684289944805134e-13
seen O 0 9.454763361116392e-12
at O 0 5.748640495920054e-13
5 O 0 6.288552035875472e-13
months O 0 3.9257900180450153e-14
of O 0 1.014227154409568e-13
age O 0 1.4603658560208288e-11
with O 0 2.358507168048491e-14
severe O 0 2.252063424634798e-09
hypertrophic B-Disease 0 0.005477307830005884
cardiomyopathy I-Disease 1 1.0
, O 0 0.00010129043221240863
hepatomegaly B-Disease 1 1.0
, O 0 6.78751121085952e-07
encephalopathy B-Disease 0 0.06102273240685463
, O 0 2.013227451413968e-08
and O 0 3.8048288075742676e-08
hypotonia B-Disease 1 0.9999997615814209
. O 1 0.5514770150184631

Biochemical O 0 1.4315151929622516e-05
studies O 0 7.207788144114602e-08
indicated O 0 0.19173623621463776
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 2.8465399282140424e-06
by O 0 5.2742480521894564e-11
a O 0 2.167889825988034e-11
stable O 0 5.2362672420258605e-08
yet O 0 1.8779944266356097e-09
inactive O 0 1.6329948948623496e-07
enzyme O 0 9.101545117573551e-08
. O 0 1.9942561380048573e-08

Molecular O 0 5.7747193693558074e-09
genetic O 0 2.1466510513601378e-10
analysis O 0 9.54572618866445e-12
of O 0 1.557895257242592e-09
her O 0 1.5349488791116528e-08
VLCAD O 1 1.0
gene O 0 2.310497926316657e-08
revealed O 0 3.3442044689024897e-09
a O 0 7.237834463713622e-12
T1372C O 0 2.7664487589618147e-08
( O 0 1.1284311159098781e-12
F458L O 0 7.001819124496933e-09
) O 0 3.099252104954431e-11
missense O 0 1.1798127985684914e-07
mutation O 0 4.636189210316388e-09
and O 0 7.737136452357074e-12
a O 0 1.0033574665557765e-10
1668 O 0 9.304578270530328e-05
ACAG O 1 0.9999524354934692
1669 O 0 0.0012002844596281648
splice O 0 9.031454283103812e-06
site O 0 1.5017937471384357e-07
mutation O 0 7.360063847272613e-08
. O 0 4.171036849243137e-09

After O 0 5.587837037523968e-08
initial O 0 2.252348849651753e-07
treatment O 0 2.682217200344894e-06
with O 0 5.956500570558632e-11
intravenous O 0 6.7502750056291916e-09
glucose O 0 1.4760219713139122e-08
and O 0 8.063860343354712e-12
carnitine O 0 8.559774417049582e-11
, O 0 5.446441908585342e-13
the O 0 3.953086122332472e-11
patient O 0 5.074971340945922e-07
has O 0 1.9788875399440187e-12
thrived O 0 1.5136424058592723e-10
on O 0 9.689320526473644e-12
a O 0 3.9303396691739434e-13
low O 0 1.6110313083572692e-09
- O 0 1.608626287730175e-10
fat O 0 5.7462436586774857e-08
diet O 0 9.476695872479013e-09
supplemented O 0 1.0052250698500131e-10
with O 0 1.3050683851743156e-13
medium O 0 9.076041251887546e-09
- O 0 6.212192427135221e-10
chain O 0 4.20751877783232e-10
triglyceride O 0 3.6318749607744394e-07
oil O 0 2.8793358808343328e-08
and O 0 2.494915081821536e-12
carnitine O 0 2.358530037938067e-10
and O 0 2.7410468643115915e-13
avoidance O 0 1.0977083686469769e-09
of O 0 5.838639988153815e-11
fasting O 0 1.2484930778100534e-07
. O 0 1.5272391351572878e-08

Her O 0 1.643346513446886e-05
ventricular O 0 0.023433247581124306
hypertrophy O 1 0.9999948740005493
resolved O 0 0.0022123397793620825
significantly O 0 5.09858068653557e-07
over O 0 4.836378519890161e-11
1 O 0 1.5357584648434397e-10
year O 0 7.105914814897751e-12
, O 0 1.2041447483221446e-12
and O 0 1.328172641312797e-11
cognitively O 0 1.7332421009541576e-07
, O 0 6.385599948116605e-12
she O 0 8.966623016998243e-13
is O 0 1.1768106563010694e-14
in O 0 1.0730859831362821e-13
the O 0 4.138381911461542e-12
superior O 0 7.337591867440096e-09
range O 0 1.5813302889355896e-09
for O 0 4.5226589834301834e-11
age O 0 1.4656259850198694e-07
. O 0 3.9640777771410285e-08

Clinical O 0 9.374946785101201e-06
recognition O 0 8.706702647032216e-05
of O 1 1.0
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 3.415352622937462e-08
important O 0 4.900383918093887e-11
because O 0 4.252631233270243e-12
it O 0 3.036718147992126e-14
is O 0 8.555480847697531e-15
one O 0 3.220106710303313e-15
of O 0 1.0515239801936124e-13
the O 0 4.373153748848946e-12
few O 0 6.548377118331672e-11
directly O 0 8.46621661665381e-11
treatable O 0 8.149696441250853e-06
causes O 0 3.945502813351709e-10
of O 0 3.378990837132889e-11
cardiomyopathy B-Disease 1 1.0
in O 0 3.922265818800952e-07
children O 0 2.395351694772785e-10
. O 0 1.0842400761934545e-11
. O 0 1.6710453853985285e-10

Cloning O 0 1.653290837566601e-07
of O 0 2.8441382582400365e-10
a O 0 2.5763226187830446e-12
novel O 0 2.540333776668291e-10
member O 0 5.12802864408024e-12
of O 0 6.173585080648802e-12
the O 0 1.4613189130985305e-11
low O 0 1.479603772835958e-09
- O 0 4.106593884389831e-11
density O 0 1.0869453115347483e-09
lipoprotein O 0 4.7216309440045734e-07
receptor O 0 2.0132702616137976e-07
family O 0 3.5138527643141515e-09
. O 0 6.3967156016531135e-09

A O 0 2.946954147375891e-08
gene O 0 2.0318231819249633e-10
encoding O 0 3.979089946426484e-09
a O 0 1.2216350153693156e-10
novel O 0 1.0566131081191088e-08
transmembrane O 0 1.1602097060858796e-09
protein O 0 3.351380284399852e-10
was O 0 1.0146092299656573e-11
identified O 0 1.7916390755972483e-13
by O 0 5.299993147670932e-15
DNA O 0 8.925534465166474e-13
sequence O 0 4.848378304194399e-14
analysis O 0 1.965617711728162e-14
within O 0 3.2631300547932007e-13
the O 0 7.0262506750295994e-12
insulin B-Disease 1 0.8742817044258118
- I-Disease 1 1.0
dependent I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.261318272050005e-10
IDDM B-Disease 0 1.2966752365173306e-05
) O 0 4.88326046266252e-12
locus O 0 9.036407039308969e-11
IDDM4 O 0 4.222488598770724e-07
on O 0 9.061091876816363e-10
chromosome O 0 1.629300472316686e-09
11q13 O 0 1.2495412704538467e-07
. O 0 1.2754331812914188e-08

Based O 0 9.914722376436202e-09
on O 0 2.4739834625364665e-09
its O 0 3.6922444268672194e-11
chromosomal O 0 3.1564728608657333e-09
position O 0 8.584062349825672e-09
, O 0 4.83394184055963e-12
this O 0 3.312344539277423e-12
gene O 0 9.535258867210405e-13
is O 0 3.9957657815099454e-14
a O 0 3.6221503904977984e-14
candidate O 0 2.4546253918344973e-11
for O 0 1.3017817618136973e-13
conferring O 0 3.0500477699035855e-09
susceptibility O 0 1.4343450516207668e-07
to O 0 1.3391425746078767e-09
diabetes B-Disease 1 0.7964722514152527
. O 0 1.3009592976231943e-06

The O 0 2.584193339316698e-07
gene O 0 7.935009094239831e-09
, O 0 8.42478517504297e-11
termed O 0 9.386354804519215e-09
low O 0 1.0701865704731972e-07
- O 0 1.0111214088226461e-09
density O 0 1.6546773951020555e-09
lipoprotein O 0 3.308808871338442e-08
receptor O 0 6.933189578006704e-10
related O 0 9.491850638809751e-10
protein O 0 1.7025676701809545e-10
5 O 0 1.7111560779436985e-10
( O 0 3.783952318148209e-14
LRP5 O 0 1.060504814631713e-06
) O 0 3.6100891156673476e-13
, O 0 4.1166828518117426e-13
encodes O 0 1.6261552651317124e-13
a O 0 5.476484608683829e-13
protein O 0 4.051984581199264e-10
of O 0 1.3185396108283953e-09
1615 O 0 9.15714099392062e-06
amino O 0 1.4473467047082522e-07
acids O 0 2.1797637472786846e-08
that O 0 2.2707504279684265e-11
contains O 0 4.7226323546256666e-11
conserved O 0 1.4213823174014095e-10
modules O 0 5.079523954232279e-11
which O 0 2.7789795746697987e-14
are O 0 9.07518299468309e-15
characteristic O 0 2.1680415709240952e-12
of O 0 1.4853415806342918e-12
the O 0 8.556259867287253e-12
low O 0 3.1914577647285114e-09
- O 0 6.934944979386515e-11
density O 0 5.16858889021421e-10
lipoprotein O 0 1.529490276652723e-07
( O 0 1.0397092214953219e-10
LDL O 0 7.893829092608939e-07
) O 0 1.013598233123858e-10
receptor O 0 5.2727244792549754e-09
family O 0 8.43582037557411e-10
. O 0 3.5283322930013128e-09

These O 0 5.4303646024322916e-09
modules O 0 2.078841321306868e-09
include O 0 9.283216556577045e-12
a O 0 3.376102782753909e-12
putative O 0 1.5533555552948997e-09
signal O 0 7.342488284045601e-10
peptide O 0 3.9785091887623025e-11
for O 0 4.283417153957969e-13
protein O 0 4.501127248701664e-11
export O 0 5.900139488090872e-09
, O 0 9.026859121297193e-12
four O 0 1.3841499561101367e-12
epidermal O 0 6.338898850266617e-10
growth O 0 1.8200295437420522e-10
factor O 0 1.5768959749085099e-10
( O 0 5.229467033018853e-13
EGF O 0 1.7191521539672294e-09
) O 0 7.125210794642345e-13
repeats O 0 1.9829160882722796e-11
with O 0 1.7655991143943062e-13
associated O 0 6.118798245857704e-10
spacer O 0 8.137887164139102e-08
domains O 0 1.1229711383009544e-08
, O 0 6.745660974250001e-11
three O 0 9.145571452928714e-12
LDL O 0 9.606200279677068e-08
- O 0 1.8664240997168235e-07
receptor O 0 4.11202982775194e-09
( O 0 5.765246353234277e-12
LDLR O 0 9.769666939973831e-05
) O 0 2.848282807527136e-12
repeats O 0 1.9931046396637342e-11
, O 0 6.179964580441816e-14
a O 0 2.7733894282684635e-13
single O 0 3.249940247473937e-11
transmembrane O 0 1.0163161978660185e-10
spanning O 0 1.4123130442911247e-10
domain O 0 2.441487012561083e-10
, O 0 4.364370843890075e-12
and O 0 2.8787920398204436e-12
a O 0 6.131830286582041e-12
cytoplasmic O 0 2.5617536980604427e-09
domain O 0 1.8688575131875496e-09
. O 0 1.5202458181207135e-09

The O 0 2.4364405248888943e-07
encoded O 0 1.568689889097641e-08
protein O 0 3.1804889832898198e-09
has O 0 3.7915257413735637e-13
a O 0 1.0956791978702571e-13
unique O 0 1.0936294187954831e-12
organization O 0 2.0920692261894303e-11
of O 0 1.3590996383872067e-10
EGF O 0 9.688004638519487e-07
and O 0 4.379287155131806e-09
LDLR O 0 0.01508793979883194
repeats O 0 2.214283201240619e-09
; O 0 5.676621932931836e-12
therefore O 0 1.3960241296295806e-10
, O 0 3.069055643303842e-12
LRP5 O 0 2.430306631140411e-05
likely O 0 1.1909678576671467e-08
represents O 0 3.827129585465272e-12
a O 0 2.7151431060065678e-14
new O 0 5.160090020203678e-13
category O 0 2.9821520686895697e-12
of O 0 2.705509861283817e-12
the O 0 8.244928351164305e-11
LDLR O 1 0.9979919195175171
family O 0 1.8404952228934235e-08
. O 0 1.617559597377749e-08

Both O 0 1.2286952255635697e-07
human O 0 2.0266233136112533e-08
and O 0 5.430781868653867e-08
mouse O 0 7.58662645239383e-06
LRP5 O 1 0.9999198913574219
cDNAs O 0 0.00034606613917276263
have O 0 4.989050506054582e-09
been O 0 5.4244092551059e-10
isolated O 0 6.08810335478438e-09
and O 0 6.302127569801641e-11
the O 0 4.523972307879376e-10
encoded O 0 3.201621412429745e-09
mature O 0 1.8299799009469098e-08
proteins O 0 2.334004083753838e-12
are O 0 5.3866118379999883e-14
95 O 0 2.0970470152037457e-11
% O 0 1.5885488996274233e-13
identical O 0 4.655586354797292e-13
, O 0 7.58280157414637e-15
indicating O 0 4.3387716379753027e-13
a O 0 3.199000851543399e-14
high O 0 9.915994240994319e-12
degree O 0 8.315650945611708e-11
of O 0 1.1630578444776773e-11
evolutionary O 0 5.988296525316628e-10
conservation O 0 4.197314995568746e-10
. O 0 1.3648060979976062e-11
. O 0 8.226521686083288e-10

The O 0 5.448824254017381e-07
APC B-Disease 0 9.559242926115985e-07
variants O 0 3.222686473236536e-08
I1307K O 0 8.094007171166595e-07
and O 0 3.3007557798114817e-10
E1317Q O 0 1.0504445668857443e-07
are O 0 2.083869188318488e-11
associated O 0 5.911854561446717e-09
with O 0 4.1664242189654033e-07
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.529062154670413e-10
but O 0 9.760319722579291e-13
not O 0 4.713179174199722e-13
always O 0 5.162541401315668e-13
with O 0 1.1435660530773484e-15
a O 0 8.197403937289585e-14
family O 0 1.6473908825628825e-12
history O 0 5.171840733453337e-11
. O 0 7.053744255358652e-10

Classical O 0 0.0022022277116775513
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.1360471552943636e-08
FAP B-Disease 0 2.3548948320240015e-06
) O 0 3.893185687026124e-12
is O 0 1.4997454233361962e-13
a O 0 2.866004742557715e-12
high O 0 0.0017489399760961533
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999793767929077
that O 0 8.940094498033346e-11
predisposes O 0 3.379576085649205e-08
to O 0 2.1291770430087453e-11
hundreds O 0 5.13296315174383e-11
or O 0 8.488007172124945e-12
thousands O 0 8.961400371765293e-11
of O 0 1.2206166388750717e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.1200764998793602
carcinoma I-Disease 1 1.0
and O 0 1.171616536427278e-11
that O 0 4.181908047932656e-14
results O 0 8.355871550236316e-12
from O 0 4.969083131078911e-11
truncating O 0 9.847195947543241e-09
mutations O 0 6.905919586186471e-11
in O 0 1.1301504870830925e-11
the O 0 1.0519514148654707e-09
APC B-Disease 0 3.377352797429012e-08
gene O 0 1.4582407503738182e-09
. O 0 1.3080122762687552e-08

A O 0 5.4097712975931245e-09
variant O 0 5.545779302451592e-08
of O 0 1.214140255001439e-08
FAP B-Disease 0 0.00013454415602609515
is O 0 2.5203412690188998e-08
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 5.459349861069995e-09
which O 0 1.5653639842683198e-11
results O 0 1.0120951993153326e-10
from O 0 6.366109028821398e-11
germ O 0 1.175535317088361e-06
- O 0 4.27032702532415e-08
line O 0 3.797788963311177e-07
mutations O 0 2.2907745145239744e-11
in O 0 6.395433228140179e-13
the O 0 1.098349601373616e-12
5 O 0 8.378342290782381e-12
and O 0 1.288479549834201e-13
3 O 0 6.508825162870879e-12
regions O 0 6.00474878154067e-12
of O 0 3.1693255658771236e-11
the O 0 2.682222888239494e-09
APC B-Disease 0 7.235571075625558e-08
gene O 0 2.5236059908451125e-09
. O 0 2.8202750357309014e-08

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 1.0378403203503694e-07
" O 0 1.5925849083942012e-08
multiple O 0 7.733119034014635e-09
" O 0 2.483974640199449e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 4.088858158307618e-12
typically O 0 4.419372420100265e-12
fewer O 0 7.552555044039455e-13
than O 0 4.146389245948852e-14
100 O 0 7.342617182673483e-13
) O 0 9.772562160816501e-16
without O 0 4.1927480367784375e-13
the O 0 4.386771328135364e-12
florid O 0 1.639151037124975e-08
phenotype O 0 4.334578473930151e-09
of O 0 2.5144076057359577e-11
classical O 0 1.503296931382181e-09
FAP B-Disease 0 1.139756591328478e-07
. O 0 1.266289295642764e-09

Another O 0 2.5748002840941808e-08
group O 0 8.752106678278082e-11
of O 0 2.0207156781193447e-10
patients O 0 6.265771190783198e-08
with O 0 5.135127739697154e-11
multiple O 0 8.082014346655342e-08
adenomas B-Disease 1 0.9999600648880005
has O 0 6.267510954671707e-10
no O 0 1.0941646894080392e-10
mutations O 0 3.0660030070350786e-11
in O 0 5.9438881767903684e-12
the O 0 2.4926252728540987e-10
APC B-Disease 0 1.29144694938077e-09
gene O 0 8.916079680121314e-12
, O 0 5.0982447430403255e-12
and O 0 1.0812393515247098e-11
their O 0 1.9171705889498014e-11
phenotype O 0 7.900270992955427e-10
probably O 0 3.983776850069454e-12
results O 0 5.195326590809457e-13
from O 0 2.9054780499929156e-13
variation O 0 1.8153631375916746e-10
at O 0 3.1220750811022935e-12
a O 0 3.34904901120453e-13
locus O 0 2.6388676400285194e-12
, O 0 3.3971851482079984e-13
or O 0 4.4855868151783e-12
loci O 0 1.2400970528236854e-10
, O 0 1.6463292317955847e-12
elsewhere O 0 4.793856631102322e-11
in O 0 1.24373883587936e-12
the O 0 1.0713452347488328e-10
genome O 0 6.859320333951757e-10
. O 0 2.6569928479602822e-09

Recently O 0 2.0464106853523845e-07
, O 0 6.183286521688203e-11
however O 0 1.3157777645211866e-10
, O 0 1.0393789778503915e-12
a O 0 6.5852569708022e-13
missense O 0 2.4305417678505137e-09
variant O 0 7.055833251001786e-09
of O 0 3.1766946904099314e-06
APC B-Disease 0 9.238120242116565e-07
( O 0 1.3265422614539002e-11
I1307K O 0 2.3862339659785903e-08
) O 0 3.1380377896877976e-13
was O 0 2.963770201480642e-11
described O 0 9.759467539671718e-12
that O 0 1.0434962084953509e-13
confers O 0 4.5492019873361045e-11
an O 0 8.960766631200927e-15
increased O 0 1.4676099224786299e-10
risk O 0 2.497267459489194e-08
of O 0 2.380702608206775e-05
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.162234086748981e-09
including O 0 6.892203821551313e-12
multiple O 0 1.0686288659522702e-10
adenomas B-Disease 0 2.7964551918557845e-06
, O 0 5.228295227310831e-11
in O 0 6.012020881129843e-10
Ashkenazim O 0 3.0034276278456673e-05
. O 0 3.641773105300672e-08

We O 0 1.0260558624963778e-08
have O 0 1.2746433249166689e-11
studied O 0 2.7296031754331374e-11
a O 0 9.74777509686782e-14
set O 0 2.0475459435592702e-12
of O 0 1.6585423355877649e-12
164 O 0 6.374131222841584e-10
patients O 0 3.2243802072784433e-10
with O 0 1.486443997403275e-12
multiple O 0 1.166551371056812e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 8.24096105134231e-07
/ I-Disease 0 8.32736350275809e-06
or I-Disease 0 1.44853288475133e-07
carcinoma I-Disease 1 1.0
and O 0 2.610958671489527e-10
analyzed O 0 6.442653077698424e-10
codons O 0 7.854624728409476e-10
1263 O 0 5.655947887817092e-08
- O 0 8.541936602490807e-10
1377 O 0 2.519152531021973e-07
( O 0 1.4927179284307535e-11
exon O 0 4.871601788636326e-09
15G O 0 1.4690845873133185e-08
) O 0 1.340729556455894e-13
of O 0 1.811882067992432e-11
the O 0 1.0769510838670726e-09
APC B-Disease 0 1.1874973893100105e-08
gene O 0 5.387164672687739e-11
for O 0 2.0974709816212744e-11
germ O 0 1.0372687029303052e-05
- O 0 4.56680055549441e-07
line O 0 6.839297839178471e-07
variants O 0 2.053040581984078e-08
. O 0 6.9874910302303306e-09

Three O 0 2.603159288128154e-08
patients O 0 1.1108368447310113e-08
with O 0 1.1486919271677665e-12
the O 0 1.1578966951919512e-10
I1307K O 0 9.284013913202216e-08
allele O 0 6.091921411766066e-10
were O 0 9.820866342380441e-12
detected O 0 2.6271373965158773e-11
, O 0 2.449962840022843e-14
each O 0 1.0176486762373659e-14
of O 0 2.405595904766966e-12
Ashkenazi O 0 2.064707693705259e-08
descent O 0 3.486815103315166e-08
. O 0 1.1564191382262834e-08

Four O 0 4.258914643173739e-08
patients O 0 9.305177854912472e-07
had O 0 4.1786474280769426e-10
a O 0 9.824425127591407e-12
germ O 0 7.04874628354446e-06
- O 0 7.145873155423033e-07
line O 0 9.809697985474486e-06
E1317Q O 0 2.2878516574564856e-06
missense O 0 6.158272469747317e-08
variant O 0 6.041889211161333e-09
of O 0 6.7163061778785504e-09
APC O 0 1.1786287501536208e-09
that O 0 2.9061101398594746e-13
was O 0 4.024853714201804e-11
not O 0 2.043040216170855e-12
present O 0 1.7068881030812832e-11
in O 0 3.0400419594872607e-12
controls O 0 1.7183176756474516e-11
; O 0 1.7901915843818172e-12
one O 0 1.3269261991272208e-12
of O 0 6.235548535848956e-12
these O 0 7.510468809368565e-12
individuals O 0 6.013192873320639e-13
had O 0 3.6519579027505245e-11
an O 0 7.712448437053113e-14
unusually O 0 6.948108755011617e-10
large O 0 1.0264380491398217e-11
number O 0 1.3745000146739295e-12
of O 0 3.203853848887661e-11
metaplastic B-Disease 0 5.136025265528588e-06
polyps I-Disease 0 3.7070304870212567e-07
of I-Disease 0 2.2571982061236895e-09
the I-Disease 0 2.8773250448921317e-09
colorectum I-Disease 0 4.538610937743215e-06
. O 0 7.522726974684701e-08

There O 0 1.4137994774898743e-08
is O 0 6.735731764018205e-12
increasing O 0 1.477543608296994e-11
evidence O 0 1.7448313627266288e-11
that O 0 2.4588870436298427e-13
there O 0 3.643120527474508e-12
exist O 0 1.4918214233383686e-11
germ O 0 2.304982693601687e-08
- O 0 5.395949798092659e-10
line O 0 4.482300752783885e-09
variants O 0 3.033453488399118e-10
of O 0 2.373014562628839e-10
the O 0 1.236436231177862e-10
APC B-Disease 0 7.59729779087337e-10
gene O 0 3.942111665312248e-13
that O 0 1.7480864371592804e-14
predispose O 0 2.1591961552047678e-10
to O 0 3.424627985706974e-12
the O 0 1.4695699518396665e-11
development O 0 7.076382813053783e-10
of O 0 3.771525314277824e-09
multiple O 0 0.0009561936603859067
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.005647753830999136
carcinoma I-Disease 1 1.0
, O 0 9.757457862524799e-12
but O 0 1.1659291154070273e-12
without O 0 1.1233614732875097e-11
the O 0 8.259850442504657e-11
florid O 0 3.0749095714099894e-08
phenotype O 0 3.5148783883443002e-09
of O 0 6.122414381026786e-11
classical O 0 1.2146514904998185e-09
FAP B-Disease 0 1.1225727902797189e-08
, O 0 3.3450796386308435e-12
and O 0 2.85914575435392e-13
possibly O 0 4.014287166564934e-12
with O 0 3.551996750113945e-14
importance O 0 1.067618882188981e-09
for O 0 3.683464200321396e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 2.7449645334520767e-10
in O 0 1.5828923119617054e-14
the O 0 4.246847692306391e-14
general O 0 5.2375152825856475e-12
population O 0 4.744112275332363e-14
. O 0 1.480391980876461e-12
. O 0 2.2450202807888786e-10

Genomic O 0 8.800157047517132e-09
structure O 0 4.1159040065075203e-10
of O 0 3.458105329867678e-11
the O 0 1.98089850078631e-10
human O 0 1.5326791924508143e-07
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 2.7574722949452735e-08
CLD B-Disease 1 0.9999288320541382
) O 0 4.454752400295803e-10
gene O 0 1.6933094926230297e-09
. O 0 1.6047298601051807e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.797718255147629e-06
CLD B-Disease 1 1.0
) O 0 8.154624892009465e-11
is O 0 1.202769979967433e-12
caused O 0 3.16918644105435e-11
by O 0 2.5164308570940763e-12
mutations O 0 7.046169897551025e-11
in O 0 1.1319497422723757e-11
a O 0 4.6743720005792966e-12
gene O 0 3.2132339324031367e-12
which O 0 5.972694127470701e-13
encodes O 0 9.067872863179061e-13
an O 0 8.01032214192178e-14
intestinal O 0 3.6036732353750267e-07
anion O 0 4.368577606328472e-07
transporter O 0 5.146632702235365e-07
. O 0 3.824553829190336e-08

We O 0 1.834466134553736e-09
report O 0 2.7401192426168564e-11
here O 0 3.3022072489646837e-12
the O 0 2.5364373145222996e-13
complete O 0 3.0965854880271593e-12
genomic O 0 9.78355313430157e-11
organization O 0 1.005713654717022e-11
of O 0 1.195531521003268e-11
the O 0 1.3886043703781326e-10
human O 0 2.342021021561891e-09
CLD B-Disease 0 0.012076275423169136
gene O 0 6.391260298777013e-10
which O 0 4.365503618319888e-12
spans O 0 7.174170979507011e-12
approximately O 0 1.6220413955134877e-13
39kb O 0 1.2423615025625168e-08
, O 0 1.337280459978718e-11
and O 0 6.039072020236347e-11
comprises O 0 1.3159735801071548e-10
21 O 0 4.642569439994304e-09
exons O 0 1.3936791276591975e-08
. O 0 6.228342730452141e-09

All O 0 2.806332588534133e-07
exon O 0 5.765377864008769e-07
/ O 0 6.513904793337133e-08
intron O 0 5.7343971349155254e-08
boundaries O 0 3.7286931875435414e-10
conform O 0 4.1544581108610146e-09
to O 0 4.0652817917541384e-11
the O 0 3.5536507070332846e-10
GT O 0 1.185972678285907e-06
/ O 0 1.9331874057115783e-07
AG O 0 2.305254611201235e-06
rule O 0 1.404455076681188e-07
. O 0 7.659286183070435e-08

An O 0 2.2468728266833438e-12
analysis O 0 4.682947606082788e-12
of O 0 2.2022685758349425e-11
the O 0 3.8223404996706734e-10
putative O 0 1.8486952058083261e-07
promoter O 0 4.3184396503193057e-08
region O 0 1.2029942597635568e-09
sequence O 0 9.212929724666807e-11
shows O 0 1.3712824278866442e-11
a O 0 4.187802882249514e-12
putative O 0 1.1780448403442279e-06
TATA O 0 8.457359217572957e-05
box O 0 8.885944424719128e-08
and O 0 1.164252583230052e-10
predicts O 0 1.7575791932955553e-09
multiple O 0 8.757312583429488e-12
transcription O 0 1.710481312144907e-09
factor O 0 1.6269714464556273e-09
binding O 0 4.7235921840638184e-09
sites O 0 1.6554926318690377e-08
. O 0 5.792668122950317e-09

The O 0 6.395021756588903e-08
genomic O 0 2.1185021736869203e-08
structure O 0 4.652781715464016e-09
was O 0 1.5924414009660381e-09
determined O 0 5.786734424972906e-10
using O 0 2.297215195845581e-11
DNA O 0 1.4610750387333837e-09
from O 0 3.9739132123850496e-11
several O 0 2.9551096812630018e-12
sources O 0 2.1017169948844838e-10
including O 0 1.058406292296643e-12
multiple O 0 2.3612192930067e-12
large O 0 1.8710251403764033e-10
- O 0 2.1506603165022398e-09
insert O 0 9.227130171041154e-09
libaries O 0 2.129856056853896e-06
and O 0 1.4525439184787103e-10
genomic O 0 1.8037592253161705e-10
DNA O 0 4.965636790643657e-10
from O 0 1.675726744865269e-11
Finnish O 0 1.826338007049344e-06
CLD B-Disease 1 0.9999979734420776
patients O 0 0.002608957001939416
and O 0 1.5647803053298048e-09
controls O 0 3.2213101519573684e-08
. O 0 5.9177693856327096e-08

Exon O 0 1.8685610712054768e-06
- O 0 2.8569722587690194e-08
specific O 0 3.44511308369988e-09
primers O 0 1.3588936198516421e-08
developed O 0 2.0762300767529496e-09
in O 0 1.7917809597145506e-11
this O 0 3.901392230110101e-12
study O 0 2.223259987568782e-12
will O 0 4.233261283832432e-14
facilitate O 0 8.664668808833209e-12
mutation O 0 2.0750155066417975e-12
screening O 0 2.339906914061718e-11
studies O 0 3.6632976925347893e-13
of O 0 9.802740081254688e-14
patients O 0 2.7325201129579924e-11
with O 0 4.850098797516862e-14
the O 0 1.1884977724196943e-10
disease O 0 3.7939802410846823e-08
. O 0 1.4745587861852982e-08

Genomic O 0 2.8798249118722197e-08
sequencing O 0 1.739616806162303e-08
of O 0 3.0143874063526255e-09
a O 0 3.455260744189559e-09
BAC O 0 7.430972618749365e-05
clone O 0 3.7357451674324693e-06
H O 1 1.0
_ O 0 3.988329666526624e-09
RG364P16 O 0 1.970725449496058e-08
revealed O 0 1.272030675236735e-10
the O 0 1.074934303894881e-12
presence O 0 7.915432632260577e-13
of O 0 2.479196015148233e-11
another O 0 9.522668244221766e-12
, O 0 2.779374603731344e-12
highly O 0 1.1950988809683594e-10
homologous O 0 1.4959729635610763e-11
gene O 0 9.338875159303761e-12
3 O 0 2.793967557312982e-10
of O 0 1.0215498585930405e-10
the O 0 5.9505214089483616e-09
CLD B-Disease 0 0.10290820151567459
gene O 0 3.1515519083313848e-09
, O 0 9.679050963495861e-12
with O 0 2.975337058436396e-14
a O 0 1.4109807072726355e-13
similar O 0 4.367302526564476e-12
genomic O 0 1.3505822848980387e-10
structure O 0 3.1715824411193694e-10
, O 0 3.698725353773469e-13
recently O 0 8.654654683887264e-13
identified O 0 1.3007146358254285e-13
as O 0 3.4523402745508663e-14
the O 0 3.1050922250086543e-11
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 6.77951339511651e-09
( O 0 4.57127521599765e-12
PDS B-Disease 0 5.026303711019864e-07
) O 0 3.104226077577099e-12
. O 0 1.5010728771081006e-10
. O 0 3.0247482296630324e-09

The O 0 3.987362049429066e-07
APCI1307K O 1 0.9999599456787109
allele O 0 3.999257842224324e-06
and O 0 2.284155087295403e-08
cancer B-Disease 0 5.6202705309260637e-05
risk O 0 2.117943598278771e-09
in O 0 1.2644248495452537e-11
a O 0 1.6874777400074925e-12
community O 0 3.2804551176185415e-12
- O 0 4.516536450394071e-12
based O 0 3.4652855129650717e-13
study O 0 7.940347733709566e-14
of O 0 4.4103748566637693e-14
Ashkenazi O 0 4.880174042654062e-10
Jews O 0 8.813725305145681e-10
. O 0 6.498288018796927e-10

Mutations O 0 9.909213076753076e-07
in O 0 1.060418419740472e-09
APC O 0 1.2727163323233981e-08
are O 0 6.983293067072682e-13
classically O 0 4.0152561830986144e-10
associated O 0 5.150697646172375e-10
with O 0 2.0265218392268025e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.090356915867119e-09
FAP B-Disease 0 7.71715065184253e-08
) O 0 3.6616768102869235e-13
, O 0 5.767384996229613e-14
a O 0 1.440029519239605e-12
highly O 1 0.8266729712486267
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999815225601196
by O 0 1.7676362062957196e-07
multiple O 0 1.0122739695361815e-06
intestinal O 1 0.9999996423721313
polyps B-Disease 0 9.265268090530299e-07
and O 0 1.6595778570827058e-11
, O 0 1.046639717169201e-13
without O 0 2.158592748990884e-12
surgical O 0 5.626723975638015e-08
intervention O 0 3.8515329814359234e-10
, O 0 2.8646697644227337e-13
the O 0 2.86153132439404e-12
development O 0 9.563668745826703e-10
of O 0 3.096193540841341e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.8975554461064803e-10
CRC B-Disease 0 4.792721483681817e-06
) O 0 1.775773278422932e-11
. O 0 5.405841552175161e-09

APC B-Disease 0 7.13127610652009e-06
is O 0 2.636158513702469e-10
a O 0 9.116490895522134e-11
tumour O 1 1.0
- O 0 7.4770109677047e-06
suppressor O 0 2.038797219938715e-06
gene O 0 2.2026896973059706e-10
, O 0 1.07245223986141e-12
and O 0 3.393443729141077e-12
somatic O 0 4.600710326485569e-06
loss O 0 4.020440513841095e-08
occurs O 0 1.0485689472261583e-07
in O 0 2.802472565122116e-08
tumours B-Disease 1 1.0
. O 0 2.508994157324196e-06

The O 0 1.290856062041712e-06
germline O 0 7.416820153594017e-07
T O 0 9.421621882665931e-08
- O 0 3.0486679847285814e-10
to O 0 5.981144832883922e-12
- O 0 7.097737675376692e-11
A O 0 4.9595196005558506e-11
transversion O 0 1.4020208327636396e-09
responsible O 0 4.361813915696594e-13
for O 0 2.4044205211917746e-13
the O 0 3.2964381224687145e-11
APC O 0 2.9349989105753593e-09
I1307K O 0 2.6650237572312108e-08
allele O 0 1.2402910642972387e-10
converts O 0 4.208495704705051e-11
the O 0 1.076920779115309e-12
wild O 0 2.9649954366717246e-12
- O 0 1.0655518622396803e-13
type O 0 1.001788387487712e-12
sequence O 0 2.3186021245319433e-13
to O 0 1.266651443020822e-13
a O 0 5.884362441754831e-12
homopolymer O 1 0.5463760495185852
tract O 1 0.9333994388580322
( O 0 1.7565986859535698e-11
A8 O 0 3.12472074881498e-08
) O 0 3.4727205648881626e-14
that O 0 1.2044927941601714e-14
is O 0 6.788582825219269e-13
genetically O 0 6.930287099748966e-08
unstable O 0 3.906614438164979e-05
and O 0 6.08665162715738e-09
prone O 0 2.806891927775723e-07
to O 0 4.0854652993971285e-09
somatic O 0 0.002750199753791094
mutation O 0 1.4004014019519673e-06
. O 0 1.8748563590520462e-08

The O 0 1.9805414197548998e-08
I1307K O 0 5.21933088748483e-07
allele O 0 4.067628456283501e-09
was O 0 1.846879454925343e-10
found O 0 1.7216245790097062e-11
in O 0 1.0332618441410979e-11
6 O 0 1.4857922892019815e-08
. O 0 6.765278559583976e-09

1 O 0 3.2158408203031286e-07
% O 0 1.958833539816851e-09
of O 0 3.1904337505217484e-10
unselected O 0 0.0007095608743838966
Ashkenazi O 0 6.225073434507067e-07
Jews O 0 9.493122732351367e-09
and O 0 1.911306703183957e-11
higher O 0 2.635298923525653e-10
proportions O 0 2.939081200636906e-10
of O 0 2.05316375012643e-10
Ashkenazim O 0 1.6066938712810952e-07
with O 0 1.0332101927496007e-12
family O 0 5.34884940159297e-12
or O 0 2.1031345068256435e-12
personal O 0 3.7027259036648275e-10
histories O 0 1.1741014382948833e-08
of O 0 1.245334235733253e-08
CRC B-Disease 1 0.9887505173683167
( O 0 1.9689753300022872e-11
ref O 0 8.617794833298831e-08
. O 0 2.151771261171831e-10
2 O 0 3.4582256502879716e-10
) O 0 8.604059847407142e-13
. O 0 3.612346810566436e-10

To O 0 1.266733828941824e-09
evaluate O 0 4.551576004985236e-09
the O 0 5.028136587648113e-11
role O 0 7.490201514581685e-11
of O 0 4.2581388415285915e-10
I1307K O 0 1.9353383606812713e-07
in O 0 1.4009589321961613e-10
cancer B-Disease 0 2.150837730141575e-08
, O 0 1.0757301082894855e-12
we O 0 6.348463421623762e-12
genotyped O 0 8.890640401659766e-08
5 O 0 3.1109166354070794e-09
, O 0 1.3116878243291108e-11
081 O 0 2.6578513256936276e-07
Ashkenazi O 0 1.4369184953011427e-08
volunteers O 0 7.628050968655486e-10
in O 0 1.330484442237101e-12
a O 0 3.9462517455179924e-12
community O 0 1.0607981854038329e-10
survey O 0 1.0765378172239437e-10
. O 0 5.783512557755444e-10

Risk O 0 5.9799636801471934e-05
of O 0 9.891500667436048e-07
developing O 1 0.8441785573959351
colorectal B-Disease 1 1.0
, I-Disease 1 0.5090286731719971
breast I-Disease 1 0.9999998807907104
and I-Disease 0 2.6411848352836387e-07
other I-Disease 0 1.4066317532979156e-07
cancers I-Disease 0 0.01015947200357914
were O 0 6.826224918654589e-09
compared O 0 5.91231730240338e-09
between O 0 8.408992391295556e-10
genotyped O 0 1.3605816775452695e-06
I1307K O 0 2.5718305707300715e-08
carriers O 0 5.5763081652226987e-11
and O 0 1.7883896403711463e-12
non O 0 2.705820636994538e-11
- O 0 3.195564472757706e-12
carriers O 0 8.823837927690592e-13
and O 0 5.599630459839078e-14
their O 0 2.1298723079806424e-14
first O 0 3.254668534463309e-14
- O 0 2.0664251559887603e-12
degree O 0 3.3136608040829074e-11
relatives O 0 5.909334133136213e-11
. O 0 2.258324083292962e-11

Sperm O 0 3.6033271921809273e-09
DNA O 0 8.593866590578259e-11
analysis O 0 2.495971962099275e-12
in O 0 2.357376229986108e-12
a O 0 2.891705208618589e-10
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 1.0
carrier O 0 6.4911614572338294e-06
suggests O 0 2.3382023073281744e-07
both O 0 8.930754746838687e-11
meiotic O 0 9.391300892502841e-08
and O 0 4.8299256955042225e-11
mitotic O 0 4.326500935292188e-09
expansion O 0 7.445331107192033e-08
in O 0 1.7595035151085625e-10
the O 0 2.946648924861961e-09
FRDA B-Disease 0 0.0022860460449010134
gene O 0 1.73753420540379e-08
. O 0 2.6318659251955978e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.6764397514634766e-07
usually O 0 7.4221313539624134e-09
caused O 0 1.597420390408999e-10
by O 0 3.718658952815701e-13
an O 0 1.4728508736521102e-14
expansion O 0 1.6946277714424696e-09
of O 0 5.392235546963775e-10
a O 0 2.8054805700783447e-10
GAA O 0 6.407915265072006e-08
trinucleotide O 0 2.0326436356299382e-07
repeat O 0 1.4698126049594862e-09
in O 0 2.130396692390235e-10
intron O 0 1.982433994740518e-09
1 O 0 2.873594140417879e-10
of O 0 3.277404736490297e-11
the O 0 1.901092172573726e-09
FRDA B-Disease 1 0.8681915402412415
gene O 0 1.2107366842428746e-07
. O 0 1.5417273857565306e-07

Occasionally O 0 8.891149860801306e-08
, O 0 1.5124244912012585e-10
a O 0 5.110153619702906e-11
fully O 0 8.782399696372067e-09
expanded O 0 3.847762997111204e-08
allele O 0 1.0312867004813597e-08
has O 0 6.71582190900355e-12
been O 0 1.1772138168789081e-12
found O 0 2.2420642274180447e-13
to O 0 3.600139392330448e-13
arise O 0 2.0736209971339292e-10
from O 0 1.5794649659353621e-12
a O 0 2.5817322997327696e-13
premutation O 0 2.636346030371328e-09
of O 0 4.611438314539029e-11
100 O 0 2.2112167999410737e-11
or O 0 9.878404517993378e-13
less O 0 5.599695152014306e-10
triplet O 0 2.493722206509119e-07
repeats O 0 7.709511251619006e-09
. O 0 4.017494781294317e-09

We O 0 2.077593741489636e-08
have O 0 3.8672107183224114e-11
examined O 0 3.246546642632353e-10
the O 0 3.0090749770367298e-12
sperm O 0 4.687084921572993e-12
DNA O 0 1.1832269539158169e-11
of O 0 1.8253259147227308e-12
a O 0 3.4450419947318345e-12
premutation O 0 3.7029954000900034e-06
carrier O 0 8.11682028256655e-08
. O 0 3.7814242404010656e-08

This O 0 2.77017662142498e-08
mans O 0 5.201643944019452e-06
leucocyte O 0 3.3281694413744844e-06
DNA O 0 1.2249242331563437e-07
showed O 0 1.7430402676765766e-09
one O 0 6.209944125763756e-13
normal O 0 7.677133234684774e-11
allele O 0 2.6736850580744154e-11
and O 0 3.140432792286818e-13
one O 0 4.601239501174012e-14
allele O 0 1.7768498261280796e-12
of O 0 6.235211999494616e-13
approximately O 0 3.058138865839194e-13
100 O 0 4.806709284072008e-12
repeats O 0 3.556137329052689e-11
. O 0 1.9181224664155394e-10

His O 0 1.8367573773048207e-07
sperm O 0 8.155799591236246e-09
showed O 0 8.530112033389159e-11
an O 0 2.1871867923566046e-14
expanded O 0 1.8518106492670938e-10
allele O 0 1.643428865216734e-10
in O 0 2.1532808522350955e-11
a O 0 1.657211867733821e-11
tight O 0 3.523142666495005e-08
range O 0 1.9401340534130895e-09
centering O 0 2.1089048563016632e-10
on O 0 2.9225038188085417e-12
a O 0 2.9426202414421093e-14
size O 0 2.0243902040806283e-12
of O 0 9.815735030338502e-12
approximately O 0 2.9676334306616425e-11
320 O 0 1.116067127604481e-09
trinucleotide O 0 6.074164389247017e-07
repeats O 0 1.0245265968933381e-08
. O 0 5.078783171796886e-09

His O 0 4.0908780647441745e-06
affected O 0 6.363113789120689e-05
son O 0 5.9501006035134196e-05
has O 0 7.518097255854173e-11
repeat O 0 9.052174287926817e-11
sizes O 0 4.534546627077418e-10
of O 0 6.804716512487374e-11
1040 O 0 2.515619046405959e-09
and O 0 3.9004119378738267e-11
540 O 0 1.289057305342567e-09
. O 0 6.118144879607712e-10

These O 0 1.1091390028639125e-08
data O 0 3.9905340143420176e-10
suggest O 0 6.194323526331758e-11
that O 0 2.2824146408582588e-14
expansion O 0 3.188892899741447e-11
occurs O 0 2.291647340640912e-12
in O 0 1.5607561900873868e-13
two O 0 4.344249450867173e-15
stages O 0 1.714234657002045e-12
, O 0 7.710445204132856e-15
the O 0 3.492428988691697e-14
first O 0 5.060186007732094e-14
during O 0 1.7856221059056598e-12
meiosis O 0 3.9175756388898364e-11
followed O 0 1.224008828321077e-11
by O 0 3.5321631687221244e-13
a O 0 7.756029434154155e-13
second O 0 2.030659668195156e-11
mitotic O 0 3.869007336732011e-09
expansion O 0 2.477498526332056e-07
. O 0 2.2460845627847448e-08

We O 0 1.1631887275598274e-07
also O 0 3.6874955866572634e-10
show O 0 1.2873728992557343e-11
that O 0 8.788862649808382e-14
in O 0 2.2974068394215896e-12
all O 0 6.6381375223023564e-12
informative O 0 8.710970833547549e-11
carrier O 0 1.1024639534618075e-11
father O 0 5.43327015323225e-11
to O 0 8.413861621314744e-12
affected O 0 2.8094621740137882e-08
child O 0 6.309361477718767e-09
transmissions O 0 7.751870256811344e-10
, O 0 1.1392739507863625e-13
with O 0 2.0257119041271286e-15
the O 0 4.445849883984859e-13
notable O 0 1.7793594288967318e-12
exception O 0 4.231344441496532e-12
of O 0 5.26355304827919e-12
the O 0 6.366956007558544e-12
premutation O 0 2.719441338783213e-09
carrier O 0 1.7814590080877934e-11
, O 0 1.2826022253824287e-13
the O 0 8.580035011467035e-13
expansion O 0 2.256706349568205e-10
size O 0 4.9524585821192346e-11
decreases O 0 8.126096240346214e-09
. O 0 3.857767993942218e-10
. O 0 3.544230242624735e-09

The O 0 1.4281613225364254e-08
R496H O 0 7.086910613907094e-07
mutation O 0 5.538789427106394e-09
of O 0 4.246346052561023e-10
arylsulfatase O 0 3.785353328566998e-05
A O 0 1.3602347337382525e-07
does O 0 1.71388986336396e-10
not O 0 1.5002912800987644e-10
cause O 0 2.1644943899445934e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 5.688143005500024e-07

Deficiency B-Disease 1 0.9979939460754395
of I-Disease 0 1.6050764770625392e-06
arylsulfatase I-Disease 1 0.9999997615814209
A I-Disease 1 0.9969275593757629
( O 0 1.0622509094559973e-08
ARSA O 0 0.01712314784526825
) O 0 1.0205288870912543e-11
enzyme O 0 7.364933551912145e-09
activity O 0 4.331266723056615e-08
causes O 0 1.770710298387712e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.5269645547988375e-09
MLD B-Disease 1 1.0
) O 0 4.0790473776475267e-10
. O 0 4.354076210688618e-09

A O 0 5.1841741566249766e-08
number O 0 1.6237844402411383e-09
of O 0 3.2831890539597453e-09
ARSA O 0 0.00033321045339107513
gene O 0 9.531731848255731e-09
mutations O 0 3.2903106905735058e-09
responsible O 0 1.219465362023442e-10
for O 0 2.0380411247522545e-10
MLD B-Disease 1 1.0
have O 0 7.4299357777363184e-09
been O 0 1.9564241893199608e-10
identified O 0 6.135580377097938e-10
. O 0 1.6799398538935861e-09

Recently O 0 4.1743259515669706e-08
, O 0 3.5931525116383867e-11
the O 0 7.887679398521641e-11
R496H O 0 1.5974151779118984e-07
mutation O 0 1.714947828190816e-08
of O 0 3.461329001197555e-09
ARSA O 0 7.711109356023371e-05
was O 0 1.5480374759846427e-09
proposed O 0 3.166118756059433e-10
to O 0 1.7485718819057472e-12
be O 0 5.767134816578312e-13
a O 0 7.555115794045594e-14
cause O 0 8.194836476071998e-11
of O 0 2.8174993449425756e-09
MLD B-Disease 1 1.0
( O 0 2.769671991753597e-10
Draghia O 0 6.25722009317542e-07
et O 0 6.113852202282999e-10
al O 0 6.390598467076458e-11
. O 0 7.959154169068228e-13
, O 0 1.7146164045869772e-13
1997 O 0 2.7939607225024865e-11
) O 0 6.736168480653282e-12
. O 0 5.678991499280528e-09

We O 0 5.319132156955675e-08
have O 0 1.3965142930949526e-10
investigated O 0 1.0961935803521783e-09
the O 0 4.359974048462334e-10
R496H O 0 1.2056622722411703e-07
mutation O 0 2.8373220439803504e-10
and O 0 1.2526380757313382e-12
found O 0 1.6819241854294786e-13
this O 0 5.581183437500595e-14
mutation O 0 4.820094844093514e-12
at O 0 2.7645338275539277e-12
a O 0 1.1934069455311197e-13
relatively O 0 8.307371283933218e-12
high O 0 1.1444186527251321e-12
frequency O 0 3.4497353433061984e-13
in O 0 2.0277772245624187e-14
an O 0 9.350975863517907e-16
African O 0 1.2092992826193659e-14
American O 0 1.0884218365188412e-14
population O 0 2.1047765005226867e-15
( O 0 1.0465408641890917e-15
f O 0 1.0700744110248017e-11
= O 0 9.709480398509274e-13
0 O 0 2.9514934333368936e-12
. O 0 1.4852245681148263e-13
09 O 0 1.2817645382579013e-11
, O 0 5.436955139576094e-13
n O 0 3.20695969779905e-11
= O 0 1.1841148894742304e-10
61 O 0 1.4696163175287325e-09
subjects O 0 4.349135496184431e-10
) O 0 6.3244370678006145e-12
. O 0 2.0671457878762567e-09

The O 0 7.498025752283866e-06
ARSA O 0 0.0005660825991071761
enzyme O 0 3.595207687112634e-08
activity O 0 4.137458731179322e-08
in O 0 4.791900556910811e-11
subjects O 0 4.076713966405521e-10
with O 0 8.45958570664003e-14
and O 0 1.5845372973791183e-12
without O 0 1.68974920861098e-11
the O 0 6.830202375907035e-11
R496H O 0 1.1904318419908577e-08
mutation O 0 5.455815313415435e-11
was O 0 1.0592994363622932e-11
determined O 0 3.670728998539374e-11
and O 0 1.4903389937079292e-12
found O 0 6.133149543785521e-13
to O 0 3.797815198176152e-13
be O 0 8.929012910996459e-12
normal O 0 5.829162432746671e-07
. O 0 2.4090033079460227e-08

It O 0 4.715631773954954e-10
is O 0 2.542255251800074e-12
therefore O 0 1.652682331265698e-11
concluded O 0 3.856522393097528e-11
that O 0 2.661481332631027e-13
the O 0 3.8346426728397276e-11
R496H O 0 1.3317416858171782e-07
mutation O 0 1.2095221713082083e-08
of O 0 2.032669366158757e-09
ARSA O 0 8.630379852547776e-06
does O 0 1.1614578743213144e-10
not O 0 2.9463313733213425e-11
negatively O 0 1.5509189488227548e-09
influence O 0 1.6612516917646758e-09
the O 0 3.3337693716717354e-11
activity O 0 3.0078859403204206e-09
of O 0 3.391137370911679e-10
ARSA O 0 3.6625009670387954e-05
and O 0 1.1629469089113886e-11
is O 0 1.7927944285373032e-13
not O 0 1.054689579486727e-13
a O 0 5.259014794825601e-13
cause O 0 2.61895505282439e-09
of O 0 4.722612700902573e-08
MLD B-Disease 1 1.0

Down O 0 3.6386421697898186e-07
- O 0 1.79064603145207e-08
regulation O 0 1.4873659637260062e-08
of O 0 1.0590277543798265e-09
transmembrane O 0 2.829952627791954e-08
carbonic O 0 2.0066770957782865e-05
anhydrases O 0 5.6610864703543484e-05
in O 0 2.0648317331506405e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.8158096671104431
lines O 0 1.0828048457867112e-09
by O 0 7.978339343350793e-12
wild O 0 4.357663669907197e-07
- O 0 4.3717950148902673e-08
type O 0 2.0147119812463643e-06
von B-Disease 1 1.0
Hippel I-Disease 1 0.9999990463256836
- I-Disease 1 0.9596328139305115
Lindau I-Disease 0 0.0046686469577252865
transgenes O 0 8.504663856001571e-05
. O 0 3.7665742524950474e-08

To O 0 9.601873962594709e-09
discover O 0 6.134772689847523e-10
genes O 0 4.647552828696e-11
involved O 0 4.3588973576424994e-12
in O 0 1.0567129116179075e-10
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 1.1429682089669768e-08
VHL B-Disease 1 0.9999814033508301
) O 0 8.414624552699479e-10
- O 0 6.166324055811856e-07
mediated O 0 3.2669501592863526e-07
carcinogenesis O 0 0.0032427466940134764
, O 0 4.495815872362918e-11
we O 0 1.905911713173669e-11
used O 0 1.013397699090035e-09
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999432563781738
lines O 0 3.247944277973147e-07
stably O 0 1.0987331506839837e-06
transfected O 0 4.110965079462403e-08
with O 0 7.473839255811576e-13
wild O 0 1.4941323733808076e-09
- O 0 1.404110938629799e-09
type O 0 3.9980502464231904e-08
VHL O 1 0.9503383636474609
- O 0 1.3361169294512365e-05
expressing O 0 8.893388780961686e-08
transgenes O 0 8.965702363639139e-06
. O 0 1.8200383422595223e-08

Large O 0 1.6797973501070373e-07
- O 0 2.2673393829109045e-08
scale O 0 8.669429973906517e-08
RNA O 0 6.0509308674738804e-09
differential O 0 1.6710715033951828e-09
display O 0 9.715140497634778e-11
technology O 0 4.92018592535004e-10
applied O 0 3.8990155548646044e-10
to O 0 7.344581540169592e-12
these O 0 1.086548385986763e-11
cell O 0 1.779911218413588e-10
lines O 0 5.473813676631911e-12
identified O 0 2.879032190601649e-13
several O 0 1.3863844967876293e-13
differentially O 0 6.883897896159397e-09
expressed O 0 1.7918673489436543e-10
genes O 0 6.904812832608798e-11
, O 0 6.048725973220592e-13
including O 0 2.4423591946619305e-13
an O 0 9.748821758540083e-13
alpha O 0 5.412403414339906e-09
carbonic O 0 8.985389285953715e-07
anhydrase O 0 4.083631665707799e-06
gene O 0 3.191920505685175e-09
, O 0 2.3779897495579405e-10
termed O 0 4.684694658863009e-07
CA12 O 1 0.999629020690918
. O 0 2.8394417768140556e-06

The O 0 2.2216408268604937e-08
deduced O 0 2.5801440983741486e-08
protein O 0 5.184465634577862e-10
sequence O 0 1.0974414085818118e-11
was O 0 1.212391124993939e-11
classified O 0 4.7032516770073585e-11
as O 0 1.8369914964178058e-12
a O 0 1.1617270730471252e-12
one O 0 5.192159202582758e-12
- O 0 2.198268056474717e-08
pass O 0 3.70519956049975e-06
transmembrane O 0 5.355015275654296e-08
CA O 0 1.8574712612462463e-07
possessing O 0 1.1254578380359703e-09
an O 0 1.8125967306964474e-12
apparently O 0 6.802176599762788e-10
intact O 0 6.679790609531722e-10
catalytic O 0 3.5182368129937913e-10
domain O 0 2.3651893776843735e-09
in O 0 8.825428582381889e-11
the O 0 7.356169562378057e-10
extracellular O 0 1.887811009737561e-07
CA O 0 3.913602631655522e-05
module O 0 3.609613088428887e-07
. O 0 1.4726531105679896e-08

Reintroduced O 0 1.5089996850292664e-05
wild O 0 2.360761527597788e-06
- O 0 1.4147767046779336e-07
type O 0 2.3550896344204375e-07
VHL B-Disease 1 0.8720118403434753
strongly O 0 1.2550613348594197e-07
inhibited O 0 5.5442143320760806e-08
the O 0 1.3664973319560403e-10
overexpression O 0 2.5827127103639214e-09
of O 0 6.026767626621243e-12
the O 0 2.6212611942133535e-11
CA12 O 0 1.1601587175391614e-05
gene O 0 3.2291790769134465e-11
in O 0 2.378894607343862e-12
the O 0 2.2139187705327856e-10
parental O 0 5.54901962459553e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999353885650635
lines O 0 3.041707543616212e-07
. O 0 4.455419500004609e-08

Similar O 0 3.679228477437846e-09
results O 0 4.581037771345109e-10
were O 0 1.745297309452276e-11
obtained O 0 1.57572253856042e-11
with O 0 6.296785467173327e-13
CA9 O 0 6.8160084083501715e-06
, O 0 1.0564086411202211e-10
encoding O 0 4.9616817321407325e-09
another O 0 5.550443660240489e-09
transmembrane O 0 3.9247445293710825e-09
CA O 0 7.103231780547503e-08
with O 0 2.9074407269756575e-13
an O 0 1.4866446019102392e-13
intact O 0 6.328340629302431e-10
catalytic O 0 2.16960049925774e-09
domain O 0 3.8678361846677944e-08
. O 0 1.606055732850109e-08

Although O 0 2.579332942787005e-07
both O 0 6.916732187001173e-10
domains O 0 1.6839531991053036e-09
of O 0 8.222694747317405e-10
the O 0 6.433937382865906e-09
VHL B-Disease 0 0.00020785829110536724
protein O 0 4.7790017276838626e-08
contribute O 0 1.2697187745658312e-09
to O 0 2.2125036178155533e-11
regulation O 0 5.995762997201837e-09
of O 0 4.841071987726764e-09
CA12 O 1 0.9996092915534973
expression O 0 8.955309382940868e-09
, O 0 2.1642323350112846e-12
the O 0 2.4236957926748737e-12
elongin O 0 4.6005665943482654e-09
binding O 0 1.2666371285163791e-09
domain O 0 8.108290927566486e-09
alone O 0 3.9290112829881707e-10
could O 0 3.036271234435617e-11
effectively O 0 1.2198057008916408e-09
regulate O 0 1.2695952023022983e-07
CA9 O 0 0.0015361871337518096
expression O 0 2.3683971903665224e-06
. O 0 1.7574316757418273e-07

We O 0 2.679796011761937e-07
mapped O 0 1.6735991721361643e-06
CA12 O 0 0.01091812364757061
and O 0 2.002531687139708e-07
CA9 O 0 0.0005459733074530959
loci O 0 1.5233472083764354e-07
to O 0 6.86133483362994e-10
chromosome O 0 2.2034891689060032e-09
bands O 0 6.507631766794475e-09
15q22 O 0 5.3910376607291255e-08
and O 0 5.675953457240368e-11
17q21 O 0 3.709290012920974e-07
. O 0 1.2312130870384408e-08

2 O 0 1.3329106707260507e-07
respectively O 0 1.117332804057014e-08
, O 0 1.0827712337846407e-10
regions O 0 7.959352288366972e-09
prone O 0 3.776796830834428e-08
to O 0 1.3633263962198328e-10
amplification O 0 3.898881914210506e-06
in O 0 1.5505730033282816e-09
some O 0 2.8779109650933776e-10
human O 0 1.1967014934555209e-08
cancers B-Disease 0 7.054409070406109e-05
. O 0 4.264515496288368e-08

Additional O 0 2.2378744191087208e-08
experiments O 0 6.691129872393731e-09
are O 0 5.781209387080433e-13
needed O 0 1.3846100481440526e-11
to O 0 5.927740394894021e-13
define O 0 2.6832331495585393e-11
the O 0 1.2195950846449755e-11
role O 0 6.472481578478906e-11
of O 0 2.2320257642149954e-08
CA O 0 0.00021887265029363334
IX O 1 1.0
and O 0 5.275745706967427e-07
CA O 0 7.105587883415865e-06
XII O 0 0.00012968140072189271
enzymes O 0 5.502102107257656e-10
in O 0 1.0250645818277171e-11
the O 0 3.580036657749308e-12
regulation O 0 9.852878929406117e-11
of O 0 6.001497042384951e-12
pH O 0 1.9097783354737885e-09
in O 0 8.758999602009876e-12
the O 0 1.1428443261185528e-11
extracellular O 0 7.19729997822327e-10
microenvironment O 0 4.7198483343890985e-07
and O 0 1.5144618198403847e-11
its O 0 4.727244203722725e-12
potential O 0 1.2425355189193965e-10
impact O 0 8.28554647114288e-09
on O 0 4.5940975468283796e-08
cancer B-Disease 0 2.703189636577008e-07
cell O 0 2.2470530325335858e-08
growth O 0 1.5077132875518373e-09
. O 0 1.726664367041053e-09

A O 0 2.038906288248654e-08
gene O 0 6.596493351551658e-10
encoding O 0 1.0140206896380732e-08
a O 0 1.7945282759779246e-10
transmembrane O 0 6.5973768670346544e-09
protein O 0 1.6777400579925938e-09
is O 0 4.623005537413016e-13
mutated O 0 1.3231264694990585e-10
in O 0 3.984268969435545e-13
patients O 0 5.259794266798679e-10
with O 0 2.8054151016143614e-11
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999973773956299
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.059527523815631866
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 3.388879107890652e-11
. O 0 3.479663224226215e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.6260649974574335e-06
WFS B-Disease 0 0.0025278397370129824
; O 0 1.932224691358897e-08
OMIM O 0 0.0013577252393588424
222300 O 0 7.166826776483504e-08
) O 0 3.1410076904887785e-13
is O 0 4.343091641531571e-14
an O 0 2.0072459319675495e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.6347874992893594e-09
by O 0 1.4137192284879863e-11
young O 0 1.2662368931160017e-08
- O 0 3.060941253352212e-06
onset O 1 1.0
non O 1 1.0
- O 1 0.9999998807907104
immune O 1 0.8044186234474182
insulin B-Disease 1 0.9999998807907104
- I-Disease 1 0.9998507499694824
dependent I-Disease 0 2.7617055820883252e-05
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 3.5688702837433084e-07
progressive O 1 0.9999959468841553
optic B-Disease 1 0.9999995231628418
atrophy I-Disease 1 0.8214317560195923
. O 0 0.0001417554885847494

Linkage O 0 1.709553202999814e-06
to O 0 3.6261810221205337e-10
markers O 0 6.6597318770789116e-09
on O 0 3.6094012223486516e-09
chromosome O 0 4.855775781464899e-09
4p O 0 4.720496690424625e-06
was O 0 4.140359999293963e-10
confirmed O 0 4.051366464530304e-10
in O 0 1.23035193144716e-11
five O 0 4.937374727814747e-12
families O 0 3.257934200195933e-11
. O 0 6.852415856961613e-10

On O 0 5.6417657212648464e-09
the O 0 5.3950722361806314e-11
basis O 0 1.1774378139151054e-09
of O 0 3.781442103889532e-10
meiotic O 0 0.006959882564842701
recombinants O 1 0.9998372793197632
and O 0 8.927034222949715e-09
disease O 0 1.0472513167769648e-06
- O 0 5.278299131106223e-09
associated O 0 6.374426320121529e-09
haplotypes O 0 1.8725657469076396e-08
, O 0 2.9143822771748873e-12
the O 0 2.1422041224239408e-11
WFS B-Disease 0 1.9850463672810292e-07
gene O 0 2.5441388579183766e-11
was O 0 7.955580638707715e-11
localized O 0 1.3986428903933756e-08
to O 0 2.497445861227021e-10
a O 0 1.26710109071837e-09
BAC O 0 8.952715688792523e-06
/ O 0 1.6968311200571407e-08
P1 O 0 3.877652687833688e-08
contig O 0 3.609471832533018e-08
of O 0 3.6620578097723566e-11
less O 0 1.167926866330049e-10
than O 0 6.586051582574415e-12
250 O 0 8.940759937958731e-11
kb O 0 6.821929243727709e-09
. O 0 4.571787837193142e-09

Mutations O 0 2.542944912420353e-07
in O 0 1.4597401065685744e-10
a O 0 2.6434127456398393e-11
novel O 0 2.114673769426645e-09
gene O 0 5.422878812666454e-10
( O 0 2.356163701644487e-11
WFS1 O 0 0.08693370223045349
) O 0 1.4323608965582935e-10
encoding O 0 2.060549242344223e-08
a O 0 1.3372589702242976e-09
putative O 0 6.460581971623469e-07
transmembrane O 0 5.824972171275533e-10
protein O 0 2.227617257322123e-10
were O 0 2.4364803577481275e-11
found O 0 1.6011524788320242e-12
in O 0 4.441832101784171e-13
all O 0 1.2977216957282822e-12
affected O 0 6.447370415330056e-11
individuals O 0 6.998146636835734e-13
in O 0 6.972931954063455e-11
six O 0 2.1309087827603435e-10
WFS B-Disease 0 2.6599129796522902e-06
families O 0 2.2308105362967012e-10
, O 0 1.0111988286640172e-12
and O 0 1.1068057277976995e-12
these O 0 5.8516585674239785e-12
mutations O 0 9.636865958007057e-12
were O 0 3.0436738199246527e-12
associated O 0 3.0058067146399026e-11
with O 0 9.779550216512667e-13
the O 0 4.4506587304482537e-10
disease O 0 1.3937885512405046e-07
phenotype O 0 1.3611967233373434e-06
. O 0 1.0871718636451533e-08

WFS1 O 1 0.9978014826774597
appears O 0 1.8104655907791312e-07
to O 0 4.025399111262651e-11
function O 0 1.827076268057226e-10
in O 0 6.59568441530034e-11
survival O 0 8.411508929384581e-07
of O 0 1.2695928752748387e-09
islet O 0 5.097273287901771e-07
beta O 0 6.654046558196569e-08
- O 0 2.5521377011727964e-08
cells O 0 7.669457957604209e-09
and O 0 1.956475433051441e-11
neurons O 0 1.3421233568955415e-10
. O 0 9.359488878368794e-12
. O 0 3.2695704477170295e-10

Stable O 0 8.953202268457972e-06
interaction O 0 1.556148987447159e-09
between O 0 3.093564640566093e-11
the O 0 1.8058927617192744e-11
products O 0 1.1561985147068299e-08
of O 0 5.161577387724492e-09
the O 0 4.789449903341847e-08
BRCA1 O 0 1.2290537654280342e-07
and O 0 2.2303308089277607e-09
BRCA2 O 0 2.6274069142573353e-08
tumor B-Disease 0 1.8753398478565941e-07
suppressor O 0 7.416388569936316e-08
genes O 0 5.5093242468107206e-11
in O 0 1.2540771372748782e-12
mitotic O 0 1.1322969228899638e-08
and O 0 1.2911069990906299e-09
meiotic O 0 5.207669801166048e-06
cells O 0 3.0027516913833097e-05
. O 0 1.4313060603399208e-07

BRCA1 O 0 0.0006303747068159282
and O 0 2.3997264975150756e-07
BRCA2 O 0 1.6302905692100467e-07
account O 0 8.276357030267967e-12
for O 0 5.6018202094143196e-14
most O 0 7.82567302517849e-14
cases O 0 4.94296931944499e-13
of O 0 3.701013454038282e-12
familial O 0 1.1469312166667578e-09
, O 0 3.7863388639702844e-12
early O 0 1.7628039472583623e-08
onset O 0 0.004610806703567505
breast B-Disease 1 0.999980092048645
and I-Disease 0 0.00023932606563903391
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.0217597868364976e-10
encode O 0 7.093430010041146e-12
products O 0 6.688852249858712e-11
that O 0 8.793024901948554e-13
each O 0 4.2515752203542423e-13
interact O 0 1.1939198544738683e-12
with O 0 2.0066016719316043e-13
hRAD51 O 0 1.8378921495809664e-08
. O 0 2.099082019313414e-09

Results O 0 3.0922123528398515e-08
presented O 0 3.943813808859886e-08
here O 0 2.3037025620453733e-09
show O 0 1.4876735954238995e-10
that O 0 3.474645701370682e-12
BRCA1 O 0 1.611185673766613e-08
and O 0 2.7476478869914445e-09
BRCA2 O 0 8.177501342743199e-08
coexist O 0 5.810047998267009e-10
in O 0 1.1778089354513854e-12
a O 0 1.9769888579945077e-13
biochemical O 0 1.4007618398537147e-09
complex O 0 7.108515109877089e-09
and O 0 1.230962970444338e-10
colocalize O 0 3.960589765483746e-06
in O 0 1.0568752095707623e-08
subnuclear O 0 5.208848597249016e-05
foci O 0 9.890802630252438e-07
in O 0 3.446517793381787e-10
somatic O 0 1.088211689648233e-07
cells O 0 9.744932638611203e-10
and O 0 9.594898660314488e-13
on O 0 2.189041916483836e-12
the O 0 3.7964030248464897e-13
axial O 0 3.8348768605089845e-11
elements O 0 6.327915275106122e-11
of O 0 6.722591927577071e-11
developing O 0 6.673082975083844e-09
synaptonemal O 0 3.876746177411405e-06
complexes O 0 7.169533233764014e-08
. O 0 1.4775541679057369e-08

Like O 0 7.081424428179162e-06
BRCA1 O 0 2.4857185053406283e-05
and O 0 1.0383412529790803e-07
RAD51 O 1 0.5399318337440491
, O 0 4.041908425733709e-07
BRCA2 O 0 2.2882379653310636e-06
relocates O 0 4.6570903577958234e-07
to O 0 1.772005986389047e-09
PCNA O 0 5.237713139649713e-06
+ O 0 1.4165546513567051e-09
replication O 0 5.0366988357808395e-11
sites O 0 4.2981178512147e-12
following O 0 2.5579414888315943e-12
exposure O 0 3.8658259926549476e-10
of O 0 2.1382046133666677e-10
S O 0 8.754371378927317e-07
phase O 0 5.625253152174992e-07
cells O 0 1.4430679762256204e-08
to O 0 1.4836809558715913e-10
hydroxyurea O 0 4.1982961107578376e-08
or O 0 3.039476725863466e-10
UV O 0 0.001068881363607943
irradiation O 0 1.465245532017434e-05
. O 0 2.220395600716074e-08

Thus O 0 8.91220861376496e-06
, O 0 7.30660474346223e-08
BRCA1 O 0 2.743288121109799e-07
and O 0 7.383415212558475e-09
BRCA2 O 0 1.2160707996144993e-08
participate O 0 4.308675638498016e-11
, O 0 8.517324757810474e-13
together O 0 8.715278525988149e-14
, O 0 2.4485987781645846e-14
in O 0 1.033773354463044e-13
a O 0 1.9316671743055402e-13
pathway O 0 1.6206089248349542e-10
( O 0 4.906558964462224e-14
s O 0 8.95215412216599e-12
) O 0 3.4039920574380645e-15
associated O 0 1.385682042200076e-12
with O 0 4.597791399452329e-14
the O 0 2.4573598364496796e-12
activation O 0 1.407483296578249e-10
of O 0 6.98363311624206e-11
double O 0 4.0079523901115355e-12
- O 0 2.0426253743988099e-10
strand O 0 3.81400189208847e-10
break O 0 5.173833930727234e-11
repair O 0 5.557307947157142e-09
and O 0 3.1358391577862577e-11
/ O 0 9.62482538113818e-10
or O 0 7.998730844338553e-11
homologous O 0 2.7881913444716133e-10
recombination O 0 2.9202960050156435e-09
. O 0 2.195371662239154e-09

Dysfunction O 1 0.7080525159835815
of O 0 1.9653091385407606e-06
this O 0 8.788947347682097e-10
pathway O 0 4.822559773742796e-08
may O 0 3.670658915710945e-11
be O 0 7.293818869193169e-13
a O 0 2.3582340507449784e-13
general O 0 4.38699111759977e-11
phenomenon O 0 8.230222059424364e-11
in O 0 3.038214482515428e-13
the O 0 6.169649752023332e-13
majority O 0 2.4320379287930474e-14
of O 0 1.8876461266477407e-14
cases O 0 9.498428519411073e-13
of O 0 2.636705437319975e-11
hereditary B-Disease 0 0.0002148586354451254
breast I-Disease 1 0.9999992847442627
and I-Disease 0 0.0004388695815578103
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.4280298055169283e-09
. O 0 1.2063398058259622e-09

A O 0 5.67852858068818e-08
novel O 0 1.3130866172161859e-08
Arg362Ser O 0 8.421887400800188e-07
mutation O 0 1.8245698285568324e-09
in O 0 2.067946942158061e-12
the O 0 5.797245929833883e-12
sterol O 0 6.194379409407702e-08
27 O 0 4.872580205983468e-08
- O 0 1.4458727548571915e-08
hydroxylase O 0 2.13310022445512e-06
gene O 0 8.914625704292689e-10
( O 0 1.3929533524900672e-12
CYP27 O 0 0.09617463499307632
) O 0 5.839483410707835e-12
: O 0 5.515122321504695e-13
its O 0 1.212103984890578e-12
effects O 0 5.318799567444188e-11
on O 0 2.0094237385137603e-10
pre O 0 6.132518048929114e-09
- O 0 1.011806194384235e-09
mRNA O 0 6.976739741482163e-10
splicing O 0 3.2627364698889494e-10
and O 0 5.954563014540226e-13
enzyme O 0 3.7771653860207977e-11
activity O 0 7.927380418770724e-10
. O 0 4.916414497735389e-10

A O 0 3.3284688782941885e-08
novel O 0 2.1776111580606994e-08
C O 0 1.391851895959917e-07
to O 0 2.510007609743403e-12
A O 0 6.280839043304454e-11
mutation O 0 5.8624277307628425e-12
in O 0 2.8468422281005545e-13
the O 0 5.963928352906156e-13
sterol O 0 1.143317085450235e-08
27 O 0 1.1274631006585878e-08
- O 0 4.171100354000146e-09
hydroxylase O 0 6.195336936798412e-07
gene O 0 5.152367976712924e-10
( O 0 1.943857401431881e-12
CYP27 O 0 0.007635873276740313
) O 0 1.852631980117647e-12
was O 0 4.392299024491564e-11
identified O 0 7.017705860867807e-12
by O 0 3.242978802164842e-12
sequencing O 0 6.468822366656468e-09
amplified O 0 8.572401100082061e-08
CYP27 O 0 9.066153870662674e-05
gene O 0 8.008194801734092e-11
products O 0 3.921741542622925e-10
from O 0 4.999426220231307e-12
a O 0 2.5567122204084303e-12
patient O 0 7.046970118551599e-09
with O 0 9.276048679174309e-12
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 6.169953437051845e-10
CTX B-Disease 0 5.182709173823241e-06
) O 0 7.724001993558716e-11
. O 0 3.2113702808089784e-09

The O 0 3.9523907702232464e-08
mutation O 0 1.5168520661745788e-08
changed O 0 2.611597382795594e-09
the O 0 6.173423577893189e-11
adrenodoxin O 0 5.259208180063979e-08
cofactor O 0 5.716656037435541e-10
binding O 0 4.473288406359188e-10
residue O 0 3.8386438916404586e-08
362Arg O 0 1.1746793759925822e-08
to O 0 3.61702647000417e-11
362Ser O 0 2.0660122856952512e-07
( O 0 4.9568717186421196e-11
CGT O 0 2.6203363177046413e-06
362Arg O 0 5.489036425387894e-07
to O 0 2.61625898723139e-09
AGT O 0 1.1615979929047171e-05
362Ser O 0 1.723394582597848e-08
) O 0 4.797071485700133e-13
, O 0 3.074954570483901e-13
and O 0 8.008137474544222e-14
was O 0 2.457445531789393e-11
responsible O 0 3.455230893067984e-11
for O 0 5.420490167828973e-10
deficiency O 0 3.914439002983272e-05
in O 0 8.14396994286426e-09
the O 0 6.2972187464538365e-09
sterol O 0 8.599304237577599e-07
27 O 0 1.0908113523555585e-07
- O 0 2.5191433383753292e-09
hydroxylase O 0 7.531455139542231e-07
activity O 0 1.088527241677184e-07
, O 0 1.5724313127615797e-12
as O 0 5.291907320334466e-13
confirmed O 0 2.279807592708849e-11
by O 0 2.8788963400694367e-12
expression O 0 1.1528018123430073e-10
of O 0 8.37614144710841e-11
mutant O 0 3.0518734761564303e-10
cDNA O 0 1.331849741603719e-09
into O 0 2.56607540771725e-10
COS O 0 3.6712253859150223e-07
- O 0 3.328450048911691e-08
1 O 0 7.616046460157122e-09
cells O 0 2.4850215218918947e-09
. O 0 4.296663025371572e-10

Quantitative O 0 1.954076545018779e-08
analysis O 0 3.10888648158425e-10
showed O 0 2.6574273337409693e-10
that O 0 1.3856971126102735e-13
the O 0 9.723867544497722e-12
expression O 0 1.750832812064118e-10
of O 0 2.0149504287303444e-10
CYP27 O 0 6.000712801323971e-06
gene O 0 7.382755864981938e-12
mRNA O 0 2.6800978103480588e-11
in O 0 6.177091715735272e-13
the O 0 2.7165134291323723e-12
patient O 0 1.6942206526593395e-09
represented O 0 5.230449753867994e-11
52 O 0 1.5103966077845143e-08
. O 0 5.803671321302772e-09

5 O 0 1.3365149875710358e-08
% O 0 4.616788895628332e-11
of O 0 2.745202502818511e-12
the O 0 2.970028736837271e-11
normal O 0 9.267807854485e-08
level O 0 1.862830316667896e-07
. O 0 1.681206818204828e-08

As O 0 1.922687342670315e-09
the O 0 1.5840161127211871e-10
mutation O 0 2.8400710602727308e-11
occurred O 0 6.099522276148406e-11
at O 0 1.1641158956937625e-12
the O 0 5.17983171546138e-13
penultimate O 0 3.796425396274117e-09
nucleotide O 0 1.0052313426101023e-09
of O 0 3.3519953479554943e-09
exon O 0 2.3897672729589203e-09
6 O 0 1.6609097430730912e-09
( O 0 6.85122531624005e-14
- O 0 8.820043306823067e-11
2 O 0 3.055508068783297e-10
position O 0 3.9843413290885366e-11
of O 0 1.768918622691018e-10
exon O 0 5.963710636436304e-10
6 O 0 4.814864507096672e-09
- O 0 9.876219841942202e-09
intron O 0 3.042211815795781e-08
6 O 0 3.0060562927758383e-09
splice O 0 1.454546261214773e-09
site O 0 1.318573999986583e-10
) O 0 5.0375553202605325e-14
of O 0 1.7131341484288853e-11
the O 0 6.03707084323446e-10
gene O 0 1.7853037104220704e-10
, O 0 1.0538626915579385e-10
we O 0 3.087151714820102e-11
hypothesized O 0 1.72394515329799e-10
that O 0 3.050041501913986e-13
the O 0 2.5145323323538804e-11
mutation O 0 7.974905458230097e-11
may O 0 1.1150877443633078e-10
partially O 0 7.551760328183832e-10
affect O 0 3.6654071444708336e-10
the O 0 2.98202296189487e-11
normal O 0 8.144339092019948e-10
splicing O 0 3.4577907204180747e-10
efficiency O 0 2.8279131925046386e-08
in O 0 3.704195283837919e-10
exon O 0 5.224990662355822e-09
6 O 0 3.684809957160695e-10
and O 0 2.333771468177731e-13
cause O 0 2.2258865757518453e-12
alternative O 0 1.7065210355937666e-10
splicing O 0 5.60901360080468e-11
elsewhere O 0 4.018962246332691e-11
, O 0 8.344741591519503e-15
which O 0 1.5400694813462565e-15
resulted O 0 8.348447801120873e-12
in O 0 1.5495564900658287e-12
decreased O 0 2.3161712547903335e-09
transcript O 0 2.9779265164897595e-10
in O 0 1.9322872295279847e-12
the O 0 3.963633588011106e-11
patient O 0 8.726116362822722e-08
. O 0 5.797121893635904e-09

Transfection O 0 1.3726704310101923e-05
of O 0 2.996320702663979e-08
constructed O 0 2.116479151936801e-07
minigenes O 0 1.7007158021442592e-05
, O 0 4.487890961635266e-11
with O 0 1.7957719187534915e-13
or O 0 2.3414683820305315e-12
without O 0 6.801835483738472e-11
the O 0 1.219532808072188e-10
mutation O 0 4.746672152555753e-11
, O 0 2.6675864208541844e-12
into O 0 8.285790803475024e-11
COS O 0 1.8441448901285185e-07
- O 0 1.5042385115293655e-08
1 O 0 1.8527936962442482e-09
cells O 0 4.6578647189265965e-11
confirmed O 0 2.909416848065338e-12
that O 0 1.1218288159585508e-14
the O 0 1.8485868218121038e-12
mutant O 0 3.9495082204688003e-10
minigene O 0 8.381439542404223e-09
was O 0 4.190841423890035e-11
responsible O 0 2.9340540413924643e-12
for O 0 7.507915730092796e-13
a O 0 2.1962770144212662e-12
mRNA O 0 7.351064201799318e-10
species O 0 1.827290705899709e-12
alternatively O 0 1.1474267716526931e-11
spliced O 0 9.849515647530893e-11
at O 0 3.797507794334187e-11
an O 0 4.836761958830482e-13
activated O 0 1.5795366152815404e-06
cryptic O 0 1.765521460583841e-06
5 O 0 1.0410933448667947e-08
splice O 0 5.454231910562157e-08
site O 0 2.7490070664271116e-08
88 O 0 2.9171744131417654e-08
bp O 0 2.5296107430961e-09
upstream O 0 2.3312746177950316e-10
from O 0 3.3212011699840227e-12
the O 0 7.528626159991614e-12
3 O 0 9.814391660478705e-11
end O 0 1.5262183183928357e-10
of O 0 5.840892769448658e-10
exon O 0 1.962091289442469e-08
6 O 0 2.377461427727212e-08
. O 0 3.528184189249828e-09

Our O 0 5.4649888170388294e-08
data O 0 2.606465598908869e-10
suggest O 0 7.716697419946073e-11
that O 0 1.6456252322199355e-13
the O 0 5.6190576497305855e-11
C O 0 6.874991242966644e-08
to O 0 4.182566185756409e-12
A O 0 8.768398507275066e-11
mutation O 0 9.710911762217389e-12
at O 0 6.875315746411592e-13
the O 0 5.799841401414596e-13
penultimate O 0 1.890800405135451e-09
nucleotide O 0 7.204400409577261e-10
of O 0 6.943935981773564e-10
exon O 0 9.64441526640769e-10
6 O 0 3.1745178707964783e-10
of O 0 9.105607760850898e-12
the O 0 7.504730864527076e-11
CYP27 O 0 7.231706695165485e-05
gene O 0 8.382886051983007e-11
not O 0 9.243392509739046e-12
only O 0 8.700970499653238e-12
causes O 0 7.36023908487482e-10
the O 0 2.6587912427267213e-10
deficiency B-Disease 0 4.246593476864291e-08
in I-Disease 0 2.3397025983307174e-10
the I-Disease 0 5.93405047322193e-10
sterol I-Disease 0 2.4896300487853296e-07
27 I-Disease 0 3.610187704339296e-08
- I-Disease 0 5.263859348403344e-10
hydroxylase I-Disease 0 7.043681193863449e-08
activity I-Disease 0 8.457735845013303e-09
, O 0 1.1444842469565675e-12
but O 0 4.463516362074316e-12
also O 0 3.679012389873337e-12
partially O 0 8.979644805506837e-10
leads O 0 1.9087056588040774e-11
to O 0 3.2478303358361715e-13
alternative O 0 1.5554479926294107e-10
pre O 0 2.486935934964407e-10
- O 0 7.838723593833752e-12
mRNA O 0 1.4562049482913508e-11
splicing O 0 2.0459854296883684e-11
of O 0 1.9076055839117867e-12
the O 0 6.10553708285666e-12
gene O 0 1.5935244443432417e-11
. O 0 5.656287660471548e-10

To O 0 2.866665127498891e-09
our O 0 4.2427841795422694e-10
knowledge O 0 3.58911789177796e-11
, O 0 3.7018992201081485e-14
this O 0 1.9739394716217565e-14
is O 0 1.2399005501245904e-14
the O 0 7.406146415546086e-14
first O 0 7.936052531277993e-13
report O 0 2.1101098299225463e-12
regarding O 0 2.2967956703201509e-10
effects O 0 1.826079842892625e-10
on O 0 2.3996915565760446e-10
pre O 0 3.836737039186744e-10
- O 0 8.911114901533068e-12
mRNA O 0 1.0896198873733276e-11
splicing O 0 9.594573399662742e-12
of O 0 8.076802031006802e-13
a O 0 2.7141281911291677e-14
mutation O 0 2.10330979521188e-13
at O 0 3.7379588356881155e-13
the O 0 1.1929796343498889e-12
- O 0 6.504534411089224e-11
2 O 0 8.033733123191666e-10
position O 0 5.614301037959457e-11
of O 0 5.890650814355247e-12
a O 0 9.421711674728606e-12
5 O 0 8.645560378717221e-10
splice O 0 4.37035874156777e-09
site O 0 7.009355762477298e-09
. O 0 3.247861535271568e-09

ATM O 0 0.00014788555563427508
germline O 0 3.2889169233385473e-05
mutations O 0 7.695690840137104e-08
in O 0 4.385804774909019e-10
classical O 1 0.9986703395843506
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 7.276734076411273e-11
the O 0 1.3067534901378686e-11
Dutch O 0 3.2820686168832935e-09
population O 0 4.292513827025557e-12
. O 0 1.3041347168840645e-10

Germline O 0 0.0007268947083503008
mutations O 0 1.422680924179076e-07
in O 0 2.3489676870269705e-10
the O 0 1.2391039583281582e-10
ATM O 0 1.6886691156514644e-08
gene O 0 5.744212072146537e-13
are O 0 2.1413244369494929e-16
responsible O 0 4.693328563210497e-16
for O 0 9.84842412563849e-15
the O 0 3.9031496612551564e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.2726775189264572e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.0772012448700963e-10
. O 0 2.0859429739061852e-09

In O 0 2.3513099023375617e-08
our O 0 7.746239760741958e-10
study O 0 1.1105662396648786e-11
, O 0 3.7908313098820867e-13
we O 0 3.4637128777138815e-13
have O 0 2.997913874612512e-13
determined O 0 6.072672226187237e-11
the O 0 3.32970213900996e-11
ATM O 0 3.312603880090137e-08
mutation O 0 4.931732799917654e-10
spectrum O 0 1.7079686998044963e-08
in O 0 8.307497918746964e-12
19 O 0 3.7330125102208456e-10
classical O 0 5.818005277546945e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999799728393555
T I-Disease 1 1.0
patients O 0 2.2213584998098668e-06
, O 0 3.9074351528911935e-14
including O 0 2.001844209739397e-15
some O 0 2.1957009981358154e-14
immigrant O 0 1.3649754070088616e-11
populations O 0 8.8219698473474e-13
, O 0 2.240515478495967e-14
as O 0 2.559629212143394e-13
well O 0 1.1086333673998583e-12
as O 0 9.91266096983523e-13
12 O 0 1.904166711461097e-12
of O 0 5.187860232548636e-13
Dutch O 0 8.880374907649369e-11
ethnic O 0 8.40618969832202e-13
origin O 0 1.2021542095119742e-10
. O 0 7.90732646027692e-10

Both O 0 2.5013660032158214e-09
the O 0 2.615244965031849e-10
protein O 0 1.8771303955666951e-10
truncation O 0 1.4811942783410359e-08
test O 0 3.586940522382065e-08
( O 0 6.378104988602473e-11
PTT O 0 2.3612292920915934e-07
) O 0 4.0234601674654646e-13
and O 0 6.274558238435202e-13
the O 0 1.5933413442803523e-12
restriction O 0 2.250968300643308e-09
endonuclease O 0 3.7163001564977094e-08
fingerprinting O 0 2.3216928468627884e-07
( O 0 1.1920069098447783e-11
REF O 0 7.777202171155295e-08
) O 0 1.5406821868638176e-13
method O 0 1.782145611639585e-11
were O 0 3.0615252086946265e-12
used O 0 9.876313092002653e-13
and O 0 2.626595121957287e-12
compared O 0 4.981668966230757e-10
for O 0 1.5613175682882563e-11
their O 0 1.0565672468876297e-11
detection O 0 4.684971854906905e-10
efficiency O 0 2.8790378969745234e-09
, O 0 1.0577199923214597e-12
identifying O 0 3.9182330990872316e-11
76 O 0 1.5703445210846212e-09
% O 0 1.4539643360816923e-12
and O 0 3.794019474132916e-14
60 O 0 9.460928134669144e-13
% O 0 8.579196245561346e-14
of O 0 1.9772489309906327e-13
the O 0 1.6733982255434654e-11
mutations O 0 2.2573951041771068e-10
, O 0 1.1570621544221282e-10
respectively O 0 2.1125543980815564e-08
. O 0 1.437368553069973e-07

Most O 0 6.177354094916154e-08
patients O 0 2.0134815770234127e-07
were O 0 2.659293063533852e-10
found O 0 3.777523866627108e-12
to O 0 8.786034508441454e-13
be O 0 9.346929480402721e-12
compound O 0 5.880312770045748e-08
heterozygote O 0 3.792457619056222e-06
. O 0 1.6418983506127915e-08

Seventeen O 0 4.862905825575581e-06
mutations O 0 1.2206021970939673e-08
were O 0 5.213808274007192e-10
distinct O 0 3.401740347741544e-11
, O 0 1.8617889348260253e-12
of O 0 9.590548841198476e-12
which O 0 2.3454944041677306e-13
10 O 0 1.8761691419205695e-12
were O 0 1.6223610996290994e-12
not O 0 1.2620581663069785e-12
reported O 0 3.5961074396073656e-11
previously O 0 4.019025945378729e-10
. O 0 2.8589497436115607e-09

Mutations O 0 6.313755875453353e-06
are O 0 6.726545986879273e-10
small O 0 8.420998898195364e-10
deletions O 0 1.335796753210161e-07
or O 0 2.653753483627952e-07
point O 0 6.260864665819099e-06
mutations O 0 1.8818396085862332e-07
frequently O 0 3.155256944609164e-09
affecting O 0 1.872590793539075e-08
splice O 0 2.346557494092849e-06
sites O 0 2.00925384774564e-07
. O 0 1.072816857572434e-07

Moreover O 0 2.6838265512196813e-06
, O 0 3.7053046741952755e-10
a O 0 9.422938818115512e-11
16 O 0 1.2030406892904466e-08
. O 0 1.1599889937485841e-08

7 O 0 1.63334516400937e-06
- O 0 7.907590315880952e-08
kb O 0 1.2033510188302898e-07
genomic O 0 3.226461320338103e-09
deletion O 0 9.46014822034158e-10
of O 0 9.1395818690998e-10
the O 0 3.1642713449464566e-10
3 O 0 3.6109967793684916e-10
end O 0 1.7530918383634742e-10
of O 0 8.062665118879764e-11
the O 0 9.074439810685675e-11
gene O 0 3.167021549524418e-12
, O 0 1.3319520182977773e-12
most O 0 2.409687466925492e-12
likely O 0 1.727275267260353e-11
a O 0 1.044057621932791e-13
result O 0 6.1543504667471716e-12
of O 0 1.0590449524283674e-11
recombination O 0 8.341858453997375e-12
between O 0 5.037906723737162e-12
two O 0 5.221891712439697e-13
LINE O 0 1.1537052557741845e-07
elements O 0 1.681442485246265e-10
, O 0 1.793643684099011e-12
was O 0 9.917663218450556e-11
identified O 0 5.839956851438899e-10
. O 0 2.842501789501739e-09

The O 0 1.7543388253216108e-07
most O 0 2.736497473065924e-09
frequently O 0 1.2993502107594423e-10
found O 0 8.327042180789057e-12
mutation O 0 7.465509113679936e-12
, O 0 3.390931470077102e-13
identified O 0 7.116739055706978e-12
in O 0 1.673982653882522e-11
three O 0 3.055062062704006e-12
unrelated O 0 5.738285957512801e-10
Turkish O 0 2.822480027475649e-09
A B-Disease 1 1.0
- I-Disease 1 0.5984708666801453
T I-Disease 1 1.0
individuals O 0 3.3329918686098026e-12
, O 0 4.395845869926106e-14
was O 0 1.9754859640480626e-12
previously O 0 2.3059234643268978e-12
described O 0 6.428624993448651e-13
to O 0 4.2096853075917345e-14
be O 0 4.367373026810742e-14
a O 0 7.024247042309792e-14
Turkish O 0 1.350443756820141e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 1.9201490886189276e-07
mutation O 0 1.523654624691062e-08
. O 0 8.993699673887079e-10

The O 0 1.059458654140144e-08
presence O 0 1.4558729777292e-09
of O 0 1.8288144332245793e-08
a O 0 1.8002338508793514e-09
founder O 0 6.885976233661495e-08
mutation O 0 1.7924982387285127e-08
among O 0 1.164003754494658e-10
relatively O 0 7.687786518495443e-11
small O 0 7.531505936487007e-14
ethnic O 0 4.832885732775939e-14
population O 0 4.637424748680716e-14
groups O 0 4.2777484706617644e-14
in O 0 9.970661313729243e-14
Western O 0 2.151615136058993e-10
Europe O 0 2.138476895563457e-11
could O 0 9.778548630545725e-12
indicate O 0 1.7075459102233737e-11
a O 0 1.208128784730214e-13
high O 0 2.847712300343974e-12
carrier O 0 9.594544803830443e-14
frequency O 0 1.178631411219433e-12
in O 0 1.6009013505038222e-13
such O 0 1.8902648543650535e-11
communities O 0 8.155220387884299e-10
. O 0 1.2768960999665069e-08

In O 0 9.146527979453367e-09
patients O 0 6.286636278218793e-08
of O 0 3.8026989890305174e-10
Dutch O 0 2.2128444854274676e-08
ethnic O 0 9.86660232682457e-12
origin O 0 9.132328920857802e-11
, O 0 4.542191817981378e-13
however O 0 6.8297568121822305e-12
, O 0 1.4950814566407067e-13
no O 0 5.77050126432388e-13
significant O 0 1.0429082944463097e-11
founder O 0 2.802747478547474e-10
effect O 0 8.431959575005976e-10
could O 0 1.3112431973549832e-10
be O 0 8.275777285682295e-11
identified O 0 1.3048967462125916e-09
. O 0 3.4959635186737614e-09

The O 0 1.2521174319601869e-08
observed O 0 1.7814371089386327e-09
genetic O 0 3.0587965493822367e-10
heterogeneity O 0 4.4232309481806453e-10
including O 0 5.175763246809129e-13
the O 0 3.832112752122363e-11
relative O 0 2.1474728839621093e-07
high O 0 2.848305484803859e-07
percentage O 0 1.814367855956789e-08
of O 0 1.2713030628219713e-10
splice O 0 5.6690701910611097e-08
- O 0 4.433979938767152e-08
site O 0 1.986973785506052e-08
mutations O 0 1.9821531915820145e-10
had O 0 6.125027568470998e-12
no O 0 1.4521767035396982e-12
reflection O 0 3.51607493120909e-11
on O 0 2.2619192976969238e-11
the O 0 2.4722262431664532e-11
phenotype O 0 3.5141226817358984e-08
. O 0 2.4007136278925145e-09

All O 0 2.566091561462258e-09
patients O 0 1.113156677945426e-09
manifested O 0 3.743329812788687e-10
classical O 0 1.8249327382591218e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
and O 0 1.995711373936615e-10
increased O 0 8.190590983225832e-10
cellular O 0 3.9163447485002223e-10
radioresistant O 0 3.6232443711980977e-09
DNA O 0 1.0773208991565753e-09
synthesis O 0 4.893692118201898e-09
. O 0 1.4002570214444177e-09

Determination O 0 3.5600926651113696e-08
of O 0 3.259862657589707e-10
the O 0 1.5554944485240974e-11
genomic O 0 3.9101100829386226e-11
structure O 0 1.1841210303953353e-11
of O 0 4.44603858937298e-12
the O 0 5.397683602165193e-12
COL4A4 O 0 0.0001287430350203067
gene O 0 1.655461705218908e-11
and O 0 7.376414203844744e-14
of O 0 2.361070540468635e-12
novel O 0 1.929911697118314e-08
mutations O 0 1.1324717661409522e-06
causing O 0 1.121513378166128e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.9256383641040884e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.495209759980412e-10
a O 0 1.3652935726415905e-10
progressive O 1 0.9998445510864258
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.328055739402771
by O 0 1.2389048720251594e-07
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999994039535522
membrane I-Disease 0 1.2565009456011467e-05
abnormalities I-Disease 0 7.728881610091776e-05
and O 0 3.617987298643044e-10
associated O 0 7.465349227686602e-09
with O 0 4.254923913205033e-10
mutations O 0 1.718568509723184e-09
in O 0 1.3695085343545799e-10
either O 0 2.674803711855134e-10
the O 0 5.254029433743312e-10
COL4A3 O 1 0.999799907207489
or O 0 1.724626885746261e-09
the O 0 1.887035416814342e-09
COL4A4 O 0 0.0032160794362425804
gene O 0 7.544154884131515e-11
, O 0 4.898519740878515e-13
which O 0 4.7622533493702976e-14
encode O 0 1.7851452737902007e-12
the O 0 4.520034953964247e-12
alpha3 O 0 1.037394952163595e-07
and O 0 5.964127802737806e-11
alpha4 O 0 2.3501492307786975e-07
type O 0 3.343154446611152e-07
IV O 1 0.9999979734420776
collagen O 0 2.7389849037717795e-06
chains O 0 1.7245135097709863e-07
, O 0 1.800483512282014e-10
respectively O 0 3.50640783075562e-09
. O 0 8.430708575701829e-09

To O 0 1.8607611285137438e-10
date O 0 6.869879598525586e-08
, O 0 6.05161363728679e-12
mutation O 0 1.1263667949734657e-12
screening O 0 1.0516620213563144e-10
in O 0 9.710300272192107e-12
the O 0 3.6951769422088887e-10
two O 0 8.114377919588023e-11
genes O 0 1.3381213914698264e-09
has O 0 8.310858078119931e-12
been O 0 9.040177460784005e-12
hampered O 0 3.9549021835227904e-08
by O 0 2.630019032417996e-12
the O 0 2.682532147801897e-11
lack O 0 3.123674652272257e-10
of O 0 3.5108862431881827e-12
genomic O 0 7.635059251498433e-12
structure O 0 1.5993218901999562e-11
information O 0 2.954130690069334e-11
. O 0 4.903818462409504e-10

We O 0 9.162761105407924e-10
report O 0 9.182698004761569e-12
here O 0 2.7795972988575723e-12
the O 0 1.81247486637226e-13
complete O 0 1.243103276565849e-12
characterization O 0 2.458356018752994e-10
of O 0 2.2923829501309e-11
the O 0 4.7189949864412384e-11
48 O 0 2.2711599267921656e-09
exons O 0 2.9108188082105357e-10
of O 0 5.0245321792097286e-11
the O 0 4.3144671169059734e-10
COL4A4 O 0 0.015794089064002037
gene O 0 3.192351105685276e-10
, O 0 3.330831053680039e-12
a O 0 4.709440845108992e-13
comprehensive O 0 3.0057281663609103e-10
gene O 0 5.08533753301732e-12
screen O 0 7.834993764888054e-10
, O 0 2.659716630964981e-12
and O 0 5.210450669014544e-13
the O 0 7.321667144094546e-13
subsequent O 0 8.002983692412258e-12
detection O 0 4.730099090188844e-10
of O 0 8.783005572832181e-12
10 O 0 3.763787458782586e-12
novel O 0 5.354853713224195e-11
mutations O 0 1.6149274625898435e-11
in O 0 5.149854609594329e-13
eight O 0 1.7967089621651056e-11
patients O 0 3.948811766463223e-08
diagnosed O 0 1.74908609551494e-06
with O 0 4.828569899473223e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 7.1128147283161525e-06

Furthermore O 0 2.163840946423079e-07
, O 0 2.560472667223479e-10
we O 0 3.088918704152732e-11
identified O 0 6.174035588335514e-11
a O 0 1.5564167793122308e-12
glycine O 0 1.1794015764010624e-10
to O 0 3.6831145772131535e-11
alanine O 0 3.3714362412951004e-09
substitution O 0 6.018428280185617e-07
in O 0 1.04731530115032e-08
the O 0 7.505224886017459e-09
collagenous O 0 5.333868671186792e-07
domain O 0 9.687181612427764e-11
that O 0 8.570101822213266e-14
is O 0 5.983649448322581e-14
apparently O 0 7.581078126372987e-12
silent O 0 5.5856864272785245e-11
in O 0 3.921122324404558e-13
the O 0 5.847641815215354e-12
heterozygous O 0 4.460512688375662e-12
carriers O 0 1.8631965761906066e-11
, O 0 1.2533406387391088e-12
in O 0 1.8168239482307946e-11
11 O 0 1.1895415763518713e-09
. O 0 6.619031100996153e-09

5 O 0 4.9584208738906455e-08
% O 0 1.5742934733609104e-10
of O 0 1.8194595136078462e-11
all O 0 1.9275241125438214e-12
control O 0 1.5653102078405645e-11
individuals O 0 2.3175816734472e-12
, O 0 8.796518201348302e-12
and O 0 2.9120667682791535e-11
in O 0 2.8458188930380324e-11
one O 0 1.048852411172918e-12
control O 0 2.2117978022012652e-12
individual O 0 2.4318630334300984e-13
homozygous O 0 5.828230693200043e-13
for O 0 6.443205479789507e-14
this O 0 7.725467943316133e-13
glycine O 0 1.1750031503332536e-10
substitution O 0 8.740892099012854e-08
. O 0 3.312742791194978e-08

There O 0 1.0749441337054577e-09
has O 0 8.286099128888835e-13
been O 0 3.833264001357195e-13
no O 0 7.22882149105375e-13
previous O 0 1.2399314908151382e-10
finding O 0 1.8152834790896577e-10
of O 0 1.6053764220758104e-11
a O 0 8.69718359830518e-13
glycine O 0 1.643305803933348e-11
substitution O 0 1.262040805194431e-09
that O 0 7.802709758690518e-13
is O 0 5.999053250688169e-14
not O 0 4.270403339756354e-14
associated O 0 7.274593687850439e-12
with O 0 3.427133929293294e-14
any O 0 1.856725710680518e-11
obvious O 0 3.843167728501129e-10
phenotype O 0 2.806729071380687e-09
in O 0 1.0133347286278571e-11
homozygous O 0 3.5172034729136215e-10
individuals O 0 2.309287483459599e-11
. O 0 3.007484261630111e-09

Founder O 0 0.0023693148978054523
BRCA1 O 0 0.00010735897376434878
and O 0 2.2112376996119565e-07
BRCA2 O 0 1.6644725064907107e-07
mutations O 0 1.86763438048132e-10
in O 0 3.774254346555761e-12
French O 0 2.104469709607315e-09
Canadian O 0 1.1332527947160997e-06
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.7959528731998944e-08
. O 0 3.3237410601572037e-09

We O 0 1.1916722719718109e-08
have O 0 3.284100422162872e-11
identified O 0 4.9333107043914026e-11
four O 0 4.2068863041581916e-13
mutations O 0 8.347058396036833e-13
in O 0 1.946854407287174e-13
each O 0 1.2061602801607951e-13
of O 0 1.186233056227337e-10
the O 0 2.4414296717623074e-07
breast B-Disease 1 0.9998455047607422
cancer I-Disease 0 0.0024280778598040342
- O 0 0.00016234940267167985
susceptibility O 0 0.00018919877766165882
genes O 0 7.016488012823174e-08
, O 0 4.3287601281249977e-10
BRCA1 O 0 3.997468578376129e-09
and O 0 1.7569214139090406e-10
BRCA2 O 0 7.786278288790527e-10
, O 0 1.0672136053569217e-13
in O 0 1.2301489308533947e-13
French O 0 1.4975524986748923e-10
Canadian O 0 1.501778790213848e-08
breast B-Disease 0 4.796928351424867e-06
cancer I-Disease 0 1.714923769213783e-06
and O 0 1.1255076515226392e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.0364324115895727e-10
from O 0 1.2475956899515861e-11
Quebec O 0 1.1215584017065794e-08
. O 0 2.742161164803747e-09

To O 0 1.98162283027159e-07
identify O 0 9.608168056729482e-07
founder O 0 2.2562110189028317e-06
effects O 0 1.9206452179787448e-06
, O 0 2.760817796598758e-09
we O 0 3.78121839395007e-10
examined O 0 4.765672745321581e-09
independently O 0 1.7616795522368278e-10
ascertained O 0 3.4642631874248764e-08
French O 0 1.3184817682088124e-09
Canadian O 0 1.6021508564278975e-09
cancer B-Disease 0 9.914495890939179e-09
families O 0 1.526307075519484e-12
for O 0 1.948997231237138e-14
the O 0 1.7030457990022119e-13
distribution O 0 2.7107488129174406e-11
of O 0 5.558552923501381e-11
these O 0 5.033167216339507e-10
eight O 0 2.1300798624945827e-10
mutations O 0 1.0837242214734033e-09
. O 0 4.050093593832571e-09

Mutations O 0 3.039028229068208e-07
were O 0 1.6101711075577896e-09
found O 0 2.7595883911324393e-11
in O 0 6.5927380742125674e-12
41 O 0 1.7843583277610264e-09
of O 0 8.628555508982672e-11
97 O 0 5.8636924649135835e-08
families O 0 5.546969550351832e-10
. O 0 1.7526848861137978e-09

Six O 0 5.404751490800663e-08
of O 0 2.864063874952194e-09
eight O 0 2.9691127334530165e-10
mutations O 0 1.0365588942740089e-10
were O 0 5.642104838887718e-11
observed O 0 9.99005531077124e-11
at O 0 6.823874798556062e-11
least O 0 1.7250955872127882e-11
twice O 0 5.108197753678212e-10
. O 0 3.450255414705339e-09

The O 0 6.978661986067891e-06
BRCA1 O 0 4.684427494794363e-06
C4446T O 0 1.6124142803164432e-06
mutation O 0 6.315370004728038e-09
was O 0 6.044487826928346e-11
the O 0 5.74504853412261e-12
most O 0 1.420177560620961e-12
common O 0 6.223001714628085e-12
mutation O 0 9.2407132293304e-12
found O 0 7.968177441648738e-13
, O 0 4.1433219702402546e-14
followed O 0 2.2110048167323093e-12
by O 0 2.736837666217351e-12
the O 0 2.8839071131159244e-09
BRCA2 O 0 8.575720755743532e-08
8765delAG O 0 2.305972799376832e-07
mutation O 0 1.942845706537355e-08
. O 0 2.230658324720025e-09

Together O 0 2.465176862642693e-07
, O 0 4.0462000416852106e-10
these O 0 6.440143557329137e-11
mutations O 0 3.05432935887584e-11
were O 0 1.6724314641503035e-11
found O 0 3.245848414264868e-13
in O 0 5.191027729195552e-13
28 O 0 8.188856259749855e-10
of O 0 1.2064403642764177e-10
41 O 0 1.6517227585666205e-09
families O 0 2.8445472973620545e-12
identified O 0 2.751094274264232e-12
to O 0 8.5848635058422e-13
have O 0 2.7698065195591592e-12
a O 0 2.8673731791717394e-11
mutation O 0 5.984543083314975e-09
. O 0 1.0736414424172835e-08

The O 0 4.114291485279864e-08
odds O 0 7.94676537907435e-08
of O 0 9.883101281804585e-12
detection O 0 5.88046389360386e-10
of O 0 6.102082727998948e-11
any O 0 2.8821776562604207e-11
of O 0 5.797804458751443e-10
the O 0 7.242095256820846e-10
four O 0 4.3095960827743696e-11
BRCA1 O 0 5.232347888295408e-10
mutations O 0 1.598087114029756e-11
was O 0 1.393879595079639e-10
18 O 0 1.0345091450147947e-09
. O 0 5.219492393848668e-09

7x O 0 0.0001513962197350338
greater O 0 6.459553247850636e-08
if O 0 4.419362653607095e-09
one O 0 2.7609676697681884e-11
or O 0 5.849917772415836e-12
more O 0 1.4335886264985748e-13
cases O 0 1.2017460637725463e-10
of O 0 2.7141891223436687e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 5.6735938863683444e-11
also O 0 2.997163403421245e-14
present O 0 2.875563556801325e-13
in O 0 8.179384903758691e-13
the O 0 7.421614017788514e-11
family O 0 1.818398764896756e-10
. O 0 1.3703138623810673e-09

The O 0 3.576010598749235e-08
odds O 0 7.85592106922195e-08
of O 0 1.3761218727037505e-11
detection O 0 5.833077354466809e-10
of O 0 3.354908711949989e-11
any O 0 1.9568784093149105e-11
of O 0 5.404560687871651e-10
the O 0 1.20292542593603e-09
four O 0 2.0200684180959882e-10
BRCA2 O 0 2.9190931893907646e-09
mutations O 0 5.596254362694175e-11
was O 0 4.1048650589736724e-10
5 O 0 3.4317868546906993e-09
. O 0 1.2062891796560393e-09

3x O 0 1.1059664473123121e-07
greater O 0 6.77197520282391e-10
if O 0 2.7347726513915482e-11
there O 0 5.8958666941666404e-12
were O 0 1.688174079694793e-11
at O 0 1.5800616023908809e-12
least O 0 2.8368090211963737e-13
five O 0 1.5238419182636402e-14
cases O 0 7.688966108775064e-13
of O 0 9.128287709048166e-11
breast B-Disease 0 6.265801175686647e-07
cancer I-Disease 0 5.784422896226715e-08
in O 0 5.872021618946732e-11
the O 0 3.6870402286837134e-09
family O 0 1.6226884280712284e-09
. O 0 6.966810239816823e-09

Interestingly O 0 5.561890930039226e-07
, O 0 1.1231285346191555e-10
the O 0 2.0821488630473617e-11
presence O 0 8.482380076113571e-11
of O 0 1.9477202073403532e-09
a O 0 7.1559100867091274e-09
breast B-Disease 0 2.4049550120253116e-05
cancer I-Disease 0 9.150561908199961e-08
case O 0 1.369263591399772e-09
< O 0 2.3721831166056973e-09
36 O 0 8.986562188839642e-11
years O 0 8.415975165029788e-13
of O 0 1.1083669789260786e-12
age O 0 2.917542943348117e-11
was O 0 8.226262553090447e-12
strongly O 0 4.256331832125371e-12
predictive O 0 2.1290713983490583e-11
of O 0 5.06739615546703e-12
the O 0 9.146125697079288e-13
presence O 0 8.222149090048037e-13
of O 0 2.4381991651362123e-12
any O 0 8.12126407789826e-12
of O 0 4.260655023236026e-11
the O 0 9.549081664284031e-11
eight O 0 1.913291053368127e-11
mutations O 0 1.628459866953591e-11
screened O 0 4.711067536078417e-09
. O 0 3.7978087341628e-09

Carriers O 0 5.888303888923474e-08
of O 0 2.1968629138058304e-09
the O 0 4.317364799000245e-10
same O 0 1.4815430826597975e-10
mutation O 0 3.126701328404202e-11
, O 0 2.8936525891349804e-14
from O 0 1.1144715386006768e-13
different O 0 1.442162578593753e-12
families O 0 4.817061680095769e-12
, O 0 3.0356774494318117e-13
shared O 0 2.332264156107433e-12
similar O 0 3.7791256235486514e-11
haplotypes O 0 9.55601042740284e-10
, O 0 1.8575607631937663e-12
indicating O 0 2.8865678944334228e-11
that O 0 8.212051508639864e-14
the O 0 5.564575709937625e-12
mutant O 0 1.1397190829987025e-10
alleles O 0 6.732879878623699e-12
were O 0 1.2896536269457748e-11
likely O 0 8.570847156996741e-12
to O 0 4.3125493275194757e-14
be O 0 1.8656376356979143e-13
identical O 0 7.272596153767852e-12
by O 0 1.5140240948972872e-13
descent O 0 2.399758690374565e-11
for O 0 1.2117081426774035e-13
a O 0 1.7267727503954278e-13
mutation O 0 1.1016462915514058e-11
in O 0 6.361562752271732e-13
the O 0 3.876574755645734e-11
founder O 0 3.881935661809166e-09
population O 0 8.921930902405784e-12
. O 0 3.844824458809626e-10

The O 0 2.4643664886525585e-09
identification O 0 4.244576956580204e-08
of O 0 1.5484665993881208e-08
common O 0 9.890305227600038e-05
BRCA1 O 0 0.00026806388632394373
and O 0 7.206632517409162e-07
BRCA2 O 0 3.962166204019013e-07
mutations O 0 3.7454722656704575e-10
will O 0 6.798482675256234e-13
facilitate O 0 5.187417769642044e-12
carrier O 0 5.048918097841359e-13
detection O 0 7.439670407505261e-11
in O 0 7.252478782457383e-13
French O 0 4.660595798178235e-10
Canadian O 0 1.4221404498471202e-08
breast B-Disease 0 4.8284731747116894e-05
cancer I-Disease 0 1.7932177797774784e-05
and O 0 3.3577612157387193e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.14988088337509e-09
. O 0 1.2116780911952674e-09

Are O 0 3.6549576698519104e-09
Dp71 O 0 1.0069975360238459e-05
and O 0 1.3673426835225655e-09
Dp140 O 0 7.768468321955879e-07
brain O 0 8.210851660805929e-07
dystrophin O 0 1.1916743005713215e-06
isoforms O 0 1.2556276374198205e-07
related O 0 1.0136576378272366e-07
to O 0 7.859001227572548e-10
cognitive B-Disease 0 2.0072702682227828e-05
impairment I-Disease 1 0.9997039437294006
in O 0 5.107283141114749e-05
Duchenne B-Disease 1 1.0
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
? O 1 0.9999910593032837

Molecular O 0 4.2426265167705424e-07
study O 0 5.969059135857435e-10
and O 0 1.6775902498752937e-12
neuropsychological O 0 6.363539140075147e-10
analysis O 0 5.298161648986666e-12
were O 0 3.1807755214441347e-12
performed O 0 2.6748978466245577e-12
concurrently O 0 5.564565301596769e-12
on O 0 1.1934771226851382e-10
49 O 0 9.724823168966168e-10
patients O 0 2.7864810459021783e-09
with O 0 2.6366162031443707e-10
Duchenne B-Disease 1 0.9999997615814209
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.1292261348216925e-07
DMD B-Disease 1 1.0
) O 0 3.7488114283841523e-13
in O 0 1.1409528378504563e-13
order O 0 2.1937065879107376e-12
to O 0 3.150343484345508e-13
find O 0 1.1008055361347302e-12
a O 0 6.777346509657467e-15
molecular O 0 1.3391099210405266e-12
explanation O 0 7.90409144385551e-12
for O 0 1.606431459209856e-13
the O 0 6.40482736291581e-11
cognitive B-Disease 0 3.986141194900483e-08
impairment I-Disease 0 7.977594407293509e-08
observed O 0 3.977010720745966e-09
in O 0 7.794536543981323e-11
most O 0 1.633987278815141e-09
DMD B-Disease 1 1.0
patients O 0 6.778647366445512e-05
. O 0 2.2171919411562158e-08

Complete O 0 1.8628358855465876e-09
analysis O 0 1.8912936494697163e-10
of O 0 2.2932324095226164e-10
the O 0 2.278436328495559e-09
dystrophin O 0 3.775828361085587e-07
gene O 0 2.3831852047351276e-09
was O 0 5.9556426457163525e-09
performed O 0 6.770748406381699e-10
to O 0 1.366465361002378e-11
define O 0 1.847992869841164e-10
the O 0 5.475320197234623e-11
localization O 0 1.3635936113587377e-07
of O 0 3.5334354886451536e-10
deletions O 0 9.28120802434762e-10
and O 0 3.6398856151365067e-11
duplications O 0 1.1502189478651559e-10
in O 0 1.61005811547682e-12
relation O 0 1.4894134536813652e-11
to O 0 6.142842853308628e-13
the O 0 2.180746035140846e-11
different O 0 1.9479764468144367e-09
DMD B-Disease 1 1.0
promoters O 0 1.612281266716309e-05
. O 0 1.7662300066945136e-08

Qualitative O 0 1.4709209850138905e-08
analysis O 0 2.8926100403836585e-10
of O 0 2.5832544991999384e-09
the O 0 2.0422378455009493e-08
Dp71 O 0 0.00011950566113227978
transcript O 0 4.585081114782952e-08
and O 0 1.4067948195251034e-12
testing O 0 1.7536653552918668e-12
for O 0 9.526745576226778e-14
the O 0 1.698479139451703e-12
specific O 0 9.939645460865787e-12
first O 0 3.902064088512347e-11
exon O 0 3.0140753781715546e-10
of O 0 3.295181141838022e-11
Dp140 O 0 1.3135074361514398e-08
were O 0 1.9230164682859652e-10
also O 0 6.266783966757394e-13
carried O 0 4.108229381682982e-12
out O 0 4.96356775125939e-12
. O 0 2.2417169509569845e-10

Neuropsychological O 0 8.192492714442778e-06
analysis O 0 2.3813040428422028e-09
assessed O 0 1.1530871546483468e-07
verbal O 0 3.0355288060945895e-08
and O 0 8.297150189129354e-10
visuospatial O 0 4.052108977248281e-07
intelligence O 0 4.658889385389386e-10
, O 0 3.575234552855022e-11
verbal O 0 4.716714130381661e-09
memory O 0 2.0689372831839137e-05
, O 0 6.315583056526464e-10
and O 0 3.682399662974234e-10
reading O 0 1.546314138067828e-06
skills O 0 2.435294632618934e-08
. O 0 2.8268329899105993e-09

Comparison O 0 3.420840357648558e-06
of O 0 4.089365290838032e-08
molecular O 0 9.246531362805399e-08
and O 0 1.277779770880727e-09
psychometric O 0 5.7683214436110575e-06
findings O 0 1.610644204674827e-07
demonstrated O 0 4.578227574825178e-09
that O 0 1.3594877827649565e-11
deletions O 0 6.3898379920601656e-09
and O 0 1.6651878487206062e-10
duplications O 0 1.5074144155136082e-09
that O 0 7.622192807477113e-13
were O 0 1.473923760819673e-11
localized O 0 3.2324837251351823e-10
in O 0 8.745061098880402e-12
the O 0 2.5499347425239627e-11
distal O 0 7.490537079490878e-09
part O 0 7.666499657332793e-10
of O 0 5.082349208151982e-09
the O 0 2.868077508821898e-08
gene O 0 3.416437133196837e-10
seemed O 0 6.782902239876876e-09
to O 0 3.1342213980406486e-13
be O 0 5.757199187869655e-13
preferentially O 0 5.821917392623277e-10
associated O 0 9.654832489047749e-10
with O 0 1.1668156718602773e-10
cognitive B-Disease 0 7.01649969414575e-06
impairment I-Disease 0 0.23739850521087646
. O 0 7.077921054587932e-06

Two O 0 4.011868881548253e-08
altered O 0 1.7054350109901861e-06
Dp71 O 0 0.0005258206510916352
transcripts O 0 1.3810351902066031e-06
and O 0 1.3118542918633125e-09
two O 0 3.7628705706893584e-11
deleted O 0 1.2336524024547657e-09
Dp140 O 0 6.625220372313834e-09
DNA O 0 6.161494925382982e-11
sequences O 0 6.223283065091845e-13
were O 0 1.5080093478201523e-13
found O 0 1.7467665904208687e-14
in O 0 7.230486012439058e-14
four O 0 1.7432195552509466e-13
patients O 0 4.0910365373125757e-11
with O 0 9.641899908693907e-13
severe O 1 0.9792211651802063
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999982118606567
. O 0 4.805816934094764e-05

These O 0 5.0287290775941074e-08
findings O 0 8.724831523920784e-09
suggest O 0 1.1898274587807123e-09
that O 0 7.932480627220739e-13
some O 0 1.1354694311530023e-12
sequences O 0 4.815130499186138e-13
located O 0 6.100923802612734e-13
in O 0 4.5439075679193364e-13
the O 0 2.466461410111087e-11
distal O 0 6.009650554972268e-09
part O 0 2.217114714042623e-09
of O 0 1.1782427478124191e-08
the O 0 2.21907758835016e-09
gene O 0 1.6228500748088903e-12
and O 0 2.0670873866757145e-12
, O 0 1.3550700275408167e-13
in O 0 1.6095782204902237e-13
particular O 0 1.579291038222852e-11
, O 0 4.775654155984854e-13
some O 0 1.2550110256581704e-11
DMD B-Disease 1 1.0
isoforms O 0 1.1819278000757549e-07
expressed O 0 2.7095227395079746e-08
in O 0 6.003357810868692e-10
the O 0 7.809361490807021e-10
brain O 0 6.8760641624976415e-09
may O 0 3.257772523967972e-11
be O 0 2.3365697397748075e-12
related O 0 9.584559812481075e-10
to O 0 2.6075482051357568e-11
the O 0 1.2564542739568196e-09
cognitive B-Disease 0 4.7065526587175555e-07
impairment I-Disease 0 9.909184655043646e-07
associated O 0 1.2689815775956959e-07
with O 0 2.3389454817390742e-09
DMD B-Disease 1 1.0
. O 0 2.4201668225032336e-08
. O 0 2.7311837236254632e-09

I1307K O 0 0.00021885761816520244
APC O 0 3.643896206995123e-06
and O 0 5.5360223072398185e-09
hMLH1 O 0 6.79453137308883e-07
mutations O 0 6.866335833244364e-10
in O 0 2.7074508000130004e-12
a O 0 4.781287128372003e-13
non O 0 2.223547568291906e-09
- O 0 4.5200135301293187e-10
Jewish O 0 8.780871030289461e-10
family O 0 2.7390520407344354e-12
with O 0 6.792517123852676e-14
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.82029224208236e-07

We O 0 6.811056718625252e-10
describe O 0 9.685278967719313e-11
a O 0 5.560477750986281e-13
French O 0 1.9767014414195927e-10
Canadian O 0 1.0773194780711037e-08
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.0960653213109026e-09
HNPCC B-Disease 1 0.9393094182014465
) O 0 5.629678320739906e-11
kindred O 0 1.7698788212783256e-08
which O 0 9.577601298854654e-13
carries O 0 1.083481394881236e-11
a O 0 1.2655503001893914e-13
novel O 0 6.055704548924012e-11
truncating O 0 1.1053754356282752e-08
mutation O 0 7.126784162814204e-10
in O 0 2.8526337542134073e-11
hMLH1 O 0 1.7572925514741655e-07
. O 0 2.1554702911430468e-08

Interestingly O 0 5.674262411048403e-07
, O 0 1.525909815169868e-10
the O 0 1.6886868292598223e-10
I1307K O 0 4.184609565527353e-07
APC O 0 9.488451802042164e-09
polymorphism O 0 2.5584527829636272e-09
, O 0 1.5014663774445824e-12
associated O 0 2.805447193998667e-11
with O 0 1.963127197694009e-13
an O 0 1.5391452625216837e-14
increased O 0 3.4994709907643085e-10
risk O 0 2.041474544967059e-08
of O 0 3.8819443943793885e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.739965810321209e-11
is O 0 1.2077226154913467e-14
also O 0 8.031333471804781e-16
present O 0 3.1102619530440703e-14
in O 0 7.948439947674454e-14
this O 0 2.8669397585112666e-12
family O 0 8.849077720585186e-11
. O 0 1.2694089113196583e-09

The O 0 3.863814583837666e-07
I1307K O 0 5.775510089733871e-06
polymorphism O 0 4.719690878118854e-07
has O 0 6.68392910463389e-11
previously O 0 2.0358797980790655e-11
only O 0 8.335555553087848e-13
been O 0 4.921098251120526e-13
identified O 0 2.882044212657031e-12
in O 0 1.1442873016319355e-13
individuals O 0 2.0043373156943683e-13
of O 0 1.1466260232961822e-11
self O 0 4.617090598735274e-10
- O 0 1.3821207511810485e-09
reported O 0 5.446925202545749e-11
Ashkenazi O 0 4.038145373641555e-09
Jewish O 0 4.762399363755776e-10
origins O 0 2.190712056204802e-09
. O 0 2.832282741671577e-10

In O 0 1.246039271762811e-09
addition O 0 1.4300023665203554e-10
, O 0 3.6153554108797614e-12
in O 0 3.750987801615091e-12
this O 0 8.848110612247329e-12
family O 0 5.229611535484402e-11
, O 0 4.7924072479541e-13
there O 0 5.766562899932326e-13
appears O 0 8.101260114135034e-12
to O 0 1.348798866649889e-13
be O 0 3.936208563953825e-12
no O 0 4.1560789532102405e-11
relationship O 0 1.7757632170267712e-11
between O 0 1.0329229659100658e-11
the O 0 3.1570236008748864e-11
I1307K O 0 5.331142194364702e-10
polymorphism O 0 5.447153839099883e-11
and O 0 6.902998002855307e-14
the O 0 6.551465777217616e-14
presence O 0 1.7109649200902632e-12
or O 0 3.2628469370798996e-11
absence O 0 1.950241390602514e-08
of O 0 3.5875340476110296e-09
cancer B-Disease 0 2.674873371688591e-07
. O 0 1.8271947843651049e-10
. O 0 1.3765064643678215e-09

Identification O 0 3.1097673769409084e-08
of O 0 1.3151205124906085e-10
a O 0 1.6892004288393547e-12
novel O 0 1.3536331777697086e-10
mutation O 0 2.6370386430052406e-10
of O 0 2.2975975288996864e-10
the O 0 8.583161736908096e-09
CPO O 0 1.7728978491504677e-05
gene O 0 1.7130163607048665e-11
in O 0 5.698293399636345e-13
a O 0 2.838475710986027e-13
Japanese O 0 1.741017641165854e-08
hereditary B-Disease 0 0.00013473276339937001
coproporphyria I-Disease 0 0.04103514552116394
family O 0 1.1381522568854052e-07
. O 0 3.152864280764334e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 6.685442599518865e-07
HCP B-Disease 1 1.0
) O 0 1.7820436098991976e-11
is O 0 6.677058211890241e-12
an O 0 1.833303127363184e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 3.8443426220169385e-09
by O 0 9.007351071607661e-13
a O 0 3.503822015513136e-12
deficiency B-Disease 0 2.40685920971373e-07
of I-Disease 0 3.938897208399794e-08
coproporphyrinogen I-Disease 1 0.9379227757453918
oxidase I-Disease 0 3.125244575130637e-06
( O 0 4.151001070651361e-11
CPO O 0 4.943953157976466e-08
) O 0 1.4477504075129446e-14
caused O 0 5.347806073842387e-13
by O 0 7.478583995568916e-14
a O 0 3.31973028710672e-13
mutation O 0 1.730190123117037e-11
in O 0 1.4219510985347128e-11
the O 0 2.7365651966704263e-09
CPO O 0 9.288073488278314e-05
gene O 0 4.987623203334124e-09
. O 0 9.718690741067348e-09

Only O 0 3.150315563971162e-08
11 O 0 5.268582903283914e-09
mutations O 0 4.403894471316505e-10
of O 0 9.57235513077137e-10
the O 0 6.131605889692082e-09
gene O 0 2.6440796774274133e-10
have O 0 7.565362399042375e-12
been O 0 3.543758385696205e-12
reported O 0 2.469196028198617e-11
in O 0 2.1423195162295627e-10
HCP B-Disease 1 1.0
patients O 0 5.165289985598065e-05
. O 0 2.9829205772102796e-08

We O 0 1.605185095954198e-09
report O 0 2.855856523487077e-11
another O 0 3.259051448850636e-12
mutation O 0 1.0399050544285249e-11
in O 0 1.620786024923021e-13
a O 0 3.8330956789699167e-13
Japanese O 0 1.526074377977693e-08
family O 0 1.0524250360077758e-09
. O 0 4.4272256971567e-09

Polymerase O 0 6.707155364438222e-08
chain O 0 1.0168692554657355e-09
reaction O 0 7.449499905831658e-10
- O 0 2.190398529222648e-09
single O 0 1.959552832497824e-11
strand O 0 5.897399235621492e-11
conformational O 0 3.7071179459502446e-12
polymorphism O 0 1.3845572258142091e-11
and O 0 3.3929161699164725e-14
direct O 0 1.065787676212196e-13
sequence O 0 2.653988953518066e-13
analyses O 0 3.5471801277525694e-12
demonstrated O 0 5.373308135242505e-12
a O 0 4.057254966022272e-12
C O 0 1.5982875467557278e-08
to O 0 1.4345038178154024e-11
T O 0 1.8461758788390625e-09
substitution O 0 8.993734090800842e-10
in O 0 2.270399666881584e-11
exon O 0 1.3244748353624658e-10
1 O 0 5.545369372028652e-11
of O 0 1.0285505953888663e-11
the O 0 2.2381368980362026e-10
CPO O 0 1.45382657024129e-07
gene O 0 3.5751098262370995e-12
at O 0 2.375866517412284e-11
nucleotide O 0 6.347658509930909e-10
position O 0 1.3259566777890086e-09
85 O 0 3.6842493500444107e-09
, O 0 1.1981699269900115e-12
which O 0 2.952814858944719e-13
lies O 0 9.214805134216686e-12
in O 0 8.458234655207841e-13
the O 0 6.423116205578339e-11
putative O 0 1.1764597296348711e-08
presequence O 0 3.648023039204418e-08
for O 0 2.480264778281782e-11
targeting O 0 1.2964464224385353e-10
to O 0 1.4641793333325381e-10
mitochondria O 0 1.8548212210589554e-07
. O 0 3.825130079349037e-08

This O 0 4.783629048432658e-10
mutation O 0 1.6346785036702727e-10
changes O 0 3.595051339955191e-11
the O 0 3.187707042773269e-11
codon O 0 2.7463104013136785e-10
for O 0 1.401214647783755e-11
glutamine O 0 2.236617557827003e-10
to O 0 1.4798866342438655e-12
a O 0 8.200254169275778e-13
termination O 0 5.726513485626583e-09
codon O 0 1.8469156204403703e-09
at O 0 2.9252228417320225e-10
amino O 0 2.593819048435364e-10
acid O 0 1.0397355199032177e-09
position O 0 1.893709411504574e-09
29 O 0 4.9426425619003567e-08
. O 0 2.014883193623973e-08

MaeI O 0 6.399650010280311e-05
restriction O 0 3.443528839852661e-07
analysis O 0 3.4065485987611055e-09
showed O 0 2.4480726334985548e-09
two O 0 5.95663004598207e-13
other O 0 4.1056421500387796e-13
carriers O 0 8.784078499302073e-12
in O 0 2.733352823594548e-12
the O 0 1.7245799233123194e-10
family O 0 2.0557186508618486e-10
. O 0 2.7533293422976612e-09

The O 0 2.7621103981800843e-07
C O 0 3.7971065466990694e-05
- O 0 7.17938428351772e-06
T O 0 2.8587469387275632e-06
mutation O 0 4.0540099055519363e-10
is O 0 1.805374290819381e-13
located O 0 3.386174533045322e-13
within O 0 1.5390059018849378e-12
a O 0 2.6768257749276714e-13
recently O 0 1.565286268656596e-11
proposed O 0 8.406924045800679e-10
putative O 0 1.1475028927065978e-08
alternative O 0 7.112828104283153e-09
translation O 0 1.627628587463903e-10
initiation O 0 8.097175152599334e-10
codon O 0 3.0626495783891983e-10
( O 0 1.497895774429936e-13
TIC O 0 3.454005137459859e-11
- O 0 2.400839249627751e-11
1 O 0 1.4614108534427572e-11
) O 0 8.28994787719457e-15
, O 0 9.212247663922118e-14
supporting O 0 7.177589143696206e-13
that O 0 1.3634179776931404e-13
TIC O 0 2.947232180527948e-10
- O 0 8.265244044736164e-10
1 O 0 2.1591890497774102e-09
is O 0 1.635880016517821e-13
the O 0 3.9827438222395095e-12
real O 0 1.2095001389322846e-10
TIC O 0 4.3075273903347977e-10
rather O 0 8.838366150065724e-11
than O 0 9.294414196614476e-12
TIC O 0 1.6808470171270073e-09
- O 0 1.705623864367567e-09
2 O 0 5.682780912508179e-10
. O 0 8.502039350322121e-12
. O 0 8.750053459571916e-11

Human B-Disease 0 6.850220390930417e-10
complement I-Disease 0 1.5783991003104347e-08
factor I-Disease 0 2.6636887923814356e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.999991774559021
associated O 0 5.795726337964879e-06
with O 0 2.7986270652036183e-06
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.005124908406287432

This O 0 3.608972565238844e-10
study O 0 7.974038096492109e-11
reports O 0 5.506611226030467e-12
on O 0 3.585134142683466e-12
six O 0 1.390107511522673e-13
cases O 0 3.419845309715619e-11
of O 0 1.6630843369114245e-09
deficiency B-Disease 0 1.1053628441004548e-05
in I-Disease 0 7.931554857343315e-10
the I-Disease 0 7.206293201056369e-11
human I-Disease 0 3.638245520826144e-12
complement I-Disease 0 1.9510830451263672e-11
regulatory I-Disease 0 9.600935602094296e-10
protein I-Disease 0 2.7089824827797315e-10
Factor I-Disease 0 2.1662427407420637e-09
H I-Disease 1 0.8225709199905396
( O 0 2.6879689338059343e-13
FH O 0 1.2466954135703645e-09
) O 0 2.532905703822347e-15
in O 0 1.0469640630253636e-15
the O 0 2.1369679876830864e-15
context O 0 1.7687607834545455e-13
of O 0 6.230334580496419e-14
an O 0 1.5975948049282845e-13
acute B-Disease 1 0.9994182586669922
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.1969066235906212e-06

Five O 0 7.396918633162386e-09
of O 0 4.866321928753692e-11
the O 0 2.2960793422815984e-12
cases O 0 4.6679478858668855e-12
were O 0 3.220386468345132e-13
observed O 0 6.715216490510434e-13
in O 0 4.49729297313968e-14
children O 0 1.1256783265939374e-14
presenting O 0 1.943835066867128e-12
with O 0 2.5032710279648818e-12
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.3126148107621702e-07
HUS B-Disease 1 1.0
) O 0 1.1361188656522359e-09
. O 0 2.227504758423038e-08

Two O 0 5.045758810773293e-10
of O 0 2.0743330664263482e-10
the O 0 8.428486242273436e-10
children O 0 3.817923061033568e-11
exhibited O 0 3.298742112800568e-10
a O 0 1.3530626619129293e-10
homozygous O 0 6.68865027364518e-07
deficiency O 0 6.090434681027546e-07
characterized O 0 1.0890822965681224e-10
by O 0 3.933866687261256e-12
the O 0 4.2459333271516186e-10
absence O 0 6.316468414979681e-08
of O 0 1.6977952377317251e-09
the O 0 1.8807275181664806e-11
150 O 0 1.8336447811517775e-12
- O 0 1.2823746784514783e-13
kD O 0 7.811916044597744e-12
form O 0 2.6563641694274387e-13
of O 0 1.383195207677046e-11
Factor O 0 2.676171229065716e-10
H O 1 0.9996383190155029
and O 0 3.826165946574367e-12
the O 0 3.9225735290124297e-13
presence O 0 1.5634883795620502e-13
, O 0 4.624960828268458e-14
upon O 0 7.200052186406847e-12
immunoblotting O 0 6.103508809474079e-09
, O 0 7.372170907592179e-13
of O 0 6.246023229877773e-12
the O 0 9.154820998502622e-12
42 O 0 4.2383659082378955e-11
- O 0 6.662834780429838e-12
kD O 0 2.310200503119475e-10
Factor O 0 8.860549516320759e-10
H O 1 0.9298349022865295
- O 0 1.2152824524491734e-08
like O 0 5.409095393815733e-11
protein O 0 3.10253628343915e-10
1 O 0 1.007302352640238e-09
( O 0 6.698353487545952e-14
FHL O 0 8.364418846440458e-08
- O 0 1.6612422548689665e-09
1 O 0 9.022633751243347e-10
) O 0 3.494514722621016e-14
and O 0 2.6913239974286907e-13
other O 0 3.2343043716333286e-13
FH O 0 1.775884506116654e-08
- O 0 5.373211320325311e-10
related O 0 4.1080316925956595e-09
protein O 0 6.179929346039614e-10
( O 0 4.668871626117843e-13
FHR O 0 2.550970748416148e-06
) O 0 5.563281172543677e-12
bands O 0 8.516529703683773e-09
. O 0 1.4285037597261407e-09

Southern O 0 3.849176550829725e-07
blot O 0 2.9772942866657104e-07
and O 0 2.7937102284325555e-11
PCR O 0 5.764262400731468e-10
analysis O 0 2.651187429314472e-12
of O 0 1.639010216610004e-12
DNA O 0 6.11121431237649e-11
of O 0 6.797322427143371e-11
one O 0 5.08615241937016e-12
patient O 0 3.8742449248729827e-08
with O 0 1.7047049535867664e-11
homozygous O 0 7.838483639943661e-08
deficiency O 0 3.7889910231569957e-07
ruled O 0 2.909312080134896e-08
out O 0 2.31485264984288e-11
the O 0 1.5536020820522412e-12
presence O 0 7.805508084497703e-13
of O 0 2.8416247219859025e-12
a O 0 1.0368558767646918e-13
large O 0 6.662894519969542e-13
deletion O 0 3.9749554017233513e-13
of O 0 4.057362952558652e-12
the O 0 6.848270561743419e-11
FH O 0 6.897688109575029e-08
gene O 0 4.254886807469882e-12
as O 0 5.793882626274616e-13
the O 0 5.1371333402439046e-12
underlying O 0 3.837507644988136e-09
defect O 0 1.8001823365310088e-09
for O 0 1.6124900026337485e-11
the O 0 1.8507106958054464e-08
deficiency O 0 0.0006341735133901238
. O 0 2.009531044677715e-06

The O 0 5.956327697731467e-08
other O 0 6.545171071792311e-10
four O 0 1.1199855279309112e-11
children O 0 5.859250259455939e-13
presented O 0 1.8949153357539217e-10
with O 0 9.769120234981443e-11
heterozygous O 0 7.209369101701668e-08
deficiency O 0 1.8105051822203677e-06
and O 0 1.1591650556086464e-10
exhibited O 0 8.604039702930777e-10
a O 0 5.309005839115866e-12
normal O 0 2.2563209967074727e-08
immunoblotting O 0 5.624674415116715e-08
pattern O 0 1.881260480729452e-09
of O 0 1.1044465689225014e-11
proteins O 0 9.022963582891452e-13
of O 0 4.879424555376266e-12
the O 0 8.761293079917465e-11
FH O 0 2.6960269678966142e-06
family O 0 7.319375106007442e-10
. O 0 1.5458658797484759e-09

Factor B-Disease 1 0.9999998807907104
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
is O 0 1.4159481746822689e-11
the O 0 5.521103105948777e-12
only O 0 1.0697280561355882e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.864212890723138e-07
with O 0 7.346676600405999e-10
HUS B-Disease 1 1.0
. O 0 2.9916550374764483e-06

These O 0 1.845226371699482e-08
observations O 0 5.017565030129845e-09
suggest O 0 2.000460075368693e-10
a O 0 1.1506655003823418e-12
role O 0 6.100985168455697e-12
for O 0 1.4348649872431007e-11
FH O 0 6.8165090851834975e-06
and O 0 8.918979443883757e-10
/ O 0 1.9936742035042698e-08
or O 0 4.6230211325770654e-10
FH O 0 9.230830499973308e-08
receptors O 0 5.936458963295976e-11
in O 0 2.769002204177501e-13
the O 0 2.488157683361303e-12
pathogenesis O 0 3.121903091596323e-08
of O 0 1.6502701982723522e-10
idiopathic O 0 1.9129738575429656e-05
HUS B-Disease 1 1.0
. O 0 2.9586686878246837e-08
. O 0 1.614541922378976e-08

Further O 0 3.1450666515553394e-09
evidence O 0 2.8202076784999974e-10
for O 0 5.871175399151107e-13
a O 0 5.394881590070622e-13
major O 0 1.6310158779120343e-10
ancient O 0 1.5406926934247167e-07
mutation O 0 2.6813197564479196e-06
underlying O 0 9.530827810522169e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 2.193881520895502e-09
linkage O 0 4.027960631702854e-09
disequilibrium O 0 2.7722102391436465e-09
studies O 0 1.8956281585668505e-13
in O 0 1.1335288185315034e-15
the O 0 9.790626832482593e-15
Japanese O 0 5.993103929791133e-11
population O 0 3.3099871042836793e-13
. O 0 2.76180519426239e-11

The O 0 4.266340056346962e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.177158861144562e-08
DM B-Disease 1 1.0
) O 0 5.030902361369272e-10
mutation O 0 2.698412160384578e-09
is O 0 9.560809175607199e-13
an O 0 2.780210957287199e-13
unstable O 0 3.643267234565428e-07
( O 0 5.631525107352431e-11
CTG O 0 2.2592207642446738e-06
) O 0 2.6417279821999706e-12
n O 0 1.3040121933649562e-11
repeat O 0 1.4543395134014592e-11
, O 0 7.392471238019255e-14
present O 0 8.10275566261176e-13
at O 0 1.6076645223406238e-12
a O 0 2.673369812740238e-14
copy O 0 7.690422083872495e-12
number O 0 1.0494047037595822e-12
of O 0 1.9580274901453976e-12
5 O 0 6.087551296385385e-11
- O 0 1.0350535012415563e-10
37 O 0 2.1306975628299085e-10
repeats O 0 3.3766437996379794e-12
on O 0 7.117227814046334e-12
normal O 0 2.7551719239404804e-10
chromosomes O 0 5.5503848045423965e-11
but O 0 3.178703134043559e-11
amplified O 0 6.988713496802745e-10
to O 0 3.033885989656149e-11
50 O 0 1.0754561824422026e-10
- O 0 2.4484718072481648e-11
3000 O 0 1.2627955972566163e-11
copies O 0 2.157869195829054e-11
on O 0 1.6565017413316951e-10
DM B-Disease 1 0.9999998807907104
chromosomes O 0 3.956177252462112e-08
. O 0 2.820865319108634e-09

Previous O 0 4.500219858982746e-07
findings O 0 1.3512071461718733e-08
in O 0 9.343441298437227e-11
Caucasian O 0 5.357369547986934e-10
populations O 0 3.368013853921603e-11
of O 0 7.289649786579311e-12
a O 0 8.743463592031375e-11
DM B-Disease 1 1.0
founder O 0 5.150116339791566e-05
chromosome O 0 3.1585567494829547e-09
raise O 0 1.1590589599208556e-10
a O 0 9.573431321774004e-14
question O 0 6.249535394395322e-13
about O 0 2.468093919072e-15
the O 0 2.0899521533963156e-14
molecular O 0 1.0393605870710407e-13
events O 0 2.82757012790881e-14
involved O 0 2.4205518232151002e-14
in O 0 2.4486001334173e-13
the O 0 1.565160848149283e-11
expansion O 0 3.513566326773798e-08
mutation O 0 5.1073620888075766e-09
. O 0 4.03851529995336e-09

To O 0 8.456250810695565e-09
investigate O 0 7.937400958724083e-09
whether O 0 2.441655988505431e-09
a O 0 3.077053889466441e-10
founder O 0 1.0657618787490719e-08
chromosome O 0 2.147056421542004e-10
for O 0 6.007108872829736e-12
the O 0 2.513940167148121e-09
DM B-Disease 1 1.0
mutation O 0 1.3146420618781463e-09
exists O 0 9.091859209942044e-13
in O 0 2.6337949511368594e-15
the O 0 4.232007844477085e-15
Japanese O 0 7.807180249508328e-12
population O 0 1.0158721940370895e-14
, O 0 1.8903053018823508e-14
we O 0 5.633657602921449e-13
genotyped O 0 1.3469306558988592e-08
families O 0 5.999711578247302e-12
using O 0 1.1504635135176078e-12
polymorphic O 0 1.1491011475683877e-09
markers O 0 6.840401578500632e-10
near O 0 7.978043781164956e-10
the O 0 2.137699045556829e-10
( O 0 9.146687747485505e-12
CTG O 0 3.3920565556400106e-07
) O 0 3.2454663956293928e-12
n O 0 2.7816579595274504e-10
repeat O 0 4.837783507127824e-10
region O 0 3.265120951390088e-10
and O 0 1.828260806635562e-11
constructed O 0 2.8124969020382196e-08
haplotypes O 0 1.3556426381455822e-07
. O 0 2.8786770300825992e-08

Six O 0 1.695129725476363e-08
different O 0 5.676324965619983e-10
haplotypes O 0 1.0193340393982453e-08
were O 0 3.5528018027530806e-11
found O 0 3.348769395464246e-12
and O 0 1.4671557371781496e-11
DM B-Disease 1 1.0
alleles O 0 1.8526841172317177e-09
were O 0 3.14114428912049e-10
always O 0 6.861043677641732e-11
haplotype O 0 1.3026437706287197e-09
A O 0 1.015098116674551e-09
. O 0 2.1082542378536573e-09

To O 0 4.716279589089822e-10
find O 0 1.2718723643723173e-11
an O 0 1.111210135646063e-15
origin O 0 2.7997634592658027e-12
of O 0 1.4516069769821005e-11
the O 0 8.056224437558157e-11
( O 0 4.5417953252469e-12
CTG O 0 2.3159255135851708e-07
) O 0 1.0068878239857804e-12
n O 0 5.591772878066337e-11
repeat O 0 9.52581555302423e-11
mutation O 0 3.1134303468682845e-11
and O 0 1.1626358513081025e-12
to O 0 1.0021476920876737e-12
investigate O 0 1.8741815391298822e-11
the O 0 1.3219704844691371e-11
mechanism O 0 4.875280179561514e-10
of O 0 3.7654640516748827e-10
the O 0 3.0797767114343344e-11
expansion O 0 3.1188778226720615e-09
mutation O 0 1.3971422976877257e-11
in O 0 9.155091235894114e-14
the O 0 7.721397848360623e-14
Japanese O 0 3.71297888268618e-11
population O 0 1.8530294147527625e-14
we O 0 5.926641420466935e-14
have O 0 4.3670060921379913e-14
studied O 0 2.627306575422872e-12
90 O 0 5.790239381714413e-12
Japanese O 0 1.8536350232523091e-09
DM B-Disease 1 1.0
families O 0 9.740213080533522e-10
comprising O 0 6.0556316905380214e-12
190 O 0 3.0468802394295613e-12
affected O 0 1.384002808191287e-11
and O 0 3.566610114885682e-12
130 O 0 6.667087437683961e-10
unaffected O 0 2.599565220862132e-07
members O 0 1.066891575085549e-10
. O 0 2.426919110121162e-09

The O 0 3.318579899769247e-08
results O 0 7.774856314313183e-09
suggest O 0 2.492683393029438e-09
that O 0 9.217366453428966e-13
a O 0 3.078142341711443e-12
few O 0 1.2129330873023036e-10
common O 0 2.6108687434245326e-10
ancestral O 0 4.477954007597873e-08
mutations O 0 1.5428849309273573e-09
in O 0 9.726747879357234e-11
both O 0 3.8676086638878004e-11
Caucasian O 0 1.1816037037704064e-10
and O 0 5.2407327609527155e-12
Japanese O 0 5.6871645170986085e-09
populations O 0 5.0948034853448565e-12
have O 0 4.5998791662607216e-14
originated O 0 7.658975450380856e-13
by O 0 1.6562045382058702e-14
expansion O 0 8.974879173173633e-11
of O 0 6.212660160626049e-12
an O 0 9.20520441555911e-14
ancestral O 0 3.088272138018766e-10
n O 0 2.227998688320021e-11
= O 0 2.312027522557991e-12
5 O 0 5.046831442340194e-12
repeat O 0 1.1997112287984169e-12
to O 0 1.6761061939415955e-12
n O 0 7.083941766516944e-11
= O 0 5.564939481450537e-11
19 O 0 1.0046659060236607e-09
- O 0 1.0775038639110335e-09
37 O 0 1.1148352241363568e-09
copies O 0 9.029347269873256e-10
. O 0 1.63578972589562e-09

These O 0 1.1934777610633773e-09
data O 0 6.024414994643124e-11
support O 0 2.836984987208968e-11
multistep O 0 1.182983240255453e-07
models O 0 1.568621144087956e-08
of O 0 2.1443744913085538e-07
triplet O 0 2.8882614060421474e-05
repeat O 0 4.035127343371414e-09
expansion O 0 7.360917209098261e-09
that O 0 1.2302874376809297e-13
have O 0 1.7900326945534395e-14
been O 0 7.427178751846179e-15
proposed O 0 1.9242132843697024e-13
for O 0 4.053870547625696e-14
both O 0 9.219376130575885e-12
DM B-Disease 1 1.0
and O 0 4.889959992482318e-09
Friedreichs B-Disease 0 7.146017014747486e-05
ataxia I-Disease 0 4.974341572960839e-05
. O 0 2.1028016661261972e-08
. O 0 4.8095706972617336e-08

The O 0 9.221565733241732e-10
molecular O 0 1.121283954574892e-09
basis O 0 1.4675805459773983e-08
of O 0 2.2450240066973493e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.53356918777925e-10
the O 0 1.5906092415418627e-11
western O 0 1.4079934440580644e-10
Cape O 0 1.7456586176578526e-09
, O 0 2.513474996711229e-13
South O 0 6.427156983707105e-12
Africa O 0 2.7789504638414675e-12
. O 0 4.820520024817476e-11

Deficiency B-Disease 0 0.3383514881134033
of I-Disease 0 1.2343177786533488e-06
the I-Disease 0 2.1375427650127676e-07
sixth I-Disease 0 5.301131750456989e-06
component I-Disease 0 5.60979231067904e-07
of I-Disease 0 1.0575673314860978e-07
human I-Disease 0 8.361033643211613e-09
complement I-Disease 0 8.454672979496536e-07
( O 0 1.8179643554439018e-11
C6 O 0 4.541451289696852e-06
) O 0 5.436146866856506e-13
has O 0 1.6215403585845278e-13
been O 0 2.577363236028196e-13
reported O 0 9.966154420823492e-14
in O 0 5.190549799325393e-14
a O 0 6.976762205880126e-15
number O 0 2.3880935206763154e-14
of O 0 6.536612885080922e-14
families O 0 3.2669024007270925e-14
from O 0 1.089452557031037e-13
the O 0 6.517281831396049e-13
western O 0 2.4057669051336106e-11
Cape O 0 6.86473877742344e-10
, O 0 3.463620449478677e-13
South O 0 5.957542618950651e-12
Africa O 0 6.486468480393359e-12
. O 0 7.633024073916417e-11

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999978542327881
is O 0 4.3439121744093256e-10
endemic O 0 1.4041094675842913e-11
in O 0 8.145880346123457e-13
the O 0 8.460852678193742e-12
Cape O 0 5.3707345237796744e-09
and O 0 1.8429530091682716e-13
almost O 0 7.981147616712911e-14
all O 0 7.448629014202447e-15
pedigrees O 0 2.952530581135093e-11
of O 0 3.7928440770051974e-12
total O 0 1.7441118771444053e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.6230403132588833e-10
C6Q0 O 0 0.00017645738262217492
) O 0 1.4189050325311148e-12
have O 0 1.1262931369883725e-13
been O 0 1.5119925710765925e-13
ascertained O 0 1.3259870978998833e-09
because O 0 8.295642645039791e-11
of O 0 2.6988844492592534e-10
recurrent O 0 8.8497722572356e-07
disease O 0 6.349287104967516e-07
. O 0 8.288300534786686e-08

We O 0 5.684713588749446e-09
have O 0 3.2954011047747755e-11
sequenced O 0 1.2824677986245092e-09
the O 0 4.80383337275736e-11
expressed O 0 1.1025702573164153e-09
exons O 0 1.1294237545200758e-08
of O 0 1.5941888920067981e-09
the O 0 7.539155966185263e-09
C6 O 0 6.795511126256315e-06
gene O 0 3.062636602657598e-11
from O 0 5.49403231242529e-12
selected O 0 1.7055018855516302e-11
cases O 0 6.393070534765899e-12
and O 0 7.591317982211243e-13
have O 0 1.2816631707757847e-13
found O 0 9.57844155553833e-13
three O 0 5.472411803222887e-13
molecular O 0 5.48726486471196e-09
defects O 0 8.938112296164036e-05
leading O 0 1.4153513916426164e-07
to O 0 8.819997510123301e-10
total O 0 9.977443227171534e-08
deficiency O 0 0.00012581146438606083
879delG O 0 7.126639502530452e-06
, O 0 1.3722217806488857e-11
which O 0 1.6763611440824555e-13
is O 0 4.1162020081482453e-14
the O 0 1.0895424102860818e-12
common O 0 1.397198884367512e-10
defect O 0 4.293552180456572e-09
in O 0 1.2082272682345518e-10
the O 0 5.394961699600742e-10
Cape O 0 1.3499707129938088e-08
and O 0 6.291482525927483e-12
hitherto O 0 1.3679584132120226e-09
unreported O 0 5.453705820279708e-10
, O 0 5.518763072399901e-13
and O 0 2.3133773542627356e-12
1195delC O 0 4.342705306470407e-09
and O 0 4.075421250471223e-11
1936delG O 0 2.179913316524562e-08
, O 0 5.6610736064166556e-12
which O 0 7.715233616908956e-13
have O 0 2.5715996172792632e-12
been O 0 6.371426823637005e-12
previously O 0 8.231002684988553e-12
reported O 0 1.1764528153740406e-12
in O 0 3.881308035386111e-12
African O 0 1.3774321093451558e-11
- O 0 2.044231034448174e-10
Americans O 0 5.632491695273245e-11
. O 0 1.5059709035369906e-10

We O 0 4.9684082625844894e-08
also O 0 7.76808894986658e-11
show O 0 2.427869103677205e-12
that O 0 2.2129982579516955e-14
the O 0 3.202361553017452e-12
879delG O 0 3.062039510837167e-08
and O 0 8.244519650313364e-11
1195delC O 0 2.4481070681758865e-07
defects O 0 5.020755793339049e-07
are O 0 4.433565060218969e-12
associated O 0 2.3491827927379916e-10
with O 0 4.306342088478132e-11
characteristic O 0 7.001457561273128e-05
C6 O 1 0.9999998807907104
/ O 0 3.754131103050895e-05
C7 O 0 2.9747798180324025e-05
region O 0 9.207229645369353e-09
DNA O 0 8.146611385484448e-09
marker O 0 7.763060416721146e-09
haplotypes O 0 2.347902539057145e-09
, O 0 1.26336831621221e-12
although O 0 6.36838932283057e-12
small O 0 1.2465745666614958e-12
variations O 0 1.9747721513585503e-10
were O 0 1.2333413457188414e-10
observed O 0 1.1338832095475482e-08
. O 0 3.209185805985726e-08

The O 0 1.347126357131856e-07
1936delG O 0 3.8557896004931536e-06
defect O 0 1.14227384528931e-06
was O 0 3.34383614131184e-08
observed O 0 1.0834431130035682e-09
only O 0 1.2001374720405078e-11
once O 0 1.7336023241942833e-11
in O 0 4.0062687867679914e-13
the O 0 5.040232554237578e-12
Cape O 0 4.120642493887772e-09
, O 0 1.0322818310868828e-13
but O 0 1.4112714089801331e-13
its O 0 8.931217717429371e-14
associated O 0 6.013783915292947e-11
haplotype O 0 9.609893991679996e-10
could O 0 1.3678533306027418e-10
be O 0 7.216554437361467e-11
deduced O 0 3.07015675105049e-08
. O 0 1.1268116217877377e-08

The O 0 7.747573249616835e-09
data O 0 4.3133149829621686e-10
from O 0 1.7277167543849892e-11
the O 0 5.4888923267659706e-11
haplotypes O 0 3.581449137257664e-09
indicate O 0 1.9846878307472338e-10
that O 0 1.2370901286869185e-13
these O 0 5.2353377709424276e-12
three O 0 4.597250314805623e-13
molecular O 0 2.101268048448901e-10
defects O 0 9.804709932836886e-09
account O 0 1.009555460063094e-11
for O 0 5.170772664209178e-12
the O 0 1.715660169487876e-09
defects O 0 3.099652531091124e-06
in O 0 2.4851969371297855e-09
all O 0 1.3998531500636346e-10
the O 0 5.514538825579507e-11
38 O 0 8.50587170142525e-11
unrelated O 0 2.4212634675002676e-10
C6Q0 O 0 8.832175240058859e-07
individuals O 0 3.516073283221788e-12
we O 0 4.2193926304279206e-12
have O 0 1.272992263901332e-13
studied O 0 4.0947111153155635e-12
from O 0 1.3381090940151052e-12
the O 0 1.842740370017193e-11
Cape O 0 2.0840351666606693e-08
. O 0 9.317249194396027e-10

We O 0 1.5510146056385565e-08
have O 0 1.8667288201323906e-11
also O 0 2.4831119148707725e-13
observed O 0 3.969933756731159e-12
the O 0 1.3715571213490652e-11
879delG O 0 1.1373079900067751e-07
defect O 0 6.620030745807526e-08
in O 0 9.110968091086136e-10
two O 0 2.0836636582810542e-10
Dutch O 0 0.008720175363123417
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 4.012920271634357e-06
, O 0 6.075924919440867e-12
but O 0 1.094443329366368e-12
the O 0 2.0494770811008145e-11
879delG O 0 7.488598186000672e-08
defect O 0 5.090617349878812e-08
in O 0 4.73153349833666e-10
the O 0 4.7381537582325e-10
Cape O 0 1.944172822732071e-08
probably O 0 3.826737191015006e-11
did O 0 1.1169918072082008e-12
not O 0 2.1218409787440023e-13
come O 0 1.7263520257423948e-12
from O 0 2.3941056927732907e-13
The O 0 3.4457321978348388e-12
Netherlands O 0 1.5544801557076937e-11
. O 0 8.39638775174123e-12
. O 0 6.285372222691876e-10

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.6465836694123936e-08
seven O 0 1.856769182850826e-10
further O 0 1.740033256369955e-10
molecular O 0 2.829407641513626e-08
defects O 0 2.172955419155187e-06
and O 0 2.491608031007786e-10
their O 0 1.3837157808449518e-10
associated O 0 4.754559856934293e-09
marker O 0 8.35486773098637e-08
haplotypes O 0 1.2012023375973513e-07
. O 0 7.2225243563650565e-09

Seven O 0 3.3043481284522613e-09
further O 0 1.0608042916304683e-10
molecular O 0 3.120627090069661e-09
bases O 0 8.713904264823213e-09
of O 0 0.00018675083993002772
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.830556843415934e-09
described O 0 2.6840192290933373e-09
. O 0 4.338350567678617e-09

All O 0 2.1870766531151276e-08
these O 0 4.051706192775839e-10
new O 0 6.132749308385144e-10
molecular O 0 9.943774692544594e-09
defects O 0 1.1620971740455843e-08
involve O 0 1.0250220117136166e-10
single O 0 1.0971238501022995e-10
- O 0 3.331597220324056e-10
nucleotide O 0 2.9238407250886667e-09
events O 0 3.338325449409041e-11
, O 0 2.717653576136958e-12
deletions O 0 4.0159914282966724e-10
and O 0 5.0705509235804413e-11
substitutions O 0 1.063474863727265e-09
, O 0 5.589307228853757e-12
some O 0 2.7020443174596842e-12
of O 0 1.502335235381569e-11
which O 0 3.2304096463792176e-12
alter O 0 8.380064642210527e-09
splice O 0 4.777670525868416e-08
sites O 0 2.528038445248626e-09
, O 0 4.3110246275568365e-12
and O 0 2.075201555734596e-12
others O 0 4.550607460296341e-11
codons O 0 1.178548370006638e-08
. O 0 1.1157845314357928e-08

They O 0 2.796341380673084e-09
are O 0 2.8115149097729386e-12
distributed O 0 4.276896111571338e-12
along O 0 7.428525156116805e-11
the O 0 2.7593369256173617e-10
C7 O 0 8.274603260360891e-07
gene O 0 1.808001838521367e-11
, O 0 1.250866489381497e-12
but O 0 1.1722686623499845e-12
predominantly O 0 2.631542986991642e-13
towards O 0 4.117799851099946e-12
the O 0 5.444138629490114e-12
3 O 0 1.2617032418837937e-10
end O 0 3.8104097654922953e-10
. O 0 3.298466833001612e-09

All O 0 8.638081361311833e-09
were O 0 3.0582775201182244e-10
found O 0 6.47062655192987e-12
in O 0 1.225409747632189e-12
compound O 0 1.687155193330625e-09
heterozygous O 0 4.0460843009348935e-10
individuals O 0 6.477220235862058e-12
. O 0 1.4371945855629065e-09

The O 0 1.3725958524446469e-05
C6 O 1 0.9980629086494446
/ O 0 0.000317441881634295
C7 O 0 0.00016287843754980713
marker O 0 1.586258804309182e-07
haplotypes O 0 2.796785558700776e-08
associated O 0 3.801337911113478e-09
with O 0 9.063887834726003e-11
most O 0 1.653703129989026e-08
C7 B-Disease 1 0.9999932050704956
defects I-Disease 0 0.0003841620637103915
are O 0 4.770217554295186e-10
tabulated O 0 1.3597128756259735e-08
. O 0 2.8509489213845995e-10
. O 0 1.6303947081297565e-09

A O 0 1.5785217328811996e-06
genome O 0 6.640353689135736e-08
- O 0 3.469368436981313e-08
wide O 0 2.0873758277417664e-09
search O 0 3.5015521732129073e-11
for O 0 2.6061135671370805e-13
chromosomal O 0 2.276525989941547e-08
loci O 0 3.9908434246171964e-07
linked O 0 5.378982223191997e-06
to O 0 2.363692352957969e-09
mental O 1 0.9999991655349731
health O 0 0.0009202237124554813
wellness O 0 8.373946229767171e-07
in O 0 7.422232967124742e-12
relatives O 0 5.7246072465710895e-11
at O 0 4.0818897198945103e-13
high O 0 1.7065593729825856e-11
risk O 0 1.0592590173053029e-11
for O 0 1.122785284884964e-11
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.0004357913276180625
the O 0 2.995930614702047e-09
Old O 0 2.2419030187847966e-08
Order O 0 1.484333544965466e-08
Amish O 0 1.5916381812530744e-07
. O 0 1.2760066336880982e-09

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999397993087769
BPAD B-Disease 1 1.0
; O 1 1.0
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 4.548373677693007e-09
is O 0 1.8821772265753545e-11
characterized O 0 5.491583576766601e-11
by O 0 2.8316695776381406e-12
episodes O 0 2.197687448690644e-10
of O 0 2.3344426391957995e-10
mania B-Disease 0 3.480729446891928e-07
and O 0 8.25548726601788e-11
/ O 0 1.6713210371221976e-08
or O 0 3.732293640812401e-10
hypomania B-Disease 0 8.563657161175797e-08
interspersed O 0 5.876985009756197e-11
with O 0 2.8763834931645966e-15
periods O 0 7.213640240699704e-10
of O 0 2.806053167603295e-10
depression B-Disease 0 1.9601950498326914e-06
. O 0 4.065971097588772e-07

Compelling O 0 2.667180183379969e-07
evidence O 0 3.983235963289644e-09
supports O 0 1.8436378812491938e-10
a O 0 8.576173625429728e-13
significant O 0 3.886747174108862e-11
genetic O 0 1.1477474526344622e-09
component O 0 3.230933742770503e-08
in O 0 1.5757233018387495e-10
the O 0 1.5218936111338621e-09
susceptibility O 0 4.0926042288447206e-07
to O 0 1.3466653348004343e-09
develop O 0 7.466721399396192e-06
BPAD B-Disease 1 1.0
. O 0 0.0007540102815255523

To O 0 7.94226906464246e-11
date O 0 1.3019159439409123e-07
, O 0 1.6727026014295987e-11
however O 0 2.981916380484506e-10
, O 0 7.0548939953840595e-12
linkage O 0 1.3547470922858906e-09
studies O 0 1.5473984940617136e-11
have O 0 2.153804478516319e-13
attempted O 0 7.888491942997788e-11
only O 0 3.309553152364142e-12
to O 0 9.580346065074519e-12
identify O 0 4.5666784243003633e-10
chromosomal O 0 2.2099222007909702e-07
loci O 0 4.288627053483651e-08
that O 0 1.3739686471891943e-11
cause O 0 8.013608665535799e-10
or O 0 2.3477916659409015e-12
increase O 0 3.652561759992512e-12
the O 0 4.632443300484068e-12
risk O 0 5.753999360313955e-11
of O 0 1.1861696347370554e-10
developing O 0 3.5919111951443483e-07
BPAD B-Disease 1 1.0
. O 0 6.524339551106095e-05

To O 0 7.006601965287018e-09
determine O 0 7.996419526534737e-09
whether O 0 4.064828917904606e-09
there O 0 1.9032063425239443e-10
could O 0 4.8164947724638196e-11
be O 0 3.435260756412539e-11
protective O 0 9.54532310970535e-07
alleles O 0 4.5197981468625414e-10
that O 0 3.785629036807958e-13
prevent O 0 5.840953588853726e-12
or O 0 4.117038307493992e-12
reduce O 0 3.684337210319022e-11
the O 0 2.811103433364437e-11
risk O 0 2.2295131019145487e-10
of O 0 1.429770607463965e-10
developing O 0 2.1696372698443156e-07
BPAD B-Disease 1 1.0
, O 0 6.68745225862466e-10
similar O 0 1.471892573101652e-11
to O 0 8.260062013716596e-13
what O 0 2.260368677170846e-13
is O 0 1.0778484936448552e-14
observed O 0 2.4962575409515075e-12
in O 0 1.5095699213221736e-12
other O 0 2.560102796422825e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.0269275013685686e-11
we O 0 6.68160242845578e-13
used O 0 1.9716998866936564e-11
mental O 0 8.207922655856237e-05
health O 0 5.0713490054477006e-05
wellness O 0 1.2557692343762028e-06
( O 0 1.1140677410540617e-13
absence O 0 4.672056838628258e-11
of O 0 4.17860320997554e-12
any O 0 6.291213106024429e-10
psychiatric B-Disease 1 0.9999898672103882
disorder I-Disease 0 1.5063982061747083e-07
) O 0 6.97645012506104e-13
as O 0 2.329538688686239e-12
the O 0 1.585822965999295e-11
phenotype O 0 1.9616452906490167e-09
in O 0 1.9582151872254983e-11
our O 0 2.546951261006569e-10
genome O 0 1.0091305568948883e-10
- O 0 4.082596483101497e-10
wide O 0 1.9499504233522202e-09
linkage O 0 3.3475613392397463e-09
scan O 0 1.0455233478978698e-07
of O 0 2.242201313507053e-09
several O 0 6.055438789287493e-11
large O 0 9.589876115434492e-11
multigeneration O 0 6.028446364325646e-08
Old O 0 1.4283465077369328e-08
Order O 0 2.9806457746417436e-08
Amish O 0 1.1435268731929682e-07
pedigrees O 0 8.486401803509125e-09
exhibiting O 0 2.9034479681611103e-11
an O 0 3.866641876744837e-15
extremely O 0 1.756022584287198e-11
high O 0 6.77370243229447e-11
incidence O 0 1.9801817963127633e-09
of O 0 3.65445584904478e-09
BPAD B-Disease 1 1.0
. O 0 0.0022592516615986824

We O 0 1.2081667932761775e-07
have O 0 2.851786584656679e-10
found O 0 9.838526694727623e-12
strong O 0 2.0683730336118478e-12
evidence O 0 4.232974647883081e-12
for O 0 1.0623819939005116e-13
a O 0 3.4734379001505333e-13
locus O 0 6.950792372228953e-12
on O 0 7.629501891370793e-11
chromosome O 0 6.027521259888147e-10
4p O 0 2.348205271118786e-06
at O 0 4.07674505265021e-10
D4S2949 O 0 4.542350495739811e-08
( O 0 2.9930802302770287e-13
maximum O 0 1.2660036907696792e-10
GENEHUNTER O 0 6.076671525079291e-06
- O 0 9.782815446612858e-09
PLUS O 0 1.0963049135170877e-08
nonparametric O 0 2.07645687311242e-08
linkage O 0 1.0753870016699807e-09
score O 0 2.6130595950912827e-11
= O 0 3.5735742707002083e-13
4 O 0 1.1434543633129235e-12
. O 0 5.874723044184751e-14
05 O 0 2.862047265850265e-10
, O 0 6.2102315477596814e-12
P O 0 1.0730231814193303e-08
= O 0 4.497057674163196e-12
5 O 0 8.822395071439448e-12
. O 0 2.365374335202425e-13
22 O 0 1.4331281820989528e-11
x O 0 3.9369030258029625e-10
10 O 0 1.2425023510065358e-10
( O 0 2.7509773430599294e-13
- O 0 3.5121491825940154e-10
4 O 0 3.284578165008156e-10
) O 0 5.2770274586687316e-14
; O 0 2.8827426556965463e-12
SIBPAL O 0 5.396965661930153e-06
Pempirical O 0 1.8462900186477782e-07
value O 0 6.150273068605827e-10
< O 0 2.6998472901773596e-10
3 O 0 2.2038988689576655e-11
x O 0 5.689979737377726e-11
10 O 0 8.996092065727268e-12
( O 0 3.009381684278799e-14
- O 0 1.0786116444450045e-10
5 O 0 1.7031719090621067e-10
) O 0 3.955259310719529e-14
) O 0 7.435657721054784e-14
and O 0 1.0222759054198671e-12
suggestive O 0 9.682101648200714e-11
evidence O 0 2.6397536500438745e-12
for O 0 9.575385596189909e-14
a O 0 1.9903265233850442e-12
locus O 0 6.199572105680673e-11
on O 0 2.263155662873828e-09
chromosome O 0 1.3769352769088528e-08
4q O 0 5.986086648590572e-08
at O 0 3.590434338729409e-10
D4S397 O 0 3.817033089603683e-08
( O 0 6.732157691556606e-13
maximum O 0 6.978577160587918e-10
GENEHUNTER O 0 1.9030278053833172e-05
- O 0 1.4089028610442256e-08
PLUS O 0 1.3209894511589937e-08
nonparametric O 0 1.9809457185715473e-08
linkage O 0 8.98224772338807e-10
score O 0 2.4899249329024542e-11
= O 0 4.4713194193198025e-13
3 O 0 1.3104569512867315e-12
. O 0 1.0539717698859058e-13
29 O 0 1.5222935412229077e-10
, O 0 5.2347388576623466e-12
P O 0 1.494777279731352e-08
= O 0 3.5677801858702285e-12
2 O 0 1.3623067084134188e-11
. O 0 4.802152599181486e-13
57 O 0 4.702121678135107e-11
x O 0 2.846135271905581e-10
10 O 0 1.195062521164303e-10
( O 0 1.5272703349396288e-13
- O 0 2.8723340372849293e-10
3 O 0 1.8371930365912448e-10
) O 0 2.5490065719518777e-14
; O 0 1.0815069543049227e-12
SIBPAL O 0 3.2949019441730343e-06
Pempirical O 0 2.9042067239970493e-07
value O 0 9.101970843694573e-10
< O 0 3.1803237821037555e-10
1 O 0 8.567418996463516e-11
x O 0 4.0916706134375147e-10
10 O 0 3.623876546066107e-11
( O 0 2.1842280046278917e-13
- O 0 2.7221280785028057e-10
3 O 0 9.274656043167795e-11
) O 0 3.653705840618105e-15
) O 0 1.0221300099239332e-15
that O 0 1.3092107574512154e-15
are O 0 7.787050355662767e-14
linked O 0 1.5410135667526248e-10
to O 0 3.8907399524390485e-10
mental O 1 0.9999544620513916
health O 1 0.9788315892219543
wellness O 0 0.0001710212673060596
. O 0 1.1316279824313824e-07

These O 0 1.5491194105266004e-08
findings O 0 6.704403254786939e-09
are O 0 7.388784896422695e-12
consistent O 0 3.476200438612409e-10
with O 0 2.4461913072405805e-13
the O 0 3.1246207010671156e-11
hypothesis O 0 1.3565855105923674e-09
that O 0 1.2877989419204233e-13
certain O 0 3.552898530934101e-10
alleles O 0 1.5279602583184726e-10
could O 0 1.1875776750880362e-10
prevent O 0 3.190841202371786e-10
or O 0 9.808440171177324e-11
modify O 0 1.296105889281307e-09
the O 0 4.7330566549375064e-11
clinical O 0 3.768000356174639e-10
manifestations O 0 5.927119683946103e-09
of O 0 6.543785513457578e-10
BPAD B-Disease 1 1.0
and O 0 1.81061780152314e-11
perhaps O 0 9.337164721956448e-12
other O 0 3.825521984694019e-13
related O 0 1.534683065074205e-07
affective B-Disease 1 0.9994903802871704
disorders I-Disease 1 0.9999985694885254
. O 0 4.3186882976442575e-05

Segregation O 0 4.3019012082368135e-05
distortion O 0 7.163182090152986e-06
in O 0 1.234599693589189e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.000613934884313494

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.674187832482858e-06
DM B-Disease 1 1.0
) O 0 2.0170431991317628e-09
is O 0 5.247687007159385e-11
an O 0 4.383291472842554e-12
autosomal B-Disease 1 0.999998927116394
dominant I-Disease 1 0.9007723927497864
disease I-Disease 1 0.987057626247406
which O 0 1.2332088475397462e-11
, O 0 1.0488279082038199e-13
in O 0 3.5178138884945503e-14
the O 0 2.696369603288895e-13
typical O 0 1.0954503797122594e-11
pedigree O 0 5.649491985337818e-11
, O 0 5.084944441967158e-14
shows O 0 4.334603151672639e-13
a O 0 6.12575785994933e-14
three O 0 5.591191572229537e-13
generation O 0 9.812118229035605e-09
anticipation O 0 3.455072032920725e-07
cascade O 0 1.1698836743789798e-07
. O 0 6.067410573962206e-09

This O 0 1.7684251632510417e-11
results O 0 4.497662520197565e-10
in O 0 3.8760072929022726e-10
infertility B-Disease 1 0.9130217432975769
and O 0 7.002049073889793e-08
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.513743516263105e-10
CDM B-Disease 0 9.268549661101133e-08
) O 0 1.684829169625382e-14
with O 0 1.4272957265070558e-15
the O 0 4.1548066528028504e-13
disappearance O 0 3.308708862448384e-11
of O 0 1.1378901987324497e-10
DM B-Disease 1 1.0
in O 0 9.806612188967279e-10
that O 0 1.9830597233760905e-11
pedigree O 0 1.9136258799790085e-08
. O 0 4.476344017678713e-10

The O 0 3.284780225598638e-09
concept O 0 5.586618723185666e-09
of O 0 6.993917889275281e-09
segregation O 0 4.690331678602888e-08
distortion O 0 3.3714233627080148e-09
, O 0 2.248008853719674e-12
where O 0 9.774926094247016e-13
there O 0 1.2385816351224207e-14
is O 0 1.593898107506912e-15
preferential O 0 1.3908727468370241e-11
transmission O 0 3.007382103764611e-12
of O 0 1.8469657227238034e-12
the O 0 6.664118042121192e-12
larger O 0 5.492411386809337e-11
allele O 0 1.6542558989307565e-11
at O 0 6.045314856345518e-12
the O 0 2.7334584248861482e-11
DM B-Disease 1 1.0
locus O 0 2.5710530926481567e-10
, O 0 2.486634596149395e-12
has O 0 1.5548997365274347e-13
been O 0 1.0650321770333537e-12
put O 0 1.17040144936853e-11
forward O 0 7.541238189467947e-10
to O 0 3.562247372079774e-11
explain O 0 8.366325965347698e-10
partially O 0 1.8289521286352084e-10
the O 0 9.674801107820152e-13
maintenance O 0 2.3088668754667196e-09
of O 0 1.1994727433517482e-09
DM B-Disease 1 1.0
in O 0 4.982609880244127e-10
the O 0 5.388017115803834e-11
population O 0 4.256873716371179e-13
. O 0 3.5372500067909485e-11

In O 0 7.314783223577592e-10
a O 0 6.16076287207612e-12
survey O 0 1.2761174061903802e-11
of O 0 9.139259661561372e-12
DM B-Disease 1 1.0
in O 0 9.15789222233343e-09
Northern O 0 2.828948986177693e-08
Ireland O 0 7.651715927536884e-10
, O 0 5.539668116588681e-12
59 O 0 3.9439679300201647e-10
pedigrees O 0 4.0351788577197567e-10
were O 0 6.463225787900484e-12
ascertained O 0 1.7826852882762978e-08
. O 0 6.067387481323294e-09

Sibships O 0 2.8413049221853726e-05
where O 0 1.561563323093651e-09
the O 0 1.6649995618345237e-11
status O 0 2.8491347059400596e-09
of O 0 2.1240196268479394e-09
all O 0 2.6587440582481747e-11
the O 0 7.506319871231071e-11
members O 0 1.1368651246096428e-12
had O 0 3.672450364644586e-12
been O 0 3.3065876425819596e-12
identified O 0 6.8275168504938755e-12
were O 0 7.360582629512002e-12
examined O 0 7.5205792982036e-11
to O 0 5.483570954083195e-13
determine O 0 9.025722877420428e-12
the O 0 1.9977279379357338e-12
transmission O 0 1.0547214490674861e-10
of O 0 4.2020949220233916e-11
the O 0 1.3216642225089004e-09
DM B-Disease 1 1.0
expansion O 0 1.9743952179851476e-06
from O 0 3.979740426096612e-10
affected O 0 2.17715312444966e-09
parents O 0 7.493216463982932e-11
to O 0 4.973195466551061e-12
their O 0 2.1473266220706222e-10
offspring O 0 4.808754638929713e-08
. O 0 2.9876452423138744e-09

Where O 0 8.791462557944385e-10
the O 0 7.621618614006564e-11
transmitting O 0 1.359965011715758e-07
parent O 0 4.6428064170989103e-10
was O 0 7.580333583057097e-10
male O 0 8.021468489438632e-10
, O 0 2.1405661965179235e-11
58 O 0 5.588494556008072e-09
. O 0 2.023555545349609e-09

3 O 0 1.70859834724979e-07
% O 0 4.3958214845929433e-10
of O 0 5.18561027451625e-11
the O 0 6.716260880779146e-11
offspring O 0 7.292720205498426e-09
were O 0 2.2632279383927312e-10
affected O 0 4.0377659549228895e-10
, O 0 1.943156789988021e-12
and O 0 7.55424097841767e-13
in O 0 2.140707045222151e-13
the O 0 2.7575966683734965e-13
case O 0 1.0195965165910037e-12
of O 0 2.1906951350614962e-13
a O 0 7.28694584057124e-14
female O 0 1.4315564792616309e-12
transmitting O 0 4.0894235220356734e-10
parent O 0 3.4721697739215074e-11
, O 0 1.0081162467312499e-11
68 O 0 1.0835987218626997e-08
. O 0 1.1508169528440249e-08

7 O 0 4.150050187945453e-07
% O 0 1.40378952906417e-09
were O 0 1.1071384087291136e-10
affected O 0 3.938279480308893e-09
. O 0 2.609512428364269e-08

Studies O 0 1.324284681913923e-07
on O 0 3.3172937730086005e-09
meiotic O 0 1.6643137996652513e-06
drive O 0 1.0629688773633461e-07
in O 0 1.2786386172081166e-08
DM B-Disease 1 1.0
have O 0 1.6636712008022414e-09
shown O 0 6.011854208898271e-12
increased O 0 3.7952392964446524e-12
transmission O 0 1.3303625779129136e-12
of O 0 4.124524615074787e-14
the O 0 1.0011632636201112e-13
larger O 0 1.5638650313967717e-12
allele O 0 1.0568166350713448e-12
at O 0 4.577398030926327e-13
the O 0 3.1686530569535742e-12
DM B-Disease 1 0.9999152421951294
locus O 0 7.756924963464584e-11
in O 0 2.09199216109901e-12
non O 0 1.0212294121458854e-08
- O 0 6.578957822966913e-08
DM O 1 1.0
heterozygotes O 0 3.652430677902885e-07
for O 0 1.9457882527440518e-10
CTGn O 0 6.502443284261972e-06
. O 0 1.3596351600142498e-08

This O 0 4.0296050940469286e-09
study O 0 2.0293250413416786e-10
provides O 0 3.3665713446151546e-13
further O 0 1.7863979067701818e-13
evidence O 0 3.1241602187204176e-12
that O 0 2.1067787000627475e-13
the O 0 1.4832686190402455e-09
DM B-Disease 1 1.0
expansion O 0 0.0017243644688278437
tends O 0 2.4734427483963373e-07
to O 0 7.087587461374056e-12
be O 0 6.136510136839357e-12
transmitted O 0 7.293008419395619e-10
preferentially O 0 1.1808794830869829e-08
. O 0 1.559054441102603e-09

Diagnosis O 1 0.9991207718849182
of O 0 6.986717198742554e-05
hemochromatosis B-Disease 1 1.0
. O 1 0.9835410714149475

If O 0 2.397350181126967e-05
untreated O 1 1.0
, O 0 2.6293971444601993e-08
hemochromatosis B-Disease 1 1.0
can O 0 4.0446423099638196e-07
cause O 0 0.00019872178381774575
serious O 0 2.384223876106262e-07
illness O 0 2.4436001694994047e-05
and O 0 3.956259798931772e-12
early B-Disease 0 5.049224927056173e-10
death I-Disease 0 3.133042714154044e-10
, O 0 5.5616200257376305e-14
but O 0 6.044352572707329e-14
the O 0 2.1614589458540667e-13
disease O 0 1.4930568933979593e-11
is O 0 3.3276085744304504e-14
still O 0 2.0089608958589328e-13
substantially O 0 2.1455172360962393e-10
under O 0 2.0500509734233674e-08
- O 0 3.341919000376947e-05
diagnosed O 0 0.12313058227300644
. O 0 5.766785875493952e-07

The O 0 3.458413999624099e-08
cornerstone O 0 7.233635642478475e-06
of O 0 2.2079065242763818e-09
screening O 0 9.201720274631953e-08
and O 0 1.646546614331168e-11
case O 0 2.3894639739063805e-11
detection O 0 7.835592175098327e-10
is O 0 7.522217034374237e-14
the O 0 2.0932802474900314e-13
measurement O 0 2.2201943061794793e-10
of O 0 1.604268454191704e-11
serum O 0 2.2706607427647185e-10
transferrin O 0 7.1852466199118226e-09
saturation O 0 4.302832756764019e-09
and O 0 4.949160439110534e-12
the O 0 4.786088626113072e-12
serum O 0 4.6291712130219764e-10
ferritin O 0 8.29538535640495e-08
level O 0 1.1696087653945142e-08
. O 0 1.5231830241546618e-09

Once O 0 1.7202124169557464e-08
the O 0 4.988665036620432e-11
diagnosis O 0 3.6571709642885253e-06
is O 0 1.4835218123399052e-11
suspected O 0 1.8381191013716602e-09
, O 0 5.6481663096574763e-11
physicians O 0 1.6944241565397533e-09
must O 0 8.820615765570139e-11
use O 0 3.050791008707421e-10
serum O 0 2.531234599700838e-07
ferritin O 0 3.0435108783422038e-05
levels O 0 1.6534402675461024e-05
and O 0 3.891944544420767e-09
hepatic O 0 0.00014942861162126064
iron O 0 4.486599573283456e-05
stores O 0 2.6686510068429925e-07
on O 0 8.702742526622842e-09
liver O 0 4.5007734428281765e-08
biopsy O 0 6.821409215262975e-09
specimens O 0 2.7878829800265237e-10
to O 0 6.544500184835211e-13
assess O 0 1.7233214855139067e-09
patients O 0 1.3617470484561522e-09
for O 0 3.53796175299112e-13
the O 0 9.07736039112983e-12
presence O 0 8.310640370323696e-11
of O 0 5.16265030725549e-09
iron B-Disease 0 0.019442018121480942
overload I-Disease 0 0.00017126523016486317
. O 0 2.55198756349273e-07

Liver O 1 0.9998719692230225
biopsy O 1 0.9911273121833801
is O 0 1.8225178033404177e-09
also O 0 6.309881870475431e-12
used O 0 1.2487734370875136e-12
to O 0 3.0880040278319365e-12
establish O 0 6.514591643913548e-11
the O 0 2.67753787891456e-11
presence O 0 9.722240373877256e-11
or O 0 1.2512836322642329e-09
absence O 0 6.914811478964111e-07
of O 0 3.318345775937814e-08
cirrhosis B-Disease 1 0.9999908208847046
, O 0 1.0650321770333537e-12
which O 0 8.962681772694669e-15
can O 0 9.153868797944636e-14
affect O 0 2.722716274661252e-09
prognosis O 1 0.9998384714126587
and O 0 6.988433165489027e-10
management O 0 3.1124953725480964e-09
. O 0 2.8816418140564792e-09

A O 0 1.0805857897366877e-07
DNA O 0 2.219853456608689e-08
- O 0 2.1353161461235004e-09
based O 0 3.578249849200965e-11
test O 0 2.1360482826970895e-10
for O 0 1.533623748828372e-11
the O 0 6.387324003043204e-10
HFE O 0 1.8925291442428716e-05
gene O 0 1.963998824683344e-10
is O 0 1.1810888638635886e-12
commercially O 0 6.449978051659144e-11
available O 0 6.935960052828483e-12
, O 0 8.621977508034909e-14
but O 0 1.0568201045182968e-13
its O 0 2.085018864104917e-14
place O 0 3.6806809770167925e-13
in O 0 1.6846556972777843e-14
the O 0 1.5525289929520236e-13
diagnosis O 0 1.2690535733383967e-08
of O 0 4.940413633747198e-10
hemochromatosis B-Disease 1 1.0
is O 0 6.762307935836986e-10
still O 0 2.7558589091314367e-11
being O 0 7.108680397799327e-12
evaluated O 0 3.524726954751145e-09
. O 0 3.6494687272181636e-09

Currently O 0 4.015165977477864e-09
, O 0 1.1555001747098892e-11
the O 0 2.320860691129578e-11
most O 0 8.897969167032116e-12
useful O 0 6.581480586215216e-12
role O 0 1.2711076765800633e-12
for O 0 7.672221690423198e-13
this O 0 1.0516329560644744e-12
test O 0 2.752523209359481e-11
is O 0 6.415405180834263e-14
in O 0 1.2440935326200886e-14
the O 0 2.9556025460180865e-14
detection O 0 1.844872449252577e-10
of O 0 1.1199496885438975e-10
hemochromatosis B-Disease 1 1.0
in O 0 1.7286685860540274e-08
the O 0 7.36850269689171e-09
family O 0 2.1770555844180528e-11
members O 0 3.163021941262646e-14
of O 0 1.2829281907655865e-12
patients O 0 1.4954232296915393e-10
with O 0 6.372097572087277e-15
a O 0 2.1884356577340364e-13
proven O 0 8.125575212680758e-11
case O 0 2.9103174731259784e-11
of O 0 1.5217820059643117e-11
the O 0 1.7312075384356973e-10
disease O 0 8.944469165328428e-09
. O 0 3.916697632888599e-09

It O 0 6.83158087391722e-12
is O 0 1.3094474506439302e-12
crucial O 0 1.151984840852549e-09
to O 0 5.252245860454252e-10
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.3620477616786957
because O 0 5.896530907989472e-08
phlebotomy O 1 0.6773619055747986
therapy O 0 2.2410376914194785e-05
can O 0 2.1717190545889054e-10
avert O 0 5.261094884190243e-07
serious O 0 6.456436676671728e-05
chronic O 0 0.1335463523864746
disease O 0 2.2316228296404006e-06
and O 0 2.8651862132855754e-11
can O 0 7.559415333285857e-13
even O 0 7.718461286776446e-12
lead O 0 5.614584318303084e-13
to O 0 1.4831862680305535e-13
normal O 0 2.4497914807852794e-09
life O 0 5.066123215380358e-11
expectancy O 0 2.034731827471603e-10
. O 0 3.5003753368068047e-12
. O 0 3.266148740355135e-10

Prevalence O 0 3.1029001092974795e-06
of O 0 2.273626398263673e-09
the O 0 1.2817273464804657e-08
I1307K O 0 2.17511405935511e-05
APC B-Disease 0 2.479127090282418e-07
gene O 0 9.855303378936142e-11
variant O 0 1.3595559400503276e-10
in O 0 2.4826490689633385e-12
Israeli O 0 2.143136779153565e-10
Jews O 0 4.8946770248026183e-11
of O 0 1.9531115006549138e-12
differing O 0 5.5043140184674044e-11
ethnic O 0 8.668891613664714e-14
origin O 0 4.258037065302256e-12
and O 0 1.2792898251151597e-12
risk O 0 3.9954976827072386e-11
for O 0 3.0888200330814186e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.028785158676328e-06

BACKGROUND O 0 0.018940187990665436
& O 0 7.270654123203713e-07
AIMS O 0 2.7338275643273846e-08
Israeli O 0 7.50220108258759e-10
Jews O 0 2.0247743759416181e-10
of O 0 8.991786482059894e-12
European O 0 4.762142416514514e-11
birth O 0 3.729365616322866e-08
, O 0 1.0055179779089318e-11
i O 0 8.322184087694584e-12
. O 0 2.374610490879503e-12
e O 0 2.1967757474206095e-12
. O 0 1.3391456997122186e-12
, O 0 1.468689319467087e-12
Ashkenazim O 0 3.5509646778564274e-08
, O 0 1.6577042473084336e-12
have O 0 3.614891589190372e-13
the O 0 3.981834306721055e-11
highest O 0 7.411760179820703e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 8.895878700343474e-09
of O 0 1.1232988280859835e-12
any O 0 9.967643030406315e-13
Israeli O 0 6.7399059666684025e-09
ethnic O 0 4.444143941739753e-10
group O 0 4.085273785925381e-11
. O 0 1.051377249150498e-10

The O 0 3.646875370577618e-07
I1307K O 0 2.436479553580284e-05
APC B-Disease 0 3.546017808275792e-07
gene O 0 2.425270539951896e-10
variant O 0 8.338052914780292e-09
was O 0 2.2128561205647657e-09
found O 0 1.9002239018406364e-11
in O 0 5.4940458432684025e-11
6 O 0 3.9385970040939355e-08
. O 0 5.482588605332239e-09

1 O 0 3.3609278915491814e-08
% O 0 7.541853253023589e-11
of O 0 2.2007892470227164e-12
American O 0 1.9198666094399908e-12
Jews O 0 8.323013805933144e-11
, O 0 6.830143547097156e-13
28 O 0 4.132564845882314e-10
% O 0 1.8185158240369148e-11
of O 0 2.6705148509220678e-11
their O 0 3.159980366262971e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 5.312693929226953e-07
, O 0 9.566792887397146e-13
but O 0 3.7825255080892184e-13
not O 0 2.0579989535446375e-13
in O 0 1.0282303437511575e-12
non O 0 8.460699918444448e-10
- O 0 1.4892380384434745e-10
Jews O 0 6.810082497921144e-10
. O 0 5.60003710070589e-10

We O 0 2.691125366993674e-08
assessed O 0 1.5039651657389186e-07
the O 0 1.1757703699544209e-09
I1307K O 0 1.3468026338614436e-07
prevalence O 0 1.0178433651475416e-09
in O 0 3.8274027366501026e-14
Israeli O 0 4.375957495666993e-12
Jews O 0 1.0938303214580447e-11
of O 0 7.530115853776609e-13
differing O 0 3.654103755690308e-11
ethnic O 0 1.752153110101684e-13
origin O 0 4.564592627487318e-12
and O 0 9.70170558473038e-13
risk O 0 3.67507274612322e-11
for O 0 3.556546168681507e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.474648787640035e-07

METHODS O 0 4.030862783110933e-06
DNA O 0 6.300994215280298e-08
samples O 0 5.62916824264903e-09
from O 0 4.35570815526809e-11
500 O 0 8.321707906100428e-12
unrelated O 0 3.0125336253350454e-11
Jews O 0 6.265857971365918e-11
of O 0 4.5723758113069835e-11
European O 0 5.494886767820617e-10
or O 0 9.6599485355231e-11
non O 0 7.56424423098423e-10
- O 0 5.746845273962853e-12
European O 0 1.6196989496147784e-12
origin O 0 2.9085624967534196e-12
, O 0 1.0936784382862066e-14
with O 0 2.847896822236369e-16
or O 0 2.6214422885022237e-14
without O 0 5.391353054100267e-13
a O 0 8.925155672032462e-14
personal O 0 1.9707223700149434e-11
and O 0 4.93628271938662e-12
/ O 0 6.544284558707147e-10
or O 0 5.1546458074147594e-11
family O 0 1.4009440309215027e-12
history O 0 2.4169466341511514e-12
of O 0 1.4049231613147417e-12
neoplasia B-Disease 0 1.013668793348188e-08
, O 0 2.3600351273939113e-12
were O 0 5.864015870105099e-12
examined O 0 6.355251741529955e-11
for O 0 2.99451923761046e-13
the O 0 1.4444096960164465e-11
I1307K O 0 7.998765538808073e-10
variant O 0 8.043921431721834e-12
by O 0 4.4579498512803406e-13
the O 0 5.692169392085278e-12
allele O 0 7.972406589062953e-12
- O 0 9.307471460218153e-12
specific O 0 1.480949043952684e-11
oligonucleotide O 0 1.1264070787220248e-09
( O 0 1.2242977898840879e-12
ASO O 0 5.001577392249601e-07
) O 0 2.400113528061576e-13
method O 0 4.4717612945888163e-10
. O 0 1.0322543930740835e-09

RESULTS O 0 1.5835395288377185e-06
In O 0 1.7588659695366715e-10
persons O 0 5.53840341643852e-11
at O 0 8.25482217303719e-12
average O 0 3.8163722182460447e-11
risk O 0 8.026301151486948e-11
for O 0 1.6938425106971522e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 7.166300330929687e-10
I1307K O 0 1.0977633024822353e-08
was O 0 7.145305874756147e-11
found O 0 1.2728594220301481e-12
in O 0 3.414323077738368e-12
5 O 0 1.224283230349954e-09
. O 0 9.313163018553894e-10

0 O 0 7.751996378146941e-08
% O 0 8.925152977790063e-11
of O 0 4.929996948871418e-12
120 O 0 3.440329271464648e-11
European O 0 1.055174211894716e-10
and O 0 1.345168004762698e-10
1 O 0 4.082966498231144e-08
. O 0 4.053300806106108e-09

6 O 0 5.715145903195662e-07
% O 0 1.2048105846318435e-09
of O 0 6.877853842013337e-11
188 O 0 2.216015371203639e-09
non O 0 3.4024771888852e-09
- O 0 1.767846008471352e-10
European O 0 2.2215031203476343e-10
Jews O 0 2.4652879737629974e-09
( O 0 6.269749259699142e-13
P O 0 6.74826683422225e-09
= O 0 3.605143527457555e-12
0 O 0 4.782839922723436e-12
. O 0 1.109665134844777e-13
08 O 0 7.572092952656817e-11
) O 0 5.177895872482408e-13
. O 0 1.9987170252200315e-10

It O 0 1.7978857291822692e-10
occurred O 0 1.265247018267246e-08
in O 0 1.175494007688016e-10
15 O 0 2.3115769298698297e-09
. O 0 3.6419587345903892e-09

4 O 0 9.139311174521936e-08
% O 0 2.600744619662976e-10
of O 0 2.0188770794016264e-11
52 O 0 3.6081052035008554e-10
Ashkenazi O 0 1.7777000982377444e-09
Israelis O 0 2.3369877144574502e-09
with O 0 2.3460291001531353e-11
familial O 0 2.4241044229711406e-06
cancer B-Disease 0 0.0368514284491539
( O 0 1.1625831373984763e-11
P O 0 7.617516928348778e-08
= O 0 3.2079736003026715e-12
0 O 0 4.262587244979743e-12
. O 0 7.516264764447292e-14
02 O 0 1.1267197244646532e-11
) O 0 4.100535202052535e-15
and O 0 2.7577438488184114e-13
was O 0 2.0474377401824562e-11
not O 0 5.973221049726529e-12
detected O 0 1.272070715430118e-08
in O 0 2.154662420705833e-10
51 O 0 2.6124791219217514e-09
non O 0 2.7123754353652885e-09
- O 0 1.0273198958188345e-10
European O 0 1.1279324696467086e-11
Jews O 0 1.222502238329426e-10
at O 0 6.573226338235649e-12
increased O 0 4.48914350137386e-10
cancer B-Disease 0 2.026588497017201e-08
risk O 0 4.0143063873010476e-10
. O 0 1.0421755680667388e-09

Colorectal B-Disease 1 0.9999979734420776
neoplasia I-Disease 0 0.00930478610098362
occurred O 0 2.096865136991255e-05
personally O 0 2.2334566196491323e-08
or O 0 1.0354834177606076e-11
in O 0 2.3765362507782717e-12
the O 0 4.2859691490315655e-12
families O 0 4.776221085300847e-12
of O 0 4.195862407518902e-12
13 O 0 2.9695190750800293e-11
of O 0 5.1834939118755585e-11
20 O 0 9.64901006317298e-11
Ashkenazi O 0 1.5872582415088488e-10
I1307K O 0 6.147236053521965e-10
carriers O 0 1.1293919792432217e-11
, O 0 3.6620611599570696e-13
8 O 0 2.941524801514106e-11
of O 0 3.584985433513488e-11
whom O 0 4.3702064189687917e-10
also O 0 8.61189591860878e-12
had O 0 3.143072607736386e-11
a O 0 1.2979098048052085e-12
personal O 0 2.8560651066378284e-10
or O 0 2.390065749480197e-11
family O 0 4.1580671197860575e-12
history O 0 7.113915793249825e-12
of O 0 2.6741438924338112e-11
noncolonic O 0 2.286566768816556e-06
neoplasia B-Disease 0 0.00012409845658112317
. O 0 3.2000912142393645e-07

CONCLUSIONS O 0 1.3028642570134252e-05
The O 0 3.819429039708666e-08
I1307K O 0 3.4871993648266653e-06
APC O 0 4.4117765440887524e-08
variant O 0 1.8671981294460238e-08
may O 0 1.4182424123987403e-08
represent O 0 8.656615979596438e-10
a O 0 2.0086804441987738e-10
susceptibility O 0 1.7380057215632405e-07
gene O 0 1.5277162868088112e-09
for O 0 2.915087060628707e-09
colorectal B-Disease 1 1.0
, I-Disease 0 1.7674418586466345e-06
or I-Disease 0 4.047760455705429e-07
other I-Disease 0 1.1066581429020061e-08
, I-Disease 0 9.9566320466149e-11
cancers I-Disease 0 9.435090930765e-08
in O 0 5.285103951702119e-11
Ashkenazi O 0 9.939716605344984e-09
Jews O 0 3.751093657911042e-09
, O 0 4.2568839078716e-12
and O 0 5.199800225813567e-12
partially O 0 3.143697802077128e-10
explains O 0 1.2528225852570518e-11
the O 0 5.478949542322975e-13
higher O 0 2.664543030661548e-10
incidence O 0 4.615085646975103e-09
of O 0 6.575167077471633e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.6062562391283564e-10
European O 0 1.2907715174481638e-10
Israelis O 0 2.1610842004804454e-09
. O 0 5.294388816245998e-10

Systematic O 0 1.442862912481857e-10
analysis O 0 2.0565020172891302e-11
of O 0 1.2160741857947244e-10
coproporphyrinogen O 0 0.00014798089978285134
oxidase O 0 0.0002603613829705864
gene O 0 1.3844902468918008e-06
defects O 0 7.403584459098056e-05
in O 0 3.7338190317370845e-09
hereditary B-Disease 1 0.9999891519546509
coproporphyria I-Disease 1 0.9999953508377075
and O 0 5.641284417379211e-08
mutation O 0 1.8112732647068697e-08
update O 0 5.259860458295407e-08
. O 0 3.200365128464e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 8.730761180686386e-08
HC B-Disease 1 1.0
) O 0 1.4639363332680233e-10
is O 0 3.132095494420839e-12
an O 0 7.47097479367187e-13
acute O 1 0.9551687240600586
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 2.8287826125961146e-07
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 0 0.004400397185236216
caused O 0 6.2593783489717225e-09
by O 0 5.0054179551173306e-12
deficient B-Disease 0 4.889008309305609e-09
activity I-Disease 0 3.1560076774184154e-10
of I-Disease 0 2.3717736108430643e-11
coproporphyrinogen I-Disease 0 2.0441316337382887e-06
III I-Disease 1 1.0
oxidase I-Disease 0 1.1973727851000149e-05
( O 0 9.239488618639768e-10
CPO O 0 1.9883252662111772e-06
) O 0 8.447630615859847e-12
. O 0 5.19626563999509e-10

Clinical O 0 5.042251359554939e-06
manifestations O 0 3.725971055246191e-06
of O 0 6.750712877590104e-09
the O 0 1.0468155231535548e-09
disease O 0 2.6135228381463094e-07
are O 0 7.59422499928622e-14
characterized O 0 1.190601436884542e-13
by O 0 8.646330213488238e-15
acute O 0 1.5431674826871244e-09
attacks O 0 1.462713110356173e-11
of O 0 1.134342255681986e-07
neurological B-Disease 1 1.0
dysfunction I-Disease 1 0.9999538660049438
often O 0 2.8238260618707045e-09
precipitated O 0 1.236271085502949e-10
by O 0 2.5789564711206636e-13
drugs O 0 3.4024994627346317e-11
, O 0 4.431110968601548e-13
fasting O 0 1.651043213257708e-08
, O 0 3.9724584732780954e-11
cyclical O 0 4.907926722808043e-07
hormonal O 0 1.0306951736538394e-07
changes O 0 2.402912535615087e-09
, O 0 7.779921151751523e-11
or O 0 2.2596157833731922e-08
infectious B-Disease 0 2.508687975932844e-05
diseases I-Disease 0 5.440770109998994e-07
. O 0 1.1343418648834813e-08

Skin O 1 1.0
photosensitivity O 1 0.9999992847442627
may O 0 4.049681592732668e-06
also O 0 1.5201812031406803e-10
be O 0 1.0926291989232784e-11
present O 0 5.058980456773554e-10
. O 0 6.004380104229767e-09

The O 0 1.7399428031694697e-07
seven O 0 6.0637552756759305e-09
exons O 0 5.730873109399681e-09
, O 0 1.743304459123074e-11
the O 0 3.272396797981969e-10
exon O 0 6.566581944866812e-09
/ O 0 3.636045020627421e-09
intron O 0 6.400498353542616e-09
boundaries O 0 4.389336949461864e-10
and O 0 1.0330983464534871e-11
part O 0 2.2336577032433524e-11
of O 0 5.436009975490208e-10
3 O 0 7.202998753008671e-10
noncoding O 0 5.344979459032118e-10
sequence O 0 6.48827476121272e-12
of O 0 3.247759006175244e-11
the O 0 1.5346494075529904e-09
CPO O 0 1.200341557705542e-06
gene O 0 2.8712150712539852e-11
were O 0 1.431409851759824e-11
systematically O 0 5.968062415789843e-12
analyzed O 0 5.863008863127295e-12
by O 0 3.1545043812329643e-13
an O 0 9.39390709317478e-14
exon O 0 9.406921075427732e-11
- O 0 4.6327375963217676e-11
by O 0 7.036272259286491e-11
- O 0 7.203650653764271e-08
exon O 0 5.686061044229973e-08
denaturing O 0 1.5673687130401959e-06
gradient O 0 7.97071990632503e-08
gel O 0 1.597845589174085e-08
electrophoresis O 0 3.0023947772406245e-09
( O 0 1.3695861285356603e-11
DGGE O 0 2.3522987248725258e-05
) O 0 3.713642674624262e-12
strategy O 0 1.0345107409603926e-10
followed O 0 9.112871048044813e-12
by O 0 8.286805215553666e-14
direct O 0 8.37200014175421e-12
sequencing O 0 1.255323511806239e-09
in O 0 1.0240293335517237e-10
seven O 0 1.6715075157325288e-10
unrelated O 0 1.9193100442294053e-08
heterozygous O 0 1.026809193227507e-09
HC B-Disease 0 3.570395347196609e-05
patients O 0 4.3306476982252207e-07
from O 0 7.437641474927759e-11
France O 0 7.214214642337069e-11
, O 0 1.7852610665822222e-12
Holland O 0 1.7561651022290903e-09
, O 0 3.909549333575013e-12
and O 0 5.691864948115244e-12
Czech O 0 5.055336593784432e-09
Republic O 0 1.4500817435703084e-08
. O 0 1.204423369927099e-07

Seven O 0 3.9098708271012583e-07
novel O 0 5.9010201169940046e-08
mutations O 0 3.532197201394638e-09
and O 0 3.688654590106033e-11
two O 0 1.4239531862664245e-12
new O 0 1.1910801511749725e-10
polymorphisms O 0 1.9022175834493282e-08
were O 0 6.567530408396749e-10
detected O 0 3.633564915617171e-08
. O 0 1.504014690567601e-08

Among O 0 4.852042820857605e-07
these O 0 2.2558379608739187e-09
mutations O 0 8.582518584709931e-10
two O 0 1.338691744262599e-11
are O 0 1.6475393965764695e-11
missense O 0 1.3811359167448245e-08
( O 0 2.267897024690879e-12
G197W O 0 4.5604245713093405e-08
, O 0 1.802520285809628e-11
W427R O 0 4.5696952888363285e-09
) O 0 4.581179728103957e-13
, O 0 1.5257424230280536e-12
two O 0 5.549860159111131e-13
are O 0 1.3520499823893584e-12
nonsense O 0 8.983224719649741e-10
( O 0 4.83747211125346e-13
Q306X O 0 1.1350819839606174e-08
, O 0 8.88904661683343e-12
Q385X O 0 2.844562807524653e-09
) O 0 3.6548251946579013e-13
, O 0 1.56985698312323e-12
two O 0 7.668165554570658e-14
are O 0 2.0623527028935246e-13
small O 0 2.7798516526872374e-12
deletions O 0 4.615620108339158e-10
( O 0 3.5525831408589337e-12
662de14bp O 0 5.5784653341106605e-08
; O 0 1.2919931791088857e-10
1168del3bp O 0 1.2739273813622276e-07
removing O 0 3.3423951606437186e-08
a O 0 6.341556446631813e-11
glycine O 0 6.646299482993001e-11
at O 0 1.4833867467700657e-10
position O 0 1.3039307134032896e-10
390 O 0 3.55197503354443e-11
) O 0 2.0455688128063164e-14
, O 0 1.2171536836139835e-13
and O 0 1.8744226548510212e-13
one O 0 4.6089427576095215e-14
is O 0 7.264516238721357e-15
a O 0 1.1101139267815502e-13
splicing O 0 6.131298802003471e-10
mutation O 0 4.922062757373169e-10
( O 0 2.969833309395681e-13
IVS1 O 0 2.0224592844897415e-07
- O 0 2.0802684574938723e-10
15c O 0 3.85778431422068e-09
- O 0 8.380967447818577e-11
- O 0 1.3786682906413716e-10
> O 0 4.774586837008599e-10
g O 0 2.234740170692362e-11
) O 0 3.404875089285577e-15
which O 0 2.529728694995433e-15
creates O 0 2.5745724996362185e-13
a O 0 5.133660694895542e-14
new O 0 4.0948383572825264e-11
acceptor O 0 1.0108691661514513e-08
splice O 0 1.1756839768395366e-07
site O 0 1.1849904169025649e-08
. O 0 2.5542497006370013e-09

The O 0 9.46390699141375e-09
pathological O 0 2.5355109301017364e-07
significance O 0 2.2703339652707655e-08
of O 0 3.207856202891435e-09
the O 0 1.2181874398109471e-09
point O 0 4.354914651116815e-09
mutations O 0 3.487228908416462e-11
G197W O 0 8.335890200328322e-09
, O 0 7.482415728676806e-12
W427R O 0 1.3954505106994475e-08
, O 0 1.5214829396370533e-11
and O 0 1.0860800973844231e-11
the O 0 2.932259990373609e-11
in O 0 2.1341210049152792e-11
- O 0 2.2273369260084053e-10
frame O 0 1.1867132831966387e-09
deletion O 0 3.4856081909673264e-10
390delGly O 0 9.659584243593144e-10
were O 0 1.07352050426196e-12
assessed O 0 5.023168946766132e-12
by O 0 4.68522356328327e-13
their O 0 2.934352413830332e-11
respective O 0 8.752294999858634e-10
expression O 0 4.853492954759453e-11
in O 0 2.0161786736666576e-12
a O 0 2.9283162266552365e-13
prokaryotic O 0 2.837592660842603e-10
system O 0 7.999767515087797e-11
using O 0 2.180728254225217e-12
site O 0 2.1913251768701514e-10
- O 0 1.9535752182608945e-10
directed O 0 1.0866774147189062e-10
mutagenesis O 0 2.4256976303149713e-06
. O 0 9.796222499858231e-09

These O 0 3.3995384285390173e-09
mutations O 0 4.608589204702085e-11
resulted O 0 4.0110900711987085e-11
in O 0 3.3547147264972876e-12
the O 0 1.6297277763421825e-11
absence O 0 2.0233856812268414e-09
or O 0 1.912443727686286e-12
a O 0 1.1825805092124941e-13
dramatic O 0 1.559671489181902e-11
decrease O 0 4.3467491828153015e-09
of O 0 5.702635164084313e-08
CPO O 0 0.00021425410523079336
activity O 0 6.517782935588912e-07
. O 0 9.664288924682296e-09

The O 0 6.87808707766635e-08
two O 0 3.3471958538200397e-10
polymorphisms O 0 2.4505313334088896e-08
were O 0 7.075303676273847e-10
localized O 0 2.0424870683655172e-08
in O 0 3.599258946440642e-10
noncoding O 0 2.716612179654021e-08
part O 0 1.3453733960222536e-10
of O 0 2.0239567799507086e-09
the O 0 2.2440709290805216e-09
gene O 0 5.286452699204691e-12
1 O 0 1.255289344692656e-10
) O 0 8.204532227760498e-15
a O 0 8.877656097229514e-13
C O 0 2.8766502513377645e-09
/ O 0 3.053321831480993e-11
G O 0 1.391918941218151e-10
polymorphism O 0 1.3924015586364025e-11
in O 0 5.109105955143634e-13
the O 0 3.057599659572752e-11
promotor O 0 7.278993763293329e-08
region O 0 6.860157442112325e-10
, O 0 2.8630941367735474e-11
142 O 0 1.6954716519634871e-09
bp O 0 1.0912515335803619e-09
upstream O 0 1.1797751664488487e-10
from O 0 2.519043567489332e-12
the O 0 1.885618614375084e-12
transcriptional O 0 1.2870986221269476e-10
initiation O 0 9.029864633802731e-10
site O 0 2.0613766249510945e-10
( O 0 3.352255200316477e-14
- O 0 1.9441550799803586e-11
142C O 0 1.255450521320256e-09
/ O 0 1.339632432761917e-10
G O 0 7.401402823958847e-10
) O 0 2.3020759696299256e-14
, O 0 2.92333296241995e-13
and O 0 1.9549114931016742e-12
2 O 0 7.086645159581906e-11
) O 0 5.6700802229412914e-14
a O 0 4.86344341535383e-12
6 O 0 8.132355899803656e-10
bp O 0 4.795450703198867e-10
deletion O 0 7.23819311779228e-12
polymorphism O 0 2.2937651777965584e-11
in O 0 1.682428827330662e-12
the O 0 7.543042579438719e-12
3 O 0 6.981409200745858e-11
noncoding O 0 7.070082297389035e-10
part O 0 1.7190093098973236e-11
of O 0 7.290547054950025e-10
the O 0 1.2719620201551152e-07
CPO O 0 0.00015032840019557625
gene O 0 1.4618750654449286e-09
, O 0 1.1331707100437072e-10
574 O 0 1.8300287507599933e-08
bp O 0 1.0790525140080831e-09
downstream O 0 6.401398300326377e-10
of O 0 3.2003098088262405e-12
the O 0 8.19651692438722e-13
last O 0 2.8322257733526257e-12
base O 0 1.599120662276743e-11
of O 0 2.945442067331383e-12
the O 0 5.283670202749224e-12
normal O 0 2.607918991870406e-09
termination O 0 3.248414515155673e-08
codon O 0 4.162278521846474e-09
( O 0 7.2254203488386626e-12
+ O 0 9.862756167322573e-10
574 O 0 2.495571083116488e-09
delATTCTT O 0 3.023440342531103e-08
) O 0 1.672370922300992e-11
. O 0 1.521501813428472e-09

Five O 0 3.48904137581485e-07
intragenic O 0 2.3420694560627453e-05
dimorphisms O 0 5.4901571274967864e-05
are O 0 3.738870046898768e-10
now O 0 2.930045789328872e-11
well O 0 2.2276152276956562e-12
characterized O 0 4.4398187383498655e-12
and O 0 5.621667411095932e-13
the O 0 2.60797980433658e-12
high O 0 8.439904330970194e-11
degree O 0 1.375561053951202e-10
of O 0 5.6295922784554975e-11
allelic O 0 7.699856752196865e-09
heterogeneity O 0 4.3959156315054315e-09
in O 0 9.269066764128198e-11
HC B-Disease 0 2.3837741537136026e-05
is O 0 6.819633052712604e-11
demonstrated O 0 2.876358040637683e-10
with O 0 3.6039728601618137e-13
seven O 0 1.3901425583578986e-12
new O 0 1.8386390500391148e-12
different O 0 2.878191933917973e-13
mutations O 0 2.0346666517422063e-13
making O 0 1.703286085308689e-13
a O 0 3.7708825997720755e-14
total O 0 1.5929585124932477e-12
of O 0 6.811689406971411e-11
nineteen O 0 3.848768983516493e-07
CPO O 0 0.0006749345920979977
gene B-Disease 0 1.9007305951390663e-08
defects I-Disease 0 1.267791503778426e-06
reported O 0 1.1967830060299889e-09
so O 0 5.3339669486840435e-11
far O 0 1.757229639576252e-10
. O 0 2.6140914086147937e-11
. O 0 3.574186502319776e-10

Coincidence O 0 2.949473127955571e-06
of O 0 1.2716971475867922e-08
two O 0 5.8214044695859e-11
novel O 0 8.279239516184589e-10
arylsulfatase O 0 3.213253592093679e-07
A O 0 6.250514328343115e-09
alleles O 0 5.678306158607427e-10
and O 0 6.002118246861698e-11
mutation O 0 7.275155478048134e-10
459 O 0 1.0292365848485474e-09
+ O 0 1.3996581671449349e-10
1G O 0 3.0273650963863474e-07
> O 0 1.9101134007826204e-09
A O 0 7.066830454149908e-11
within O 0 7.293376839967447e-12
a O 0 8.943871576509721e-13
family O 0 1.5745809170408798e-11
with O 0 1.1508547587135709e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.563704721263548e-11
molecular O 0 1.2228234050337683e-11
basis O 0 3.176034955865159e-12
of O 0 2.1524832697489282e-12
phenotypic O 0 2.6283830667495067e-09
heterogeneity O 0 2.1795137854496716e-06
. O 0 4.495510381730128e-07

In O 0 1.4620200605719447e-09
a O 0 4.102030173869231e-11
family O 0 5.953535581193492e-11
with O 0 8.410327013812224e-13
three O 0 2.93737603684896e-11
siblings O 0 3.3957150424868132e-09
, O 0 3.384076059740476e-13
one O 0 1.9071924283451704e-14
developed O 0 2.296153718550631e-12
classical O 0 1.9777885995608813e-09
late O 0 1.0067717994388659e-05
infantile O 0 0.2864663004875183
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.6914203371243275e-10
MLD B-Disease 1 1.0
) O 0 2.6386963360852667e-12
, O 0 1.7146687173417996e-13
fatal O 0 1.2843023519670815e-11
at O 0 1.575548372323432e-11
age O 0 6.343591762991707e-10
5 O 0 5.687104606688642e-11
years O 0 1.0246847858066954e-12
, O 0 1.6127435487327951e-13
with O 0 1.1355690693326537e-12
deficient O 0 1.9657513803394977e-06
arylsulfatase O 0 4.329682269599289e-05
A O 0 2.3741115455777617e-06
( O 0 3.05328089200696e-11
ARSA O 0 9.233522177964915e-07
) O 0 7.652575404956674e-14
activity O 0 1.081536336183797e-11
and O 0 4.531260349577293e-14
increased O 0 6.382376571689719e-11
galactosylsulfatide O 0 1.1826825812022435e-06
( O 0 1.8385777622587085e-10
GS O 1 0.9999978542327881
) O 0 5.246456047380832e-11
excretion O 0 2.1245028847260983e-08
. O 0 8.729937883700245e-10

The O 0 3.1754058227306814e-07
two O 0 4.1516126647600515e-10
other O 0 4.4392389764169593e-10
siblings O 0 3.611482313203851e-08
, O 0 8.947970836503671e-12
apparently O 0 5.499576349876634e-09
healthy O 0 1.9808021889389238e-08
at O 0 3.5998151681759794e-10
12 O 0 1.5238535433503841e-10
( O 0 5.910227277201863e-14
1 O 0 4.442008427751887e-10
/ O 0 2.1295465391091284e-11
2 O 0 3.227356576429585e-11
) O 0 3.974602155103028e-15
and O 0 6.354359855138825e-13
15 O 0 4.393285214787657e-12
years O 0 3.3529494285200467e-12
, O 0 1.5362189330955095e-13
respectively O 0 7.400167284510317e-12
, O 0 5.299118891084753e-13
and O 0 2.45565438643236e-12
their O 0 4.9750197017583986e-11
father O 0 1.9728567668408914e-09
, O 0 2.832076066716649e-11
apparently O 0 1.915324077117475e-08
healthy O 0 3.526367642336936e-09
as O 0 3.156341724444567e-12
well O 0 2.6755201786715643e-12
, O 0 9.095224573485439e-13
presented O 0 1.7386273531982965e-09
ARSA O 0 9.673071872384753e-06
and O 0 3.904046252944937e-10
GS O 1 0.9996351003646851
values O 0 4.870401304479799e-10
within O 0 8.893591592340488e-12
the O 0 6.240554405699539e-13
range O 0 5.676083214556371e-11
of O 0 5.490064999835731e-11
MLD B-Disease 1 1.0
patients O 0 0.032287951558828354
. O 0 4.391267083292405e-08

Mutation O 0 1.8321731687365173e-08
screening O 0 1.280657091484727e-08
and O 0 1.7047569952910457e-11
sequence O 0 6.004198874198785e-12
analysis O 0 9.685472909803927e-13
disclosed O 0 5.842987760296126e-10
the O 0 1.837300624141225e-11
involvement O 0 6.514181555283827e-11
of O 0 2.0557147650812624e-10
three O 0 4.2625736274004566e-11
different O 0 1.2734781007495144e-09
ARSA O 0 2.2636035282630473e-05
mutations O 0 2.8535929175177444e-10
being O 0 1.4624808525667832e-12
the O 0 9.225457854242225e-13
molecular O 0 6.9449489562001254e-12
basis O 0 3.9992946454514566e-11
of O 0 1.9733400677401924e-11
intrafamilial O 0 9.342889484287298e-07
phenotypic O 0 3.2839119512573234e-07
heterogeneity O 0 1.4431719137064647e-05
. O 0 4.874876822213992e-07

The O 0 8.681472429827863e-09
late O 0 1.389032149745617e-05
infantile O 0 1.633723877603188e-05
patient O 0 6.300474524323363e-06
inherited O 0 1.0772679388537654e-06
from O 0 4.02172162239367e-08
his O 0 1.7310087230271165e-07
mother O 0 3.573412854507296e-08
the O 0 2.007611854537572e-10
frequent O 0 2.6800416053074372e-11
0 O 0 9.67303875887282e-11
- O 0 3.5492730282582485e-11
type O 0 5.989884144241842e-10
mutation O 0 1.263382176652783e-09
459 O 0 4.246848428479666e-10
+ O 0 1.3030226203580852e-11
1G O 0 1.3464528159090605e-08
> O 0 3.956156235940256e-11
A O 0 2.0140002512936128e-11
, O 0 1.2401566590065222e-13
and O 0 2.133280395865897e-13
from O 0 1.0919124979191785e-11
his O 0 1.0644098102918775e-10
father O 0 1.2850258357399724e-10
a O 0 2.500335279532334e-13
novel O 0 1.1102591068734569e-11
, O 0 1.343430168542284e-13
single O 0 3.696455901786022e-12
basepair O 0 2.3936642890021176e-08
microdeletion O 0 3.938258785751714e-08
of O 0 3.518854374551239e-10
guanine O 0 1.065663779442616e-09
at O 0 1.0939310568502947e-10
nucleotide O 0 6.955759856985821e-10
7 O 0 4.4271220023262003e-10
in O 0 2.640555482602558e-11
exon O 0 2.605949900313931e-09
1 O 0 2.191761216963073e-09
( O 0 1.998268954819804e-12
7delG O 0 5.4911833302639934e-08
) O 0 4.0220528296774916e-11
. O 0 8.37795521846374e-09

The O 0 3.783574342719476e-08
two O 0 1.6440943051421186e-09
clinically O 0 0.0038888996932655573
unaffected O 0 3.782426938414574e-05
siblings O 0 2.1361158175636774e-08
carried O 0 2.0562314004268778e-11
the O 0 2.77706035251013e-11
maternal O 0 8.143616270217535e-08
mutation O 0 8.688727959338394e-09
459 O 0 5.66867841556018e-09
+ O 0 5.394529822844163e-10
1G O 0 3.857864498968411e-07
> O 0 1.6002298375283885e-09
A O 0 2.508440399839884e-10
and O 0 1.0666585887122992e-12
, O 0 2.344166256506436e-13
on O 0 1.1432826040047583e-11
their O 0 8.79977427731271e-12
paternal O 0 4.298632561017257e-09
allele O 0 2.1311648279453976e-10
, O 0 7.322072093605969e-13
a O 0 2.0590824780907652e-13
novel O 0 4.468093256493333e-11
cytosine O 0 8.742463003530432e-11
to O 0 3.2981408402965595e-12
thymidine O 0 4.783156981602588e-09
transition O 0 1.5647924067607732e-09
at O 0 1.3732698311841318e-10
nucleotide O 0 7.758294451321035e-09
2435 O 0 8.118776122501004e-07
in O 0 2.1171507602613104e-10
exon O 0 6.163593635477582e-09
8 O 0 4.191690883281751e-10
, O 0 9.253525951134073e-14
resulting O 0 2.2941050101255023e-12
in O 0 3.649496069929592e-13
substitution O 0 6.441743805041256e-10
of O 0 1.0897326097047966e-10
alanine O 0 1.9594539324430116e-09
464 O 0 4.4912953356401886e-09
by O 0 1.559190415667544e-10
valine O 0 2.937888439191738e-07
( O 0 1.8926062106405794e-11
A464V O 0 5.0218183389461046e-08
) O 0 1.952941107441486e-11
. O 0 2.822598377250074e-09

The O 0 3.5915476814807334e-08
fathers O 0 9.867054018286581e-08
genotype O 0 1.1457358617406044e-08
thus O 0 1.3327157433185022e-10
was O 0 2.4581545132740246e-10
7delG O 0 4.249332334893552e-07
/ O 0 1.3721563618673827e-07
A464V O 0 1.2259345112397568e-06
. O 0 2.4572850421122894e-08

Mutation O 0 3.668705858217436e-06
A464V O 0 1.1647665587588563e-06
was O 0 5.18371401359019e-10
not O 0 6.51878941451689e-12
found O 0 1.3749562469481114e-12
in O 0 3.849206652202508e-13
18 O 0 1.1123687387870618e-10
unrelated O 0 1.0088028545851557e-07
MLD B-Disease 1 1.0
patients O 1 0.9961506128311157
and O 0 1.064209387280357e-09
50 O 0 1.2769173496351982e-09
controls O 0 1.0914180670340556e-09
. O 0 1.4910641610299535e-08

A464V O 0 4.903074568574084e-06
, O 0 4.4390102704738865e-10
although O 0 1.6974002203795635e-09
clearly O 0 1.9735615808258444e-08
modifying O 0 6.3190445871441625e-06
ARSA O 1 0.9999814033508301
and O 0 5.271812710816448e-07
GS O 1 1.0
levels O 0 1.710821015876718e-05
, O 0 2.6384863044404128e-11
apparently O 0 4.811869236398536e-10
bears O 0 8.519417393770823e-10
little O 0 1.1404746504822816e-12
significance O 0 2.169042506369734e-12
for O 0 1.4078087382917576e-13
clinical O 0 2.7285985970681992e-11
manifestation O 0 3.2850810960383114e-09
of O 0 2.7692401705081693e-09
MLD B-Disease 1 1.0
, O 0 5.694901217268011e-10
mimicking O 0 4.08596401157979e-09
the O 0 1.401295607328379e-10
frequent O 0 1.2133131166436328e-09
ARSA O 0 6.546732765855268e-05
pseudodeficiency O 0 1.6105846952996217e-05
allele O 0 9.135849268204765e-07
. O 0 7.951586411536482e-08

Our O 0 4.439014844592748e-08
results O 0 6.027521259888147e-10
demonstrate O 0 2.470350313199532e-11
that O 0 9.02915268323045e-15
in O 0 3.1756213869464645e-13
certain O 0 4.4431250345589035e-11
genetic O 0 5.358258836629659e-10
conditions O 0 9.75197622210544e-07
MLD B-Disease 1 1.0
- O 1 0.969044029712677
like O 0 4.3851319020404844e-08
ARSA O 0 0.003544069128111005
and O 0 9.144848212017109e-10
GS O 1 1.0
values O 0 1.9279451646259105e-10
need O 0 5.409812138187919e-13
not O 0 8.767427125825396e-15
be O 0 2.805239459507166e-14
paralleled O 0 2.935415799321106e-11
by O 0 3.982134175357921e-13
clinical O 0 5.319248375101893e-10
disease O 0 6.497569149388482e-10
, O 0 2.463487584498242e-13
a O 0 2.567094757252586e-13
finding O 0 2.1277235182082244e-11
with O 0 5.245657424060579e-14
serious O 0 1.7396349638598707e-10
diagnostic O 0 4.199665681881015e-08
and O 0 2.2908848429370465e-10
prognostic O 0 0.0008681695908308029
implications O 0 1.3174362720747013e-06
. O 0 3.743526377775197e-08

Moreover O 0 7.881659257691354e-06
, O 0 2.712841284946421e-09
further O 0 5.8170172678728704e-08
ARSA O 0 0.0010866305092349648
alleles O 0 2.3102386137452413e-07
functionally O 0 4.721793089856874e-08
similar O 0 1.893788043050293e-10
to O 0 1.1200473708228298e-11
A464V O 0 1.712352570848452e-08
might O 0 5.217974316518159e-11
exist O 0 3.695567723366322e-12
which O 0 4.285653998565078e-14
, O 0 8.734399786552646e-14
together O 0 6.121926560522309e-14
with O 0 2.5547794403005947e-14
0 O 0 2.0492436914043566e-10
- O 0 1.4006436288571678e-10
type O 0 1.7119599071691027e-09
mutations O 0 4.358036986840119e-10
, O 0 7.223487758466207e-13
may O 0 2.382520569721436e-10
cause O 0 2.37373740219482e-07
pathological O 0 0.0007824998465366662
ARSA O 0 0.03651507943868637
and O 0 8.741038115545052e-09
GS O 1 1.0
levels O 0 3.928737868363896e-08
, O 0 8.669090158187551e-14
but O 0 3.1804206756256073e-14
not O 0 1.658448836702915e-14
clinical O 0 8.693335222693943e-13
outbreak O 0 1.5009517934094774e-11
of O 0 5.607170977528497e-12
the O 0 3.772629778020509e-11
disease O 0 1.7897642257125312e-09
. O 0 1.7202073099298332e-10
. O 0 2.170850388338863e-09

Human O 0 0.0013671728083863854
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.00011887363507412374
to O 0 4.8689940967960865e-08
hematological B-Disease 1 0.9999997615814209
malignancy I-Disease 1 0.9999992847442627
and O 0 5.851265694190033e-09
neurofibromatosis B-Disease 0 7.098446076270193e-05
type I-Disease 0 2.6575826268526725e-06
1 I-Disease 0 1.28113133541774e-05
. O 0 4.604572012567587e-08

Heterozygous O 0 6.091230488891597e-07
germ O 0 6.820091584813781e-06
- O 0 1.1664680243939074e-07
line O 0 7.233307997012162e-08
mutations O 0 2.4971266721074414e-10
in O 0 6.728844911818577e-13
the O 0 6.559799578531589e-12
DNA O 0 6.9137415792397405e-09
mismatch O 0 8.79016806720756e-05
repair O 0 0.026108376681804657
genes O 0 6.466702870966401e-07
lead O 0 1.268567206835769e-08
to O 0 2.0517478827031255e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.326141374302097e-06

The O 0 9.970362313538317e-09
disease O 0 4.4308769986400875e-08
susceptibility O 0 7.369672516688297e-08
of O 0 6.310639832918241e-08
individuals O 0 2.2973489777200484e-09
who O 0 3.0257583105708363e-09
constitutionally O 0 1.2266444855413283e-06
lack O 0 1.914354470500257e-06
both O 0 6.520857465108776e-11
wild O 0 7.173302507545998e-10
- O 0 2.1369071442900456e-11
type O 0 1.1691526913271133e-10
alleles O 0 1.2337123510286485e-11
is O 0 5.169143108343932e-13
unknown O 0 2.8126331819144923e-10
. O 0 2.0725456073567017e-10

We O 0 6.488036774499051e-09
have O 0 3.00511872330933e-11
identified O 0 4.06593300694702e-11
three O 0 1.0933625966408345e-12
offspring O 0 2.4846222301810883e-10
in O 0 7.879792738446634e-13
a O 0 2.859017536605002e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9924955368041992
who O 0 4.693306854264279e-10
developed O 0 2.1020307716668185e-09
hematological B-Disease 1 0.9999352693557739
malignancy I-Disease 1 0.9988528490066528
at O 0 6.954525844093951e-10
a O 0 9.492452397036333e-13
very O 0 5.703241156250483e-13
early O 0 2.17374132582826e-10
age O 0 2.243325109008154e-10
, O 0 3.505290675775985e-13
and O 0 5.879804564241919e-13
at O 0 5.8000548808223584e-12
least O 0 1.2382426898063792e-12
two O 0 1.835175484883947e-14
of O 0 2.0406013033838488e-13
them O 0 3.225265310358681e-14
displayed O 0 5.675323058729198e-12
signs O 0 5.1833554809421756e-11
of O 0 4.112794133037667e-11
neurofibromatosis B-Disease 0 1.6771623734257446e-07
type I-Disease 0 2.0195617622675854e-08
1 I-Disease 0 5.864855268100655e-08
( O 0 1.0590247428998723e-11
NF1 B-Disease 0 6.19378124611103e-06
) O 0 9.426534552936516e-11
. O 0 1.0383388371337787e-08

DNA O 0 5.398814284518494e-09
sequence O 0 1.5542964484915878e-11
analysis O 0 1.0122679604263052e-12
and O 0 4.697061424703552e-13
allele O 0 1.0255529064862046e-12
- O 0 1.3269008287963846e-12
specific O 0 1.5843529830097958e-12
amplification O 0 5.193907526290786e-10
in O 0 9.027547806517155e-12
two O 0 5.972913569990412e-12
siblings O 0 1.7066846824675963e-09
revealed O 0 2.987039504631639e-10
a O 0 2.647055491467043e-11
homozygous O 0 1.914637337563363e-08
MLH1 O 0 0.0002849666925612837
mutation O 0 1.3041610458230934e-08
( O 0 5.901826336668359e-13
C676T O 0 2.7718451978131498e-09
- O 0 1.8668944168354074e-09
- O 0 4.40530811829376e-09
> O 0 1.6459244633892922e-08
Arg226Stop O 0 1.394620881001174e-07
) O 0 4.0716739875545915e-12
. O 0 1.9099302694947085e-10

Thus O 0 1.0614007095455236e-07
, O 0 6.731522284031399e-11
a O 0 1.086162930430401e-11
homozygous O 0 5.463891561419132e-09
germ O 0 0.00016751547809690237
- O 0 1.5786685253260657e-05
line O 0 2.0076417058589868e-05
MLH1 O 1 0.9999940395355225
mutation O 0 1.3022714711041772e-06
and O 0 3.8919402423065463e-11
consequent O 0 9.256550401914865e-05
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 0.9999926090240479
results O 0 1.378421984554734e-06
in O 0 6.326723589467065e-10
a O 0 1.0311360792991664e-10
mutator O 0 0.0006119345780462027
phenotype O 0 2.6186623358626093e-07
characterized O 0 1.8378824503950675e-11
by O 0 1.3191638536733108e-12
leukemia B-Disease 1 0.9999969005584717
and O 0 5.316484674722233e-08
/ O 1 0.9999943971633911
or O 0 0.010399016551673412
lymphoma B-Disease 1 1.0
associated O 0 1.1172965059813578e-05
with O 0 1.0990507115504755e-10
neurofibromatosis B-Disease 0 0.0001684541057329625
type I-Disease 0 3.406950384032825e-07
1 I-Disease 0 3.252165754474845e-07
. O 0 3.741017218228393e-10
. O 0 1.6767035537768038e-09

Missense O 0 0.0015892543597146869
mutations O 0 4.145366858665511e-07
in O 0 3.7076022807447373e-10
the O 0 5.530341185000509e-10
most O 0 4.8246778100446974e-11
ancient O 0 6.483060754902681e-10
residues O 0 4.105948026023043e-09
of O 0 5.807186675976794e-11
the O 0 9.116044030754722e-10
PAX6 O 0 6.263728573685512e-05
paired O 0 3.741204679386101e-09
domain O 0 2.4277049814891427e-10
underlie O 0 3.5548641807992e-10
a O 0 5.3520100677662e-13
spectrum O 0 1.8639529031361235e-08
of O 0 1.173057206926842e-10
human O 0 4.257428827258991e-07
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.0001322104362770915

Mutations O 0 2.858586469756119e-07
of O 0 6.709401367821499e-10
the O 0 2.55368337587214e-10
human O 0 1.5520820184633521e-09
PAX6 O 1 0.9997475743293762
gene O 0 1.8585799352877075e-06
underlie O 1 0.9994058609008789
aniridia B-Disease 1 1.0
( O 0 1.3006579138163943e-06
congenital B-Disease 1 1.0
absence I-Disease 1 0.9741640090942383
of I-Disease 0 2.648145937200752e-06
the I-Disease 0 2.8753353475963195e-08
iris I-Disease 0 6.784327410969127e-07
) O 0 7.34595056225279e-13
, O 0 2.4912144287563e-13
a O 0 1.5613724234971732e-13
rare O 0 3.4894946931984805e-09
dominant O 0 3.5256285627838224e-05
malformation B-Disease 1 1.0
of I-Disease 1 0.9999911785125732
the I-Disease 0 0.428477019071579
eye I-Disease 1 0.9999442100524902
. O 0 3.873772413953702e-07

The O 0 8.513544713650845e-08
spectrum O 0 2.64998907368863e-05
of O 0 2.4502702444806346e-07
PAX6 O 1 0.9999641180038452
mutations O 0 2.18716172639688e-06
in O 0 1.0405018180392744e-08
aniridia B-Disease 1 1.0
patients O 1 0.9658254981040955
is O 0 9.296896585908598e-12
highly O 0 2.1728129018239173e-10
biased O 0 7.419773823125198e-11
, O 0 4.200536132033944e-13
with O 0 3.2937746903853246e-14
92 O 0 1.0970093722306729e-09
% O 0 2.4679375296848827e-12
of O 0 1.3102619033159013e-12
all O 0 3.2989902042784847e-12
reported O 0 3.90198949540288e-11
mutations O 0 9.011381224555137e-11
leading O 0 7.602627555280961e-11
to O 0 3.6019681161347794e-12
premature O 0 3.4543250482244048e-09
truncation O 0 1.5807671616130392e-08
of O 0 4.547332732585119e-09
the O 0 1.2214259603737787e-09
protein O 0 1.0091888436036811e-09
( O 0 1.4846646047977918e-12
nonsense O 0 6.949593123195541e-10
, O 0 5.102717293842263e-13
splicing O 0 8.218331570830628e-11
, O 0 1.181260059386624e-12
insertions O 0 5.409940898037924e-11
and O 0 6.444515060488598e-12
deletions O 0 6.463426321934307e-11
) O 0 2.968960797697373e-13
and O 0 6.769088761737763e-12
just O 0 1.962567608426724e-11
2 O 0 1.2579594310668796e-10
% O 0 5.942275751319448e-13
leading O 0 6.481094279959729e-14
to O 0 7.052273499061953e-15
substitution O 0 4.0628966857525484e-10
of O 0 2.537360599408345e-10
one O 0 6.019472680723892e-12
amino O 0 9.141211225471846e-12
acid O 0 1.856470879801897e-11
by O 0 1.741532265620016e-12
another O 0 1.4591798255803035e-11
( O 0 5.374476471503575e-12
missense O 0 3.1016519130844245e-08
) O 0 1.400888693242619e-11
. O 0 3.158183270457471e-09

The O 0 9.673062351112094e-10
extraordinary O 0 3.562500572318328e-10
conservation O 0 1.495694901265665e-09
of O 0 7.627344936200764e-12
the O 0 5.903769140225279e-11
PAX6 O 0 4.161212473263731e-06
protein O 0 1.0812694073436546e-09
at O 0 2.1681337281087565e-11
the O 0 1.311552776106506e-11
amino O 0 1.0064783451113613e-09
acid O 0 6.743264435726815e-08
level O 0 2.4500602648913627e-06
amongst O 0 2.530433391711995e-07
vertebrates O 0 1.1141819413751364e-06
predicts O 0 1.4565097572472041e-08
that O 0 6.40310443555947e-11
pathological O 0 3.819824632955715e-05
missense O 0 3.0893130315234885e-05
mutations O 0 9.73672520387936e-09
should O 0 2.573614099610211e-10
in O 0 2.7026745424985066e-11
fact O 0 1.5064239786144462e-11
be O 0 3.617638740655016e-12
common O 0 9.970847064666444e-11
even O 0 1.9172547230383863e-11
though O 0 8.79205649256809e-12
they O 0 9.911715545540822e-13
are O 0 1.2827636359808575e-13
hardly O 0 7.891471504040126e-11
ever O 0 9.06135930178742e-12
seen O 0 8.350554969727142e-11
in O 0 1.0805122074852846e-10
aniridia B-Disease 1 1.0
patients O 0 0.1791108101606369
. O 0 9.256360300469169e-08

This O 0 3.042684437737364e-10
indicates O 0 6.755591086538004e-10
that O 0 1.071131098856655e-13
there O 0 3.8902588832614993e-13
is O 0 3.013770331385113e-14
a O 0 6.775023521799622e-14
heavy O 0 1.0872299505138017e-08
ascertainment O 0 1.031560032060952e-06
bias O 0 3.6327314489881246e-09
in O 0 4.9101400029227804e-12
the O 0 3.577531500209563e-12
selection O 0 1.88621049335147e-10
of O 0 1.3128090628478084e-11
patients O 0 1.8667048462539526e-10
for O 0 3.759654480101071e-12
PAX6 O 0 8.327835416821472e-07
mutation O 0 1.3662836140238e-10
analysis O 0 2.224727780469893e-12
and O 0 2.260579961069209e-13
that O 0 5.307653459536016e-14
the O 0 1.2724139797359868e-10
missing O 0 6.384138373505266e-08
PAX6 O 0 0.08797383308410645
missense O 0 0.00018316648493055254
mutations O 0 6.493449689060071e-08
frequently O 0 1.6741590058710898e-10
may O 0 5.488727805591509e-10
underlie O 0 1.5350313731232745e-07
phenotypes O 0 5.589727720689552e-07
distinct O 0 1.2678795791032371e-09
from O 0 1.4122968072793896e-10
textbook O 0 3.2897986557145487e-07
aniridia B-Disease 1 1.0
. O 0 9.632985893404111e-07

Here O 0 6.543866248875929e-08
we O 0 1.9507231940885106e-10
present O 0 4.605059111817411e-10
four O 0 2.214686420365375e-11
novel O 0 1.6258956847536865e-08
PAX6 O 0 0.004234533756971359
missense O 0 3.165878661093302e-05
mutations O 0 6.943227504052629e-08
, O 0 5.35736698059619e-11
two O 0 9.445781830319522e-13
in O 0 2.5589469779263574e-12
association O 0 4.154071617940014e-12
with O 0 3.7055601642688174e-13
atypical O 0 4.9733657760953065e-06
phenotypes O 0 1.2947364666615613e-05
ectopia B-Disease 0 1.3806499737256672e-05
pupillae I-Disease 0 1.447995691705728e-05
( O 0 9.291808641953558e-12
displaced B-Disease 0 1.0966473285023426e-09
pupils I-Disease 0 3.269740700417856e-09
) O 0 1.1958918230692284e-11
and O 0 3.946468041249318e-09
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.5075607895851135
( O 0 1.8025761439055543e-10
searching B-Disease 0 1.4882626686585354e-08
gaze I-Disease 0 7.840794125080208e-10
) O 0 5.665485916235384e-14
, O 0 1.9815605319800644e-13
and O 0 6.163792349786479e-13
two O 0 1.1981693035737623e-13
in O 0 2.982237286980327e-12
association O 0 1.526584414435206e-11
with O 0 3.5233353235832043e-13
more O 0 1.0594731689184123e-11
recognizable O 0 8.342988166987197e-08
aniridia B-Disease 1 1.0
phenotypes O 0 9.740192581375595e-06
. O 0 3.45124462342028e-08

Strikingly O 0 4.166704820818268e-05
, O 0 2.3208188704160193e-09
all O 0 1.6751459941399816e-10
four O 0 2.0134203332355938e-11
mutations O 0 3.5027279687849244e-11
are O 0 9.277301149523964e-13
located O 0 4.7774423306279346e-12
within O 0 1.0636407032915685e-10
the O 0 1.1369540864336614e-08
PAX6 O 0 0.024361692368984222
paired O 0 9.125985656055491e-08
domain O 0 5.557360793773114e-09
and O 0 7.359856474264959e-11
affect O 0 7.573689231321623e-09
amino O 0 2.1511401548934828e-09
acids O 0 6.228803028918151e-10
which O 0 2.352803498903433e-12
are O 0 2.498704910515459e-13
highly O 0 1.4330488184999268e-11
conserved O 0 2.5121930577465257e-11
in O 0 3.143280774553503e-12
all O 0 2.988290170868879e-12
known O 0 3.954315000442854e-11
paired O 0 2.62262767058985e-10
domain O 0 2.1810674100120053e-10
proteins O 0 9.044149457126949e-11
. O 0 3.958694205774549e-10

Our O 0 5.244223189038166e-08
results O 0 3.5441827250792812e-09
support O 0 1.0071466993721856e-09
the O 0 5.5401360582463255e-11
hypothesis O 0 7.912029365009232e-11
that O 0 6.400598113180016e-16
the O 0 1.659189312905405e-14
under O 0 7.734490131694471e-13
- O 0 1.3374717132419445e-11
representation O 0 3.9034950272132107e-10
of O 0 1.0880322198758563e-09
missense O 0 1.5667126262997044e-07
mutations O 0 4.1959941077251983e-10
is O 0 2.9717821628007235e-13
caused O 0 1.577743491409933e-11
by O 0 2.588529564306885e-11
ascertainment O 0 8.973452167992946e-06
bias O 0 3.212670662833261e-08
and O 0 3.531304762494081e-11
suggest O 0 1.4485342612891028e-11
that O 0 2.8082947496995596e-15
a O 0 1.986698667719427e-14
substantial O 0 4.397781444565041e-11
burden O 0 7.817997982328961e-08
of O 0 1.3767021300736815e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.809581995010376
related I-Disease 1 0.9987990856170654
disease I-Disease 1 0.9999983310699463
remains O 0 2.1281897133462735e-08
to O 0 2.733497564584575e-13
be O 0 5.972603054488212e-13
uncovered O 0 4.315734714044339e-10
. O 0 4.9136368585056545e-11
. O 0 1.0043325060493657e-09

The O 0 4.4904129303802165e-09
chromosomal O 0 5.4314341468852945e-08
order O 0 3.8638845012428646e-07
of O 0 4.595031896315049e-06
genes O 0 2.0919689802667563e-07
controlling O 0 8.005942575550762e-09
the O 0 5.320143880993555e-09
major O 0 6.700659582747903e-07
histocompatibility O 0 0.0233832485973835
complex O 0 4.5048759602650534e-06
, O 0 2.7482530140510164e-11
properdin O 0 1.733737242659572e-08
factor O 0 1.1578051406502254e-08
B O 0 1.3514398233382963e-05
, O 0 5.407934842126261e-13
and O 0 1.308154431133024e-12
deficiency B-Disease 0 6.113808570518131e-09
of I-Disease 0 8.911570148484316e-09
the I-Disease 0 4.312429080499669e-09
second I-Disease 0 4.736276260075556e-09
component I-Disease 0 3.195948750089883e-08
of I-Disease 0 8.50445314171111e-09
complement I-Disease 0 1.7575732869090643e-08
. O 0 5.1466567896341076e-08

The O 0 6.061350088515383e-09
relationship O 0 1.0136064210186646e-09
of O 0 1.8593252493204204e-09
the O 0 3.469391163246627e-10
genes O 0 2.9401564516362555e-11
coding O 0 1.0270299194425903e-10
for O 0 1.4234924003431182e-11
HLA O 0 1.8965701542583702e-07
to O 0 2.4487345484658363e-10
those O 0 5.4598648518977555e-11
coding O 0 2.961628511877201e-11
for O 0 3.292112134116454e-13
properdin O 0 1.5862580582393093e-08
Factor O 0 2.8740084090372875e-08
B O 0 5.514394274541701e-07
allotypes O 0 1.264856130944736e-08
and O 0 1.100148509618204e-12
for O 0 5.580728479163966e-13
deficiency B-Disease 0 9.858566407672242e-09
of I-Disease 0 1.4112481849792857e-08
the I-Disease 0 5.8860778473501796e-09
second I-Disease 0 2.673657295559906e-09
component I-Disease 0 2.990394420976372e-08
of I-Disease 0 6.164771093608579e-08
complement I-Disease 0 2.6115241524848898e-08
( O 0 7.069711569634984e-12
C2 O 0 4.3812400929432727e-10
) O 0 1.2353297909346167e-15
was O 0 1.6096611619564188e-13
studied O 0 3.207146191414739e-13
in O 0 5.634371685577302e-15
families O 0 3.219182461832587e-13
of O 0 7.159772991496838e-13
patients O 0 8.85568396391534e-10
with O 0 3.5770626044540066e-11
connective O 1 0.9999992847442627
tissue O 1 1.0
disorders O 1 0.9999992847442627
. O 0 9.60286456574977e-07

Patients O 0 0.0002092933573294431
were O 0 7.356973252825583e-09
selected O 0 3.6745435583185326e-09
because O 0 2.7187955012331066e-11
they O 0 2.9351456161397227e-12
were O 0 3.498868555995571e-11
heterozygous O 0 9.683634449864087e-11
or O 0 3.55171794752529e-11
homozygous O 0 1.6973265459796494e-08
for O 0 3.457926212036e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.5949673297654954e-06

12 O 0 9.845115300777252e-08
families O 0 4.134220465967786e-10
with O 0 2.797036040280698e-12
15 O 0 5.404323655255894e-10
matings O 0 9.433396712665854e-07
informative O 0 7.960206716006724e-08
for O 0 9.86834880478682e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 6.7855419061402245e-09
found O 0 3.087883282404391e-10
. O 0 1.7241565952730298e-09

Of O 0 2.1333139557100367e-06
57 O 0 1.356006350761163e-06
informative O 0 2.6256685714542982e-08
meioses O 0 2.9196414175203245e-07
, O 0 2.1373717032369122e-11
two O 0 7.67970376961552e-13
crossovers O 0 4.490068317153373e-10
were O 0 5.164398075852006e-11
noted O 0 1.9727079345055465e-11
between O 0 1.090734932929216e-10
the O 0 4.960724595548527e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 8.836039538939744e-11
and O 0 3.5221478511537896e-12
the O 0 3.240117896208261e-11
HLA O 0 1.7324686041320092e-07
- O 0 0.0047867861576378345
B O 0 0.0005099467234686017
gene O 0 4.045925920681537e-12
, O 0 1.0439297368984145e-14
with O 0 5.608311684633619e-17
a O 0 5.791597835367527e-16
recombinant O 0 2.207372739454483e-12
fraction O 0 1.931176468739082e-10
of O 0 7.338536028855813e-11
0 O 0 1.6583708850603784e-09
. O 0 1.406737087927823e-10

035 O 0 0.00874556228518486
. O 0 4.518907644524006e-06

A O 0 3.413971683130512e-08
lod O 0 2.1472610569617245e-06
score O 0 2.5194029085184866e-09
of O 0 4.8905893224038266e-11
13 O 0 1.7819620778958267e-11
was O 0 7.126189287103013e-13
calculated O 0 7.966706287720893e-12
for O 0 5.754304151228684e-12
linkage O 0 5.260372404336522e-07
between O 0 0.0002157761191483587
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.154160266305439e-10
HLA O 0 4.8984762912596125e-08
- O 0 7.428740786963317e-07
B O 0 1.6113814353957423e-06
at O 0 1.987893763445367e-13
a O 0 2.4177994320046447e-16
maximum O 0 2.7763303944239662e-14
likelihood O 0 6.270573795451317e-13
value O 0 4.1704101109985015e-12
of O 0 6.379448835511226e-13
the O 0 1.6459680840519297e-12
recombinant O 0 7.594135736921359e-11
fraction O 0 7.839388582731033e-10
of O 0 1.0146659901177912e-10
0 O 0 1.3879960514273648e-09
. O 0 2.4024987554938093e-10

04 O 0 0.0007587553700432181
. O 0 5.890494321647566e-06

18 O 0 9.590710305928951e-07
families O 0 3.36618022345192e-09
with O 0 1.229788840206858e-11
21 O 0 5.023943039361711e-09
informative O 0 5.027429583748244e-10
matings O 0 3.776996049253967e-09
for O 0 3.703435561691615e-12
both O 0 8.326089817600746e-12
properdin O 0 1.664156741298939e-07
Factor O 0 8.837114506832222e-08
B O 0 4.130018623982323e-06
allotype O 0 2.39728290551966e-08
and O 0 2.913433383433528e-11
HLA O 0 5.956032111953391e-08
- O 0 2.566056764408131e-06
B O 0 2.8982631192775443e-05
were O 0 1.04901113837097e-11
found O 0 1.9951841827986483e-12
. O 0 8.202561546655218e-11

Of O 0 4.991350579075515e-06
72 O 0 3.932827439712128e-06
informative O 0 7.505499866056198e-08
meioses O 0 2.626258037707885e-06
, O 0 1.3858075798012237e-10
three O 0 7.520876282862687e-12
recombinants O 0 2.049246319302256e-07
were O 0 1.2160377149683654e-09
found O 0 2.4266573125930613e-11
, O 0 5.648300837463038e-13
giving O 0 1.0211184111805216e-12
a O 0 8.338795420229778e-14
recombinant O 0 8.76597336385565e-11
fraction O 0 5.5338897908541185e-09
of O 0 1.449218300919597e-09
0 O 0 1.3144949129184624e-08
. O 0 1.0050050791576837e-09

042 O 0 0.0015511128585785627
. O 0 5.991254511172883e-06

A O 0 2.395344900207874e-08
lod O 0 1.1797694696724648e-06
score O 0 5.261894475694362e-09
of O 0 3.3884087202729063e-10
16 O 0 7.268969315354923e-10
between O 0 7.502082982613345e-11
HLA O 0 1.4553997971233912e-06
- O 0 0.00011960746633121744
B O 0 5.451592733152211e-05
and O 0 9.752931968975975e-13
Factor O 0 1.1389497678315763e-10
B O 0 5.233808053617395e-09
allotypes O 0 2.6268781594396273e-10
was O 0 9.195733367481362e-13
calculated O 0 7.1032051768282756e-12
at O 0 3.3121153931482683e-13
a O 0 6.833941863061211e-15
maximum O 0 8.782600298060106e-13
likelihood O 0 2.4885812160979626e-11
value O 0 4.02887827266607e-11
of O 0 3.8223144267768294e-12
the O 0 4.828320469135727e-12
recombinant O 0 2.0496344899090246e-10
fraction O 0 6.730742629912356e-10
of O 0 2.6760638149880833e-10
0 O 0 4.033219092036688e-09
. O 0 2.370526552830654e-10

04 O 0 0.0008969230111688375
. O 0 7.517601261497475e-06

A O 0 1.0772314595897114e-07
crossover O 0 1.5480974724368934e-08
was O 0 8.387719963032225e-10
shown O 0 2.0167565534245924e-11
to O 0 1.8998932201780283e-12
have O 0 5.955960009039474e-13
occurred O 0 1.297030122193732e-10
between O 0 1.2797779329332126e-12
genes O 0 3.410962647314858e-13
for O 0 1.0224195893127758e-13
Factor O 0 4.170104261902452e-10
B O 0 3.972600381985103e-08
and O 0 2.1436867038426843e-12
HLA O 0 1.11969822302882e-09
- O 0 1.640532616420387e-07
D O 0 2.1960639529083892e-08
, O 0 6.941118144664082e-13
in O 0 2.897950976410435e-13
which O 0 3.5948696276710823e-13
HLA O 0 1.43190899137835e-08
- O 0 1.084004793483473e-06
D O 0 5.674273850786449e-08
segregared O 0 2.6614575432404308e-08
with O 0 2.0240619076627997e-12
HLA O 0 2.489842998443237e-08
- O 0 3.7190723389812774e-08
A O 0 2.5485187293838862e-08
and O 0 8.739696466530944e-11
B O 0 4.263214350430644e-07
. O 0 7.033561927327625e-11

These O 0 2.4290169875484935e-09
studies O 0 6.315797190792338e-11
suggest O 0 6.6570551154887525e-12
that O 0 2.2839301522074862e-14
the O 0 2.518860771003051e-12
genes O 0 2.3270341816677975e-12
for O 0 2.6988405000399895e-12
Factor O 0 2.0627060166589217e-06
B O 1 0.9999998807907104
and O 0 3.1048546134115895e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.076753679585712e-12
located O 0 7.918573565954268e-13
outside O 0 2.7241301662345174e-12
those O 0 6.040793408025602e-13
for O 0 5.886919098897769e-13
HLA O 0 9.57405799084654e-09
, O 0 1.4874649905891046e-12
that O 0 1.2297870614376687e-14
the O 0 2.7719718339279387e-13
order O 0 1.8266886267492843e-11
of O 0 3.584158317360142e-11
genese O 0 1.1297081492500638e-08
is O 0 7.946715659644388e-13
HLA O 0 5.2398755473470615e-11
- O 0 1.0855628895800606e-10
A O 0 2.120327108334763e-10
, O 0 1.8338116940762317e-13
- O 0 2.1208841974318382e-11
B O 0 5.265317959413096e-09
, O 0 9.467633687936742e-15
- O 0 1.496166255124387e-12
D O 0 1.630949889031008e-11
, O 0 2.5343855974361423e-14
Factor O 0 1.0779869219490479e-09
B O 0 0.00016573790344409645
allotype O 0 0.0005572609370574355
, O 0 6.349662271531997e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 8.722954650264292e-12
that O 0 8.999893115913676e-14
the O 0 3.0057838162900197e-11
genes O 0 2.937494969490473e-10
coding O 0 3.406913862136207e-08
for O 0 2.6247523265965356e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.0326227367917227e-09
Factor O 0 1.6939855740361054e-08
B O 0 1.7612889280371746e-07
allotypes O 0 2.7616182673995127e-09
are O 0 1.1348237074441242e-13
approximately O 0 1.3275323765618574e-14
3 O 0 4.076326407496944e-13
- O 0 1.0947021284249403e-12
- O 0 7.907261651007857e-11
5 O 0 1.0233616037913507e-10
centimorgans O 0 1.2323589926310774e-09
from O 0 7.215834700591284e-12
the O 0 3.24787696737161e-11
HLA O 0 4.180610524429085e-09
- O 0 3.87807252977268e-09
A O 0 3.433567430377593e-09
and O 0 2.6516629603873243e-12
HLA O 0 2.740488058705637e-09
- O 0 4.8858325385481294e-08
B O 0 9.061842831670219e-08
loci O 0 3.929277476305559e-12
, O 0 3.6946039794433314e-15
and O 0 1.0604085537759881e-16
that O 0 1.5785514454545504e-17
the O 0 9.156519333443185e-15
apparent O 0 8.262429802841087e-12
lack O 0 4.951070109449063e-11
of O 0 9.2059511055953e-12
recombinants O 0 2.029488577193206e-09
between O 0 3.717951727738589e-12
the O 0 1.7330437432350188e-11
Factor O 0 3.0554296870377584e-08
B O 0 0.0008393091266043484
gene O 0 7.75942226027837e-08
and O 0 1.0811883157657576e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 6.852602041362843e-09
suggests O 0 9.306024839617066e-10
that O 0 4.210707574715117e-13
these O 0 7.543804990406411e-12
two O 0 1.2003107925998013e-12
genes O 0 7.55722828066352e-12
lie O 0 1.8599583678780007e-11
in O 0 3.5901758454158494e-13
close O 0 1.0057424511267232e-11
proximity O 0 1.932334292575888e-09
to O 0 8.475830454157673e-11
one O 0 8.294250702922668e-11
another O 0 2.916298036392817e-10
. O 0 8.227718950593044e-09

Distribution O 0 4.8658190365813425e-08
of O 0 8.21075651913361e-09
emerin O 0 7.037477189442143e-05
and O 0 3.926975633561369e-09
lamins O 0 3.96244877265417e-06
in O 0 2.089803850802152e-11
the O 0 5.723352000663873e-11
heart O 0 2.0535486644490675e-09
and O 0 3.1458776555970402e-12
implications O 0 9.187502147955939e-11
for O 0 1.2486597693317503e-11
Emery B-Disease 0 3.245574043830857e-05
- I-Disease 1 0.9998995065689087
Dreifuss I-Disease 1 0.8776798844337463
muscular I-Disease 1 0.9591557383537292
dystrophy I-Disease 1 0.9999986886978149
. O 0 0.00010773442045319825

Emerin O 1 0.7628063559532166
is O 0 2.594582326764794e-09
a O 0 2.636695549396162e-11
nuclear O 0 2.54395811083441e-08
membrane O 0 1.0187509502657122e-08
protein O 0 3.008469584564466e-10
which O 0 3.3819079264460483e-13
is O 0 2.1873299070433727e-13
missing O 0 3.6683284881933176e-11
or O 0 9.47834519204882e-12
defective O 0 5.770263555859856e-08
in O 0 5.078298670468939e-09
Emery B-Disease 1 0.997454822063446
- I-Disease 1 1.0
Dreifuss I-Disease 1 0.9999986886978149
muscular I-Disease 1 0.9999954700469971
dystrophy I-Disease 1 1.0
( O 0 2.9538421486563493e-08
EDMD B-Disease 1 1.0
) O 0 9.418612556544304e-10
. O 0 1.0023791574553798e-08

It O 0 6.900389287745057e-11
is O 0 2.090293216294725e-12
one O 0 4.811466980045309e-13
member O 0 6.439301674342202e-13
of O 0 1.2791342637874514e-11
a O 0 8.242093639532211e-12
family O 0 1.3024394063254618e-10
of O 0 1.203297239626977e-09
lamina O 1 0.9989761114120483
- O 0 3.67272093626525e-07
associated O 0 3.691679495432254e-08
proteins O 0 6.516455430816137e-11
which O 0 7.282068963674129e-14
includes O 0 2.3801460477014535e-13
LAP1 O 0 6.110330105002504e-06
, O 0 5.947043552056996e-11
LAP2 O 0 0.006036162842065096
and O 0 6.294733179146306e-09
lamin O 0 2.8012598249915754e-06
B O 0 6.471820142905926e-06
receptor O 0 4.375613649187926e-09
( O 0 2.917409369640467e-11
LBR O 0 1.12916313810274e-06
) O 0 3.927226599476086e-11
. O 0 7.725482475962053e-09

A O 0 6.483332981588319e-07
panel O 0 6.306368049990851e-08
of O 0 3.7401131081082895e-09
16 O 0 1.624730039395672e-08
monoclonal O 0 2.870201143423401e-08
antibodies O 0 4.2379518561119767e-08
( O 0 3.321849045834213e-11
mAbs O 0 4.392255448237847e-08
) O 0 1.8456872315220085e-12
has O 0 2.7155380266478957e-13
been O 0 5.345154115328488e-13
mapped O 0 1.3908044160793054e-10
to O 0 1.5469086081520977e-11
six O 0 2.7052013407136144e-11
specific O 0 5.024313742829634e-10
sites O 0 3.2498446156381533e-09
throughout O 0 1.4187936381304667e-09
the O 0 9.206592155308613e-10
emerin O 0 4.200674936782889e-07
molecule O 0 1.066243204839168e-09
using O 0 2.5108048973265795e-10
phage O 0 1.7844228317187572e-09
- O 0 4.564603209300522e-11
displayed O 0 1.481497841071544e-10
peptide O 0 1.368860719219711e-10
libraries O 0 1.9930639083565183e-10
and O 0 2.093888430698687e-12
has O 0 1.0757500033993506e-13
been O 0 1.3251955143043365e-13
used O 0 9.1196137013555e-13
to O 0 2.3412462940575196e-11
localize O 0 2.0964345992524613e-07
emerin O 0 1.7654708699410548e-06
in O 0 1.3717985081207473e-10
human O 0 3.5693425992633365e-10
and O 0 8.019479524890016e-10
rabbit O 0 7.807001622950338e-08
heart O 0 6.900280169475081e-08
. O 0 2.8553053255109262e-08

Several O 0 3.1083740736903565e-07
mAbs O 0 1.1016018106602132e-05
against O 0 1.9718795485346163e-08
different O 0 1.221165746301267e-08
emerin O 0 1.65198725881055e-05
epitopes O 0 9.654257837610203e-07
did O 0 2.6637567707155085e-09
not O 0 7.39981756425756e-11
recognize O 0 4.2706485570143116e-10
intercalated O 0 7.934088586125654e-08
discs O 0 6.122572671074522e-09
in O 0 4.429239613967795e-11
the O 0 1.2641410140901144e-10
heart O 0 1.172651131753355e-08
, O 0 5.731301717937232e-12
though O 0 4.254686186699885e-11
they O 0 2.757955539292589e-12
recognized O 0 6.128816898431921e-11
cardiomyocyte O 0 1.0867493926980387e-07
nuclei O 0 2.885604146740661e-07
strongly O 0 3.115405489140244e-09
, O 0 1.245548456041412e-11
both O 0 5.856079943883374e-12
at O 0 5.7123587110519125e-11
the O 0 1.0720074133940827e-10
rim O 0 9.483924756636952e-10
and O 0 2.4592647362986497e-11
in O 0 7.163646065233564e-11
intranuclear O 0 1.2253535714989994e-06
spots O 0 7.524190692720367e-08
or O 0 2.8602190060844634e-10
channels O 0 1.213817713008325e-09
. O 0 7.861789552698895e-10

A O 0 1.1832535165012814e-06
polyclonal O 0 4.3342508433852345e-05
rabbit O 0 1.9039219978367328e-06
antiserum O 0 3.077778274018783e-06
against O 0 3.590287533938863e-08
emerin O 0 0.00010517582995817065
did O 0 3.823343490694242e-07
recognize O 0 1.6796876778357728e-08
both O 0 3.455693786680314e-10
nuclear O 0 3.4976192608837664e-08
membrane O 0 2.898089768166301e-09
and O 0 9.825694945175822e-13
intercalated O 0 3.938495085620275e-10
discs O 0 3.5279534849053107e-10
but O 0 1.78069815837123e-11
, O 0 7.52780433474487e-13
after O 0 6.8285581182603305e-12
affinity O 0 6.39440306260397e-11
purification O 0 1.4185562946522623e-08
against O 0 5.382830292610663e-11
a O 0 3.1401467797537164e-12
pure O 0 5.515246592757705e-10
- O 0 1.3413097021963694e-10
emerin O 0 1.919002556860505e-08
band O 0 3.3110592045915155e-10
on O 0 9.322697128166801e-12
a O 0 2.4594310420698873e-13
western O 0 1.1392713161750834e-10
blot O 0 2.864611658992544e-08
, O 0 2.404229159508331e-12
it O 0 4.2284378038923154e-13
stained O 0 1.4945378268294007e-08
only O 0 5.307062081461034e-12
the O 0 1.1875770332403501e-11
nuclear O 0 1.3609220417265533e-08
membrane O 0 2.839089674466777e-08
. O 0 2.1705770514302003e-09

These O 0 5.233957711681114e-09
results O 0 4.705138501037709e-10
would O 0 2.1256385540624478e-11
not O 0 2.086274295681756e-12
be O 0 1.4776555630133248e-12
expected O 0 2.187617864635172e-09
if O 0 2.2812964017848714e-10
immunostaining O 0 1.5482486048767896e-07
at O 0 8.445540100598947e-11
intercalated O 0 4.83415174556967e-09
discs O 0 9.889862262468796e-10
were O 0 4.99675925635934e-11
due O 0 1.597399879038619e-09
to O 0 6.4596765436686354e-12
a O 0 1.365935684873032e-12
product O 0 2.4160135003725713e-10
of O 0 2.9021485214997256e-10
the O 0 4.943589981820651e-10
emerin O 0 1.9414868290823506e-07
gene O 0 3.4272699261928e-11
and O 0 6.313613260672257e-12
, O 0 3.2656955481838446e-13
therefore O 0 6.375283634341145e-11
, O 0 1.169637628938014e-12
cast O 0 7.428185150315514e-11
some O 0 8.004522066874797e-13
doubt O 0 3.643761681271229e-11
upon O 0 9.611314348567657e-12
the O 0 4.680947469914987e-12
hypothesis O 0 4.299499367643733e-10
that O 0 5.270190750819581e-13
cardiac B-Disease 0 2.721646069403505e-06
defects I-Disease 0 7.624887985002715e-06
in O 0 6.888760850642939e-08
EDMD B-Disease 1 1.0
are O 0 1.909231883701068e-09
caused O 0 4.3868925159173955e-10
by O 0 4.8885912679041965e-12
absence O 0 4.718525303815113e-08
of O 0 4.952454002449258e-09
emerin O 0 1.7617588810026064e-06
from O 0 2.092362505479173e-09
intercalated O 0 9.793336630536942e-07
discs O 0 3.1132395861277473e-07
. O 0 2.494140005637746e-08

Although O 0 1.2354624914223677e-06
emerin O 0 4.730762884719297e-05
was O 0 3.007141913258238e-08
abundant O 0 2.387599806752405e-08
in O 0 3.1698154517867394e-11
the O 0 8.985704541553119e-11
membranes O 0 2.0275453538332044e-10
of O 0 2.9759392172756804e-10
cardiomyocyte O 0 1.0858605037356028e-07
nuclei O 0 4.190064473164057e-08
, O 0 1.817273545187681e-12
it O 0 2.9645346778534726e-14
was O 0 4.311914367227665e-11
absent O 0 4.751115056933486e-09
from O 0 4.2936872807208815e-11
many O 0 9.635910125371794e-12
non O 0 1.0743824718772998e-09
- O 0 4.459530245082277e-10
myocyte O 0 6.976693356364194e-08
cells O 0 7.08829772655406e-10
in O 0 1.289387325208169e-12
the O 0 1.8977427268529468e-11
heart O 0 3.7169363142908196e-09
. O 0 6.9290155835233236e-09

This O 0 2.2333521143558244e-10
distribution O 0 5.9666455110019e-10
of O 0 9.201150952264925e-10
emerin O 0 3.008856992892106e-06
was O 0 5.854123852344628e-09
similar O 0 6.258477069920332e-11
to O 0 1.5065957379226114e-12
that O 0 2.2031485522652078e-13
of O 0 7.804057400306874e-11
lamin O 0 9.48656975197082e-09
A O 0 7.899547682654884e-10
, O 0 6.38882501589888e-13
a O 0 2.326864558237912e-13
candidate O 0 6.036423444433225e-11
gene O 0 2.882350662401084e-13
for O 0 1.2305644513359998e-13
an O 0 3.0137130719578784e-14
autosomal O 0 1.2042983277282815e-09
form O 0 8.868399348216371e-09
of O 0 2.253439561172854e-05
EDMD B-Disease 1 1.0
. O 0 0.0007426278316415846

In O 0 6.902976412703765e-09
contrast O 0 7.354562825412359e-08
, O 0 5.125904589675656e-09
lamin O 0 4.8959740524878725e-05
B1 O 0 6.0167210904182866e-05
was O 0 9.590306326856535e-09
absent O 0 1.4721875629675196e-07
from O 0 5.242437595143201e-10
cardiomyocyte O 0 2.4136928914231248e-05
nuclei O 0 0.00017332997231278569
, O 0 4.744628578912113e-10
showing O 0 2.4384680941125225e-09
that O 0 1.5309065126700716e-10
lamin O 0 3.29100621456746e-05
B1 O 0 1.0896504818447283e-06
is O 0 3.802794938754378e-13
not O 0 1.540294313536611e-13
essential O 0 1.394862957776466e-11
for O 0 7.399584417422389e-13
localization O 0 4.8095706972617336e-08
of O 0 2.471312876561882e-10
emerin O 0 3.6577083051270165e-07
to O 0 6.75963521268308e-11
the O 0 2.733490933604088e-10
nuclear O 0 1.2942101648150128e-06
lamina O 1 0.9937357902526855
. O 0 6.436788169139618e-08

Lamin O 1 0.9651790857315063
B1 O 0 0.002271905541419983
is O 0 2.139363269870742e-10
also O 0 2.962210338131044e-11
almost O 0 5.607858274969679e-11
completely O 0 5.609468445300081e-09
absent O 0 1.8436085724715667e-07
from O 0 5.287142945675782e-10
skeletal O 0 5.183264875086024e-07
muscle O 0 2.5589483811927494e-06
nuclei O 1 0.940435528755188
. O 0 1.6599688024143688e-06

In O 0 6.452423662040019e-08
EDMD B-Disease 1 1.0
, O 0 2.3922697156564254e-10
the O 0 1.459285643712338e-11
additional O 0 2.3471124349638828e-11
absence O 0 2.4408285170807176e-08
of O 0 1.3412834221071535e-07
lamin O 0 0.003256090683862567
B1 O 0 0.10467647016048431
from O 0 3.6288550830931854e-08
heart O 1 0.9999994039535522
and O 0 9.024007340485696e-06
skeletal O 1 0.9999997615814209
muscle O 1 1.0
nuclei O 1 1.0
which O 0 1.6254902845957986e-07
already O 0 6.007370156879688e-09
lack O 0 2.7020238491104465e-08
emerin O 0 3.373979780008085e-07
may O 0 6.968468024837193e-10
offer O 0 2.7673259517246862e-11
an O 0 2.4942356851648728e-15
alternative O 0 2.6830438912273102e-11
explanation O 0 2.130789815424361e-11
of O 0 3.2098588110401893e-12
why O 0 4.305305244256541e-12
these O 0 4.752791584773652e-13
tissues O 0 1.7497078785844167e-10
are O 0 5.650671445513178e-13
particularly O 0 1.8557344896863448e-11
affected O 0 9.775867615413603e-11
. O 0 2.6477434134086764e-10
. O 0 3.523006331107581e-09

Genetic O 0 1.0894058277699514e-07
mapping O 0 9.339102824412748e-09
of O 0 1.4165438821933662e-09
the O 0 1.4938596137881177e-08
copper B-Disease 0 0.04056219011545181
toxicosis I-Disease 1 0.6730070114135742
locus O 0 3.0173108456210684e-08
in O 0 1.1317651260611683e-09
Bedlington O 0 1.3606563697976526e-07
terriers O 0 3.897800127106166e-08
to O 0 2.017372033313869e-11
dog O 0 2.1951749307191903e-09
chromosome O 0 8.255596900541562e-11
10 O 0 1.2676074599704545e-11
, O 0 1.4213096303193617e-13
in O 0 3.8250696013375496e-13
a O 0 1.3379151302464476e-12
region O 0 8.022998931878078e-10
syntenic O 0 2.627923834097601e-07
to O 0 1.3571774259979463e-10
human O 0 9.709791859435768e-10
chromosome O 0 1.6628145527164406e-09
region O 0 5.634450128688684e-10
2p13 O 0 6.131713803370076e-08
- O 0 1.7149282882655825e-08
p16 O 0 2.4644899454528968e-08
. O 0 1.848861064246421e-09

Abnormal O 1 0.9999996423721313
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 0 9.576868251315318e-06
accumulation I-Disease 0 6.011350137669069e-07
is O 0 4.0535730154445115e-12
recognized O 0 9.942280505825796e-12
as O 0 2.6543042937199335e-12
an O 0 1.9855415055169967e-12
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.00012092848191969097
man O 0 2.589862617696781e-07
, O 0 4.507536358056008e-11
mouse O 0 1.1155334433965436e-08
, O 0 1.933283567956412e-11
rat O 0 2.3357149814273725e-07
and O 0 1.102649568873737e-10
dog O 0 2.5139038939414604e-07
. O 0 2.061028858690861e-08

The O 0 3.0044414955909815e-08
major O 0 1.452471138918554e-07
cause O 0 2.104040322592482e-05
of O 0 0.0015957177383825183
hepatic B-Disease 1 1.0
copper I-Disease 0 0.08908789604902267
accumulation I-Disease 0 0.005710743833333254
in O 0 1.6626148235943106e-09
man O 0 7.481766872707851e-10
is O 0 5.997077292228814e-13
a O 0 2.1916865024229626e-12
dysfunctional O 0 1.3914564078731928e-07
ATP7B O 1 0.9998261332511902
gene O 0 1.5662861230225644e-08
, O 0 2.2408436217702388e-11
causing O 0 1.0393137017672416e-08
Wilson B-Disease 0 1.7413102568752947e-06
disease I-Disease 0 7.963514008224593e-07
( O 0 4.520528743001684e-11
WD B-Disease 0 1.2088866242265794e-05
) O 0 2.2976018310139068e-10
. O 0 1.791917014770661e-08

Mutations O 0 9.227254054167133e-07
in O 0 1.9829482500455242e-09
the O 0 9.708167603150741e-09
ATP7B O 1 0.9999985694885254
genes O 0 1.1738667637928302e-07
have O 0 1.0771600972292461e-10
also O 0 2.124445801568453e-12
been O 0 3.69838838373826e-12
demonstrated O 0 5.250403445344887e-10
in O 0 3.3114888609020454e-10
mouse O 0 1.495365324899467e-07
and O 0 1.737835098047924e-09
rat O 0 2.0180368665023707e-06
. O 0 1.0672184025395381e-08

The O 0 6.580350486729003e-07
ATP7B O 1 0.9988740086555481
gene O 0 1.873440957922412e-08
has O 0 1.1114816532431515e-11
been O 0 1.6971287656458722e-12
excluded O 0 2.008029159616953e-10
in O 0 4.82057969930505e-13
the O 0 5.264916107250439e-13
much O 0 8.520220987073834e-12
rarer O 0 1.1828315109596588e-06
human O 0 1.3668980614056636e-07
copper B-Disease 1 0.9829399585723877
overload I-Disease 1 0.9618691205978394
disease O 0 0.0003259177028667182
non B-Disease 0 4.998721010451845e-07
- I-Disease 0 5.044529682862731e-09
Indian I-Disease 0 1.6249143697244506e-10
childhood I-Disease 0 5.344900522175067e-09
cirrhosis I-Disease 0 0.00011890991299878806
, O 0 7.83677983617892e-12
indicating O 0 7.394742596034121e-10
genetic O 0 2.285683420311102e-09
heterogeneity O 0 1.1614483952371302e-07
. O 0 2.706227597570887e-08

By O 0 1.2920227387969163e-10
investigating O 0 1.1317953241274381e-09
the O 0 6.745676794928102e-10
common O 0 8.733357503842853e-07
autosomal O 1 0.9998706579208374
recessive O 1 0.9999840259552002
copper B-Disease 1 0.9998965263366699
toxicosis I-Disease 1 0.9999452829360962
( O 0 4.1154249452723946e-10
CT B-Disease 0 1.0645230759109836e-05
) O 0 2.997653861247507e-11
in O 0 5.225068155922941e-10
Bedlington O 0 8.643208957437309e-07
terriers O 0 1.8920898980923084e-07
, O 0 2.924661814812657e-12
we O 0 8.957051138118455e-13
have O 0 1.431514818793153e-13
identified O 0 2.0205277067360944e-13
a O 0 1.6876650782844367e-15
new O 0 1.3298417271892515e-13
locus O 0 4.05911063225059e-13
involved O 0 1.656492732695844e-13
in O 0 4.79091349925298e-11
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.0735758451119182e-06

We O 0 3.8405754132497805e-09
examined O 0 4.3360008916693005e-09
whether O 0 3.439517559655769e-10
the O 0 3.829033534685777e-09
WD B-Disease 0 0.0019392273388803005
gene O 0 1.2211289401875547e-07
ATP7B O 1 0.9999998807907104
was O 0 9.24295164850264e-08
also O 0 7.733521288633138e-12
causative O 0 1.1274688960227763e-09
for O 0 1.5539257380847715e-11
CT B-Disease 0 8.181292798781215e-08
by O 0 4.026172624460589e-12
investigating O 0 1.4242046431078847e-10
the O 0 1.7245174732671842e-10
chromosomal O 0 2.551845668108399e-08
co O 0 3.989074848220753e-09
- O 0 1.4956043514757766e-08
localization O 0 1.1320266821712721e-05
of O 0 1.1955608059111e-08
ATP7B O 1 0.5381395220756531
and O 0 1.9217992475173418e-10
C04107 O 0 2.923149056144325e-09
, O 0 1.303113297606781e-13
using O 0 7.575620090006369e-14
fluorescence O 0 3.921075686363906e-10
in O 0 3.0864685807152625e-11
situ O 0 4.8095799343172985e-08
hybridization O 0 1.4659292668639523e-09
( O 0 1.4869488019347843e-12
FISH O 0 2.3293480921893206e-08
) O 0 9.96380278631137e-13
. O 0 4.42296921310259e-10

C04107 O 0 6.036848935764283e-05
is O 0 2.0313427329110567e-10
an O 0 2.0599557216255393e-12
anonymous O 0 1.1179611680844914e-09
microsatellite O 0 8.44403800215332e-08
marker O 0 4.3227910140331005e-08
closely O 0 4.2035419589581124e-09
linked O 0 3.1626093743852834e-08
to O 0 2.5423514404820935e-09
CT B-Disease 1 0.7940307855606079
. O 0 4.601657224156952e-07

However O 0 4.6234141336753964e-05
, O 0 1.871459289759514e-07
BAC O 0 0.0001696362451184541
clones O 0 1.7813297290558694e-06
containing O 0 9.028938485755589e-09
ATP7B O 1 0.5862873792648315
and O 0 4.167283407241484e-09
C04107 O 0 4.237418522734515e-07
mapped O 0 4.4233008367200455e-09
to O 0 7.433301890680255e-11
the O 0 1.570248708837596e-09
canine O 0 6.42900843672578e-08
chromosome O 0 8.19017298425706e-09
regions O 0 9.2612300051087e-09
CFA22q11 O 0 4.196697318548104e-06
and O 0 1.2663811110869005e-09
CFA10q26 O 0 4.237982011545682e-06
, O 0 2.4383956659379535e-11
respectively O 0 1.8796310341517852e-10
, O 0 9.17364274821697e-13
demonstrating O 0 1.3702863496667383e-11
that O 0 9.122814266168677e-13
WD B-Disease 0 9.241805543069859e-08
cannot O 0 7.139288049629045e-10
be O 0 3.7867087937515365e-11
homologous O 0 2.170166268911089e-10
to O 0 4.133605402412144e-10
CT B-Disease 0 1.3755587133346125e-05
. O 0 3.574415075036086e-08

The O 0 8.345835453837935e-07
copper O 0 1.4757350072613917e-05
transport O 0 1.3007835150347091e-05
genes O 0 3.135790507258207e-07
CTR1 O 1 0.9974881410598755
and O 0 1.5620317483922008e-08
CTR2 O 1 0.9999947547912598
were O 0 9.568275061155873e-08
also O 0 1.6324694374070248e-10
excluded O 0 1.0092066737854566e-08
as O 0 3.2888033962841234e-10
candidate O 0 6.333222390964011e-09
genes O 0 2.091717944685545e-11
for O 0 2.9865920934263324e-12
CT B-Disease 0 2.630496567235241e-07
since O 0 2.060273063264617e-09
they O 0 6.12155048873575e-11
both O 0 1.6932464111385492e-11
mapped O 0 8.019174213558244e-10
to O 0 1.3109607843730942e-10
canine O 0 1.0844468079085345e-07
chromosome O 0 8.870586043485673e-08
region O 0 1.9013905117049035e-08
CFA11q22 O 0 9.659883653512225e-05
. O 0 3.0977147957855777e-07

2 O 0 4.316008471505484e-06
- O 0 7.48234356251487e-07
22 O 0 1.070366266731071e-07
. O 0 1.132139271220467e-08

5 O 0 7.841092156013474e-06
. O 0 1.996300227347092e-07

A O 0 1.3354286920730374e-07
transcribed O 0 3.6925718038816058e-09
sequence O 0 4.9702016807762206e-11
identified O 0 3.045696680969989e-11
from O 0 2.113348124971326e-12
the O 0 4.548091070422089e-11
C04107 O 0 4.495085548228417e-08
- O 0 2.558687040021823e-09
containing O 0 9.259988886789472e-10
BAC O 0 2.3573322494030435e-07
was O 0 2.809705801354312e-10
found O 0 6.513790158299559e-13
to O 0 1.2351521173036006e-13
be O 0 7.585412332977715e-13
homologous O 0 3.961847776928762e-12
to O 0 9.178950134691721e-12
a O 0 1.3559089614978426e-11
gene O 0 1.70839609819895e-11
expressed O 0 1.0464715899383137e-10
from O 0 3.2422443202451134e-11
human O 0 2.413861298344866e-11
chromosome O 0 1.4252535263103994e-10
2p13 O 0 5.116342016719955e-09
- O 0 2.9380273214307806e-10
p16 O 0 3.012793625689625e-10
, O 0 1.9834700830563545e-13
a O 0 2.4910896777438282e-14
region O 0 2.555079411936667e-12
devoid O 0 5.354581222860588e-10
of O 0 3.716108584045363e-12
any O 0 4.3862212473211315e-11
positional O 0 7.900534626514855e-08
candidate O 0 8.560437549931521e-07
genes O 0 2.1512645886900827e-08
. O 0 1.0697495333999996e-08

Molecular O 0 1.0781802117776351e-09
analysis O 0 3.6266562669640123e-11
of O 0 7.489472930721774e-11
the O 0 9.761376151828927e-10
APC B-Disease 0 7.3825701107921304e-09
gene O 0 1.1349372830427029e-11
in O 0 3.5286094792613687e-12
205 O 0 4.124813685058015e-11
families O 0 2.2660981164462912e-12
: O 0 4.0878009934268086e-14
extended O 0 5.475531694720814e-10
genotype O 0 4.12058156484818e-08
- O 0 5.2004256900772816e-08
phenotype O 0 6.664766516450982e-08
correlations O 0 1.942881855399037e-09
in O 0 1.9800803791741872e-12
FAP B-Disease 0 1.2861667286756528e-09
and O 0 3.2094271494977414e-14
evidence O 0 9.173585014451285e-14
for O 0 1.1416792024840448e-14
the O 0 5.787873435733615e-13
role O 0 2.7148454925102206e-12
of O 0 6.630371252036582e-11
APC B-Disease 0 1.3526583186873609e-09
amino O 0 5.6793323516268757e-11
acid O 0 2.9139293755697793e-10
changes O 0 8.806067874900236e-09
in O 0 1.1378822819096968e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.999790370464325
. O 0 1.0124014124812675e-06

BACKGROUND O 0 0.2808237373828888
/ O 0 4.287558112991974e-06
AIMS O 0 8.637624659968424e-08
The O 0 1.2364385904017894e-10
development O 0 1.0565199826118032e-09
of O 0 6.124933804585453e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.973209774023935e-12
a O 0 1.071012006024271e-14
variable O 0 5.195911517881513e-13
range O 0 6.825039123269094e-13
of O 0 6.364330178317001e-13
extracolonic O 0 1.6337145325451274e-07
manifestations O 0 7.5271927926223725e-06
in O 0 1.835048351495061e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.9025122022806613e-10
FAP B-Disease 0 2.7783732647890247e-08
) O 0 2.099862438879191e-13
is O 0 8.645736443392213e-15
the O 0 7.912012787558015e-15
result O 0 3.7776371115440244e-13
of O 0 3.2110588060046963e-12
the O 0 3.365688977519099e-11
dominant O 0 4.290198063472417e-08
inheritance O 0 5.004731065127999e-07
of O 0 1.3699180101411912e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 1.0
( O 0 1.047298803236174e-09
APC B-Disease 0 5.000924119258343e-08
) O 0 2.628441908569812e-10
gene O 0 2.0397996625121095e-09
mutations O 0 3.003243875809858e-08
. O 0 6.786631701061197e-08

In O 0 5.423250737379703e-10
this O 0 4.959630796330661e-12
study O 0 2.486909766660772e-12
, O 0 5.53632211621846e-15
direct O 0 7.899967979048059e-14
mutation O 0 1.9853965747915897e-13
analysis O 0 2.967998297218749e-13
of O 0 1.663069855439847e-11
the O 0 1.6923538126434323e-09
APC B-Disease 0 3.253939695468944e-08
gene O 0 2.635952567331401e-10
was O 0 2.245920560639547e-09
performed O 0 1.0592150767596564e-10
to O 0 8.769931829355482e-12
determine O 0 3.6616826237789724e-10
genotype O 0 2.6210659598291386e-07
- O 0 1.869664600917531e-07
phenotype O 0 2.678922328414046e-07
correlations O 0 4.2633261365665476e-09
for O 0 6.245165842799771e-12
nine O 0 3.869394388233971e-11
extracolonic O 0 8.023327779937972e-08
manifestations O 0 2.344950189581141e-08
and O 0 6.501728409130658e-12
to O 0 5.486155149961314e-13
investigate O 0 3.5789715375350584e-12
the O 0 1.9919597655376764e-12
incidence O 0 6.1410249108107e-10
of O 0 1.7585070899439614e-10
APC B-Disease 0 1.0775639935900472e-08
mutations O 0 8.494203118658561e-10
in O 0 5.940505309887101e-10
non O 1 0.9998289346694946
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.7441449169127736e-07

METHODS O 0 1.235814806932467e-06
The O 0 1.4673685200250475e-07
APC B-Disease 0 1.8224427833501977e-07
gene O 0 1.6352773302141799e-10
was O 0 7.910625626772472e-11
analysed O 0 2.9687163838332253e-10
in O 0 2.2946434249243586e-12
190 O 0 3.514975463470016e-11
unrelated O 0 8.485523395052041e-10
FAP B-Disease 0 4.7006579961816897e-08
and O 0 4.165935998945436e-11
15 O 0 5.579164685798332e-09
non O 1 0.8946221470832825
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 4.968522375747852e-07
using O 0 1.7372202634757805e-11
denaturing O 0 3.063243241285818e-07
gradient O 0 2.9392523970273032e-08
gel O 0 6.117354622858784e-09
electrophoresis O 0 2.5012739102159287e-10
, O 0 5.529945858867569e-12
the O 0 1.5157623420303246e-11
protein O 0 4.0525697381221804e-11
truncation O 0 1.186260645269499e-09
test O 0 2.9412233759629203e-10
, O 0 1.4034715230260009e-12
and O 0 2.8600507921174023e-13
direct O 0 1.1819412636115967e-11
sequencing O 0 3.072059051589804e-09
. O 0 1.759880352558696e-09

RESULTS O 0 0.00043175704195164144
Chain O 0 2.3500012957811123e-07
terminating O 0 2.144247588375947e-07
signals O 0 1.7866851109715753e-08
were O 0 2.161238549236444e-11
only O 0 3.2115838309067224e-13
identified O 0 2.398384876117765e-12
in O 0 5.72463409141688e-13
patients O 0 1.4236017920055133e-10
belonging O 0 1.5519523600265872e-12
to O 0 9.215256596001309e-13
the O 0 1.810625677167721e-10
FAP B-Disease 0 1.666646494413726e-05
group O 0 8.407608637073238e-11
( O 0 1.1295803702127127e-13
105 O 0 3.2840534736067184e-09
patients O 0 1.439202645947546e-09
) O 0 9.419784830627664e-13
. O 0 1.1408332056817017e-09

Amino O 0 3.6327614338915737e-07
acid O 0 5.606409114733424e-09
changes O 0 9.162324232647734e-10
were O 0 6.238957128701372e-10
identified O 0 3.308481613673031e-11
in O 0 4.611840423440761e-12
four O 0 8.178698061682421e-13
patients O 0 7.720172418013149e-11
, O 0 1.4936905607786793e-13
three O 0 3.418446081759896e-13
of O 0 7.181461536553968e-10
whom O 0 6.642339567264344e-09
belonged O 0 1.5730154956372644e-09
to O 0 4.253466936304795e-12
the O 0 1.6380367895418857e-10
non O 0 8.644890385767212e-07
- O 0 4.23264054916217e-07
FAP O 0 1.0514864925426082e-06
group O 0 2.7812956798767274e-11
of O 0 4.625164140570348e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.0451576347113587e-05
. O 0 4.161976985272986e-09

Genotype O 0 0.0037450415547937155
- O 0 0.0009596727904863656
phenotype O 0 2.057085839624051e-05
correlations O 0 6.611475811268974e-08
identified O 0 2.3093678358510061e-10
significant O 0 5.497127406051128e-11
differences O 0 2.5409359061256964e-09
in O 0 2.9203098272923e-11
the O 0 4.2210207551462986e-11
nature O 0 6.19905168863788e-11
of O 0 5.8338503299004696e-12
certain O 0 3.3084077144529545e-10
extracolonic O 0 5.820302249048837e-07
manifestations O 0 5.872310637755618e-08
in O 0 6.029886312486354e-11
FAP B-Disease 0 5.174117845285764e-08
patients O 0 1.6163375082811626e-09
belonging O 0 3.853983972235131e-12
to O 0 5.097602895354214e-12
three O 0 3.702787382264816e-11
mutation O 0 7.241811772473739e-08
subgroups O 0 4.014349315184518e-07
. O 0 1.218615608422624e-08

CONCLUSIONS O 0 9.283176041208208e-05
Extended O 0 8.06891966931289e-06
genotype O 0 7.061301403155085e-06
- O 0 1.0628872360030073e-06
phenotype O 0 3.605728977618128e-07
correlations O 0 3.706557505367414e-09
made O 0 1.1862458931810593e-11
in O 0 3.2307037362185043e-13
this O 0 1.245191016269187e-13
study O 0 5.762692298176553e-13
may O 0 2.173739270180941e-12
have O 0 9.322247834786523e-13
the O 0 4.963435044913478e-12
potential O 0 9.908166301308974e-12
to O 0 1.2271640951674878e-12
determine O 0 2.034082798030301e-11
the O 0 8.469992068826926e-12
most O 0 1.2319058533688532e-12
appropriate O 0 7.3642800191287e-11
surveillance O 0 2.917221464393549e-10
and O 0 6.5882503445802154e-12
prophylactic O 0 3.904161530954298e-06
treatment O 0 1.7764859876479022e-06
regimens O 0 1.2758326306538947e-07
for O 0 3.512455604148812e-11
those O 0 2.4732180192721387e-10
patients O 0 4.972954270598962e-10
with O 0 3.1128094893362324e-13
mutations O 0 4.305748466104653e-12
associated O 0 4.5130763709488875e-11
with O 0 3.947711949003896e-12
life O 0 1.8249701749795122e-09
threatening O 0 1.2581640174147424e-09
conditions O 0 1.915681059472263e-05
. O 0 1.086747332124105e-07

This O 0 7.064761664565822e-09
study O 0 3.586314301085025e-10
also O 0 5.020694688988303e-13
provided O 0 3.981875864190326e-13
evidence O 0 1.464454208940924e-12
for O 0 6.642516398036591e-13
the O 0 6.503926563983242e-11
pathological O 0 5.267119149721111e-07
nature O 0 4.835569722416722e-10
of O 0 2.0618434043440104e-11
amino O 0 4.937242888830573e-12
acid O 0 3.5008157397292683e-12
changes O 0 2.1580997405790114e-11
in O 0 5.284681026118676e-11
APC O 0 1.1653483733553571e-09
associated O 0 1.5478360260168245e-10
with O 0 2.5803257100442956e-12
both O 0 1.9547819959941926e-11
FAP B-Disease 0 3.124932845821604e-07
and O 0 3.0683330876080106e-10
non O 0 0.033173490315675735
- O 1 0.9999666213989258
FAP O 1 0.9999910593032837
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.7027717806049623e-06
. O 0 5.134647915183699e-11
. O 0 4.6265319353366863e-10

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 4.880897904513404e-05
cancer B-Disease 0 0.4914756417274475
risk O 0 4.733431424597256e-09
of O 0 4.5683856697564806e-10
the O 0 2.358900186294477e-09
APC O 0 6.045753053740555e-08
I1307K O 0 1.4033665252100036e-07
polymorphism O 0 1.1215758632943107e-07
. O 0 4.83850559618304e-09

Germ O 0 0.0006104724598117173
- O 0 3.910473424184602e-06
line O 0 7.016005270088499e-07
and O 0 2.511063579291317e-10
somatic O 0 4.2962085444742115e-07
truncating O 0 1.0555379503784934e-07
mutations O 0 4.3886166922746384e-10
of O 0 6.223432186258648e-11
the O 0 3.325762443218139e-10
APC B-Disease 0 1.2097135737576536e-08
gene O 0 5.5594435305339474e-11
are O 0 3.5091994414482297e-12
thought O 0 2.819324287917091e-11
to O 0 8.636520318350271e-12
initiate O 0 5.503230937620174e-08
colorectal B-Disease 1 1.0
tumor I-Disease 0 0.00046992875286377966
formation O 0 9.963720231098705e-07
in O 0 9.122136930272973e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.8321587706159335e-06
sporadic O 0 0.04403408616781235
colorectal O 1 1.0
carcinogenesis O 1 0.9997590184211731
, O 0 4.760258409675089e-09
respectively O 0 5.0998988143646784e-08
. O 0 4.976830680902822e-08

Recently O 0 3.708370286403806e-07
, O 0 9.031857900465567e-11
an O 0 1.5563544376873129e-12
isoleucine O 0 3.058751696372042e-09
- O 0 4.667456643403511e-09
- O 0 1.1170580016539589e-08
> O 0 1.5359093552547165e-08
lysine O 0 4.672371378688922e-10
polymorphism O 0 5.671322092504205e-11
at O 0 1.0264178829794135e-12
codon O 0 5.024656732355304e-11
1307 O 0 9.410913826002343e-09
( O 0 2.9379387919865885e-13
I1307K O 0 1.9281298779816325e-09
) O 0 6.102506737784563e-13
of O 0 1.7864550116986067e-10
the O 0 6.791718298870819e-09
APC B-Disease 0 3.582639607202509e-08
gene O 0 1.7411619368523645e-10
has O 0 5.707693866152663e-12
been O 0 4.8232949752258225e-12
identified O 0 8.169846743566467e-12
in O 0 6.314488862346757e-13
6 O 0 4.8009391601100404e-11
% O 0 2.555697081914332e-13
- O 0 7.85143759902962e-13
7 O 0 5.947710206288814e-12
% O 0 4.005006233338132e-14
of O 0 1.4850767778061894e-14
the O 0 5.025619677356818e-13
Ashkenazi O 0 5.247479673009536e-10
Jewish O 0 9.83459647052598e-10
population O 0 2.7068622950737753e-12
. O 0 1.5111155382552255e-10

To O 0 8.613333379869914e-10
assess O 0 7.18661752330263e-09
the O 0 4.981457607522444e-11
risk O 0 4.6401216202696105e-11
of O 0 1.911809035734513e-12
this O 0 3.5750757822888835e-12
common O 0 4.047244317462173e-09
APC B-Disease 0 7.108450006398925e-08
allelic O 0 1.59250063802574e-07
variant O 0 5.441200983113959e-07
in O 0 2.711177558012423e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9998846054077148
, O 0 2.775013996370035e-09
we O 0 4.1241215303911005e-11
have O 0 5.490896908162679e-13
analyzed O 0 4.769393647380271e-12
a O 0 1.6808306320132554e-13
large O 0 8.719328210837762e-12
cohort O 0 1.632451507305177e-09
of O 0 1.025514308888864e-11
unselected O 0 0.00019468205573502928
Ashkenazi O 0 9.258016007152037e-07
Jewish O 0 8.576800070159152e-08
subjects O 0 3.971047490836099e-08
with O 0 2.701004871152879e-11
adenomatous B-Disease 0 5.475460966408718e-06
polyps I-Disease 0 6.709292392770294e-07
and O 0 2.386140451893226e-10
. O 0 3.954062854916174e-09
or O 0 0.11026639491319656
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 9.481056564841772e-12
for O 0 5.636204393824618e-13
the O 0 1.8904894316662535e-10
APC O 0 9.370130449326552e-09
I1307K O 0 2.968192980290496e-08
polymorphism O 0 8.38657232549167e-09
. O 0 3.947966398243352e-09

The O 0 5.391916033659072e-07
APC O 0 1.033358898894221e-06
I1307K O 0 7.804825372659252e-07
allele O 0 5.187950069540648e-09
was O 0 7.084729469752915e-10
identified O 0 4.895535712923227e-11
in O 0 1.0078124966506063e-11
48 O 0 1.2167430396559098e-09
( O 0 8.619314436448741e-14
10 O 0 1.261875152980263e-12
. O 0 1.138835119957049e-13
1 O 0 1.3429344442039692e-11
% O 0 1.4195431939298397e-13
) O 0 2.011090209633388e-15
of O 0 1.133022603690137e-12
476 O 0 1.4723638308566933e-08
patients O 0 9.713356519114313e-08
. O 0 7.949338964863273e-09

Compared O 0 3.900551703850397e-08
with O 0 1.678748936737029e-12
the O 0 6.38522264576058e-12
frequency O 0 2.4723348368560494e-11
in O 0 6.849321457225166e-13
two O 0 3.019247924048417e-14
separate O 0 9.120808763200122e-14
population O 0 2.7529285681572244e-14
control O 0 2.3865842028319983e-12
groups O 0 4.558369198597034e-13
, O 0 3.382688552010238e-13
the O 0 7.79748002277536e-11
APC O 0 6.1244875837473955e-09
I1307K O 0 1.498659862875229e-08
allele O 0 1.0340076711523594e-10
is O 0 3.63594584670314e-14
associated O 0 4.705750220913851e-13
with O 0 1.6263396811449886e-15
an O 0 3.4466652067438217e-16
estimated O 0 3.4315683161787597e-14
relative O 0 1.911095413864583e-11
risk O 0 2.215087835377716e-11
of O 0 3.608406282107346e-11
1 O 0 2.4597468950560142e-08
. O 0 4.865974290169106e-09

5 O 0 1.0860526344913524e-06
- O 0 1.957259172513659e-07
1 O 0 1.1567350099994655e-07
. O 0 2.6903952399237596e-09

7 O 0 9.609102562535554e-07
for O 0 7.824185743743328e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9808692932128906
( O 0 2.7086413667554154e-10
both O 0 1.1388026077696622e-09
P O 0 1.8389532669971231e-06
= O 0 7.086712466852774e-11
. O 0 6.5062686141481585e-12
01 O 0 5.139961234412738e-10
) O 0 1.1976444141970077e-12
. O 0 4.513543983009072e-10

Furthermore O 0 8.089155301149731e-08
, O 0 5.37718654325392e-11
compared O 0 9.520118027239732e-10
with O 0 1.0977260767042196e-11
noncarriers O 0 5.9445930673973635e-05
, O 0 2.7049567030701382e-09
APC O 0 7.796167977858204e-08
I1307K O 0 7.861361694949665e-08
carriers O 0 3.029498596429647e-10
had O 0 5.705648193493618e-12
increased O 0 3.1611935291664395e-11
numbers O 0 1.5653647822411187e-10
of O 0 1.8600798679102581e-10
adenomas B-Disease 0 0.0008193321991711855
and O 0 1.0986598226736533e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9869565963745117
per O 0 2.2446677405696391e-07
patient O 0 8.799857823760249e-06
( O 0 1.3103618667562045e-12
P O 0 1.0438372832766163e-08
= O 0 2.251991345139648e-12
. O 0 6.231906809171794e-13
03 O 0 1.7702103671801694e-11
) O 0 1.4627694875138895e-14
, O 0 7.002682938725413e-14
as O 0 4.661557598262256e-13
well O 0 3.952026694179628e-13
as O 0 3.676246590131327e-13
a O 0 5.904652851732028e-13
younger O 0 8.077599700229143e-10
age O 0 8.757071179310572e-10
at O 0 9.644170878564395e-11
diagnosis O 0 1.1304113201049404e-07
. O 0 7.571753002366677e-09

We O 0 3.816055915706329e-09
conclude O 0 8.879197821443086e-09
that O 0 3.939543136155521e-12
the O 0 4.710490331127914e-10
APC O 0 2.2730512228008593e-07
I1307K O 0 1.309489675804798e-06
variant O 0 3.1763827337272232e-06
leads O 0 7.354310582741164e-08
to O 0 4.7558065124908566e-11
increased O 0 5.172686812215943e-08
adenoma B-Disease 1 1.0
formation O 0 5.642639848701947e-07
and O 0 1.9044592292072338e-10
directly O 0 3.5945232901291035e-11
contributes O 0 2.290790604084214e-12
to O 0 2.290855222533694e-13
3 O 0 2.3109266236720494e-11
% O 0 2.490625435926097e-13
- O 0 6.612607596906406e-13
4 O 0 3.566405851196386e-12
% O 0 3.16053742422176e-14
of O 0 1.9383906846716197e-14
all O 0 6.00076141121092e-13
Ashkenazi O 0 7.96795305291198e-08
Jewish O 0 0.00015923648606985807
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.287258323325659e-07

The O 0 1.0348808032745183e-08
estimated O 0 3.4587799291330157e-10
relative O 0 2.718125458045506e-08
risk O 0 7.566062221187053e-10
for O 0 5.511444599315407e-12
carriers O 0 3.0734406686327986e-10
may O 0 2.5461352470834697e-10
justify O 0 1.2776912861056644e-10
specific O 0 2.8122672593444697e-11
clinical O 0 9.31969258710641e-12
screening O 0 7.038272048509597e-11
for O 0 6.012424173980346e-13
the O 0 4.9351148168064185e-12
360 O 0 6.769944327356114e-11
, O 0 1.6758367968067872e-13
000 O 0 5.280204658925092e-12
Americans O 0 1.5689515049026152e-14
expected O 0 2.099727509918825e-12
to O 0 2.683501749804751e-13
harbor O 0 1.3838774570729129e-09
this O 0 2.1676529928654764e-12
allele O 0 2.4643360269083203e-11
, O 0 3.113914020299452e-13
and O 0 7.93025245623101e-14
genetic O 0 7.564632378614586e-14
testing O 0 1.124224736741286e-12
in O 0 1.9337389491318885e-13
the O 0 2.2687795652592824e-12
setting O 0 1.8314622041160078e-10
of O 0 1.9757015468080397e-11
long O 0 3.424654223399548e-12
- O 0 6.280919361001391e-12
term O 0 1.146544081898071e-09
- O 0 6.467359980888432e-11
outcome O 0 1.655179215909186e-09
studies O 0 3.591273329064948e-12
may O 0 7.769592261230862e-13
impact O 0 3.471010978639555e-11
significantly O 0 1.203789565806801e-07
on O 0 3.747563823708333e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 7.452917571981743e-08
in O 0 1.4187636525678227e-13
this O 0 7.952700862212322e-14
population O 0 8.821965375013438e-14
. O 0 3.95315412349273e-11

Localization O 0 7.941051990201231e-06
of O 0 3.2492756929514144e-08
human O 0 2.582328573197401e-09
BRCA1 O 0 2.248862429610199e-08
and O 0 2.4870530981879746e-11
its O 0 4.2041457121166914e-12
loss O 0 8.789714095458478e-11
in O 0 1.1577017990094252e-11
high O 0 1.1094733132210877e-08
- O 0 8.352851743609335e-10
grade O 0 1.639713964607381e-08
, O 0 1.7382633960699723e-12
non B-Disease 0 3.408312068131636e-07
- I-Disease 0 2.566057810327038e-05
inherited I-Disease 1 0.9965781569480896
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 3.7862525914533762e-06

Although O 0 5.359477750488395e-09
the O 0 1.8448444161212052e-10
link O 0 2.1451407317130133e-10
between O 0 3.233353029763464e-10
the O 0 1.4552796301359194e-08
BRCA1 O 0 2.503716132196132e-07
tumour B-Disease 1 1.0
- O 0 1.2692779819190037e-05
suppressor O 0 2.3376321678370005e-06
gene O 0 1.4251700930500988e-09
and O 0 3.644249901846308e-10
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 5.70775978564475e-12
established O 0 5.298273104969997e-12
, O 0 3.574615579124245e-14
the O 0 5.551321663639641e-13
role O 0 1.0434012594900954e-12
, O 0 1.9722094237676485e-13
if O 0 1.7878771651092668e-13
any O 0 4.476160327809842e-12
, O 0 5.809618194504984e-13
of O 0 3.530550157782031e-11
BRCA1 O 0 4.094145300559404e-10
in O 0 2.9106231314024456e-11
non B-Disease 0 0.0004964289837516844
- I-Disease 0 0.4152446389198303
familial I-Disease 0 0.06158336251974106
cancers I-Disease 1 0.9990957975387573
is O 0 2.118680578200305e-11
unclear O 0 8.310204968609014e-09
. O 0 2.159073586582849e-09

BRCA1 O 0 0.00010092733282363042
mutations O 0 6.235370619833702e-08
are O 0 6.91983926756623e-12
rare O 0 1.257565995782528e-10
in O 0 1.0882163919978538e-10
sporadic B-Disease 0 1.8372691556578502e-05
cancers I-Disease 0 0.17045603692531586
, O 0 2.1306000019816196e-10
but O 0 6.753942405346436e-10
loss O 0 8.622661340496052e-08
of O 0 1.0061451121146092e-06
BRCA1 O 0 6.821642806187356e-09
resulting O 0 2.4251364805216724e-10
from O 0 7.843358774961562e-12
reduced O 0 1.9688710384269115e-10
expression O 0 1.8992455178001855e-11
or O 0 8.306610607689002e-12
incorrect O 0 6.481403747038428e-10
subcellular O 0 1.3045520574905822e-07
localization O 0 6.46577831275863e-08
is O 0 8.403079664390245e-13
postulated O 0 3.008468127396746e-11
to O 0 3.758998388708919e-14
be O 0 2.3379091902437504e-14
important O 0 1.2380679164161745e-12
in O 0 1.4032038335096142e-12
non B-Disease 0 4.6236573325586505e-06
- I-Disease 0 0.3947150707244873
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 7.606824965478154e-06

Epigenetic O 0 0.0003229816793464124
loss O 0 8.11959762359038e-06
, O 0 6.187595436024651e-10
however O 0 7.357642828331734e-10
, O 0 8.050363761030743e-13
has O 0 1.705349559212154e-14
not O 0 1.340324861054355e-14
received O 0 1.6718278237487505e-12
general O 0 7.36992897265587e-11
acceptance O 0 9.507909126682534e-09
due O 0 1.4209500243111961e-08
to O 0 2.553565518759182e-11
controversy O 0 2.764184658943236e-09
regarding O 0 1.0771812331000774e-09
the O 0 2.132250348507725e-10
subcellular O 0 5.398844677984016e-06
localization O 0 2.049384784186259e-05
of O 0 1.414059056514816e-07
BRCA1 O 0 1.2373952529287635e-08
proteins O 0 1.5943666525908284e-11
, O 0 9.442504287152098e-13
reports O 0 2.0287309158983913e-12
of O 0 3.0613441469318214e-12
which O 0 7.967751350194952e-13
have O 0 2.0883843699498472e-12
ranged O 0 8.228535186560748e-09
from O 0 1.1059305381200257e-11
exclusively O 0 8.465759343545542e-12
nuclear O 0 8.444094867776641e-10
, O 0 3.3947382665350245e-12
to O 0 4.3795314597083745e-12
conditionally O 0 1.1536652522181612e-08
nuclear O 0 1.1567853341887258e-08
, O 0 2.788773769205055e-12
to O 0 1.7789794160352757e-12
the O 0 3.73598291192323e-10
ER O 0 1.4646238923887722e-05
/ O 0 4.461472080663498e-09
golgi O 0 1.1613243344754665e-07
, O 0 4.8724305840019966e-12
to O 0 4.190615302684941e-12
cytoplasmic O 0 2.4988813240867103e-09
invaginations O 0 8.700805409489476e-08
into O 0 3.538385695556201e-10
the O 0 1.2714485020381971e-10
nucleus O 0 1.2645473113082062e-08
. O 0 8.445837806903e-09

In O 0 4.685777987845086e-09
an O 0 1.5545684314485775e-12
attempt O 0 2.1772518510321248e-10
to O 0 5.666431733553079e-12
resolve O 0 2.2294451007542904e-10
this O 0 2.6925009530970323e-12
issue O 0 6.497383187031858e-10
, O 0 1.139304904758387e-12
we O 0 1.708809092490493e-12
have O 0 1.989544813618682e-12
comprehensively O 0 2.530751075369153e-08
characterized O 0 1.1595730597946385e-08
19 O 0 1.5235325889761953e-08
anti O 0 5.639965934278734e-07
- O 0 6.506760655611288e-06
BRCA1 O 0 3.171803797386019e-08
antibodies O 0 1.652784797911977e-09
. O 0 4.1103360715055715e-09

These O 0 3.3220061368410825e-08
reagents O 0 9.363189974465058e-07
detect O 0 1.2654618686269714e-08
a O 0 5.0438129367558204e-11
220 O 0 6.083166748105384e-10
- O 0 3.919955915421269e-09
kD O 0 9.375014542456483e-08
protein O 0 1.498467572247364e-09
localized O 0 1.938817995039699e-08
in O 0 8.656413780228078e-11
discrete O 0 1.7554951936560315e-09
nuclear O 0 2.8497124660020745e-08
foci O 0 2.63019074964177e-07
in O 0 3.450107213809339e-11
all O 0 1.0174250331118628e-11
epithelial O 0 6.6006999865919624e-09
cell O 0 2.936460186120371e-09
lines O 0 1.2986930107705685e-11
, O 0 2.0361369315320503e-14
including O 0 8.913752914496524e-15
those O 0 5.44733529117547e-13
derived O 0 2.306471263979759e-10
from O 0 1.556148987447159e-09
breast B-Disease 0 7.714735943409323e-07
malignancies I-Disease 0 2.5691692826512735e-06
. O 0 1.2165533469499223e-08

Immunohistochemical O 0 0.00021666444081347436
staining O 0 6.0703310737153515e-05
of O 0 2.6978943878930295e-07
human O 0 2.2165117741224094e-07
breast O 0 0.00525960186496377
specimens O 0 4.314053512644023e-06
also O 0 1.1079375195066632e-09
revealed O 0 2.5390147584403167e-07
BRCA1 O 0 2.593852173049527e-07
nuclear O 0 8.350789215683108e-08
foci O 0 4.988277737538738e-07
in O 0 4.2197026428603124e-10
benign O 1 0.9998327493667603
breast O 1 0.9999223947525024
, O 0 1.8715979877015343e-08
invasive B-Disease 1 0.9998236298561096
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 1.2079541420462192e-06
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 3.939911493944237e-06

Conversely O 0 3.830264540738426e-05
, O 0 4.6479854631797934e-08
BRCA1 O 0 5.1137011070068183e-08
expression O 0 6.496280735568405e-10
was O 0 2.827101330815651e-10
reduced O 0 3.214518373706454e-10
or O 0 8.239358847972333e-12
undetectable O 0 2.146909039435485e-10
in O 0 6.326544648403709e-13
the O 0 5.072344454182254e-13
majority O 0 8.504528597194985e-14
of O 0 5.448855342621295e-12
high O 0 6.511520211915922e-08
- O 0 1.5020142996036157e-07
grade O 0 0.00021471137006301433
, O 0 2.3041992758265906e-09
ductal B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 1.0
, O 0 1.2868432708312838e-10
suggesting O 0 6.245982064889688e-10
that O 0 8.819451245700716e-12
absence O 0 2.9387655331447604e-07
of O 0 7.166143234371702e-08
BRCA1 O 0 2.3665251980276025e-09
may O 0 3.392707642602133e-11
contribute O 0 3.1058484777080064e-12
to O 0 2.4659790810906135e-13
the O 0 4.028061738325928e-12
pathogenesis O 0 4.0459782191248905e-09
of O 0 1.462082083007743e-12
a O 0 1.2405209509364773e-13
significant O 0 1.8967404036285274e-11
percentage O 0 7.067942675575978e-09
of O 0 7.221073738961081e-10
sporadic B-Disease 0 0.0009769947500899434
breast I-Disease 0 0.4598066210746765
cancers I-Disease 0 0.00022337419795803726
. O 0 2.3199392629180693e-08
. O 0 5.815231673977905e-08

